id	sid	tid	token	lemma	pos
ajlsi-1012	1	1	pa	pa	PROPN
ajlsi-1012	1	2	ge	ge	PROPN
ajlsi-1012	1	3	1	1	NUM
ajlsi-1012	1	4	pa	pa	PROPN
ajlsi-1012	1	5	ge	ge	PROPN
ajlsi-1012	1	6	29	29	NUM
ajlsi-1012	1	7	american	american	PROPN
ajlsi-1012	1	8	journal	journal	PROPN
ajlsi-1012	1	9	of	of	ADP
ajlsi-1012	1	10	life	life	NOUN
ajlsi-1012	1	11	science	science	NOUN
ajlsi-1012	1	12	and	and	CCONJ
ajlsi-1012	1	13	innovation	innovation	NOUN
ajlsi-1012	1	14	(	(	PUNCT
ajlsi-1012	1	15	ajlsi	ajlsi	NOUN
ajlsi-1012	1	16	)	)	PUNCT
ajlsi-1012	1	17	laboratory	laboratory	NOUN
ajlsi-1012	1	18	diagnosis	diagnosis	NOUN
ajlsi-1012	1	19	of	of	ADP
ajlsi-1012	1	20	novel	novel	ADJ
ajlsi-1012	1	21	human	human	ADJ
ajlsi-1012	1	22	coronavirus	coronavirus	NOUN
ajlsi-1012	1	23	(	(	PUNCT
ajlsi-1012	1	24	sars	sar	NOUN
ajlsi-1012	1	25	-	-	PUNCT
ajlsi-1012	1	26	cov-2	cov-2	NOUN
ajlsi-1012	1	27	)	)	PUNCT
ajlsi-1012	1	28	infections	infection	NOUN
ajlsi-1012	1	29	-	-	PUNCT
ajlsi-1012	1	30	a	a	DET
ajlsi-1012	1	31	review	review	NOUN
ajlsi-1012	1	32	aswathy	aswathy	ADJ
ajlsi-1012	1	33	c	c	NOUN
ajlsi-1012	1	34	ashok1	ashok1	PROPN
ajlsi-1012	1	35	*	*	PROPN
ajlsi-1012	1	36	,	,	PUNCT
ajlsi-1012	1	37	r.	r.	PROPN
ajlsi-1012	1	38	harish1	harish1	ADV
ajlsi-1012	1	39	volume	volume	NOUN
ajlsi-1012	1	40	1	1	NUM
ajlsi-1012	1	41	issue	issue	NOUN
ajlsi-1012	1	42	2	2	NUM
ajlsi-1012	1	43	,	,	PUNCT
ajlsi-1012	1	44	year	year	NOUN
ajlsi-1012	1	45	2022	2022	NUM
ajlsi-1012	1	46	issn	issn	X
ajlsi-1012	1	47	:	:	PUNCT
ajlsi-1012	1	48	2833	2833	NUM
ajlsi-1012	1	49	-	-	SYM
ajlsi-1012	1	50	1397	1397	NUM
ajlsi-1012	1	51	(	(	PUNCT
ajlsi-1012	1	52	online	online	ADJ
ajlsi-1012	1	53	)	)	PUNCT
ajlsi-1012	1	54	doi	doi	NOUN
ajlsi-1012	1	55	:	:	PUNCT
ajlsi-1012	1	56	https://doi.org/10.54536/ajlsi.v1i2.1012	https://doi.org/10.54536/ajlsi.v1i2.1012	NOUN
ajlsi-1012	1	57	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	1	58	article	article	NOUN
ajlsi-1012	1	59	information	information	NOUN
ajlsi-1012	1	60	abstract	abstract	ADV
ajlsi-1012	1	61	received	receive	VERB
ajlsi-1012	1	62	:	:	PUNCT
ajlsi-1012	1	63	november	november	PROPN
ajlsi-1012	1	64	26	26	NUM
ajlsi-1012	1	65	,	,	PUNCT
ajlsi-1012	1	66	2022	2022	NUM
ajlsi-1012	1	67	accepted	accept	VERB
ajlsi-1012	1	68	:	:	PUNCT
ajlsi-1012	1	69	november	november	PROPN
ajlsi-1012	1	70	29	29	NUM
ajlsi-1012	1	71	,	,	PUNCT
ajlsi-1012	1	72	2022	2022	NUM
ajlsi-1012	1	73	published	publish	VERB
ajlsi-1012	1	74	:	:	PUNCT
ajlsi-1012	1	75	december	december	PROPN
ajlsi-1012	1	76	03	03	NUM
ajlsi-1012	1	77	,	,	PUNCT
ajlsi-1012	1	78	2022	2022	NUM
ajlsi-1012	1	79	covid-19	covid-19	PROPN
ajlsi-1012	1	80	is	be	AUX
ajlsi-1012	1	81	a	a	DET
ajlsi-1012	1	82	pandemic	pandemic	ADJ
ajlsi-1012	1	83	,	,	PUNCT
ajlsi-1012	1	84	highly	highly	ADV
ajlsi-1012	1	85	contagious	contagious	ADJ
ajlsi-1012	1	86	infectious	infectious	ADJ
ajlsi-1012	1	87	disease	disease	NOUN
ajlsi-1012	1	88	caused	cause	VERB
ajlsi-1012	1	89	by	by	ADP
ajlsi-1012	1	90	the	the	DET
ajlsi-1012	1	91	severe	severe	ADJ
ajlsi-1012	1	92	acute	acute	ADJ
ajlsi-1012	1	93	respiratory	respiratory	ADJ
ajlsi-1012	1	94	syndrome	syndrome	NOUN
ajlsi-1012	1	95	corona	corona	NOUN
ajlsi-1012	1	96	virus-2	virus-2	NUM
ajlsi-1012	1	97	(	(	PUNCT
ajlsi-1012	1	98	sars	sar	NOUN
ajlsi-1012	1	99	-	-	PUNCT
ajlsi-1012	1	100	cov-2	cov-2	NOUN
ajlsi-1012	1	101	)	)	PUNCT
ajlsi-1012	1	102	.	.	PUNCT
ajlsi-1012	2	1	the	the	DET
ajlsi-1012	2	2	world	world	PROPN
ajlsi-1012	2	3	health	health	PROPN
ajlsi-1012	2	4	organization	organization	NOUN
ajlsi-1012	2	5	has	have	AUX
ajlsi-1012	2	6	declared	declare	VERB
ajlsi-1012	2	7	the	the	DET
ajlsi-1012	2	8	ongoing	ongoing	ADJ
ajlsi-1012	2	9	outbreak	outbreak	NOUN
ajlsi-1012	2	10	a	a	DET
ajlsi-1012	2	11	global	global	ADJ
ajlsi-1012	2	12	public	public	ADJ
ajlsi-1012	2	13	health	health	NOUN
ajlsi-1012	2	14	emergency	emergency	NOUN
ajlsi-1012	2	15	.	.	PUNCT
ajlsi-1012	3	1	this	this	DET
ajlsi-1012	3	2	disease	disease	NOUN
ajlsi-1012	3	3	has	have	AUX
ajlsi-1012	3	4	spread	spread	VERB
ajlsi-1012	3	5	rapidly	rapidly	ADV
ajlsi-1012	3	6	and	and	CCONJ
ajlsi-1012	3	7	affected	affect	VERB
ajlsi-1012	3	8	millions	million	NOUN
ajlsi-1012	3	9	of	of	ADP
ajlsi-1012	3	10	people	people	NOUN
ajlsi-1012	3	11	worldwide	worldwide	ADV
ajlsi-1012	3	12	.	.	PUNCT
ajlsi-1012	4	1	currently	currently	ADV
ajlsi-1012	4	2	,	,	PUNCT
ajlsi-1012	4	3	there	there	PRON
ajlsi-1012	4	4	are	be	VERB
ajlsi-1012	4	5	no	no	DET
ajlsi-1012	4	6	specific	specific	ADJ
ajlsi-1012	4	7	clinical	clinical	ADJ
ajlsi-1012	4	8	signs	sign	NOUN
ajlsi-1012	4	9	or	or	CCONJ
ajlsi-1012	4	10	symptoms	symptom	NOUN
ajlsi-1012	4	11	of	of	ADP
ajlsi-1012	4	12	sars	sar	NOUN
ajlsi-1012	4	13	that	that	PRON
ajlsi-1012	4	14	can	can	AUX
ajlsi-1012	4	15	be	be	AUX
ajlsi-1012	4	16	used	use	VERB
ajlsi-1012	4	17	to	to	PART
ajlsi-1012	4	18	differentiate	differentiate	VERB
ajlsi-1012	4	19	it	it	PRON
ajlsi-1012	4	20	from	from	ADP
ajlsi-1012	4	21	other	other	ADJ
ajlsi-1012	4	22	causes	cause	NOUN
ajlsi-1012	4	23	of	of	ADP
ajlsi-1012	4	24	communityor	communityor	NOUN
ajlsi-1012	4	25	hospital	hospital	NOUN
ajlsi-1012	4	26	-	-	PUNCT
ajlsi-1012	4	27	acquired	acquire	VERB
ajlsi-1012	4	28	viral	viral	ADJ
ajlsi-1012	4	29	pneumonia	pneumonia	NOUN
ajlsi-1012	4	30	.	.	PUNCT
ajlsi-1012	5	1	accurate	accurate	ADJ
ajlsi-1012	5	2	diagnosis	diagnosis	NOUN
ajlsi-1012	5	3	of	of	ADP
ajlsi-1012	5	4	cases	case	NOUN
ajlsi-1012	5	5	holds	hold	VERB
ajlsi-1012	5	6	the	the	DET
ajlsi-1012	5	7	key	key	NOUN
ajlsi-1012	5	8	to	to	ADP
ajlsi-1012	5	9	managing	manage	VERB
ajlsi-1012	5	10	any	any	DET
ajlsi-1012	5	11	pandemic	pandemic	ADJ
ajlsi-1012	5	12	through	through	ADP
ajlsi-1012	5	13	identification	identification	NOUN
ajlsi-1012	5	14	,	,	PUNCT
ajlsi-1012	5	15	isolation	isolation	NOUN
ajlsi-1012	5	16	,	,	PUNCT
ajlsi-1012	5	17	and	and	CCONJ
ajlsi-1012	5	18	treatment	treatment	NOUN
ajlsi-1012	5	19	of	of	ADP
ajlsi-1012	5	20	patients	patient	NOUN
ajlsi-1012	5	21	while	while	SCONJ
ajlsi-1012	5	22	defining	define	VERB
ajlsi-1012	5	23	the	the	DET
ajlsi-1012	5	24	epidemiology	epidemiology	NOUN
ajlsi-1012	5	25	of	of	ADP
ajlsi-1012	5	26	the	the	DET
ajlsi-1012	5	27	pathogen	pathogen	NOUN
ajlsi-1012	5	28	.	.	PUNCT
ajlsi-1012	6	1	because	because	SCONJ
ajlsi-1012	6	2	an	an	DET
ajlsi-1012	6	3	increasing	increase	VERB
ajlsi-1012	6	4	number	number	NOUN
ajlsi-1012	6	5	of	of	ADP
ajlsi-1012	6	6	asymptomatic	asymptomatic	ADJ
ajlsi-1012	6	7	symptomatic	symptomatic	ADJ
ajlsi-1012	6	8	individuals	individual	NOUN
ajlsi-1012	6	9	must	must	AUX
ajlsi-1012	6	10	be	be	AUX
ajlsi-1012	6	11	tested	test	VERB
ajlsi-1012	6	12	for	for	ADP
ajlsi-1012	6	13	covid-19	covid-19	PROPN
ajlsi-1012	6	14	,	,	PUNCT
ajlsi-1012	6	15	a	a	DET
ajlsi-1012	6	16	safe	safe	ADJ
ajlsi-1012	6	17	and	and	CCONJ
ajlsi-1012	6	18	efficient	efficient	ADJ
ajlsi-1012	6	19	screening	screening	NOUN
ajlsi-1012	6	20	system	system	NOUN
ajlsi-1012	6	21	is	be	AUX
ajlsi-1012	6	22	required	require	VERB
ajlsi-1012	6	23	.	.	PUNCT
ajlsi-1012	7	1	the	the	DET
ajlsi-1012	7	2	diagnosis	diagnosis	NOUN
ajlsi-1012	7	3	of	of	ADP
ajlsi-1012	7	4	suspected	suspect	VERB
ajlsi-1012	7	5	cases	case	NOUN
ajlsi-1012	7	6	is	be	AUX
ajlsi-1012	7	7	presently	presently	ADV
ajlsi-1012	7	8	confirmed	confirm	VERB
ajlsi-1012	7	9	by	by	ADP
ajlsi-1012	7	10	nucleic	nucleic	ADJ
ajlsi-1012	7	11	acid	acid	NOUN
ajlsi-1012	7	12	assays	assay	NOUN
ajlsi-1012	7	13	with	with	ADP
ajlsi-1012	7	14	real	real	ADJ
ajlsi-1012	7	15	-	-	PUNCT
ajlsi-1012	7	16	time	time	NOUN
ajlsi-1012	7	17	pcr	pcr	NOUN
ajlsi-1012	7	18	using	use	VERB
ajlsi-1012	7	19	respiratory	respiratory	ADJ
ajlsi-1012	7	20	samples	sample	NOUN
ajlsi-1012	7	21	.	.	PUNCT
ajlsi-1012	8	1	on	on	ADP
ajlsi-1012	8	2	the	the	DET
ajlsi-1012	8	3	other	other	ADJ
ajlsi-1012	8	4	side	side	NOUN
ajlsi-1012	8	5	,	,	PUNCT
ajlsi-1012	8	6	serological	serological	ADJ
ajlsi-1012	8	7	tests	test	NOUN
ajlsi-1012	8	8	are	be	AUX
ajlsi-1012	8	9	comparatively	comparatively	ADV
ajlsi-1012	8	10	easier	easy	ADJ
ajlsi-1012	8	11	to	to	PART
ajlsi-1012	8	12	perform	perform	VERB
ajlsi-1012	8	13	,	,	PUNCT
ajlsi-1012	8	14	but	but	CCONJ
ajlsi-1012	8	15	their	their	PRON
ajlsi-1012	8	16	utility	utility	NOUN
ajlsi-1012	8	17	may	may	AUX
ajlsi-1012	8	18	be	be	AUX
ajlsi-1012	8	19	limited	limit	VERB
ajlsi-1012	8	20	by	by	ADP
ajlsi-1012	8	21	their	their	PRON
ajlsi-1012	8	22	ease	ease	NOUN
ajlsi-1012	8	23	of	of	ADP
ajlsi-1012	8	24	performance	performance	NOUN
ajlsi-1012	8	25	and	and	CCONJ
ajlsi-1012	8	26	the	the	DET
ajlsi-1012	8	27	fact	fact	NOUN
ajlsi-1012	8	28	that	that	SCONJ
ajlsi-1012	8	29	antibodies	antibodie	VERB
ajlsi-1012	8	30	appear	appear	VERB
ajlsi-1012	8	31	later	later	ADV
ajlsi-1012	8	32	in	in	ADP
ajlsi-1012	8	33	the	the	DET
ajlsi-1012	8	34	disease	disease	NOUN
ajlsi-1012	8	35	course	course	NOUN
ajlsi-1012	8	36	.	.	PUNCT
ajlsi-1012	9	1	this	this	DET
ajlsi-1012	9	2	review	review	NOUN
ajlsi-1012	9	3	is	be	AUX
ajlsi-1012	9	4	aimed	aim	VERB
ajlsi-1012	9	5	at	at	ADP
ajlsi-1012	9	6	summarizing	summarize	VERB
ajlsi-1012	9	7	the	the	DET
ajlsi-1012	9	8	currently	currently	ADV
ajlsi-1012	9	9	available	available	ADJ
ajlsi-1012	9	10	information	information	NOUN
ajlsi-1012	9	11	on	on	ADP
ajlsi-1012	9	12	different	different	ADJ
ajlsi-1012	9	13	methods	method	NOUN
ajlsi-1012	9	14	used	use	VERB
ajlsi-1012	9	15	for	for	ADP
ajlsi-1012	9	16	screening	screen	VERB
ajlsi-1012	9	17	and	and	CCONJ
ajlsi-1012	9	18	diagnosing	diagnose	VERB
ajlsi-1012	9	19	covid-19	covid-19	PROPN
ajlsi-1012	9	20	infections	infection	NOUN
ajlsi-1012	9	21	.	.	PUNCT
ajlsi-1012	10	1	keywords	keyword	VERB
ajlsi-1012	10	2	sars	sar	NOUN
ajlsi-1012	10	3	-	-	PUNCT
ajlsi-1012	10	4	cov2	cov2	PROPN
ajlsi-1012	10	5	,	,	PUNCT
ajlsi-1012	10	6	rtpcr	rtpcr	PROPN
ajlsi-1012	10	7	,	,	PUNCT
ajlsi-1012	10	8	immunological	immunological	ADJ
ajlsi-1012	10	9	rapid	rapid	ADJ
ajlsi-1012	10	10	assay	assay	NOUN
ajlsi-1012	10	11	introduction	introduction	NOUN
ajlsi-1012	10	12	severe	severe	ADJ
ajlsi-1012	10	13	acute	acute	ADJ
ajlsi-1012	10	14	respiratory	respiratory	ADJ
ajlsi-1012	10	15	syndrome	syndrome	NOUN
ajlsi-1012	10	16	coronavirus	coronavirus	NOUN
ajlsi-1012	10	17	(	(	PUNCT
ajlsi-1012	10	18	sarscov-2	sarscov-2	NUM
ajlsi-1012	10	19	)	)	PUNCT
ajlsi-1012	10	20	is	be	AUX
ajlsi-1012	10	21	a	a	DET
ajlsi-1012	10	22	novel	novel	ADJ
ajlsi-1012	10	23	virus	virus	NOUN
ajlsi-1012	10	24	that	that	PRON
ajlsi-1012	10	25	caused	cause	VERB
ajlsi-1012	10	26	the	the	DET
ajlsi-1012	10	27	first	first	ADJ
ajlsi-1012	10	28	major	major	ADJ
ajlsi-1012	10	29	pandemic	pandemic	ADJ
ajlsi-1012	10	30	disease	disease	NOUN
ajlsi-1012	10	31	in	in	ADP
ajlsi-1012	10	32	the	the	DET
ajlsi-1012	10	33	family	family	NOUN
ajlsi-1012	10	34	coronaviridae	coronaviridae	NOUN
ajlsi-1012	10	35	.	.	PUNCT
ajlsi-1012	11	1	many	many	ADJ
ajlsi-1012	11	2	coronavirus	coronavirus	NOUN
ajlsi-1012	11	3	infections	infection	NOUN
ajlsi-1012	11	4	in	in	ADP
ajlsi-1012	11	5	the	the	DET
ajlsi-1012	11	6	past	past	ADJ
ajlsi-1012	11	7	20	20	NUM
ajlsi-1012	11	8	years	year	NOUN
ajlsi-1012	11	9	were	be	AUX
ajlsi-1012	11	10	not	not	PART
ajlsi-1012	11	11	regarded	regard	VERB
ajlsi-1012	11	12	as	as	ADP
ajlsi-1012	11	13	highly	highly	ADV
ajlsi-1012	11	14	pathogenic	pathogenic	ADJ
ajlsi-1012	11	15	to	to	ADP
ajlsi-1012	11	16	human	human	ADJ
ajlsi-1012	11	17	beings	being	NOUN
ajlsi-1012	11	18	until	until	ADP
ajlsi-1012	11	19	the	the	DET
ajlsi-1012	11	20	outbreaks	outbreak	NOUN
ajlsi-1012	11	21	of	of	ADP
ajlsi-1012	11	22	sars	sars	PROPN
ajlsi-1012	11	23	(	(	PUNCT
ajlsi-1012	11	24	severe	severe	ADJ
ajlsi-1012	11	25	acute	acute	ADJ
ajlsi-1012	11	26	respiratory	respiratory	ADJ
ajlsi-1012	11	27	syndrome	syndrome	NOUN
ajlsi-1012	11	28	)	)	PUNCT
ajlsi-1012	11	29	and	and	CCONJ
ajlsi-1012	11	30	mers	mer	NOUN
ajlsi-1012	11	31	(	(	PUNCT
ajlsi-1012	11	32	middle	middle	PROPN
ajlsi-1012	11	33	east	east	PROPN
ajlsi-1012	11	34	respiratory	respiratory	ADJ
ajlsi-1012	11	35	syndrome	syndrome	NOUN
ajlsi-1012	11	36	)	)	PUNCT
ajlsi-1012	11	37	(	(	PUNCT
ajlsi-1012	11	38	zhong	zhong	PROPN
ajlsi-1012	11	39	et	et	PROPN
ajlsi-1012	11	40	al	al	PROPN
ajlsi-1012	11	41	.	.	PROPN
ajlsi-1012	11	42	,	,	PUNCT
ajlsi-1012	11	43	2003	2003	NUM
ajlsi-1012	11	44	;	;	PUNCT
ajlsi-1012	11	45	drosten	drosten	VERB
ajlsi-1012	11	46	et	et	PROPN
ajlsi-1012	11	47	al	al	PROPN
ajlsi-1012	11	48	.	.	PROPN
ajlsi-1012	11	49	,	,	PUNCT
ajlsi-1012	11	50	2003	2003	NUM
ajlsi-1012	11	51	;	;	PUNCT
ajlsi-1012	11	52	fouchier	fouchier	X
ajlsi-1012	11	53	et	et	PROPN
ajlsi-1012	11	54	al	al	PROPN
ajlsi-1012	11	55	.	.	PROPN
ajlsi-1012	11	56	,	,	PUNCT
ajlsi-1012	11	57	2003	2003	NUM
ajlsi-1012	11	58	)	)	PUNCT
ajlsi-1012	11	59	.	.	PUNCT
ajlsi-1012	12	1	at	at	ADP
ajlsi-1012	12	2	the	the	DET
ajlsi-1012	12	3	end	end	NOUN
ajlsi-1012	12	4	of	of	ADP
ajlsi-1012	12	5	2019	2019	NUM
ajlsi-1012	12	6	,	,	PUNCT
ajlsi-1012	12	7	the	the	DET
ajlsi-1012	12	8	china	china	PROPN
ajlsi-1012	12	9	office	office	PROPN
ajlsi-1012	12	10	of	of	ADP
ajlsi-1012	12	11	the	the	PRON
ajlsi-1012	12	12	who	who	PRON
ajlsi-1012	12	13	(	(	PUNCT
ajlsi-1012	12	14	world	world	NOUN
ajlsi-1012	12	15	health	health	NOUN
ajlsi-1012	12	16	organization	organization	PROPN
ajlsi-1012	12	17	)	)	PUNCT
ajlsi-1012	12	18	reported	report	VERB
ajlsi-1012	12	19	a	a	DET
ajlsi-1012	12	20	cluster	cluster	NOUN
ajlsi-1012	12	21	of	of	ADP
ajlsi-1012	12	22	pneumonia	pneumonia	NOUN
ajlsi-1012	12	23	cases	case	NOUN
ajlsi-1012	12	24	in	in	ADP
ajlsi-1012	12	25	wuhan	wuhan	PROPN
ajlsi-1012	12	26	city	city	PROPN
ajlsi-1012	12	27	,	,	PUNCT
ajlsi-1012	12	28	china	china	PROPN
ajlsi-1012	12	29	,	,	PUNCT
ajlsi-1012	12	30	and	and	CCONJ
ajlsi-1012	12	31	the	the	DET
ajlsi-1012	12	32	causative	causative	ADJ
ajlsi-1012	12	33	pathogen	pathogen	NOUN
ajlsi-1012	12	34	was	be	AUX
ajlsi-1012	12	35	identified	identify	VERB
ajlsi-1012	12	36	as	as	ADP
ajlsi-1012	12	37	novel	novel	ADJ
ajlsi-1012	12	38	coronavirus	coronavirus	NOUN
ajlsi-1012	12	39	(	(	PUNCT
ajlsi-1012	12	40	ncov	ncov	ADV
ajlsi-1012	12	41	2019	2019	NUM
ajlsi-1012	12	42	)	)	PUNCT
ajlsi-1012	12	43	;	;	PUNCT
ajlsi-1012	12	44	the	the	DET
ajlsi-1012	12	45	who	who	PRON
ajlsi-1012	12	46	named	name	VERB
ajlsi-1012	12	47	this	this	DET
ajlsi-1012	12	48	disease	disease	NOUN
ajlsi-1012	12	49	covid-19	covid-19	PROPN
ajlsi-1012	12	50	(	(	PUNCT
ajlsi-1012	12	51	wu	wu	PROPN
ajlsi-1012	12	52	et	et	PROPN
ajlsi-1012	12	53	al	al	PROPN
ajlsi-1012	12	54	.	.	PROPN
ajlsi-1012	12	55	,	,	PUNCT
ajlsi-1012	12	56	2020	2020	NUM
ajlsi-1012	12	57	;	;	PUNCT
ajlsi-1012	12	58	zhou	zhou	PROPN
ajlsi-1012	12	59	et	et	PROPN
ajlsi-1012	12	60	al	al	PROPN
ajlsi-1012	12	61	.	.	PROPN
ajlsi-1012	12	62	,	,	PUNCT
ajlsi-1012	12	63	2020	2020	NUM
ajlsi-1012	12	64	;	;	PUNCT
ajlsi-1012	12	65	wang	wang	PROPN
ajlsi-1012	12	66	et	et	PROPN
ajlsi-1012	12	67	al	al	PROPN
ajlsi-1012	12	68	.	.	PROPN
ajlsi-1012	12	69	,	,	PUNCT
ajlsi-1012	12	70	2020	2020	NUM
ajlsi-1012	12	71	)	)	PUNCT
ajlsi-1012	12	72	.	.	PUNCT
ajlsi-1012	13	1	covid-19	covid-19	PROPN
ajlsi-1012	13	2	is	be	AUX
ajlsi-1012	13	3	an	an	DET
ajlsi-1012	13	4	extremely	extremely	ADV
ajlsi-1012	13	5	infectious	infectious	ADJ
ajlsi-1012	13	6	disease	disease	NOUN
ajlsi-1012	13	7	.	.	PUNCT
ajlsi-1012	14	1	coronaviruses	coronaviruse	NOUN
ajlsi-1012	14	2	are	be	AUX
ajlsi-1012	14	3	enveloped	envelop	VERB
ajlsi-1012	14	4	rna	rna	NOUN
ajlsi-1012	14	5	viruses	virus	NOUN
ajlsi-1012	14	6	belonging	belong	VERB
ajlsi-1012	14	7	to	to	ADP
ajlsi-1012	14	8	the	the	DET
ajlsi-1012	14	9	coronaviridae	coronaviridae	NOUN
ajlsi-1012	14	10	family	family	NOUN
ajlsi-1012	14	11	and	and	CCONJ
ajlsi-1012	14	12	the	the	DET
ajlsi-1012	14	13	order	order	NOUN
ajlsi-1012	14	14	nidovirales	nidovirale	NOUN
ajlsi-1012	14	15	,	,	PUNCT
ajlsi-1012	14	16	which	which	PRON
ajlsi-1012	14	17	contain	contain	VERB
ajlsi-1012	14	18	approximately	approximately	ADV
ajlsi-1012	14	19	27–32	27–32	NUM
ajlsi-1012	14	20	kilobytes	kilobyte	NOUN
ajlsi-1012	14	21	of	of	ADP
ajlsi-1012	14	22	positivesense	positivesense	ADJ
ajlsi-1012	14	23	single	single	ADJ
ajlsi-1012	14	24	-	-	PUNCT
ajlsi-1012	14	25	stranded	strand	VERB
ajlsi-1012	14	26	rna	rna	NOUN
ajlsi-1012	14	27	.	.	PUNCT
ajlsi-1012	15	1	this	this	PRON
ajlsi-1012	15	2	subfamily	subfamily	ADV
ajlsi-1012	15	3	consists	consist	VERB
ajlsi-1012	15	4	of	of	ADP
ajlsi-1012	15	5	four	four	NUM
ajlsi-1012	15	6	genera	genera	NOUN
ajlsi-1012	15	7	:	:	PUNCT
ajlsi-1012	15	8	alpha	alpha	NOUN
ajlsi-1012	15	9	coronavirus	coronavirus	NOUN
ajlsi-1012	15	10	,	,	PUNCT
ajlsi-1012	15	11	beta	beta	NOUN
ajlsi-1012	15	12	coronavirus	coronavirus	NOUN
ajlsi-1012	15	13	,	,	PUNCT
ajlsi-1012	15	14	gamma	gamma	NOUN
ajlsi-1012	15	15	coronavirus	coronavirus	PROPN
ajlsi-1012	15	16	,	,	PUNCT
ajlsi-1012	15	17	and	and	CCONJ
ajlsi-1012	15	18	delta	delta	NOUN
ajlsi-1012	15	19	coronavirus	coronavirus	NOUN
ajlsi-1012	15	20	,	,	PUNCT
ajlsi-1012	15	21	on	on	ADP
ajlsi-1012	15	22	the	the	DET
ajlsi-1012	15	23	basis	basis	NOUN
ajlsi-1012	15	24	of	of	ADP
ajlsi-1012	15	25	their	their	PRON
ajlsi-1012	15	26	phylogenetic	phylogenetic	ADJ
ajlsi-1012	15	27	relationships	relationship	NOUN
ajlsi-1012	15	28	and	and	CCONJ
ajlsi-1012	15	29	genomic	genomic	NOUN
ajlsi-1012	15	30	structures	structure	NOUN
ajlsi-1012	15	31	.	.	PUNCT
ajlsi-1012	16	1	these	these	DET
ajlsi-1012	16	2	subfamilies	subfamily	NOUN
ajlsi-1012	16	3	are	be	AUX
ajlsi-1012	16	4	broadly	broadly	ADV
ajlsi-1012	16	5	distributed	distribute	VERB
ajlsi-1012	16	6	and	and	CCONJ
ajlsi-1012	16	7	cause	cause	VERB
ajlsi-1012	16	8	infections	infection	NOUN
ajlsi-1012	16	9	in	in	ADP
ajlsi-1012	16	10	humans	human	NOUN
ajlsi-1012	16	11	and	and	CCONJ
ajlsi-1012	16	12	other	other	ADJ
ajlsi-1012	16	13	mammals	mammal	NOUN
ajlsi-1012	16	14	.	.	PUNCT
ajlsi-1012	17	1	alpha	alpha	NOUN
ajlsi-1012	17	2	and	and	CCONJ
ajlsi-1012	17	3	beta	beta	NOUN
ajlsi-1012	17	4	coronaviruses	coronaviruse	NOUN
ajlsi-1012	17	5	infect	infect	VERB
ajlsi-1012	17	6	only	only	ADV
ajlsi-1012	17	7	mammals	mammal	NOUN
ajlsi-1012	17	8	.	.	PUNCT
ajlsi-1012	18	1	gamma	gamma	PROPN
ajlsi-1012	18	2	and	and	CCONJ
ajlsi-1012	18	3	delta	delta	NOUN
ajlsi-1012	18	4	coronaviruses	coronaviruse	NOUN
ajlsi-1012	18	5	infect	infect	VERB
ajlsi-1012	18	6	birds	bird	NOUN
ajlsi-1012	18	7	,	,	PUNCT
ajlsi-1012	18	8	but	but	CCONJ
ajlsi-1012	18	9	some	some	PRON
ajlsi-1012	18	10	of	of	ADP
ajlsi-1012	18	11	them	they	PRON
ajlsi-1012	18	12	can	can	AUX
ajlsi-1012	18	13	also	also	ADV
ajlsi-1012	18	14	infect	infect	VERB
ajlsi-1012	18	15	mammals	mammal	NOUN
ajlsi-1012	18	16	.	.	PUNCT
ajlsi-1012	19	1	although	although	SCONJ
ajlsi-1012	19	2	the	the	DET
ajlsi-1012	19	3	source	source	NOUN
ajlsi-1012	19	4	of	of	ADP
ajlsi-1012	19	5	the	the	DET
ajlsi-1012	19	6	beta	beta	ADJ
ajlsi-1012	19	7	coronavirus	coronavirus	NOUN
ajlsi-1012	19	8	2019	2019	NUM
ajlsi-1012	19	9	sars	sar	NOUN
ajlsi-1012	19	10	cov-2	cov-2	PART
ajlsi-1012	19	11	is	be	AUX
ajlsi-1012	19	12	unknown	unknown	ADJ
ajlsi-1012	19	13	,	,	PUNCT
ajlsi-1012	19	14	initial	initial	ADJ
ajlsi-1012	19	15	cases	case	NOUN
ajlsi-1012	19	16	have	have	AUX
ajlsi-1012	19	17	been	be	AUX
ajlsi-1012	19	18	linked	link	VERB
ajlsi-1012	19	19	to	to	ADP
ajlsi-1012	19	20	the	the	DET
ajlsi-1012	19	21	south	south	PROPN
ajlsi-1012	19	22	hunan	hunan	PROPN
ajlsi-1012	19	23	seafood	seafood	PROPN
ajlsi-1012	19	24	market	market	NOUN
ajlsi-1012	19	25	.	.	PUNCT
ajlsi-1012	20	1	the	the	DET
ajlsi-1012	20	2	infected	infected	ADJ
ajlsi-1012	20	3	people	people	NOUN
ajlsi-1012	20	4	may	may	AUX
ajlsi-1012	20	5	have	have	VERB
ajlsi-1012	20	6	severe	severe	ADJ
ajlsi-1012	20	7	symptoms	symptom	NOUN
ajlsi-1012	20	8	in	in	ADP
ajlsi-1012	20	9	the	the	DET
ajlsi-1012	20	10	respiratory	respiratory	ADJ
ajlsi-1012	20	11	and	and	CCONJ
ajlsi-1012	20	12	digestive	digestive	ADJ
ajlsi-1012	20	13	organs	organ	NOUN
ajlsi-1012	20	14	.	.	PUNCT
ajlsi-1012	21	1	like	like	ADP
ajlsi-1012	21	2	other	other	ADJ
ajlsi-1012	21	3	coronaviruses	coronaviruse	NOUN
ajlsi-1012	21	4	,	,	PUNCT
ajlsi-1012	21	5	the	the	DET
ajlsi-1012	21	6	sars	sar	NOUN
ajlsi-1012	21	7	-	-	PUNCT
ajlsi-1012	21	8	cov-2	cov-2	PART
ajlsi-1012	21	9	has	have	VERB
ajlsi-1012	21	10	at	at	ADV
ajlsi-1012	21	11	least	least	ADJ
ajlsi-1012	21	12	six	six	NUM
ajlsi-1012	21	13	open	open	ADJ
ajlsi-1012	21	14	reading	reading	NOUN
ajlsi-1012	21	15	frames	frame	NOUN
ajlsi-1012	21	16	(	(	PUNCT
ajlsi-1012	21	17	orfs	orfs	PROPN
ajlsi-1012	21	18	)	)	PUNCT
ajlsi-1012	21	19	and	and	CCONJ
ajlsi-1012	21	20	many	many	ADJ
ajlsi-1012	21	21	other	other	ADJ
ajlsi-1012	21	22	accessory	accessory	NOUN
ajlsi-1012	21	23	genes	gene	NOUN
ajlsi-1012	21	24	.	.	PUNCT
ajlsi-1012	22	1	there	there	PRON
ajlsi-1012	22	2	are	be	VERB
ajlsi-1012	22	3	two	two	NUM
ajlsi-1012	22	4	open	open	ADJ
ajlsi-1012	22	5	reading	reading	NOUN
ajlsi-1012	22	6	frames	frame	NOUN
ajlsi-1012	22	7	(	(	PUNCT
ajlsi-1012	22	8	orfs	orfs	PROPN
ajlsi-1012	22	9	)	)	PUNCT
ajlsi-1012	22	10	at	at	ADP
ajlsi-1012	22	11	the	the	DET
ajlsi-1012	22	12	5	5	NUM
ajlsi-1012	22	13	’	'	PUNCT
ajlsi-1012	22	14	terminal	terminal	ADJ
ajlsi-1012	22	15	two	two	NUM
ajlsi-1012	22	16	-	-	PUNCT
ajlsi-1012	22	17	thirds	third	NOUN
ajlsi-1012	22	18	of	of	ADP
ajlsi-1012	22	19	the	the	DET
ajlsi-1012	22	20	genome	genome	NOUN
ajlsi-1012	22	21	,	,	PUNCT
ajlsi-1012	22	22	orfs1	orfs1	NOUN
ajlsi-1012	22	23	and	and	CCONJ
ajlsi-1012	22	24	orf2	orf2	ADJ
ajlsi-1012	22	25	.	.	PUNCT
ajlsi-1012	23	1	these	these	PRON
ajlsi-1012	23	2	orf	orf	PROPN
ajlsi-1012	23	3	encode	encode	VERB
ajlsi-1012	23	4	two	two	NUM
ajlsi-1012	23	5	polyproteins	polyprotein	NOUN
ajlsi-1012	23	6	,	,	PUNCT
ajlsi-1012	23	7	namely	namely	ADV
ajlsi-1012	23	8	pp1a	pp1a	ADJ
ajlsi-1012	23	9	and	and	CCONJ
ajlsi-1012	23	10	pp1ab	pp1ab	PROPN
ajlsi-1012	23	11	,	,	PUNCT
ajlsi-1012	23	12	which	which	PRON
ajlsi-1012	23	13	are	be	AUX
ajlsi-1012	23	14	further	far	ADV
ajlsi-1012	23	15	cleaved	cleave	VERB
ajlsi-1012	23	16	into	into	ADP
ajlsi-1012	23	17	11	11	NUM
ajlsi-1012	23	18	and	and	CCONJ
ajlsi-1012	23	19	16	16	NUM
ajlsi-1012	23	20	proteins	protein	NOUN
ajlsi-1012	23	21	,	,	PUNCT
ajlsi-1012	23	22	respectively	respectively	ADV
ajlsi-1012	23	23	.	.	PUNCT
ajlsi-1012	24	1	nucleocapsid	nucleocapsid	ADJ
ajlsi-1012	24	2	(	(	PUNCT
ajlsi-1012	24	3	n	n	CCONJ
ajlsi-1012	24	4	)	)	PUNCT
ajlsi-1012	24	5	,	,	PUNCT
ajlsi-1012	24	6	membrane	membrane	NOUN
ajlsi-1012	24	7	protein	protein	NOUN
ajlsi-1012	24	8	(	(	PUNCT
ajlsi-1012	24	9	m	m	NOUN
ajlsi-1012	24	10	)	)	PUNCT
ajlsi-1012	24	11	,	,	PUNCT
ajlsi-1012	24	12	envelope	envelope	NOUN
ajlsi-1012	24	13	protein	protein	NOUN
ajlsi-1012	24	14	(	(	PUNCT
ajlsi-1012	24	15	e	e	NOUN
ajlsi-1012	24	16	)	)	PUNCT
ajlsi-1012	24	17	,	,	PUNCT
ajlsi-1012	24	18	and	and	CCONJ
ajlsi-1012	24	19	spike	spike	ADJ
ajlsi-1012	24	20	(	(	PUNCT
ajlsi-1012	24	21	s	s	X
ajlsi-1012	24	22	)	)	PUNCT
ajlsi-1012	24	23	are	be	AUX
ajlsi-1012	24	24	among	among	ADP
ajlsi-1012	24	25	the	the	DET
ajlsi-1012	24	26	structural	structural	ADJ
ajlsi-1012	24	27	proteins	protein	NOUN
ajlsi-1012	24	28	found	find	VERB
ajlsi-1012	24	29	at	at	ADP
ajlsi-1012	24	30	3	3	NUM
ajlsi-1012	24	31	’	'	PUNCT
ajlsi-1012	24	32	terminals	terminal	NOUN
ajlsi-1012	24	33	.	.	PUNCT
ajlsi-1012	25	1	in	in	ADP
ajlsi-1012	25	2	the	the	DET
ajlsi-1012	25	3	case	case	NOUN
ajlsi-1012	25	4	of	of	ADP
ajlsi-1012	25	5	covid-19	covid-19	PROPN
ajlsi-1012	25	6	,	,	PUNCT
ajlsi-1012	25	7	the	the	DET
ajlsi-1012	25	8	spike	spike	ADJ
ajlsi-1012	25	9	protein	protein	NOUN
ajlsi-1012	25	10	appears	appear	VERB
ajlsi-1012	25	11	to	to	PART
ajlsi-1012	25	12	be	be	AUX
ajlsi-1012	25	13	the	the	DET
ajlsi-1012	25	14	primary	primary	ADJ
ajlsi-1012	25	15	protein	protein	NOUN
ajlsi-1012	25	16	interacting	interact	VERB
ajlsi-1012	25	17	with	with	ADP
ajlsi-1012	25	18	host	host	NOUN
ajlsi-1012	25	19	cells	cell	NOUN
ajlsi-1012	25	20	.	.	PUNCT
ajlsi-1012	26	1	hence	hence	ADV
ajlsi-1012	26	2	,	,	PUNCT
ajlsi-1012	26	3	the	the	DET
ajlsi-1012	26	4	spike	spike	ADJ
ajlsi-1012	26	5	protein	protein	NOUN
ajlsi-1012	26	6	is	be	AUX
ajlsi-1012	26	7	likely	likely	ADJ
ajlsi-1012	26	8	the	the	DET
ajlsi-1012	26	9	protein	protein	NOUN
ajlsi-1012	26	10	to	to	PART
ajlsi-1012	26	11	which	which	PRON
ajlsi-1012	26	12	antibodies	antibody	NOUN
ajlsi-1012	26	13	are	be	AUX
ajlsi-1012	26	14	raised	raise	VERB
ajlsi-1012	26	15	,	,	PUNCT
ajlsi-1012	26	16	but	but	CCONJ
ajlsi-1012	26	17	this	this	PRON
ajlsi-1012	26	18	is	be	AUX
ajlsi-1012	26	19	not	not	PART
ajlsi-1012	26	20	clear	clear	ADJ
ajlsi-1012	26	21	at	at	ADP
ajlsi-1012	26	22	this	this	DET
ajlsi-1012	26	23	time	time	NOUN
ajlsi-1012	26	24	.	.	PUNCT
ajlsi-1012	27	1	these	these	DET
ajlsi-1012	27	2	viruses	virus	NOUN
ajlsi-1012	27	3	also	also	ADV
ajlsi-1012	27	4	contain	contain	VERB
ajlsi-1012	27	5	some	some	DET
ajlsi-1012	27	6	accessory	accessory	ADJ
ajlsi-1012	27	7	proteins	protein	NOUN
ajlsi-1012	27	8	,	,	PUNCT
ajlsi-1012	27	9	which	which	PRON
ajlsi-1012	27	10	aid	aid	VERB
ajlsi-1012	27	11	in	in	ADP
ajlsi-1012	27	12	virus	virus	NOUN
ajlsi-1012	27	13	replication	replication	NOUN
ajlsi-1012	27	14	.	.	PUNCT
ajlsi-1012	28	1	the	the	DET
ajlsi-1012	28	2	s	s	PROPN
ajlsi-1012	28	3	gene	gene	NOUN
ajlsi-1012	28	4	aids	aid	NOUN
ajlsi-1012	28	5	sars	sar	NOUN
ajlsi-1012	28	6	-	-	PUNCT
ajlsi-1012	28	7	cov-2	cov-2	NOUN
ajlsi-1012	28	8	in	in	ADP
ajlsi-1012	28	9	host	host	NOUN
ajlsi-1012	28	10	specificity	specificity	NOUN
ajlsi-1012	28	11	and	and	CCONJ
ajlsi-1012	28	12	receptor	receptor	NOUN
ajlsi-1012	28	13	binding	bind	VERB
ajlsi-1012	28	14	,	,	PUNCT
ajlsi-1012	28	15	and	and	CCONJ
ajlsi-1012	28	16	some	some	DET
ajlsi-1012	28	17	virion	virion	NOUN
ajlsi-1012	28	18	may	may	AUX
ajlsi-1012	28	19	also	also	ADV
ajlsi-1012	28	20	contain	contain	VERB
ajlsi-1012	28	21	hemagglutinin	hemagglutinin	ADJ
ajlsi-1012	28	22	esterase	esterase	NOUN
ajlsi-1012	28	23	(	(	PUNCT
ajlsi-1012	28	24	he	he	PRON
ajlsi-1012	28	25	)	)	PUNCT
ajlsi-1012	28	26	protein	protein	NOUN
ajlsi-1012	28	27	.	.	PUNCT
ajlsi-1012	29	1	(	(	PUNCT
ajlsi-1012	29	2	cui	cui	PROPN
ajlsi-1012	29	3	,	,	PUNCT
ajlsi-1012	29	4	j.	j.	PROPN
ajlsi-1012	29	5	,	,	PUNCT
ajlsi-1012	29	6	et	et	PROPN
ajlsi-1012	29	7	al	al	PROPN
ajlsi-1012	29	8	.	.	PROPN
ajlsi-1012	29	9	,	,	PUNCT
ajlsi-1012	29	10	2019	2019	NUM
ajlsi-1012	29	11	;	;	PUNCT
ajlsi-1012	29	12	huang	huang	PROPN
ajlsi-1012	29	13	c	c	PROPN
ajlsi-1012	29	14	et	et	PROPN
ajlsi-1012	29	15	al	al	PROPN
ajlsi-1012	29	16	.	.	PROPN
ajlsi-1012	29	17	,2020	,2020	PUNCT
ajlsi-1012	29	18	and	and	CCONJ
ajlsi-1012	29	19	miller	miller	PROPN
ajlsi-1012	29	20	et	et	PROPN
ajlsi-1012	29	21	al	al	PROPN
ajlsi-1012	29	22	.	.	PROPN
ajlsi-1012	29	23	,2016	,2016	PUNCT
ajlsi-1012	29	24	)	)	PUNCT
ajlsi-1012	29	25	clinical	clinical	ADJ
ajlsi-1012	29	26	manifestations	manifestation	NOUN
ajlsi-1012	29	27	of	of	ADP
ajlsi-1012	29	28	covid-19	covid-19	PROPN
ajlsi-1012	29	29	infection	infection	NOUN
ajlsi-1012	29	30	include	include	VERB
ajlsi-1012	29	31	fever	fever	NOUN
ajlsi-1012	29	32	and	and	CCONJ
ajlsi-1012	29	33	cough	cough	NOUN
ajlsi-1012	29	34	as	as	ADP
ajlsi-1012	29	35	primary	primary	ADJ
ajlsi-1012	29	36	clinical	clinical	ADJ
ajlsi-1012	29	37	manifestations	manifestation	NOUN
ajlsi-1012	29	38	,	,	PUNCT
ajlsi-1012	29	39	as	as	ADV
ajlsi-1012	29	40	well	well	ADV
ajlsi-1012	29	41	as	as	ADP
ajlsi-1012	29	42	shortness	shortness	NOUN
ajlsi-1012	29	43	of	of	ADP
ajlsi-1012	29	44	breath	breath	NOUN
ajlsi-1012	29	45	and	and	CCONJ
ajlsi-1012	29	46	myalgia	myalgia	NOUN
ajlsi-1012	29	47	.	.	PUNCT
ajlsi-1012	30	1	some	some	DET
ajlsi-1012	30	2	patients	patient	NOUN
ajlsi-1012	30	3	have	have	VERB
ajlsi-1012	30	4	serious	serious	ADJ
ajlsi-1012	30	5	complications	complication	NOUN
ajlsi-1012	30	6	such	such	ADJ
ajlsi-1012	30	7	as	as	ADP
ajlsi-1012	30	8	acute	acute	ADJ
ajlsi-1012	30	9	respiratory	respiratory	ADJ
ajlsi-1012	30	10	distress	distress	NOUN
ajlsi-1012	30	11	syndrome	syndrome	NOUN
ajlsi-1012	30	12	(	(	PUNCT
ajlsi-1012	30	13	ards	ard	NOUN
ajlsi-1012	30	14	)	)	PUNCT
ajlsi-1012	30	15	and	and	CCONJ
ajlsi-1012	30	16	cytokine	cytokine	ADJ
ajlsi-1012	30	17	storm	storm	NOUN
ajlsi-1012	30	18	,	,	PUNCT
ajlsi-1012	30	19	which	which	PRON
ajlsi-1012	30	20	may	may	AUX
ajlsi-1012	30	21	lead	lead	VERB
ajlsi-1012	30	22	to	to	ADP
ajlsi-1012	30	23	death	death	NOUN
ajlsi-1012	30	24	.	.	PUNCT
ajlsi-1012	31	1	(	(	PUNCT
ajlsi-1012	31	2	malik	malik	PROPN
ajlsi-1012	31	3	et	et	PROPN
ajlsi-1012	31	4	al	al	PROPN
ajlsi-1012	31	5	.	.	PROPN
ajlsi-1012	31	6	,	,	PUNCT
ajlsi-1012	31	7	2020	2020	NUM
ajlsi-1012	31	8	)	)	PUNCT
ajlsi-1012	31	9	.	.	PUNCT
ajlsi-1012	32	1	it	it	PRON
ajlsi-1012	32	2	has	have	VERB
ajlsi-1012	32	3	the	the	DET
ajlsi-1012	32	4	capacity	capacity	NOUN
ajlsi-1012	32	5	for	for	ADP
ajlsi-1012	32	6	humanto	humanto	ADP
ajlsi-1012	32	7	-	-	PUNCT
ajlsi-1012	32	8	human	human	ADJ
ajlsi-1012	32	9	transmission	transmission	NOUN
ajlsi-1012	32	10	.	.	PUNCT
ajlsi-1012	33	1	the	the	DET
ajlsi-1012	33	2	lack	lack	NOUN
ajlsi-1012	33	3	of	of	ADP
ajlsi-1012	33	4	awareness	awareness	NOUN
ajlsi-1012	33	5	in	in	ADP
ajlsi-1012	33	6	hospital	hospital	NOUN
ajlsi-1012	33	7	infection	infection	NOUN
ajlsi-1012	33	8	control	control	NOUN
ajlsi-1012	33	9	and	and	CCONJ
ajlsi-1012	33	10	international	international	ADJ
ajlsi-1012	33	11	air	air	NOUN
ajlsi-1012	33	12	travel	travel	NOUN
ajlsi-1012	33	13	facilitated	facilitate	VERB
ajlsi-1012	33	14	the	the	DET
ajlsi-1012	33	15	rapid	rapid	ADJ
ajlsi-1012	33	16	global	global	ADJ
ajlsi-1012	33	17	dissemination	dissemination	NOUN
ajlsi-1012	33	18	of	of	ADP
ajlsi-1012	33	19	this	this	DET
ajlsi-1012	33	20	agent	agent	NOUN
ajlsi-1012	33	21	.	.	PUNCT
ajlsi-1012	34	1	the	the	DET
ajlsi-1012	34	2	collection	collection	NOUN
ajlsi-1012	34	3	of	of	ADP
ajlsi-1012	34	4	appropriate	appropriate	ADJ
ajlsi-1012	34	5	specimens	specimen	NOUN
ajlsi-1012	34	6	is	be	AUX
ajlsi-1012	34	7	very	very	ADV
ajlsi-1012	34	8	crucial	crucial	ADJ
ajlsi-1012	34	9	for	for	ADP
ajlsi-1012	34	10	the	the	DET
ajlsi-1012	34	11	detection	detection	NOUN
ajlsi-1012	34	12	of	of	ADP
ajlsi-1012	34	13	most	most	ADJ
ajlsi-1012	34	14	of	of	ADP
ajlsi-1012	34	15	the	the	DET
ajlsi-1012	34	16	infected	infected	ADJ
ajlsi-1012	34	17	cases	case	NOUN
ajlsi-1012	34	18	of	of	ADP
ajlsi-1012	34	19	covid-19	covid-19	PROPN
ajlsi-1012	34	20	.	.	PUNCT
ajlsi-1012	35	1	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	35	2	swabs	swab	NOUN
ajlsi-1012	35	3	are	be	AUX
ajlsi-1012	35	4	typically	typically	ADV
ajlsi-1012	35	5	collected	collect	VERB
ajlsi-1012	35	6	,	,	PUNCT
ajlsi-1012	35	7	but	but	CCONJ
ajlsi-1012	35	8	we	we	PRON
ajlsi-1012	35	9	may	may	AUX
ajlsi-1012	35	10	miss	miss	VERB
ajlsi-1012	35	11	the	the	DET
ajlsi-1012	35	12	detection	detection	NOUN
ajlsi-1012	35	13	in	in	ADP
ajlsi-1012	35	14	some	some	DET
ajlsi-1012	35	15	cases	case	NOUN
ajlsi-1012	35	16	;	;	PUNCT
ajlsi-1012	35	17	therefore	therefore	ADV
ajlsi-1012	35	18	,	,	PUNCT
ajlsi-1012	35	19	lower	low	ADJ
ajlsi-1012	35	20	respiratory	respiratory	ADJ
ajlsi-1012	35	21	tract	tract	NOUN
ajlsi-1012	35	22	specimens	specimen	NOUN
ajlsi-1012	35	23	such	such	ADJ
ajlsi-1012	35	24	as	as	ADP
ajlsi-1012	35	25	sputum	sputum	NOUN
ajlsi-1012	35	26	and	and	CCONJ
ajlsi-1012	35	27	bronchoalveolar	bronchoalveolar	ADJ
ajlsi-1012	35	28	lavage	lavage	NOUN
ajlsi-1012	35	29	(	(	PUNCT
ajlsi-1012	35	30	bal	bal	ADJ
ajlsi-1012	35	31	)	)	PUNCT
ajlsi-1012	35	32	may	may	AUX
ajlsi-1012	35	33	be	be	AUX
ajlsi-1012	35	34	an	an	DET
ajlsi-1012	35	35	alternative	alternative	ADJ
ajlsi-1012	35	36	choice	choice	NOUN
ajlsi-1012	35	37	.	.	PUNCT
ajlsi-1012	36	1	therefore	therefore	ADV
ajlsi-1012	36	2	,	,	PUNCT
ajlsi-1012	36	3	there	there	PRON
ajlsi-1012	36	4	is	be	VERB
ajlsi-1012	36	5	an	an	DET
ajlsi-1012	36	6	urgent	urgent	ADJ
ajlsi-1012	36	7	need	need	NOUN
ajlsi-1012	36	8	to	to	PART
ajlsi-1012	36	9	have	have	AUX
ajlsi-1012	36	10	an	an	DET
ajlsi-1012	36	11	1	1	NUM
ajlsi-1012	36	12	department	department	NOUN
ajlsi-1012	36	13	of	of	ADP
ajlsi-1012	36	14	biosciences	biosciences	PROPN
ajlsi-1012	36	15	mar	mar	PROPN
ajlsi-1012	36	16	thoma	thoma	PROPN
ajlsi-1012	36	17	college	college	PROPN
ajlsi-1012	36	18	,	,	PUNCT
ajlsi-1012	36	19	thiruvalla	thiruvalla	PROPN
ajlsi-1012	36	20	,	,	PUNCT
ajlsi-1012	36	21	kerala	kerala	PROPN
ajlsi-1012	36	22	,	,	PUNCT
ajlsi-1012	36	23	india	india	PROPN
ajlsi-1012	36	24	*	*	PUNCT
ajlsi-1012	36	25	corresponding	correspond	VERB
ajlsi-1012	36	26	author	author	NOUN
ajlsi-1012	36	27	’s	’s	PART
ajlsi-1012	36	28	e	e	NOUN
ajlsi-1012	36	29	-	-	NOUN
ajlsi-1012	36	30	mail	mail	NOUN
ajlsi-1012	36	31	:	:	PUNCT
ajlsi-1012	36	32	aswathycashok5@gmail.com	aswathycashok5@gmail.com	X
ajlsi-1012	36	33	https://doi.org/10.54536/ajlsi.v1i2.1012	https://doi.org/10.54536/ajlsi.v1i2.1012	PROPN
ajlsi-1012	36	34	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	36	35	mailto	mailto	NOUN
ajlsi-1012	36	36	:	:	PUNCT
ajlsi-1012	36	37	aswathycashok5%40gmail.com?subject=	aswathycashok5%40gmail.com?subject=	X
ajlsi-1012	36	38	pa	pa	PROPN
ajlsi-1012	36	39	ge	ge	PROPN
ajlsi-1012	36	40	30	30	NUM
ajlsi-1012	36	41	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	36	42	am	am	NOUN
ajlsi-1012	36	43	.	.	PUNCT
ajlsi-1012	37	1	j.	j.	PROPN
ajlsi-1012	37	2	life	life	PROPN
ajlsi-1012	37	3	sci	sci	PROPN
ajlsi-1012	37	4	.	.	PUNCT
ajlsi-1012	37	5	innov	innov	PROPN
ajlsi-1012	37	6	.	.	PUNCT
ajlsi-1012	38	1	1(2	1(2	NUM
ajlsi-1012	38	2	)	)	PUNCT
ajlsi-1012	38	3	29	29	NUM
ajlsi-1012	38	4	-	-	SYM
ajlsi-1012	38	5	42	42	NUM
ajlsi-1012	38	6	,	,	PUNCT
ajlsi-1012	38	7	2022	2022	NUM
ajlsi-1012	38	8	accurate	accurate	ADJ
ajlsi-1012	38	9	,	,	PUNCT
ajlsi-1012	38	10	rapid	rapid	ADJ
ajlsi-1012	38	11	,	,	PUNCT
ajlsi-1012	38	12	readily	readily	ADV
ajlsi-1012	38	13	available	available	ADJ
ajlsi-1012	38	14	,	,	PUNCT
ajlsi-1012	38	15	and	and	CCONJ
ajlsi-1012	38	16	reliable	reliable	ADJ
ajlsi-1012	38	17	diagnostic	diagnostic	ADJ
ajlsi-1012	38	18	test	test	NOUN
ajlsi-1012	38	19	for	for	ADP
ajlsi-1012	38	20	sars	sar	NOUN
ajlsi-1012	38	21	-	-	PUNCT
ajlsi-1012	38	22	cov-2	cov-2	PART
ajlsi-1012	38	23	infection	infection	NOUN
ajlsi-1012	38	24	.	.	PUNCT
ajlsi-1012	39	1	various	various	ADJ
ajlsi-1012	39	2	immunological	immunological	ADJ
ajlsi-1012	39	3	,	,	PUNCT
ajlsi-1012	39	4	nucleic	nucleic	ADJ
ajlsi-1012	39	5	acid	acid	NOUN
ajlsi-1012	39	6	,	,	PUNCT
ajlsi-1012	39	7	and	and	CCONJ
ajlsi-1012	39	8	amplification	amplification	NOUN
ajlsi-1012	39	9	diagnostic	diagnostic	ADJ
ajlsi-1012	39	10	tests	test	NOUN
ajlsi-1012	39	11	have	have	AUX
ajlsi-1012	39	12	been	be	AUX
ajlsi-1012	39	13	developed	develop	VERB
ajlsi-1012	39	14	and	and	CCONJ
ajlsi-1012	39	15	are	be	AUX
ajlsi-1012	39	16	widely	widely	ADV
ajlsi-1012	39	17	available	available	ADJ
ajlsi-1012	39	18	to	to	ADP
ajlsi-1012	39	19	date	date	NOUN
ajlsi-1012	39	20	.	.	PUNCT
ajlsi-1012	40	1	various	various	ADJ
ajlsi-1012	40	2	integrated	integrate	VERB
ajlsi-1012	40	3	point	point	NOUN
ajlsi-1012	40	4	-	-	PUNCT
ajlsi-1012	40	5	of	of	ADP
ajlsi-1012	40	6	-	-	PUNCT
ajlsi-1012	40	7	care	care	NOUN
ajlsi-1012	40	8	molecular	molecular	ADJ
ajlsi-1012	40	9	devices	device	NOUN
ajlsi-1012	40	10	are	be	AUX
ajlsi-1012	40	11	currently	currently	ADV
ajlsi-1012	40	12	under	under	ADP
ajlsi-1012	40	13	development	development	NOUN
ajlsi-1012	40	14	,	,	PUNCT
ajlsi-1012	40	15	and	and	CCONJ
ajlsi-1012	40	16	some	some	PRON
ajlsi-1012	40	17	are	be	AUX
ajlsi-1012	40	18	available	available	ADJ
ajlsi-1012	40	19	to	to	PART
ajlsi-1012	40	20	provide	provide	VERB
ajlsi-1012	40	21	accurate	accurate	ADJ
ajlsi-1012	40	22	and	and	CCONJ
ajlsi-1012	40	23	fast	fast	ADJ
ajlsi-1012	40	24	diagnostic	diagnostic	ADJ
ajlsi-1012	40	25	services	service	NOUN
ajlsi-1012	40	26	for	for	ADP
ajlsi-1012	40	27	sars	sar	NOUN
ajlsi-1012	40	28	-	-	PUNCT
ajlsi-1012	40	29	cov-2	cov-2	NOUN
ajlsi-1012	40	30	infections	infection	NOUN
ajlsi-1012	40	31	.	.	PUNCT
ajlsi-1012	41	1	(	(	PUNCT
ajlsi-1012	41	2	loeffelholz	loeffelholz	INTJ
ajlsi-1012	41	3	et	et	PROPN
ajlsi-1012	41	4	al	al	PROPN
ajlsi-1012	41	5	.	.	PROPN
ajlsi-1012	41	6	,	,	PUNCT
ajlsi-1012	41	7	2020	2020	NUM
ajlsi-1012	41	8	)	)	PUNCT
ajlsi-1012	41	9	.	.	PUNCT
ajlsi-1012	42	1	in	in	ADP
ajlsi-1012	42	2	view	view	NOUN
ajlsi-1012	42	3	of	of	ADP
ajlsi-1012	42	4	the	the	DET
ajlsi-1012	42	5	present	present	ADJ
ajlsi-1012	42	6	crisis	crisis	NOUN
ajlsi-1012	42	7	of	of	ADP
ajlsi-1012	42	8	the	the	DET
ajlsi-1012	42	9	covid-19	covid-19	PROPN
ajlsi-1012	42	10	pandemic	pandemic	ADJ
ajlsi-1012	42	11	,	,	PUNCT
ajlsi-1012	42	12	fast	fast	ADJ
ajlsi-1012	42	13	and	and	CCONJ
ajlsi-1012	42	14	reliable	reliable	ADJ
ajlsi-1012	42	15	testing	testing	NOUN
ajlsi-1012	42	16	strategies	strategy	NOUN
ajlsi-1012	42	17	are	be	AUX
ajlsi-1012	42	18	imperative	imperative	ADJ
ajlsi-1012	42	19	.	.	PUNCT
ajlsi-1012	43	1	in	in	ADP
ajlsi-1012	43	2	this	this	DET
ajlsi-1012	43	3	review	review	NOUN
ajlsi-1012	43	4	,	,	PUNCT
ajlsi-1012	43	5	we	we	PRON
ajlsi-1012	43	6	attempt	attempt	VERB
ajlsi-1012	43	7	to	to	PART
ajlsi-1012	43	8	learn	learn	VERB
ajlsi-1012	43	9	more	more	ADJ
ajlsi-1012	43	10	about	about	ADP
ajlsi-1012	43	11	the	the	DET
ajlsi-1012	43	12	current	current	ADJ
ajlsi-1012	43	13	diagnostic	diagnostic	ADJ
ajlsi-1012	43	14	methods	method	NOUN
ajlsi-1012	43	15	for	for	ADP
ajlsi-1012	43	16	sars	sar	NOUN
ajlsi-1012	43	17	and	and	CCONJ
ajlsi-1012	43	18	cov-2	cov-2	PART
ajlsi-1012	43	19	infections	infection	NOUN
ajlsi-1012	43	20	.	.	PUNCT
ajlsi-1012	44	1	the	the	DET
ajlsi-1012	44	2	different	different	ADJ
ajlsi-1012	44	3	methods	method	NOUN
ajlsi-1012	44	4	used	use	VERB
ajlsi-1012	44	5	for	for	ADP
ajlsi-1012	44	6	screening	screening	NOUN
ajlsi-1012	44	7	and	and	CCONJ
ajlsi-1012	44	8	sample	sample	NOUN
ajlsi-1012	44	9	collection	collection	NOUN
ajlsi-1012	44	10	will	will	AUX
ajlsi-1012	44	11	also	also	ADV
ajlsi-1012	44	12	be	be	AUX
ajlsi-1012	44	13	discussed	discuss	VERB
ajlsi-1012	44	14	.	.	PUNCT
ajlsi-1012	45	1	screening	screening	NOUN
ajlsi-1012	45	2	and	and	CCONJ
ajlsi-1012	45	3	specimen	speciman	NOUN
ajlsi-1012	45	4	collection	collection	NOUN
ajlsi-1012	45	5	of	of	ADP
ajlsi-1012	45	6	patients	patient	NOUN
ajlsi-1012	45	7	with	with	ADP
ajlsi-1012	45	8	covid-19	covid-19	PROPN
ajlsi-1012	45	9	pneumonia	pneumonia	NOUN
ajlsi-1012	45	10	.	.	PUNCT
ajlsi-1012	46	1	accurate	accurate	ADJ
ajlsi-1012	46	2	diagnoses	diagnosis	NOUN
ajlsi-1012	46	3	of	of	ADP
ajlsi-1012	46	4	cases	case	NOUN
ajlsi-1012	46	5	hold	hold	VERB
ajlsi-1012	46	6	the	the	DET
ajlsi-1012	46	7	key	key	NOUN
ajlsi-1012	46	8	to	to	ADP
ajlsi-1012	46	9	managing	manage	VERB
ajlsi-1012	46	10	any	any	DET
ajlsi-1012	46	11	pandemic	pandemic	ADJ
ajlsi-1012	46	12	through	through	ADP
ajlsi-1012	46	13	identification	identification	NOUN
ajlsi-1012	46	14	,	,	PUNCT
ajlsi-1012	46	15	isolation	isolation	NOUN
ajlsi-1012	46	16	,	,	PUNCT
ajlsi-1012	46	17	and	and	CCONJ
ajlsi-1012	46	18	treatment	treatment	NOUN
ajlsi-1012	46	19	of	of	ADP
ajlsi-1012	46	20	patients	patient	NOUN
ajlsi-1012	46	21	while	while	SCONJ
ajlsi-1012	46	22	defining	define	VERB
ajlsi-1012	46	23	the	the	DET
ajlsi-1012	46	24	epidemiology	epidemiology	NOUN
ajlsi-1012	46	25	of	of	ADP
ajlsi-1012	46	26	the	the	DET
ajlsi-1012	46	27	pathogen	pathogen	NOUN
ajlsi-1012	46	28	.	.	PUNCT
ajlsi-1012	47	1	because	because	SCONJ
ajlsi-1012	47	2	an	an	DET
ajlsi-1012	47	3	increasing	increase	VERB
ajlsi-1012	47	4	number	number	NOUN
ajlsi-1012	47	5	of	of	ADP
ajlsi-1012	47	6	asymptomatic	asymptomatic	ADJ
ajlsi-1012	47	7	symptomatic	symptomatic	ADJ
ajlsi-1012	47	8	individuals	individual	NOUN
ajlsi-1012	47	9	must	must	AUX
ajlsi-1012	47	10	be	be	AUX
ajlsi-1012	47	11	tested	test	VERB
ajlsi-1012	47	12	for	for	ADP
ajlsi-1012	47	13	covid-19	covid-19	PROPN
ajlsi-1012	47	14	,	,	PUNCT
ajlsi-1012	47	15	a	a	DET
ajlsi-1012	47	16	safe	safe	ADJ
ajlsi-1012	47	17	and	and	CCONJ
ajlsi-1012	47	18	efficient	efficient	ADJ
ajlsi-1012	47	19	screening	screening	NOUN
ajlsi-1012	47	20	system	system	NOUN
ajlsi-1012	47	21	is	be	AUX
ajlsi-1012	47	22	required	require	VERB
ajlsi-1012	47	23	.	.	PUNCT
ajlsi-1012	48	1	presently	presently	ADV
ajlsi-1012	48	2	,	,	PUNCT
ajlsi-1012	48	3	no	no	DET
ajlsi-1012	48	4	specific	specific	ADJ
ajlsi-1012	48	5	clinical	clinical	ADJ
ajlsi-1012	48	6	signs	sign	NOUN
ajlsi-1012	48	7	or	or	CCONJ
ajlsi-1012	48	8	symptoms	symptom	NOUN
ajlsi-1012	48	9	of	of	ADP
ajlsi-1012	48	10	covid-19	covid-19	PROPN
ajlsi-1012	48	11	can	can	AUX
ajlsi-1012	48	12	be	be	AUX
ajlsi-1012	48	13	used	use	VERB
ajlsi-1012	48	14	to	to	PART
ajlsi-1012	48	15	differentiate	differentiate	VERB
ajlsi-1012	48	16	it	it	PRON
ajlsi-1012	48	17	from	from	ADP
ajlsi-1012	48	18	other	other	ADJ
ajlsi-1012	48	19	causes	cause	NOUN
ajlsi-1012	48	20	of	of	ADP
ajlsi-1012	48	21	communityor	communityor	NOUN
ajlsi-1012	48	22	hospital	hospital	NOUN
ajlsi-1012	48	23	-	-	PUNCT
ajlsi-1012	48	24	acquired	acquire	VERB
ajlsi-1012	48	25	pneumonia	pneumonia	NOUN
ajlsi-1012	48	26	.	.	PUNCT
ajlsi-1012	49	1	in	in	ADP
ajlsi-1012	49	2	order	order	NOUN
ajlsi-1012	49	3	to	to	PART
ajlsi-1012	49	4	decide	decide	VERB
ajlsi-1012	49	5	if	if	SCONJ
ajlsi-1012	49	6	a	a	DET
ajlsi-1012	49	7	patient	patient	NOUN
ajlsi-1012	49	8	should	should	AUX
ajlsi-1012	49	9	be	be	AUX
ajlsi-1012	49	10	tested	test	VERB
ajlsi-1012	49	11	,	,	PUNCT
ajlsi-1012	49	12	who	who	PRON
ajlsi-1012	49	13	published	publish	VERB
ajlsi-1012	49	14	case	case	NOUN
ajlsi-1012	49	15	definitions	definition	NOUN
ajlsi-1012	49	16	for	for	ADP
ajlsi-1012	49	17	surveillance	surveillance	NOUN
ajlsi-1012	49	18	but	but	CCONJ
ajlsi-1012	49	19	encouraged	encouraged	ADJ
ajlsi-1012	49	20	countries	country	NOUN
ajlsi-1012	49	21	to	to	PART
ajlsi-1012	49	22	adapt	adapt	VERB
ajlsi-1012	49	23	these	these	PRON
ajlsi-1012	49	24	depending	depend	VERB
ajlsi-1012	49	25	on	on	ADP
ajlsi-1012	49	26	their	their	PRON
ajlsi-1012	49	27	local	local	ADJ
ajlsi-1012	49	28	epidemiological	epidemiological	ADJ
ajlsi-1012	49	29	situation	situation	NOUN
ajlsi-1012	49	30	and	and	CCONJ
ajlsi-1012	49	31	other	other	ADJ
ajlsi-1012	49	32	factors	factor	NOUN
ajlsi-1012	49	33	.	.	PUNCT
ajlsi-1012	50	1	(	(	PUNCT
ajlsi-1012	50	2	who	who	PRON
ajlsi-1012	50	3	2020	2020	NUM
ajlsi-1012	50	4	)	)	PUNCT
ajlsi-1012	50	5	.	.	PUNCT
ajlsi-1012	51	1	a	a	DET
ajlsi-1012	51	2	suspect	suspect	ADJ
ajlsi-1012	51	3	case	case	NOUN
ajlsi-1012	51	4	is	be	AUX
ajlsi-1012	51	5	defined	define	VERB
ajlsi-1012	51	6	as	as	ADP
ajlsi-1012	51	7	(	(	PUNCT
ajlsi-1012	51	8	i	i	NOUN
ajlsi-1012	51	9	)	)	PUNCT
ajlsi-1012	51	10	a	a	DET
ajlsi-1012	51	11	patient	patient	NOUN
ajlsi-1012	51	12	with	with	ADP
ajlsi-1012	51	13	acute	acute	ADJ
ajlsi-1012	51	14	respiratory	respiratory	ADJ
ajlsi-1012	51	15	illness	illness	NOUN
ajlsi-1012	51	16	(	(	PUNCT
ajlsi-1012	51	17	fever	fever	NOUN
ajlsi-1012	51	18	and	and	CCONJ
ajlsi-1012	51	19	at	at	ADV
ajlsi-1012	51	20	least	least	ADV
ajlsi-1012	51	21	one	one	NUM
ajlsi-1012	51	22	sign	sign	NOUN
ajlsi-1012	51	23	or	or	CCONJ
ajlsi-1012	51	24	symptom	symptom	NOUN
ajlsi-1012	51	25	of	of	ADP
ajlsi-1012	51	26	respiratory	respiratory	ADJ
ajlsi-1012	51	27	disease	disease	NOUN
ajlsi-1012	51	28	,	,	PUNCT
ajlsi-1012	51	29	such	such	ADJ
ajlsi-1012	51	30	as	as	ADP
ajlsi-1012	51	31	cough	cough	NOUN
ajlsi-1012	51	32	or	or	CCONJ
ajlsi-1012	51	33	shortness	shortness	NOUN
ajlsi-1012	51	34	of	of	ADP
ajlsi-1012	51	35	breath	breath	NOUN
ajlsi-1012	51	36	)	)	PUNCT
ajlsi-1012	51	37	and	and	CCONJ
ajlsi-1012	51	38	a	a	DET
ajlsi-1012	51	39	history	history	NOUN
ajlsi-1012	51	40	of	of	ADP
ajlsi-1012	51	41	travel	travel	NOUN
ajlsi-1012	51	42	to	to	ADP
ajlsi-1012	51	43	or	or	CCONJ
ajlsi-1012	51	44	residence	residence	NOUN
ajlsi-1012	51	45	in	in	ADP
ajlsi-1012	51	46	a	a	DET
ajlsi-1012	51	47	location	location	NOUN
ajlsi-1012	51	48	reporting	reporting	NOUN
ajlsi-1012	51	49	community	community	NOUN
ajlsi-1012	51	50	transmission	transmission	NOUN
ajlsi-1012	51	51	of	of	ADP
ajlsi-1012	51	52	covid-19	covid-19	PROPN
ajlsi-1012	51	53	disease	disease	NOUN
ajlsi-1012	51	54	within	within	ADP
ajlsi-1012	51	55	14	14	NUM
ajlsi-1012	51	56	days	day	NOUN
ajlsi-1012	51	57	of	of	ADP
ajlsi-1012	51	58	the	the	DET
ajlsi-1012	51	59	onset	onset	NOUN
ajlsi-1012	51	60	of	of	ADP
ajlsi-1012	51	61	symptoms	symptom	NOUN
ajlsi-1012	51	62	(	(	PUNCT
ajlsi-1012	51	63	ii	ii	NOUN
ajlsi-1012	51	64	)	)	PUNCT
ajlsi-1012	51	65	a	a	DET
ajlsi-1012	51	66	patient	patient	NOUN
ajlsi-1012	51	67	with	with	ADP
ajlsi-1012	51	68	severe	severe	ADJ
ajlsi-1012	51	69	acute	acute	ADJ
ajlsi-1012	51	70	respiratory	respiratory	ADJ
ajlsi-1012	51	71	illness	illness	NOUN
ajlsi-1012	51	72	(	(	PUNCT
ajlsi-1012	51	73	fever	fever	NOUN
ajlsi-1012	51	74	and	and	CCONJ
ajlsi-1012	51	75	at	at	ADV
ajlsi-1012	51	76	least	least	ADV
ajlsi-1012	51	77	one	one	NUM
ajlsi-1012	51	78	sign	sign	NOUN
ajlsi-1012	51	79	or	or	CCONJ
ajlsi-1012	51	80	symptom	symptom	NOUN
ajlsi-1012	51	81	of	of	ADP
ajlsi-1012	51	82	respiratory	respiratory	ADJ
ajlsi-1012	51	83	disease	disease	NOUN
ajlsi-1012	51	84	,	,	PUNCT
ajlsi-1012	51	85	e.g.	e.g.	ADV
ajlsi-1012	51	86	,	,	PUNCT
ajlsi-1012	51	87	cough	cough	NOUN
ajlsi-1012	51	88	,	,	PUNCT
ajlsi-1012	51	89	shortness	shortness	NOUN
ajlsi-1012	51	90	of	of	ADP
ajlsi-1012	51	91	breath	breath	NOUN
ajlsi-1012	51	92	,	,	PUNCT
ajlsi-1012	51	93	and	and	CCONJ
ajlsi-1012	51	94	requiring	require	VERB
ajlsi-1012	51	95	hospitalization	hospitalization	NOUN
ajlsi-1012	51	96	)	)	PUNCT
ajlsi-1012	51	97	and	and	CCONJ
ajlsi-1012	51	98	in	in	ADP
ajlsi-1012	51	99	the	the	DET
ajlsi-1012	51	100	absence	absence	NOUN
ajlsi-1012	51	101	of	of	ADP
ajlsi-1012	51	102	an	an	DET
ajlsi-1012	51	103	alternative	alternative	ADJ
ajlsi-1012	51	104	diagnosis	diagnosis	NOUN
ajlsi-1012	51	105	that	that	PRON
ajlsi-1012	51	106	fully	fully	ADV
ajlsi-1012	51	107	explains	explain	VERB
ajlsi-1012	51	108	the	the	DET
ajlsi-1012	51	109	clinical	clinical	ADJ
ajlsi-1012	51	110	presentation	presentation	NOUN
ajlsi-1012	51	111	.	.	PUNCT
ajlsi-1012	52	1	as	as	ADP
ajlsi-1012	52	2	per	per	ADP
ajlsi-1012	52	3	the	the	PRON
ajlsi-1012	52	4	who	who	PRON
ajlsi-1012	52	5	guidelines	guideline	VERB
ajlsi-1012	52	6	,	,	PUNCT
ajlsi-1012	52	7	a	a	DET
ajlsi-1012	52	8	“	"	PUNCT
ajlsi-1012	52	9	probable	probable	ADJ
ajlsi-1012	52	10	case	case	NOUN
ajlsi-1012	52	11	”	"	PUNCT
ajlsi-1012	52	12	is	be	AUX
ajlsi-1012	52	13	a	a	DET
ajlsi-1012	52	14	suspect	suspect	ADJ
ajlsi-1012	52	15	case	case	NOUN
ajlsi-1012	52	16	for	for	SCONJ
ajlsi-1012	52	17	whom	whom	PRON
ajlsi-1012	52	18	testing	testing	NOUN
ajlsi-1012	52	19	for	for	ADP
ajlsi-1012	52	20	the	the	DET
ajlsi-1012	52	21	sars	sar	NOUN
ajlsi-1012	52	22	-	-	PUNCT
ajlsi-1012	52	23	cov-2	cov-2	NOUN
ajlsi-1012	52	24	is	be	AUX
ajlsi-1012	52	25	inconclusive	inconclusive	ADJ
ajlsi-1012	52	26	or	or	CCONJ
ajlsi-1012	52	27	for	for	ADP
ajlsi-1012	52	28	whom	whom	PRON
ajlsi-1012	52	29	testing	testing	NOUN
ajlsi-1012	52	30	could	could	AUX
ajlsi-1012	52	31	not	not	PART
ajlsi-1012	52	32	be	be	AUX
ajlsi-1012	52	33	performed	perform	VERB
ajlsi-1012	52	34	for	for	ADP
ajlsi-1012	52	35	any	any	DET
ajlsi-1012	52	36	reason	reason	NOUN
ajlsi-1012	52	37	.	.	PUNCT
ajlsi-1012	53	1	who	who	PRON
ajlsi-1012	53	2	further	far	ADV
ajlsi-1012	53	3	defines	define	VERB
ajlsi-1012	53	4	a	a	DET
ajlsi-1012	53	5	“	"	PUNCT
ajlsi-1012	53	6	contact	contact	NOUN
ajlsi-1012	53	7	”	"	PUNCT
ajlsi-1012	53	8	as	as	ADP
ajlsi-1012	53	9	a	a	DET
ajlsi-1012	53	10	person	person	NOUN
ajlsi-1012	53	11	who	who	PRON
ajlsi-1012	53	12	experienced	experience	VERB
ajlsi-1012	53	13	any	any	DET
ajlsi-1012	53	14	one	one	NUM
ajlsi-1012	53	15	of	of	ADP
ajlsi-1012	53	16	the	the	DET
ajlsi-1012	53	17	following	following	ADJ
ajlsi-1012	53	18	exposures	exposure	NOUN
ajlsi-1012	53	19	during	during	ADP
ajlsi-1012	53	20	the	the	DET
ajlsi-1012	53	21	2	2	NUM
ajlsi-1012	53	22	days	day	NOUN
ajlsi-1012	53	23	before	before	ADV
ajlsi-1012	53	24	and	and	CCONJ
ajlsi-1012	53	25	the	the	DET
ajlsi-1012	53	26	14	14	NUM
ajlsi-1012	53	27	days	day	NOUN
ajlsi-1012	53	28	after	after	ADP
ajlsi-1012	53	29	the	the	DET
ajlsi-1012	53	30	onset	onset	NOUN
ajlsi-1012	53	31	of	of	ADP
ajlsi-1012	53	32	symptoms	symptom	NOUN
ajlsi-1012	53	33	of	of	ADP
ajlsi-1012	53	34	a	a	DET
ajlsi-1012	53	35	probable	probable	ADJ
ajlsi-1012	53	36	or	or	CCONJ
ajlsi-1012	53	37	confirmed	confirm	VERB
ajlsi-1012	53	38	case	case	NOUN
ajlsi-1012	53	39	:	:	PUNCT
ajlsi-1012	53	40	(	(	PUNCT
ajlsi-1012	53	41	i	i	NOUN
ajlsi-1012	53	42	)	)	PUNCT
ajlsi-1012	53	43	face	face	NOUN
ajlsi-1012	53	44	-	-	PUNCT
ajlsi-1012	53	45	to	to	ADP
ajlsi-1012	53	46	-	-	PUNCT
ajlsi-1012	53	47	face	face	NOUN
ajlsi-1012	53	48	contact	contact	NOUN
ajlsi-1012	53	49	with	with	ADP
ajlsi-1012	53	50	a	a	DET
ajlsi-1012	53	51	probable	probable	ADJ
ajlsi-1012	53	52	or	or	CCONJ
ajlsi-1012	53	53	confirmed	confirm	VERB
ajlsi-1012	53	54	case	case	NOUN
ajlsi-1012	53	55	within	within	ADP
ajlsi-1012	53	56	1	1	NUM
ajlsi-1012	53	57	meter	meter	NOUN
ajlsi-1012	53	58	and	and	CCONJ
ajlsi-1012	53	59	for	for	ADP
ajlsi-1012	53	60	more	more	ADJ
ajlsi-1012	53	61	than	than	ADP
ajlsi-1012	53	62	15	15	NUM
ajlsi-1012	53	63	min	min	NOUN
ajlsi-1012	53	64	.	.	PROPN
ajlsi-1012	53	65	(	(	PUNCT
ajlsi-1012	53	66	ii	ii	NOUN
ajlsi-1012	53	67	)	)	PUNCT
ajlsi-1012	53	68	direct	direct	ADJ
ajlsi-1012	53	69	physical	physical	ADJ
ajlsi-1012	53	70	contact	contact	NOUN
ajlsi-1012	53	71	with	with	ADP
ajlsi-1012	53	72	a	a	DET
ajlsi-1012	53	73	probable	probable	ADJ
ajlsi-1012	53	74	or	or	CCONJ
ajlsi-1012	53	75	confirmed	confirm	VERB
ajlsi-1012	53	76	case	case	NOUN
ajlsi-1012	53	77	.	.	PUNCT
ajlsi-1012	54	1	(	(	PUNCT
ajlsi-1012	54	2	iii	iii	X
ajlsi-1012	54	3	)	)	PUNCT
ajlsi-1012	54	4	direct	direct	ADJ
ajlsi-1012	54	5	care	care	NOUN
ajlsi-1012	54	6	for	for	ADP
ajlsi-1012	54	7	a	a	DET
ajlsi-1012	54	8	patient	patient	NOUN
ajlsi-1012	54	9	with	with	ADP
ajlsi-1012	54	10	probable	probable	ADJ
ajlsi-1012	54	11	or	or	CCONJ
ajlsi-1012	54	12	confirmed	confirm	VERB
ajlsi-1012	54	13	covid-19	covid-19	PROPN
ajlsi-1012	54	14	disease	disease	NOUN
ajlsi-1012	54	15	without	without	ADP
ajlsi-1012	54	16	using	use	VERB
ajlsi-1012	54	17	proper	proper	ADJ
ajlsi-1012	54	18	personal	personal	ADJ
ajlsi-1012	54	19	protective	protective	ADJ
ajlsi-1012	54	20	equipment	equipment	NOUN
ajlsi-1012	54	21	.	.	PUNCT
ajlsi-1012	55	1	for	for	ADP
ajlsi-1012	55	2	confirmed	confirm	VERB
ajlsi-1012	55	3	asymptomatic	asymptomatic	ADJ
ajlsi-1012	55	4	cases	case	NOUN
ajlsi-1012	55	5	,	,	PUNCT
ajlsi-1012	55	6	the	the	DET
ajlsi-1012	55	7	period	period	NOUN
ajlsi-1012	55	8	of	of	ADP
ajlsi-1012	55	9	contact	contact	NOUN
ajlsi-1012	55	10	is	be	AUX
ajlsi-1012	55	11	measured	measure	VERB
ajlsi-1012	55	12	as	as	ADP
ajlsi-1012	55	13	the	the	DET
ajlsi-1012	55	14	2	2	NUM
ajlsi-1012	55	15	days	day	NOUN
ajlsi-1012	55	16	before	before	ADV
ajlsi-1012	55	17	through	through	ADP
ajlsi-1012	55	18	the	the	DET
ajlsi-1012	55	19	14	14	NUM
ajlsi-1012	55	20	days	day	NOUN
ajlsi-1012	55	21	after	after	ADP
ajlsi-1012	55	22	the	the	DET
ajlsi-1012	55	23	date	date	NOUN
ajlsi-1012	55	24	on	on	ADP
ajlsi-1012	55	25	which	which	PRON
ajlsi-1012	55	26	the	the	DET
ajlsi-1012	55	27	sample	sample	NOUN
ajlsi-1012	55	28	was	be	AUX
ajlsi-1012	55	29	taken	take	VERB
ajlsi-1012	55	30	,	,	PUNCT
ajlsi-1012	55	31	which	which	PRON
ajlsi-1012	55	32	led	lead	VERB
ajlsi-1012	55	33	to	to	ADP
ajlsi-1012	55	34	confirmation	confirmation	NOUN
ajlsi-1012	55	35	.	.	PUNCT
ajlsi-1012	56	1	(	(	PUNCT
ajlsi-1012	56	2	venter	venter	NOUN
ajlsi-1012	56	3	,	,	PUNCT
ajlsi-1012	56	4	m.	m.	NOUN
ajlsi-1012	56	5	,	,	PUNCT
ajlsi-1012	56	6	&	&	CCONJ
ajlsi-1012	56	7	richter	richter	PROPN
ajlsi-1012	56	8	,	,	PUNCT
ajlsi-1012	56	9	2020	2020	NUM
ajlsi-1012	56	10	)	)	PUNCT
ajlsi-1012	56	11	.	.	PUNCT
ajlsi-1012	57	1	specific	specific	ADJ
ajlsi-1012	57	2	and	and	CCONJ
ajlsi-1012	57	3	real	real	ADJ
ajlsi-1012	57	4	-	-	PUNCT
ajlsi-1012	57	5	time	time	NOUN
ajlsi-1012	57	6	diagnostic	diagnostic	ADJ
ajlsi-1012	57	7	tests	test	NOUN
ajlsi-1012	57	8	should	should	AUX
ajlsi-1012	57	9	be	be	AUX
ajlsi-1012	57	10	performed	perform	VERB
ajlsi-1012	57	11	not	not	PART
ajlsi-1012	57	12	only	only	ADV
ajlsi-1012	57	13	for	for	ADP
ajlsi-1012	57	14	the	the	DET
ajlsi-1012	57	15	identification	identification	NOUN
ajlsi-1012	57	16	of	of	ADP
ajlsi-1012	57	17	potential	potential	ADJ
ajlsi-1012	57	18	cases	case	NOUN
ajlsi-1012	57	19	but	but	CCONJ
ajlsi-1012	57	20	also	also	ADV
ajlsi-1012	57	21	for	for	ADP
ajlsi-1012	57	22	contacts	contact	NOUN
ajlsi-1012	57	23	who	who	PRON
ajlsi-1012	57	24	need	need	VERB
ajlsi-1012	57	25	to	to	PART
ajlsi-1012	57	26	be	be	AUX
ajlsi-1012	57	27	quarantined	quarantine	VERB
ajlsi-1012	57	28	and	and	CCONJ
ajlsi-1012	57	29	guided	guide	VERB
ajlsi-1012	57	30	on	on	ADP
ajlsi-1012	57	31	epidemiological	epidemiological	ADJ
ajlsi-1012	57	32	questions	question	NOUN
ajlsi-1012	57	33	around	around	ADP
ajlsi-1012	57	34	the	the	DET
ajlsi-1012	57	35	infection	infection	NOUN
ajlsi-1012	57	36	.	.	PUNCT
ajlsi-1012	58	1	selection	selection	NOUN
ajlsi-1012	58	2	of	of	ADP
ajlsi-1012	58	3	the	the	DET
ajlsi-1012	58	4	relevant	relevant	ADJ
ajlsi-1012	58	5	specimen	speciman	NOUN
ajlsi-1012	58	6	and	and	CCONJ
ajlsi-1012	58	7	knowledge	knowledge	NOUN
ajlsi-1012	58	8	of	of	ADP
ajlsi-1012	58	9	the	the	DET
ajlsi-1012	58	10	incubation	incubation	NOUN
ajlsi-1012	58	11	period	period	NOUN
ajlsi-1012	58	12	,	,	PUNCT
ajlsi-1012	58	13	viremia	viremia	NOUN
ajlsi-1012	58	14	,	,	PUNCT
ajlsi-1012	58	15	and	and	CCONJ
ajlsi-1012	58	16	shedding	shed	VERB
ajlsi-1012	58	17	period	period	NOUN
ajlsi-1012	58	18	are	be	AUX
ajlsi-1012	58	19	important	important	ADJ
ajlsi-1012	58	20	criteria	criterion	NOUN
ajlsi-1012	58	21	in	in	ADP
ajlsi-1012	58	22	diagnosing	diagnose	VERB
ajlsi-1012	58	23	individual	individual	ADJ
ajlsi-1012	58	24	cases	case	NOUN
ajlsi-1012	58	25	and	and	CCONJ
ajlsi-1012	58	26	defining	define	VERB
ajlsi-1012	58	27	transmissibility	transmissibility	NOUN
ajlsi-1012	58	28	to	to	PART
ajlsi-1012	58	29	inform	inform	VERB
ajlsi-1012	58	30	the	the	DET
ajlsi-1012	58	31	extent	extent	NOUN
ajlsi-1012	58	32	of	of	ADP
ajlsi-1012	58	33	isolation	isolation	NOUN
ajlsi-1012	58	34	periods	period	NOUN
ajlsi-1012	58	35	for	for	ADP
ajlsi-1012	58	36	patients	patient	NOUN
ajlsi-1012	58	37	.	.	PUNCT
ajlsi-1012	59	1	nucleic	nucleic	ADJ
ajlsi-1012	59	2	acid	acid	NOUN
ajlsi-1012	59	3	testing	testing	NOUN
ajlsi-1012	59	4	(	(	PUNCT
ajlsi-1012	59	5	reverse	reverse	VERB
ajlsi-1012	59	6	transcriptase	transcriptase	NOUN
ajlsi-1012	59	7	pcr	pcr	NOUN
ajlsi-1012	59	8	)	)	PUNCT
ajlsi-1012	59	9	is	be	AUX
ajlsi-1012	59	10	recommended	recommend	VERB
ajlsi-1012	59	11	for	for	ADP
ajlsi-1012	59	12	the	the	DET
ajlsi-1012	59	13	diagnosis	diagnosis	NOUN
ajlsi-1012	59	14	of	of	ADP
ajlsi-1012	59	15	acute	acute	ADJ
ajlsi-1012	59	16	cases	case	NOUN
ajlsi-1012	59	17	.	.	PUNCT
ajlsi-1012	60	1	serological	serological	ADJ
ajlsi-1012	60	2	assays	assay	NOUN
ajlsi-1012	60	3	have	have	VERB
ajlsi-1012	60	4	an	an	DET
ajlsi-1012	60	5	important	important	ADJ
ajlsi-1012	60	6	role	role	NOUN
ajlsi-1012	60	7	in	in	ADP
ajlsi-1012	60	8	answering	answer	VERB
ajlsi-1012	60	9	epidemiological	epidemiological	ADJ
ajlsi-1012	60	10	questions	question	NOUN
ajlsi-1012	60	11	,	,	PUNCT
ajlsi-1012	60	12	including	include	VERB
ajlsi-1012	60	13	determining	determine	VERB
ajlsi-1012	60	14	the	the	DET
ajlsi-1012	60	15	exposure	exposure	NOUN
ajlsi-1012	60	16	rate	rate	NOUN
ajlsi-1012	60	17	and	and	CCONJ
ajlsi-1012	60	18	accessing	access	VERB
ajlsi-1012	60	19	community	community	NOUN
ajlsi-1012	60	20	spreads	spread	NOUN
ajlsi-1012	60	21	,	,	PUNCT
ajlsi-1012	60	22	but	but	CCONJ
ajlsi-1012	60	23	are	be	AUX
ajlsi-1012	60	24	not	not	PART
ajlsi-1012	60	25	relevant	relevant	ADJ
ajlsi-1012	60	26	for	for	ADP
ajlsi-1012	60	27	accurate	accurate	ADJ
ajlsi-1012	60	28	diagnoses	diagnosis	NOUN
ajlsi-1012	60	29	of	of	ADP
ajlsi-1012	60	30	acute	acute	ADJ
ajlsi-1012	60	31	cases	case	NOUN
ajlsi-1012	60	32	.	.	PUNCT
ajlsi-1012	61	1	only	only	ADV
ajlsi-1012	61	2	laboratory	laboratory	NOUN
ajlsi-1012	61	3	confirmation	confirmation	NOUN
ajlsi-1012	61	4	can	can	AUX
ajlsi-1012	61	5	be	be	AUX
ajlsi-1012	61	6	used	use	VERB
ajlsi-1012	61	7	to	to	PART
ajlsi-1012	61	8	make	make	VERB
ajlsi-1012	61	9	an	an	DET
ajlsi-1012	61	10	etiological	etiological	ADJ
ajlsi-1012	61	11	diagnosis	diagnosis	NOUN
ajlsi-1012	61	12	and	and	CCONJ
ajlsi-1012	61	13	differentiate	differentiate	VERB
ajlsi-1012	61	14	atypical	atypical	ADJ
ajlsi-1012	61	15	pneumonia	pneumonia	NOUN
ajlsi-1012	61	16	from	from	ADP
ajlsi-1012	61	17	other	other	ADJ
ajlsi-1012	61	18	causes	cause	NOUN
ajlsi-1012	61	19	.	.	PUNCT
ajlsi-1012	62	1	proper	proper	ADJ
ajlsi-1012	62	2	collection	collection	NOUN
ajlsi-1012	62	3	of	of	ADP
ajlsi-1012	62	4	samples	sample	NOUN
ajlsi-1012	62	5	is	be	AUX
ajlsi-1012	62	6	the	the	DET
ajlsi-1012	62	7	most	most	ADV
ajlsi-1012	62	8	important	important	ADJ
ajlsi-1012	62	9	step	step	NOUN
ajlsi-1012	62	10	in	in	ADP
ajlsi-1012	62	11	the	the	DET
ajlsi-1012	62	12	laboratory	laboratory	NOUN
ajlsi-1012	62	13	diagnosis	diagnosis	NOUN
ajlsi-1012	62	14	of	of	ADP
ajlsi-1012	62	15	infectious	infectious	ADJ
ajlsi-1012	62	16	diseases	disease	NOUN
ajlsi-1012	62	17	.	.	PUNCT
ajlsi-1012	63	1	a	a	DET
ajlsi-1012	63	2	specimen	speciman	NOUN
ajlsi-1012	63	3	that	that	PRON
ajlsi-1012	63	4	is	be	AUX
ajlsi-1012	63	5	not	not	PART
ajlsi-1012	63	6	collected	collect	VERB
ajlsi-1012	63	7	correctly	correctly	ADV
ajlsi-1012	63	8	may	may	AUX
ajlsi-1012	63	9	lead	lead	VERB
ajlsi-1012	63	10	to	to	ADP
ajlsi-1012	63	11	a	a	DET
ajlsi-1012	63	12	negative	negative	ADJ
ajlsi-1012	63	13	result	result	NOUN
ajlsi-1012	63	14	.	.	PUNCT
ajlsi-1012	64	1	as	as	ADP
ajlsi-1012	64	2	per	per	ADP
ajlsi-1012	64	3	the	the	DET
ajlsi-1012	64	4	center	center	NOUN
ajlsi-1012	64	5	for	for	ADP
ajlsi-1012	64	6	disease	disease	NOUN
ajlsi-1012	64	7	control	control	NOUN
ajlsi-1012	64	8	and	and	CCONJ
ajlsi-1012	64	9	prevention	prevention	NOUN
ajlsi-1012	64	10	(	(	PUNCT
ajlsi-1012	64	11	cdc	cdc	NOUN
ajlsi-1012	64	12	)	)	PUNCT
ajlsi-1012	64	13	recommendations	recommendation	NOUN
ajlsi-1012	64	14	,	,	PUNCT
ajlsi-1012	64	15	the	the	DET
ajlsi-1012	64	16	upper	upper	ADJ
ajlsi-1012	64	17	respiratory	respiratory	ADJ
ajlsi-1012	64	18	specimen	speciman	NOUN
ajlsi-1012	64	19	should	should	AUX
ajlsi-1012	64	20	be	be	AUX
ajlsi-1012	64	21	collected	collect	VERB
ajlsi-1012	64	22	for	for	ADP
ajlsi-1012	64	23	rt	rt	ADJ
ajlsi-1012	64	24	-	-	PUNCT
ajlsi-1012	64	25	pcr	pcr	NOUN
ajlsi-1012	64	26	-	-	PUNCT
ajlsi-1012	64	27	based	base	VERB
ajlsi-1012	64	28	testing	testing	NOUN
ajlsi-1012	64	29	of	of	ADP
ajlsi-1012	64	30	covid-19	covid-19	PROPN
ajlsi-1012	64	31	,	,	PUNCT
ajlsi-1012	64	32	and	and	CCONJ
ajlsi-1012	64	33	especially	especially	ADV
ajlsi-1012	64	34	the	the	DET
ajlsi-1012	64	35	nasopharyngeal	nasopharyngeal	NOUN
ajlsi-1012	64	36	exudate	exudate	NOUN
ajlsi-1012	64	37	is	be	AUX
ajlsi-1012	64	38	the	the	DET
ajlsi-1012	64	39	preferred	preferred	ADJ
ajlsi-1012	64	40	choice	choice	NOUN
ajlsi-1012	64	41	(	(	PUNCT
ajlsi-1012	64	42	cdc	cdc	PROPN
ajlsi-1012	64	43	,	,	PUNCT
ajlsi-1012	64	44	2020	2020	NUM
ajlsi-1012	64	45	)	)	PUNCT
ajlsi-1012	64	46	.	.	PUNCT
ajlsi-1012	65	1	within	within	ADP
ajlsi-1012	65	2	a	a	DET
ajlsi-1012	65	3	week	week	NOUN
ajlsi-1012	65	4	from	from	ADP
ajlsi-1012	65	5	the	the	DET
ajlsi-1012	65	6	onset	onset	NOUN
ajlsi-1012	65	7	of	of	ADP
ajlsi-1012	65	8	symptoms	symptom	NOUN
ajlsi-1012	65	9	,	,	PUNCT
ajlsi-1012	65	10	patients	patient	NOUN
ajlsi-1012	65	11	with	with	ADP
ajlsi-1012	65	12	covid-19	covid-19	PROPN
ajlsi-1012	65	13	usually	usually	ADV
ajlsi-1012	65	14	possess	possess	VERB
ajlsi-1012	65	15	high	high	ADJ
ajlsi-1012	65	16	viral	viral	ADJ
ajlsi-1012	65	17	loads	load	NOUN
ajlsi-1012	65	18	in	in	ADP
ajlsi-1012	65	19	their	their	PRON
ajlsi-1012	65	20	upper	upper	ADJ
ajlsi-1012	65	21	and	and	CCONJ
ajlsi-1012	65	22	lower	low	ADJ
ajlsi-1012	65	23	respiratory	respiratory	ADJ
ajlsi-1012	65	24	tracts	tract	NOUN
ajlsi-1012	65	25	.	.	PUNCT
ajlsi-1012	66	1	(	(	PUNCT
ajlsi-1012	66	2	zhou	zhou	X
ajlsi-1012	66	3	et	et	PROPN
ajlsi-1012	66	4	al	al	PROPN
ajlsi-1012	66	5	.	.	PROPN
ajlsi-1012	66	6	,	,	PUNCT
ajlsi-1012	66	7	2020	2020	NUM
ajlsi-1012	66	8	)	)	PUNCT
ajlsi-1012	66	9	.	.	PUNCT
ajlsi-1012	67	1	a	a	DET
ajlsi-1012	67	2	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	67	3	swab	swab	NOUN
ajlsi-1012	67	4	and/or	and/or	CCONJ
ajlsi-1012	67	5	an	an	DET
ajlsi-1012	67	6	oropharyngeal	oropharyngeal	NOUN
ajlsi-1012	67	7	swab	swab	NOUN
ajlsi-1012	67	8	are	be	AUX
ajlsi-1012	67	9	often	often	ADV
ajlsi-1012	67	10	recommended	recommend	VERB
ajlsi-1012	67	11	for	for	ADP
ajlsi-1012	67	12	screening	screen	VERB
ajlsi-1012	67	13	or	or	CCONJ
ajlsi-1012	67	14	diagnosing	diagnose	VERB
ajlsi-1012	67	15	early	early	ADJ
ajlsi-1012	67	16	infections	infection	NOUN
ajlsi-1012	67	17	.	.	PUNCT
ajlsi-1012	68	1	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	68	2	swabs	swab	NOUN
ajlsi-1012	68	3	usually	usually	ADV
ajlsi-1012	68	4	reach	reach	VERB
ajlsi-1012	68	5	the	the	DET
ajlsi-1012	68	6	correct	correct	ADJ
ajlsi-1012	68	7	area	area	NOUN
ajlsi-1012	68	8	to	to	PART
ajlsi-1012	68	9	be	be	AUX
ajlsi-1012	68	10	tested	test	VERB
ajlsi-1012	68	11	in	in	ADP
ajlsi-1012	68	12	the	the	DET
ajlsi-1012	68	13	nasal	nasal	ADJ
ajlsi-1012	68	14	cavity	cavity	NOUN
ajlsi-1012	68	15	(	(	PUNCT
ajlsi-1012	68	16	wang	wang	PROPN
ajlsi-1012	68	17	et	et	PROPN
ajlsi-1012	68	18	al	al	PROPN
ajlsi-1012	68	19	.	.	PROPN
ajlsi-1012	68	20	,	,	PUNCT
ajlsi-1012	68	21	2020	2020	NUM
ajlsi-1012	68	22	)	)	PUNCT
ajlsi-1012	68	23	reported	report	VERB
ajlsi-1012	68	24	that	that	SCONJ
ajlsi-1012	68	25	oropharyngeal	oropharyngeal	ADJ
ajlsi-1012	68	26	swabs	swab	NOUN
ajlsi-1012	68	27	were	be	AUX
ajlsi-1012	68	28	used	use	VERB
ajlsi-1012	68	29	much	much	ADV
ajlsi-1012	68	30	more	more	ADV
ajlsi-1012	68	31	frequently	frequently	ADV
ajlsi-1012	68	32	than	than	ADP
ajlsi-1012	68	33	nasal	nasal	ADJ
ajlsi-1012	68	34	swabs	swab	NOUN
ajlsi-1012	68	35	in	in	ADP
ajlsi-1012	68	36	china	china	PROPN
ajlsi-1012	68	37	during	during	ADP
ajlsi-1012	68	38	the	the	DET
ajlsi-1012	68	39	current	current	ADJ
ajlsi-1012	68	40	covid-19	covid-19	PROPN
ajlsi-1012	68	41	outbreak	outbreak	NOUN
ajlsi-1012	68	42	;	;	PUNCT
ajlsi-1012	68	43	however	however	ADV
ajlsi-1012	68	44	,	,	PUNCT
ajlsi-1012	68	45	the	the	DET
ajlsi-1012	68	46	sarscov-2	sarscov-2	PROPN
ajlsi-1012	68	47	rna	rna	NOUN
ajlsi-1012	68	48	was	be	AUX
ajlsi-1012	68	49	detected	detect	VERB
ajlsi-1012	68	50	in	in	ADP
ajlsi-1012	68	51	only	only	ADV
ajlsi-1012	68	52	32	32	NUM
ajlsi-1012	68	53	%	%	NOUN
ajlsi-1012	68	54	of	of	ADP
ajlsi-1012	68	55	oropharyngeal	oropharyngeal	ADJ
ajlsi-1012	68	56	swabs	swab	NOUN
ajlsi-1012	68	57	,	,	PUNCT
ajlsi-1012	68	58	which	which	PRON
ajlsi-1012	68	59	was	be	AUX
ajlsi-1012	68	60	significantly	significantly	ADV
ajlsi-1012	68	61	lower	low	ADJ
ajlsi-1012	68	62	than	than	ADP
ajlsi-1012	68	63	the	the	DET
ajlsi-1012	68	64	level	level	NOUN
ajlsi-1012	68	65	in	in	ADP
ajlsi-1012	68	66	nasal	nasal	PROPN
ajlsi-1012	68	67	swabs	swab	NOUN
ajlsi-1012	68	68	(	(	PUNCT
ajlsi-1012	68	69	63	63	NUM
ajlsi-1012	68	70	%	%	NOUN
ajlsi-1012	68	71	)	)	PUNCT
ajlsi-1012	68	72	.	.	PUNCT
ajlsi-1012	69	1	for	for	ADP
ajlsi-1012	69	2	the	the	DET
ajlsi-1012	69	3	late	late	ADJ
ajlsi-1012	69	4	detection	detection	NOUN
ajlsi-1012	69	5	and	and	CCONJ
ajlsi-1012	69	6	monitoring	monitoring	NOUN
ajlsi-1012	69	7	of	of	ADP
ajlsi-1012	69	8	patients	patient	NOUN
ajlsi-1012	69	9	with	with	ADP
ajlsi-1012	69	10	severe	severe	ADJ
ajlsi-1012	69	11	covid-19	covid-19	PROPN
ajlsi-1012	69	12	pneumonia	pneumonia	NOUN
ajlsi-1012	69	13	.	.	PUNCT
ajlsi-1012	70	1	ideally	ideally	ADV
ajlsi-1012	70	2	,	,	PUNCT
ajlsi-1012	70	3	sputum	sputum	NOUN
ajlsi-1012	70	4	sampling	sampling	NOUN
ajlsi-1012	70	5	or	or	CCONJ
ajlsi-1012	70	6	bronchoalveolar	bronchoalveolar	ADJ
ajlsi-1012	70	7	lavage	lavage	NOUN
ajlsi-1012	70	8	(	(	PUNCT
ajlsi-1012	70	9	bal	bal	ADJ
ajlsi-1012	70	10	)	)	PUNCT
ajlsi-1012	70	11	has	have	AUX
ajlsi-1012	70	12	been	be	AUX
ajlsi-1012	70	13	used	use	VERB
ajlsi-1012	70	14	for	for	ADP
ajlsi-1012	70	15	collecting	collect	VERB
ajlsi-1012	70	16	lower	low	ADJ
ajlsi-1012	70	17	respiratory	respiratory	ADJ
ajlsi-1012	70	18	tract	tract	NOUN
ajlsi-1012	70	19	specimens	specimen	NOUN
ajlsi-1012	70	20	as	as	SCONJ
ajlsi-1012	70	21	they	they	PRON
ajlsi-1012	70	22	have	have	AUX
ajlsi-1012	70	23	yielded	yield	VERB
ajlsi-1012	70	24	the	the	DET
ajlsi-1012	70	25	highest	high	ADJ
ajlsi-1012	70	26	viral	viral	ADJ
ajlsi-1012	70	27	loads	load	NOUN
ajlsi-1012	70	28	for	for	ADP
ajlsi-1012	70	29	the	the	DET
ajlsi-1012	70	30	diagnosis	diagnosis	NOUN
ajlsi-1012	70	31	of	of	ADP
ajlsi-1012	70	32	covid-19	covid-19	PROPN
ajlsi-1012	70	33	(	(	PUNCT
ajlsi-1012	70	34	li	li	PROPN
ajlsi-1012	70	35	et	et	PROPN
ajlsi-1012	70	36	al	al	PROPN
ajlsi-1012	70	37	.	.	PROPN
ajlsi-1012	70	38	,	,	PUNCT
ajlsi-1012	70	39	2020	2020	NUM
ajlsi-1012	70	40	;	;	PUNCT
ajlsi-1012	70	41	yu	yu	PROPN
ajlsi-1012	70	42	et	et	PROPN
ajlsi-1012	70	43	al	al	PROPN
ajlsi-1012	70	44	.	.	PROPN
ajlsi-1012	70	45	,	,	PUNCT
ajlsi-1012	70	46	2020	2020	NUM
ajlsi-1012	70	47	)	)	PUNCT
ajlsi-1012	70	48	.	.	PUNCT
ajlsi-1012	71	1	a	a	DET
ajlsi-1012	71	2	recent	recent	ADJ
ajlsi-1012	71	3	study	study	NOUN
ajlsi-1012	71	4	revealed	reveal	VERB
ajlsi-1012	71	5	that	that	SCONJ
ajlsi-1012	71	6	samples	sample	NOUN
ajlsi-1012	71	7	of	of	ADP
ajlsi-1012	71	8	bronchoalveolar	bronchoalveolar	ADJ
ajlsi-1012	71	9	lavage	lavage	NOUN
ajlsi-1012	71	10	fluid	fluid	NOUN
ajlsi-1012	71	11	yielded	yield	VERB
ajlsi-1012	71	12	the	the	DET
ajlsi-1012	71	13	highest	high	ADJ
ajlsi-1012	71	14	sars	sar	NOUN
ajlsi-1012	71	15	-	-	PUNCT
ajlsi-1012	71	16	cov-2	cov-2	NOUN
ajlsi-1012	71	17	rna	rna	NOUN
ajlsi-1012	71	18	rate	rate	NOUN
ajlsi-1012	71	19	,	,	PUNCT
ajlsi-1012	71	20	although	although	SCONJ
ajlsi-1012	71	21	this	this	DET
ajlsi-1012	71	22	study	study	NOUN
ajlsi-1012	71	23	did	do	AUX
ajlsi-1012	71	24	not	not	PART
ajlsi-1012	71	25	compare	compare	VERB
ajlsi-1012	71	26	or	or	CCONJ
ajlsi-1012	71	27	evaluate	evaluate	VERB
ajlsi-1012	71	28	results	result	NOUN
ajlsi-1012	71	29	from	from	ADP
ajlsi-1012	71	30	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	71	31	swabs	swab	NOUN
ajlsi-1012	71	32	(	(	PUNCT
ajlsi-1012	71	33	wang	wang	PROPN
ajlsi-1012	71	34	et	et	PROPN
ajlsi-1012	71	35	al	al	PROPN
ajlsi-1012	71	36	.	.	PROPN
ajlsi-1012	71	37	,	,	PUNCT
ajlsi-1012	71	38	2020	2020	NUM
ajlsi-1012	71	39	)	)	PUNCT
ajlsi-1012	71	40	.	.	PUNCT
ajlsi-1012	72	1	patients	patient	NOUN
ajlsi-1012	72	2	who	who	PRON
ajlsi-1012	72	3	present	present	VERB
ajlsi-1012	72	4	with	with	ADP
ajlsi-1012	72	5	severe	severe	ADJ
ajlsi-1012	72	6	pneumonia	pneumonia	NOUN
ajlsi-1012	72	7	and	and	CCONJ
ajlsi-1012	72	8	acute	acute	ADJ
ajlsi-1012	72	9	respiratory	respiratory	ADJ
ajlsi-1012	72	10	distress	distress	NOUN
ajlsi-1012	72	11	syndrome	syndrome	NOUN
ajlsi-1012	72	12	may	may	AUX
ajlsi-1012	72	13	require	require	VERB
ajlsi-1012	72	14	emergent	emergent	ADJ
ajlsi-1012	72	15	intubation	intubation	NOUN
ajlsi-1012	72	16	as	as	ADV
ajlsi-1012	72	17	well	well	ADV
ajlsi-1012	72	18	as	as	ADP
ajlsi-1012	72	19	respiratory	respiratory	ADJ
ajlsi-1012	72	20	isolation	isolation	NOUN
ajlsi-1012	72	21	in	in	ADP
ajlsi-1012	72	22	a	a	DET
ajlsi-1012	72	23	negative	negative	ADJ
ajlsi-1012	72	24	-	-	PUNCT
ajlsi-1012	72	25	pressure	pressure	NOUN
ajlsi-1012	72	26	room	room	NOUN
ajlsi-1012	72	27	.	.	PUNCT
ajlsi-1012	73	1	if	if	SCONJ
ajlsi-1012	73	2	possible	possible	ADJ
ajlsi-1012	73	3	,	,	PUNCT
ajlsi-1012	73	4	a	a	DET
ajlsi-1012	73	5	lower	low	ADJ
ajlsi-1012	73	6	respiratory	respiratory	ADJ
ajlsi-1012	73	7	tract	tract	NOUN
ajlsi-1012	73	8	sputum	sputum	NOUN
ajlsi-1012	73	9	specimen	speciman	NOUN
ajlsi-1012	73	10	should	should	AUX
ajlsi-1012	73	11	be	be	AUX
ajlsi-1012	73	12	collected	collect	VERB
ajlsi-1012	73	13	during	during	ADP
ajlsi-1012	73	14	the	the	DET
ajlsi-1012	73	15	intubation	intubation	NOUN
ajlsi-1012	73	16	procedure	procedure	NOUN
ajlsi-1012	73	17	.	.	PUNCT
ajlsi-1012	74	1	alternatively	alternatively	ADV
ajlsi-1012	74	2	,	,	PUNCT
ajlsi-1012	74	3	sputum	sputum	PROPN
ajlsi-1012	74	4	and/or	and/or	CCONJ
ajlsi-1012	74	5	bronchoalveolar	bronchoalveolar	ADJ
ajlsi-1012	74	6	lavage	lavage	NOUN
ajlsi-1012	74	7	fluid	fluid	NOUN
ajlsi-1012	74	8	specimens	specimen	NOUN
ajlsi-1012	74	9	may	may	AUX
ajlsi-1012	74	10	be	be	AUX
ajlsi-1012	74	11	collected	collect	VERB
ajlsi-1012	74	12	after	after	ADP
ajlsi-1012	74	13	intubation	intubation	NOUN
ajlsi-1012	74	14	(	(	PUNCT
ajlsi-1012	74	15	pan	pan	NOUN
ajlsi-1012	74	16	et	et	PROPN
ajlsi-1012	74	17	al	al	PROPN
ajlsi-1012	74	18	.	.	PROPN
ajlsi-1012	74	19	,	,	PUNCT
ajlsi-1012	74	20	2020	2020	NUM
ajlsi-1012	74	21	)	)	PUNCT
ajlsi-1012	74	22	.	.	PUNCT
ajlsi-1012	75	1	collecting	collect	VERB
ajlsi-1012	75	2	a	a	DET
ajlsi-1012	75	3	respiratory	respiratory	ADJ
ajlsi-1012	75	4	swab	swab	NOUN
ajlsi-1012	75	5	specimen	speciman	NOUN
ajlsi-1012	75	6	may	may	AUX
ajlsi-1012	75	7	carry	carry	VERB
ajlsi-1012	75	8	a	a	DET
ajlsi-1012	75	9	theoretical	theoretical	ADJ
ajlsi-1012	75	10	risk	risk	NOUN
ajlsi-1012	75	11	of	of	ADP
ajlsi-1012	75	12	transmitting	transmit	VERB
ajlsi-1012	75	13	sars	sar	NOUN
ajlsi-1012	75	14	-	-	PUNCT
ajlsi-1012	75	15	cov-2	cov-2	NOUN
ajlsi-1012	75	16	,	,	PUNCT
ajlsi-1012	75	17	particularly	particularly	ADV
ajlsi-1012	75	18	if	if	SCONJ
ajlsi-1012	75	19	chances	chance	NOUN
ajlsi-1012	75	20	of	of	ADP
ajlsi-1012	75	21	airborne	airborne	ADJ
ajlsi-1012	75	22	transmission	transmission	NOUN
ajlsi-1012	75	23	are	be	AUX
ajlsi-1012	75	24	demonstrated	demonstrate	VERB
ajlsi-1012	75	25	.	.	PUNCT
ajlsi-1012	76	1	currently	currently	ADV
ajlsi-1012	76	2	,	,	PUNCT
ajlsi-1012	76	3	biosafety	biosafety	NOUN
ajlsi-1012	76	4	level	level	NOUN
ajlsi-1012	76	5	(	(	PUNCT
ajlsi-1012	76	6	bsl)-2	bsl)-2	NOUN
ajlsi-1012	76	7	conditions	condition	NOUN
ajlsi-1012	76	8	are	be	AUX
ajlsi-1012	76	9	recommended	recommend	VERB
ajlsi-1012	76	10	for	for	ADP
ajlsi-1012	76	11	the	the	DET
ajlsi-1012	76	12	handling	handling	NOUN
ajlsi-1012	76	13	of	of	ADP
ajlsi-1012	76	14	specimens	specimen	NOUN
ajlsi-1012	76	15	for	for	ADP
ajlsi-1012	76	16	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	76	17	pa	pa	PROPN
ajlsi-1012	76	18	ge	ge	PROPN
ajlsi-1012	76	19	31	31	NUM
ajlsi-1012	76	20	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	76	21	am	am	NOUN
ajlsi-1012	76	22	.	.	PUNCT
ajlsi-1012	77	1	j.	j.	PROPN
ajlsi-1012	77	2	life	life	PROPN
ajlsi-1012	77	3	sci	sci	PROPN
ajlsi-1012	77	4	.	.	PUNCT
ajlsi-1012	77	5	innov	innov	PROPN
ajlsi-1012	77	6	.	.	PUNCT
ajlsi-1012	78	1	1(2	1(2	NUM
ajlsi-1012	78	2	)	)	PUNCT
ajlsi-1012	78	3	29	29	NUM
ajlsi-1012	78	4	-	-	SYM
ajlsi-1012	78	5	42	42	NUM
ajlsi-1012	78	6	,	,	PUNCT
ajlsi-1012	78	7	2022	2022	NUM
ajlsi-1012	78	8	molecular	molecular	ADJ
ajlsi-1012	78	9	testing	testing	NOUN
ajlsi-1012	78	10	.	.	PUNCT
ajlsi-1012	79	1	while	while	SCONJ
ajlsi-1012	79	2	collecting	collect	VERB
ajlsi-1012	79	3	specimens	specimen	NOUN
ajlsi-1012	79	4	,	,	PUNCT
ajlsi-1012	79	5	health	health	NOUN
ajlsi-1012	79	6	care	care	NOUN
ajlsi-1012	79	7	professionals	professional	NOUN
ajlsi-1012	79	8	should	should	AUX
ajlsi-1012	79	9	follow	follow	VERB
ajlsi-1012	79	10	who	who	PRON
ajlsi-1012	79	11	infection	infection	NOUN
ajlsi-1012	79	12	prevention	prevention	NOUN
ajlsi-1012	79	13	and	and	CCONJ
ajlsi-1012	79	14	control	control	NOUN
ajlsi-1012	79	15	guidelines	guideline	NOUN
ajlsi-1012	79	16	and	and	CCONJ
ajlsi-1012	79	17	wear	wear	VERB
ajlsi-1012	79	18	personal	personal	ADJ
ajlsi-1012	79	19	protective	protective	ADJ
ajlsi-1012	79	20	equipment	equipment	NOUN
ajlsi-1012	79	21	(	(	PUNCT
ajlsi-1012	79	22	ppe	ppe	PROPN
ajlsi-1012	79	23	)	)	PUNCT
ajlsi-1012	79	24	such	such	ADJ
ajlsi-1012	79	25	as	as	ADP
ajlsi-1012	79	26	gloves	glove	NOUN
ajlsi-1012	79	27	,	,	PUNCT
ajlsi-1012	79	28	gowns	gown	NOUN
ajlsi-1012	79	29	,	,	PUNCT
ajlsi-1012	79	30	eye	eye	NOUN
ajlsi-1012	79	31	protection	protection	NOUN
ajlsi-1012	79	32	,	,	PUNCT
ajlsi-1012	79	33	and	and	CCONJ
ajlsi-1012	79	34	n95	n95	ADJ
ajlsi-1012	79	35	masks	mask	NOUN
ajlsi-1012	79	36	(	(	PUNCT
ajlsi-1012	79	37	who	who	PRON
ajlsi-1012	79	38	2020	2020	NUM
ajlsi-1012	79	39	)	)	PUNCT
ajlsi-1012	79	40	.	.	PUNCT
ajlsi-1012	80	1	all	all	DET
ajlsi-1012	80	2	specimens	specimen	NOUN
ajlsi-1012	80	3	collected	collect	VERB
ajlsi-1012	80	4	for	for	ADP
ajlsi-1012	80	5	laboratory	laboratory	NOUN
ajlsi-1012	80	6	investigations	investigation	NOUN
ajlsi-1012	80	7	are	be	AUX
ajlsi-1012	80	8	regarded	regard	VERB
ajlsi-1012	80	9	as	as	ADP
ajlsi-1012	80	10	potentially	potentially	ADV
ajlsi-1012	80	11	infectious	infectious	ADJ
ajlsi-1012	80	12	.	.	PUNCT
ajlsi-1012	81	1	testing	testing	NOUN
ajlsi-1012	81	2	of	of	ADP
ajlsi-1012	81	3	specimens	specimen	NOUN
ajlsi-1012	81	4	from	from	ADP
ajlsi-1012	81	5	multiple	multiple	ADJ
ajlsi-1012	81	6	sites	site	NOUN
ajlsi-1012	81	7	(	(	PUNCT
ajlsi-1012	81	8	e.g.	e.g.	ADV
ajlsi-1012	81	9	,	,	PUNCT
ajlsi-1012	81	10	upper	upper	ADJ
ajlsi-1012	81	11	and	and	CCONJ
ajlsi-1012	81	12	lower	low	ADJ
ajlsi-1012	81	13	respiratory	respiratory	ADJ
ajlsi-1012	81	14	tracts	tract	NOUN
ajlsi-1012	81	15	)	)	PUNCT
ajlsi-1012	81	16	may	may	AUX
ajlsi-1012	81	17	improve	improve	VERB
ajlsi-1012	81	18	the	the	DET
ajlsi-1012	81	19	sensitivity	sensitivity	NOUN
ajlsi-1012	81	20	of	of	ADP
ajlsi-1012	81	21	the	the	DET
ajlsi-1012	81	22	rt	rt	NOUN
ajlsi-1012	81	23	-	-	PUNCT
ajlsi-1012	81	24	pcr	pcr	PROPN
ajlsi-1012	81	25	and	and	CCONJ
ajlsi-1012	81	26	reduce	reduce	VERB
ajlsi-1012	81	27	false	false	ADJ
ajlsi-1012	81	28	-	-	PUNCT
ajlsi-1012	81	29	negative	negative	ADJ
ajlsi-1012	81	30	test	test	NOUN
ajlsi-1012	81	31	results	result	NOUN
ajlsi-1012	81	32	,	,	PUNCT
ajlsi-1012	81	33	especially	especially	ADV
ajlsi-1012	81	34	during	during	ADP
ajlsi-1012	81	35	the	the	DET
ajlsi-1012	81	36	second	second	ADJ
ajlsi-1012	81	37	week	week	NOUN
ajlsi-1012	81	38	of	of	ADP
ajlsi-1012	81	39	illness	illness	NOUN
ajlsi-1012	81	40	.	.	PUNCT
ajlsi-1012	82	1	for	for	ADP
ajlsi-1012	82	2	asymptomatic	asymptomatic	ADJ
ajlsi-1012	82	3	patients	patient	NOUN
ajlsi-1012	82	4	and	and	CCONJ
ajlsi-1012	82	5	patients	patient	NOUN
ajlsi-1012	82	6	with	with	ADP
ajlsi-1012	82	7	mild	mild	ADJ
ajlsi-1012	82	8	symptoms	symptom	NOUN
ajlsi-1012	82	9	,	,	PUNCT
ajlsi-1012	82	10	the	the	DET
ajlsi-1012	82	11	collection	collection	NOUN
ajlsi-1012	82	12	of	of	ADP
ajlsi-1012	82	13	both	both	DET
ajlsi-1012	82	14	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	82	15	swabs	swab	NOUN
ajlsi-1012	82	16	and	and	CCONJ
ajlsi-1012	82	17	oropharyngeal	oropharyngeal	NOUN
ajlsi-1012	82	18	swabs	swab	NOUN
ajlsi-1012	82	19	is	be	AUX
ajlsi-1012	82	20	recommended	recommend	VERB
ajlsi-1012	82	21	;	;	PUNCT
ajlsi-1012	82	22	these	these	PRON
ajlsi-1012	82	23	should	should	AUX
ajlsi-1012	82	24	be	be	AUX
ajlsi-1012	82	25	placed	place	VERB
ajlsi-1012	82	26	together	together	ADV
ajlsi-1012	82	27	in	in	ADP
ajlsi-1012	82	28	the	the	DET
ajlsi-1012	82	29	same	same	ADJ
ajlsi-1012	82	30	viral	viral	ADJ
ajlsi-1012	82	31	transport	transport	NOUN
ajlsi-1012	82	32	medium	medium	NOUN
ajlsi-1012	82	33	(	(	PUNCT
ajlsi-1012	82	34	vtm	vtm	ADJ
ajlsi-1012	82	35	)	)	PUNCT
ajlsi-1012	82	36	to	to	PART
ajlsi-1012	82	37	increase	increase	VERB
ajlsi-1012	82	38	the	the	DET
ajlsi-1012	82	39	sensitivity	sensitivity	NOUN
ajlsi-1012	82	40	(	(	PUNCT
ajlsi-1012	82	41	who	who	PRON
ajlsi-1012	82	42	2020	2020	NUM
ajlsi-1012	82	43	,	,	PUNCT
ajlsi-1012	82	44	cdc	cdc	PROPN
ajlsi-1012	82	45	2020	2020	NUM
ajlsi-1012	82	46	)	)	PUNCT
ajlsi-1012	82	47	.	.	PUNCT
ajlsi-1012	83	1	additional	additional	ADJ
ajlsi-1012	83	2	clinical	clinical	ADJ
ajlsi-1012	83	3	specimens	specimen	NOUN
ajlsi-1012	83	4	can	can	AUX
ajlsi-1012	83	5	be	be	AUX
ajlsi-1012	83	6	collected	collect	VERB
ajlsi-1012	83	7	as	as	SCONJ
ajlsi-1012	83	8	the	the	DET
ajlsi-1012	83	9	covid-19	covid-19	PROPN
ajlsi-1012	83	10	virus	virus	NOUN
ajlsi-1012	83	11	has	have	AUX
ajlsi-1012	83	12	been	be	AUX
ajlsi-1012	83	13	detected	detect	VERB
ajlsi-1012	83	14	in	in	ADP
ajlsi-1012	83	15	blood	blood	NOUN
ajlsi-1012	83	16	,	,	PUNCT
ajlsi-1012	83	17	urine	urine	NOUN
ajlsi-1012	83	18	,	,	PUNCT
ajlsi-1012	83	19	and	and	CCONJ
ajlsi-1012	83	20	stool	stool	NOUN
ajlsi-1012	83	21	.	.	PUNCT
ajlsi-1012	84	1	in	in	ADP
ajlsi-1012	84	2	the	the	DET
ajlsi-1012	84	3	case	case	NOUN
ajlsi-1012	84	4	of	of	ADP
ajlsi-1012	84	5	deceased	deceased	ADJ
ajlsi-1012	84	6	patients	patient	NOUN
ajlsi-1012	84	7	,	,	PUNCT
ajlsi-1012	84	8	the	the	DET
ajlsi-1012	84	9	collection	collection	NOUN
ajlsi-1012	84	10	of	of	ADP
ajlsi-1012	84	11	autopsy	autopsy	ADJ
ajlsi-1012	84	12	material	material	NOUN
ajlsi-1012	84	13	,	,	PUNCT
ajlsi-1012	84	14	including	include	VERB
ajlsi-1012	84	15	lung	lung	NOUN
ajlsi-1012	84	16	tissue	tissue	NOUN
ajlsi-1012	84	17	,	,	PUNCT
ajlsi-1012	84	18	is	be	AUX
ajlsi-1012	84	19	also	also	ADV
ajlsi-1012	84	20	considered	consider	VERB
ajlsi-1012	84	21	.	.	PUNCT
ajlsi-1012	85	1	(	(	PUNCT
ajlsi-1012	85	2	kaijin	kaijin	VERB
ajlsi-1012	85	3	et	et	PROPN
ajlsi-1012	85	4	al	al	PROPN
ajlsi-1012	85	5	.	.	PROPN
ajlsi-1012	85	6	,	,	PUNCT
ajlsi-1012	85	7	2020	2020	NUM
ajlsi-1012	85	8	)	)	PUNCT
ajlsi-1012	85	9	.	.	PUNCT
ajlsi-1012	86	1	as	as	SCONJ
ajlsi-1012	86	2	serological	serological	ADJ
ajlsi-1012	86	3	assays	assay	NOUN
ajlsi-1012	86	4	become	become	VERB
ajlsi-1012	86	5	available	available	ADJ
ajlsi-1012	86	6	retrospectively	retrospectively	ADV
ajlsi-1012	86	7	in	in	ADP
ajlsi-1012	86	8	recovered	recovered	ADJ
ajlsi-1012	86	9	patients	patient	NOUN
ajlsi-1012	86	10	,	,	PUNCT
ajlsi-1012	86	11	paired	pair	VERB
ajlsi-1012	86	12	serum	serum	NOUN
ajlsi-1012	86	13	(	(	PUNCT
ajlsi-1012	86	14	acute	acute	ADJ
ajlsi-1012	86	15	and	and	CCONJ
ajlsi-1012	86	16	convalescent	convalescent	NOUN
ajlsi-1012	86	17	)	)	PUNCT
ajlsi-1012	86	18	can	can	AUX
ajlsi-1012	86	19	be	be	AUX
ajlsi-1012	86	20	useful	useful	ADJ
ajlsi-1012	86	21	in	in	ADP
ajlsi-1012	86	22	defining	define	VERB
ajlsi-1012	86	23	cases	case	NOUN
ajlsi-1012	86	24	(	(	PUNCT
ajlsi-1012	86	25	zhang	zhang	X
ajlsi-1012	86	26	et	et	PROPN
ajlsi-1012	86	27	al	al	PROPN
ajlsi-1012	86	28	.	.	PROPN
ajlsi-1012	86	29	,	,	PUNCT
ajlsi-1012	86	30	2020	2020	NUM
ajlsi-1012	86	31	;	;	PUNCT
ajlsi-1012	86	32	shix	shix	VERB
ajlsi-1012	86	33	et	et	NOUN
ajlsi-1012	86	34	al	al	PROPN
ajlsi-1012	86	35	.	.	PROPN
ajlsi-1012	86	36	,	,	PUNCT
ajlsi-1012	86	37	2005	2005	NUM
ajlsi-1012	86	38	;	;	PUNCT
ajlsi-1012	87	1	ding	de	VERB
ajlsi-1012	87	2	y.	y.	PROPN
ajlsi-1012	87	3	et	et	PROPN
ajlsi-1012	87	4	al	al	PROPN
ajlsi-1012	87	5	.	.	PROPN
ajlsi-1012	87	6	,	,	PUNCT
ajlsi-1012	87	7	2004	2004	NUM
ajlsi-1012	87	8	)	)	PUNCT
ajlsi-1012	87	9	.	.	PUNCT
ajlsi-1012	88	1	several	several	ADJ
ajlsi-1012	88	2	studies	study	NOUN
ajlsi-1012	88	3	reported	report	VERB
ajlsi-1012	88	4	the	the	DET
ajlsi-1012	88	5	detection	detection	NOUN
ajlsi-1012	88	6	of	of	ADP
ajlsi-1012	88	7	higher	high	ADJ
ajlsi-1012	88	8	viral	viral	ADJ
ajlsi-1012	88	9	loads	load	NOUN
ajlsi-1012	88	10	in	in	ADP
ajlsi-1012	88	11	older	old	ADJ
ajlsi-1012	88	12	patients	patient	NOUN
ajlsi-1012	88	13	.	.	PUNCT
ajlsi-1012	89	1	however	however	ADV
ajlsi-1012	89	2	,	,	PUNCT
ajlsi-1012	89	3	the	the	DET
ajlsi-1012	89	4	viral	viral	ADJ
ajlsi-1012	89	5	load	load	NOUN
ajlsi-1012	89	6	did	do	AUX
ajlsi-1012	89	7	not	not	PART
ajlsi-1012	89	8	positively	positively	ADV
ajlsi-1012	89	9	correlate	correlate	VERB
ajlsi-1012	89	10	with	with	ADP
ajlsi-1012	89	11	disease	disease	NOUN
ajlsi-1012	89	12	severity	severity	NOUN
ajlsi-1012	89	13	(	(	PUNCT
ajlsi-1012	89	14	tsang	tsang	PROPN
ajlsi-1012	89	15	et	et	PROPN
ajlsi-1012	89	16	al	al	PROPN
ajlsi-1012	89	17	.	.	PROPN
ajlsi-1012	89	18	,	,	PUNCT
ajlsi-1012	89	19	2020	2020	NUM
ajlsi-1012	89	20	;	;	PUNCT
ajlsi-1012	89	21	pung	pung	PROPN
ajlsi-1012	89	22	et	et	PROPN
ajlsi-1012	89	23	al	al	PROPN
ajlsi-1012	89	24	.	.	PROPN
ajlsi-1012	89	25	,	,	PUNCT
ajlsi-1012	89	26	2020	2020	NUM
ajlsi-1012	89	27	;	;	PUNCT
ajlsi-1012	89	28	wang	wang	PROPN
ajlsi-1012	89	29	et	et	PROPN
ajlsi-1012	89	30	al	al	PROPN
ajlsi-1012	89	31	.	.	PROPN
ajlsi-1012	89	32	,	,	PUNCT
ajlsi-1012	89	33	2020	2020	NUM
ajlsi-1012	89	34	)	)	PUNCT
ajlsi-1012	89	35	.	.	PUNCT
ajlsi-1012	90	1	since	since	SCONJ
ajlsi-1012	90	2	sars	sar	NOUN
ajlsi-1012	90	3	-	-	PUNCT
ajlsi-1012	90	4	cov-2	cov-2	X
ajlsi-1012	90	5	and	and	CCONJ
ajlsi-1012	90	6	most	most	ADJ
ajlsi-1012	90	7	other	other	ADJ
ajlsi-1012	90	8	respiratory	respiratory	ADJ
ajlsi-1012	90	9	viruses	virus	NOUN
ajlsi-1012	90	10	are	be	AUX
ajlsi-1012	90	11	rna	rna	NOUN
ajlsi-1012	90	12	-	-	PUNCT
ajlsi-1012	90	13	based	base	VERB
ajlsi-1012	90	14	,	,	PUNCT
ajlsi-1012	90	15	care	care	NOUN
ajlsi-1012	90	16	should	should	AUX
ajlsi-1012	90	17	be	be	AUX
ajlsi-1012	90	18	taken	take	VERB
ajlsi-1012	90	19	to	to	PART
ajlsi-1012	90	20	select	select	VERB
ajlsi-1012	90	21	extraction	extraction	NOUN
ajlsi-1012	90	22	and	and	CCONJ
ajlsi-1012	90	23	inactivation	inactivation	NOUN
ajlsi-1012	90	24	protocols	protocol	NOUN
ajlsi-1012	90	25	that	that	PRON
ajlsi-1012	90	26	will	will	AUX
ajlsi-1012	90	27	not	not	PART
ajlsi-1012	90	28	damage	damage	VERB
ajlsi-1012	90	29	rna	rna	NOUN
ajlsi-1012	90	30	.	.	PUNCT
ajlsi-1012	91	1	a	a	DET
ajlsi-1012	91	2	recent	recent	ADJ
ajlsi-1012	91	3	study	study	NOUN
ajlsi-1012	91	4	suggests	suggest	VERB
ajlsi-1012	91	5	that	that	SCONJ
ajlsi-1012	91	6	heat	heat	NOUN
ajlsi-1012	91	7	inactivation	inactivation	NOUN
ajlsi-1012	91	8	at	at	ADP
ajlsi-1012	91	9	56	56	NUM
ajlsi-1012	91	10	°	°	NOUN
ajlsi-1012	91	11	c	c	NOUN
ajlsi-1012	91	12	for	for	ADP
ajlsi-1012	91	13	30	30	NUM
ajlsi-1012	91	14	min	min	NOUN
ajlsi-1012	91	15	may	may	AUX
ajlsi-1012	91	16	result	result	VERB
ajlsi-1012	91	17	in	in	ADP
ajlsi-1012	91	18	false	false	ADJ
ajlsi-1012	91	19	negatives	negative	NOUN
ajlsi-1012	91	20	for	for	ADP
ajlsi-1012	91	21	samples	sample	NOUN
ajlsi-1012	91	22	with	with	ADP
ajlsi-1012	91	23	low	low	ADJ
ajlsi-1012	91	24	viral	viral	ADJ
ajlsi-1012	91	25	loads	load	NOUN
ajlsi-1012	91	26	(	(	PUNCT
ajlsi-1012	91	27	pan	pan	NOUN
ajlsi-1012	91	28	et	et	PROPN
ajlsi-1012	91	29	al	al	PROPN
ajlsi-1012	91	30	.	.	PROPN
ajlsi-1012	91	31	,	,	PUNCT
ajlsi-1012	91	32	2020	2020	NUM
ajlsi-1012	91	33	)	)	PUNCT
ajlsi-1012	91	34	.	.	PUNCT
ajlsi-1012	92	1	specimens	specimen	NOUN
ajlsi-1012	92	2	for	for	ADP
ajlsi-1012	92	3	virus	virus	NOUN
ajlsi-1012	92	4	detection	detection	NOUN
ajlsi-1012	92	5	should	should	AUX
ajlsi-1012	92	6	reach	reach	VERB
ajlsi-1012	92	7	the	the	DET
ajlsi-1012	92	8	laboratory	laboratory	NOUN
ajlsi-1012	92	9	as	as	ADV
ajlsi-1012	92	10	soon	soon	ADV
ajlsi-1012	92	11	as	as	ADP
ajlsi-1012	92	12	possible	possible	ADJ
ajlsi-1012	92	13	after	after	ADP
ajlsi-1012	92	14	collection	collection	NOUN
ajlsi-1012	92	15	.	.	PUNCT
ajlsi-1012	93	1	correct	correct	ADJ
ajlsi-1012	93	2	handling	handling	NOUN
ajlsi-1012	93	3	of	of	ADP
ajlsi-1012	93	4	specimens	specimen	NOUN
ajlsi-1012	93	5	during	during	ADP
ajlsi-1012	93	6	transportation	transportation	NOUN
ajlsi-1012	93	7	is	be	AUX
ajlsi-1012	93	8	essential	essential	ADJ
ajlsi-1012	93	9	.	.	PUNCT
ajlsi-1012	94	1	specimens	specimen	NOUN
ajlsi-1012	94	2	that	that	PRON
ajlsi-1012	94	3	can	can	AUX
ajlsi-1012	94	4	be	be	AUX
ajlsi-1012	94	5	delivered	deliver	VERB
ajlsi-1012	94	6	to	to	ADP
ajlsi-1012	94	7	the	the	DET
ajlsi-1012	94	8	laboratory	laboratory	NOUN
ajlsi-1012	94	9	can	can	AUX
ajlsi-1012	94	10	be	be	AUX
ajlsi-1012	94	11	stored	store	VERB
ajlsi-1012	94	12	and	and	CCONJ
ajlsi-1012	94	13	shipped	ship	VERB
ajlsi-1012	94	14	at	at	ADP
ajlsi-1012	94	15	2–8	2–8	NUM
ajlsi-1012	94	16	°	°	ADP
ajlsi-1012	94	17	c	c	NOUN
ajlsi-1012	94	18	.	.	PUNCT
ajlsi-1012	95	1	when	when	SCONJ
ajlsi-1012	95	2	there	there	PRON
ajlsi-1012	95	3	is	be	VERB
ajlsi-1012	95	4	likely	likely	ADJ
ajlsi-1012	95	5	to	to	PART
ajlsi-1012	95	6	be	be	AUX
ajlsi-1012	95	7	a	a	DET
ajlsi-1012	95	8	delay	delay	NOUN
ajlsi-1012	95	9	in	in	ADP
ajlsi-1012	95	10	specimens	specimen	NOUN
ajlsi-1012	95	11	reaching	reach	VERB
ajlsi-1012	95	12	the	the	DET
ajlsi-1012	95	13	laboratory	laboratory	NOUN
ajlsi-1012	95	14	,	,	PUNCT
ajlsi-1012	95	15	the	the	DET
ajlsi-1012	95	16	use	use	NOUN
ajlsi-1012	95	17	of	of	ADP
ajlsi-1012	95	18	viral	viral	ADJ
ajlsi-1012	95	19	transport	transport	NOUN
ajlsi-1012	95	20	medium	medium	NOUN
ajlsi-1012	95	21	(	(	PUNCT
ajlsi-1012	95	22	vtm	vtm	ADJ
ajlsi-1012	95	23	)	)	PUNCT
ajlsi-1012	95	24	is	be	AUX
ajlsi-1012	95	25	strongly	strongly	ADV
ajlsi-1012	95	26	recommended	recommend	VERB
ajlsi-1012	95	27	in	in	ADP
ajlsi-1012	95	28	the	the	DET
ajlsi-1012	95	29	laboratory	laboratory	NOUN
ajlsi-1012	95	30	biosafety	biosafety	NOUN
ajlsi-1012	95	31	guidance	guidance	NOUN
ajlsi-1012	95	32	related	relate	VERB
ajlsi-1012	95	33	to	to	ADP
ajlsi-1012	95	34	the	the	DET
ajlsi-1012	95	35	novel	novel	ADJ
ajlsi-1012	95	36	coronavirus	coronavirus	NOUN
ajlsi-1012	95	37	(	(	PUNCT
ajlsi-1012	95	38	2019	2019	NUM
ajlsi-1012	95	39	-	-	PUNCT
ajlsi-1012	95	40	ncov	ncov	NOUN
ajlsi-1012	95	41	)	)	PUNCT
ajlsi-1012	95	42	.	.	PUNCT
ajlsi-1012	96	1	(	(	PUNCT
ajlsi-1012	96	2	guidance	guidance	NOUN
ajlsi-1012	96	3	on	on	ADP
ajlsi-1012	96	4	regulations	regulation	NOUN
ajlsi-1012	96	5	for	for	ADP
ajlsi-1012	96	6	the	the	DET
ajlsi-1012	96	7	transport	transport	NOUN
ajlsi-1012	96	8	of	of	ADP
ajlsi-1012	96	9	infectious	infectious	ADJ
ajlsi-1012	96	10	substances	substance	NOUN
ajlsi-1012	96	11	,	,	PUNCT
ajlsi-1012	96	12	2019–2020	2019–2020	NUM
ajlsi-1012	96	13	)	)	PUNCT
ajlsi-1012	96	14	the	the	DET
ajlsi-1012	96	15	primary	primary	ADJ
ajlsi-1012	96	16	container	container	NOUN
ajlsi-1012	96	17	should	should	AUX
ajlsi-1012	96	18	be	be	AUX
ajlsi-1012	96	19	sealed	seal	VERB
ajlsi-1012	96	20	with	with	ADP
ajlsi-1012	96	21	a	a	DET
ajlsi-1012	96	22	screw	screw	NOUN
ajlsi-1012	96	23	cap	cap	NOUN
ajlsi-1012	96	24	.	.	PUNCT
ajlsi-1012	97	1	the	the	DET
ajlsi-1012	97	2	container	container	NOUN
ajlsi-1012	97	3	should	should	AUX
ajlsi-1012	97	4	be	be	AUX
ajlsi-1012	97	5	made	make	VERB
ajlsi-1012	97	6	of	of	ADP
ajlsi-1012	97	7	plastic	plastic	NOUN
ajlsi-1012	97	8	that	that	PRON
ajlsi-1012	97	9	has	have	VERB
ajlsi-1012	97	10	a	a	DET
ajlsi-1012	97	11	low	low	ADJ
ajlsi-1012	97	12	risk	risk	NOUN
ajlsi-1012	97	13	of	of	ADP
ajlsi-1012	97	14	breakage	breakage	NOUN
ajlsi-1012	97	15	.	.	PUNCT
ajlsi-1012	98	1	patient	patient	ADJ
ajlsi-1012	98	2	information	information	NOUN
ajlsi-1012	98	3	should	should	AUX
ajlsi-1012	98	4	be	be	AUX
ajlsi-1012	98	5	recorded	record	VERB
ajlsi-1012	98	6	on	on	ADP
ajlsi-1012	98	7	the	the	DET
ajlsi-1012	98	8	specimen	speciman	NOUN
ajlsi-1012	98	9	container	container	NOUN
ajlsi-1012	98	10	using	use	VERB
ajlsi-1012	98	11	two	two	NUM
ajlsi-1012	98	12	or	or	CCONJ
ajlsi-1012	98	13	more	more	ADJ
ajlsi-1012	98	14	identifiers	identifier	NOUN
ajlsi-1012	98	15	(	(	PUNCT
ajlsi-1012	98	16	e.g.	e.g.	ADV
ajlsi-1012	98	17	,	,	PUNCT
ajlsi-1012	98	18	name	name	NOUN
ajlsi-1012	98	19	,	,	PUNCT
ajlsi-1012	98	20	patient	patient	ADJ
ajlsi-1012	98	21	number	number	NOUN
ajlsi-1012	98	22	)	)	PUNCT
ajlsi-1012	98	23	,	,	PUNCT
ajlsi-1012	98	24	along	along	ADP
ajlsi-1012	98	25	with	with	ADP
ajlsi-1012	98	26	the	the	DET
ajlsi-1012	98	27	necessary	necessary	ADJ
ajlsi-1012	98	28	information	information	NOUN
ajlsi-1012	98	29	for	for	ADP
ajlsi-1012	98	30	testing	testing	NOUN
ajlsi-1012	98	31	requests	request	NOUN
ajlsi-1012	98	32	.	.	PUNCT
ajlsi-1012	99	1	the	the	DET
ajlsi-1012	99	2	outer	outer	ADJ
ajlsi-1012	99	3	surface	surface	NOUN
ajlsi-1012	99	4	of	of	ADP
ajlsi-1012	99	5	the	the	DET
ajlsi-1012	99	6	primary	primary	ADJ
ajlsi-1012	99	7	container	container	NOUN
ajlsi-1012	99	8	should	should	AUX
ajlsi-1012	99	9	be	be	AUX
ajlsi-1012	99	10	disinfected	disinfect	VERB
ajlsi-1012	99	11	using	use	VERB
ajlsi-1012	99	12	appropriate	appropriate	ADJ
ajlsi-1012	99	13	disinfectants	disinfectant	NOUN
ajlsi-1012	99	14	,	,	PUNCT
ajlsi-1012	99	15	such	such	ADJ
ajlsi-1012	99	16	as	as	ADP
ajlsi-1012	99	17	70	70	NUM
ajlsi-1012	99	18	%	%	NOUN
ajlsi-1012	99	19	ethanol	ethanol	NOUN
ajlsi-1012	99	20	.	.	PUNCT
ajlsi-1012	100	1	the	the	DET
ajlsi-1012	100	2	container	container	NOUN
ajlsi-1012	100	3	should	should	AUX
ajlsi-1012	100	4	be	be	AUX
ajlsi-1012	100	5	packed	pack	VERB
ajlsi-1012	100	6	in	in	ADP
ajlsi-1012	100	7	a	a	DET
ajlsi-1012	100	8	zipper	zipper	NOUN
ajlsi-1012	100	9	bag	bag	NOUN
ajlsi-1012	100	10	and	and	CCONJ
ajlsi-1012	100	11	placed	place	VERB
ajlsi-1012	100	12	in	in	ADP
ajlsi-1012	100	13	a	a	DET
ajlsi-1012	100	14	secondary	secondary	ADJ
ajlsi-1012	100	15	container	container	NOUN
ajlsi-1012	100	16	before	before	ADP
ajlsi-1012	100	17	transportation	transportation	NOUN
ajlsi-1012	100	18	.	.	PUNCT
ajlsi-1012	101	1	the	the	DET
ajlsi-1012	101	2	secondary	secondary	ADJ
ajlsi-1012	101	3	container	container	NOUN
ajlsi-1012	101	4	should	should	AUX
ajlsi-1012	101	5	be	be	AUX
ajlsi-1012	101	6	sealed	seal	VERB
ajlsi-1012	101	7	and	and	CCONJ
ajlsi-1012	101	8	shock	shock	NOUN
ajlsi-1012	101	9	-	-	PUNCT
ajlsi-1012	101	10	resistant	resistant	ADJ
ajlsi-1012	101	11	,	,	PUNCT
ajlsi-1012	101	12	and	and	CCONJ
ajlsi-1012	101	13	it	it	PRON
ajlsi-1012	101	14	should	should	AUX
ajlsi-1012	101	15	be	be	AUX
ajlsi-1012	101	16	labelled	label	VERB
ajlsi-1012	101	17	to	to	PART
ajlsi-1012	101	18	indicate	indicate	VERB
ajlsi-1012	101	19	that	that	SCONJ
ajlsi-1012	101	20	it	it	PRON
ajlsi-1012	101	21	contains	contain	VERB
ajlsi-1012	101	22	infectious	infectious	ADJ
ajlsi-1012	101	23	substances	substance	NOUN
ajlsi-1012	101	24	.	.	PUNCT
ajlsi-1012	102	1	when	when	SCONJ
ajlsi-1012	102	2	transporting	transport	VERB
ajlsi-1012	102	3	specimens	specimen	NOUN
ajlsi-1012	102	4	to	to	ADP
ajlsi-1012	102	5	a	a	DET
ajlsi-1012	102	6	laboratory	laboratory	NOUN
ajlsi-1012	102	7	within	within	ADP
ajlsi-1012	102	8	the	the	DET
ajlsi-1012	102	9	same	same	ADJ
ajlsi-1012	102	10	institution	institution	NOUN
ajlsi-1012	102	11	,	,	PUNCT
ajlsi-1012	102	12	the	the	DET
ajlsi-1012	102	13	specimens	specimen	NOUN
ajlsi-1012	102	14	should	should	AUX
ajlsi-1012	102	15	be	be	AUX
ajlsi-1012	102	16	transported	transport	VERB
ajlsi-1012	102	17	in	in	ADP
ajlsi-1012	102	18	person	person	NOUN
ajlsi-1012	102	19	;	;	PUNCT
ajlsi-1012	102	20	the	the	DET
ajlsi-1012	102	21	pneumatic	pneumatic	ADJ
ajlsi-1012	102	22	tube	tube	NOUN
ajlsi-1012	102	23	system	system	NOUN
ajlsi-1012	102	24	should	should	AUX
ajlsi-1012	102	25	not	not	PART
ajlsi-1012	102	26	be	be	AUX
ajlsi-1012	102	27	used	use	VERB
ajlsi-1012	102	28	.	.	PUNCT
ajlsi-1012	103	1	a	a	DET
ajlsi-1012	103	2	separate	separate	ADJ
ajlsi-1012	103	3	route	route	NOUN
ajlsi-1012	103	4	should	should	AUX
ajlsi-1012	103	5	be	be	AUX
ajlsi-1012	103	6	used	use	VERB
ajlsi-1012	103	7	for	for	ADP
ajlsi-1012	103	8	transportation	transportation	NOUN
ajlsi-1012	103	9	.	.	PUNCT
ajlsi-1012	104	1	the	the	DET
ajlsi-1012	104	2	personnel	personnel	NOUN
ajlsi-1012	104	3	transporting	transport	VERB
ajlsi-1012	104	4	the	the	DET
ajlsi-1012	104	5	specimen	speciman	NOUN
ajlsi-1012	104	6	should	should	AUX
ajlsi-1012	104	7	be	be	AUX
ajlsi-1012	104	8	trained	train	VERB
ajlsi-1012	104	9	in	in	ADP
ajlsi-1012	104	10	spill	spill	NOUN
ajlsi-1012	104	11	decontamination	decontamination	NOUN
ajlsi-1012	104	12	procedures	procedure	NOUN
ajlsi-1012	104	13	in	in	ADP
ajlsi-1012	104	14	case	case	NOUN
ajlsi-1012	104	15	of	of	ADP
ajlsi-1012	104	16	specimen	speciman	NOUN
ajlsi-1012	104	17	leakage	leakage	NOUN
ajlsi-1012	104	18	.	.	PUNCT
ajlsi-1012	105	1	specimens	specimen	NOUN
ajlsi-1012	105	2	may	may	AUX
ajlsi-1012	105	3	be	be	AUX
ajlsi-1012	105	4	frozen	freeze	VERB
ajlsi-1012	105	5	to	to	ADP
ajlsi-1012	105	6	-20	-20	NUM
ajlsi-1012	105	7	°	°	NOUN
ajlsi-1012	105	8	c	c	NOUN
ajlsi-1012	105	9	or	or	CCONJ
ajlsi-1012	105	10	,	,	PUNCT
ajlsi-1012	105	11	ideally	ideally	ADV
ajlsi-1012	105	12	,	,	PUNCT
ajlsi-1012	105	13	-70	-70	PROPN
ajlsi-1012	105	14	°	°	PROPN
ajlsi-1012	105	15	c	c	NOUN
ajlsi-1012	105	16	and	and	CCONJ
ajlsi-1012	105	17	shipped	ship	VERB
ajlsi-1012	105	18	on	on	ADP
ajlsi-1012	105	19	dry	dry	ADJ
ajlsi-1012	105	20	ice	ice	NOUN
ajlsi-1012	105	21	if	if	SCONJ
ajlsi-1012	105	22	further	further	ADJ
ajlsi-1012	105	23	delays	delay	NOUN
ajlsi-1012	105	24	are	be	AUX
ajlsi-1012	105	25	expected	expect	VERB
ajlsi-1012	105	26	.	.	PUNCT
ajlsi-1012	106	1	it	it	PRON
ajlsi-1012	106	2	is	be	AUX
ajlsi-1012	106	3	important	important	ADJ
ajlsi-1012	106	4	to	to	PART
ajlsi-1012	106	5	avoid	avoid	VERB
ajlsi-1012	106	6	repeated	repeat	VERB
ajlsi-1012	106	7	freezing	freezing	NOUN
ajlsi-1012	106	8	and	and	CCONJ
ajlsi-1012	106	9	thawing	thawing	NOUN
ajlsi-1012	106	10	of	of	ADP
ajlsi-1012	106	11	specimens	specimen	NOUN
ajlsi-1012	106	12	(	(	PUNCT
ajlsi-1012	106	13	kwon	kwon	PROPN
ajlsi-1012	106	14	et	et	PROPN
ajlsi-1012	106	15	al	al	PROPN
ajlsi-1012	106	16	.	.	PROPN
ajlsi-1012	106	17	,	,	PUNCT
ajlsi-1012	106	18	2020	2020	NUM
ajlsi-1012	106	19	;	;	PUNCT
ajlsi-1012	106	20	korea	korea	PROPN
ajlsi-1012	106	21	center	center	PROPN
ajlsi-1012	106	22	for	for	ADP
ajlsi-1012	106	23	disease	disease	NOUN
ajlsi-1012	106	24	control	control	NOUN
ajlsi-1012	106	25	and	and	CCONJ
ajlsi-1012	106	26	prevention	prevention	NOUN
ajlsi-1012	106	27	,	,	PUNCT
ajlsi-1012	106	28	2020	2020	NUM
ajlsi-1012	106	29	;	;	PUNCT
ajlsi-1012	106	30	cdc	cdc	PROPN
ajlsi-1012	106	31	,	,	PUNCT
ajlsi-1012	106	32	2020	2020	NUM
ajlsi-1012	106	33	)	)	PUNCT
ajlsi-1012	106	34	.	.	PUNCT
ajlsi-1012	107	1	who	who	PRON
ajlsi-1012	107	2	documents	document	VERB
ajlsi-1012	107	3	a	a	DET
ajlsi-1012	107	4	summary	summary	NOUN
ajlsi-1012	107	5	of	of	ADP
ajlsi-1012	107	6	the	the	DET
ajlsi-1012	107	7	optimum	optimum	ADJ
ajlsi-1012	107	8	sample	sample	NOUN
ajlsi-1012	107	9	collection	collection	NOUN
ajlsi-1012	107	10	procedures	procedure	NOUN
ajlsi-1012	107	11	and	and	CCONJ
ajlsi-1012	107	12	storage	storage	NOUN
ajlsi-1012	107	13	,	,	PUNCT
ajlsi-1012	107	14	which	which	PRON
ajlsi-1012	107	15	are	be	AUX
ajlsi-1012	107	16	similar	similar	ADJ
ajlsi-1012	107	17	to	to	ADP
ajlsi-1012	107	18	those	those	PRON
ajlsi-1012	107	19	for	for	ADP
ajlsi-1012	107	20	influenza	influenza	NOUN
ajlsi-1012	107	21	.	.	PUNCT
ajlsi-1012	108	1	the	the	DET
ajlsi-1012	108	2	specimen	speciman	NOUN
ajlsi-1012	108	3	collection	collection	NOUN
ajlsi-1012	108	4	and	and	CCONJ
ajlsi-1012	108	5	storage	storage	NOUN
ajlsi-1012	108	6	temperature	temperature	NOUN
ajlsi-1012	108	7	protocol	protocol	NOUN
ajlsi-1012	108	8	to	to	PART
ajlsi-1012	108	9	investigate	investigate	VERB
ajlsi-1012	108	10	emerging	emerge	VERB
ajlsi-1012	108	11	acute	acute	ADJ
ajlsi-1012	108	12	respiratory	respiratory	ADJ
ajlsi-1012	108	13	diseases	disease	NOUN
ajlsi-1012	108	14	is	be	AUX
ajlsi-1012	108	15	summarized	summarize	VERB
ajlsi-1012	108	16	in	in	ADP
ajlsi-1012	108	17	table	table	NOUN
ajlsi-1012	108	18	1	1	NUM
ajlsi-1012	108	19	.	.	PUNCT
ajlsi-1012	108	20	table	table	NOUN
ajlsi-1012	108	21	1	1	NUM
ajlsi-1012	108	22	:	:	PUNCT
ajlsi-1012	108	23	the	the	DET
ajlsi-1012	108	24	specimen	speciman	NOUN
ajlsi-1012	108	25	collection	collection	NOUN
ajlsi-1012	108	26	and	and	CCONJ
ajlsi-1012	108	27	storage	storage	NOUN
ajlsi-1012	108	28	protocol	protocol	NOUN
ajlsi-1012	108	29	to	to	PART
ajlsi-1012	108	30	investigate	investigate	VERB
ajlsi-1012	108	31	non	non	ADJ
ajlsi-1012	108	32	-	-	ADJ
ajlsi-1012	108	33	seasonal	seasonal	ADJ
ajlsi-1012	108	34	influenza	influenza	NOUN
ajlsi-1012	108	35	and	and	CCONJ
ajlsi-1012	108	36	other	other	ADJ
ajlsi-1012	108	37	emerging	emerge	VERB
ajlsi-1012	108	38	acute	acute	ADJ
ajlsi-1012	108	39	respiratory	respiratory	ADJ
ajlsi-1012	108	40	diseases	disease	NOUN
ajlsi-1012	108	41	specimen	speciman	NOUN
ajlsi-1012	108	42	types	type	VERB
ajlsi-1012	108	43	collection	collection	NOUN
ajlsi-1012	108	44	material	material	NOUN
ajlsi-1012	108	45	storage	storage	NOUN
ajlsi-1012	108	46	temperature	temperature	NOUN
ajlsi-1012	108	47	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	108	48	and	and	CCONJ
ajlsi-1012	108	49	oropharyngeal	oropharyngeal	ADJ
ajlsi-1012	108	50	swabs	swab	NOUN
ajlsi-1012	108	51	dacron	dacron	NOUN
ajlsi-1012	108	52	or	or	CCONJ
ajlsi-1012	108	53	polyester	polyester	NOUN
ajlsi-1012	108	54	flocked	flock	VERB
ajlsi-1012	108	55	swabs	swab	NOUN
ajlsi-1012	108	56	2	2	NUM
ajlsi-1012	108	57	-	-	SYM
ajlsi-1012	108	58	8	8	NUM
ajlsi-1012	108	59	°	°	ADP
ajlsi-1012	108	60	c	c	NOUN
ajlsi-1012	108	61	sputum	sputum	NOUN
ajlsi-1012	108	62	sterile	sterile	ADJ
ajlsi-1012	108	63	container	container	NOUN
ajlsi-1012	108	64	2	2	NUM
ajlsi-1012	108	65	-	-	SYM
ajlsi-1012	108	66	8	8	NUM
ajlsi-1012	108	67	°	°	ADP
ajlsi-1012	108	68	c	c	NOUN
ajlsi-1012	108	69	bronchoalveolar	bronchoalveolar	ADJ
ajlsi-1012	108	70	lavage	lavage	NOUN
ajlsi-1012	108	71	sterile	sterile	ADJ
ajlsi-1012	108	72	container	container	NOUN
ajlsi-1012	108	73	2	2	NUM
ajlsi-1012	108	74	-	-	SYM
ajlsi-1012	108	75	8	8	NUM
ajlsi-1012	108	76	°	°	ADP
ajlsi-1012	108	77	c	c	NOUN
ajlsi-1012	108	78	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	108	79	or	or	CCONJ
ajlsi-1012	108	80	nasal	nasal	ADJ
ajlsi-1012	108	81	aspirates	aspirate	NOUN
ajlsi-1012	108	82	or	or	CCONJ
ajlsi-1012	108	83	washes	wash	VERB
ajlsi-1012	108	84	sterile	sterile	ADJ
ajlsi-1012	108	85	container	container	NOUN
ajlsi-1012	108	86	2	2	NUM
ajlsi-1012	108	87	-	-	SYM
ajlsi-1012	108	88	8	8	NUM
ajlsi-1012	108	89	°	°	NOUN
ajlsi-1012	108	90	c	c	NOUN
ajlsi-1012	108	91	tissue	tissue	NOUN
ajlsi-1012	108	92	from	from	ADP
ajlsi-1012	108	93	biopsy	biopsy	NOUN
ajlsi-1012	108	94	or	or	CCONJ
ajlsi-1012	108	95	autopsy	autopsy	ADJ
ajlsi-1012	108	96	,	,	PUNCT
ajlsi-1012	108	97	including	include	VERB
ajlsi-1012	108	98	lung	lung	NOUN
ajlsi-1012	108	99	tissue	tissue	NOUN
ajlsi-1012	108	100	sterile	sterile	ADJ
ajlsi-1012	108	101	container	container	NOUN
ajlsi-1012	108	102	with	with	ADP
ajlsi-1012	108	103	saline	saline	NOUN
ajlsi-1012	108	104	or	or	CCONJ
ajlsi-1012	108	105	vtm	vtm	ADJ
ajlsi-1012	108	106	2	2	NUM
ajlsi-1012	108	107	-	-	SYM
ajlsi-1012	108	108	8	8	NUM
ajlsi-1012	108	109	°	°	NOUN
ajlsi-1012	108	110	c	c	NOUN
ajlsi-1012	108	111	serum	serum	NOUN
ajlsi-1012	108	112	serum	serum	NOUN
ajlsi-1012	108	113	separator	separator	NOUN
ajlsi-1012	108	114	tubes	tube	NOUN
ajlsi-1012	108	115	2	2	NUM
ajlsi-1012	108	116	-	-	SYM
ajlsi-1012	108	117	8	8	NUM
ajlsi-1012	108	118	°	°	ADP
ajlsi-1012	108	119	c	c	NOUN
ajlsi-1012	108	120	whole	whole	ADJ
ajlsi-1012	108	121	blood	blood	NOUN
ajlsi-1012	108	122	collection	collection	NOUN
ajlsi-1012	108	123	tube	tube	NOUN
ajlsi-1012	108	124	2	2	NUM
ajlsi-1012	108	125	-	-	SYM
ajlsi-1012	108	126	8	8	NUM
ajlsi-1012	108	127	°	°	NOUN
ajlsi-1012	108	128	c	c	NOUN
ajlsi-1012	108	129	stool	stool	NOUN
ajlsi-1012	108	130	stool	stool	NOUN
ajlsi-1012	108	131	container	container	NOUN
ajlsi-1012	108	132	2	2	NUM
ajlsi-1012	108	133	-	-	SYM
ajlsi-1012	108	134	8	8	NUM
ajlsi-1012	108	135	°	°	ADP
ajlsi-1012	108	136	c	c	NOUN
ajlsi-1012	108	137	urine	urine	NOUN
ajlsi-1012	108	138	urine	urine	NOUN
ajlsi-1012	108	139	collection	collection	NOUN
ajlsi-1012	108	140	container	container	NOUN
ajlsi-1012	108	141	2	2	NUM
ajlsi-1012	108	142	-	-	SYM
ajlsi-1012	108	143	8	8	NUM
ajlsi-1012	108	144	°	°	NOUN
ajlsi-1012	108	145	c	c	NOUN
ajlsi-1012	108	146	surveillance	surveillance	NOUN
ajlsi-1012	108	147	and	and	CCONJ
ajlsi-1012	108	148	sampling	sample	VERB
ajlsi-1012	108	149	strategies	strategy	NOUN
ajlsi-1012	108	150	individual	individual	ADJ
ajlsi-1012	108	151	case	case	NOUN
ajlsi-1012	108	152	definition	definition	NOUN
ajlsi-1012	108	153	mechanisms	mechanism	NOUN
ajlsi-1012	108	154	(	(	PUNCT
ajlsi-1012	108	155	2.1	2.1	NUM
ajlsi-1012	108	156	)	)	PUNCT
ajlsi-1012	108	157	,	,	PUNCT
ajlsi-1012	108	158	as	as	SCONJ
ajlsi-1012	108	159	mentioned	mention	VERB
ajlsi-1012	108	160	above	above	ADV
ajlsi-1012	108	161	,	,	PUNCT
ajlsi-1012	108	162	help	help	VERB
ajlsi-1012	108	163	choose	choose	VERB
ajlsi-1012	108	164	whether	whether	SCONJ
ajlsi-1012	108	165	a	a	DET
ajlsi-1012	108	166	patient	patient	NOUN
ajlsi-1012	108	167	should	should	AUX
ajlsi-1012	108	168	be	be	AUX
ajlsi-1012	108	169	tested	test	VERB
ajlsi-1012	108	170	or	or	CCONJ
ajlsi-1012	108	171	not	not	PART
ajlsi-1012	108	172	.	.	PUNCT
ajlsi-1012	109	1	however	however	ADV
ajlsi-1012	109	2	,	,	PUNCT
ajlsi-1012	109	3	a	a	DET
ajlsi-1012	109	4	pandemic	pandemic	ADJ
ajlsi-1012	109	5	like	like	ADP
ajlsi-1012	109	6	covid-19	covid-19	PROPN
ajlsi-1012	109	7	necessitates	necessitate	VERB
ajlsi-1012	109	8	robust	robust	ADJ
ajlsi-1012	109	9	surveillance	surveillance	NOUN
ajlsi-1012	109	10	systems	system	NOUN
ajlsi-1012	109	11	at	at	ADP
ajlsi-1012	109	12	local	local	ADJ
ajlsi-1012	109	13	and	and	CCONJ
ajlsi-1012	109	14	global	global	ADJ
ajlsi-1012	109	15	levels	level	NOUN
ajlsi-1012	109	16	,	,	PUNCT
ajlsi-1012	109	17	which	which	PRON
ajlsi-1012	109	18	are	be	AUX
ajlsi-1012	109	19	required	require	VERB
ajlsi-1012	109	20	to	to	PART
ajlsi-1012	109	21	strengthen	strengthen	VERB
ajlsi-1012	109	22	the	the	DET
ajlsi-1012	109	23	effective	effective	ADJ
ajlsi-1012	109	24	implementation	implementation	NOUN
ajlsi-1012	109	25	of	of	ADP
ajlsi-1012	109	26	control	control	NOUN
ajlsi-1012	109	27	measures	measure	NOUN
ajlsi-1012	109	28	.	.	PUNCT
ajlsi-1012	110	1	the	the	DET
ajlsi-1012	110	2	aim	aim	NOUN
ajlsi-1012	110	3	of	of	ADP
ajlsi-1012	110	4	these	these	DET
ajlsi-1012	110	5	surveillance	surveillance	NOUN
ajlsi-1012	110	6	systems	system	NOUN
ajlsi-1012	110	7	is	be	AUX
ajlsi-1012	110	8	to	to	PART
ajlsi-1012	110	9	limit	limit	VERB
ajlsi-1012	110	10	the	the	DET
ajlsi-1012	110	11	spread	spread	NOUN
ajlsi-1012	110	12	of	of	ADP
ajlsi-1012	110	13	disease	disease	NOUN
ajlsi-1012	110	14	,	,	PUNCT
ajlsi-1012	110	15	enable	enable	VERB
ajlsi-1012	110	16	public	public	ADJ
ajlsi-1012	110	17	health	health	NOUN
ajlsi-1012	110	18	authorities	authority	NOUN
ajlsi-1012	110	19	to	to	PART
ajlsi-1012	110	20	manage	manage	VERB
ajlsi-1012	110	21	the	the	DET
ajlsi-1012	110	22	risk	risk	NOUN
ajlsi-1012	110	23	,	,	PUNCT
ajlsi-1012	110	24	and	and	CCONJ
ajlsi-1012	110	25	thereby	thereby	ADV
ajlsi-1012	110	26	enable	enable	VERB
ajlsi-1012	110	27	economic	economic	ADJ
ajlsi-1012	110	28	and	and	CCONJ
ajlsi-1012	110	29	social	social	ADJ
ajlsi-1012	110	30	activity	activity	NOUN
ajlsi-1012	110	31	to	to	PART
ajlsi-1012	110	32	resume	resume	VERB
ajlsi-1012	110	33	to	to	ADP
ajlsi-1012	110	34	the	the	DET
ajlsi-1012	110	35	extent	extent	NOUN
ajlsi-1012	110	36	possible	possible	ADJ
ajlsi-1012	110	37	.	.	PUNCT
ajlsi-1012	111	1	surveillance	surveillance	NOUN
ajlsi-1012	111	2	is	be	AUX
ajlsi-1012	111	3	also	also	ADV
ajlsi-1012	111	4	necessary	necessary	ADJ
ajlsi-1012	111	5	to	to	PART
ajlsi-1012	111	6	predict	predict	VERB
ajlsi-1012	111	7	the	the	DET
ajlsi-1012	111	8	longer	long	ADJ
ajlsi-1012	111	9	-	-	PUNCT
ajlsi-1012	111	10	term	term	NOUN
ajlsi-1012	111	11	trends	trend	NOUN
ajlsi-1012	111	12	of	of	ADP
ajlsi-1012	111	13	covid-19	covid-19	PROPN
ajlsi-1012	111	14	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	111	15	pa	pa	PROPN
ajlsi-1012	111	16	ge	ge	PROPN
ajlsi-1012	111	17	32	32	NUM
ajlsi-1012	111	18	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	111	19	am	am	NOUN
ajlsi-1012	111	20	.	.	PUNCT
ajlsi-1012	112	1	j.	j.	PROPN
ajlsi-1012	112	2	life	life	PROPN
ajlsi-1012	112	3	sci	sci	PROPN
ajlsi-1012	112	4	.	.	PUNCT
ajlsi-1012	112	5	innov	innov	PROPN
ajlsi-1012	112	6	.	.	PUNCT
ajlsi-1012	113	1	1(2	1(2	NUM
ajlsi-1012	113	2	)	)	PUNCT
ajlsi-1012	113	3	29	29	NUM
ajlsi-1012	113	4	-	-	SYM
ajlsi-1012	113	5	42	42	NUM
ajlsi-1012	113	6	,	,	PUNCT
ajlsi-1012	113	7	2022	2022	NUM
ajlsi-1012	113	8	transmission	transmission	NOUN
ajlsi-1012	113	9	and	and	CCONJ
ajlsi-1012	113	10	the	the	DET
ajlsi-1012	113	11	changes	change	NOUN
ajlsi-1012	113	12	ahead	ahead	ADV
ajlsi-1012	113	13	(	(	PUNCT
ajlsi-1012	113	14	who	who	PRON
ajlsi-1012	113	15	2020	2020	NUM
ajlsi-1012	113	16	)	)	PUNCT
ajlsi-1012	113	17	.	.	PUNCT
ajlsi-1012	114	1	a	a	DET
ajlsi-1012	114	2	“	"	PUNCT
ajlsi-1012	114	3	case	case	NOUN
ajlsi-1012	114	4	sample	sample	NOUN
ajlsi-1012	114	5	”	"	PUNCT
ajlsi-1012	114	6	is	be	AUX
ajlsi-1012	114	7	considered	consider	VERB
ajlsi-1012	114	8	a	a	DET
ajlsi-1012	114	9	subset	subset	NOUN
ajlsi-1012	114	10	of	of	ADP
ajlsi-1012	114	11	individuals	individual	NOUN
ajlsi-1012	114	12	from	from	ADP
ajlsi-1012	114	13	a	a	DET
ajlsi-1012	114	14	larger	large	ADJ
ajlsi-1012	114	15	population	population	NOUN
ajlsi-1012	114	16	.	.	PUNCT
ajlsi-1012	115	1	sampling	sample	VERB
ajlsi-1012	115	2	is	be	AUX
ajlsi-1012	115	3	simply	simply	ADV
ajlsi-1012	115	4	stated	state	VERB
ajlsi-1012	115	5	as	as	ADP
ajlsi-1012	115	6	selecting	select	VERB
ajlsi-1012	115	7	a	a	DET
ajlsi-1012	115	8	portion	portion	NOUN
ajlsi-1012	115	9	of	of	ADP
ajlsi-1012	115	10	the	the	DET
ajlsi-1012	115	11	infected	infected	ADJ
ajlsi-1012	115	12	population	population	NOUN
ajlsi-1012	115	13	that	that	PRON
ajlsi-1012	115	14	will	will	AUX
ajlsi-1012	115	15	actually	actually	ADV
ajlsi-1012	115	16	collect	collect	VERB
ajlsi-1012	115	17	evidence	evidence	NOUN
ajlsi-1012	115	18	from	from	ADP
ajlsi-1012	115	19	the	the	DET
ajlsi-1012	115	20	research	research	NOUN
ajlsi-1012	115	21	area	area	NOUN
ajlsi-1012	115	22	under	under	ADP
ajlsi-1012	115	23	surveillance	surveillance	NOUN
ajlsi-1012	115	24	.	.	PUNCT
ajlsi-1012	116	1	samples	sample	NOUN
ajlsi-1012	116	2	are	be	AUX
ajlsi-1012	116	3	used	use	VERB
ajlsi-1012	116	4	to	to	PART
ajlsi-1012	116	5	make	make	VERB
ajlsi-1012	116	6	inferences	inference	NOUN
ajlsi-1012	116	7	about	about	ADP
ajlsi-1012	116	8	populations	population	NOUN
ajlsi-1012	116	9	.	.	PUNCT
ajlsi-1012	117	1	(	(	PUNCT
ajlsi-1012	117	2	landreneau	landreneau	PROPN
ajlsi-1012	117	3	,	,	PUNCT
ajlsi-1012	117	4	k.	k.	PROPN
ajlsi-1012	117	5	j.	j.	PROPN
ajlsi-1012	117	6	,	,	PUNCT
ajlsi-1012	117	7	et	et	PROPN
ajlsi-1012	117	8	al	al	PROPN
ajlsi-1012	117	9	.	.	PROPN
ajlsi-1012	117	10	,	,	PUNCT
ajlsi-1012	117	11	2009	2009	NUM
ajlsi-1012	117	12	)	)	PUNCT
ajlsi-1012	117	13	.	.	PUNCT
ajlsi-1012	118	1	there	there	PRON
ajlsi-1012	118	2	are	be	VERB
ajlsi-1012	118	3	two	two	NUM
ajlsi-1012	118	4	types	type	NOUN
ajlsi-1012	118	5	of	of	ADP
ajlsi-1012	118	6	sampling	sample	VERB
ajlsi-1012	118	7	methods	method	NOUN
ajlsi-1012	118	8	employed	employ	VERB
ajlsi-1012	118	9	in	in	ADP
ajlsi-1012	118	10	epidemiological	epidemiological	ADJ
ajlsi-1012	118	11	surveillance	surveillance	NOUN
ajlsi-1012	118	12	:	:	PUNCT
ajlsi-1012	118	13	probability	probability	NOUN
ajlsi-1012	118	14	sampling	sample	VERB
ajlsi-1012	118	15	this	this	PRON
ajlsi-1012	118	16	includes	include	VERB
ajlsi-1012	118	17	some	some	DET
ajlsi-1012	118	18	form	form	NOUN
ajlsi-1012	118	19	of	of	ADP
ajlsi-1012	118	20	random	random	ADJ
ajlsi-1012	118	21	selection	selection	NOUN
ajlsi-1012	118	22	in	in	ADP
ajlsi-1012	118	23	choosing	choose	VERB
ajlsi-1012	118	24	the	the	DET
ajlsi-1012	118	25	elements	element	NOUN
ajlsi-1012	118	26	.	.	PUNCT
ajlsi-1012	119	1	greater	great	ADJ
ajlsi-1012	119	2	confidence	confidence	NOUN
ajlsi-1012	119	3	can	can	AUX
ajlsi-1012	119	4	be	be	AUX
ajlsi-1012	119	5	placed	place	VERB
ajlsi-1012	119	6	in	in	ADP
ajlsi-1012	119	7	the	the	DET
ajlsi-1012	119	8	representativeness	representativeness	NOUN
ajlsi-1012	119	9	of	of	ADP
ajlsi-1012	119	10	probability	probability	NOUN
ajlsi-1012	119	11	samples	sample	NOUN
ajlsi-1012	119	12	.	.	PUNCT
ajlsi-1012	120	1	this	this	DET
ajlsi-1012	120	2	type	type	NOUN
ajlsi-1012	120	3	of	of	ADP
ajlsi-1012	120	4	sampling	sampling	NOUN
ajlsi-1012	120	5	involves	involve	VERB
ajlsi-1012	120	6	a	a	DET
ajlsi-1012	120	7	selection	selection	NOUN
ajlsi-1012	120	8	process	process	NOUN
ajlsi-1012	120	9	in	in	ADP
ajlsi-1012	120	10	which	which	PRON
ajlsi-1012	120	11	each	each	DET
ajlsi-1012	120	12	element	element	NOUN
ajlsi-1012	120	13	in	in	ADP
ajlsi-1012	120	14	the	the	DET
ajlsi-1012	120	15	population	population	NOUN
ajlsi-1012	120	16	has	have	VERB
ajlsi-1012	120	17	an	an	DET
ajlsi-1012	120	18	equal	equal	ADJ
ajlsi-1012	120	19	and	and	CCONJ
ajlsi-1012	120	20	independent	independent	ADJ
ajlsi-1012	120	21	chance	chance	NOUN
ajlsi-1012	120	22	of	of	ADP
ajlsi-1012	120	23	being	be	AUX
ajlsi-1012	120	24	selected	select	VERB
ajlsi-1012	120	25	.	.	PUNCT
ajlsi-1012	121	1	•	•	NUM
ajlsi-1012	121	2	simple	simple	ADJ
ajlsi-1012	121	3	random	random	ADJ
ajlsi-1012	121	4	sampling	sampling	NOUN
ajlsi-1012	121	5	:	:	PUNCT
ajlsi-1012	121	6	in	in	ADP
ajlsi-1012	121	7	a	a	DET
ajlsi-1012	121	8	simple	simple	ADJ
ajlsi-1012	121	9	random	random	ADJ
ajlsi-1012	121	10	sample	sample	NOUN
ajlsi-1012	121	11	,	,	PUNCT
ajlsi-1012	121	12	every	every	DET
ajlsi-1012	121	13	member	member	NOUN
ajlsi-1012	121	14	of	of	ADP
ajlsi-1012	121	15	the	the	DET
ajlsi-1012	121	16	population	population	NOUN
ajlsi-1012	121	17	has	have	VERB
ajlsi-1012	121	18	an	an	DET
ajlsi-1012	121	19	equal	equal	ADJ
ajlsi-1012	121	20	chance	chance	NOUN
ajlsi-1012	121	21	of	of	ADP
ajlsi-1012	121	22	being	be	AUX
ajlsi-1012	121	23	selected	select	VERB
ajlsi-1012	121	24	.	.	PUNCT
ajlsi-1012	122	1	•	•	NUM
ajlsi-1012	122	2	stratified	stratify	VERB
ajlsi-1012	122	3	random	random	ADJ
ajlsi-1012	122	4	sampling	sampling	NOUN
ajlsi-1012	122	5	:	:	PUNCT
ajlsi-1012	122	6	this	this	DET
ajlsi-1012	122	7	sampling	sampling	NOUN
ajlsi-1012	122	8	method	method	NOUN
ajlsi-1012	122	9	is	be	AUX
ajlsi-1012	122	10	appropriate	appropriate	ADJ
ajlsi-1012	122	11	when	when	SCONJ
ajlsi-1012	122	12	the	the	DET
ajlsi-1012	122	13	population	population	NOUN
ajlsi-1012	122	14	has	have	VERB
ajlsi-1012	122	15	mixed	mixed	ADJ
ajlsi-1012	122	16	characteristics	characteristic	NOUN
ajlsi-1012	122	17	(	(	PUNCT
ajlsi-1012	122	18	like	like	INTJ
ajlsi-1012	122	19	age	age	NOUN
ajlsi-1012	122	20	,	,	PUNCT
ajlsi-1012	122	21	demography	demography	NOUN
ajlsi-1012	122	22	,	,	PUNCT
ajlsi-1012	122	23	etc	etc	X
ajlsi-1012	122	24	.	.	X
ajlsi-1012	122	25	)	)	PUNCT
ajlsi-1012	123	1	and	and	CCONJ
ajlsi-1012	123	2	you	you	PRON
ajlsi-1012	123	3	want	want	VERB
ajlsi-1012	123	4	to	to	PART
ajlsi-1012	123	5	ensure	ensure	VERB
ajlsi-1012	123	6	that	that	SCONJ
ajlsi-1012	123	7	every	every	DET
ajlsi-1012	123	8	characteristic	characteristic	NOUN
ajlsi-1012	123	9	is	be	AUX
ajlsi-1012	123	10	proportionally	proportionally	ADV
ajlsi-1012	123	11	represented	represent	VERB
ajlsi-1012	123	12	in	in	ADP
ajlsi-1012	123	13	the	the	DET
ajlsi-1012	123	14	sample	sample	NOUN
ajlsi-1012	123	15	.	.	PUNCT
ajlsi-1012	124	1	•	•	NUM
ajlsi-1012	124	2	cluster	cluster	NOUN
ajlsi-1012	124	3	sampling	sampling	NOUN
ajlsi-1012	124	4	:	:	PUNCT
ajlsi-1012	124	5	cluster	cluster	NOUN
ajlsi-1012	124	6	sampling	sampling	NOUN
ajlsi-1012	124	7	also	also	ADV
ajlsi-1012	124	8	involves	involve	VERB
ajlsi-1012	124	9	dividing	divide	VERB
ajlsi-1012	124	10	the	the	DET
ajlsi-1012	124	11	population	population	NOUN
ajlsi-1012	124	12	into	into	ADP
ajlsi-1012	124	13	subgroups	subgroup	NOUN
ajlsi-1012	124	14	,	,	PUNCT
ajlsi-1012	124	15	but	but	CCONJ
ajlsi-1012	124	16	each	each	DET
ajlsi-1012	124	17	subgroup	subgroup	NOUN
ajlsi-1012	124	18	should	should	AUX
ajlsi-1012	124	19	have	have	VERB
ajlsi-1012	124	20	similar	similar	ADJ
ajlsi-1012	124	21	characteristics	characteristic	NOUN
ajlsi-1012	124	22	to	to	ADP
ajlsi-1012	124	23	the	the	DET
ajlsi-1012	124	24	whole	whole	ADJ
ajlsi-1012	124	25	sample	sample	NOUN
ajlsi-1012	124	26	.	.	PUNCT
ajlsi-1012	125	1	instead	instead	ADV
ajlsi-1012	125	2	of	of	ADP
ajlsi-1012	125	3	sampling	sample	VERB
ajlsi-1012	125	4	individuals	individual	NOUN
ajlsi-1012	125	5	from	from	ADP
ajlsi-1012	125	6	each	each	DET
ajlsi-1012	125	7	subgroup	subgroup	NOUN
ajlsi-1012	125	8	,	,	PUNCT
ajlsi-1012	125	9	entire	entire	ADJ
ajlsi-1012	125	10	subgroups	subgroup	NOUN
ajlsi-1012	125	11	are	be	AUX
ajlsi-1012	125	12	randomly	randomly	ADV
ajlsi-1012	125	13	selected	select	VERB
ajlsi-1012	125	14	.	.	PUNCT
ajlsi-1012	126	1	•	•	NUM
ajlsi-1012	126	2	systematic	systematic	ADJ
ajlsi-1012	126	3	sampling	sampling	NOUN
ajlsi-1012	126	4	:	:	PUNCT
ajlsi-1012	126	5	this	this	PRON
ajlsi-1012	126	6	is	be	AUX
ajlsi-1012	126	7	similar	similar	ADJ
ajlsi-1012	126	8	to	to	ADP
ajlsi-1012	126	9	simple	simple	ADJ
ajlsi-1012	126	10	random	random	ADJ
ajlsi-1012	126	11	sampling	sampling	NOUN
ajlsi-1012	126	12	,	,	PUNCT
ajlsi-1012	126	13	but	but	CCONJ
ajlsi-1012	126	14	it	it	PRON
ajlsi-1012	126	15	is	be	AUX
ajlsi-1012	126	16	usually	usually	ADV
ajlsi-1012	126	17	slightly	slightly	ADV
ajlsi-1012	126	18	easier	easy	ADJ
ajlsi-1012	126	19	to	to	PART
ajlsi-1012	126	20	conduct	conduct	VERB
ajlsi-1012	126	21	.	.	PUNCT
ajlsi-1012	127	1	every	every	DET
ajlsi-1012	127	2	member	member	NOUN
ajlsi-1012	127	3	of	of	ADP
ajlsi-1012	127	4	the	the	DET
ajlsi-1012	127	5	population	population	NOUN
ajlsi-1012	127	6	is	be	AUX
ajlsi-1012	127	7	listed	list	VERB
ajlsi-1012	127	8	with	with	ADP
ajlsi-1012	127	9	a	a	DET
ajlsi-1012	127	10	number	number	NOUN
ajlsi-1012	127	11	,	,	PUNCT
ajlsi-1012	127	12	but	but	CCONJ
ajlsi-1012	127	13	instead	instead	ADV
ajlsi-1012	127	14	of	of	ADP
ajlsi-1012	127	15	randomly	randomly	ADV
ajlsi-1012	127	16	generating	generate	VERB
ajlsi-1012	127	17	numbers	number	NOUN
ajlsi-1012	127	18	,	,	PUNCT
ajlsi-1012	127	19	individuals	individual	NOUN
ajlsi-1012	127	20	are	be	AUX
ajlsi-1012	127	21	chosen	choose	VERB
ajlsi-1012	127	22	at	at	ADP
ajlsi-1012	127	23	regular	regular	ADJ
ajlsi-1012	127	24	intervals	interval	NOUN
ajlsi-1012	127	25	for	for	ADP
ajlsi-1012	127	26	sampling	sample	VERB
ajlsi-1012	127	27	.	.	PUNCT
ajlsi-1012	128	1	non	non	ADJ
ajlsi-1012	128	2	-	-	NOUN
ajlsi-1012	128	3	probability	probability	NOUN
ajlsi-1012	128	4	sampling	sample	VERB
ajlsi-1012	128	5	the	the	DET
ajlsi-1012	128	6	elements	element	NOUN
ajlsi-1012	128	7	that	that	PRON
ajlsi-1012	128	8	make	make	VERB
ajlsi-1012	128	9	up	up	ADP
ajlsi-1012	128	10	the	the	DET
ajlsi-1012	128	11	sample	sample	NOUN
ajlsi-1012	128	12	are	be	AUX
ajlsi-1012	128	13	selected	select	VERB
ajlsi-1012	128	14	by	by	ADP
ajlsi-1012	128	15	nonrandom	nonrandom	NOUN
ajlsi-1012	128	16	methods	method	NOUN
ajlsi-1012	128	17	.	.	PUNCT
ajlsi-1012	129	1	this	this	DET
ajlsi-1012	129	2	type	type	NOUN
ajlsi-1012	129	3	of	of	ADP
ajlsi-1012	129	4	sampling	sampling	NOUN
ajlsi-1012	129	5	is	be	AUX
ajlsi-1012	129	6	less	less	ADV
ajlsi-1012	129	7	likely	likely	ADJ
ajlsi-1012	129	8	than	than	ADP
ajlsi-1012	129	9	probability	probability	NOUN
ajlsi-1012	129	10	sampling	sample	VERB
ajlsi-1012	129	11	to	to	PART
ajlsi-1012	129	12	produce	produce	VERB
ajlsi-1012	129	13	representative	representative	ADJ
ajlsi-1012	129	14	samples	sample	NOUN
ajlsi-1012	129	15	.	.	PUNCT
ajlsi-1012	130	1	even	even	ADV
ajlsi-1012	130	2	though	though	SCONJ
ajlsi-1012	130	3	this	this	PRON
ajlsi-1012	130	4	is	be	AUX
ajlsi-1012	130	5	true	true	ADJ
ajlsi-1012	130	6	,	,	PUNCT
ajlsi-1012	130	7	researchers	researcher	NOUN
ajlsi-1012	130	8	can	can	AUX
ajlsi-1012	130	9	and	and	CCONJ
ajlsi-1012	130	10	do	do	AUX
ajlsi-1012	130	11	use	use	VERB
ajlsi-1012	130	12	non	non	ADJ
ajlsi-1012	130	13	-	-	ADJ
ajlsi-1012	130	14	probability	probability	ADJ
ajlsi-1012	130	15	samples	sample	NOUN
ajlsi-1012	130	16	.	.	PUNCT
ajlsi-1012	131	1	the	the	DET
ajlsi-1012	131	2	three	three	NUM
ajlsi-1012	131	3	main	main	ADJ
ajlsi-1012	131	4	methods	method	NOUN
ajlsi-1012	131	5	are	be	AUX
ajlsi-1012	131	6	:	:	PUNCT
ajlsi-1012	131	7	•	•	NUM
ajlsi-1012	131	8	convenience	convenience	NOUN
ajlsi-1012	131	9	sampling	sampling	NOUN
ajlsi-1012	131	10	:	:	PUNCT
ajlsi-1012	131	11	a	a	DET
ajlsi-1012	131	12	convenience	convenience	NOUN
ajlsi-1012	131	13	sample	sample	NOUN
ajlsi-1012	131	14	includes	include	VERB
ajlsi-1012	131	15	the	the	DET
ajlsi-1012	131	16	individuals	individual	NOUN
ajlsi-1012	131	17	who	who	PRON
ajlsi-1012	131	18	happen	happen	VERB
ajlsi-1012	131	19	to	to	PART
ajlsi-1012	131	20	be	be	AUX
ajlsi-1012	131	21	most	most	ADV
ajlsi-1012	131	22	accessible	accessible	ADJ
ajlsi-1012	131	23	to	to	ADP
ajlsi-1012	131	24	the	the	DET
ajlsi-1012	131	25	researcher	researcher	NOUN
ajlsi-1012	131	26	.	.	PUNCT
ajlsi-1012	132	1	•	•	NOUN
ajlsi-1012	132	2	quota	quota	NOUN
ajlsi-1012	132	3	sampling	sampling	NOUN
ajlsi-1012	132	4	is	be	AUX
ajlsi-1012	132	5	primarily	primarily	ADV
ajlsi-1012	132	6	motivated	motivate	VERB
ajlsi-1012	132	7	by	by	ADP
ajlsi-1012	132	8	ease	ease	NOUN
ajlsi-1012	132	9	of	of	ADP
ajlsi-1012	132	10	access	access	NOUN
ajlsi-1012	132	11	.	.	PUNCT
ajlsi-1012	133	1	instead	instead	ADV
ajlsi-1012	133	2	of	of	ADP
ajlsi-1012	133	3	the	the	DET
ajlsi-1012	133	4	researcher	researcher	NOUN
ajlsi-1012	133	5	choosing	choose	VERB
ajlsi-1012	133	6	participants	participant	NOUN
ajlsi-1012	133	7	and	and	CCONJ
ajlsi-1012	133	8	directly	directly	ADV
ajlsi-1012	133	9	contacting	contact	VERB
ajlsi-1012	133	10	them	they	PRON
ajlsi-1012	133	11	,	,	PUNCT
ajlsi-1012	133	12	people	people	NOUN
ajlsi-1012	133	13	volunteer	volunteer	VERB
ajlsi-1012	133	14	themselves	themselves	PRON
ajlsi-1012	133	15	(	(	PUNCT
ajlsi-1012	133	16	e.g.	e.g.	ADV
ajlsi-1012	133	17	,	,	PUNCT
ajlsi-1012	133	18	by	by	ADP
ajlsi-1012	133	19	responding	respond	VERB
ajlsi-1012	133	20	to	to	ADP
ajlsi-1012	133	21	a	a	DET
ajlsi-1012	133	22	public	public	ADJ
ajlsi-1012	133	23	online	online	ADJ
ajlsi-1012	133	24	survey	survey	NOUN
ajlsi-1012	133	25	)	)	PUNCT
ajlsi-1012	133	26	.	.	PUNCT
ajlsi-1012	134	1	•	•	NUM
ajlsi-1012	134	2	purposive	purposive	ADJ
ajlsi-1012	134	3	sampling	sampling	NOUN
ajlsi-1012	134	4	:	:	PUNCT
ajlsi-1012	134	5	this	this	DET
ajlsi-1012	134	6	type	type	NOUN
ajlsi-1012	134	7	of	of	ADP
ajlsi-1012	134	8	sampling	sampling	NOUN
ajlsi-1012	134	9	involves	involve	VERB
ajlsi-1012	134	10	the	the	DET
ajlsi-1012	134	11	researcher	researcher	NOUN
ajlsi-1012	134	12	using	use	VERB
ajlsi-1012	134	13	their	their	PRON
ajlsi-1012	134	14	judgement	judgement	NOUN
ajlsi-1012	134	15	to	to	PART
ajlsi-1012	134	16	select	select	VERB
ajlsi-1012	134	17	a	a	DET
ajlsi-1012	134	18	sample	sample	NOUN
ajlsi-1012	134	19	that	that	PRON
ajlsi-1012	134	20	is	be	AUX
ajlsi-1012	134	21	most	most	ADV
ajlsi-1012	134	22	useful	useful	ADJ
ajlsi-1012	134	23	for	for	ADP
ajlsi-1012	134	24	the	the	DET
ajlsi-1012	134	25	purposes	purpose	NOUN
ajlsi-1012	134	26	of	of	ADP
ajlsi-1012	134	27	the	the	DET
ajlsi-1012	134	28	research	research	NOUN
ajlsi-1012	134	29	.	.	PUNCT
ajlsi-1012	135	1	any	any	DET
ajlsi-1012	135	2	covid-19	covid-19	PROPN
ajlsi-1012	135	3	surveillance	surveillance	NOUN
ajlsi-1012	135	4	system	system	NOUN
ajlsi-1012	135	5	placed	place	VERB
ajlsi-1012	135	6	should	should	AUX
ajlsi-1012	135	7	be	be	AUX
ajlsi-1012	135	8	geographically	geographically	ADV
ajlsi-1012	135	9	comprehensive	comprehensive	ADJ
ajlsi-1012	135	10	and	and	CCONJ
ajlsi-1012	135	11	include	include	VERB
ajlsi-1012	135	12	all	all	DET
ajlsi-1012	135	13	people	people	NOUN
ajlsi-1012	135	14	and	and	CCONJ
ajlsi-1012	135	15	communities	community	NOUN
ajlsi-1012	135	16	at	at	ADP
ajlsi-1012	135	17	risk	risk	NOUN
ajlsi-1012	135	18	.	.	PUNCT
ajlsi-1012	136	1	surveillance	surveillance	NOUN
ajlsi-1012	136	2	for	for	ADP
ajlsi-1012	136	3	vulnerable	vulnerable	ADJ
ajlsi-1012	136	4	or	or	CCONJ
ajlsi-1012	136	5	high	high	ADJ
ajlsi-1012	136	6	-	-	PUNCT
ajlsi-1012	136	7	risk	risk	NOUN
ajlsi-1012	136	8	populations	population	NOUN
ajlsi-1012	136	9	should	should	AUX
ajlsi-1012	136	10	be	be	AUX
ajlsi-1012	136	11	enhanced	enhance	VERB
ajlsi-1012	136	12	.	.	PUNCT
ajlsi-1012	137	1	this	this	PRON
ajlsi-1012	137	2	will	will	AUX
ajlsi-1012	137	3	require	require	VERB
ajlsi-1012	137	4	a	a	DET
ajlsi-1012	137	5	combination	combination	NOUN
ajlsi-1012	137	6	of	of	ADP
ajlsi-1012	137	7	surveillance	surveillance	NOUN
ajlsi-1012	137	8	systems	system	NOUN
ajlsi-1012	137	9	,	,	PUNCT
ajlsi-1012	137	10	including	include	VERB
ajlsi-1012	137	11	contact	contact	NOUN
ajlsi-1012	137	12	tracing	trace	VERB
ajlsi-1012	137	13	,	,	PUNCT
ajlsi-1012	137	14	in	in	ADP
ajlsi-1012	137	15	the	the	DET
ajlsi-1012	137	16	entire	entire	ADJ
ajlsi-1012	137	17	health	health	NOUN
ajlsi-1012	137	18	care	care	NOUN
ajlsi-1012	137	19	system	system	NOUN
ajlsi-1012	137	20	,	,	PUNCT
ajlsi-1012	137	21	at	at	ADP
ajlsi-1012	137	22	the	the	DET
ajlsi-1012	137	23	community	community	NOUN
ajlsi-1012	137	24	level	level	NOUN
ajlsi-1012	137	25	,	,	PUNCT
ajlsi-1012	137	26	as	as	ADV
ajlsi-1012	137	27	well	well	ADV
ajlsi-1012	137	28	as	as	ADP
ajlsi-1012	137	29	in	in	ADP
ajlsi-1012	137	30	closed	closed	ADJ
ajlsi-1012	137	31	residential	residential	ADJ
ajlsi-1012	137	32	settings	setting	NOUN
ajlsi-1012	137	33	and	and	CCONJ
ajlsi-1012	137	34	for	for	ADP
ajlsi-1012	137	35	vulnerable	vulnerable	ADJ
ajlsi-1012	137	36	groups	group	NOUN
ajlsi-1012	137	37	.	.	PUNCT
ajlsi-1012	138	1	surveillance	surveillance	NOUN
ajlsi-1012	138	2	at	at	ADP
ajlsi-1012	138	3	the	the	DET
ajlsi-1012	138	4	primary	primary	ADJ
ajlsi-1012	138	5	care	care	NOUN
ajlsi-1012	138	6	level	level	NOUN
ajlsi-1012	138	7	is	be	AUX
ajlsi-1012	138	8	needed	need	VERB
ajlsi-1012	138	9	to	to	PART
ajlsi-1012	138	10	detect	detect	VERB
ajlsi-1012	138	11	cases	case	NOUN
ajlsi-1012	138	12	and	and	CCONJ
ajlsi-1012	138	13	clusters	cluster	NOUN
ajlsi-1012	138	14	in	in	ADP
ajlsi-1012	138	15	the	the	DET
ajlsi-1012	138	16	community	community	NOUN
ajlsi-1012	138	17	.	.	PUNCT
ajlsi-1012	139	1	where	where	SCONJ
ajlsi-1012	139	2	possible	possible	ADJ
ajlsi-1012	139	3	,	,	PUNCT
ajlsi-1012	139	4	testing	testing	NOUN
ajlsi-1012	139	5	facilities	facility	NOUN
ajlsi-1012	139	6	are	be	AUX
ajlsi-1012	139	7	made	make	VERB
ajlsi-1012	139	8	available	available	ADJ
ajlsi-1012	139	9	at	at	ADP
ajlsi-1012	139	10	primary	primary	ADJ
ajlsi-1012	139	11	care	care	NOUN
ajlsi-1012	139	12	clinics	clinic	NOUN
ajlsi-1012	139	13	.	.	PUNCT
ajlsi-1012	140	1	a	a	DET
ajlsi-1012	140	2	complementary	complementary	ADJ
ajlsi-1012	140	3	option	option	NOUN
ajlsi-1012	140	4	is	be	AUX
ajlsi-1012	140	5	to	to	PART
ajlsi-1012	140	6	establish	establish	VERB
ajlsi-1012	140	7	dedicated	dedicated	ADJ
ajlsi-1012	140	8	covid-19	covid-19	PROPN
ajlsi-1012	140	9	community	community	NOUN
ajlsi-1012	140	10	testing	testing	NOUN
ajlsi-1012	140	11	facilities	facility	NOUN
ajlsi-1012	140	12	.	.	PUNCT
ajlsi-1012	141	1	patients	patient	NOUN
ajlsi-1012	141	2	with	with	ADP
ajlsi-1012	141	3	probable	probable	ADJ
ajlsi-1012	141	4	and	and	CCONJ
ajlsi-1012	141	5	confirmed	confirm	VERB
ajlsi-1012	141	6	covid-19	covid-19	PROPN
ajlsi-1012	141	7	cases	case	NOUN
ajlsi-1012	141	8	are	be	AUX
ajlsi-1012	141	9	notified	notify	VERB
ajlsi-1012	141	10	within	within	ADP
ajlsi-1012	141	11	24	24	NUM
ajlsi-1012	141	12	hours	hour	NOUN
ajlsi-1012	141	13	of	of	ADP
ajlsi-1012	141	14	identification	identification	NOUN
ajlsi-1012	141	15	.	.	PUNCT
ajlsi-1012	142	1	fast	fast	ADJ
ajlsi-1012	142	2	data	datum	NOUN
ajlsi-1012	142	3	reporting	reporting	NOUN
ajlsi-1012	142	4	and	and	CCONJ
ajlsi-1012	142	5	analysis	analysis	NOUN
ajlsi-1012	142	6	are	be	AUX
ajlsi-1012	142	7	critical	critical	ADJ
ajlsi-1012	142	8	to	to	ADP
ajlsi-1012	142	9	detecting	detect	VERB
ajlsi-1012	142	10	new	new	ADJ
ajlsi-1012	142	11	cases	case	NOUN
ajlsi-1012	142	12	and	and	CCONJ
ajlsi-1012	142	13	clusters	cluster	NOUN
ajlsi-1012	142	14	.	.	PUNCT
ajlsi-1012	143	1	therefore	therefore	ADV
ajlsi-1012	143	2	,	,	PUNCT
ajlsi-1012	143	3	only	only	ADV
ajlsi-1012	143	4	the	the	DET
ajlsi-1012	143	5	minimum	minimum	ADJ
ajlsi-1012	143	6	number	number	NOUN
ajlsi-1012	143	7	of	of	ADP
ajlsi-1012	143	8	data	datum	NOUN
ajlsi-1012	143	9	variables	variable	NOUN
ajlsi-1012	143	10	are	be	AUX
ajlsi-1012	143	11	to	to	PART
ajlsi-1012	143	12	be	be	AUX
ajlsi-1012	143	13	collected	collect	VERB
ajlsi-1012	143	14	(	(	PUNCT
ajlsi-1012	143	15	e.g.	e.g.	ADV
ajlsi-1012	143	16	,	,	PUNCT
ajlsi-1012	143	17	age	age	NOUN
ajlsi-1012	143	18	,	,	PUNCT
ajlsi-1012	143	19	sex	sex	NOUN
ajlsi-1012	143	20	,	,	PUNCT
ajlsi-1012	143	21	date	date	NOUN
ajlsi-1012	143	22	of	of	ADP
ajlsi-1012	143	23	illness	illness	NOUN
ajlsi-1012	143	24	onset	onset	NOUN
ajlsi-1012	143	25	,	,	PUNCT
ajlsi-1012	143	26	date	date	NOUN
ajlsi-1012	143	27	of	of	ADP
ajlsi-1012	143	28	sample	sample	NOUN
ajlsi-1012	143	29	taken	take	VERB
ajlsi-1012	143	30	,	,	PUNCT
ajlsi-1012	143	31	test	test	NOUN
ajlsi-1012	143	32	result	result	NOUN
ajlsi-1012	143	33	,	,	PUNCT
ajlsi-1012	143	34	location	location	NOUN
ajlsi-1012	143	35	of	of	ADP
ajlsi-1012	143	36	testing	testing	NOUN
ajlsi-1012	143	37	site	site	NOUN
ajlsi-1012	143	38	,	,	PUNCT
ajlsi-1012	143	39	etc	etc	X
ajlsi-1012	143	40	.	.	X
ajlsi-1012	143	41	)	)	PUNCT
ajlsi-1012	143	42	.	.	PUNCT
ajlsi-1012	144	1	data	datum	NOUN
ajlsi-1012	144	2	reporting	report	VERB
ajlsi-1012	144	3	to	to	ADP
ajlsi-1012	144	4	local	local	ADJ
ajlsi-1012	144	5	or	or	CCONJ
ajlsi-1012	144	6	national	national	ADJ
ajlsi-1012	144	7	public	public	ADJ
ajlsi-1012	144	8	health	health	NOUN
ajlsi-1012	144	9	authorities	authority	NOUN
ajlsi-1012	144	10	is	be	AUX
ajlsi-1012	144	11	done	do	VERB
ajlsi-1012	144	12	on	on	ADP
ajlsi-1012	144	13	a	a	DET
ajlsi-1012	144	14	daily	daily	ADJ
ajlsi-1012	144	15	basis	basis	NOUN
ajlsi-1012	144	16	.	.	PUNCT
ajlsi-1012	145	1	patients	patient	NOUN
ajlsi-1012	145	2	with	with	ADP
ajlsi-1012	145	3	probable	probable	ADJ
ajlsi-1012	145	4	or	or	CCONJ
ajlsi-1012	145	5	confirmed	confirm	VERB
ajlsi-1012	145	6	covid-19	covid-19	PROPN
ajlsi-1012	145	7	diagnoses	diagnosis	NOUN
ajlsi-1012	145	8	in	in	ADP
ajlsi-1012	145	9	hospitals	hospital	NOUN
ajlsi-1012	145	10	are	be	AUX
ajlsi-1012	145	11	notified	notify	VERB
ajlsi-1012	145	12	within	within	ADP
ajlsi-1012	145	13	24	24	NUM
ajlsi-1012	145	14	hours	hour	NOUN
ajlsi-1012	145	15	of	of	ADP
ajlsi-1012	145	16	identification	identification	NOUN
ajlsi-1012	145	17	.	.	PUNCT
ajlsi-1012	146	1	all	all	DET
ajlsi-1012	146	2	covid-19	covid-19	PROPN
ajlsi-1012	146	3	deaths	death	NOUN
ajlsi-1012	146	4	are	be	AUX
ajlsi-1012	146	5	reported	report	VERB
ajlsi-1012	146	6	within	within	ADP
ajlsi-1012	146	7	24	24	NUM
ajlsi-1012	146	8	hours	hour	NOUN
ajlsi-1012	146	9	of	of	ADP
ajlsi-1012	146	10	the	the	DET
ajlsi-1012	146	11	death	death	NOUN
ajlsi-1012	146	12	.	.	PUNCT
ajlsi-1012	147	1	the	the	DET
ajlsi-1012	147	2	minimum	minimum	ADJ
ajlsi-1012	147	3	essential	essential	ADJ
ajlsi-1012	147	4	data	datum	NOUN
ajlsi-1012	147	5	from	from	ADP
ajlsi-1012	147	6	hospital	hospital	NOUN
ajlsi-1012	147	7	settings	setting	NOUN
ajlsi-1012	147	8	includes	include	VERB
ajlsi-1012	147	9	:	:	PUNCT
ajlsi-1012	147	10	age	age	NOUN
ajlsi-1012	147	11	,	,	PUNCT
ajlsi-1012	147	12	sex/	sex/	ADJ
ajlsi-1012	147	13	gender	gender	NOUN
ajlsi-1012	147	14	,	,	PUNCT
ajlsi-1012	147	15	and	and	CCONJ
ajlsi-1012	147	16	place	place	NOUN
ajlsi-1012	147	17	of	of	ADP
ajlsi-1012	147	18	residence	residence	NOUN
ajlsi-1012	147	19	;	;	PUNCT
ajlsi-1012	147	20	date	date	NOUN
ajlsi-1012	147	21	of	of	ADP
ajlsi-1012	147	22	onset	onset	NOUN
ajlsi-1012	147	23	;	;	PUNCT
ajlsi-1012	147	24	date	date	NOUN
ajlsi-1012	147	25	of	of	ADP
ajlsi-1012	147	26	sample	sample	NOUN
ajlsi-1012	147	27	collection	collection	NOUN
ajlsi-1012	147	28	;	;	PUNCT
ajlsi-1012	147	29	date	date	NOUN
ajlsi-1012	147	30	of	of	ADP
ajlsi-1012	147	31	admission	admission	NOUN
ajlsi-1012	147	32	;	;	PUNCT
ajlsi-1012	147	33	laboratory	laboratory	NOUN
ajlsi-1012	147	34	test	test	NOUN
ajlsi-1012	147	35	result	result	NOUN
ajlsi-1012	147	36	;	;	PUNCT
ajlsi-1012	147	37	severity	severity	NOUN
ajlsi-1012	147	38	on	on	ADP
ajlsi-1012	147	39	admission	admission	NOUN
ajlsi-1012	147	40	:	:	PUNCT
ajlsi-1012	147	41	admitted	admit	VERB
ajlsi-1012	147	42	to	to	ADP
ajlsi-1012	147	43	the	the	DET
ajlsi-1012	147	44	intensive	intensive	ADJ
ajlsi-1012	147	45	care	care	NOUN
ajlsi-1012	147	46	unit	unit	NOUN
ajlsi-1012	147	47	(	(	PUNCT
ajlsi-1012	147	48	icu	icu	PROPN
ajlsi-1012	147	49	)	)	PUNCT
ajlsi-1012	147	50	;	;	PUNCT
ajlsi-1012	147	51	treated	treat	VERB
ajlsi-1012	147	52	with	with	ADP
ajlsi-1012	147	53	ventilation	ventilation	NOUN
ajlsi-1012	147	54	,	,	PUNCT
ajlsi-1012	147	55	if	if	SCONJ
ajlsi-1012	147	56	the	the	DET
ajlsi-1012	147	57	case	case	NOUN
ajlsi-1012	147	58	is	be	AUX
ajlsi-1012	147	59	a	a	DET
ajlsi-1012	147	60	health	health	NOUN
ajlsi-1012	147	61	care	care	NOUN
ajlsi-1012	147	62	worker	worker	NOUN
ajlsi-1012	147	63	;	;	PUNCT
ajlsi-1012	147	64	outcome	outcome	NOUN
ajlsi-1012	147	65	(	(	PUNCT
ajlsi-1012	147	66	discharge	discharge	NOUN
ajlsi-1012	147	67	or	or	CCONJ
ajlsi-1012	147	68	death	death	NOUN
ajlsi-1012	147	69	)	)	PUNCT
ajlsi-1012	147	70	;	;	PUNCT
ajlsi-1012	147	71	etc	etc	X
ajlsi-1012	147	72	.	.	X
ajlsi-1012	147	73	existing	exist	VERB
ajlsi-1012	147	74	sentinel	sentinel	ADJ
ajlsi-1012	147	75	surveillance	surveillance	NOUN
ajlsi-1012	147	76	of	of	ADP
ajlsi-1012	147	77	influenza	influenza	NOUN
ajlsi-1012	147	78	-	-	PUNCT
ajlsi-1012	147	79	like	like	ADJ
ajlsi-1012	147	80	illness	illness	NOUN
ajlsi-1012	147	81	(	(	PUNCT
ajlsi-1012	147	82	ili	ili	NOUN
ajlsi-1012	147	83	)	)	PUNCT
ajlsi-1012	147	84	or	or	CCONJ
ajlsi-1012	147	85	acute	acute	ADJ
ajlsi-1012	147	86	respiratory	respiratory	ADJ
ajlsi-1012	147	87	infections	infection	NOUN
ajlsi-1012	147	88	(	(	PUNCT
ajlsi-1012	147	89	ari	ari	PROPN
ajlsi-1012	147	90	)	)	PUNCT
ajlsi-1012	147	91	is	be	AUX
ajlsi-1012	147	92	useful	useful	ADJ
ajlsi-1012	147	93	to	to	PART
ajlsi-1012	147	94	monitor	monitor	VERB
ajlsi-1012	147	95	trends	trend	NOUN
ajlsi-1012	147	96	in	in	ADP
ajlsi-1012	147	97	community	community	NOUN
ajlsi-1012	147	98	transmission	transmission	NOUN
ajlsi-1012	147	99	of	of	ADP
ajlsi-1012	147	100	the	the	DET
ajlsi-1012	147	101	covid-19	covid-19	PROPN
ajlsi-1012	147	102	virus	virus	NOUN
ajlsi-1012	147	103	and	and	CCONJ
ajlsi-1012	147	104	to	to	PART
ajlsi-1012	147	105	ensure	ensure	VERB
ajlsi-1012	147	106	that	that	SCONJ
ajlsi-1012	147	107	other	other	ADJ
ajlsi-1012	147	108	priority	priority	NOUN
ajlsi-1012	147	109	respiratory	respiratory	ADJ
ajlsi-1012	147	110	diseases	disease	NOUN
ajlsi-1012	147	111	are	be	AUX
ajlsi-1012	147	112	being	be	AUX
ajlsi-1012	147	113	detected	detect	VERB
ajlsi-1012	147	114	.	.	PUNCT
ajlsi-1012	148	1	integration	integration	NOUN
ajlsi-1012	148	2	of	of	ADP
ajlsi-1012	148	3	covid-19	covid-19	PROPN
ajlsi-1012	148	4	with	with	ADP
ajlsi-1012	148	5	the	the	DET
ajlsi-1012	148	6	global	global	ADJ
ajlsi-1012	148	7	influenza	influenza	NOUN
ajlsi-1012	148	8	surveillance	surveillance	NOUN
ajlsi-1012	148	9	and	and	CCONJ
ajlsi-1012	148	10	response	response	NOUN
ajlsi-1012	148	11	system	system	NOUN
ajlsi-1012	148	12	(	(	PUNCT
ajlsi-1012	148	13	gisrs	gisrs	NOUN
ajlsi-1012	148	14	)	)	PUNCT
ajlsi-1012	148	15	is	be	AUX
ajlsi-1012	148	16	described	describe	VERB
ajlsi-1012	148	17	in	in	ADP
ajlsi-1012	148	18	operational	operational	ADJ
ajlsi-1012	148	19	considerations	consideration	NOUN
ajlsi-1012	148	20	for	for	ADP
ajlsi-1012	148	21	covid-19	covid-19	PROPN
ajlsi-1012	148	22	surveillance	surveillance	NOUN
ajlsi-1012	148	23	using	use	VERB
ajlsi-1012	148	24	gisrs	gisrs	NOUN
ajlsi-1012	148	25	.	.	PUNCT
ajlsi-1012	149	1	virologic	virologic	ADJ
ajlsi-1012	149	2	sentinel	sentinel	ADJ
ajlsi-1012	149	3	surveillance	surveillance	NOUN
ajlsi-1012	149	4	of	of	ADP
ajlsi-1012	149	5	covid-19	covid-19	PROPN
ajlsi-1012	149	6	is	be	AUX
ajlsi-1012	149	7	conducted	conduct	VERB
ajlsi-1012	149	8	using	use	VERB
ajlsi-1012	149	9	clinical	clinical	ADJ
ajlsi-1012	149	10	specimens	specimen	NOUN
ajlsi-1012	149	11	obtained	obtain	VERB
ajlsi-1012	149	12	through	through	ADP
ajlsi-1012	149	13	sentinel	sentinel	ADJ
ajlsi-1012	149	14	surveillance	surveillance	NOUN
ajlsi-1012	149	15	of	of	ADP
ajlsi-1012	149	16	ili	ili	PROPN
ajlsi-1012	149	17	,	,	PUNCT
ajlsi-1012	149	18	ari	ari	PROPN
ajlsi-1012	149	19	,	,	PUNCT
ajlsi-1012	149	20	and	and	CCONJ
ajlsi-1012	149	21	sari	sari	ADJ
ajlsi-1012	149	22	(	(	PUNCT
ajlsi-1012	149	23	severe	severe	ADJ
ajlsi-1012	149	24	acute	acute	ADJ
ajlsi-1012	149	25	respiratory	respiratory	ADJ
ajlsi-1012	149	26	infection	infection	NOUN
ajlsi-1012	149	27	)	)	PUNCT
ajlsi-1012	149	28	.	.	PUNCT
ajlsi-1012	150	1	integrated	integrate	VERB
ajlsi-1012	150	2	epidemiological	epidemiological	ADJ
ajlsi-1012	150	3	and	and	CCONJ
ajlsi-1012	150	4	virological	virological	ADJ
ajlsi-1012	150	5	surveillance	surveillance	NOUN
ajlsi-1012	150	6	will	will	AUX
ajlsi-1012	150	7	play	play	VERB
ajlsi-1012	150	8	a	a	DET
ajlsi-1012	150	9	significant	significant	ADJ
ajlsi-1012	150	10	role	role	NOUN
ajlsi-1012	150	11	in	in	ADP
ajlsi-1012	150	12	monitoring	monitor	VERB
ajlsi-1012	150	13	the	the	DET
ajlsi-1012	150	14	spread	spread	NOUN
ajlsi-1012	150	15	and	and	CCONJ
ajlsi-1012	150	16	evolution	evolution	NOUN
ajlsi-1012	150	17	of	of	ADP
ajlsi-1012	150	18	covid-19	covid-19	PROPN
ajlsi-1012	150	19	virus	virus	NOUN
ajlsi-1012	150	20	,	,	PUNCT
ajlsi-1012	150	21	understanding	understand	VERB
ajlsi-1012	150	22	the	the	DET
ajlsi-1012	150	23	cocirculation	cocirculation	NOUN
ajlsi-1012	150	24	of	of	ADP
ajlsi-1012	150	25	covid-19	covid-19	PROPN
ajlsi-1012	150	26	virus	virus	NOUN
ajlsi-1012	150	27	with	with	ADP
ajlsi-1012	150	28	influenza	influenza	NOUN
ajlsi-1012	150	29	and	and	CCONJ
ajlsi-1012	150	30	other	other	ADJ
ajlsi-1012	150	31	respiratory	respiratory	ADJ
ajlsi-1012	150	32	viruses	virus	NOUN
ajlsi-1012	150	33	,	,	PUNCT
ajlsi-1012	150	34	and	and	CCONJ
ajlsi-1012	150	35	subsequent	subsequent	ADJ
ajlsi-1012	150	36	interpretation	interpretation	NOUN
ajlsi-1012	150	37	of	of	ADP
ajlsi-1012	150	38	respiratory	respiratory	ADJ
ajlsi-1012	150	39	epidemiological	epidemiological	ADJ
ajlsi-1012	150	40	and	and	CCONJ
ajlsi-1012	150	41	disease	disease	NOUN
ajlsi-1012	150	42	observations	observation	NOUN
ajlsi-1012	150	43	in	in	ADP
ajlsi-1012	150	44	relation	relation	NOUN
ajlsi-1012	150	45	to	to	ADP
ajlsi-1012	150	46	covid-19	covid-19	PROPN
ajlsi-1012	150	47	,	,	PUNCT
ajlsi-1012	150	48	as	as	ADV
ajlsi-1012	150	49	well	well	ADV
ajlsi-1012	150	50	as	as	ADP
ajlsi-1012	150	51	supporting	support	VERB
ajlsi-1012	150	52	the	the	DET
ajlsi-1012	150	53	update	update	NOUN
ajlsi-1012	150	54	of	of	ADP
ajlsi-1012	150	55	diagnostic	diagnostic	ADJ
ajlsi-1012	150	56	tests	test	NOUN
ajlsi-1012	150	57	.	.	PUNCT
ajlsi-1012	151	1	infections	infection	NOUN
ajlsi-1012	151	2	in	in	ADP
ajlsi-1012	151	3	health	health	NOUN
ajlsi-1012	151	4	workers	worker	NOUN
ajlsi-1012	151	5	should	should	AUX
ajlsi-1012	151	6	,	,	PUNCT
ajlsi-1012	151	7	at	at	ADP
ajlsi-1012	151	8	a	a	DET
ajlsi-1012	151	9	minimum	minimum	NOUN
ajlsi-1012	151	10	,	,	PUNCT
ajlsi-1012	151	11	be	be	AUX
ajlsi-1012	151	12	systematically	systematically	ADV
ajlsi-1012	151	13	integrated	integrate	VERB
ajlsi-1012	151	14	into	into	ADP
ajlsi-1012	151	15	the	the	DET
ajlsi-1012	151	16	national	national	ADJ
ajlsi-1012	151	17	surveillance	surveillance	NOUN
ajlsi-1012	151	18	system	system	NOUN
ajlsi-1012	151	19	.	.	PUNCT
ajlsi-1012	152	1	dedicated	dedicate	VERB
ajlsi-1012	152	2	enhanced	enhanced	ADJ
ajlsi-1012	152	3	surveillance	surveillance	NOUN
ajlsi-1012	152	4	for	for	ADP
ajlsi-1012	152	5	some	some	DET
ajlsi-1012	152	6	high	high	ADJ
ajlsi-1012	152	7	-	-	PUNCT
ajlsi-1012	152	8	risk	risk	NOUN
ajlsi-1012	152	9	groups	group	NOUN
ajlsi-1012	152	10	is	be	AUX
ajlsi-1012	152	11	necessary	necessary	ADJ
ajlsi-1012	152	12	to	to	PART
ajlsi-1012	152	13	ensure	ensure	VERB
ajlsi-1012	152	14	the	the	DET
ajlsi-1012	152	15	prompt	prompt	ADJ
ajlsi-1012	152	16	detection	detection	NOUN
ajlsi-1012	152	17	of	of	ADP
ajlsi-1012	152	18	cases	case	NOUN
ajlsi-1012	152	19	and	and	CCONJ
ajlsi-1012	152	20	clusters	cluster	NOUN
ajlsi-1012	152	21	,	,	PUNCT
ajlsi-1012	152	22	faster	fast	ADV
ajlsi-1012	152	23	than	than	ADP
ajlsi-1012	152	24	through	through	ADP
ajlsi-1012	152	25	primary	primary	ADJ
ajlsi-1012	152	26	care	care	NOUN
ajlsi-1012	152	27	or	or	CCONJ
ajlsi-1012	152	28	hospital	hospital	NOUN
ajlsi-1012	152	29	-	-	PUNCT
ajlsi-1012	152	30	based	base	VERB
ajlsi-1012	152	31	surveillance	surveillance	NOUN
ajlsi-1012	152	32	.	.	PUNCT
ajlsi-1012	153	1	people	people	NOUN
ajlsi-1012	153	2	who	who	PRON
ajlsi-1012	153	3	live	live	VERB
ajlsi-1012	153	4	in	in	ADP
ajlsi-1012	153	5	closed	closed	ADJ
ajlsi-1012	153	6	environments	environment	NOUN
ajlsi-1012	153	7	,	,	PUNCT
ajlsi-1012	153	8	such	such	ADJ
ajlsi-1012	153	9	as	as	ADP
ajlsi-1012	153	10	prisons	prison	NOUN
ajlsi-1012	153	11	,	,	PUNCT
ajlsi-1012	153	12	or	or	CCONJ
ajlsi-1012	153	13	residential	residential	ADJ
ajlsi-1012	153	14	facilities	facility	NOUN
ajlsi-1012	153	15	,	,	PUNCT
ajlsi-1012	153	16	such	such	ADJ
ajlsi-1012	153	17	as	as	ADP
ajlsi-1012	153	18	retirement	retirement	NOUN
ajlsi-1012	153	19	communities	community	NOUN
ajlsi-1012	153	20	or	or	CCONJ
ajlsi-1012	153	21	care	care	VERB
ajlsi-1012	153	22	homes	home	NOUN
ajlsi-1012	153	23	for	for	ADP
ajlsi-1012	153	24	persons	person	NOUN
ajlsi-1012	153	25	with	with	ADP
ajlsi-1012	153	26	disabilities	disability	NOUN
ajlsi-1012	153	27	,	,	PUNCT
ajlsi-1012	153	28	can	can	AUX
ajlsi-1012	153	29	be	be	AUX
ajlsi-1012	153	30	especially	especially	ADV
ajlsi-1012	153	31	vulnerable	vulnerable	ADJ
ajlsi-1012	153	32	because	because	SCONJ
ajlsi-1012	153	33	they	they	PRON
ajlsi-1012	153	34	may	may	AUX
ajlsi-1012	153	35	not	not	PART
ajlsi-1012	153	36	be	be	AUX
ajlsi-1012	153	37	able	able	ADJ
ajlsi-1012	153	38	to	to	PART
ajlsi-1012	153	39	seek	seek	VERB
ajlsi-1012	153	40	help	help	VERB
ajlsi-1012	153	41	themselves	themselves	PRON
ajlsi-1012	153	42	.	.	PUNCT
ajlsi-1012	154	1	vulnerable	vulnerable	ADJ
ajlsi-1012	154	2	groups	group	NOUN
ajlsi-1012	154	3	may	may	AUX
ajlsi-1012	154	4	also	also	ADV
ajlsi-1012	154	5	live	live	VERB
ajlsi-1012	154	6	in	in	ADP
ajlsi-1012	154	7	settings	setting	NOUN
ajlsi-1012	154	8	where	where	SCONJ
ajlsi-1012	154	9	the	the	DET
ajlsi-1012	154	10	probability	probability	NOUN
ajlsi-1012	154	11	of	of	ADP
ajlsi-1012	154	12	transmission	transmission	NOUN
ajlsi-1012	154	13	is	be	AUX
ajlsi-1012	154	14	higher	high	ADJ
ajlsi-1012	154	15	than	than	ADP
ajlsi-1012	154	16	in	in	ADP
ajlsi-1012	154	17	the	the	DET
ajlsi-1012	154	18	general	general	ADJ
ajlsi-1012	154	19	population	population	NOUN
ajlsi-1012	154	20	or	or	CCONJ
ajlsi-1012	154	21	have	have	VERB
ajlsi-1012	154	22	health	health	NOUN
ajlsi-1012	154	23	conditions	condition	NOUN
ajlsi-1012	154	24	or	or	CCONJ
ajlsi-1012	154	25	predisposing	predispose	VERB
ajlsi-1012	154	26	factors	factor	NOUN
ajlsi-1012	154	27	that	that	PRON
ajlsi-1012	154	28	increase	increase	VERB
ajlsi-1012	154	29	their	their	PRON
ajlsi-1012	154	30	risk	risk	NOUN
ajlsi-1012	154	31	of	of	ADP
ajlsi-1012	154	32	severe	severe	ADJ
ajlsi-1012	154	33	illness	illness	NOUN
ajlsi-1012	154	34	.	.	PUNCT
ajlsi-1012	155	1	enhanced	enhance	VERB
ajlsi-1012	155	2	surveillance	surveillance	NOUN
ajlsi-1012	155	3	includes	include	VERB
ajlsi-1012	155	4	the	the	DET
ajlsi-1012	155	5	use	use	NOUN
ajlsi-1012	155	6	of	of	ADP
ajlsi-1012	155	7	active	active	ADJ
ajlsi-1012	155	8	case	case	NOUN
ajlsi-1012	155	9	finding	finding	NOUN
ajlsi-1012	155	10	,	,	PUNCT
ajlsi-1012	155	11	such	such	ADJ
ajlsi-1012	155	12	as	as	ADP
ajlsi-1012	155	13	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	155	14	pa	pa	PROPN
ajlsi-1012	155	15	ge	ge	PROPN
ajlsi-1012	155	16	33	33	NUM
ajlsi-1012	155	17	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	155	18	am	am	NOUN
ajlsi-1012	155	19	.	.	PUNCT
ajlsi-1012	156	1	j.	j.	PROPN
ajlsi-1012	156	2	life	life	PROPN
ajlsi-1012	156	3	sci	sci	PROPN
ajlsi-1012	156	4	.	.	PUNCT
ajlsi-1012	156	5	innov	innov	PROPN
ajlsi-1012	156	6	.	.	PUNCT
ajlsi-1012	157	1	1(2	1(2	NUM
ajlsi-1012	157	2	)	)	PUNCT
ajlsi-1012	157	3	29	29	NUM
ajlsi-1012	157	4	-	-	SYM
ajlsi-1012	157	5	42	42	NUM
ajlsi-1012	157	6	,	,	PUNCT
ajlsi-1012	157	7	2022	2022	NUM
ajlsi-1012	157	8	through	through	ADP
ajlsi-1012	157	9	daily	daily	ADJ
ajlsi-1012	157	10	screening	screening	NOUN
ajlsi-1012	157	11	of	of	ADP
ajlsi-1012	157	12	signs	sign	NOUN
ajlsi-1012	157	13	and	and	CCONJ
ajlsi-1012	157	14	symptoms	symptom	NOUN
ajlsi-1012	157	15	,	,	PUNCT
ajlsi-1012	157	16	including	include	VERB
ajlsi-1012	157	17	daily	daily	ADJ
ajlsi-1012	157	18	temperature	temperature	NOUN
ajlsi-1012	157	19	monitoring	monitoring	NOUN
ajlsi-1012	157	20	,	,	PUNCT
ajlsi-1012	157	21	and	and	CCONJ
ajlsi-1012	157	22	daily	daily	ADJ
ajlsi-1012	157	23	zero	zero	NUM
ajlsi-1012	157	24	reporting	report	VERB
ajlsi-1012	157	25	for	for	ADP
ajlsi-1012	157	26	all	all	DET
ajlsi-1012	157	27	individuals	individual	NOUN
ajlsi-1012	157	28	in	in	ADP
ajlsi-1012	157	29	high	high	ADJ
ajlsi-1012	157	30	-	-	PUNCT
ajlsi-1012	157	31	risk	risk	NOUN
ajlsi-1012	157	32	groups	group	NOUN
ajlsi-1012	157	33	under	under	ADP
ajlsi-1012	157	34	surveillance	surveillance	NOUN
ajlsi-1012	157	35	.	.	PUNCT
ajlsi-1012	158	1	while	while	SCONJ
ajlsi-1012	158	2	surveillance	surveillance	NOUN
ajlsi-1012	158	3	systems	system	NOUN
ajlsi-1012	158	4	will	will	AUX
ajlsi-1012	158	5	typically	typically	ADV
ajlsi-1012	158	6	capture	capture	VERB
ajlsi-1012	158	7	the	the	DET
ajlsi-1012	158	8	number	number	NOUN
ajlsi-1012	158	9	of	of	ADP
ajlsi-1012	158	10	covid-19	covid-19	PROPN
ajlsi-1012	158	11	cases	case	NOUN
ajlsi-1012	158	12	,	,	PUNCT
ajlsi-1012	158	13	it	it	PRON
ajlsi-1012	158	14	is	be	AUX
ajlsi-1012	158	15	also	also	ADV
ajlsi-1012	158	16	important	important	ADJ
ajlsi-1012	158	17	to	to	PART
ajlsi-1012	158	18	collect	collect	VERB
ajlsi-1012	158	19	information	information	NOUN
ajlsi-1012	158	20	on	on	ADP
ajlsi-1012	158	21	the	the	DET
ajlsi-1012	158	22	total	total	ADJ
ajlsi-1012	158	23	number	number	NOUN
ajlsi-1012	158	24	of	of	ADP
ajlsi-1012	158	25	laboratory	laboratory	NOUN
ajlsi-1012	158	26	tests	test	NOUN
ajlsi-1012	158	27	conducted	conduct	VERB
ajlsi-1012	158	28	for	for	ADP
ajlsi-1012	158	29	the	the	DET
ajlsi-1012	158	30	covid-19	covid-19	PROPN
ajlsi-1012	158	31	virus	virus	NOUN
ajlsi-1012	158	32	.	.	PUNCT
ajlsi-1012	159	1	data	datum	NOUN
ajlsi-1012	159	2	on	on	ADP
ajlsi-1012	159	3	the	the	DET
ajlsi-1012	159	4	number	number	NOUN
ajlsi-1012	159	5	of	of	ADP
ajlsi-1012	159	6	tests	test	NOUN
ajlsi-1012	159	7	conducted	conduct	VERB
ajlsi-1012	159	8	for	for	ADP
ajlsi-1012	159	9	sars	sar	NOUN
ajlsi-1012	159	10	-	-	PUNCT
ajlsi-1012	159	11	cov-2	cov-2	NOUN
ajlsi-1012	159	12	are	be	AUX
ajlsi-1012	159	13	collected	collect	VERB
ajlsi-1012	159	14	from	from	ADP
ajlsi-1012	159	15	all	all	DET
ajlsi-1012	159	16	relevant	relevant	ADJ
ajlsi-1012	159	17	laboratories	laboratory	NOUN
ajlsi-1012	159	18	.	.	PUNCT
ajlsi-1012	160	1	knowing	know	VERB
ajlsi-1012	160	2	the	the	DET
ajlsi-1012	160	3	testing	testing	NOUN
ajlsi-1012	160	4	denominator	denominator	NOUN
ajlsi-1012	160	5	can	can	AUX
ajlsi-1012	160	6	indicate	indicate	VERB
ajlsi-1012	160	7	the	the	DET
ajlsi-1012	160	8	level	level	NOUN
ajlsi-1012	160	9	of	of	ADP
ajlsi-1012	160	10	surveillance	surveillance	NOUN
ajlsi-1012	160	11	activity	activity	NOUN
ajlsi-1012	160	12	,	,	PUNCT
ajlsi-1012	160	13	and	and	CCONJ
ajlsi-1012	160	14	the	the	DET
ajlsi-1012	160	15	proportion	proportion	NOUN
ajlsi-1012	160	16	of	of	ADP
ajlsi-1012	160	17	positive	positive	ADJ
ajlsi-1012	160	18	tests	test	NOUN
ajlsi-1012	160	19	can	can	AUX
ajlsi-1012	160	20	indicate	indicate	VERB
ajlsi-1012	160	21	the	the	DET
ajlsi-1012	160	22	intensity	intensity	NOUN
ajlsi-1012	160	23	of	of	ADP
ajlsi-1012	160	24	transmission	transmission	NOUN
ajlsi-1012	160	25	among	among	ADP
ajlsi-1012	160	26	symptomatic	symptomatic	ADJ
ajlsi-1012	160	27	individuals	individual	NOUN
ajlsi-1012	160	28	.	.	PUNCT
ajlsi-1012	161	1	presently	presently	ADV
ajlsi-1012	161	2	,	,	PUNCT
ajlsi-1012	161	3	reverse	reverse	VERB
ajlsi-1012	161	4	transcriptase	transcriptase	NOUN
ajlsi-1012	161	5	polymerase	polymerase	NOUN
ajlsi-1012	161	6	chain	chain	NOUN
ajlsi-1012	161	7	reaction	reaction	NOUN
ajlsi-1012	161	8	(	(	PUNCT
ajlsi-1012	161	9	rtpcr	rtpcr	NOUN
ajlsi-1012	161	10	)	)	PUNCT
ajlsi-1012	161	11	testing	testing	NOUN
ajlsi-1012	161	12	(	(	PUNCT
ajlsi-1012	161	13	explained	explain	VERB
ajlsi-1012	161	14	in	in	ADP
ajlsi-1012	161	15	2.3	2.3	NUM
ajlsi-1012	161	16	)	)	PUNCT
ajlsi-1012	161	17	is	be	AUX
ajlsi-1012	161	18	the	the	DET
ajlsi-1012	161	19	most	most	ADV
ajlsi-1012	161	20	common	common	ADJ
ajlsi-1012	161	21	and	and	CCONJ
ajlsi-1012	161	22	reliable	reliable	ADJ
ajlsi-1012	161	23	laboratory	laboratory	NOUN
ajlsi-1012	161	24	diagnostic	diagnostic	ADJ
ajlsi-1012	161	25	method	method	NOUN
ajlsi-1012	161	26	.	.	PUNCT
ajlsi-1012	162	1	if	if	SCONJ
ajlsi-1012	162	2	other	other	ADJ
ajlsi-1012	162	3	diagnostic	diagnostic	ADJ
ajlsi-1012	162	4	methods	method	NOUN
ajlsi-1012	162	5	are	be	AUX
ajlsi-1012	162	6	used	use	VERB
ajlsi-1012	162	7	,	,	PUNCT
ajlsi-1012	162	8	the	the	DET
ajlsi-1012	162	9	number	number	NOUN
ajlsi-1012	162	10	of	of	ADP
ajlsi-1012	162	11	tests	test	NOUN
ajlsi-1012	162	12	conducted	conduct	VERB
ajlsi-1012	162	13	and	and	CCONJ
ajlsi-1012	162	14	cases	case	NOUN
ajlsi-1012	162	15	confirmed	confirm	VERB
ajlsi-1012	162	16	by	by	ADP
ajlsi-1012	162	17	different	different	ADJ
ajlsi-1012	162	18	laboratory	laboratory	NOUN
ajlsi-1012	162	19	diagnostic	diagnostic	ADJ
ajlsi-1012	162	20	methods	method	NOUN
ajlsi-1012	162	21	need	need	VERB
ajlsi-1012	162	22	to	to	PART
ajlsi-1012	162	23	be	be	AUX
ajlsi-1012	162	24	recorded	record	VERB
ajlsi-1012	162	25	.	.	PUNCT
ajlsi-1012	163	1	it	it	PRON
ajlsi-1012	163	2	is	be	AUX
ajlsi-1012	163	3	widely	widely	ADV
ajlsi-1012	163	4	accepted	accept	VERB
ajlsi-1012	163	5	that	that	SCONJ
ajlsi-1012	163	6	a	a	DET
ajlsi-1012	163	7	large	large	ADJ
ajlsi-1012	163	8	fraction	fraction	NOUN
ajlsi-1012	163	9	of	of	ADP
ajlsi-1012	163	10	covid-19	covid-19	PROPN
ajlsi-1012	163	11	cases	case	NOUN
ajlsi-1012	163	12	goes	goes	AUX
ajlsi-1012	163	13	undetected	undetecte	VERB
ajlsi-1012	163	14	.	.	PUNCT
ajlsi-1012	164	1	however	however	ADV
ajlsi-1012	164	2	,	,	PUNCT
ajlsi-1012	164	3	this	this	PRON
ajlsi-1012	164	4	is	be	AUX
ajlsi-1012	164	5	subject	subject	ADJ
ajlsi-1012	164	6	to	to	ADP
ajlsi-1012	164	7	significant	significant	ADJ
ajlsi-1012	164	8	ascertainment	ascertainment	NOUN
ajlsi-1012	164	9	bias	bias	NOUN
ajlsi-1012	164	10	because	because	SCONJ
ajlsi-1012	164	11	tests	test	NOUN
ajlsi-1012	164	12	are	be	AUX
ajlsi-1012	164	13	typically	typically	ADV
ajlsi-1012	164	14	ordered	order	VERB
ajlsi-1012	164	15	only	only	ADV
ajlsi-1012	164	16	from	from	ADP
ajlsi-1012	164	17	symptomatic	symptomatic	ADJ
ajlsi-1012	164	18	cases	case	NOUN
ajlsi-1012	164	19	,	,	PUNCT
ajlsi-1012	164	20	whereas	whereas	SCONJ
ajlsi-1012	164	21	a	a	DET
ajlsi-1012	164	22	large	large	ADJ
ajlsi-1012	164	23	proportion	proportion	NOUN
ajlsi-1012	164	24	of	of	ADP
ajlsi-1012	164	25	infected	infected	ADJ
ajlsi-1012	164	26	people	people	NOUN
ajlsi-1012	164	27	may	may	AUX
ajlsi-1012	164	28	show	show	VERB
ajlsi-1012	164	29	little	little	ADJ
ajlsi-1012	164	30	to	to	ADP
ajlsi-1012	164	31	no	no	DET
ajlsi-1012	164	32	symptoms	symptom	NOUN
ajlsi-1012	164	33	(	(	PUNCT
ajlsi-1012	164	34	mizumoto	mizumoto	NOUN
ajlsi-1012	164	35	et	et	PROPN
ajlsi-1012	164	36	al	al	PROPN
ajlsi-1012	164	37	.	.	PROPN
ajlsi-1012	164	38	,	,	PUNCT
ajlsi-1012	164	39	2020	2020	NUM
ajlsi-1012	164	40	)	)	PUNCT
ajlsi-1012	164	41	.	.	PUNCT
ajlsi-1012	165	1	non	non	ADJ
ajlsi-1012	165	2	-	-	ADJ
ajlsi-1012	165	3	symptomatic	symptomatic	ADJ
ajlsi-1012	165	4	infections	infection	NOUN
ajlsi-1012	165	5	can	can	AUX
ajlsi-1012	165	6	still	still	ADV
ajlsi-1012	165	7	shed	shed	VERB
ajlsi-1012	165	8	the	the	DET
ajlsi-1012	165	9	sars	sar	NOUN
ajlsi-1012	165	10	-	-	PUNCT
ajlsi-1012	165	11	cov-2	cov-2	PART
ajlsi-1012	165	12	virus	virus	NOUN
ajlsi-1012	165	13	and	and	CCONJ
ajlsi-1012	165	14	are	be	AUX
ajlsi-1012	165	15	therefore	therefore	ADV
ajlsi-1012	165	16	detectable	detectable	ADJ
ajlsi-1012	165	17	by	by	ADP
ajlsi-1012	165	18	rt	rt	PROPN
ajlsi-1012	165	19	-	-	PUNCT
ajlsi-1012	165	20	pcr	pcr	NOUN
ajlsi-1012	165	21	-	-	PUNCT
ajlsi-1012	165	22	based	base	VERB
ajlsi-1012	165	23	tests	test	NOUN
ajlsi-1012	165	24	.	.	PUNCT
ajlsi-1012	166	1	it	it	PRON
ajlsi-1012	166	2	is	be	AUX
ajlsi-1012	166	3	therefore	therefore	ADV
ajlsi-1012	166	4	possible	possible	ADJ
ajlsi-1012	166	5	to	to	PART
ajlsi-1012	166	6	test	test	VERB
ajlsi-1012	166	7	randomly	randomly	ADV
ajlsi-1012	166	8	selected	select	VERB
ajlsi-1012	166	9	individuals	individual	NOUN
ajlsi-1012	166	10	to	to	PART
ajlsi-1012	166	11	estimate	estimate	VERB
ajlsi-1012	166	12	the	the	DET
ajlsi-1012	166	13	true	true	ADJ
ajlsi-1012	166	14	disease	disease	NOUN
ajlsi-1012	166	15	prevalence	prevalence	NOUN
ajlsi-1012	166	16	in	in	ADP
ajlsi-1012	166	17	a	a	DET
ajlsi-1012	166	18	population	population	NOUN
ajlsi-1012	166	19	.	.	PUNCT
ajlsi-1012	167	1	recent	recent	ADJ
ajlsi-1012	167	2	technical	technical	ADJ
ajlsi-1012	167	3	advances	advance	NOUN
ajlsi-1012	167	4	have	have	AUX
ajlsi-1012	167	5	enabled	enable	VERB
ajlsi-1012	167	6	high	high	ADJ
ajlsi-1012	167	7	-	-	PUNCT
ajlsi-1012	167	8	throughput	throughput	NOUN
ajlsi-1012	167	9	pcr	pcr	NOUN
ajlsi-1012	167	10	,	,	PUNCT
ajlsi-1012	167	11	in	in	ADP
ajlsi-1012	167	12	which	which	PRON
ajlsi-1012	167	13	multiple	multiple	ADJ
ajlsi-1012	167	14	samples	sample	NOUN
ajlsi-1012	167	15	are	be	AUX
ajlsi-1012	167	16	pooled	pool	VERB
ajlsi-1012	167	17	into	into	ADP
ajlsi-1012	167	18	one	one	NUM
ajlsi-1012	167	19	tube	tube	NOUN
ajlsi-1012	167	20	.	.	PUNCT
ajlsi-1012	168	1	combining	combine	VERB
ajlsi-1012	168	2	probes	probe	NOUN
ajlsi-1012	168	3	from	from	ADP
ajlsi-1012	168	4	several	several	ADJ
ajlsi-1012	168	5	individuals	individual	NOUN
ajlsi-1012	168	6	and	and	CCONJ
ajlsi-1012	168	7	testing	test	VERB
ajlsi-1012	168	8	them	they	PRON
ajlsi-1012	168	9	together	together	ADV
ajlsi-1012	168	10	reduces	reduce	VERB
ajlsi-1012	168	11	the	the	DET
ajlsi-1012	168	12	total	total	ADJ
ajlsi-1012	168	13	amount	amount	NOUN
ajlsi-1012	168	14	of	of	ADP
ajlsi-1012	168	15	testing	testing	NOUN
ajlsi-1012	168	16	needed	need	VERB
ajlsi-1012	168	17	.	.	PUNCT
ajlsi-1012	169	1	this	this	DET
ajlsi-1012	169	2	method	method	NOUN
ajlsi-1012	169	3	is	be	AUX
ajlsi-1012	169	4	known	know	VERB
ajlsi-1012	169	5	as	as	ADP
ajlsi-1012	169	6	“	"	PUNCT
ajlsi-1012	169	7	pooling	pool	VERB
ajlsi-1012	169	8	”	"	PUNCT
ajlsi-1012	169	9	or	or	CCONJ
ajlsi-1012	169	10	“	"	PUNCT
ajlsi-1012	169	11	group	group	NOUN
ajlsi-1012	169	12	testing	testing	NOUN
ajlsi-1012	169	13	.	.	PUNCT
ajlsi-1012	169	14	”	"	PUNCT
ajlsi-1012	170	1	the	the	DET
ajlsi-1012	170	2	main	main	ADJ
ajlsi-1012	170	3	idea	idea	NOUN
ajlsi-1012	170	4	is	be	AUX
ajlsi-1012	170	5	that	that	SCONJ
ajlsi-1012	170	6	when	when	SCONJ
ajlsi-1012	170	7	samples	sample	NOUN
ajlsi-1012	170	8	from	from	ADP
ajlsi-1012	170	9	several	several	ADJ
ajlsi-1012	170	10	people	people	NOUN
ajlsi-1012	170	11	are	be	AUX
ajlsi-1012	170	12	mixed	mix	VERB
ajlsi-1012	170	13	together	together	ADV
ajlsi-1012	170	14	and	and	CCONJ
ajlsi-1012	170	15	tested	test	VERB
ajlsi-1012	170	16	,	,	PUNCT
ajlsi-1012	170	17	the	the	DET
ajlsi-1012	170	18	test	test	NOUN
ajlsi-1012	170	19	will	will	AUX
ajlsi-1012	170	20	report	report	VERB
ajlsi-1012	170	21	negative	negative	ADJ
ajlsi-1012	170	22	when	when	SCONJ
ajlsi-1012	170	23	everyone	everyone	PRON
ajlsi-1012	170	24	is	be	AUX
ajlsi-1012	170	25	healthy	healthy	ADJ
ajlsi-1012	170	26	and	and	CCONJ
ajlsi-1012	170	27	positive	positive	ADJ
ajlsi-1012	170	28	when	when	SCONJ
ajlsi-1012	170	29	at	at	ADV
ajlsi-1012	170	30	least	least	ADJ
ajlsi-1012	170	31	one	one	NUM
ajlsi-1012	170	32	is	be	AUX
ajlsi-1012	170	33	positive	positive	ADJ
ajlsi-1012	170	34	(	(	PUNCT
ajlsi-1012	170	35	abdalhamid	abdalhamid	NOUN
ajlsi-1012	170	36	et	et	PROPN
ajlsi-1012	170	37	al	al	PROPN
ajlsi-1012	170	38	.	.	PROPN
ajlsi-1012	170	39	,	,	PUNCT
ajlsi-1012	170	40	2020	2020	NUM
ajlsi-1012	170	41	)	)	PUNCT
ajlsi-1012	170	42	.	.	PUNCT
ajlsi-1012	171	1	the	the	DET
ajlsi-1012	171	2	other	other	ADJ
ajlsi-1012	171	3	ideas	idea	NOUN
ajlsi-1012	171	4	include	include	VERB
ajlsi-1012	171	5	using	use	VERB
ajlsi-1012	171	6	ten	ten	NUM
ajlsi-1012	171	7	-	-	ADJ
ajlsi-1012	171	8	fold	fold	VERB
ajlsi-1012	171	9	fewer	few	ADJ
ajlsi-1012	171	10	tests	test	NOUN
ajlsi-1012	171	11	(	(	PUNCT
ajlsi-1012	171	12	verdun	verdun	PROPN
ajlsi-1012	171	13	et	et	PROPN
ajlsi-1012	171	14	al	al	PROPN
ajlsi-1012	171	15	.	.	PROPN
ajlsi-1012	171	16	,	,	PUNCT
ajlsi-1012	171	17	2021	2021	NUM
ajlsi-1012	171	18	)	)	PUNCT
ajlsi-1012	171	19	and	and	CCONJ
ajlsi-1012	171	20	clearing	clear	VERB
ajlsi-1012	171	21	20	20	NUM
ajlsi-1012	171	22	times	time	NOUN
ajlsi-1012	171	23	the	the	DET
ajlsi-1012	171	24	number	number	NOUN
ajlsi-1012	171	25	of	of	ADP
ajlsi-1012	171	26	people	people	NOUN
ajlsi-1012	171	27	from	from	ADP
ajlsi-1012	171	28	isolation	isolation	NOUN
ajlsi-1012	171	29	with	with	ADP
ajlsi-1012	171	30	the	the	DET
ajlsi-1012	171	31	same	same	ADJ
ajlsi-1012	171	32	number	number	NOUN
ajlsi-1012	171	33	of	of	ADP
ajlsi-1012	171	34	tests	test	NOUN
ajlsi-1012	171	35	(	(	PUNCT
ajlsi-1012	171	36	gollier	gollier	NOUN
ajlsi-1012	171	37	and	and	CCONJ
ajlsi-1012	171	38	gossner	gossner	NOUN
ajlsi-1012	171	39	,	,	PUNCT
ajlsi-1012	171	40	2020	2020	NUM
ajlsi-1012	171	41	)	)	PUNCT
ajlsi-1012	171	42	.	.	PUNCT
ajlsi-1012	172	1	however	however	ADV
ajlsi-1012	172	2	,	,	PUNCT
ajlsi-1012	172	3	their	their	PRON
ajlsi-1012	172	4	efficiency	efficiency	NOUN
ajlsi-1012	172	5	is	be	AUX
ajlsi-1012	172	6	highly	highly	ADV
ajlsi-1012	172	7	dependent	dependent	ADJ
ajlsi-1012	172	8	on	on	ADP
ajlsi-1012	172	9	the	the	DET
ajlsi-1012	172	10	frequency	frequency	NOUN
ajlsi-1012	172	11	of	of	ADP
ajlsi-1012	172	12	positive	positive	ADJ
ajlsi-1012	172	13	samples	sample	NOUN
ajlsi-1012	172	14	,	,	PUNCT
ajlsi-1012	172	15	which	which	PRON
ajlsi-1012	172	16	varies	vary	VERB
ajlsi-1012	172	17	significantly	significantly	ADV
ajlsi-1012	172	18	across	across	ADP
ajlsi-1012	172	19	regions	region	NOUN
ajlsi-1012	172	20	and	and	CCONJ
ajlsi-1012	172	21	even	even	ADV
ajlsi-1012	172	22	within	within	ADP
ajlsi-1012	172	23	regions	region	NOUN
ajlsi-1012	172	24	as	as	ADP
ajlsi-1012	172	25	testing	testing	NOUN
ajlsi-1012	172	26	criteria	criterion	NOUN
ajlsi-1012	172	27	and	and	CCONJ
ajlsi-1012	172	28	conditions	condition	NOUN
ajlsi-1012	172	29	change	change	VERB
ajlsi-1012	172	30	.	.	PUNCT
ajlsi-1012	173	1	two	two	NUM
ajlsi-1012	173	2	possible	possible	ADJ
ajlsi-1012	173	3	optimized	optimize	VERB
ajlsi-1012	173	4	pooling	pooling	NOUN
ajlsi-1012	173	5	strategies	strategy	NOUN
ajlsi-1012	173	6	are	be	AUX
ajlsi-1012	173	7	currently	currently	ADV
ajlsi-1012	173	8	employed	employ	VERB
ajlsi-1012	173	9	for	for	ADP
ajlsi-1012	173	10	diagnostic	diagnostic	ADJ
ajlsi-1012	173	11	sarscov-2	sarscov-2	NUM
ajlsi-1012	173	12	testing	testing	NOUN
ajlsi-1012	173	13	on	on	ADP
ajlsi-1012	173	14	large	large	ADJ
ajlsi-1012	173	15	scales	scale	NOUN
ajlsi-1012	173	16	;	;	PUNCT
ajlsi-1012	173	17	both	both	PRON
ajlsi-1012	173	18	address	address	VERB
ajlsi-1012	173	19	dynamic	dynamic	ADJ
ajlsi-1012	173	20	conditions	condition	NOUN
ajlsi-1012	173	21	.	.	PUNCT
ajlsi-1012	174	1	in	in	ADP
ajlsi-1012	174	2	the	the	DET
ajlsi-1012	174	3	first	first	ADJ
ajlsi-1012	174	4	,	,	PUNCT
ajlsi-1012	174	5	an	an	DET
ajlsi-1012	174	6	estimate	estimate	NOUN
ajlsi-1012	174	7	of	of	ADP
ajlsi-1012	174	8	the	the	DET
ajlsi-1012	174	9	target	target	NOUN
ajlsi-1012	174	10	frequency	frequency	NOUN
ajlsi-1012	174	11	determines	determine	VERB
ajlsi-1012	174	12	the	the	DET
ajlsi-1012	174	13	initial	initial	ADJ
ajlsi-1012	174	14	pool	pool	NOUN
ajlsi-1012	174	15	size	size	NOUN
ajlsi-1012	174	16	,	,	PUNCT
ajlsi-1012	174	17	and	and	CCONJ
ajlsi-1012	174	18	any	any	DET
ajlsi-1012	174	19	subsequent	subsequent	ADJ
ajlsi-1012	174	20	pools	pool	NOUN
ajlsi-1012	174	21	found	find	VERB
ajlsi-1012	174	22	positive	positive	ADJ
ajlsi-1012	174	23	are	be	AUX
ajlsi-1012	174	24	re	re	VERB
ajlsi-1012	174	25	-	-	VERB
ajlsi-1012	174	26	pooled	pool	VERB
ajlsi-1012	174	27	at	at	ADP
ajlsi-1012	174	28	half	half	ADJ
ajlsi-1012	174	29	size	size	NOUN
ajlsi-1012	174	30	and	and	CCONJ
ajlsi-1012	174	31	tested	test	VERB
ajlsi-1012	174	32	again	again	ADV
ajlsi-1012	174	33	.	.	PUNCT
ajlsi-1012	175	1	the	the	DET
ajlsi-1012	175	2	second	second	ADJ
ajlsi-1012	175	3	method	method	NOUN
ajlsi-1012	175	4	is	be	AUX
ajlsi-1012	175	5	a	a	DET
ajlsi-1012	175	6	simpler	simple	ADJ
ajlsi-1012	175	7	approach	approach	NOUN
ajlsi-1012	175	8	of	of	ADP
ajlsi-1012	175	9	optimized	optimize	VERB
ajlsi-1012	175	10	one	one	NUM
ajlsi-1012	175	11	-	-	PUNCT
ajlsi-1012	175	12	time	time	NOUN
ajlsi-1012	175	13	pooling	pooling	NOUN
ajlsi-1012	175	14	followed	follow	VERB
ajlsi-1012	175	15	by	by	ADP
ajlsi-1012	175	16	individual	individual	ADJ
ajlsi-1012	175	17	tests	test	NOUN
ajlsi-1012	175	18	on	on	ADP
ajlsi-1012	175	19	positive	positive	ADJ
ajlsi-1012	175	20	pools	pool	NOUN
ajlsi-1012	175	21	.	.	PUNCT
ajlsi-1012	176	1	these	these	DET
ajlsi-1012	176	2	strategies	strategy	NOUN
ajlsi-1012	176	3	are	be	AUX
ajlsi-1012	176	4	convenient	convenient	ADJ
ajlsi-1012	176	5	,	,	PUNCT
ajlsi-1012	176	6	and	and	CCONJ
ajlsi-1012	176	7	they	they	PRON
ajlsi-1012	176	8	offer	offer	VERB
ajlsi-1012	176	9	a	a	DET
ajlsi-1012	176	10	significant	significant	ADJ
ajlsi-1012	176	11	reduction	reduction	NOUN
ajlsi-1012	176	12	in	in	ADP
ajlsi-1012	176	13	the	the	DET
ajlsi-1012	176	14	number	number	NOUN
ajlsi-1012	176	15	of	of	ADP
ajlsi-1012	176	16	materials	material	NOUN
ajlsi-1012	176	17	,	,	PUNCT
ajlsi-1012	176	18	equipment	equipment	NOUN
ajlsi-1012	176	19	,	,	PUNCT
ajlsi-1012	176	20	and	and	CCONJ
ajlsi-1012	176	21	time	time	NOUN
ajlsi-1012	176	22	needed	need	VERB
ajlsi-1012	176	23	to	to	PART
ajlsi-1012	176	24	test	test	VERB
ajlsi-1012	176	25	large	large	ADJ
ajlsi-1012	176	26	numbers	number	NOUN
ajlsi-1012	176	27	of	of	ADP
ajlsi-1012	176	28	samples	sample	NOUN
ajlsi-1012	176	29	.	.	PUNCT
ajlsi-1012	177	1	(	(	PUNCT
ajlsi-1012	177	2	shani	shani	NOUN
ajlsi-1012	177	3	et	et	PROPN
ajlsi-1012	177	4	al	al	PROPN
ajlsi-1012	177	5	.	.	PROPN
ajlsi-1012	177	6	,	,	PUNCT
ajlsi-1012	177	7	2020	2020	NUM
ajlsi-1012	177	8	)	)	PUNCT
ajlsi-1012	177	9	.	.	PUNCT
ajlsi-1012	178	1	on	on	ADP
ajlsi-1012	178	2	the	the	DET
ajlsi-1012	178	3	other	other	ADJ
ajlsi-1012	178	4	hand	hand	NOUN
ajlsi-1012	178	5	,	,	PUNCT
ajlsi-1012	178	6	a	a	DET
ajlsi-1012	178	7	pool	pool	NOUN
ajlsi-1012	178	8	testing	testing	NOUN
ajlsi-1012	178	9	strategy	strategy	NOUN
ajlsi-1012	178	10	could	could	AUX
ajlsi-1012	178	11	potentially	potentially	ADV
ajlsi-1012	178	12	increase	increase	VERB
ajlsi-1012	178	13	worldwide	worldwide	ADV
ajlsi-1012	178	14	testing	testing	NOUN
ajlsi-1012	178	15	capacity	capacity	NOUN
ajlsi-1012	178	16	many	many	ADJ
ajlsi-1012	178	17	times	time	NOUN
ajlsi-1012	178	18	over	over	ADV
ajlsi-1012	178	19	,	,	PUNCT
ajlsi-1012	178	20	thus	thus	ADV
ajlsi-1012	178	21	boosting	boost	VERB
ajlsi-1012	178	22	a	a	DET
ajlsi-1012	178	23	country	country	NOUN
ajlsi-1012	178	24	’s	’s	PART
ajlsi-1012	178	25	capacity	capacity	NOUN
ajlsi-1012	178	26	to	to	PART
ajlsi-1012	178	27	test	test	VERB
ajlsi-1012	178	28	mildly	mildly	ADV
ajlsi-1012	178	29	to	to	ADP
ajlsi-1012	178	30	asymptomatically	asymptomatically	ADV
ajlsi-1012	178	31	affected	affect	VERB
ajlsi-1012	178	32	individuals	individual	NOUN
ajlsi-1012	178	33	.	.	PUNCT
ajlsi-1012	179	1	this	this	DET
ajlsi-1012	179	2	strategy	strategy	NOUN
ajlsi-1012	179	3	proposes	propose	VERB
ajlsi-1012	179	4	that	that	SCONJ
ajlsi-1012	179	5	instead	instead	ADV
ajlsi-1012	179	6	of	of	ADP
ajlsi-1012	179	7	individually	individually	ADV
ajlsi-1012	179	8	testing	test	VERB
ajlsi-1012	179	9	patients	patient	NOUN
ajlsi-1012	179	10	with	with	ADP
ajlsi-1012	179	11	low	low	ADJ
ajlsi-1012	179	12	clinical	clinical	ADJ
ajlsi-1012	179	13	suspicion	suspicion	NOUN
ajlsi-1012	179	14	of	of	ADP
ajlsi-1012	179	15	sars	sar	NOUN
ajlsi-1012	179	16	-	-	PUNCT
ajlsi-1012	179	17	cov-2	cov-2	NOUN
ajlsi-1012	179	18	infections	infection	NOUN
ajlsi-1012	179	19	,	,	PUNCT
ajlsi-1012	179	20	samples	sample	NOUN
ajlsi-1012	179	21	are	be	AUX
ajlsi-1012	179	22	pooled	pool	VERB
ajlsi-1012	179	23	together	together	ADV
ajlsi-1012	179	24	in	in	ADP
ajlsi-1012	179	25	what	what	PRON
ajlsi-1012	179	26	is	be	AUX
ajlsi-1012	179	27	called	call	VERB
ajlsi-1012	179	28	a	a	DET
ajlsi-1012	179	29	“	"	PUNCT
ajlsi-1012	179	30	minipool	minipool	NOUN
ajlsi-1012	179	31	”	"	PUNCT
ajlsi-1012	179	32	and	and	CCONJ
ajlsi-1012	179	33	then	then	ADV
ajlsi-1012	179	34	tested	test	VERB
ajlsi-1012	179	35	together	together	ADV
ajlsi-1012	179	36	,	,	PUNCT
ajlsi-1012	179	37	running	run	VERB
ajlsi-1012	179	38	a	a	DET
ajlsi-1012	179	39	single	single	ADJ
ajlsi-1012	179	40	rt	rt	NOUN
ajlsi-1012	179	41	-	-	PUNCT
ajlsi-1012	179	42	pcr	pcr	PROPN
ajlsi-1012	179	43	for	for	ADP
ajlsi-1012	179	44	all	all	DET
ajlsi-1012	179	45	the	the	DET
ajlsi-1012	179	46	unified	unified	ADJ
ajlsi-1012	179	47	samples	sample	NOUN
ajlsi-1012	179	48	.	.	PUNCT
ajlsi-1012	180	1	preliminary	preliminary	ADJ
ajlsi-1012	180	2	results	result	NOUN
ajlsi-1012	180	3	showed	show	VERB
ajlsi-1012	180	4	that	that	SCONJ
ajlsi-1012	180	5	there	there	PRON
ajlsi-1012	180	6	is	be	VERB
ajlsi-1012	180	7	no	no	DET
ajlsi-1012	180	8	dilution	dilution	NOUN
ajlsi-1012	180	9	and	and	CCONJ
ajlsi-1012	180	10	no	no	DET
ajlsi-1012	180	11	decrease	decrease	NOUN
ajlsi-1012	180	12	in	in	ADP
ajlsi-1012	180	13	test	test	NOUN
ajlsi-1012	180	14	sensitivity	sensitivity	NOUN
ajlsi-1012	180	15	when	when	SCONJ
ajlsi-1012	180	16	minipools	minipool	NOUN
ajlsi-1012	180	17	of	of	ADP
ajlsi-1012	180	18	five	five	NUM
ajlsi-1012	180	19	samples	sample	NOUN
ajlsi-1012	180	20	each	each	PRON
ajlsi-1012	180	21	are	be	AUX
ajlsi-1012	180	22	used	use	VERB
ajlsi-1012	180	23	.	.	PUNCT
ajlsi-1012	181	1	since	since	SCONJ
ajlsi-1012	181	2	the	the	DET
ajlsi-1012	181	3	rt	rt	PROPN
ajlsi-1012	181	4	-	-	PUNCT
ajlsi-1012	181	5	pcr	pcr	NOUN
ajlsi-1012	181	6	looks	look	VERB
ajlsi-1012	181	7	directly	directly	ADV
ajlsi-1012	181	8	at	at	ADP
ajlsi-1012	181	9	the	the	DET
ajlsi-1012	181	10	viral	viral	ADJ
ajlsi-1012	181	11	rna	rna	NOUN
ajlsi-1012	181	12	,	,	PUNCT
ajlsi-1012	181	13	a	a	DET
ajlsi-1012	181	14	negative	negative	ADJ
ajlsi-1012	181	15	result	result	NOUN
ajlsi-1012	181	16	in	in	ADP
ajlsi-1012	181	17	a	a	DET
ajlsi-1012	181	18	pool	pool	NOUN
ajlsi-1012	181	19	test	test	NOUN
ajlsi-1012	181	20	is	be	AUX
ajlsi-1012	181	21	reliable	reliable	ADJ
ajlsi-1012	181	22	.	.	PUNCT
ajlsi-1012	182	1	thus	thus	ADV
ajlsi-1012	182	2	,	,	PUNCT
ajlsi-1012	182	3	the	the	DET
ajlsi-1012	182	4	infection	infection	NOUN
ajlsi-1012	182	5	was	be	AUX
ajlsi-1012	182	6	discarded	discard	VERB
ajlsi-1012	182	7	in	in	ADP
ajlsi-1012	182	8	all	all	DET
ajlsi-1012	182	9	the	the	DET
ajlsi-1012	182	10	patients	patient	NOUN
ajlsi-1012	182	11	included	include	VERB
ajlsi-1012	182	12	in	in	ADP
ajlsi-1012	182	13	the	the	DET
ajlsi-1012	182	14	pooled	pooled	ADJ
ajlsi-1012	182	15	sample	sample	NOUN
ajlsi-1012	182	16	.	.	PUNCT
ajlsi-1012	183	1	nucleic	nucleic	ADJ
ajlsi-1012	183	2	acid	acid	NOUN
ajlsi-1012	183	3	amplification	amplification	NOUN
ajlsi-1012	183	4	assay	assay	ADP
ajlsi-1012	183	5	sars	sar	NOUN
ajlsi-1012	183	6	-	-	PUNCT
ajlsi-1012	183	7	cov-2	cov-2	PART
ajlsi-1012	183	8	is	be	AUX
ajlsi-1012	183	9	a	a	DET
ajlsi-1012	183	10	single	single	ADV
ajlsi-1012	183	11	-	-	PUNCT
ajlsi-1012	183	12	stranded	strand	VERB
ajlsi-1012	183	13	,	,	PUNCT
ajlsi-1012	183	14	positive	positive	ADJ
ajlsi-1012	183	15	-	-	PUNCT
ajlsi-1012	183	16	sense	sense	NOUN
ajlsi-1012	183	17	rna	rna	NOUN
ajlsi-1012	183	18	virus	virus	NOUN
ajlsi-1012	183	19	.	.	PUNCT
ajlsi-1012	184	1	the	the	DET
ajlsi-1012	184	2	availability	availability	NOUN
ajlsi-1012	184	3	of	of	ADP
ajlsi-1012	184	4	sequence	sequence	NOUN
ajlsi-1012	184	5	data	datum	NOUN
ajlsi-1012	184	6	has	have	AUX
ajlsi-1012	184	7	facilitated	facilitate	VERB
ajlsi-1012	184	8	the	the	DET
ajlsi-1012	184	9	design	design	NOUN
ajlsi-1012	184	10	of	of	ADP
ajlsi-1012	184	11	primers	primer	NOUN
ajlsi-1012	184	12	and	and	CCONJ
ajlsi-1012	184	13	probes	probe	NOUN
ajlsi-1012	184	14	needed	need	VERB
ajlsi-1012	184	15	for	for	ADP
ajlsi-1012	184	16	the	the	DET
ajlsi-1012	184	17	development	development	NOUN
ajlsi-1012	184	18	of	of	ADP
ajlsi-1012	184	19	sars	sar	NOUN
ajlsi-1012	184	20	-	-	PUNCT
ajlsi-1012	184	21	cov-2	cov-2	NOUN
ajlsi-1012	184	22	-	-	PUNCT
ajlsi-1012	184	23	specific	specific	ADJ
ajlsi-1012	184	24	testing	testing	NOUN
ajlsi-1012	184	25	.	.	PUNCT
ajlsi-1012	185	1	routine	routine	ADJ
ajlsi-1012	185	2	confirmation	confirmation	NOUN
ajlsi-1012	185	3	of	of	ADP
ajlsi-1012	185	4	cases	case	NOUN
ajlsi-1012	185	5	of	of	ADP
ajlsi-1012	185	6	covid-19	covid-19	PROPN
ajlsi-1012	185	7	is	be	AUX
ajlsi-1012	185	8	based	base	VERB
ajlsi-1012	185	9	on	on	ADP
ajlsi-1012	185	10	the	the	DET
ajlsi-1012	185	11	detection	detection	NOUN
ajlsi-1012	185	12	of	of	ADP
ajlsi-1012	185	13	unique	unique	ADJ
ajlsi-1012	185	14	sequences	sequence	NOUN
ajlsi-1012	185	15	of	of	ADP
ajlsi-1012	185	16	virus	virus	NOUN
ajlsi-1012	185	17	rna	rna	NOUN
ajlsi-1012	185	18	by	by	ADP
ajlsi-1012	185	19	real	real	ADJ
ajlsi-1012	185	20	-	-	PUNCT
ajlsi-1012	185	21	time	time	NOUN
ajlsi-1012	185	22	reverse	reverse	NOUN
ajlsi-1012	185	23	transcription	transcription	NOUN
ajlsi-1012	185	24	polymerase	polymerase	NOUN
ajlsi-1012	185	25	chain	chain	NOUN
ajlsi-1012	185	26	reaction	reaction	NOUN
ajlsi-1012	185	27	(	(	PUNCT
ajlsi-1012	185	28	rt	rt	NOUN
ajlsi-1012	185	29	-	-	PUNCT
ajlsi-1012	185	30	pcr	pcr	NOUN
ajlsi-1012	185	31	)	)	PUNCT
ajlsi-1012	185	32	,	,	PUNCT
ajlsi-1012	185	33	with	with	ADP
ajlsi-1012	185	34	confirmation	confirmation	NOUN
ajlsi-1012	185	35	by	by	ADP
ajlsi-1012	185	36	nucleic	nucleic	ADJ
ajlsi-1012	185	37	acid	acid	NOUN
ajlsi-1012	185	38	sequencing	sequencing	NOUN
ajlsi-1012	185	39	when	when	SCONJ
ajlsi-1012	185	40	necessary	necessary	ADJ
ajlsi-1012	185	41	.	.	PUNCT
ajlsi-1012	186	1	the	the	DET
ajlsi-1012	186	2	majority	majority	NOUN
ajlsi-1012	186	3	of	of	ADP
ajlsi-1012	186	4	molecular	molecular	ADJ
ajlsi-1012	186	5	diagnostic	diagnostic	ADJ
ajlsi-1012	186	6	tests	test	NOUN
ajlsi-1012	186	7	have	have	AUX
ajlsi-1012	186	8	utilized	utilize	VERB
ajlsi-1012	186	9	real	real	ADJ
ajlsi-1012	186	10	-	-	PUNCT
ajlsi-1012	186	11	time	time	NOUN
ajlsi-1012	186	12	rt	rt	ADJ
ajlsi-1012	186	13	-	-	PUNCT
ajlsi-1012	186	14	pcr	pcr	ADJ
ajlsi-1012	186	15	technology	technology	NOUN
ajlsi-1012	186	16	targeting	target	VERB
ajlsi-1012	186	17	different	different	ADJ
ajlsi-1012	186	18	sarscov-2	sarscov-2	NUM
ajlsi-1012	186	19	genomic	genomic	ADJ
ajlsi-1012	186	20	regions	region	NOUN
ajlsi-1012	186	21	,	,	PUNCT
ajlsi-1012	186	22	including	include	VERB
ajlsi-1012	186	23	the	the	DET
ajlsi-1012	186	24	orf1b	orf1b	PROPN
ajlsi-1012	186	25	or	or	CCONJ
ajlsi-1012	186	26	orf8	orf8	NOUN
ajlsi-1012	186	27	regions	region	NOUN
ajlsi-1012	186	28	and	and	CCONJ
ajlsi-1012	186	29	the	the	DET
ajlsi-1012	186	30	nucleocapsid	nucleocapsid	ADJ
ajlsi-1012	186	31	(	(	PUNCT
ajlsi-1012	186	32	n	n	CCONJ
ajlsi-1012	186	33	)	)	PUNCT
ajlsi-1012	186	34	,	,	PUNCT
ajlsi-1012	186	35	spike	spike	X
ajlsi-1012	186	36	(	(	PUNCT
ajlsi-1012	186	37	s	s	NOUN
ajlsi-1012	186	38	)	)	PUNCT
ajlsi-1012	186	39	protein	protein	NOUN
ajlsi-1012	186	40	,	,	PUNCT
ajlsi-1012	186	41	rna	rna	NOUN
ajlsi-1012	186	42	-	-	PUNCT
ajlsi-1012	186	43	dependent	dependent	ADJ
ajlsi-1012	186	44	rna	rna	NOUN
ajlsi-1012	186	45	polymerase	polymerase	NOUN
ajlsi-1012	186	46	(	(	PUNCT
ajlsi-1012	186	47	rdrp	rdrp	PROPN
ajlsi-1012	186	48	)	)	PUNCT
ajlsi-1012	186	49	,	,	PUNCT
ajlsi-1012	186	50	or	or	CCONJ
ajlsi-1012	186	51	envelope	envelope	NOUN
ajlsi-1012	186	52	(	(	PUNCT
ajlsi-1012	186	53	e	e	NOUN
ajlsi-1012	186	54	)	)	PUNCT
ajlsi-1012	186	55	genes	gene	NOUN
ajlsi-1012	186	56	.	.	PUNCT
ajlsi-1012	187	1	the	the	DET
ajlsi-1012	187	2	most	most	ADV
ajlsi-1012	187	3	widely	widely	ADV
ajlsi-1012	187	4	used	use	VERB
ajlsi-1012	187	5	method	method	NOUN
ajlsi-1012	187	6	of	of	ADP
ajlsi-1012	187	7	covid-19	covid-19	PROPN
ajlsi-1012	187	8	diagnostics	diagnostic	NOUN
ajlsi-1012	187	9	is	be	AUX
ajlsi-1012	187	10	a	a	DET
ajlsi-1012	187	11	reverse	reverse	ADJ
ajlsi-1012	187	12	transcription	transcription	NOUN
ajlsi-1012	187	13	quantitative	quantitative	ADJ
ajlsi-1012	187	14	polymerase	polymerase	NOUN
ajlsi-1012	187	15	chain	chain	NOUN
ajlsi-1012	187	16	reaction	reaction	NOUN
ajlsi-1012	187	17	(	(	PUNCT
ajlsi-1012	187	18	rt	rt	NOUN
ajlsi-1012	187	19	-	-	PUNCT
ajlsi-1012	187	20	qpcr	qpcr	ADV
ajlsi-1012	187	21	)	)	PUNCT
ajlsi-1012	187	22	assay	assay	VERB
ajlsi-1012	187	23	to	to	PART
ajlsi-1012	187	24	detect	detect	VERB
ajlsi-1012	187	25	the	the	DET
ajlsi-1012	187	26	presence	presence	NOUN
ajlsi-1012	187	27	of	of	ADP
ajlsi-1012	187	28	sarscov-2	sarscov-2	NUM
ajlsi-1012	187	29	rna	rna	NOUN
ajlsi-1012	187	30	in	in	ADP
ajlsi-1012	187	31	patient	patient	ADJ
ajlsi-1012	187	32	samples	sample	NOUN
ajlsi-1012	187	33	,	,	PUNCT
ajlsi-1012	187	34	typically	typically	ADV
ajlsi-1012	187	35	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	187	36	swabs	swab	NOUN
ajlsi-1012	187	37	.	.	PUNCT
ajlsi-1012	188	1	rna	rna	NOUN
ajlsi-1012	188	2	extraction	extraction	NOUN
ajlsi-1012	188	3	is	be	AUX
ajlsi-1012	188	4	a	a	DET
ajlsi-1012	188	5	major	major	ADJ
ajlsi-1012	188	6	bottleneck	bottleneck	NOUN
ajlsi-1012	188	7	in	in	ADP
ajlsi-1012	188	8	current	current	ADJ
ajlsi-1012	188	9	covid-19	covid-19	PROPN
ajlsi-1012	188	10	testing	testing	NOUN
ajlsi-1012	188	11	.	.	PUNCT
ajlsi-1012	189	1	(	(	PUNCT
ajlsi-1012	189	2	shen	shen	NOUN
ajlsi-1012	189	3	et	et	PROPN
ajlsi-1012	189	4	al	al	PROPN
ajlsi-1012	189	5	.	.	PROPN
ajlsi-1012	189	6	,	,	PUNCT
ajlsi-1012	189	7	2020	2020	NUM
ajlsi-1012	189	8	;	;	PUNCT
ajlsi-1012	189	9	smyrlaki	smyrlaki	NOUN
ajlsi-1012	189	10	et	et	PROPN
ajlsi-1012	189	11	al	al	PROPN
ajlsi-1012	189	12	.	.	PROPN
ajlsi-1012	189	13	,	,	PUNCT
ajlsi-1012	189	14	2020	2020	NUM
ajlsi-1012	189	15	)	)	PUNCT
ajlsi-1012	189	16	.	.	PUNCT
ajlsi-1012	190	1	because	because	SCONJ
ajlsi-1012	190	2	of	of	ADP
ajlsi-1012	190	3	its	its	PRON
ajlsi-1012	190	4	high	high	ADJ
ajlsi-1012	190	5	sensitivity	sensitivity	NOUN
ajlsi-1012	190	6	and	and	CCONJ
ajlsi-1012	190	7	specificity	specificity	NOUN
ajlsi-1012	190	8	,	,	PUNCT
ajlsi-1012	190	9	polymerase	polymerase	NOUN
ajlsi-1012	190	10	chain	chain	NOUN
ajlsi-1012	190	11	reaction	reaction	NOUN
ajlsi-1012	190	12	(	(	PUNCT
ajlsi-1012	190	13	pcr	pcr	NOUN
ajlsi-1012	190	14	)	)	PUNCT
ajlsi-1012	190	15	is	be	AUX
ajlsi-1012	190	16	regarded	regard	VERB
ajlsi-1012	190	17	as	as	ADP
ajlsi-1012	190	18	the	the	DET
ajlsi-1012	190	19	gold	gold	ADJ
ajlsi-1012	190	20	standard	standard	ADJ
ajlsi-1012	190	21	test	test	NOUN
ajlsi-1012	190	22	for	for	ADP
ajlsi-1012	190	23	the	the	DET
ajlsi-1012	190	24	molecular	molecular	ADJ
ajlsi-1012	190	25	diagnosis	diagnosis	NOUN
ajlsi-1012	190	26	of	of	ADP
ajlsi-1012	190	27	viral	viral	ADJ
ajlsi-1012	190	28	and	and	CCONJ
ajlsi-1012	190	29	bacterial	bacterial	ADJ
ajlsi-1012	190	30	infections	infection	NOUN
ajlsi-1012	190	31	.	.	PUNCT
ajlsi-1012	191	1	isothermal	isothermal	ADJ
ajlsi-1012	191	2	nucleic	nucleic	ADJ
ajlsi-1012	191	3	acid	acid	NOUN
ajlsi-1012	191	4	amplification	amplification	NOUN
ajlsi-1012	191	5	,	,	PUNCT
ajlsi-1012	191	6	including	include	VERB
ajlsi-1012	191	7	transcription	transcription	NOUN
ajlsi-1012	191	8	-	-	PUNCT
ajlsi-1012	191	9	mediated	mediate	VERB
ajlsi-1012	191	10	amplification	amplification	NOUN
ajlsi-1012	191	11	and	and	CCONJ
ajlsi-1012	191	12	crispr	crispr	NOUN
ajlsi-1012	191	13	-	-	PUNCT
ajlsi-1012	191	14	based	base	VERB
ajlsi-1012	191	15	methodologies	methodology	NOUN
ajlsi-1012	191	16	,	,	PUNCT
ajlsi-1012	191	17	is	be	AUX
ajlsi-1012	191	18	considered	consider	VERB
ajlsi-1012	191	19	a	a	DET
ajlsi-1012	191	20	promising	promising	ADJ
ajlsi-1012	191	21	alternative	alternative	NOUN
ajlsi-1012	191	22	assay	assay	VERB
ajlsi-1012	191	23	due	due	ADP
ajlsi-1012	191	24	to	to	ADP
ajlsi-1012	191	25	its	its	PRON
ajlsi-1012	191	26	fundamental	fundamental	ADJ
ajlsi-1012	191	27	advantage	advantage	NOUN
ajlsi-1012	191	28	in	in	ADP
ajlsi-1012	191	29	quick	quick	ADJ
ajlsi-1012	191	30	procedure	procedure	NOUN
ajlsi-1012	191	31	time	time	NOUN
ajlsi-1012	191	32	at	at	ADP
ajlsi-1012	191	33	constant	constant	ADJ
ajlsi-1012	191	34	temperature	temperature	NOUN
ajlsi-1012	191	35	without	without	ADP
ajlsi-1012	191	36	thermocycler	thermocycler	NOUN
ajlsi-1012	191	37	operations	operation	NOUN
ajlsi-1012	191	38	.	.	PUNCT
ajlsi-1012	192	1	as	as	SCONJ
ajlsi-1012	192	2	such	such	ADJ
ajlsi-1012	192	3	,	,	PUNCT
ajlsi-1012	192	4	real	real	ADJ
ajlsi-1012	192	5	-	-	PUNCT
ajlsi-1012	192	6	time	time	NOUN
ajlsi-1012	192	7	reverse	reverse	ADJ
ajlsi-1012	192	8	transcriptase	transcriptase	NOUN
ajlsi-1012	192	9	-	-	PUNCT
ajlsi-1012	192	10	pcr	pcr	ADJ
ajlsi-1012	192	11	(	(	PUNCT
ajlsi-1012	192	12	rt	rt	NOUN
ajlsi-1012	192	13	-	-	PUNCT
ajlsi-1012	192	14	pcr	pcr	NOUN
ajlsi-1012	192	15	)	)	PUNCT
ajlsi-1012	192	16	is	be	AUX
ajlsi-1012	192	17	of	of	ADP
ajlsi-1012	192	18	great	great	ADJ
ajlsi-1012	192	19	interest	interest	NOUN
ajlsi-1012	192	20	today	today	NOUN
ajlsi-1012	192	21	for	for	ADP
ajlsi-1012	192	22	the	the	DET
ajlsi-1012	192	23	detection	detection	NOUN
ajlsi-1012	192	24	of	of	ADP
ajlsi-1012	192	25	sars	sar	NOUN
ajlsi-1012	192	26	-	-	PUNCT
ajlsi-1012	192	27	cov-2	cov-2	NOUN
ajlsi-1012	192	28	due	due	ADP
ajlsi-1012	192	29	to	to	ADP
ajlsi-1012	192	30	its	its	PRON
ajlsi-1012	192	31	benefits	benefit	NOUN
ajlsi-1012	192	32	as	as	ADP
ajlsi-1012	192	33	a	a	DET
ajlsi-1012	192	34	specific	specific	ADJ
ajlsi-1012	192	35	and	and	CCONJ
ajlsi-1012	192	36	simple	simple	ADJ
ajlsi-1012	192	37	qualitative	qualitative	NOUN
ajlsi-1012	192	38	assay	assay	NOUN
ajlsi-1012	192	39	.	.	PUNCT
ajlsi-1012	193	1	furthermore	furthermore	ADV
ajlsi-1012	193	2	,	,	PUNCT
ajlsi-1012	193	3	realtime	realtime	VERB
ajlsi-1012	193	4	rt	rt	PROPN
ajlsi-1012	193	5	-	-	PUNCT
ajlsi-1012	193	6	pcr	pcr	PROPN
ajlsi-1012	193	7	has	have	VERB
ajlsi-1012	193	8	sufficient	sufficient	ADJ
ajlsi-1012	193	9	sensitivity	sensitivity	NOUN
ajlsi-1012	193	10	to	to	PART
ajlsi-1012	193	11	aid	aid	VERB
ajlsi-1012	193	12	us	we	PRON
ajlsi-1012	193	13	in	in	ADP
ajlsi-1012	193	14	early	early	ADJ
ajlsi-1012	193	15	infection	infection	NOUN
ajlsi-1012	193	16	diagnosis	diagnosis	NOUN
ajlsi-1012	193	17	.	.	PUNCT
ajlsi-1012	194	1	therefore	therefore	ADV
ajlsi-1012	194	2	,	,	PUNCT
ajlsi-1012	194	3	the	the	DET
ajlsi-1012	194	4	“	"	PUNCT
ajlsi-1012	194	5	criterion	criterion	NOUN
ajlsi-1012	194	6	-	-	PUNCT
ajlsi-1012	194	7	referenced	reference	VERB
ajlsi-1012	194	8	”	"	PUNCT
ajlsi-1012	194	9	real	real	ADJ
ajlsi-1012	194	10	-	-	PUNCT
ajlsi-1012	194	11	time	time	NOUN
ajlsi-1012	194	12	rt	rt	NOUN
ajlsi-1012	194	13	-	-	PUNCT
ajlsi-1012	194	14	pcr	pcr	NOUN
ajlsi-1012	194	15	assay	assay	NOUN
ajlsi-1012	194	16	can	can	AUX
ajlsi-1012	194	17	be	be	AUX
ajlsi-1012	194	18	considered	consider	VERB
ajlsi-1012	194	19	as	as	ADP
ajlsi-1012	194	20	the	the	DET
ajlsi-1012	194	21	main	main	ADJ
ajlsi-1012	194	22	method	method	NOUN
ajlsi-1012	194	23	to	to	PART
ajlsi-1012	194	24	be	be	AUX
ajlsi-1012	194	25	applied	apply	VERB
ajlsi-1012	194	26	to	to	PART
ajlsi-1012	194	27	detect	detect	VERB
ajlsi-1012	194	28	the	the	DET
ajlsi-1012	194	29	causative	causative	ADJ
ajlsi-1012	194	30	agent	agent	NOUN
ajlsi-1012	194	31	of	of	ADP
ajlsi-1012	194	32	covid-19	covid-19	PROPN
ajlsi-1012	194	33	,	,	PUNCT
ajlsi-1012	194	34	i.e.	i.e.	X
ajlsi-1012	194	35	,	,	PUNCT
ajlsi-1012	194	36	sars	sar	NOUN
ajlsi-1012	194	37	-	-	PUNCT
ajlsi-1012	194	38	cov-2	cov-2	PUNCT
ajlsi-1012	194	39	(	(	PUNCT
ajlsi-1012	194	40	carter	carter	PROPN
ajlsi-1012	194	41	et	et	PROPN
ajlsi-1012	194	42	al	al	PROPN
ajlsi-1012	194	43	.	.	PROPN
ajlsi-1012	194	44	,	,	PUNCT
ajlsi-1012	194	45	2020	2020	NUM
ajlsi-1012	194	46	;	;	PUNCT
ajlsi-1012	194	47	shen	shen	PROPN
ajlsi-1012	194	48	et	et	PROPN
ajlsi-1012	194	49	al	al	PROPN
ajlsi-1012	194	50	.	.	PROPN
ajlsi-1012	194	51	,	,	PUNCT
ajlsi-1012	194	52	2020	2020	NUM
ajlsi-1012	194	53	;	;	PUNCT
ajlsi-1012	194	54	wan	wan	PROPN
ajlsi-1012	194	55	et	et	PROPN
ajlsi-1012	194	56	al	al	PROPN
ajlsi-1012	194	57	.	.	PROPN
ajlsi-1012	194	58	,	,	PUNCT
ajlsi-1012	194	59	2016	2016	NUM
ajlsi-1012	194	60	;	;	PUNCT
ajlsi-1012	194	61	noh	noh	PROPN
ajlsi-1012	194	62	et	et	PROPN
ajlsi-1012	194	63	al	al	PROPN
ajlsi-1012	194	64	.	.	PROPN
ajlsi-1012	194	65	,	,	PUNCT
ajlsi-1012	194	66	2017	2017	NUM
ajlsi-1012	194	67	;	;	PUNCT
ajlsi-1012	194	68	etc	etc	X
ajlsi-1012	194	69	.	.	X
ajlsi-1012	194	70	)	)	PUNCT
ajlsi-1012	194	71	.	.	PUNCT
ajlsi-1012	195	1	reverse	reverse	VERB
ajlsi-1012	195	2	transcription	transcription	NOUN
ajlsi-1012	195	3	-	-	PUNCT
ajlsi-1012	195	4	polymerase	polymerase	NOUN
ajlsi-1012	195	5	chain	chain	NOUN
ajlsi-1012	195	6	reaction	reaction	NOUN
ajlsi-1012	195	7	(	(	PUNCT
ajlsi-1012	195	8	rt	rt	NOUN
ajlsi-1012	195	9	-	-	PUNCT
ajlsi-1012	195	10	pcr	pcr	NOUN
ajlsi-1012	195	11	)	)	PUNCT
ajlsi-1012	195	12	in	in	ADP
ajlsi-1012	195	13	acute	acute	ADJ
ajlsi-1012	195	14	respiratory	respiratory	ADJ
ajlsi-1012	195	15	infections	infection	NOUN
ajlsi-1012	195	16	,	,	PUNCT
ajlsi-1012	195	17	rt	rt	NOUN
ajlsi-1012	195	18	-	-	PUNCT
ajlsi-1012	195	19	pcr	pcr	PROPN
ajlsi-1012	195	20	is	be	AUX
ajlsi-1012	195	21	routinely	routinely	ADV
ajlsi-1012	195	22	used	use	VERB
ajlsi-1012	195	23	to	to	PART
ajlsi-1012	195	24	detect	detect	VERB
ajlsi-1012	195	25	causative	causative	ADJ
ajlsi-1012	195	26	viruses	virus	NOUN
ajlsi-1012	195	27	from	from	ADP
ajlsi-1012	195	28	respiratory	respiratory	ADJ
ajlsi-1012	195	29	secretions	secretion	NOUN
ajlsi-1012	195	30	in	in	ADP
ajlsi-1012	195	31	nucleic	nucleic	ADJ
ajlsi-1012	195	32	acid	acid	NOUN
ajlsi-1012	195	33	testing	testing	NOUN
ajlsi-1012	195	34	assays	assay	NOUN
ajlsi-1012	195	35	.	.	PUNCT
ajlsi-1012	196	1	the	the	DET
ajlsi-1012	196	2	real	real	ADJ
ajlsi-1012	196	3	-	-	PUNCT
ajlsi-1012	196	4	time	time	NOUN
ajlsi-1012	196	5	reverse	reverse	VERB
ajlsi-1012	196	6	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	196	7	pa	pa	PROPN
ajlsi-1012	196	8	ge	ge	PROPN
ajlsi-1012	196	9	34	34	NUM
ajlsi-1012	196	10	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	196	11	am	am	NOUN
ajlsi-1012	196	12	.	.	PUNCT
ajlsi-1012	197	1	j.	j.	PROPN
ajlsi-1012	197	2	life	life	PROPN
ajlsi-1012	197	3	sci	sci	PROPN
ajlsi-1012	197	4	.	.	PUNCT
ajlsi-1012	197	5	innov	innov	PROPN
ajlsi-1012	197	6	.	.	PUNCT
ajlsi-1012	198	1	1(2	1(2	NUM
ajlsi-1012	198	2	)	)	PUNCT
ajlsi-1012	198	3	29	29	NUM
ajlsi-1012	198	4	-	-	SYM
ajlsi-1012	198	5	42	42	NUM
ajlsi-1012	198	6	,	,	PUNCT
ajlsi-1012	198	7	2022	2022	NUM
ajlsi-1012	198	8	transcription	transcription	NOUN
ajlsi-1012	198	9	(	(	PUNCT
ajlsi-1012	198	10	pcr	pcr	NOUN
ajlsi-1012	198	11	)	)	PUNCT
ajlsi-1012	198	12	method	method	NOUN
ajlsi-1012	198	13	is	be	AUX
ajlsi-1012	198	14	one	one	NUM
ajlsi-1012	198	15	of	of	ADP
ajlsi-1012	198	16	the	the	DET
ajlsi-1012	198	17	best	good	ADJ
ajlsi-1012	198	18	and	and	CCONJ
ajlsi-1012	198	19	most	most	ADV
ajlsi-1012	198	20	accurate	accurate	ADJ
ajlsi-1012	198	21	laboratory	laboratory	NOUN
ajlsi-1012	198	22	methods	method	NOUN
ajlsi-1012	198	23	for	for	ADP
ajlsi-1012	198	24	detecting	detect	VERB
ajlsi-1012	198	25	,	,	PUNCT
ajlsi-1012	198	26	tracking	tracking	NOUN
ajlsi-1012	198	27	,	,	PUNCT
ajlsi-1012	198	28	and	and	CCONJ
ajlsi-1012	198	29	studying	study	VERB
ajlsi-1012	198	30	the	the	DET
ajlsi-1012	198	31	coronavirus	coronavirus	NOUN
ajlsi-1012	198	32	.	.	PUNCT
ajlsi-1012	199	1	real	real	ADJ
ajlsi-1012	199	2	-	-	PUNCT
ajlsi-1012	199	3	time	time	NOUN
ajlsi-1012	199	4	rt	rt	NOUN
ajlsi-1012	199	5	-	-	PUNCT
ajlsi-1012	199	6	pcr	pcr	PROPN
ajlsi-1012	199	7	is	be	AUX
ajlsi-1012	199	8	a	a	DET
ajlsi-1012	199	9	method	method	NOUN
ajlsi-1012	199	10	by	by	ADP
ajlsi-1012	199	11	which	which	PRON
ajlsi-1012	199	12	the	the	DET
ajlsi-1012	199	13	presence	presence	NOUN
ajlsi-1012	199	14	of	of	ADP
ajlsi-1012	199	15	specific	specific	ADJ
ajlsi-1012	199	16	target	target	NOUN
ajlsi-1012	199	17	genetic	genetic	ADJ
ajlsi-1012	199	18	material	material	NOUN
ajlsi-1012	199	19	can	can	AUX
ajlsi-1012	199	20	be	be	AUX
ajlsi-1012	199	21	detected	detect	VERB
ajlsi-1012	199	22	(	(	PUNCT
ajlsi-1012	199	23	sethuraman	sethuraman	NOUN
ajlsi-1012	199	24	et	et	PROPN
ajlsi-1012	199	25	al	al	PROPN
ajlsi-1012	199	26	.	.	PROPN
ajlsi-1012	199	27	,	,	PUNCT
ajlsi-1012	199	28	2020	2020	NUM
ajlsi-1012	199	29	)	)	PUNCT
ajlsi-1012	199	30	.	.	PUNCT
ajlsi-1012	200	1	this	this	DET
ajlsi-1012	200	2	reaction	reaction	NOUN
ajlsi-1012	200	3	relies	rely	VERB
ajlsi-1012	200	4	on	on	ADP
ajlsi-1012	200	5	small	small	ADJ
ajlsi-1012	200	6	dna	dna	NOUN
ajlsi-1012	200	7	sequence	sequence	NOUN
ajlsi-1012	200	8	primers	primer	NOUN
ajlsi-1012	200	9	designed	design	VERB
ajlsi-1012	200	10	to	to	PART
ajlsi-1012	200	11	specifically	specifically	ADV
ajlsi-1012	200	12	recognize	recognize	VERB
ajlsi-1012	200	13	complementary	complementary	ADJ
ajlsi-1012	200	14	sequences	sequence	NOUN
ajlsi-1012	200	15	on	on	ADP
ajlsi-1012	200	16	the	the	DET
ajlsi-1012	200	17	viral	viral	ADJ
ajlsi-1012	200	18	rna	rna	NOUN
ajlsi-1012	200	19	genome	genome	NOUN
ajlsi-1012	200	20	and	and	CCONJ
ajlsi-1012	200	21	the	the	DET
ajlsi-1012	200	22	reverse	reverse	ADJ
ajlsi-1012	200	23	transcriptase	transcriptase	NOUN
ajlsi-1012	200	24	to	to	PART
ajlsi-1012	200	25	generate	generate	VERB
ajlsi-1012	200	26	a	a	DET
ajlsi-1012	200	27	short	short	ADJ
ajlsi-1012	200	28	complementary	complementary	ADJ
ajlsi-1012	200	29	dna	dna	PROPN
ajlsi-1012	200	30	copy	copy	NOUN
ajlsi-1012	200	31	(	(	PUNCT
ajlsi-1012	200	32	cdna	cdna	PROPN
ajlsi-1012	200	33	)	)	PUNCT
ajlsi-1012	200	34	of	of	ADP
ajlsi-1012	200	35	the	the	DET
ajlsi-1012	200	36	viral	viral	ADJ
ajlsi-1012	200	37	rna	rna	NOUN
ajlsi-1012	200	38	.	.	PUNCT
ajlsi-1012	201	1	in	in	ADP
ajlsi-1012	201	2	real	real	ADJ
ajlsi-1012	201	3	-	-	PUNCT
ajlsi-1012	201	4	time	time	NOUN
ajlsi-1012	201	5	rt	rt	NOUN
ajlsi-1012	201	6	-	-	PUNCT
ajlsi-1012	201	7	pcr	pcr	NOUN
ajlsi-1012	201	8	,	,	PUNCT
ajlsi-1012	201	9	the	the	DET
ajlsi-1012	201	10	amplification	amplification	NOUN
ajlsi-1012	201	11	of	of	ADP
ajlsi-1012	201	12	dna	dna	PROPN
ajlsi-1012	201	13	is	be	AUX
ajlsi-1012	201	14	monitored	monitor	VERB
ajlsi-1012	201	15	in	in	ADP
ajlsi-1012	201	16	real	real	ADJ
ajlsi-1012	201	17	time	time	NOUN
ajlsi-1012	201	18	as	as	SCONJ
ajlsi-1012	201	19	the	the	DET
ajlsi-1012	201	20	pcr	pcr	ADJ
ajlsi-1012	201	21	reaction	reaction	NOUN
ajlsi-1012	201	22	progresses	progress	VERB
ajlsi-1012	201	23	.	.	PUNCT
ajlsi-1012	202	1	this	this	PRON
ajlsi-1012	202	2	is	be	AUX
ajlsi-1012	202	3	done	do	VERB
ajlsi-1012	202	4	using	use	VERB
ajlsi-1012	202	5	a	a	DET
ajlsi-1012	202	6	fluorescent	fluorescent	ADJ
ajlsi-1012	202	7	dye	dye	NOUN
ajlsi-1012	202	8	or	or	CCONJ
ajlsi-1012	202	9	a	a	DET
ajlsi-1012	202	10	sequence	sequence	NOUN
ajlsi-1012	202	11	-	-	PUNCT
ajlsi-1012	202	12	specific	specific	ADJ
ajlsi-1012	202	13	dna	dna	NOUN
ajlsi-1012	202	14	probe	probe	NOUN
ajlsi-1012	202	15	labelled	label	VERB
ajlsi-1012	202	16	with	with	ADP
ajlsi-1012	202	17	a	a	DET
ajlsi-1012	202	18	fluorescent	fluorescent	ADJ
ajlsi-1012	202	19	molecule	molecule	NOUN
ajlsi-1012	202	20	until	until	SCONJ
ajlsi-1012	202	21	the	the	DET
ajlsi-1012	202	22	viral	viral	ADJ
ajlsi-1012	202	23	cdna	cdna	NOUN
ajlsi-1012	202	24	can	can	AUX
ajlsi-1012	202	25	be	be	AUX
ajlsi-1012	202	26	detected	detect	VERB
ajlsi-1012	202	27	.	.	PUNCT
ajlsi-1012	203	1	coronaviruses	coronaviruse	NOUN
ajlsi-1012	203	2	have	have	VERB
ajlsi-1012	203	3	a	a	DET
ajlsi-1012	203	4	number	number	NOUN
ajlsi-1012	203	5	of	of	ADP
ajlsi-1012	203	6	molecular	molecular	ADJ
ajlsi-1012	203	7	targets	target	NOUN
ajlsi-1012	203	8	within	within	ADP
ajlsi-1012	203	9	their	their	PRON
ajlsi-1012	203	10	positive	positive	ADJ
ajlsi-1012	203	11	-	-	PUNCT
ajlsi-1012	203	12	sense	sense	NOUN
ajlsi-1012	203	13	,	,	PUNCT
ajlsi-1012	203	14	single	single	ADJ
ajlsi-1012	203	15	-	-	PUNCT
ajlsi-1012	203	16	stranded	strand	VERB
ajlsi-1012	203	17	rna	rna	NOUN
ajlsi-1012	203	18	genome	genome	NOUN
ajlsi-1012	203	19	that	that	PRON
ajlsi-1012	203	20	can	can	AUX
ajlsi-1012	203	21	be	be	AUX
ajlsi-1012	203	22	used	use	VERB
ajlsi-1012	203	23	for	for	ADP
ajlsi-1012	203	24	pcr	pcr	ADJ
ajlsi-1012	203	25	assays	assay	NOUN
ajlsi-1012	203	26	(	(	PUNCT
ajlsi-1012	203	27	corman	corman	NOUN
ajlsi-1012	203	28	et	et	PROPN
ajlsi-1012	203	29	al	al	PROPN
ajlsi-1012	203	30	.	.	PROPN
ajlsi-1012	203	31	,	,	PUNCT
ajlsi-1012	203	32	2020	2020	NUM
ajlsi-1012	203	33	)	)	PUNCT
ajlsi-1012	203	34	.	.	PUNCT
ajlsi-1012	204	1	these	these	PRON
ajlsi-1012	204	2	include	include	VERB
ajlsi-1012	204	3	genes	gene	NOUN
ajlsi-1012	204	4	encoding	encode	VERB
ajlsi-1012	204	5	structural	structural	ADJ
ajlsi-1012	204	6	proteins	protein	NOUN
ajlsi-1012	204	7	,	,	PUNCT
ajlsi-1012	204	8	including	include	VERB
ajlsi-1012	204	9	envelope	envelope	NOUN
ajlsi-1012	204	10	glycoproteins	glycoprotein	NOUN
ajlsi-1012	204	11	spike	spike	NOUN
ajlsi-1012	204	12	(	(	PUNCT
ajlsi-1012	204	13	s	s	NOUN
ajlsi-1012	204	14	)	)	PUNCT
ajlsi-1012	204	15	,	,	PUNCT
ajlsi-1012	204	16	envelope	envelope	NOUN
ajlsi-1012	204	17	(	(	PUNCT
ajlsi-1012	204	18	e	e	NOUN
ajlsi-1012	204	19	)	)	PUNCT
ajlsi-1012	204	20	,	,	PUNCT
ajlsi-1012	204	21	transmembrane	transmembrane	NOUN
ajlsi-1012	204	22	(	(	PUNCT
ajlsi-1012	204	23	m	m	NOUN
ajlsi-1012	204	24	)	)	PUNCT
ajlsi-1012	204	25	,	,	PUNCT
ajlsi-1012	204	26	helicase	helicase	NOUN
ajlsi-1012	204	27	(	(	PUNCT
ajlsi-1012	204	28	hel	hel	PROPN
ajlsi-1012	204	29	)	)	PUNCT
ajlsi-1012	204	30	,	,	PUNCT
ajlsi-1012	204	31	and	and	CCONJ
ajlsi-1012	204	32	nucleocapsid	nucleocapsid	ADJ
ajlsi-1012	204	33	(	(	PUNCT
ajlsi-1012	204	34	n	n	CCONJ
ajlsi-1012	204	35	)	)	PUNCT
ajlsi-1012	204	36	(	(	PUNCT
ajlsi-1012	204	37	chan	chan	PROPN
ajlsi-1012	204	38	et	et	PROPN
ajlsi-1012	204	39	al	al	PROPN
ajlsi-1012	204	40	.	.	PROPN
ajlsi-1012	204	41	,	,	PUNCT
ajlsi-1012	204	42	2020	2020	NUM
ajlsi-1012	204	43	)	)	PUNCT
ajlsi-1012	204	44	.	.	PUNCT
ajlsi-1012	205	1	in	in	ADP
ajlsi-1012	205	2	addition	addition	NOUN
ajlsi-1012	205	3	to	to	ADP
ajlsi-1012	205	4	the	the	DET
ajlsi-1012	205	5	genes	gene	NOUN
ajlsi-1012	205	6	that	that	PRON
ajlsi-1012	205	7	encode	encode	VERB
ajlsi-1012	205	8	structural	structural	ADJ
ajlsi-1012	205	9	proteins	protein	NOUN
ajlsi-1012	205	10	,	,	PUNCT
ajlsi-1012	205	11	there	there	PRON
ajlsi-1012	205	12	are	be	VERB
ajlsi-1012	205	13	species	species	NOUN
ajlsi-1012	205	14	-	-	PUNCT
ajlsi-1012	205	15	specific	specific	ADJ
ajlsi-1012	205	16	accessory	accessory	NOUN
ajlsi-1012	205	17	genes	gene	NOUN
ajlsi-1012	205	18	that	that	PRON
ajlsi-1012	205	19	are	be	AUX
ajlsi-1012	205	20	required	require	VERB
ajlsi-1012	205	21	for	for	ADP
ajlsi-1012	205	22	viral	viral	ADJ
ajlsi-1012	205	23	replication	replication	NOUN
ajlsi-1012	205	24	,	,	PUNCT
ajlsi-1012	205	25	like	like	ADP
ajlsi-1012	205	26	rnadependent	rnadependent	NOUN
ajlsi-1012	205	27	rna	rna	NOUN
ajlsi-1012	205	28	polymerase	polymerase	NOUN
ajlsi-1012	205	29	(	(	PUNCT
ajlsi-1012	205	30	rdrp	rdrp	PROPN
ajlsi-1012	205	31	)	)	PUNCT
ajlsi-1012	205	32	,	,	PUNCT
ajlsi-1012	205	33	hemagglutinin	hemagglutinin	ADJ
ajlsi-1012	205	34	esterase	esterase	NOUN
ajlsi-1012	205	35	(	(	PUNCT
ajlsi-1012	205	36	he	he	PRON
ajlsi-1012	205	37	)	)	PUNCT
ajlsi-1012	205	38	,	,	PUNCT
ajlsi-1012	205	39	and	and	CCONJ
ajlsi-1012	205	40	open	open	ADJ
ajlsi-1012	205	41	reading	reading	NOUN
ajlsi-1012	205	42	frames	frame	NOUN
ajlsi-1012	205	43	orf1a	orf1a	PROPN
ajlsi-1012	205	44	and	and	CCONJ
ajlsi-1012	205	45	orf1b	orf1b	PROPN
ajlsi-1012	205	46	(	(	PUNCT
ajlsi-1012	205	47	corman	corman	NOUN
ajlsi-1012	205	48	et	et	PROPN
ajlsi-1012	205	49	al	al	PROPN
ajlsi-1012	205	50	.	.	PROPN
ajlsi-1012	205	51	,	,	PUNCT
ajlsi-1012	205	52	2020	2020	NUM
ajlsi-1012	205	53	;	;	PUNCT
ajlsi-1012	205	54	lan	lan	PROPN
ajlsi-1012	205	55	et	et	PROPN
ajlsi-1012	205	56	al	al	PROPN
ajlsi-1012	205	57	.	.	PROPN
ajlsi-1012	205	58	,	,	PUNCT
ajlsi-1012	205	59	2020	2020	NUM
ajlsi-1012	205	60	)	)	PUNCT
ajlsi-1012	205	61	.	.	PUNCT
ajlsi-1012	206	1	the	the	DET
ajlsi-1012	206	2	assay	assay	NOUN
ajlsi-1012	206	3	includes	include	VERB
ajlsi-1012	206	4	at	at	ADV
ajlsi-1012	206	5	least	least	ADV
ajlsi-1012	206	6	two	two	NUM
ajlsi-1012	206	7	molecular	molecular	ADJ
ajlsi-1012	206	8	targets	target	NOUN
ajlsi-1012	206	9	to	to	PART
ajlsi-1012	206	10	avoid	avoid	VERB
ajlsi-1012	206	11	potential	potential	ADJ
ajlsi-1012	206	12	cross	cross	NOUN
ajlsi-1012	206	13	-	-	NOUN
ajlsi-1012	206	14	reaction	reaction	NOUN
ajlsi-1012	206	15	with	with	ADP
ajlsi-1012	206	16	other	other	ADJ
ajlsi-1012	206	17	endemic	endemic	ADJ
ajlsi-1012	206	18	coronaviruses	coronaviruse	NOUN
ajlsi-1012	206	19	as	as	ADV
ajlsi-1012	206	20	well	well	ADV
ajlsi-1012	206	21	as	as	ADP
ajlsi-1012	206	22	potential	potential	ADJ
ajlsi-1012	206	23	genetic	genetic	ADJ
ajlsi-1012	206	24	drift	drift	NOUN
ajlsi-1012	206	25	of	of	ADP
ajlsi-1012	206	26	sars	sar	NOUN
ajlsi-1012	206	27	-	-	PUNCT
ajlsi-1012	206	28	cov-2	cov-2	NOUN
ajlsi-1012	206	29	.	.	PUNCT
ajlsi-1012	207	1	in	in	ADP
ajlsi-1012	207	2	the	the	DET
ajlsi-1012	207	3	united	united	PROPN
ajlsi-1012	207	4	states	states	PROPN
ajlsi-1012	207	5	,	,	PUNCT
ajlsi-1012	207	6	the	the	DET
ajlsi-1012	207	7	cdc	cdc	PROPN
ajlsi-1012	207	8	recommends	recommend	VERB
ajlsi-1012	207	9	two	two	NUM
ajlsi-1012	207	10	nucleocapsid	nucleocapsid	ADJ
ajlsi-1012	207	11	protein	protein	NOUN
ajlsi-1012	207	12	targets	target	NOUN
ajlsi-1012	207	13	(	(	PUNCT
ajlsi-1012	207	14	n1	n1	NOUN
ajlsi-1012	207	15	and	and	CCONJ
ajlsi-1012	207	16	n2	n2	ADJ
ajlsi-1012	207	17	)	)	PUNCT
ajlsi-1012	207	18	(	(	PUNCT
ajlsi-1012	207	19	holshue	holshue	NOUN
ajlsi-1012	207	20	et	et	PROPN
ajlsi-1012	207	21	al	al	PROPN
ajlsi-1012	207	22	.	.	PROPN
ajlsi-1012	207	23	,	,	PUNCT
ajlsi-1012	207	24	2020	2020	NUM
ajlsi-1012	207	25	)	)	PUNCT
ajlsi-1012	207	26	,	,	PUNCT
ajlsi-1012	207	27	while	while	SCONJ
ajlsi-1012	207	28	the	the	PRON
ajlsi-1012	207	29	who	who	PRON
ajlsi-1012	207	30	recommends	recommend	VERB
ajlsi-1012	207	31	first	first	ADJ
ajlsi-1012	207	32	-	-	PUNCT
ajlsi-1012	207	33	line	line	NOUN
ajlsi-1012	207	34	screening	screening	NOUN
ajlsi-1012	207	35	with	with	ADP
ajlsi-1012	207	36	an	an	DET
ajlsi-1012	207	37	e	e	NOUN
ajlsi-1012	207	38	gene	gene	NOUN
ajlsi-1012	207	39	assay	assay	NOUN
ajlsi-1012	207	40	followed	follow	VERB
ajlsi-1012	207	41	by	by	ADP
ajlsi-1012	207	42	a	a	DET
ajlsi-1012	207	43	confirmatory	confirmatory	NOUN
ajlsi-1012	207	44	assay	assay	NOUN
ajlsi-1012	207	45	using	use	VERB
ajlsi-1012	207	46	the	the	DET
ajlsi-1012	207	47	rdrp	rdrp	NOUN
ajlsi-1012	207	48	gene	gene	NOUN
ajlsi-1012	207	49	(	(	PUNCT
ajlsi-1012	207	50	corman	corman	NOUN
ajlsi-1012	207	51	et	et	PROPN
ajlsi-1012	207	52	al	al	PROPN
ajlsi-1012	207	53	.	.	PROPN
ajlsi-1012	207	54	,	,	PUNCT
ajlsi-1012	207	55	2020	2020	NUM
ajlsi-1012	207	56	)	)	PUNCT
ajlsi-1012	207	57	.	.	PUNCT
ajlsi-1012	208	1	rt	rt	NOUN
ajlsi-1012	208	2	-	-	PUNCT
ajlsi-1012	208	3	pcr	pcr	PROPN
ajlsi-1012	208	4	has	have	AUX
ajlsi-1012	208	5	traditionally	traditionally	ADV
ajlsi-1012	208	6	been	be	AUX
ajlsi-1012	208	7	carried	carry	VERB
ajlsi-1012	208	8	out	out	ADP
ajlsi-1012	208	9	as	as	ADP
ajlsi-1012	208	10	a	a	DET
ajlsi-1012	208	11	one	one	NUM
ajlsi-1012	208	12	-	-	PUNCT
ajlsi-1012	208	13	step	step	NOUN
ajlsi-1012	208	14	or	or	CCONJ
ajlsi-1012	208	15	two	two	NUM
ajlsi-1012	208	16	-	-	PUNCT
ajlsi-1012	208	17	step	step	NOUN
ajlsi-1012	208	18	procedure	procedure	NOUN
ajlsi-1012	208	19	.	.	PUNCT
ajlsi-1012	209	1	onestep	onestep	VERB
ajlsi-1012	209	2	real	real	ADJ
ajlsi-1012	209	3	-	-	PUNCT
ajlsi-1012	209	4	time	time	NOUN
ajlsi-1012	209	5	rt	rt	PROPN
ajlsi-1012	209	6	-	-	PUNCT
ajlsi-1012	209	7	pcr	pcr	NOUN
ajlsi-1012	209	8	uses	use	VERB
ajlsi-1012	209	9	a	a	DET
ajlsi-1012	209	10	single	single	ADJ
ajlsi-1012	209	11	tube	tube	NOUN
ajlsi-1012	209	12	containing	contain	VERB
ajlsi-1012	209	13	the	the	DET
ajlsi-1012	209	14	necessary	necessary	ADJ
ajlsi-1012	209	15	primers	primer	NOUN
ajlsi-1012	209	16	to	to	PART
ajlsi-1012	209	17	run	run	VERB
ajlsi-1012	209	18	the	the	DET
ajlsi-1012	209	19	entire	entire	ADJ
ajlsi-1012	209	20	rt	rt	ADJ
ajlsi-1012	209	21	-	-	PUNCT
ajlsi-1012	209	22	pcr	pcr	NOUN
ajlsi-1012	209	23	reaction	reaction	NOUN
ajlsi-1012	209	24	.	.	PUNCT
ajlsi-1012	210	1	two	two	NUM
ajlsi-1012	210	2	-	-	PUNCT
ajlsi-1012	210	3	step	step	NOUN
ajlsi-1012	210	4	real	real	ADJ
ajlsi-1012	210	5	-	-	PUNCT
ajlsi-1012	210	6	time	time	NOUN
ajlsi-1012	210	7	rt	rt	NOUN
ajlsi-1012	210	8	-	-	PUNCT
ajlsi-1012	210	9	pcr	pcr	NOUN
ajlsi-1012	210	10	involves	involve	VERB
ajlsi-1012	210	11	more	more	ADJ
ajlsi-1012	210	12	than	than	ADP
ajlsi-1012	210	13	one	one	NUM
ajlsi-1012	210	14	tube	tube	NOUN
ajlsi-1012	210	15	to	to	PART
ajlsi-1012	210	16	run	run	VERB
ajlsi-1012	210	17	the	the	DET
ajlsi-1012	210	18	separate	separate	ADJ
ajlsi-1012	210	19	reverse	reverse	ADJ
ajlsi-1012	210	20	transcription	transcription	NOUN
ajlsi-1012	210	21	and	and	CCONJ
ajlsi-1012	210	22	amplification	amplification	NOUN
ajlsi-1012	210	23	reactions	reaction	NOUN
ajlsi-1012	210	24	but	but	CCONJ
ajlsi-1012	210	25	offers	offer	VERB
ajlsi-1012	210	26	greater	great	ADJ
ajlsi-1012	210	27	flexibility	flexibility	NOUN
ajlsi-1012	210	28	and	and	CCONJ
ajlsi-1012	210	29	higher	high	ADJ
ajlsi-1012	210	30	sensitivity	sensitivity	NOUN
ajlsi-1012	210	31	than	than	ADP
ajlsi-1012	210	32	the	the	DET
ajlsi-1012	210	33	one	one	NUM
ajlsi-1012	210	34	-	-	PUNCT
ajlsi-1012	210	35	step	step	NOUN
ajlsi-1012	210	36	procedure	procedure	NOUN
ajlsi-1012	210	37	.	.	PUNCT
ajlsi-1012	211	1	(	(	PUNCT
ajlsi-1012	211	2	vanguilder	vanguilder	NOUN
ajlsi-1012	211	3	,	,	PUNCT
ajlsi-1012	211	4	h.	h.	PROPN
ajlsi-1012	211	5	d.	d.	PROPN
ajlsi-1012	211	6	,	,	PUNCT
ajlsi-1012	211	7	et	et	PROPN
ajlsi-1012	211	8	al	al	PROPN
ajlsi-1012	211	9	.	.	PROPN
ajlsi-1012	211	10	,	,	PUNCT
ajlsi-1012	211	11	2008	2008	NUM
ajlsi-1012	211	12	;	;	PUNCT
ajlsi-1012	211	13	wong	wong	PROPN
ajlsi-1012	211	14	et	et	PROPN
ajlsi-1012	211	15	al	al	PROPN
ajlsi-1012	211	16	.	.	PROPN
ajlsi-1012	211	17	,	,	PUNCT
ajlsi-1012	211	18	2005	2005	NUM
ajlsi-1012	211	19	)	)	PUNCT
ajlsi-1012	211	20	.	.	PUNCT
ajlsi-1012	212	1	positive	positive	ADJ
ajlsi-1012	212	2	test	test	NOUN
ajlsi-1012	212	3	results	result	NOUN
ajlsi-1012	212	4	from	from	ADP
ajlsi-1012	212	5	a	a	DET
ajlsi-1012	212	6	single	single	ADJ
ajlsi-1012	212	7	sample	sample	NOUN
ajlsi-1012	212	8	must	must	AUX
ajlsi-1012	212	9	be	be	AUX
ajlsi-1012	212	10	confirmed	confirm	VERB
ajlsi-1012	212	11	by	by	ADP
ajlsi-1012	212	12	a	a	DET
ajlsi-1012	212	13	repeat	repeat	NOUN
ajlsi-1012	212	14	test	test	NOUN
ajlsi-1012	212	15	detecting	detect	VERB
ajlsi-1012	212	16	a	a	DET
ajlsi-1012	212	17	different	different	ADJ
ajlsi-1012	212	18	region	region	NOUN
ajlsi-1012	212	19	of	of	ADP
ajlsi-1012	212	20	the	the	DET
ajlsi-1012	212	21	sars	sar	NOUN
ajlsi-1012	212	22	-	-	PUNCT
ajlsi-1012	212	23	cov-2	cov-2	NOUN
ajlsi-1012	212	24	genome	genome	NOUN
ajlsi-1012	212	25	on	on	ADP
ajlsi-1012	212	26	the	the	DET
ajlsi-1012	212	27	same	same	ADJ
ajlsi-1012	212	28	sample	sample	NOUN
ajlsi-1012	212	29	.	.	PUNCT
ajlsi-1012	213	1	if	if	SCONJ
ajlsi-1012	213	2	possible	possible	ADJ
ajlsi-1012	213	3	,	,	PUNCT
ajlsi-1012	213	4	another	another	DET
ajlsi-1012	213	5	repeat	repeat	NOUN
ajlsi-1012	213	6	sample	sample	NOUN
ajlsi-1012	213	7	should	should	AUX
ajlsi-1012	213	8	also	also	ADV
ajlsi-1012	213	9	be	be	AUX
ajlsi-1012	213	10	tested	test	VERB
ajlsi-1012	213	11	to	to	PART
ajlsi-1012	213	12	exclude	exclude	VERB
ajlsi-1012	213	13	false	false	ADJ
ajlsi-1012	213	14	positive	positive	ADJ
ajlsi-1012	213	15	results	result	NOUN
ajlsi-1012	213	16	due	due	ADP
ajlsi-1012	213	17	to	to	ADP
ajlsi-1012	213	18	amplicon	amplicon	NOUN
ajlsi-1012	213	19	carryover	carryover	NOUN
ajlsi-1012	213	20	.	.	PUNCT
ajlsi-1012	214	1	since	since	SCONJ
ajlsi-1012	214	2	the	the	DET
ajlsi-1012	214	3	viral	viral	ADJ
ajlsi-1012	214	4	load	load	NOUN
ajlsi-1012	214	5	in	in	ADP
ajlsi-1012	214	6	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	214	7	aspirate	aspirate	NOUN
ajlsi-1012	214	8	usually	usually	ADV
ajlsi-1012	214	9	peaks	peak	VERB
ajlsi-1012	214	10	on	on	ADP
ajlsi-1012	214	11	the	the	DET
ajlsi-1012	214	12	10th	10th	ADJ
ajlsi-1012	214	13	day	day	NOUN
ajlsi-1012	214	14	after	after	ADP
ajlsi-1012	214	15	the	the	DET
ajlsi-1012	214	16	onset	onset	NOUN
ajlsi-1012	214	17	of	of	ADP
ajlsi-1012	214	18	symptoms	symptom	NOUN
ajlsi-1012	214	19	,	,	PUNCT
ajlsi-1012	214	20	suspected	suspect	VERB
ajlsi-1012	214	21	sars	sar	NOUN
ajlsi-1012	214	22	cases	case	NOUN
ajlsi-1012	214	23	must	must	AUX
ajlsi-1012	214	24	have	have	VERB
ajlsi-1012	214	25	the	the	DET
ajlsi-1012	214	26	tests	test	NOUN
ajlsi-1012	214	27	repeated	repeat	VERB
ajlsi-1012	214	28	as	as	SCONJ
ajlsi-1012	214	29	the	the	DET
ajlsi-1012	214	30	disease	disease	NOUN
ajlsi-1012	214	31	evolves	evolve	VERB
ajlsi-1012	214	32	to	to	PART
ajlsi-1012	214	33	avoid	avoid	VERB
ajlsi-1012	214	34	false	false	ADJ
ajlsi-1012	214	35	-	-	PUNCT
ajlsi-1012	214	36	negative	negative	ADJ
ajlsi-1012	214	37	results	result	NOUN
ajlsi-1012	214	38	.	.	PUNCT
ajlsi-1012	215	1	stool	stool	NOUN
ajlsi-1012	215	2	specimens	specimen	NOUN
ajlsi-1012	215	3	should	should	AUX
ajlsi-1012	215	4	be	be	AUX
ajlsi-1012	215	5	sent	send	VERB
ajlsi-1012	215	6	for	for	ADP
ajlsi-1012	215	7	testing	testing	NOUN
ajlsi-1012	215	8	on	on	ADP
ajlsi-1012	215	9	a	a	DET
ajlsi-1012	215	10	regular	regular	ADJ
ajlsi-1012	215	11	basis	basis	NOUN
ajlsi-1012	215	12	,	,	PUNCT
ajlsi-1012	215	13	as	as	SCONJ
ajlsi-1012	215	14	a	a	DET
ajlsi-1012	215	15	high	high	ADJ
ajlsi-1012	215	16	percentage	percentage	NOUN
ajlsi-1012	215	17	of	of	ADP
ajlsi-1012	215	18	patients	patient	NOUN
ajlsi-1012	215	19	develop	develop	VERB
ajlsi-1012	215	20	diarrhoea	diarrhoea	NOUN
ajlsi-1012	215	21	and	and	CCONJ
ajlsi-1012	215	22	shed	shed	VERB
ajlsi-1012	215	23	virus	virus	NOUN
ajlsi-1012	215	24	during	during	ADP
ajlsi-1012	215	25	the	the	DET
ajlsi-1012	215	26	second	second	ADJ
ajlsi-1012	215	27	week	week	NOUN
ajlsi-1012	215	28	of	of	ADP
ajlsi-1012	215	29	illness	illness	NOUN
ajlsi-1012	215	30	.	.	PUNCT
ajlsi-1012	216	1	viral	viral	ADJ
ajlsi-1012	216	2	load	load	NOUN
ajlsi-1012	216	3	determination	determination	NOUN
ajlsi-1012	216	4	of	of	ADP
ajlsi-1012	216	5	nasopharyngeal	nasopharyngeal	ADJ
ajlsi-1012	216	6	specimens	specimen	NOUN
ajlsi-1012	216	7	or	or	CCONJ
ajlsi-1012	216	8	serum	serum	NOUN
ajlsi-1012	216	9	upon	upon	SCONJ
ajlsi-1012	216	10	presentation	presentation	NOUN
ajlsi-1012	216	11	might	might	AUX
ajlsi-1012	216	12	have	have	VERB
ajlsi-1012	216	13	clinical	clinical	ADJ
ajlsi-1012	216	14	value	value	NOUN
ajlsi-1012	216	15	as	as	SCONJ
ajlsi-1012	216	16	it	it	PRON
ajlsi-1012	216	17	is	be	AUX
ajlsi-1012	216	18	an	an	DET
ajlsi-1012	216	19	important	important	ADJ
ajlsi-1012	216	20	prognostic	prognostic	ADJ
ajlsi-1012	216	21	factor	factor	NOUN
ajlsi-1012	216	22	.	.	PUNCT
ajlsi-1012	217	1	any	any	DET
ajlsi-1012	217	2	treatment	treatment	NOUN
ajlsi-1012	217	3	regimen	regiman	NOUN
ajlsi-1012	217	4	would	would	AUX
ajlsi-1012	217	5	benefit	benefit	VERB
ajlsi-1012	217	6	from	from	ADP
ajlsi-1012	217	7	long	long	ADJ
ajlsi-1012	217	8	-	-	PUNCT
ajlsi-1012	217	9	term	term	NOUN
ajlsi-1012	217	10	monitoring	monitoring	NOUN
ajlsi-1012	217	11	of	of	ADP
ajlsi-1012	217	12	viral	viral	ADJ
ajlsi-1012	217	13	load	load	NOUN
ajlsi-1012	217	14	.	.	PUNCT
ajlsi-1012	218	1	(	(	PUNCT
ajlsi-1012	218	2	cheng	cheng	PROPN
ajlsi-1012	218	3	et	et	PROPN
ajlsi-1012	218	4	al	al	PROPN
ajlsi-1012	218	5	.	.	PROPN
ajlsi-1012	218	6	,	,	PUNCT
ajlsi-1012	218	7	2004	2004	NUM
ajlsi-1012	218	8	;	;	PUNCT
ajlsi-1012	218	9	peiris	peiris	NOUN
ajlsi-1012	218	10	et	et	PROPN
ajlsi-1012	218	11	al	al	PROPN
ajlsi-1012	218	12	.	.	PROPN
ajlsi-1012	218	13	,	,	PUNCT
ajlsi-1012	218	14	2003	2003	NUM
ajlsi-1012	218	15	;	;	PUNCT
ajlsi-1012	218	16	chan	chan	PROPN
ajlsi-1012	218	17	k.	k.	PROPN
ajlsi-1012	218	18	et	et	PROPN
ajlsi-1012	219	1	al	al	PROPN
ajlsi-1012	219	2	.	.	PROPN
ajlsi-1012	219	3	,	,	PUNCT
ajlsi-1012	219	4	2004	2004	NUM
ajlsi-1012	219	5	;	;	PUNCT
ajlsi-1012	219	6	chu	chu	PROPN
ajlsi-1012	219	7	et	et	PROPN
ajlsi-1012	219	8	al	al	PROPN
ajlsi-1012	219	9	.	.	PROPN
ajlsi-1012	219	10	,	,	PUNCT
ajlsi-1012	219	11	2020	2020	NUM
ajlsi-1012	219	12	;	;	PUNCT
ajlsi-1012	219	13	etc	etc	X
ajlsi-1012	219	14	.	.	X
ajlsi-1012	219	15	)	)	PUNCT
ajlsi-1012	219	16	.	.	PUNCT
ajlsi-1012	220	1	apart	apart	ADV
ajlsi-1012	220	2	from	from	ADP
ajlsi-1012	220	3	sensitivity	sensitivity	NOUN
ajlsi-1012	220	4	issues	issue	NOUN
ajlsi-1012	220	5	,	,	PUNCT
ajlsi-1012	220	6	rt	rt	PROPN
ajlsi-1012	220	7	-	-	PUNCT
ajlsi-1012	220	8	pcr	pcr	PROPN
ajlsi-1012	220	9	has	have	VERB
ajlsi-1012	220	10	some	some	DET
ajlsi-1012	220	11	other	other	ADJ
ajlsi-1012	220	12	drawbacks	drawback	NOUN
ajlsi-1012	220	13	,	,	PUNCT
ajlsi-1012	220	14	such	such	ADJ
ajlsi-1012	220	15	as	as	ADP
ajlsi-1012	220	16	possible	possible	ADJ
ajlsi-1012	220	17	biological	biological	ADJ
ajlsi-1012	220	18	safety	safety	NOUN
ajlsi-1012	220	19	hazards	hazard	NOUN
ajlsi-1012	220	20	that	that	PRON
ajlsi-1012	220	21	may	may	AUX
ajlsi-1012	220	22	occur	occur	VERB
ajlsi-1012	220	23	during	during	ADP
ajlsi-1012	220	24	transport	transport	NOUN
ajlsi-1012	220	25	and	and	CCONJ
ajlsi-1012	220	26	sample	sample	NOUN
ajlsi-1012	220	27	processing	processing	NOUN
ajlsi-1012	220	28	,	,	PUNCT
ajlsi-1012	220	29	nucleic	nucleic	ADJ
ajlsi-1012	220	30	acid	acid	NOUN
ajlsi-1012	220	31	extraction	extraction	NOUN
ajlsi-1012	220	32	,	,	PUNCT
ajlsi-1012	220	33	and	and	CCONJ
ajlsi-1012	220	34	the	the	DET
ajlsi-1012	220	35	requirement	requirement	NOUN
ajlsi-1012	220	36	of	of	ADP
ajlsi-1012	220	37	sophisticated	sophisticated	ADJ
ajlsi-1012	220	38	laboratory	laboratory	NOUN
ajlsi-1012	220	39	equipment	equipment	NOUN
ajlsi-1012	220	40	like	like	ADP
ajlsi-1012	220	41	biosafety	biosafety	NOUN
ajlsi-1012	220	42	cabinets	cabinet	NOUN
ajlsi-1012	220	43	.	.	PUNCT
ajlsi-1012	221	1	technical	technical	ADJ
ajlsi-1012	221	2	expertise	expertise	NOUN
ajlsi-1012	221	3	,	,	PUNCT
ajlsi-1012	221	4	along	along	ADP
ajlsi-1012	221	5	with	with	ADP
ajlsi-1012	221	6	sample	sample	NOUN
ajlsi-1012	221	7	transportation	transportation	NOUN
ajlsi-1012	221	8	,	,	PUNCT
ajlsi-1012	221	9	which	which	PRON
ajlsi-1012	221	10	is	be	AUX
ajlsi-1012	221	11	inevitable	inevitable	ADJ
ajlsi-1012	221	12	,	,	PUNCT
ajlsi-1012	221	13	makes	make	VERB
ajlsi-1012	221	14	the	the	DET
ajlsi-1012	221	15	overall	overall	ADJ
ajlsi-1012	221	16	process	process	NOUN
ajlsi-1012	221	17	time	time	NOUN
ajlsi-1012	221	18	-	-	PUNCT
ajlsi-1012	221	19	consuming	consume	VERB
ajlsi-1012	221	20	.	.	PUNCT
ajlsi-1012	222	1	all	all	DET
ajlsi-1012	222	2	these	these	DET
ajlsi-1012	222	3	drawbacks	drawback	NOUN
ajlsi-1012	222	4	could	could	AUX
ajlsi-1012	222	5	make	make	VERB
ajlsi-1012	222	6	the	the	DET
ajlsi-1012	222	7	process	process	NOUN
ajlsi-1012	222	8	less	less	ADV
ajlsi-1012	222	9	useful	useful	ADJ
ajlsi-1012	222	10	in	in	ADP
ajlsi-1012	222	11	case	case	NOUN
ajlsi-1012	222	12	of	of	ADP
ajlsi-1012	222	13	a	a	DET
ajlsi-1012	222	14	health	health	NOUN
ajlsi-1012	222	15	emergency	emergency	NOUN
ajlsi-1012	222	16	or	or	CCONJ
ajlsi-1012	222	17	global	global	ADJ
ajlsi-1012	222	18	outbreak	outbreak	PROPN
ajlsi-1012	222	19	situation	situation	NOUN
ajlsi-1012	222	20	.	.	PUNCT
ajlsi-1012	223	1	moreover	moreover	ADV
ajlsi-1012	223	2	,	,	PUNCT
ajlsi-1012	223	3	in	in	ADP
ajlsi-1012	223	4	pcr	pcr	PROPN
ajlsi-1012	223	5	,	,	PUNCT
ajlsi-1012	223	6	we	we	PRON
ajlsi-1012	223	7	are	be	AUX
ajlsi-1012	223	8	able	able	ADJ
ajlsi-1012	223	9	to	to	PART
ajlsi-1012	223	10	detect	detect	VERB
ajlsi-1012	223	11	not	not	PART
ajlsi-1012	223	12	only	only	ADV
ajlsi-1012	223	13	the	the	DET
ajlsi-1012	223	14	target	target	NOUN
ajlsi-1012	223	15	virus	virus	NOUN
ajlsi-1012	223	16	,	,	PUNCT
ajlsi-1012	223	17	but	but	CCONJ
ajlsi-1012	223	18	it	it	PRON
ajlsi-1012	223	19	can	can	AUX
ajlsi-1012	223	20	also	also	ADV
ajlsi-1012	223	21	perform	perform	VERB
ajlsi-1012	223	22	codetection	codetection	NOUN
ajlsi-1012	223	23	of	of	ADP
ajlsi-1012	223	24	several	several	ADJ
ajlsi-1012	223	25	other	other	ADJ
ajlsi-1012	223	26	respiratory	respiratory	ADJ
ajlsi-1012	223	27	viruses	virus	NOUN
ajlsi-1012	223	28	,	,	PUNCT
ajlsi-1012	223	29	which	which	PRON
ajlsi-1012	223	30	leads	lead	VERB
ajlsi-1012	223	31	to	to	ADP
ajlsi-1012	223	32	an	an	DET
ajlsi-1012	223	33	increase	increase	NOUN
ajlsi-1012	223	34	in	in	ADP
ajlsi-1012	223	35	false	false	ADJ
ajlsi-1012	223	36	positive	positive	ADJ
ajlsi-1012	223	37	or	or	CCONJ
ajlsi-1012	223	38	negative	negative	ADJ
ajlsi-1012	223	39	results	result	NOUN
ajlsi-1012	223	40	(	(	PUNCT
ajlsi-1012	223	41	cho	cho	NOUN
ajlsi-1012	223	42	et	et	PROPN
ajlsi-1012	223	43	al	al	PROPN
ajlsi-1012	223	44	.	.	PROPN
ajlsi-1012	223	45	,	,	PUNCT
ajlsi-1012	223	46	2014	2014	NUM
ajlsi-1012	223	47	)	)	PUNCT
ajlsi-1012	223	48	.	.	PUNCT
ajlsi-1012	224	1	isothermal	isothermal	ADJ
ajlsi-1012	224	2	nucleic	nucleic	ADJ
ajlsi-1012	224	3	acid	acid	NOUN
ajlsi-1012	224	4	amplification	amplification	NOUN
ajlsi-1012	224	5	isothermal	isothermal	ADJ
ajlsi-1012	224	6	nucleic	nucleic	ADJ
ajlsi-1012	224	7	acid	acid	NOUN
ajlsi-1012	224	8	amplification	amplification	NOUN
ajlsi-1012	224	9	is	be	AUX
ajlsi-1012	224	10	an	an	DET
ajlsi-1012	224	11	alternative	alternative	ADJ
ajlsi-1012	224	12	strategy	strategy	NOUN
ajlsi-1012	224	13	that	that	PRON
ajlsi-1012	224	14	allows	allow	VERB
ajlsi-1012	224	15	amplification	amplification	NOUN
ajlsi-1012	224	16	at	at	ADP
ajlsi-1012	224	17	a	a	DET
ajlsi-1012	224	18	constant	constant	ADJ
ajlsi-1012	224	19	temperature	temperature	NOUN
ajlsi-1012	224	20	and	and	CCONJ
ajlsi-1012	224	21	eliminates	eliminate	VERB
ajlsi-1012	224	22	the	the	DET
ajlsi-1012	224	23	need	need	NOUN
ajlsi-1012	224	24	for	for	ADP
ajlsi-1012	224	25	a	a	DET
ajlsi-1012	224	26	thermal	thermal	ADJ
ajlsi-1012	224	27	cycler	cycler	NOUN
ajlsi-1012	224	28	.	.	PUNCT
ajlsi-1012	225	1	therefore	therefore	ADV
ajlsi-1012	225	2	,	,	PUNCT
ajlsi-1012	225	3	several	several	ADJ
ajlsi-1012	225	4	methods	method	NOUN
ajlsi-1012	225	5	based	base	VERB
ajlsi-1012	225	6	on	on	ADP
ajlsi-1012	225	7	this	this	DET
ajlsi-1012	225	8	principle	principle	NOUN
ajlsi-1012	225	9	have	have	AUX
ajlsi-1012	225	10	been	be	AUX
ajlsi-1012	225	11	developed	develop	VERB
ajlsi-1012	225	12	.	.	PUNCT
ajlsi-1012	226	1	isothermal	isothermal	ADJ
ajlsi-1012	226	2	amplification	amplification	NOUN
ajlsi-1012	226	3	techniques	technique	NOUN
ajlsi-1012	226	4	are	be	AUX
ajlsi-1012	226	5	conducted	conduct	VERB
ajlsi-1012	226	6	at	at	ADP
ajlsi-1012	226	7	a	a	DET
ajlsi-1012	226	8	single	single	ADJ
ajlsi-1012	226	9	temperature	temperature	NOUN
ajlsi-1012	226	10	and	and	CCONJ
ajlsi-1012	226	11	do	do	AUX
ajlsi-1012	226	12	not	not	PART
ajlsi-1012	226	13	need	need	VERB
ajlsi-1012	226	14	specialized	specialized	ADJ
ajlsi-1012	226	15	laboratory	laboratory	NOUN
ajlsi-1012	226	16	equipment	equipment	NOUN
ajlsi-1012	226	17	to	to	PART
ajlsi-1012	226	18	provide	provide	VERB
ajlsi-1012	226	19	similar	similar	ADJ
ajlsi-1012	226	20	analytical	analytical	ADJ
ajlsi-1012	226	21	sensitivities	sensitivity	NOUN
ajlsi-1012	226	22	to	to	ADP
ajlsi-1012	226	23	pcr	pcr	PROPN
ajlsi-1012	226	24	.	.	PUNCT
ajlsi-1012	227	1	isothermal	isothermal	ADJ
ajlsi-1012	227	2	amplification	amplification	NOUN
ajlsi-1012	227	3	techniques	technique	NOUN
ajlsi-1012	227	4	can	can	AUX
ajlsi-1012	227	5	be	be	AUX
ajlsi-1012	227	6	multiplexed	multiplexe	VERB
ajlsi-1012	227	7	during	during	ADP
ajlsi-1012	227	8	the	the	DET
ajlsi-1012	227	9	amplification	amplification	NOUN
ajlsi-1012	227	10	or	or	CCONJ
ajlsi-1012	227	11	readout	readout	VERB
ajlsi-1012	227	12	stage	stage	NOUN
ajlsi-1012	227	13	.	.	PUNCT
ajlsi-1012	228	1	this	this	PRON
ajlsi-1012	228	2	is	be	AUX
ajlsi-1012	228	3	done	do	VERB
ajlsi-1012	228	4	by	by	ADP
ajlsi-1012	228	5	using	use	VERB
ajlsi-1012	228	6	polymeric	polymeric	ADJ
ajlsi-1012	228	7	beads	bead	NOUN
ajlsi-1012	228	8	encoded	encode	VERB
ajlsi-1012	228	9	with	with	ADP
ajlsi-1012	228	10	unique	unique	ADJ
ajlsi-1012	228	11	optical	optical	ADJ
ajlsi-1012	228	12	signatures	signature	NOUN
ajlsi-1012	228	13	like	like	ADP
ajlsi-1012	228	14	organic	organic	ADJ
ajlsi-1012	228	15	fluorescent	fluorescent	ADJ
ajlsi-1012	228	16	molecules	molecule	NOUN
ajlsi-1012	228	17	for	for	ADP
ajlsi-1012	228	18	each	each	DET
ajlsi-1012	228	19	gene	gene	NOUN
ajlsi-1012	228	20	.	.	PUNCT
ajlsi-1012	229	1	multiplexing	multiplexing	NOUN
ajlsi-1012	229	2	increases	increase	VERB
ajlsi-1012	229	3	the	the	DET
ajlsi-1012	229	4	amount	amount	NOUN
ajlsi-1012	229	5	of	of	ADP
ajlsi-1012	229	6	information	information	NOUN
ajlsi-1012	229	7	gained	gain	VERB
ajlsi-1012	229	8	from	from	ADP
ajlsi-1012	229	9	a	a	DET
ajlsi-1012	229	10	single	single	ADJ
ajlsi-1012	229	11	test	test	NOUN
ajlsi-1012	229	12	and	and	CCONJ
ajlsi-1012	229	13	improves	improve	VERB
ajlsi-1012	229	14	clinical	clinical	ADJ
ajlsi-1012	229	15	sensitivity	sensitivity	NOUN
ajlsi-1012	229	16	and	and	CCONJ
ajlsi-1012	229	17	specificity	specificity	NOUN
ajlsi-1012	229	18	.	.	PUNCT
ajlsi-1012	230	1	loopmediated	loopmediate	VERB
ajlsi-1012	230	2	isothermal	isothermal	ADJ
ajlsi-1012	230	3	amplification	amplification	NOUN
ajlsi-1012	230	4	(	(	PUNCT
ajlsi-1012	230	5	lamp	lamp	NOUN
ajlsi-1012	230	6	)	)	PUNCT
ajlsi-1012	230	7	is	be	AUX
ajlsi-1012	230	8	a	a	DET
ajlsi-1012	230	9	relatively	relatively	ADV
ajlsi-1012	230	10	new	new	ADJ
ajlsi-1012	230	11	molecular	molecular	ADJ
ajlsi-1012	230	12	amplification	amplification	NOUN
ajlsi-1012	230	13	point	point	NOUN
ajlsi-1012	230	14	-	-	PUNCT
ajlsi-1012	230	15	of	of	ADP
ajlsi-1012	230	16	-	-	PUNCT
ajlsi-1012	230	17	care	care	NOUN
ajlsi-1012	230	18	technique	technique	NOUN
ajlsi-1012	230	19	that	that	PRON
ajlsi-1012	230	20	is	be	AUX
ajlsi-1012	230	21	widely	widely	ADV
ajlsi-1012	230	22	used	use	VERB
ajlsi-1012	230	23	for	for	ADP
ajlsi-1012	230	24	covid-19	covid-19	PROPN
ajlsi-1012	230	25	diagnosis	diagnosis	NOUN
ajlsi-1012	230	26	.	.	PUNCT
ajlsi-1012	231	1	the	the	DET
ajlsi-1012	231	2	technique	technique	NOUN
ajlsi-1012	231	3	is	be	AUX
ajlsi-1012	231	4	based	base	VERB
ajlsi-1012	231	5	on	on	ADP
ajlsi-1012	231	6	the	the	DET
ajlsi-1012	231	7	synthesis	synthesis	NOUN
ajlsi-1012	231	8	of	of	ADP
ajlsi-1012	231	9	target	target	NOUN
ajlsi-1012	231	10	dna	dna	NOUN
ajlsi-1012	231	11	at	at	ADP
ajlsi-1012	231	12	a	a	DET
ajlsi-1012	231	13	constant	constant	ADJ
ajlsi-1012	231	14	temperature	temperature	NOUN
ajlsi-1012	231	15	of	of	ADP
ajlsi-1012	231	16	60–650c	60–650c	NUM
ajlsi-1012	231	17	using	use	VERB
ajlsi-1012	231	18	a	a	DET
ajlsi-1012	231	19	specially	specially	ADV
ajlsi-1012	231	20	designed	design	VERB
ajlsi-1012	231	21	primer	primer	NOUN
ajlsi-1012	231	22	and	and	CCONJ
ajlsi-1012	231	23	dna	dna	PROPN
ajlsi-1012	231	24	polymerase	polymerase	NOUN
ajlsi-1012	231	25	that	that	PRON
ajlsi-1012	231	26	has	have	AUX
ajlsi-1012	231	27	strand	strand	VERB
ajlsi-1012	231	28	displacement	displacement	ADJ
ajlsi-1012	231	29	activity	activity	NOUN
ajlsi-1012	231	30	instead	instead	ADV
ajlsi-1012	231	31	of	of	ADP
ajlsi-1012	231	32	heat	heat	NOUN
ajlsi-1012	231	33	denaturation	denaturation	NOUN
ajlsi-1012	231	34	as	as	ADP
ajlsi-1012	231	35	in	in	ADP
ajlsi-1012	231	36	other	other	ADJ
ajlsi-1012	231	37	pcr	pcr	ADJ
ajlsi-1012	231	38	techniques	technique	NOUN
ajlsi-1012	231	39	.	.	PUNCT
ajlsi-1012	232	1	this	this	DET
ajlsi-1012	232	2	novel	novel	ADJ
ajlsi-1012	232	3	technique	technique	NOUN
ajlsi-1012	232	4	can	can	AUX
ajlsi-1012	232	5	amplify	amplify	VERB
ajlsi-1012	232	6	any	any	DET
ajlsi-1012	232	7	genomic	genomic	ADJ
ajlsi-1012	232	8	material	material	NOUN
ajlsi-1012	232	9	with	with	ADP
ajlsi-1012	232	10	high	high	ADJ
ajlsi-1012	232	11	efficiency	efficiency	NOUN
ajlsi-1012	232	12	and	and	CCONJ
ajlsi-1012	232	13	in	in	ADP
ajlsi-1012	232	14	a	a	DET
ajlsi-1012	232	15	shorter	short	ADJ
ajlsi-1012	232	16	amount	amount	NOUN
ajlsi-1012	232	17	of	of	ADP
ajlsi-1012	232	18	time	time	NOUN
ajlsi-1012	232	19	.	.	PUNCT
ajlsi-1012	233	1	rtlamp	rtlamp	NOUN
ajlsi-1012	233	2	has	have	AUX
ajlsi-1012	233	3	been	be	AUX
ajlsi-1012	233	4	developed	develop	VERB
ajlsi-1012	233	5	as	as	ADP
ajlsi-1012	233	6	a	a	DET
ajlsi-1012	233	7	rapid	rapid	ADJ
ajlsi-1012	233	8	and	and	CCONJ
ajlsi-1012	233	9	cost	cost	NOUN
ajlsi-1012	233	10	-	-	PUNCT
ajlsi-1012	233	11	effective	effective	ADJ
ajlsi-1012	233	12	testing	testing	NOUN
ajlsi-1012	233	13	alternative	alternative	NOUN
ajlsi-1012	233	14	for	for	ADP
ajlsi-1012	233	15	sars	sar	NOUN
ajlsi-1012	233	16	-	-	PUNCT
ajlsi-1012	233	17	cov-2	cov-2	NOUN
ajlsi-1012	233	18	.	.	PUNCT
ajlsi-1012	234	1	it	it	PRON
ajlsi-1012	234	2	requires	require	VERB
ajlsi-1012	234	3	a	a	DET
ajlsi-1012	234	4	set	set	NOUN
ajlsi-1012	234	5	of	of	ADP
ajlsi-1012	234	6	four	four	NUM
ajlsi-1012	234	7	primers	primer	NOUN
ajlsi-1012	234	8	specific	specific	ADJ
ajlsi-1012	234	9	for	for	ADP
ajlsi-1012	234	10	the	the	DET
ajlsi-1012	234	11	target	target	NOUN
ajlsi-1012	234	12	gene	gene	NOUN
ajlsi-1012	234	13	or	or	CCONJ
ajlsi-1012	234	14	region	region	NOUN
ajlsi-1012	234	15	to	to	PART
ajlsi-1012	234	16	enhance	enhance	VERB
ajlsi-1012	234	17	the	the	DET
ajlsi-1012	234	18	sensitivity	sensitivity	NOUN
ajlsi-1012	234	19	and	and	CCONJ
ajlsi-1012	234	20	combines	combine	VERB
ajlsi-1012	234	21	lamp	lamp	NOUN
ajlsi-1012	234	22	with	with	ADP
ajlsi-1012	234	23	a	a	DET
ajlsi-1012	234	24	reverse	reverse	ADJ
ajlsi-1012	234	25	transcription	transcription	NOUN
ajlsi-1012	234	26	step	step	NOUN
ajlsi-1012	234	27	to	to	PART
ajlsi-1012	234	28	allow	allow	VERB
ajlsi-1012	234	29	for	for	ADP
ajlsi-1012	234	30	the	the	DET
ajlsi-1012	234	31	detection	detection	NOUN
ajlsi-1012	234	32	of	of	ADP
ajlsi-1012	234	33	rna	rna	PROPN
ajlsi-1012	234	34	.	.	PUNCT
ajlsi-1012	235	1	photometry	photometry	NOUN
ajlsi-1012	235	2	can	can	AUX
ajlsi-1012	235	3	be	be	AUX
ajlsi-1012	235	4	used	use	VERB
ajlsi-1012	235	5	to	to	PART
ajlsi-1012	235	6	detect	detect	VERB
ajlsi-1012	235	7	the	the	DET
ajlsi-1012	235	8	amplification	amplification	NOUN
ajlsi-1012	235	9	product	product	NOUN
ajlsi-1012	235	10	by	by	ADP
ajlsi-1012	235	11	measuring	measure	VERB
ajlsi-1012	235	12	the	the	DET
ajlsi-1012	235	13	turbidity	turbidity	NOUN
ajlsi-1012	235	14	caused	cause	VERB
ajlsi-1012	235	15	by	by	ADP
ajlsi-1012	235	16	magnesium	magnesium	NOUN
ajlsi-1012	235	17	pyrophosphate	pyrophosphate	NOUN
ajlsi-1012	235	18	precipitate	precipitate	NOUN
ajlsi-1012	235	19	in	in	ADP
ajlsi-1012	235	20	the	the	DET
ajlsi-1012	235	21	solution	solution	NOUN
ajlsi-1012	235	22	as	as	ADP
ajlsi-1012	235	23	a	a	DET
ajlsi-1012	235	24	byproduct	byproduct	NOUN
ajlsi-1012	235	25	of	of	ADP
ajlsi-1012	235	26	amplification	amplification	NOUN
ajlsi-1012	235	27	.	.	PUNCT
ajlsi-1012	236	1	the	the	DET
ajlsi-1012	236	2	reaction	reaction	NOUN
ajlsi-1012	236	3	can	can	AUX
ajlsi-1012	236	4	be	be	AUX
ajlsi-1012	236	5	followed	follow	VERB
ajlsi-1012	236	6	in	in	ADP
ajlsi-1012	236	7	real	real	ADJ
ajlsi-1012	236	8	time	time	NOUN
ajlsi-1012	236	9	either	either	CCONJ
ajlsi-1012	236	10	by	by	ADP
ajlsi-1012	236	11	measuring	measure	VERB
ajlsi-1012	236	12	the	the	DET
ajlsi-1012	236	13	turbidity	turbidity	NOUN
ajlsi-1012	236	14	or	or	CCONJ
ajlsi-1012	236	15	by	by	ADP
ajlsi-1012	236	16	fluorescence	fluorescence	NOUN
ajlsi-1012	236	17	using	use	VERB
ajlsi-1012	236	18	intercalating	intercalate	VERB
ajlsi-1012	236	19	dyes	dye	NOUN
ajlsi-1012	236	20	.	.	PUNCT
ajlsi-1012	237	1	since	since	SCONJ
ajlsi-1012	237	2	real	real	ADJ
ajlsi-1012	237	3	-	-	PUNCT
ajlsi-1012	237	4	time	time	NOUN
ajlsi-1012	237	5	rt	rt	NOUN
ajlsi-1012	237	6	-	-	PUNCT
ajlsi-1012	237	7	lamp	lamp	NOUN
ajlsi-1012	237	8	diagnostic	diagnostic	ADJ
ajlsi-1012	237	9	testing	testing	NOUN
ajlsi-1012	237	10	requires	require	VERB
ajlsi-1012	237	11	only	only	ADV
ajlsi-1012	237	12	heating	heating	NOUN
ajlsi-1012	237	13	and	and	CCONJ
ajlsi-1012	237	14	visual	visual	ADJ
ajlsi-1012	237	15	inspection	inspection	NOUN
ajlsi-1012	237	16	,	,	PUNCT
ajlsi-1012	237	17	its	its	PRON
ajlsi-1012	237	18	simplicity	simplicity	NOUN
ajlsi-1012	237	19	and	and	CCONJ
ajlsi-1012	237	20	sensitivity	sensitivity	NOUN
ajlsi-1012	237	21	make	make	VERB
ajlsi-1012	237	22	it	it	PRON
ajlsi-1012	237	23	a	a	DET
ajlsi-1012	237	24	promising	promising	ADJ
ajlsi-1012	237	25	candidate	candidate	NOUN
ajlsi-1012	237	26	for	for	ADP
ajlsi-1012	237	27	virus	virus	NOUN
ajlsi-1012	237	28	detection	detection	NOUN
ajlsi-1012	237	29	.	.	PUNCT
ajlsi-1012	238	1	the	the	DET
ajlsi-1012	238	2	rt	rt	PROPN
ajlsi-1012	238	3	-	-	PUNCT
ajlsi-1012	238	4	lamp	lamp	PROPN
ajlsi-1012	238	5	test	test	NOUN
ajlsi-1012	238	6	uses	use	VERB
ajlsi-1012	238	7	reverse	reverse	VERB
ajlsi-1012	238	8	transcriptase	transcriptase	NOUN
ajlsi-1012	238	9	to	to	PART
ajlsi-1012	238	10	convert	convert	VERB
ajlsi-1012	238	11	the	the	DET
ajlsi-1012	238	12	viral	viral	ADJ
ajlsi-1012	238	13	rna	rna	NOUN
ajlsi-1012	238	14	to	to	ADP
ajlsi-1012	238	15	cdna	cdna	PROPN
ajlsi-1012	238	16	,	,	PUNCT
ajlsi-1012	238	17	which	which	PRON
ajlsi-1012	238	18	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	238	19	pa	pa	PROPN
ajlsi-1012	238	20	ge	ge	PROPN
ajlsi-1012	238	21	35	35	NUM
ajlsi-1012	238	22	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	238	23	am	am	NOUN
ajlsi-1012	238	24	.	.	PUNCT
ajlsi-1012	239	1	j.	j.	PROPN
ajlsi-1012	239	2	life	life	PROPN
ajlsi-1012	239	3	sci	sci	PROPN
ajlsi-1012	239	4	.	.	PUNCT
ajlsi-1012	239	5	innov	innov	PROPN
ajlsi-1012	239	6	.	.	PUNCT
ajlsi-1012	240	1	1(2	1(2	NUM
ajlsi-1012	240	2	)	)	PUNCT
ajlsi-1012	240	3	29	29	NUM
ajlsi-1012	240	4	-	-	SYM
ajlsi-1012	240	5	42	42	NUM
ajlsi-1012	240	6	,	,	PUNCT
ajlsi-1012	240	7	2022	2022	NUM
ajlsi-1012	240	8	is	be	AUX
ajlsi-1012	240	9	subsequently	subsequently	ADV
ajlsi-1012	240	10	amplified	amplify	VERB
ajlsi-1012	240	11	by	by	ADP
ajlsi-1012	240	12	the	the	DET
ajlsi-1012	240	13	dna	dna	PROPN
ajlsi-1012	240	14	-	-	PUNCT
ajlsi-1012	240	15	dependent	dependent	ADJ
ajlsi-1012	240	16	dna	dna	NOUN
ajlsi-1012	240	17	polymerase	polymerase	NOUN
ajlsi-1012	240	18	for	for	ADP
ajlsi-1012	240	19	rapid	rapid	ADJ
ajlsi-1012	240	20	colorimetric	colorimetric	ADJ
ajlsi-1012	240	21	detection	detection	NOUN
ajlsi-1012	240	22	with	with	ADP
ajlsi-1012	240	23	a	a	DET
ajlsi-1012	240	24	dnabinding	dnabinding	NOUN
ajlsi-1012	240	25	dye	dye	NOUN
ajlsi-1012	240	26	.	.	PUNCT
ajlsi-1012	241	1	lamp	lamp	PROPN
ajlsi-1012	241	2	has	have	AUX
ajlsi-1012	241	3	been	be	AUX
ajlsi-1012	241	4	shown	show	VERB
ajlsi-1012	241	5	to	to	PART
ajlsi-1012	241	6	be	be	AUX
ajlsi-1012	241	7	effective	effective	ADJ
ajlsi-1012	241	8	at	at	ADP
ajlsi-1012	241	9	detecting	detect	VERB
ajlsi-1012	241	10	viral	viral	ADJ
ajlsi-1012	241	11	rna	rna	NOUN
ajlsi-1012	241	12	in	in	ADP
ajlsi-1012	241	13	cell	cell	NOUN
ajlsi-1012	241	14	lysates	lysate	NOUN
ajlsi-1012	241	15	at	at	ADP
ajlsi-1012	241	16	levels	level	NOUN
ajlsi-1012	241	17	of	of	ADP
ajlsi-1012	241	18	approximately	approximately	ADV
ajlsi-1012	241	19	480	480	NUM
ajlsi-1012	241	20	rna	rna	NOUN
ajlsi-1012	241	21	copies	copy	NOUN
ajlsi-1012	241	22	without	without	ADP
ajlsi-1012	241	23	interference	interference	NOUN
ajlsi-1012	241	24	,	,	PUNCT
ajlsi-1012	241	25	providing	provide	VERB
ajlsi-1012	241	26	an	an	DET
ajlsi-1012	241	27	alternative	alternative	NOUN
ajlsi-1012	241	28	to	to	ADP
ajlsi-1012	241	29	rt	rt	NOUN
ajlsi-1012	241	30	-	-	PUNCT
ajlsi-1012	241	31	pcr	pcr	PROPN
ajlsi-1012	241	32	for	for	ADP
ajlsi-1012	241	33	rapid	rapid	ADJ
ajlsi-1012	241	34	and	and	CCONJ
ajlsi-1012	241	35	simple	simple	ADJ
ajlsi-1012	241	36	detection	detection	NOUN
ajlsi-1012	241	37	of	of	ADP
ajlsi-1012	241	38	sars	sar	NOUN
ajlsi-1012	241	39	-	-	PUNCT
ajlsi-1012	241	40	cov-2	cov-2	NOUN
ajlsi-1012	241	41	rna	rna	NOUN
ajlsi-1012	241	42	.	.	PUNCT
ajlsi-1012	242	1	(	(	PUNCT
ajlsi-1012	242	2	notomi	notomi	NOUN
ajlsi-1012	242	3	et	et	PROPN
ajlsi-1012	242	4	al	al	PROPN
ajlsi-1012	242	5	.	.	PROPN
ajlsi-1012	242	6	,	,	PUNCT
ajlsi-1012	242	7	2000	2000	NUM
ajlsi-1012	242	8	;	;	PUNCT
ajlsi-1012	242	9	thai	thai	PROPN
ajlsi-1012	242	10	et	et	PROPN
ajlsi-1012	242	11	al	al	PROPN
ajlsi-1012	242	12	.	.	PROPN
ajlsi-1012	242	13	,	,	PUNCT
ajlsi-1012	242	14	2004	2004	NUM
ajlsi-1012	242	15	)	)	PUNCT
ajlsi-1012	242	16	.	.	PUNCT
ajlsi-1012	243	1	transcriptionmediated	transcriptionmediate	VERB
ajlsi-1012	243	2	amplification	amplification	NOUN
ajlsi-1012	243	3	(	(	PUNCT
ajlsi-1012	243	4	tma	tma	PROPN
ajlsi-1012	243	5	)	)	PUNCT
ajlsi-1012	243	6	is	be	AUX
ajlsi-1012	243	7	a	a	DET
ajlsi-1012	243	8	patented	patented	ADJ
ajlsi-1012	243	9	single	single	ADJ
ajlsi-1012	243	10	-	-	PUNCT
ajlsi-1012	243	11	tube	tube	NOUN
ajlsi-1012	243	12	,	,	PUNCT
ajlsi-1012	243	13	isothermal	isothermal	ADJ
ajlsi-1012	243	14	amplification	amplification	NOUN
ajlsi-1012	243	15	technology	technology	NOUN
ajlsi-1012	243	16	modelled	model	VERB
ajlsi-1012	243	17	after	after	ADP
ajlsi-1012	243	18	retroviral	retroviral	ADJ
ajlsi-1012	243	19	replication	replication	NOUN
ajlsi-1012	243	20	that	that	PRON
ajlsi-1012	243	21	can	can	AUX
ajlsi-1012	243	22	be	be	AUX
ajlsi-1012	243	23	used	use	VERB
ajlsi-1012	243	24	to	to	PART
ajlsi-1012	243	25	amplify	amplify	VERB
ajlsi-1012	243	26	specific	specific	ADJ
ajlsi-1012	243	27	regions	region	NOUN
ajlsi-1012	243	28	of	of	ADP
ajlsi-1012	243	29	either	either	CCONJ
ajlsi-1012	243	30	rna	rna	PROPN
ajlsi-1012	243	31	or	or	CCONJ
ajlsi-1012	243	32	dna	dna	PROPN
ajlsi-1012	243	33	much	much	ADV
ajlsi-1012	243	34	more	more	ADV
ajlsi-1012	243	35	efficiently	efficiently	ADV
ajlsi-1012	243	36	than	than	ADP
ajlsi-1012	243	37	rt	rt	NOUN
ajlsi-1012	243	38	-	-	PUNCT
ajlsi-1012	243	39	pcr	pcr	NOUN
ajlsi-1012	243	40	.	.	PUNCT
ajlsi-1012	244	1	it	it	PRON
ajlsi-1012	244	2	uses	use	VERB
ajlsi-1012	244	3	a	a	DET
ajlsi-1012	244	4	retroviral	retroviral	ADJ
ajlsi-1012	244	5	reverse	reverse	NOUN
ajlsi-1012	244	6	transcriptase	transcriptase	NOUN
ajlsi-1012	244	7	and	and	CCONJ
ajlsi-1012	244	8	t7	t7	PROPN
ajlsi-1012	244	9	rna	rna	PROPN
ajlsi-1012	244	10	polymerase	polymerase	NOUN
ajlsi-1012	244	11	and	and	CCONJ
ajlsi-1012	244	12	has	have	AUX
ajlsi-1012	244	13	been	be	AUX
ajlsi-1012	244	14	used	use	VERB
ajlsi-1012	244	15	for	for	ADP
ajlsi-1012	244	16	the	the	DET
ajlsi-1012	244	17	detection	detection	NOUN
ajlsi-1012	244	18	of	of	ADP
ajlsi-1012	244	19	nucleic	nucleic	ADJ
ajlsi-1012	244	20	acids	acid	NOUN
ajlsi-1012	244	21	from	from	ADP
ajlsi-1012	244	22	multiple	multiple	ADJ
ajlsi-1012	244	23	pathogens	pathogen	NOUN
ajlsi-1012	244	24	.	.	PUNCT
ajlsi-1012	245	1	the	the	DET
ajlsi-1012	245	2	initial	initial	ADJ
ajlsi-1012	245	3	step	step	NOUN
ajlsi-1012	245	4	involves	involve	VERB
ajlsi-1012	245	5	hybridization	hybridization	NOUN
ajlsi-1012	245	6	of	of	ADP
ajlsi-1012	245	7	the	the	DET
ajlsi-1012	245	8	viral	viral	ADJ
ajlsi-1012	245	9	rna	rna	NOUN
ajlsi-1012	245	10	target	target	NOUN
ajlsi-1012	245	11	to	to	ADP
ajlsi-1012	245	12	a	a	DET
ajlsi-1012	245	13	specific	specific	ADJ
ajlsi-1012	245	14	capture	capture	NOUN
ajlsi-1012	245	15	probe	probe	NOUN
ajlsi-1012	245	16	and	and	CCONJ
ajlsi-1012	245	17	an	an	DET
ajlsi-1012	245	18	additional	additional	ADJ
ajlsi-1012	245	19	oligonucleotide	oligonucleotide	NOUN
ajlsi-1012	245	20	containing	contain	VERB
ajlsi-1012	245	21	a	a	DET
ajlsi-1012	245	22	t7	t7	PROPN
ajlsi-1012	245	23	promoter	promoter	NOUN
ajlsi-1012	245	24	primer	primer	NOUN
ajlsi-1012	245	25	,	,	PUNCT
ajlsi-1012	245	26	which	which	PRON
ajlsi-1012	245	27	are	be	AUX
ajlsi-1012	245	28	captured	capture	VERB
ajlsi-1012	245	29	onto	onto	ADP
ajlsi-1012	245	30	magnetic	magnetic	ADJ
ajlsi-1012	245	31	microparticles	microparticle	NOUN
ajlsi-1012	245	32	.	.	PUNCT
ajlsi-1012	246	1	then	then	ADV
ajlsi-1012	246	2	,	,	PUNCT
ajlsi-1012	246	3	the	the	DET
ajlsi-1012	246	4	captured	capture	VERB
ajlsi-1012	246	5	rna	rna	NOUN
ajlsi-1012	246	6	target	target	NOUN
ajlsi-1012	246	7	hybridized	hybridize	VERB
ajlsi-1012	246	8	to	to	ADP
ajlsi-1012	246	9	the	the	DET
ajlsi-1012	246	10	t7	t7	PROPN
ajlsi-1012	246	11	promoter	promoter	NOUN
ajlsi-1012	246	12	primer	primer	NOUN
ajlsi-1012	246	13	is	be	AUX
ajlsi-1012	246	14	reverse	reverse	ADJ
ajlsi-1012	246	15	transcribed	transcribe	VERB
ajlsi-1012	246	16	into	into	ADP
ajlsi-1012	246	17	a	a	DET
ajlsi-1012	246	18	complementary	complementary	ADJ
ajlsi-1012	246	19	cdna	cdna	PROPN
ajlsi-1012	246	20	.	.	PUNCT
ajlsi-1012	247	1	the	the	DET
ajlsi-1012	247	2	rnase	rnase	PROPN
ajlsi-1012	247	3	activity	activity	NOUN
ajlsi-1012	247	4	of	of	ADP
ajlsi-1012	247	5	the	the	DET
ajlsi-1012	247	6	reverse	reverse	ADJ
ajlsi-1012	247	7	transcriptase	transcriptase	NOUN
ajlsi-1012	247	8	subsequently	subsequently	ADV
ajlsi-1012	247	9	degrades	degrade	VERB
ajlsi-1012	247	10	the	the	DET
ajlsi-1012	247	11	target	target	NOUN
ajlsi-1012	247	12	rna	rna	NOUN
ajlsi-1012	247	13	strand	strand	NOUN
ajlsi-1012	247	14	from	from	ADP
ajlsi-1012	247	15	the	the	DET
ajlsi-1012	247	16	hybrid	hybrid	ADJ
ajlsi-1012	247	17	rna	rna	NOUN
ajlsi-1012	247	18	cdna	cdna	PROPN
ajlsi-1012	247	19	duplex	duplex	NOUN
ajlsi-1012	247	20	,	,	PUNCT
ajlsi-1012	247	21	leaving	leave	VERB
ajlsi-1012	247	22	a	a	DET
ajlsi-1012	247	23	single	single	ADJ
ajlsi-1012	247	24	-	-	PUNCT
ajlsi-1012	247	25	stranded	strand	VERB
ajlsi-1012	247	26	cdna	cdna	PROPN
ajlsi-1012	247	27	,	,	PUNCT
ajlsi-1012	247	28	which	which	PRON
ajlsi-1012	247	29	includes	include	VERB
ajlsi-1012	247	30	the	the	DET
ajlsi-1012	247	31	t7	t7	PROPN
ajlsi-1012	247	32	promoter	promoter	NOUN
ajlsi-1012	247	33	.	.	PUNCT
ajlsi-1012	248	1	an	an	DET
ajlsi-1012	248	2	additional	additional	ADJ
ajlsi-1012	248	3	primer	primer	NOUN
ajlsi-1012	248	4	is	be	AUX
ajlsi-1012	248	5	used	use	VERB
ajlsi-1012	248	6	to	to	PART
ajlsi-1012	248	7	generate	generate	VERB
ajlsi-1012	248	8	double	double	ADJ
ajlsi-1012	248	9	-	-	PUNCT
ajlsi-1012	248	10	stranded	strand	VERB
ajlsi-1012	248	11	dna	dna	NOUN
ajlsi-1012	248	12	,	,	PUNCT
ajlsi-1012	248	13	which	which	PRON
ajlsi-1012	248	14	is	be	AUX
ajlsi-1012	248	15	subsequently	subsequently	ADV
ajlsi-1012	248	16	transcribed	transcribe	VERB
ajlsi-1012	248	17	into	into	ADP
ajlsi-1012	248	18	rna	rna	NOUN
ajlsi-1012	248	19	amplicons	amplicon	NOUN
ajlsi-1012	248	20	by	by	ADP
ajlsi-1012	248	21	t7	t7	PROPN
ajlsi-1012	248	22	rna	rna	PROPN
ajlsi-1012	248	23	polymerase	polymerase	NOUN
ajlsi-1012	248	24	.	.	PUNCT
ajlsi-1012	249	1	these	these	DET
ajlsi-1012	249	2	new	new	ADJ
ajlsi-1012	249	3	rna	rna	NOUN
ajlsi-1012	249	4	amplicons	amplicon	NOUN
ajlsi-1012	249	5	then	then	ADV
ajlsi-1012	249	6	reenter	reenter	VERB
ajlsi-1012	249	7	the	the	DET
ajlsi-1012	249	8	tma	tma	PROPN
ajlsi-1012	249	9	process	process	NOUN
ajlsi-1012	249	10	,	,	PUNCT
ajlsi-1012	249	11	allowing	allow	VERB
ajlsi-1012	249	12	this	this	DET
ajlsi-1012	249	13	exponential	exponential	ADJ
ajlsi-1012	249	14	amplification	amplification	NOUN
ajlsi-1012	249	15	to	to	PART
ajlsi-1012	249	16	generate	generate	VERB
ajlsi-1012	249	17	billions	billion	NOUN
ajlsi-1012	249	18	of	of	ADP
ajlsi-1012	249	19	rna	rna	NOUN
ajlsi-1012	249	20	amplicons	amplicon	NOUN
ajlsi-1012	249	21	.	.	PUNCT
ajlsi-1012	250	1	the	the	DET
ajlsi-1012	250	2	detection	detection	NOUN
ajlsi-1012	250	3	process	process	NOUN
ajlsi-1012	250	4	involves	involve	VERB
ajlsi-1012	250	5	the	the	DET
ajlsi-1012	250	6	use	use	NOUN
ajlsi-1012	250	7	of	of	ADP
ajlsi-1012	250	8	single	single	ADJ
ajlsi-1012	250	9	-	-	PUNCT
ajlsi-1012	250	10	stranded	strand	VERB
ajlsi-1012	250	11	nucleic	nucleic	ADJ
ajlsi-1012	250	12	acid	acid	NOUN
ajlsi-1012	250	13	pyrotechnics	pyrotechnic	NOUN
ajlsi-1012	250	14	that	that	PRON
ajlsi-1012	250	15	hybridize	hybridize	VERB
ajlsi-1012	250	16	specifically	specifically	ADV
ajlsi-1012	250	17	to	to	ADP
ajlsi-1012	250	18	the	the	DET
ajlsi-1012	250	19	rna	rna	NOUN
ajlsi-1012	250	20	amplicon	amplicon	NOUN
ajlsi-1012	250	21	in	in	ADP
ajlsi-1012	250	22	real	real	ADJ
ajlsi-1012	250	23	time	time	NOUN
ajlsi-1012	250	24	.	.	PUNCT
ajlsi-1012	251	1	each	each	DET
ajlsi-1012	251	2	torch	torch	NOUN
ajlsi-1012	251	3	is	be	AUX
ajlsi-1012	251	4	conjugated	conjugate	VERB
ajlsi-1012	251	5	to	to	ADP
ajlsi-1012	251	6	a	a	DET
ajlsi-1012	251	7	fluorophore	fluorophore	NOUN
ajlsi-1012	251	8	and	and	CCONJ
ajlsi-1012	251	9	a	a	DET
ajlsi-1012	251	10	quencher	quencher	NOUN
ajlsi-1012	251	11	.	.	PUNCT
ajlsi-1012	252	1	when	when	SCONJ
ajlsi-1012	252	2	the	the	DET
ajlsi-1012	252	3	torch	torch	NOUN
ajlsi-1012	252	4	hybridizes	hybridize	VERB
ajlsi-1012	252	5	with	with	ADP
ajlsi-1012	252	6	the	the	DET
ajlsi-1012	252	7	rna	rna	NOUN
ajlsi-1012	252	8	amplicon	amplicon	NOUN
ajlsi-1012	252	9	,	,	PUNCT
ajlsi-1012	252	10	the	the	DET
ajlsi-1012	252	11	fluorophore	fluorophore	NOUN
ajlsi-1012	252	12	is	be	AUX
ajlsi-1012	252	13	able	able	ADJ
ajlsi-1012	252	14	to	to	PART
ajlsi-1012	252	15	emit	emit	VERB
ajlsi-1012	252	16	a	a	DET
ajlsi-1012	252	17	signal	signal	NOUN
ajlsi-1012	252	18	upon	upon	SCONJ
ajlsi-1012	252	19	excitation	excitation	NOUN
ajlsi-1012	252	20	.	.	PUNCT
ajlsi-1012	253	1	(	(	PUNCT
ajlsi-1012	253	2	kacian	kacian	PROPN
ajlsi-1012	253	3	et	et	PROPN
ajlsi-1012	253	4	al	al	PROPN
ajlsi-1012	253	5	.	.	PROPN
ajlsi-1012	253	6	,	,	PUNCT
ajlsi-1012	253	7	1999	1999	NUM
ajlsi-1012	253	8	)	)	PUNCT
ajlsi-1012	253	9	clustered	cluster	VERB
ajlsi-1012	253	10	regularly	regularly	ADV
ajlsi-1012	253	11	interspaced	interspace	VERB
ajlsi-1012	253	12	short	short	ADJ
ajlsi-1012	253	13	palindromic	palindromic	ADJ
ajlsi-1012	253	14	repeats	repeat	NOUN
ajlsi-1012	253	15	(	(	PUNCT
ajlsi-1012	253	16	crispr	crispr	NOUN
ajlsi-1012	253	17	)	)	PUNCT
ajlsi-1012	253	18	represents	represent	VERB
ajlsi-1012	253	19	a	a	DET
ajlsi-1012	253	20	family	family	NOUN
ajlsi-1012	253	21	of	of	ADP
ajlsi-1012	253	22	nucleic	nucleic	ADJ
ajlsi-1012	253	23	acid	acid	NOUN
ajlsi-1012	253	24	sequences	sequence	NOUN
ajlsi-1012	253	25	found	find	VERB
ajlsi-1012	253	26	in	in	ADP
ajlsi-1012	253	27	prokaryotic	prokaryotic	ADJ
ajlsi-1012	253	28	organisms	organism	NOUN
ajlsi-1012	253	29	,	,	PUNCT
ajlsi-1012	253	30	such	such	ADJ
ajlsi-1012	253	31	as	as	ADP
ajlsi-1012	253	32	bacteria	bacteria	NOUN
ajlsi-1012	253	33	.	.	PUNCT
ajlsi-1012	254	1	these	these	DET
ajlsi-1012	254	2	sequences	sequence	NOUN
ajlsi-1012	254	3	can	can	AUX
ajlsi-1012	254	4	be	be	AUX
ajlsi-1012	254	5	recognized	recognize	VERB
ajlsi-1012	254	6	and	and	CCONJ
ajlsi-1012	254	7	cut	cut	VERB
ajlsi-1012	254	8	by	by	ADP
ajlsi-1012	254	9	a	a	DET
ajlsi-1012	254	10	set	set	NOUN
ajlsi-1012	254	11	of	of	ADP
ajlsi-1012	254	12	bacterial	bacterial	ADJ
ajlsi-1012	254	13	enzymes	enzyme	NOUN
ajlsi-1012	254	14	called	call	VERB
ajlsi-1012	254	15	crispr	crispr	NOUN
ajlsi-1012	254	16	-	-	PUNCT
ajlsi-1012	254	17	associated	associate	VERB
ajlsi-1012	254	18	enzymes	enzyme	NOUN
ajlsi-1012	254	19	.	.	PUNCT
ajlsi-1012	255	1	certain	certain	ADJ
ajlsi-1012	255	2	enzymes	enzyme	NOUN
ajlsi-1012	255	3	in	in	ADP
ajlsi-1012	255	4	these	these	DET
ajlsi-1012	255	5	families	family	NOUN
ajlsi-1012	255	6	can	can	AUX
ajlsi-1012	255	7	be	be	AUX
ajlsi-1012	255	8	programmed	program	VERB
ajlsi-1012	255	9	to	to	PART
ajlsi-1012	255	10	target	target	VERB
ajlsi-1012	255	11	and	and	CCONJ
ajlsi-1012	255	12	cut	cut	VERB
ajlsi-1012	255	13	viral	viral	ADJ
ajlsi-1012	255	14	rna	rna	NOUN
ajlsi-1012	255	15	sequences	sequence	NOUN
ajlsi-1012	255	16	.	.	PUNCT
ajlsi-1012	256	1	the	the	DET
ajlsi-1012	256	2	crispr	crispr	NOUN
ajlsi-1012	256	3	-	-	PUNCT
ajlsi-1012	256	4	based	base	VERB
ajlsi-1012	256	5	methods	method	NOUN
ajlsi-1012	256	6	do	do	AUX
ajlsi-1012	256	7	not	not	PART
ajlsi-1012	256	8	require	require	VERB
ajlsi-1012	256	9	complex	complex	ADJ
ajlsi-1012	256	10	instrumentation	instrumentation	NOUN
ajlsi-1012	256	11	and	and	CCONJ
ajlsi-1012	256	12	can	can	AUX
ajlsi-1012	256	13	be	be	AUX
ajlsi-1012	256	14	read	read	VERB
ajlsi-1012	256	15	using	use	VERB
ajlsi-1012	256	16	paper	paper	NOUN
ajlsi-1012	256	17	strips	strip	NOUN
ajlsi-1012	256	18	to	to	PART
ajlsi-1012	256	19	detect	detect	VERB
ajlsi-1012	256	20	the	the	DET
ajlsi-1012	256	21	presence	presence	NOUN
ajlsi-1012	256	22	of	of	ADP
ajlsi-1012	256	23	the	the	DET
ajlsi-1012	256	24	sars	sar	NOUN
ajlsi-1012	256	25	-	-	PUNCT
ajlsi-1012	256	26	cov-2	cov-2	PART
ajlsi-1012	256	27	virus	virus	NOUN
ajlsi-1012	256	28	without	without	ADP
ajlsi-1012	256	29	loss	loss	NOUN
ajlsi-1012	256	30	of	of	ADP
ajlsi-1012	256	31	sensitivity	sensitivity	NOUN
ajlsi-1012	256	32	or	or	CCONJ
ajlsi-1012	256	33	specificity	specificity	NOUN
ajlsi-1012	256	34	.	.	PUNCT
ajlsi-1012	257	1	these	these	DET
ajlsi-1012	257	2	tests	test	NOUN
ajlsi-1012	257	3	are	be	AUX
ajlsi-1012	257	4	both	both	CCONJ
ajlsi-1012	257	5	low	low	ADJ
ajlsi-1012	257	6	-	-	PUNCT
ajlsi-1012	257	7	cost	cost	NOUN
ajlsi-1012	257	8	and	and	CCONJ
ajlsi-1012	257	9	can	can	AUX
ajlsi-1012	257	10	be	be	AUX
ajlsi-1012	257	11	performed	perform	VERB
ajlsi-1012	257	12	in	in	ADP
ajlsi-1012	257	13	as	as	ADV
ajlsi-1012	257	14	little	little	ADJ
ajlsi-1012	257	15	as	as	ADP
ajlsi-1012	257	16	an	an	DET
ajlsi-1012	257	17	hour	hour	NOUN
ajlsi-1012	257	18	.	.	PUNCT
ajlsi-1012	258	1	these	these	DET
ajlsi-1012	258	2	tests	test	NOUN
ajlsi-1012	258	3	have	have	VERB
ajlsi-1012	258	4	great	great	ADJ
ajlsi-1012	258	5	potential	potential	NOUN
ajlsi-1012	258	6	for	for	ADP
ajlsi-1012	258	7	point	point	NOUN
ajlsi-1012	258	8	-	-	PUNCT
ajlsi-1012	258	9	of	of	ADP
ajlsi-1012	258	10	-	-	PUNCT
ajlsi-1012	258	11	care	care	NOUN
ajlsi-1012	258	12	diagnosis	diagnosis	NOUN
ajlsi-1012	258	13	.	.	PUNCT
ajlsi-1012	259	1	(	(	PUNCT
ajlsi-1012	259	2	zhang	zhang	PROPN
ajlsi-1012	259	3	et	et	PROPN
ajlsi-1012	259	4	al	al	PROPN
ajlsi-1012	259	5	.	.	PROPN
ajlsi-1012	259	6	,	,	PUNCT
ajlsi-1012	259	7	2020	2020	NUM
ajlsi-1012	259	8	;	;	PUNCT
ajlsi-1012	259	9	broughton	broughton	PROPN
ajlsi-1012	259	10	et	et	PROPN
ajlsi-1012	259	11	al	al	PROPN
ajlsi-1012	259	12	.	.	PROPN
ajlsi-1012	259	13	,	,	PUNCT
ajlsi-1012	259	14	2020	2020	NUM
ajlsi-1012	259	15	)	)	PUNCT
ajlsi-1012	259	16	.	.	PUNCT
ajlsi-1012	260	1	the	the	DET
ajlsi-1012	260	2	rolling	rolling	ADJ
ajlsi-1012	260	3	circle	circle	NOUN
ajlsi-1012	260	4	amplification	amplification	NOUN
ajlsi-1012	260	5	(	(	PUNCT
ajlsi-1012	260	6	rca	rca	NOUN
ajlsi-1012	260	7	)	)	PUNCT
ajlsi-1012	260	8	method	method	NOUN
ajlsi-1012	260	9	has	have	AUX
ajlsi-1012	260	10	attracted	attract	VERB
ajlsi-1012	260	11	considerable	considerable	ADJ
ajlsi-1012	260	12	attention	attention	NOUN
ajlsi-1012	260	13	in	in	ADP
ajlsi-1012	260	14	nucleic	nucleic	ADJ
ajlsi-1012	260	15	acid	acid	NOUN
ajlsi-1012	260	16	determination	determination	NOUN
ajlsi-1012	260	17	.	.	PUNCT
ajlsi-1012	261	1	in	in	ADP
ajlsi-1012	261	2	isothermal	isothermal	ADJ
ajlsi-1012	261	3	conditions	condition	NOUN
ajlsi-1012	261	4	,	,	PUNCT
ajlsi-1012	261	5	rca	rca	PROPN
ajlsi-1012	261	6	is	be	AUX
ajlsi-1012	261	7	capable	capable	ADJ
ajlsi-1012	261	8	of	of	ADP
ajlsi-1012	261	9	a	a	DET
ajlsi-1012	261	10	109	109	NUM
ajlsi-1012	261	11	-	-	ADJ
ajlsi-1012	261	12	fold	fold	ADJ
ajlsi-1012	261	13	signal	signal	NOUN
ajlsi-1012	261	14	amplification	amplification	NOUN
ajlsi-1012	261	15	of	of	ADP
ajlsi-1012	261	16	each	each	DET
ajlsi-1012	261	17	circle	circle	NOUN
ajlsi-1012	261	18	within	within	ADP
ajlsi-1012	261	19	90	90	NUM
ajlsi-1012	261	20	minutes	minute	NOUN
ajlsi-1012	261	21	.	.	PUNCT
ajlsi-1012	262	1	an	an	DET
ajlsi-1012	262	2	efficient	efficient	ADJ
ajlsi-1012	262	3	assay	assay	NOUN
ajlsi-1012	262	4	for	for	ADP
ajlsi-1012	262	5	the	the	DET
ajlsi-1012	262	6	detection	detection	NOUN
ajlsi-1012	262	7	of	of	ADP
ajlsi-1012	262	8	sars	sar	NOUN
ajlsi-1012	262	9	-	-	PUNCT
ajlsi-1012	262	10	cov-2	cov-2	NUM
ajlsi-1012	262	11	by	by	ADP
ajlsi-1012	262	12	rca	rca	PROPN
ajlsi-1012	262	13	has	have	AUX
ajlsi-1012	262	14	been	be	AUX
ajlsi-1012	262	15	set	set	VERB
ajlsi-1012	262	16	up	up	ADP
ajlsi-1012	262	17	in	in	ADP
ajlsi-1012	262	18	both	both	CCONJ
ajlsi-1012	262	19	liquid	liquid	ADJ
ajlsi-1012	262	20	and	and	CCONJ
ajlsi-1012	262	21	solid	solid	ADJ
ajlsi-1012	262	22	phases	phase	NOUN
ajlsi-1012	262	23	and	and	CCONJ
ajlsi-1012	262	24	has	have	AUX
ajlsi-1012	262	25	yielded	yield	VERB
ajlsi-1012	262	26	preliminary	preliminary	ADJ
ajlsi-1012	262	27	results	result	NOUN
ajlsi-1012	262	28	on	on	ADP
ajlsi-1012	262	29	a	a	DET
ajlsi-1012	262	30	small	small	ADJ
ajlsi-1012	262	31	number	number	NOUN
ajlsi-1012	262	32	of	of	ADP
ajlsi-1012	262	33	clinical	clinical	ADJ
ajlsi-1012	262	34	respiratory	respiratory	ADJ
ajlsi-1012	262	35	specimens	specimen	NOUN
ajlsi-1012	262	36	.	.	PUNCT
ajlsi-1012	263	1	the	the	DET
ajlsi-1012	263	2	main	main	ADJ
ajlsi-1012	263	3	advantage	advantage	NOUN
ajlsi-1012	263	4	of	of	ADP
ajlsi-1012	263	5	rca	rca	PROPN
ajlsi-1012	263	6	is	be	AUX
ajlsi-1012	263	7	that	that	SCONJ
ajlsi-1012	263	8	it	it	PRON
ajlsi-1012	263	9	can	can	AUX
ajlsi-1012	263	10	be	be	AUX
ajlsi-1012	263	11	performed	perform	VERB
ajlsi-1012	263	12	under	under	ADP
ajlsi-1012	263	13	isothermal	isothermal	ADJ
ajlsi-1012	263	14	conditions	condition	NOUN
ajlsi-1012	263	15	with	with	ADP
ajlsi-1012	263	16	minimal	minimal	ADJ
ajlsi-1012	263	17	reagents	reagent	NOUN
ajlsi-1012	263	18	and	and	CCONJ
ajlsi-1012	263	19	avoids	avoid	VERB
ajlsi-1012	263	20	the	the	DET
ajlsi-1012	263	21	generation	generation	NOUN
ajlsi-1012	263	22	of	of	ADP
ajlsi-1012	263	23	false	false	ADJ
ajlsi-1012	263	24	-	-	PUNCT
ajlsi-1012	263	25	positive	positive	ADJ
ajlsi-1012	263	26	results	result	NOUN
ajlsi-1012	263	27	,	,	PUNCT
ajlsi-1012	263	28	which	which	PRON
ajlsi-1012	263	29	are	be	AUX
ajlsi-1012	263	30	frequently	frequently	ADV
ajlsi-1012	263	31	encountered	encounter	VERB
ajlsi-1012	263	32	in	in	ADP
ajlsi-1012	263	33	pcr	pcr	NOUN
ajlsi-1012	263	34	-	-	PUNCT
ajlsi-1012	263	35	based	base	VERB
ajlsi-1012	263	36	assays	assay	NOUN
ajlsi-1012	263	37	.	.	PUNCT
ajlsi-1012	264	1	(	(	PUNCT
ajlsi-1012	264	2	chapin	chapin	NOUN
ajlsi-1012	264	3	et	et	PROPN
ajlsi-1012	264	4	al	al	PROPN
ajlsi-1012	264	5	.	.	PROPN
ajlsi-1012	264	6	,	,	PUNCT
ajlsi-1012	264	7	2011	2011	NUM
ajlsi-1012	264	8	,	,	PUNCT
ajlsi-1012	264	9	xu	xu	PROPN
ajlsi-1012	264	10	et	et	PROPN
ajlsi-1012	264	11	al	al	PROPN
ajlsi-1012	264	12	.	.	PROPN
ajlsi-1012	264	13	,	,	PUNCT
ajlsi-1012	264	14	2019	2019	NUM
ajlsi-1012	264	15	,	,	PUNCT
ajlsi-1012	264	16	wang	wang	PROPN
ajlsi-1012	264	17	et	et	PROPN
ajlsi-1012	264	18	al	al	PROPN
ajlsi-1012	264	19	.	.	PROPN
ajlsi-1012	264	20	,	,	PUNCT
ajlsi-1012	264	21	2005	2005	NUM
ajlsi-1012	264	22	,	,	PUNCT
ajlsi-1012	264	23	etc	etc	X
ajlsi-1012	264	24	.	.	X
ajlsi-1012	264	25	)	)	PUNCT
ajlsi-1012	264	26	.	.	PUNCT
ajlsi-1012	265	1	cartridge	cartridge	NOUN
ajlsi-1012	265	2	based	base	VERB
ajlsi-1012	265	3	nucleic	nucleic	ADJ
ajlsi-1012	265	4	acid	acid	NOUN
ajlsi-1012	265	5	amplification	amplification	NOUN
ajlsi-1012	265	6	test	test	NOUN
ajlsi-1012	265	7	(	(	PUNCT
ajlsi-1012	265	8	cb	cb	PROPN
ajlsi-1012	265	9	-	-	PROPN
ajlsi-1012	265	10	naat	naat	PROPN
ajlsi-1012	265	11	)	)	PUNCT
ajlsi-1012	265	12	and	and	CCONJ
ajlsi-1012	265	13	true	true	ADJ
ajlsi-1012	265	14	naat	naat	PROPN
ajlsi-1012	265	15	unlike	unlike	ADP
ajlsi-1012	265	16	traditional	traditional	ADJ
ajlsi-1012	265	17	rt	rt	ADJ
ajlsi-1012	265	18	-	-	PUNCT
ajlsi-1012	265	19	pcr	pcr	ADJ
ajlsi-1012	265	20	tests	test	NOUN
ajlsi-1012	265	21	,	,	PUNCT
ajlsi-1012	265	22	the	the	DET
ajlsi-1012	265	23	sample	sample	NOUN
ajlsi-1012	265	24	preparation	preparation	NOUN
ajlsi-1012	265	25	in	in	ADP
ajlsi-1012	265	26	cb	cb	PROPN
ajlsi-1012	265	27	-	-	PUNCT
ajlsi-1012	265	28	naat	naat	PROPN
ajlsi-1012	265	29	tests	test	NOUN
ajlsi-1012	265	30	is	be	AUX
ajlsi-1012	265	31	automated	automate	VERB
ajlsi-1012	265	32	,	,	PUNCT
ajlsi-1012	265	33	and	and	CCONJ
ajlsi-1012	265	34	the	the	DET
ajlsi-1012	265	35	results	result	NOUN
ajlsi-1012	265	36	are	be	AUX
ajlsi-1012	265	37	available	available	ADJ
ajlsi-1012	265	38	within	within	ADP
ajlsi-1012	265	39	half	half	DET
ajlsi-1012	265	40	an	an	DET
ajlsi-1012	265	41	hour	hour	NOUN
ajlsi-1012	265	42	.	.	PUNCT
ajlsi-1012	266	1	the	the	DET
ajlsi-1012	266	2	test	test	NOUN
ajlsi-1012	266	3	uses	use	VERB
ajlsi-1012	266	4	noseor	noseor	NOUN
ajlsi-1012	266	5	throat	throat	NOUN
ajlsi-1012	266	6	-	-	PUNCT
ajlsi-1012	266	7	swab	swab	NOUN
ajlsi-1012	266	8	samples	sample	NOUN
ajlsi-1012	266	9	,	,	PUNCT
ajlsi-1012	266	10	which	which	PRON
ajlsi-1012	266	11	are	be	AUX
ajlsi-1012	266	12	collected	collect	VERB
ajlsi-1012	266	13	from	from	ADP
ajlsi-1012	266	14	patients	patient	NOUN
ajlsi-1012	266	15	and	and	CCONJ
ajlsi-1012	266	16	dipped	dip	VERB
ajlsi-1012	266	17	in	in	ADP
ajlsi-1012	266	18	a	a	DET
ajlsi-1012	266	19	solution	solution	NOUN
ajlsi-1012	266	20	that	that	PRON
ajlsi-1012	266	21	inactivates	inactivate	VERB
ajlsi-1012	266	22	the	the	DET
ajlsi-1012	266	23	virus	virus	NOUN
ajlsi-1012	266	24	.	.	PUNCT
ajlsi-1012	267	1	a	a	DET
ajlsi-1012	267	2	few	few	ADJ
ajlsi-1012	267	3	drops	drop	NOUN
ajlsi-1012	267	4	of	of	ADP
ajlsi-1012	267	5	the	the	DET
ajlsi-1012	267	6	solution	solution	NOUN
ajlsi-1012	267	7	are	be	AUX
ajlsi-1012	267	8	then	then	ADV
ajlsi-1012	267	9	placed	place	VERB
ajlsi-1012	267	10	on	on	ADP
ajlsi-1012	267	11	a	a	DET
ajlsi-1012	267	12	cartridge	cartridge	NOUN
ajlsi-1012	267	13	.	.	PUNCT
ajlsi-1012	268	1	on	on	ADP
ajlsi-1012	268	2	inserting	insert	VERB
ajlsi-1012	268	3	this	this	DET
ajlsi-1012	268	4	cartridge	cartridge	NOUN
ajlsi-1012	268	5	into	into	ADP
ajlsi-1012	268	6	a	a	DET
ajlsi-1012	268	7	machine	machine	NOUN
ajlsi-1012	268	8	,	,	PUNCT
ajlsi-1012	268	9	a	a	DET
ajlsi-1012	268	10	preprogrammed	preprogrammed	ADJ
ajlsi-1012	268	11	reaction	reaction	NOUN
ajlsi-1012	268	12	is	be	AUX
ajlsi-1012	268	13	initiated	initiate	VERB
ajlsi-1012	268	14	,	,	PUNCT
ajlsi-1012	268	15	which	which	PRON
ajlsi-1012	268	16	extracts	extract	VERB
ajlsi-1012	268	17	the	the	DET
ajlsi-1012	268	18	nucleic	nucleic	ADJ
ajlsi-1012	268	19	acids	acid	NOUN
ajlsi-1012	268	20	or	or	CCONJ
ajlsi-1012	268	21	the	the	DET
ajlsi-1012	268	22	genetic	genetic	ADJ
ajlsi-1012	268	23	material	material	NOUN
ajlsi-1012	268	24	from	from	ADP
ajlsi-1012	268	25	the	the	DET
ajlsi-1012	268	26	samples	sample	NOUN
ajlsi-1012	268	27	.	.	PUNCT
ajlsi-1012	269	1	this	this	PRON
ajlsi-1012	269	2	has	have	VERB
ajlsi-1012	269	3	to	to	PART
ajlsi-1012	269	4	be	be	AUX
ajlsi-1012	269	5	followed	follow	VERB
ajlsi-1012	269	6	by	by	ADP
ajlsi-1012	269	7	rtpcr	rtpcr	NOUN
ajlsi-1012	269	8	.	.	PUNCT
ajlsi-1012	270	1	the	the	DET
ajlsi-1012	270	2	purified	purified	ADJ
ajlsi-1012	270	3	nucleic	nucleic	ADJ
ajlsi-1012	270	4	acid	acid	NOUN
ajlsi-1012	270	5	is	be	AUX
ajlsi-1012	270	6	added	add	VERB
ajlsi-1012	270	7	into	into	ADP
ajlsi-1012	270	8	a	a	DET
ajlsi-1012	270	9	microtube	microtube	NOUN
ajlsi-1012	270	10	containing	contain	VERB
ajlsi-1012	270	11	freeze	freeze	NOUN
ajlsi-1012	270	12	-	-	PUNCT
ajlsi-1012	270	13	dried	dry	VERB
ajlsi-1012	270	14	rt	rt	ADJ
ajlsi-1012	270	15	-	-	PUNCT
ajlsi-1012	270	16	pcr	pcr	ADJ
ajlsi-1012	270	17	reagents	reagent	NOUN
ajlsi-1012	270	18	and	and	CCONJ
ajlsi-1012	270	19	allowed	allow	VERB
ajlsi-1012	270	20	to	to	PART
ajlsi-1012	270	21	stand	stand	VERB
ajlsi-1012	270	22	for	for	ADP
ajlsi-1012	270	23	a	a	DET
ajlsi-1012	270	24	minute	minute	NOUN
ajlsi-1012	270	25	,	,	PUNCT
ajlsi-1012	270	26	then	then	ADV
ajlsi-1012	270	27	applied	apply	VERB
ajlsi-1012	270	28	to	to	ADP
ajlsi-1012	270	29	a	a	DET
ajlsi-1012	270	30	microchip	microchip	NOUN
ajlsi-1012	270	31	and	and	CCONJ
ajlsi-1012	270	32	then	then	ADV
ajlsi-1012	270	33	inserted	insert	VERB
ajlsi-1012	270	34	into	into	ADP
ajlsi-1012	270	35	another	another	DET
ajlsi-1012	270	36	machine	machine	NOUN
ajlsi-1012	270	37	,	,	PUNCT
ajlsi-1012	270	38	where	where	SCONJ
ajlsi-1012	270	39	the	the	DET
ajlsi-1012	270	40	reverse	reverse	ADJ
ajlsi-1012	270	41	transcription	transcription	NOUN
ajlsi-1012	270	42	and	and	CCONJ
ajlsi-1012	270	43	pcr	pcr	NOUN
ajlsi-1012	270	44	take	take	VERB
ajlsi-1012	270	45	place	place	NOUN
ajlsi-1012	270	46	.	.	PUNCT
ajlsi-1012	271	1	the	the	DET
ajlsi-1012	271	2	advantage	advantage	NOUN
ajlsi-1012	271	3	of	of	ADP
ajlsi-1012	271	4	this	this	DET
ajlsi-1012	271	5	test	test	NOUN
ajlsi-1012	271	6	is	be	AUX
ajlsi-1012	271	7	that	that	SCONJ
ajlsi-1012	271	8	it	it	PRON
ajlsi-1012	271	9	is	be	AUX
ajlsi-1012	271	10	quick	quick	ADJ
ajlsi-1012	271	11	and	and	CCONJ
ajlsi-1012	271	12	portable	portable	ADJ
ajlsi-1012	271	13	.	.	PUNCT
ajlsi-1012	272	1	this	this	PRON
ajlsi-1012	272	2	allows	allow	VERB
ajlsi-1012	272	3	the	the	DET
ajlsi-1012	272	4	easy	easy	ADJ
ajlsi-1012	272	5	setup	setup	NOUN
ajlsi-1012	272	6	of	of	ADP
ajlsi-1012	272	7	mobile	mobile	ADJ
ajlsi-1012	272	8	testing	testing	NOUN
ajlsi-1012	272	9	centers	center	NOUN
ajlsi-1012	272	10	or	or	CCONJ
ajlsi-1012	272	11	kiosks	kiosk	NOUN
ajlsi-1012	272	12	in	in	ADP
ajlsi-1012	272	13	containment	containment	NOUN
ajlsi-1012	272	14	zones	zone	NOUN
ajlsi-1012	272	15	instead	instead	ADV
ajlsi-1012	272	16	of	of	ADP
ajlsi-1012	272	17	having	have	VERB
ajlsi-1012	272	18	to	to	PART
ajlsi-1012	272	19	transport	transport	VERB
ajlsi-1012	272	20	samples	sample	NOUN
ajlsi-1012	272	21	to	to	ADP
ajlsi-1012	272	22	labs	lab	NOUN
ajlsi-1012	272	23	.	.	PUNCT
ajlsi-1012	273	1	true	true	ADJ
ajlsi-1012	273	2	nat	nat	PROPN
ajlsi-1012	273	3	is	be	AUX
ajlsi-1012	273	4	an	an	DET
ajlsi-1012	273	5	indigenously	indigenously	ADV
ajlsi-1012	273	6	developed	develop	VERB
ajlsi-1012	273	7	,	,	PUNCT
ajlsi-1012	273	8	portable	portable	ADJ
ajlsi-1012	273	9	version	version	NOUN
ajlsi-1012	273	10	of	of	ADP
ajlsi-1012	273	11	cb	cb	PROPN
ajlsi-1012	273	12	-	-	PROPN
ajlsi-1012	273	13	naat	naat	PROPN
ajlsi-1012	273	14	,	,	PUNCT
ajlsi-1012	273	15	also	also	ADV
ajlsi-1012	273	16	known	know	VERB
ajlsi-1012	273	17	as	as	ADP
ajlsi-1012	273	18	the	the	DET
ajlsi-1012	273	19	genexpert	genexpert	PROPN
ajlsi-1012	273	20	test	test	NOUN
ajlsi-1012	273	21	.	.	PUNCT
ajlsi-1012	274	1	both	both	PRON
ajlsi-1012	274	2	of	of	ADP
ajlsi-1012	274	3	these	these	DET
ajlsi-1012	274	4	tests	test	NOUN
ajlsi-1012	274	5	were	be	AUX
ajlsi-1012	274	6	originally	originally	ADV
ajlsi-1012	274	7	designed	design	VERB
ajlsi-1012	274	8	to	to	PART
ajlsi-1012	274	9	screen	screen	VERB
ajlsi-1012	274	10	for	for	ADP
ajlsi-1012	274	11	tuberculosis	tuberculosis	NOUN
ajlsi-1012	274	12	.	.	PUNCT
ajlsi-1012	275	1	immunological	immunological	ADJ
ajlsi-1012	275	2	assays	assay	NOUN
ajlsi-1012	275	3	immunological	immunological	ADJ
ajlsi-1012	275	4	tests	test	NOUN
ajlsi-1012	275	5	measure	measure	VERB
ajlsi-1012	275	6	the	the	DET
ajlsi-1012	275	7	antibodies	antibody	NOUN
ajlsi-1012	275	8	generated	generate	VERB
ajlsi-1012	275	9	by	by	ADP
ajlsi-1012	275	10	the	the	DET
ajlsi-1012	275	11	host	host	NOUN
ajlsi-1012	275	12	body	body	NOUN
ajlsi-1012	275	13	’s	’s	PART
ajlsi-1012	275	14	immune	immune	ADJ
ajlsi-1012	275	15	response	response	NOUN
ajlsi-1012	275	16	against	against	ADP
ajlsi-1012	275	17	the	the	DET
ajlsi-1012	275	18	virus	virus	NOUN
ajlsi-1012	275	19	infection	infection	NOUN
ajlsi-1012	275	20	(	(	PUNCT
ajlsi-1012	275	21	antibody	antibody	NOUN
ajlsi-1012	275	22	test	test	NOUN
ajlsi-1012	275	23	)	)	PUNCT
ajlsi-1012	275	24	or	or	CCONJ
ajlsi-1012	275	25	the	the	DET
ajlsi-1012	275	26	proteins	protein	NOUN
ajlsi-1012	275	27	of	of	ADP
ajlsi-1012	275	28	covid-19	covid-19	PROPN
ajlsi-1012	275	29	virus	virus	NOUN
ajlsi-1012	275	30	present	present	ADJ
ajlsi-1012	275	31	in	in	ADP
ajlsi-1012	275	32	the	the	DET
ajlsi-1012	275	33	respiratory	respiratory	ADJ
ajlsi-1012	275	34	specimens	specimen	NOUN
ajlsi-1012	275	35	(	(	PUNCT
ajlsi-1012	275	36	antigen	antigen	ADJ
ajlsi-1012	275	37	test	test	NOUN
ajlsi-1012	275	38	)	)	PUNCT
ajlsi-1012	275	39	.	.	PUNCT
ajlsi-1012	276	1	when	when	SCONJ
ajlsi-1012	276	2	a	a	DET
ajlsi-1012	276	3	virus	virus	NOUN
ajlsi-1012	276	4	enters	enter	VERB
ajlsi-1012	276	5	the	the	DET
ajlsi-1012	276	6	human	human	ADJ
ajlsi-1012	276	7	body	body	NOUN
ajlsi-1012	276	8	,	,	PUNCT
ajlsi-1012	276	9	it	it	PRON
ajlsi-1012	276	10	triggers	trigger	VERB
ajlsi-1012	276	11	an	an	DET
ajlsi-1012	276	12	immune	immune	ADJ
ajlsi-1012	276	13	response	response	NOUN
ajlsi-1012	276	14	that	that	PRON
ajlsi-1012	276	15	results	result	VERB
ajlsi-1012	276	16	in	in	ADP
ajlsi-1012	276	17	the	the	DET
ajlsi-1012	276	18	production	production	NOUN
ajlsi-1012	276	19	of	of	ADP
ajlsi-1012	276	20	an	an	DET
ajlsi-1012	276	21	antibody	antibody	NOUN
ajlsi-1012	276	22	against	against	ADP
ajlsi-1012	276	23	the	the	DET
ajlsi-1012	276	24	virus	virus	NOUN
ajlsi-1012	276	25	;	;	PUNCT
ajlsi-1012	276	26	detecting	detect	VERB
ajlsi-1012	276	27	such	such	DET
ajlsi-1012	276	28	an	an	DET
ajlsi-1012	276	29	antibody	antibody	NOUN
ajlsi-1012	276	30	in	in	ADP
ajlsi-1012	276	31	an	an	DET
ajlsi-1012	276	32	infected	infected	ADJ
ajlsi-1012	276	33	person	person	NOUN
ajlsi-1012	276	34	is	be	AUX
ajlsi-1012	276	35	extremely	extremely	ADV
ajlsi-1012	276	36	useful	useful	ADJ
ajlsi-1012	276	37	regardless	regardless	ADV
ajlsi-1012	276	38	of	of	ADP
ajlsi-1012	276	39	whether	whether	SCONJ
ajlsi-1012	276	40	the	the	DET
ajlsi-1012	276	41	person	person	NOUN
ajlsi-1012	276	42	has	have	AUX
ajlsi-1012	276	43	symptoms	symptom	NOUN
ajlsi-1012	276	44	.	.	PUNCT
ajlsi-1012	277	1	antibody	antibody	NOUN
ajlsi-1012	277	2	tests	test	NOUN
ajlsi-1012	277	3	are	be	AUX
ajlsi-1012	277	4	blood	blood	NOUN
ajlsi-1012	277	5	-	-	PUNCT
ajlsi-1012	277	6	based	base	VERB
ajlsi-1012	277	7	tests	test	NOUN
ajlsi-1012	277	8	that	that	PRON
ajlsi-1012	277	9	can	can	AUX
ajlsi-1012	277	10	be	be	AUX
ajlsi-1012	277	11	used	use	VERB
ajlsi-1012	277	12	to	to	PART
ajlsi-1012	277	13	identify	identify	VERB
ajlsi-1012	277	14	whether	whether	SCONJ
ajlsi-1012	277	15	people	people	NOUN
ajlsi-1012	277	16	have	have	AUX
ajlsi-1012	277	17	been	be	AUX
ajlsi-1012	277	18	exposed	expose	VERB
ajlsi-1012	277	19	to	to	ADP
ajlsi-1012	277	20	a	a	DET
ajlsi-1012	277	21	particular	particular	ADJ
ajlsi-1012	277	22	pathogen	pathogen	NOUN
ajlsi-1012	277	23	.	.	PUNCT
ajlsi-1012	278	1	the	the	DET
ajlsi-1012	278	2	serum	serum	NOUN
ajlsi-1012	278	3	includes	include	VERB
ajlsi-1012	278	4	antibodies	antibody	NOUN
ajlsi-1012	278	5	to	to	ADP
ajlsi-1012	278	6	specific	specific	ADJ
ajlsi-1012	278	7	components	component	NOUN
ajlsi-1012	278	8	of	of	ADP
ajlsi-1012	278	9	pathogens	pathogen	NOUN
ajlsi-1012	278	10	,	,	PUNCT
ajlsi-1012	278	11	called	call	VERB
ajlsi-1012	278	12	antigens	antigen	NOUN
ajlsi-1012	278	13	.	.	PUNCT
ajlsi-1012	279	1	these	these	DET
ajlsi-1012	279	2	antigens	antigen	NOUN
ajlsi-1012	279	3	are	be	AUX
ajlsi-1012	279	4	recognized	recognize	VERB
ajlsi-1012	279	5	by	by	ADP
ajlsi-1012	279	6	the	the	DET
ajlsi-1012	279	7	immune	immune	ADJ
ajlsi-1012	279	8	system	system	NOUN
ajlsi-1012	279	9	as	as	ADP
ajlsi-1012	279	10	foreign	foreign	ADJ
ajlsi-1012	279	11	and	and	CCONJ
ajlsi-1012	279	12	are	be	AUX
ajlsi-1012	279	13	targeted	target	VERB
ajlsi-1012	279	14	by	by	ADP
ajlsi-1012	279	15	the	the	DET
ajlsi-1012	279	16	immune	immune	ADJ
ajlsi-1012	279	17	response	response	NOUN
ajlsi-1012	279	18	.	.	PUNCT
ajlsi-1012	280	1	these	these	DET
ajlsi-1012	280	2	types	type	NOUN
ajlsi-1012	280	3	of	of	ADP
ajlsi-1012	280	4	tests	test	NOUN
ajlsi-1012	280	5	are	be	AUX
ajlsi-1012	280	6	often	often	ADV
ajlsi-1012	280	7	used	use	VERB
ajlsi-1012	280	8	in	in	ADP
ajlsi-1012	280	9	viral	viral	ADJ
ajlsi-1012	280	10	infections	infection	NOUN
ajlsi-1012	280	11	to	to	PART
ajlsi-1012	280	12	see	see	VERB
ajlsi-1012	280	13	if	if	SCONJ
ajlsi-1012	280	14	the	the	DET
ajlsi-1012	280	15	patient	patient	NOUN
ajlsi-1012	280	16	has	have	VERB
ajlsi-1012	280	17	an	an	DET
ajlsi-1012	280	18	immune	immune	ADJ
ajlsi-1012	280	19	response	response	NOUN
ajlsi-1012	280	20	to	to	ADP
ajlsi-1012	280	21	a	a	DET
ajlsi-1012	280	22	pathogen	pathogen	NOUN
ajlsi-1012	280	23	of	of	ADP
ajlsi-1012	280	24	interest	interest	NOUN
ajlsi-1012	280	25	,	,	PUNCT
ajlsi-1012	280	26	such	such	ADJ
ajlsi-1012	280	27	as	as	ADP
ajlsi-1012	280	28	sars	sar	NOUN
ajlsi-1012	280	29	-	-	PUNCT
ajlsi-1012	280	30	cov-2	cov-2	NOUN
ajlsi-1012	280	31	.	.	PUNCT
ajlsi-1012	281	1	the	the	DET
ajlsi-1012	281	2	role	role	NOUN
ajlsi-1012	281	3	of	of	ADP
ajlsi-1012	281	4	serological	serological	ADJ
ajlsi-1012	281	5	assays	assay	NOUN
ajlsi-1012	281	6	to	to	PART
ajlsi-1012	281	7	detect	detect	VERB
ajlsi-1012	281	8	igg	igg	PROPN
ajlsi-1012	281	9	,	,	PUNCT
ajlsi-1012	281	10	iga	iga	PROPN
ajlsi-1012	281	11	,	,	PUNCT
ajlsi-1012	281	12	or	or	CCONJ
ajlsi-1012	281	13	igm	igm	NOUN
ajlsi-1012	281	14	anti	anti	ADJ
ajlsi-1012	281	15	-	-	ADJ
ajlsi-1012	281	16	sarscov-2	sarscov-2	NUM
ajlsi-1012	281	17	antibodies	antibodie	VERB
ajlsi-1012	281	18	in	in	ADP
ajlsi-1012	281	19	serum	serum	NOUN
ajlsi-1012	281	20	,	,	PUNCT
ajlsi-1012	281	21	plasma	plasma	NOUN
ajlsi-1012	281	22	,	,	PUNCT
ajlsi-1012	281	23	or	or	CCONJ
ajlsi-1012	281	24	capillary	capillary	ADJ
ajlsi-1012	281	25	blood	blood	NOUN
ajlsi-1012	281	26	provides	provide	VERB
ajlsi-1012	281	27	a	a	DET
ajlsi-1012	281	28	clear	clear	ADJ
ajlsi-1012	281	29	picture	picture	NOUN
ajlsi-1012	281	30	of	of	ADP
ajlsi-1012	281	31	the	the	DET
ajlsi-1012	281	32	outbreak	outbreak	NOUN
ajlsi-1012	281	33	size	size	NOUN
ajlsi-1012	281	34	in	in	ADP
ajlsi-1012	281	35	each	each	DET
ajlsi-1012	281	36	country	country	NOUN
ajlsi-1012	281	37	and	and	CCONJ
ajlsi-1012	281	38	helps	help	VERB
ajlsi-1012	281	39	to	to	PART
ajlsi-1012	281	40	assess	assess	VERB
ajlsi-1012	281	41	the	the	DET
ajlsi-1012	281	42	degree	degree	NOUN
ajlsi-1012	281	43	of	of	ADP
ajlsi-1012	281	44	immunization	immunization	NOUN
ajlsi-1012	281	45	.	.	PUNCT
ajlsi-1012	282	1	(	(	PUNCT
ajlsi-1012	282	2	okba	okba	NOUN
ajlsi-1012	282	3	et	et	PROPN
ajlsi-1012	282	4	al	al	PROPN
ajlsi-1012	282	5	.	.	PROPN
ajlsi-1012	282	6	,	,	PUNCT
ajlsi-1012	282	7	2020	2020	NUM
ajlsi-1012	282	8	)	)	PUNCT
ajlsi-1012	282	9	.	.	PUNCT
ajlsi-1012	283	1	serological	serological	ADJ
ajlsi-1012	283	2	testing	testing	NOUN
ajlsi-1012	283	3	for	for	ADP
ajlsi-1012	283	4	covid-19	covid-19	PROPN
ajlsi-1012	283	5	is	be	AUX
ajlsi-1012	283	6	particularly	particularly	ADV
ajlsi-1012	283	7	attractive	attractive	ADJ
ajlsi-1012	283	8	because	because	SCONJ
ajlsi-1012	283	9	of	of	ADP
ajlsi-1012	283	10	the	the	DET
ajlsi-1012	283	11	relatively	relatively	ADV
ajlsi-1012	283	12	short	short	ADJ
ajlsi-1012	283	13	time	time	NOUN
ajlsi-1012	283	14	to	to	ADP
ajlsi-1012	283	15	diagnosis	diagnosis	VERB
ajlsi-1012	283	16	and	and	CCONJ
ajlsi-1012	283	17	the	the	DET
ajlsi-1012	283	18	ability	ability	NOUN
ajlsi-1012	283	19	to	to	PART
ajlsi-1012	283	20	test	test	VERB
ajlsi-1012	283	21	for	for	ADP
ajlsi-1012	283	22	an	an	DET
ajlsi-1012	283	23	active	active	ADJ
ajlsi-1012	283	24	immune	immune	ADJ
ajlsi-1012	283	25	response	response	NOUN
ajlsi-1012	283	26	against	against	ADP
ajlsi-1012	283	27	the	the	DET
ajlsi-1012	283	28	virus	virus	NOUN
ajlsi-1012	283	29	.	.	PUNCT
ajlsi-1012	284	1	serological	serological	ADJ
ajlsi-1012	284	2	tests	test	NOUN
ajlsi-1012	284	3	have	have	VERB
ajlsi-1012	284	4	variable	variable	ADJ
ajlsi-1012	284	5	sensitivity	sensitivity	NOUN
ajlsi-1012	284	6	and	and	CCONJ
ajlsi-1012	284	7	specificity	specificity	NOUN
ajlsi-1012	284	8	.	.	PUNCT
ajlsi-1012	285	1	research	research	NOUN
ajlsi-1012	285	2	has	have	AUX
ajlsi-1012	285	3	demonstrated	demonstrate	VERB
ajlsi-1012	285	4	that	that	SCONJ
ajlsi-1012	285	5	the	the	DET
ajlsi-1012	285	6	spike	spike	ADJ
ajlsi-1012	285	7	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	285	8	pa	pa	PROPN
ajlsi-1012	285	9	ge	ge	PROPN
ajlsi-1012	285	10	36	36	NUM
ajlsi-1012	285	11	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	285	12	am	am	NOUN
ajlsi-1012	285	13	.	.	PUNCT
ajlsi-1012	286	1	j.	j.	PROPN
ajlsi-1012	286	2	life	life	PROPN
ajlsi-1012	286	3	sci	sci	PROPN
ajlsi-1012	286	4	.	.	PUNCT
ajlsi-1012	286	5	innov	innov	PROPN
ajlsi-1012	286	6	.	.	PUNCT
ajlsi-1012	287	1	1(2	1(2	NUM
ajlsi-1012	287	2	)	)	PUNCT
ajlsi-1012	287	3	29	29	NUM
ajlsi-1012	287	4	-	-	SYM
ajlsi-1012	287	5	42	42	NUM
ajlsi-1012	287	6	,	,	PUNCT
ajlsi-1012	287	7	2022	2022	NUM
ajlsi-1012	287	8	(	(	PUNCT
ajlsi-1012	287	9	s	s	NOUN
ajlsi-1012	287	10	)	)	PUNCT
ajlsi-1012	287	11	and	and	CCONJ
ajlsi-1012	287	12	nucleocapsid	nucleocapsid	ADJ
ajlsi-1012	287	13	(	(	PUNCT
ajlsi-1012	287	14	n	n	CCONJ
ajlsi-1012	287	15	)	)	PUNCT
ajlsi-1012	287	16	proteins	protein	NOUN
ajlsi-1012	287	17	are	be	AUX
ajlsi-1012	287	18	the	the	DET
ajlsi-1012	287	19	primary	primary	ADJ
ajlsi-1012	287	20	viral	viral	ADJ
ajlsi-1012	287	21	antigens	antigen	NOUN
ajlsi-1012	287	22	against	against	ADP
ajlsi-1012	287	23	which	which	PRON
ajlsi-1012	287	24	antibodies	antibody	NOUN
ajlsi-1012	287	25	are	be	AUX
ajlsi-1012	287	26	raised	raise	VERB
ajlsi-1012	287	27	.	.	PUNCT
ajlsi-1012	288	1	(	(	PUNCT
ajlsi-1012	288	2	chan	chan	PROPN
ajlsi-1012	288	3	et	et	PROPN
ajlsi-1012	288	4	al	al	PROPN
ajlsi-1012	288	5	.	.	PROPN
ajlsi-1012	288	6	,	,	PUNCT
ajlsi-1012	288	7	2009	2009	NUM
ajlsi-1012	288	8	;	;	PUNCT
ajlsi-1012	288	9	kumar	kumar	PROPN
ajlsi-1012	288	10	et	et	PROPN
ajlsi-1012	288	11	al	al	PROPN
ajlsi-1012	288	12	.	.	PROPN
ajlsi-1012	288	13	,	,	PUNCT
ajlsi-1012	288	14	2020	2020	NUM
ajlsi-1012	288	15	)	)	PUNCT
ajlsi-1012	288	16	.	.	PUNCT
ajlsi-1012	289	1	these	these	DET
ajlsi-1012	289	2	antigens	antigen	NOUN
ajlsi-1012	289	3	are	be	AUX
ajlsi-1012	289	4	the	the	PRON
ajlsi-1012	289	5	most	most	ADV
ajlsi-1012	289	6	commonly	commonly	ADV
ajlsi-1012	289	7	used	use	VERB
ajlsi-1012	289	8	in	in	ADP
ajlsi-1012	289	9	serological	serological	ADJ
ajlsi-1012	289	10	tests	test	NOUN
ajlsi-1012	289	11	.	.	PUNCT
ajlsi-1012	290	1	during	during	ADP
ajlsi-1012	290	2	infection	infection	NOUN
ajlsi-1012	290	3	,	,	PUNCT
ajlsi-1012	290	4	several	several	ADJ
ajlsi-1012	290	5	types	type	NOUN
ajlsi-1012	290	6	of	of	ADP
ajlsi-1012	290	7	antibodies	antibody	NOUN
ajlsi-1012	290	8	are	be	AUX
ajlsi-1012	290	9	raised	raise	VERB
ajlsi-1012	290	10	against	against	ADP
ajlsi-1012	290	11	the	the	DET
ajlsi-1012	290	12	virus	virus	NOUN
ajlsi-1012	290	13	.	.	PUNCT
ajlsi-1012	291	1	igm	igm	PROPN
ajlsi-1012	291	2	antibodies	antibody	NOUN
ajlsi-1012	291	3	emerge	emerge	VERB
ajlsi-1012	291	4	first	first	ADV
ajlsi-1012	291	5	,	,	PUNCT
ajlsi-1012	291	6	after	after	ADP
ajlsi-1012	291	7	5	5	NUM
ajlsi-1012	291	8	days	day	NOUN
ajlsi-1012	291	9	of	of	ADP
ajlsi-1012	291	10	postsymptom	postsymptom	NOUN
ajlsi-1012	291	11	onset	onset	NOUN
ajlsi-1012	291	12	.	.	PUNCT
ajlsi-1012	292	1	igg	igg	PROPN
ajlsi-1012	292	2	antibodies	antibodie	VERB
ajlsi-1012	292	3	typically	typically	ADV
ajlsi-1012	292	4	emerge	emerge	VERB
ajlsi-1012	292	5	after	after	ADP
ajlsi-1012	292	6	10	10	NUM
ajlsi-1012	292	7	days	day	NOUN
ajlsi-1012	292	8	of	of	ADP
ajlsi-1012	292	9	post	post	ADJ
ajlsi-1012	292	10	-	-	ADJ
ajlsi-1012	292	11	symptom	symptom	ADJ
ajlsi-1012	292	12	onset	onset	NOUN
ajlsi-1012	292	13	.	.	PUNCT
ajlsi-1012	293	1	many	many	ADJ
ajlsi-1012	293	2	serology	serology	NOUN
ajlsi-1012	293	3	tests	test	NOUN
ajlsi-1012	293	4	detect	detect	VERB
ajlsi-1012	293	5	both	both	DET
ajlsi-1012	293	6	igg	igg	PROPN
ajlsi-1012	293	7	and	and	CCONJ
ajlsi-1012	293	8	igm	igm	PROPN
ajlsi-1012	293	9	simultaneously	simultaneously	ADV
ajlsi-1012	293	10	,	,	PUNCT
ajlsi-1012	293	11	which	which	PRON
ajlsi-1012	293	12	increases	increase	VERB
ajlsi-1012	293	13	the	the	DET
ajlsi-1012	293	14	specificity	specificity	NOUN
ajlsi-1012	293	15	of	of	ADP
ajlsi-1012	293	16	the	the	DET
ajlsi-1012	293	17	test	test	NOUN
ajlsi-1012	293	18	.	.	PUNCT
ajlsi-1012	294	1	iga	iga	PROPN
ajlsi-1012	294	2	antibodies	antibodie	VERB
ajlsi-1012	294	3	may	may	AUX
ajlsi-1012	294	4	also	also	ADV
ajlsi-1012	294	5	increase	increase	VERB
ajlsi-1012	294	6	during	during	ADP
ajlsi-1012	294	7	infection	infection	NOUN
ajlsi-1012	294	8	and	and	CCONJ
ajlsi-1012	294	9	are	be	AUX
ajlsi-1012	294	10	typically	typically	ADV
ajlsi-1012	294	11	found	find	VERB
ajlsi-1012	294	12	in	in	ADP
ajlsi-1012	294	13	mucous	mucous	ADJ
ajlsi-1012	294	14	.	.	PUNCT
ajlsi-1012	295	1	while	while	SCONJ
ajlsi-1012	295	2	serological	serological	ADJ
ajlsi-1012	295	3	tests	test	NOUN
ajlsi-1012	295	4	are	be	AUX
ajlsi-1012	295	5	now	now	ADV
ajlsi-1012	295	6	widely	widely	ADV
ajlsi-1012	295	7	available	available	ADJ
ajlsi-1012	295	8	,	,	PUNCT
ajlsi-1012	295	9	the	the	DET
ajlsi-1012	295	10	correlates	correlate	NOUN
ajlsi-1012	295	11	of	of	ADP
ajlsi-1012	295	12	immunity	immunity	NOUN
ajlsi-1012	295	13	are	be	AUX
ajlsi-1012	295	14	still	still	ADV
ajlsi-1012	295	15	poorly	poorly	ADV
ajlsi-1012	295	16	understood	understand	VERB
ajlsi-1012	295	17	.	.	PUNCT
ajlsi-1012	296	1	the	the	DET
ajlsi-1012	296	2	presence	presence	NOUN
ajlsi-1012	296	3	of	of	ADP
ajlsi-1012	296	4	antibodies	antibody	NOUN
ajlsi-1012	296	5	only	only	ADV
ajlsi-1012	296	6	indicates	indicate	VERB
ajlsi-1012	296	7	a	a	DET
ajlsi-1012	296	8	previous	previous	ADJ
ajlsi-1012	296	9	sars	sar	NOUN
ajlsi-1012	296	10	-	-	PUNCT
ajlsi-1012	296	11	cov-2	cov-2	NOUN
ajlsi-1012	296	12	infection	infection	NOUN
ajlsi-1012	296	13	.	.	PUNCT
ajlsi-1012	297	1	the	the	DET
ajlsi-1012	297	2	results	result	NOUN
ajlsi-1012	297	3	of	of	ADP
ajlsi-1012	297	4	serological	serological	ADJ
ajlsi-1012	297	5	tests	test	NOUN
ajlsi-1012	297	6	can	can	AUX
ajlsi-1012	297	7	then	then	ADV
ajlsi-1012	297	8	be	be	AUX
ajlsi-1012	297	9	used	use	VERB
ajlsi-1012	297	10	to	to	PART
ajlsi-1012	297	11	estimate	estimate	VERB
ajlsi-1012	297	12	the	the	DET
ajlsi-1012	297	13	true	true	ADJ
ajlsi-1012	297	14	spread	spread	NOUN
ajlsi-1012	297	15	of	of	ADP
ajlsi-1012	297	16	the	the	DET
ajlsi-1012	297	17	virus	virus	NOUN
ajlsi-1012	297	18	through	through	ADP
ajlsi-1012	297	19	a	a	DET
ajlsi-1012	297	20	population	population	NOUN
ajlsi-1012	297	21	,	,	PUNCT
ajlsi-1012	297	22	even	even	ADV
ajlsi-1012	297	23	if	if	SCONJ
ajlsi-1012	297	24	individuals	individual	NOUN
ajlsi-1012	297	25	were	be	AUX
ajlsi-1012	297	26	asymptomatic	asymptomatic	ADJ
ajlsi-1012	297	27	or	or	CCONJ
ajlsi-1012	297	28	were	be	AUX
ajlsi-1012	297	29	never	never	ADV
ajlsi-1012	297	30	diagnosed	diagnose	VERB
ajlsi-1012	297	31	.	.	PUNCT
ajlsi-1012	298	1	the	the	DET
ajlsi-1012	298	2	presence	presence	NOUN
ajlsi-1012	298	3	of	of	ADP
ajlsi-1012	298	4	antibodies	antibody	NOUN
ajlsi-1012	298	5	does	do	AUX
ajlsi-1012	298	6	not	not	PART
ajlsi-1012	298	7	indicate	indicate	VERB
ajlsi-1012	298	8	that	that	SCONJ
ajlsi-1012	298	9	an	an	DET
ajlsi-1012	298	10	individual	individual	NOUN
ajlsi-1012	298	11	is	be	AUX
ajlsi-1012	298	12	protected	protect	VERB
ajlsi-1012	298	13	from	from	ADP
ajlsi-1012	298	14	reinfection	reinfection	NOUN
ajlsi-1012	298	15	since	since	SCONJ
ajlsi-1012	298	16	there	there	PRON
ajlsi-1012	298	17	is	be	VERB
ajlsi-1012	298	18	limited	limited	ADJ
ajlsi-1012	298	19	understanding	understanding	NOUN
ajlsi-1012	298	20	of	of	ADP
ajlsi-1012	298	21	the	the	DET
ajlsi-1012	298	22	levels	level	NOUN
ajlsi-1012	298	23	and	and	CCONJ
ajlsi-1012	298	24	persistence	persistence	NOUN
ajlsi-1012	298	25	of	of	ADP
ajlsi-1012	298	26	antibodies	antibody	NOUN
ajlsi-1012	298	27	necessary	necessary	ADJ
ajlsi-1012	298	28	for	for	ADP
ajlsi-1012	298	29	protective	protective	ADJ
ajlsi-1012	298	30	immunity	immunity	NOUN
ajlsi-1012	298	31	.	.	PUNCT
ajlsi-1012	299	1	therefore	therefore	ADV
ajlsi-1012	299	2	,	,	PUNCT
ajlsi-1012	299	3	serological	serological	ADJ
ajlsi-1012	299	4	tests	test	NOUN
ajlsi-1012	299	5	can	can	AUX
ajlsi-1012	299	6	not	not	PART
ajlsi-1012	299	7	inform	inform	VERB
ajlsi-1012	299	8	an	an	DET
ajlsi-1012	299	9	individual	individual	NOUN
ajlsi-1012	299	10	of	of	ADP
ajlsi-1012	299	11	their	their	PRON
ajlsi-1012	299	12	immunity	immunity	NOUN
ajlsi-1012	299	13	to	to	ADP
ajlsi-1012	299	14	reinfection	reinfection	NOUN
ajlsi-1012	299	15	(	(	PUNCT
ajlsi-1012	299	16	yu	yu	PROPN
ajlsi-1012	299	17	et	et	PROPN
ajlsi-1012	299	18	al	al	PROPN
ajlsi-1012	299	19	.	.	PROPN
ajlsi-1012	299	20	,	,	PUNCT
ajlsi-1012	299	21	2020	2020	NUM
ajlsi-1012	299	22	)	)	PUNCT
ajlsi-1012	299	23	.	.	PUNCT
ajlsi-1012	300	1	however	however	ADV
ajlsi-1012	300	2	,	,	PUNCT
ajlsi-1012	300	3	the	the	DET
ajlsi-1012	300	4	test	test	NOUN
ajlsi-1012	300	5	results	result	NOUN
ajlsi-1012	300	6	may	may	AUX
ajlsi-1012	300	7	also	also	ADV
ajlsi-1012	300	8	help	help	VERB
ajlsi-1012	300	9	in	in	ADP
ajlsi-1012	300	10	choosing	choose	VERB
ajlsi-1012	300	11	convalescent	convalescent	NOUN
ajlsi-1012	300	12	plasma	plasma	NOUN
ajlsi-1012	300	13	,	,	PUNCT
ajlsi-1012	300	14	which	which	PRON
ajlsi-1012	300	15	can	can	AUX
ajlsi-1012	300	16	be	be	AUX
ajlsi-1012	300	17	used	use	VERB
ajlsi-1012	300	18	as	as	ADP
ajlsi-1012	300	19	a	a	DET
ajlsi-1012	300	20	promising	promising	ADJ
ajlsi-1012	300	21	treatment	treatment	NOUN
ajlsi-1012	300	22	option	option	NOUN
ajlsi-1012	300	23	for	for	ADP
ajlsi-1012	300	24	covid-19	covid-19	PROPN
ajlsi-1012	300	25	-	-	PUNCT
ajlsi-1012	300	26	infected	infect	VERB
ajlsi-1012	300	27	individuals	individual	NOUN
ajlsi-1012	300	28	.	.	PUNCT
ajlsi-1012	301	1	antibody	antibody	NOUN
ajlsi-1012	301	2	tests	test	VERB
ajlsi-1012	301	3	the	the	DET
ajlsi-1012	301	4	determination	determination	NOUN
ajlsi-1012	301	5	of	of	ADP
ajlsi-1012	301	6	sars	sar	NOUN
ajlsi-1012	301	7	-	-	PUNCT
ajlsi-1012	301	8	cov-2	cov-2	PART
ajlsi-1012	301	9	exposure	exposure	NOUN
ajlsi-1012	301	10	relies	rely	VERB
ajlsi-1012	301	11	largely	largely	ADV
ajlsi-1012	301	12	on	on	ADP
ajlsi-1012	301	13	the	the	DET
ajlsi-1012	301	14	detection	detection	NOUN
ajlsi-1012	301	15	of	of	ADP
ajlsi-1012	301	16	either	either	CCONJ
ajlsi-1012	301	17	igm	igm	PROPN
ajlsi-1012	301	18	or	or	CCONJ
ajlsi-1012	301	19	igg	igg	PROPN
ajlsi-1012	301	20	antibodies	antibody	NOUN
ajlsi-1012	301	21	that	that	PRON
ajlsi-1012	301	22	are	be	AUX
ajlsi-1012	301	23	specific	specific	ADJ
ajlsi-1012	301	24	for	for	ADP
ajlsi-1012	301	25	various	various	ADJ
ajlsi-1012	301	26	viral	viral	ADJ
ajlsi-1012	301	27	antigens	antigen	NOUN
ajlsi-1012	301	28	,	,	PUNCT
ajlsi-1012	301	29	including	include	VERB
ajlsi-1012	301	30	the	the	DET
ajlsi-1012	301	31	spike	spike	ADJ
ajlsi-1012	301	32	glycoprotein	glycoprotein	NOUN
ajlsi-1012	301	33	(	(	PUNCT
ajlsi-1012	301	34	s1	s1	NOUN
ajlsi-1012	301	35	and	and	CCONJ
ajlsi-1012	301	36	s2	s2	NOUN
ajlsi-1012	301	37	subunits	subunit	NOUN
ajlsi-1012	301	38	)	)	PUNCT
ajlsi-1012	301	39	and	and	CCONJ
ajlsi-1012	301	40	nucleocapsid	nucleocapsid	ADJ
ajlsi-1012	301	41	protein	protein	NOUN
ajlsi-1012	301	42	.	.	PUNCT
ajlsi-1012	302	1	the	the	DET
ajlsi-1012	302	2	methodology	methodology	NOUN
ajlsi-1012	302	3	for	for	ADP
ajlsi-1012	302	4	these	these	DET
ajlsi-1012	302	5	determinations	determination	NOUN
ajlsi-1012	302	6	includes	include	VERB
ajlsi-1012	302	7	the	the	DET
ajlsi-1012	302	8	traditional	traditional	ADJ
ajlsi-1012	302	9	enzyme	enzyme	NOUN
ajlsi-1012	302	10	-	-	PUNCT
ajlsi-1012	302	11	linked	link	VERB
ajlsi-1012	302	12	immunosorbent	immunosorbent	NOUN
ajlsi-1012	302	13	assay	assay	PROPN
ajlsi-1012	302	14	(	(	PUNCT
ajlsi-1012	302	15	elisa	elisa	NOUN
ajlsi-1012	302	16	)	)	PUNCT
ajlsi-1012	302	17	,	,	PUNCT
ajlsi-1012	302	18	immunochromatographic	immunochromatographic	ADJ
ajlsi-1012	302	19	lateral	lateral	ADJ
ajlsi-1012	302	20	flow	flow	NOUN
ajlsi-1012	302	21	assay	assay	NOUN
ajlsi-1012	302	22	,	,	PUNCT
ajlsi-1012	302	23	neutralization	neutralization	NOUN
ajlsi-1012	302	24	bioassay	bioassay	NOUN
ajlsi-1012	302	25	,	,	PUNCT
ajlsi-1012	302	26	and	and	CCONJ
ajlsi-1012	302	27	specific	specific	ADJ
ajlsi-1012	302	28	luminescent	luminescent	NOUN
ajlsi-1012	302	29	immunoassays	immunoassay	NOUN
ajlsi-1012	302	30	.	.	PUNCT
ajlsi-1012	303	1	each	each	PRON
ajlsi-1012	303	2	of	of	ADP
ajlsi-1012	303	3	these	these	DET
ajlsi-1012	303	4	formats	format	NOUN
ajlsi-1012	303	5	brings	bring	VERB
ajlsi-1012	303	6	advantages	advantage	NOUN
ajlsi-1012	303	7	(	(	PUNCT
ajlsi-1012	303	8	speed	speed	NOUN
ajlsi-1012	303	9	,	,	PUNCT
ajlsi-1012	303	10	multiplexing	multiplexing	NOUN
ajlsi-1012	303	11	,	,	PUNCT
ajlsi-1012	303	12	automation	automation	NOUN
ajlsi-1012	303	13	)	)	PUNCT
ajlsi-1012	303	14	and	and	CCONJ
ajlsi-1012	303	15	disadvantages	disadvantage	NOUN
ajlsi-1012	303	16	(	(	PUNCT
ajlsi-1012	303	17	trained	train	VERB
ajlsi-1012	303	18	personnel	personnel	NOUN
ajlsi-1012	303	19	,	,	PUNCT
ajlsi-1012	303	20	dedicated	dedicated	ADJ
ajlsi-1012	303	21	laboratory	laboratory	NOUN
ajlsi-1012	303	22	requirements	requirement	NOUN
ajlsi-1012	303	23	,	,	PUNCT
ajlsi-1012	303	24	etc	etc	X
ajlsi-1012	303	25	.	.	X
ajlsi-1012	303	26	)	)	PUNCT
ajlsi-1012	303	27	.	.	PUNCT
ajlsi-1012	304	1	rapid	rapid	ADJ
ajlsi-1012	304	2	antigen	antigen	ADJ
ajlsi-1012	304	3	tests	test	NOUN
ajlsi-1012	304	4	,	,	PUNCT
ajlsi-1012	304	5	which	which	PRON
ajlsi-1012	304	6	use	use	VERB
ajlsi-1012	304	7	antibodies	antibody	NOUN
ajlsi-1012	304	8	to	to	PART
ajlsi-1012	304	9	detect	detect	VERB
ajlsi-1012	304	10	the	the	DET
ajlsi-1012	304	11	presence	presence	NOUN
ajlsi-1012	304	12	of	of	ADP
ajlsi-1012	304	13	viral	viral	ADJ
ajlsi-1012	304	14	antigen(s	antigen(s	NOUN
ajlsi-1012	304	15	)	)	PUNCT
ajlsi-1012	304	16	in	in	ADP
ajlsi-1012	304	17	serological	serological	ADJ
ajlsi-1012	304	18	samples	sample	NOUN
ajlsi-1012	304	19	,	,	PUNCT
ajlsi-1012	304	20	are	be	AUX
ajlsi-1012	304	21	complementary	complementary	ADJ
ajlsi-1012	304	22	to	to	ADP
ajlsi-1012	304	23	these	these	PRON
ajlsi-1012	304	24	.	.	PUNCT
ajlsi-1012	305	1	major	major	ADJ
ajlsi-1012	305	2	diagnostic	diagnostic	ADJ
ajlsi-1012	305	3	companies	company	NOUN
ajlsi-1012	305	4	are	be	AUX
ajlsi-1012	305	5	currently	currently	ADV
ajlsi-1012	305	6	focusing	focus	VERB
ajlsi-1012	305	7	on	on	ADP
ajlsi-1012	305	8	the	the	DET
ajlsi-1012	305	9	development	development	NOUN
ajlsi-1012	305	10	of	of	ADP
ajlsi-1012	305	11	highthroughput	highthroughput	VERB
ajlsi-1012	305	12	serology	serology	NOUN
ajlsi-1012	305	13	tests	test	NOUN
ajlsi-1012	305	14	.	.	PUNCT
ajlsi-1012	306	1	•	•	NUM
ajlsi-1012	306	2	enzyme	enzyme	NOUN
ajlsi-1012	306	3	-	-	PUNCT
ajlsi-1012	306	4	linked	link	VERB
ajlsi-1012	306	5	immunosorbent	immunosorbent	ADJ
ajlsi-1012	306	6	assays	assay	NOUN
ajlsi-1012	306	7	(	(	PUNCT
ajlsi-1012	306	8	elisa	elisa	NOUN
ajlsi-1012	306	9	):	):	PUNCT
ajlsi-1012	306	10	a	a	DET
ajlsi-1012	306	11	faster	fast	ADV
ajlsi-1012	306	12	serological	serological	ADJ
ajlsi-1012	306	13	test	test	NOUN
ajlsi-1012	306	14	performed	perform	VERB
ajlsi-1012	306	15	in	in	ADP
ajlsi-1012	306	16	a	a	DET
ajlsi-1012	306	17	laboratory	laboratory	NOUN
ajlsi-1012	306	18	that	that	PRON
ajlsi-1012	306	19	provides	provide	VERB
ajlsi-1012	306	20	a	a	DET
ajlsi-1012	306	21	readout	readout	NOUN
ajlsi-1012	306	22	of	of	ADP
ajlsi-1012	306	23	antigen	antigen	NOUN
ajlsi-1012	306	24	-	-	PUNCT
ajlsi-1012	306	25	antibody	antibody	NOUN
ajlsi-1012	306	26	interactions	interaction	NOUN
ajlsi-1012	306	27	.	.	PUNCT
ajlsi-1012	307	1	essentially	essentially	ADV
ajlsi-1012	307	2	,	,	PUNCT
ajlsi-1012	307	3	patient	patient	ADJ
ajlsi-1012	307	4	antibodies	antibody	NOUN
ajlsi-1012	307	5	are	be	AUX
ajlsi-1012	307	6	“	"	PUNCT
ajlsi-1012	307	7	sandwiched	sandwich	VERB
ajlsi-1012	307	8	”	"	PUNCT
ajlsi-1012	307	9	between	between	ADP
ajlsi-1012	307	10	the	the	DET
ajlsi-1012	307	11	viral	viral	ADJ
ajlsi-1012	307	12	protein	protein	NOUN
ajlsi-1012	307	13	of	of	ADP
ajlsi-1012	307	14	interest	interest	NOUN
ajlsi-1012	307	15	and	and	CCONJ
ajlsi-1012	307	16	reporter	reporter	NOUN
ajlsi-1012	307	17	antibodies	antibodie	VERB
ajlsi-1012	307	18	so	so	SCONJ
ajlsi-1012	307	19	that	that	SCONJ
ajlsi-1012	307	20	any	any	DET
ajlsi-1012	307	21	active	active	ADJ
ajlsi-1012	307	22	patient	patient	ADJ
ajlsi-1012	307	23	antibodies	antibody	NOUN
ajlsi-1012	307	24	are	be	AUX
ajlsi-1012	307	25	detected	detect	VERB
ajlsi-1012	307	26	.	.	PUNCT
ajlsi-1012	308	1	a	a	DET
ajlsi-1012	308	2	serological	serological	ADJ
ajlsi-1012	308	3	assay	assay	NOUN
ajlsi-1012	308	4	was	be	AUX
ajlsi-1012	308	5	performed	perform	VERB
ajlsi-1012	308	6	using	use	VERB
ajlsi-1012	308	7	an	an	DET
ajlsi-1012	308	8	elisa	elisa	NOUN
ajlsi-1012	308	9	kit	kit	NOUN
ajlsi-1012	308	10	that	that	PRON
ajlsi-1012	308	11	was	be	AUX
ajlsi-1012	308	12	developed	develop	VERB
ajlsi-1012	308	13	for	for	ADP
ajlsi-1012	308	14	detecting	detect	VERB
ajlsi-1012	308	15	igm	igm	PROPN
ajlsi-1012	308	16	or	or	CCONJ
ajlsi-1012	308	17	igg	igg	PROPN
ajlsi-1012	308	18	antibodies	antibodie	VERB
ajlsi-1012	308	19	against	against	ADP
ajlsi-1012	308	20	the	the	DET
ajlsi-1012	308	21	n	n	ADJ
ajlsi-1012	308	22	proteins	protein	NOUN
ajlsi-1012	308	23	of	of	ADP
ajlsi-1012	308	24	sars	sar	NOUN
ajlsi-1012	308	25	-	-	PUNCT
ajlsi-1012	308	26	cov-2	cov-2	NOUN
ajlsi-1012	308	27	.	.	PUNCT
ajlsi-1012	309	1	for	for	ADP
ajlsi-1012	309	2	igm	igm	PROPN
ajlsi-1012	309	3	detection	detection	PROPN
ajlsi-1012	309	4	,	,	PUNCT
ajlsi-1012	309	5	elisa	elisa	NOUN
ajlsi-1012	309	6	plates	plate	NOUN
ajlsi-1012	309	7	were	be	AUX
ajlsi-1012	309	8	previously	previously	ADV
ajlsi-1012	309	9	coated	coat	VERB
ajlsi-1012	309	10	with	with	ADP
ajlsi-1012	309	11	mouse	mouse	NOUN
ajlsi-1012	309	12	and	and	CCONJ
ajlsi-1012	309	13	anti	anti	ADJ
ajlsi-1012	309	14	-	-	ADJ
ajlsi-1012	309	15	human	human	ADJ
ajlsi-1012	309	16	antibodies	antibody	NOUN
ajlsi-1012	309	17	.	.	PUNCT
ajlsi-1012	310	1	this	this	DET
ajlsi-1012	310	2	test	test	NOUN
ajlsi-1012	310	3	can	can	AUX
ajlsi-1012	310	4	be	be	AUX
ajlsi-1012	310	5	qualitative	qualitative	ADJ
ajlsi-1012	310	6	or	or	CCONJ
ajlsi-1012	310	7	quantitative	quantitative	ADJ
ajlsi-1012	310	8	and	and	CCONJ
ajlsi-1012	310	9	is	be	AUX
ajlsi-1012	310	10	generally	generally	ADV
ajlsi-1012	310	11	a	a	DET
ajlsi-1012	310	12	lab	lab	NOUN
ajlsi-1012	310	13	-	-	PUNCT
ajlsi-1012	310	14	based	base	VERB
ajlsi-1012	310	15	test	test	NOUN
ajlsi-1012	310	16	that	that	PRON
ajlsi-1012	310	17	is	be	AUX
ajlsi-1012	310	18	obtainable	obtainable	ADJ
ajlsi-1012	310	19	within	within	ADP
ajlsi-1012	310	20	a	a	DET
ajlsi-1012	310	21	few	few	ADJ
ajlsi-1012	310	22	hours	hour	NOUN
ajlsi-1012	310	23	.	.	PUNCT
ajlsi-1012	311	1	these	these	DET
ajlsi-1012	311	2	tests	test	NOUN
ajlsi-1012	311	3	usually	usually	ADV
ajlsi-1012	311	4	use	use	VERB
ajlsi-1012	311	5	whole	whole	ADJ
ajlsi-1012	311	6	blood	blood	NOUN
ajlsi-1012	311	7	,	,	PUNCT
ajlsi-1012	311	8	plasma	plasma	NOUN
ajlsi-1012	311	9	,	,	PUNCT
ajlsi-1012	311	10	or	or	CCONJ
ajlsi-1012	311	11	serum	serum	NOUN
ajlsi-1012	311	12	samples	sample	NOUN
ajlsi-1012	311	13	from	from	ADP
ajlsi-1012	311	14	patients	patient	NOUN
ajlsi-1012	311	15	.	.	PUNCT
ajlsi-1012	312	1	the	the	DET
ajlsi-1012	312	2	test	test	NOUN
ajlsi-1012	312	3	relies	rely	VERB
ajlsi-1012	312	4	on	on	ADP
ajlsi-1012	312	5	a	a	DET
ajlsi-1012	312	6	plate	plate	NOUN
ajlsi-1012	312	7	that	that	PRON
ajlsi-1012	312	8	is	be	AUX
ajlsi-1012	312	9	coated	coat	VERB
ajlsi-1012	312	10	with	with	ADP
ajlsi-1012	312	11	a	a	DET
ajlsi-1012	312	12	viral	viral	ADJ
ajlsi-1012	312	13	protein	protein	NOUN
ajlsi-1012	312	14	of	of	ADP
ajlsi-1012	312	15	interest	interest	NOUN
ajlsi-1012	312	16	,	,	PUNCT
ajlsi-1012	312	17	such	such	ADJ
ajlsi-1012	312	18	as	as	ADP
ajlsi-1012	312	19	spike	spike	ADJ
ajlsi-1012	312	20	protein	protein	NOUN
ajlsi-1012	312	21	.	.	PUNCT
ajlsi-1012	313	1	patient	patient	ADJ
ajlsi-1012	313	2	samples	sample	NOUN
ajlsi-1012	313	3	are	be	AUX
ajlsi-1012	313	4	then	then	ADV
ajlsi-1012	313	5	incubated	incubate	VERB
ajlsi-1012	313	6	with	with	ADP
ajlsi-1012	313	7	the	the	DET
ajlsi-1012	313	8	protein	protein	NOUN
ajlsi-1012	313	9	,	,	PUNCT
ajlsi-1012	313	10	and	and	CCONJ
ajlsi-1012	313	11	if	if	SCONJ
ajlsi-1012	313	12	the	the	DET
ajlsi-1012	313	13	patient	patient	NOUN
ajlsi-1012	313	14	has	have	VERB
ajlsi-1012	313	15	antibodies	antibody	NOUN
ajlsi-1012	313	16	to	to	ADP
ajlsi-1012	313	17	the	the	DET
ajlsi-1012	313	18	viral	viral	ADJ
ajlsi-1012	313	19	protein	protein	NOUN
ajlsi-1012	313	20	,	,	PUNCT
ajlsi-1012	313	21	they	they	PRON
ajlsi-1012	313	22	bind	bind	VERB
ajlsi-1012	313	23	together	together	ADV
ajlsi-1012	313	24	.	.	PUNCT
ajlsi-1012	314	1	the	the	DET
ajlsi-1012	314	2	bound	bind	VERB
ajlsi-1012	314	3	antibody	antibody	NOUN
ajlsi-1012	314	4	-	-	PUNCT
ajlsi-1012	314	5	protein	protein	NOUN
ajlsi-1012	314	6	complex	complex	NOUN
ajlsi-1012	314	7	can	can	AUX
ajlsi-1012	314	8	then	then	ADV
ajlsi-1012	314	9	be	be	AUX
ajlsi-1012	314	10	detected	detect	VERB
ajlsi-1012	314	11	with	with	ADP
ajlsi-1012	314	12	another	another	DET
ajlsi-1012	314	13	wash	wash	NOUN
ajlsi-1012	314	14	of	of	ADP
ajlsi-1012	314	15	antibodies	antibody	NOUN
ajlsi-1012	314	16	that	that	PRON
ajlsi-1012	314	17	produce	produce	VERB
ajlsi-1012	314	18	a	a	DET
ajlsi-1012	314	19	colored	colored	ADJ
ajlsi-1012	314	20	or	or	CCONJ
ajlsi-1012	314	21	fluorescent	fluorescent	NOUN
ajlsi-1012	314	22	-	-	PUNCT
ajlsi-1012	314	23	based	base	VERB
ajlsi-1012	314	24	readout	readout	NOUN
ajlsi-1012	314	25	.	.	PUNCT
ajlsi-1012	315	1	(	(	PUNCT
ajlsi-1012	315	2	liu	liu	PROPN
ajlsi-1012	315	3	et	et	PROPN
ajlsi-1012	315	4	al	al	PROPN
ajlsi-1012	315	5	.	.	PROPN
ajlsi-1012	315	6	,	,	PUNCT
ajlsi-1012	315	7	2020	2020	NUM
ajlsi-1012	315	8	)	)	PUNCT
ajlsi-1012	315	9	.	.	PUNCT
ajlsi-1012	316	1	elisa	elisa	PROPN
ajlsi-1012	316	2	is	be	AUX
ajlsi-1012	316	3	speedy	speedy	ADJ
ajlsi-1012	316	4	,	,	PUNCT
ajlsi-1012	316	5	has	have	VERB
ajlsi-1012	316	6	the	the	DET
ajlsi-1012	316	7	ability	ability	NOUN
ajlsi-1012	316	8	to	to	PART
ajlsi-1012	316	9	test	test	VERB
ajlsi-1012	316	10	multiple	multiple	ADJ
ajlsi-1012	316	11	samples	sample	NOUN
ajlsi-1012	316	12	,	,	PUNCT
ajlsi-1012	316	13	and	and	CCONJ
ajlsi-1012	316	14	is	be	AUX
ajlsi-1012	316	15	adaptable	adaptable	ADJ
ajlsi-1012	316	16	to	to	ADP
ajlsi-1012	316	17	automation	automation	VERB
ajlsi-1012	316	18	for	for	ADP
ajlsi-1012	316	19	increased	increase	VERB
ajlsi-1012	316	20	throughput	throughput	NOUN
ajlsi-1012	316	21	,	,	PUNCT
ajlsi-1012	316	22	but	but	CCONJ
ajlsi-1012	316	23	can	can	AUX
ajlsi-1012	316	24	be	be	AUX
ajlsi-1012	316	25	variable	variable	ADJ
ajlsi-1012	316	26	in	in	ADP
ajlsi-1012	316	27	sensitivity	sensitivity	NOUN
ajlsi-1012	316	28	and	and	CCONJ
ajlsi-1012	316	29	is	be	AUX
ajlsi-1012	316	30	suitable	suitable	ADJ
ajlsi-1012	316	31	for	for	ADP
ajlsi-1012	316	32	point	point	NOUN
ajlsi-1012	316	33	-	-	PUNCT
ajlsi-1012	316	34	of	of	ADP
ajlsi-1012	316	35	-	-	PUNCT
ajlsi-1012	316	36	care	care	NOUN
ajlsi-1012	316	37	determinations	determination	NOUN
ajlsi-1012	316	38	.	.	PUNCT
ajlsi-1012	317	1	•	•	NUM
ajlsi-1012	317	2	lateral	lateral	ADJ
ajlsi-1012	317	3	flow	flow	NOUN
ajlsi-1012	317	4	assays	assay	NOUN
ajlsi-1012	317	5	(	(	PUNCT
ajlsi-1012	317	6	lfas	lfas	NOUN
ajlsi-1012	317	7	):	):	PUNCT
ajlsi-1012	317	8	lateral	lateral	ADJ
ajlsi-1012	317	9	flow	flow	NOUN
ajlsi-1012	317	10	assays	assay	NOUN
ajlsi-1012	317	11	(	(	PUNCT
ajlsi-1012	317	12	lfas	lfas	NOUN
ajlsi-1012	317	13	)	)	PUNCT
ajlsi-1012	317	14	,	,	PUNCT
ajlsi-1012	317	15	also	also	ADV
ajlsi-1012	317	16	called	call	VERB
ajlsi-1012	317	17	rapid	rapid	ADJ
ajlsi-1012	317	18	diagnostic	diagnostic	ADJ
ajlsi-1012	317	19	tests	test	NOUN
ajlsi-1012	317	20	(	(	PUNCT
ajlsi-1012	317	21	rdts	rdts	ADJ
ajlsi-1012	317	22	)	)	PUNCT
ajlsi-1012	317	23	,	,	PUNCT
ajlsi-1012	317	24	display	display	VERB
ajlsi-1012	317	25	a	a	DET
ajlsi-1012	317	26	colorimetric	colorimetric	ADJ
ajlsi-1012	317	27	,	,	PUNCT
ajlsi-1012	317	28	qualitative	qualitative	ADJ
ajlsi-1012	317	29	readout	readout	NOUN
ajlsi-1012	317	30	of	of	ADP
ajlsi-1012	317	31	the	the	DET
ajlsi-1012	317	32	presence	presence	NOUN
ajlsi-1012	317	33	of	of	ADP
ajlsi-1012	317	34	antibodies	antibody	NOUN
ajlsi-1012	317	35	.	.	PUNCT
ajlsi-1012	318	1	these	these	PRON
ajlsi-1012	318	2	are	be	AUX
ajlsi-1012	318	3	often	often	ADV
ajlsi-1012	318	4	used	use	VERB
ajlsi-1012	318	5	in	in	ADP
ajlsi-1012	318	6	point	point	NOUN
ajlsi-1012	318	7	-	-	PUNCT
ajlsi-1012	318	8	of	of	ADP
ajlsi-1012	318	9	-	-	PUNCT
ajlsi-1012	318	10	care	care	NOUN
ajlsi-1012	318	11	settings	setting	NOUN
ajlsi-1012	318	12	.	.	PUNCT
ajlsi-1012	319	1	the	the	DET
ajlsi-1012	319	2	patient	patient	ADJ
ajlsi-1012	319	3	sample	sample	NOUN
ajlsi-1012	319	4	is	be	AUX
ajlsi-1012	319	5	passed	pass	VERB
ajlsi-1012	319	6	through	through	ADP
ajlsi-1012	319	7	a	a	DET
ajlsi-1012	319	8	membrane	membrane	NOUN
ajlsi-1012	319	9	on	on	ADP
ajlsi-1012	319	10	which	which	PRON
ajlsi-1012	319	11	the	the	DET
ajlsi-1012	319	12	target	target	NOUN
ajlsi-1012	319	13	antigen	antigen	NOUN
ajlsi-1012	319	14	is	be	AUX
ajlsi-1012	319	15	anchored	anchor	VERB
ajlsi-1012	319	16	.	.	PUNCT
ajlsi-1012	320	1	if	if	SCONJ
ajlsi-1012	320	2	the	the	DET
ajlsi-1012	320	3	sample	sample	NOUN
ajlsi-1012	320	4	contains	contain	VERB
ajlsi-1012	320	5	antibodies	antibody	NOUN
ajlsi-1012	320	6	specific	specific	ADJ
ajlsi-1012	320	7	to	to	ADP
ajlsi-1012	320	8	that	that	DET
ajlsi-1012	320	9	antigen	antigen	ADV
ajlsi-1012	320	10	,	,	PUNCT
ajlsi-1012	320	11	they	they	PRON
ajlsi-1012	320	12	form	form	VERB
ajlsi-1012	320	13	a	a	DET
ajlsi-1012	320	14	complex	complex	NOUN
ajlsi-1012	320	15	that	that	PRON
ajlsi-1012	320	16	results	result	VERB
ajlsi-1012	320	17	in	in	ADP
ajlsi-1012	320	18	a	a	DET
ajlsi-1012	320	19	colored	colored	ADJ
ajlsi-1012	320	20	band	band	NOUN
ajlsi-1012	320	21	on	on	ADP
ajlsi-1012	320	22	the	the	DET
ajlsi-1012	320	23	strip	strip	NOUN
ajlsi-1012	320	24	.	.	PUNCT
ajlsi-1012	321	1	these	these	PRON
ajlsi-1012	321	2	are	be	AUX
ajlsi-1012	321	3	similar	similar	ADJ
ajlsi-1012	321	4	to	to	ADP
ajlsi-1012	321	5	pregnancy	pregnancy	NOUN
ajlsi-1012	321	6	tests	test	NOUN
ajlsi-1012	321	7	.	.	PUNCT
ajlsi-1012	322	1	this	this	PRON
ajlsi-1012	322	2	is	be	AUX
ajlsi-1012	322	3	facilitated	facilitate	VERB
ajlsi-1012	322	4	by	by	ADP
ajlsi-1012	322	5	a	a	DET
ajlsi-1012	322	6	recombinant	recombinant	ADJ
ajlsi-1012	322	7	antigen	antigen	ADJ
ajlsi-1012	322	8	present	present	ADJ
ajlsi-1012	322	9	on	on	ADP
ajlsi-1012	322	10	immunochromatographic	immunochromatographic	ADJ
ajlsi-1012	322	11	paper	paper	NOUN
ajlsi-1012	322	12	,	,	PUNCT
ajlsi-1012	322	13	on	on	ADP
ajlsi-1012	322	14	which	which	PRON
ajlsi-1012	322	15	the	the	DET
ajlsi-1012	322	16	test	test	NOUN
ajlsi-1012	322	17	sera	sera	NOUN
ajlsi-1012	322	18	are	be	AUX
ajlsi-1012	322	19	applied	apply	VERB
ajlsi-1012	322	20	,	,	PUNCT
ajlsi-1012	322	21	and	and	CCONJ
ajlsi-1012	322	22	antigen	antigen	ADJ
ajlsi-1012	322	23	antibody	antibody	NOUN
ajlsi-1012	322	24	binding	bind	VERB
ajlsi-1012	322	25	is	be	AUX
ajlsi-1012	322	26	detected	detect	VERB
ajlsi-1012	322	27	visually	visually	ADV
ajlsi-1012	322	28	by	by	ADP
ajlsi-1012	322	29	a	a	DET
ajlsi-1012	322	30	color	color	NOUN
ajlsi-1012	322	31	change	change	NOUN
ajlsi-1012	322	32	on	on	ADP
ajlsi-1012	322	33	a	a	DET
ajlsi-1012	322	34	membrane	membrane	NOUN
ajlsi-1012	322	35	.	.	PUNCT
ajlsi-1012	323	1	the	the	DET
ajlsi-1012	323	2	results	result	NOUN
ajlsi-1012	323	3	can	can	AUX
ajlsi-1012	323	4	be	be	AUX
ajlsi-1012	323	5	obtained	obtain	VERB
ajlsi-1012	323	6	within	within	ADP
ajlsi-1012	323	7	15–20	15–20	NUM
ajlsi-1012	323	8	minutes	minute	NOUN
ajlsi-1012	323	9	.	.	PUNCT
ajlsi-1012	324	1	the	the	DET
ajlsi-1012	324	2	test	test	NOUN
ajlsi-1012	324	3	is	be	AUX
ajlsi-1012	324	4	inexpensive	inexpensive	ADJ
ajlsi-1012	324	5	and	and	CCONJ
ajlsi-1012	324	6	requires	require	VERB
ajlsi-1012	324	7	no	no	DET
ajlsi-1012	324	8	trained	train	VERB
ajlsi-1012	324	9	personnel	personnel	NOUN
ajlsi-1012	324	10	,	,	PUNCT
ajlsi-1012	324	11	but	but	CCONJ
ajlsi-1012	324	12	it	it	PRON
ajlsi-1012	324	13	provides	provide	VERB
ajlsi-1012	324	14	only	only	ADV
ajlsi-1012	324	15	qualitative	qualitative	ADJ
ajlsi-1012	324	16	results	result	NOUN
ajlsi-1012	324	17	.	.	PUNCT
ajlsi-1012	325	1	when	when	SCONJ
ajlsi-1012	325	2	used	use	VERB
ajlsi-1012	325	3	in	in	ADP
ajlsi-1012	325	4	conjunction	conjunction	NOUN
ajlsi-1012	325	5	with	with	ADP
ajlsi-1012	325	6	rapid	rapid	ADJ
ajlsi-1012	325	7	antigen	antigen	ADJ
ajlsi-1012	325	8	tests	test	NOUN
ajlsi-1012	325	9	,	,	PUNCT
ajlsi-1012	325	10	where	where	SCONJ
ajlsi-1012	325	11	antisars	antisar	NOUN
ajlsi-1012	325	12	-	-	PUNCT
ajlsi-1012	325	13	cov2	cov2	PROPN
ajlsi-1012	325	14	antibodies	antibody	NOUN
ajlsi-1012	325	15	are	be	AUX
ajlsi-1012	325	16	used	use	VERB
ajlsi-1012	325	17	in	in	ADP
ajlsi-1012	325	18	place	place	NOUN
ajlsi-1012	325	19	of	of	ADP
ajlsi-1012	325	20	immobilized	immobilized	ADJ
ajlsi-1012	325	21	viral	viral	ADJ
ajlsi-1012	325	22	antigen	antigen	ADV
ajlsi-1012	325	23	,	,	PUNCT
ajlsi-1012	325	24	they	they	PRON
ajlsi-1012	325	25	allow	allow	VERB
ajlsi-1012	325	26	for	for	ADP
ajlsi-1012	325	27	a	a	DET
ajlsi-1012	325	28	more	more	ADV
ajlsi-1012	325	29	direct	direct	ADJ
ajlsi-1012	325	30	assessment	assessment	NOUN
ajlsi-1012	325	31	of	of	ADP
ajlsi-1012	325	32	ongoing	ongoing	ADJ
ajlsi-1012	325	33	infection	infection	NOUN
ajlsi-1012	325	34	.	.	PUNCT
ajlsi-1012	326	1	•	•	NUM
ajlsi-1012	326	2	neutralization	neutralization	NOUN
ajlsi-1012	326	3	assays	assay	NOUN
ajlsi-1012	326	4	:	:	PUNCT
ajlsi-1012	326	5	determine	determine	VERB
ajlsi-1012	326	6	an	an	DET
ajlsi-1012	326	7	antibody	antibody	NOUN
ajlsi-1012	326	8	’s	’s	PART
ajlsi-1012	326	9	ability	ability	NOUN
ajlsi-1012	326	10	to	to	PART
ajlsi-1012	326	11	prevent	prevent	VERB
ajlsi-1012	326	12	virus	virus	NOUN
ajlsi-1012	326	13	infection	infection	NOUN
ajlsi-1012	326	14	of	of	ADP
ajlsi-1012	326	15	cultured	cultured	ADJ
ajlsi-1012	326	16	cells	cell	NOUN
ajlsi-1012	326	17	and	and	CCONJ
ajlsi-1012	326	18	the	the	DET
ajlsi-1012	326	19	cytopathic	cytopathic	ADJ
ajlsi-1012	326	20	effects	effect	NOUN
ajlsi-1012	326	21	of	of	ADP
ajlsi-1012	326	22	viral	viral	ADJ
ajlsi-1012	326	23	replication	replication	NOUN
ajlsi-1012	326	24	.	.	PUNCT
ajlsi-1012	327	1	for	for	ADP
ajlsi-1012	327	2	this	this	DET
ajlsi-1012	327	3	assay	assay	NOUN
ajlsi-1012	327	4	,	,	PUNCT
ajlsi-1012	327	5	patient	patient	ADJ
ajlsi-1012	327	6	samples	sample	NOUN
ajlsi-1012	327	7	of	of	ADP
ajlsi-1012	327	8	whole	whole	ADJ
ajlsi-1012	327	9	blood	blood	NOUN
ajlsi-1012	327	10	,	,	PUNCT
ajlsi-1012	327	11	serum	serum	NOUN
ajlsi-1012	327	12	,	,	PUNCT
ajlsi-1012	327	13	or	or	CCONJ
ajlsi-1012	327	14	plasma	plasma	NOUN
ajlsi-1012	327	15	are	be	AUX
ajlsi-1012	327	16	diluted	dilute	VERB
ajlsi-1012	327	17	and	and	CCONJ
ajlsi-1012	327	18	added	add	VERB
ajlsi-1012	327	19	at	at	ADP
ajlsi-1012	327	20	decreasing	decrease	VERB
ajlsi-1012	327	21	concentrations	concentration	NOUN
ajlsi-1012	327	22	to	to	ADP
ajlsi-1012	327	23	the	the	DET
ajlsi-1012	327	24	cell	cell	NOUN
ajlsi-1012	327	25	cultures	culture	NOUN
ajlsi-1012	327	26	.	.	PUNCT
ajlsi-1012	328	1	if	if	SCONJ
ajlsi-1012	328	2	neutralizing	neutralize	VERB
ajlsi-1012	328	3	antibodies	antibody	NOUN
ajlsi-1012	328	4	are	be	AUX
ajlsi-1012	328	5	present	present	ADJ
ajlsi-1012	328	6	,	,	PUNCT
ajlsi-1012	328	7	their	their	PRON
ajlsi-1012	328	8	levels	level	NOUN
ajlsi-1012	328	9	can	can	AUX
ajlsi-1012	328	10	be	be	AUX
ajlsi-1012	328	11	measured	measure	VERB
ajlsi-1012	328	12	by	by	ADP
ajlsi-1012	328	13	determining	determine	VERB
ajlsi-1012	328	14	the	the	DET
ajlsi-1012	328	15	threshold	threshold	NOUN
ajlsi-1012	328	16	at	at	ADP
ajlsi-1012	328	17	which	which	PRON
ajlsi-1012	328	18	they	they	PRON
ajlsi-1012	328	19	are	be	AUX
ajlsi-1012	328	20	able	able	ADJ
ajlsi-1012	328	21	to	to	PART
ajlsi-1012	328	22	prevent	prevent	VERB
ajlsi-1012	328	23	viral	viral	ADJ
ajlsi-1012	328	24	replication	replication	NOUN
ajlsi-1012	328	25	in	in	ADP
ajlsi-1012	328	26	the	the	DET
ajlsi-1012	328	27	infected	infected	ADJ
ajlsi-1012	328	28	cell	cell	NOUN
ajlsi-1012	328	29	cultures	culture	NOUN
ajlsi-1012	328	30	.	.	PUNCT
ajlsi-1012	329	1	the	the	DET
ajlsi-1012	329	2	time	time	NOUN
ajlsi-1012	329	3	to	to	PART
ajlsi-1012	329	4	results	result	NOUN
ajlsi-1012	329	5	for	for	ADP
ajlsi-1012	329	6	neutralization	neutralization	NOUN
ajlsi-1012	329	7	assays	assay	NOUN
ajlsi-1012	329	8	is	be	AUX
ajlsi-1012	329	9	typically	typically	ADV
ajlsi-1012	329	10	3–5	3–5	NUM
ajlsi-1012	329	11	days	day	NOUN
ajlsi-1012	329	12	,	,	PUNCT
ajlsi-1012	329	13	but	but	CCONJ
ajlsi-1012	329	14	recent	recent	ADJ
ajlsi-1012	329	15	advances	advance	NOUN
ajlsi-1012	329	16	have	have	AUX
ajlsi-1012	329	17	reduced	reduce	VERB
ajlsi-1012	329	18	this	this	PRON
ajlsi-1012	329	19	to	to	ADP
ajlsi-1012	329	20	hours	hour	NOUN
ajlsi-1012	329	21	.	.	PUNCT
ajlsi-1012	330	1	this	this	DET
ajlsi-1012	330	2	type	type	NOUN
ajlsi-1012	330	3	of	of	ADP
ajlsi-1012	330	4	testing	testing	NOUN
ajlsi-1012	330	5	requires	require	VERB
ajlsi-1012	330	6	cell	cell	NOUN
ajlsi-1012	330	7	culture	culture	NOUN
ajlsi-1012	330	8	facilities	facility	NOUN
ajlsi-1012	330	9	,	,	PUNCT
ajlsi-1012	330	10	and	and	CCONJ
ajlsi-1012	330	11	in	in	ADP
ajlsi-1012	330	12	the	the	DET
ajlsi-1012	330	13	case	case	NOUN
ajlsi-1012	330	14	of	of	ADP
ajlsi-1012	330	15	the	the	DET
ajlsi-1012	330	16	sars	sars	PROPN
ajlsi-1012	330	17	coronavirus	coronavirus	PROPN
ajlsi-1012	330	18	,	,	PUNCT
ajlsi-1012	330	19	biosafety	biosafety	NOUN
ajlsi-1012	330	20	level	level	NOUN
ajlsi-1012	330	21	3	3	NUM
ajlsi-1012	330	22	(	(	PUNCT
ajlsi-1012	330	23	bsl3	bsl3	PROPN
ajlsi-1012	330	24	)	)	PUNCT
ajlsi-1012	330	25	laboratories	laboratory	NOUN
ajlsi-1012	330	26	are	be	AUX
ajlsi-1012	330	27	required	require	VERB
ajlsi-1012	330	28	.	.	PUNCT
ajlsi-1012	331	1	despite	despite	SCONJ
ajlsi-1012	331	2	these	these	DET
ajlsi-1012	331	3	limitations	limitation	NOUN
ajlsi-1012	331	4	,	,	PUNCT
ajlsi-1012	331	5	the	the	DET
ajlsi-1012	331	6	determination	determination	NOUN
ajlsi-1012	331	7	of	of	ADP
ajlsi-1012	331	8	neutralizing	neutralize	VERB
ajlsi-1012	331	9	antibodies	antibody	NOUN
ajlsi-1012	331	10	is	be	AUX
ajlsi-1012	331	11	important	important	ADJ
ajlsi-1012	331	12	in	in	ADP
ajlsi-1012	331	13	the	the	DET
ajlsi-1012	331	14	short	short	ADJ
ajlsi-1012	331	15	term	term	NOUN
ajlsi-1012	331	16	for	for	ADP
ajlsi-1012	331	17	the	the	DET
ajlsi-1012	331	18	therapeutic	therapeutic	ADJ
ajlsi-1012	331	19	application	application	NOUN
ajlsi-1012	331	20	of	of	ADP
ajlsi-1012	331	21	convalescent	convalescent	NOUN
ajlsi-1012	331	22	plasma	plasma	NOUN
ajlsi-1012	331	23	and	and	CCONJ
ajlsi-1012	331	24	in	in	ADP
ajlsi-1012	331	25	the	the	DET
ajlsi-1012	331	26	long	long	ADJ
ajlsi-1012	331	27	term	term	NOUN
ajlsi-1012	331	28	for	for	ADP
ajlsi-1012	331	29	vaccine	vaccine	NOUN
ajlsi-1012	331	30	development	development	NOUN
ajlsi-1012	331	31	.	.	PUNCT
ajlsi-1012	332	1	•	•	NUM
ajlsi-1012	332	2	luminescent	luminescent	PROPN
ajlsi-1012	332	3	immunoassay	immunoassay	PROPN
ajlsi-1012	332	4	:	:	PUNCT
ajlsi-1012	332	5	this	this	DET
ajlsi-1012	332	6	test	test	NOUN
ajlsi-1012	332	7	shows	show	VERB
ajlsi-1012	332	8	whether	whether	SCONJ
ajlsi-1012	332	9	a	a	DET
ajlsi-1012	332	10	patient	patient	NOUN
ajlsi-1012	332	11	has	have	VERB
ajlsi-1012	332	12	antibodies	antibody	NOUN
ajlsi-1012	332	13	to	to	ADP
ajlsi-1012	332	14	a	a	DET
ajlsi-1012	332	15	pathogen	pathogen	NOUN
ajlsi-1012	332	16	by	by	ADP
ajlsi-1012	332	17	displaying	display	VERB
ajlsi-1012	332	18	a	a	DET
ajlsi-1012	332	19	fluorescent	fluorescent	ADJ
ajlsi-1012	332	20	signal	signal	NOUN
ajlsi-1012	332	21	when	when	SCONJ
ajlsi-1012	332	22	patient	patient	ADJ
ajlsi-1012	332	23	antibodies	antibodie	VERB
ajlsi-1012	332	24	interact	interact	VERB
ajlsi-1012	332	25	with	with	ADP
ajlsi-1012	332	26	virus	virus	NOUN
ajlsi-1012	332	27	proteins	protein	NOUN
ajlsi-1012	332	28	.	.	PUNCT
ajlsi-1012	333	1	luminescent	luminescent	NOUN
ajlsi-1012	333	2	immunoassays	immunoassay	NOUN
ajlsi-1012	333	3	comprise	comprise	NOUN
ajlsi-1012	333	4	methods	method	NOUN
ajlsi-1012	333	5	that	that	PRON
ajlsi-1012	333	6	lower	lower	VERB
ajlsi-1012	333	7	the	the	DET
ajlsi-1012	333	8	limits	limit	NOUN
ajlsi-1012	333	9	of	of	ADP
ajlsi-1012	333	10	detection	detection	NOUN
ajlsi-1012	333	11	for	for	ADP
ajlsi-1012	333	12	antibody	antibody	NOUN
ajlsi-1012	333	13	-	-	PUNCT
ajlsi-1012	333	14	based	base	VERB
ajlsi-1012	333	15	reagents	reagent	NOUN
ajlsi-1012	333	16	.	.	PUNCT
ajlsi-1012	334	1	generally	generally	ADV
ajlsi-1012	334	2	,	,	PUNCT
ajlsi-1012	334	3	they	they	PRON
ajlsi-1012	334	4	involve	involve	VERB
ajlsi-1012	334	5	chemiluminescence	chemiluminescence	NOUN
ajlsi-1012	334	6	and	and	CCONJ
ajlsi-1012	334	7	fluorescence	fluorescence	NOUN
ajlsi-1012	334	8	.	.	PUNCT
ajlsi-1012	335	1	for	for	ADP
ajlsi-1012	335	2	sarscov-2	sarscov-2	NUM
ajlsi-1012	335	3	,	,	PUNCT
ajlsi-1012	335	4	two	two	NUM
ajlsi-1012	335	5	-	-	PUNCT
ajlsi-1012	335	6	step	step	NOUN
ajlsi-1012	335	7	chemiluminescent	chemiluminescent	NOUN
ajlsi-1012	335	8	immunoassays	immunoassay	NOUN
ajlsi-1012	335	9	for	for	ADP
ajlsi-1012	335	10	the	the	DET
ajlsi-1012	335	11	detection	detection	NOUN
ajlsi-1012	335	12	of	of	ADP
ajlsi-1012	335	13	igg	igg	PROPN
ajlsi-1012	335	14	and	and	CCONJ
ajlsi-1012	335	15	igm	igm	PROPN
ajlsi-1012	335	16	sars	sars	PROPN
ajlsi-1012	335	17	-	-	PUNCT
ajlsi-1012	335	18	cov-2	cov-2	NOUN
ajlsi-1012	335	19	antibodies	antibody	NOUN
ajlsi-1012	335	20	in	in	ADP
ajlsi-1012	335	21	human	human	ADJ
ajlsi-1012	335	22	serum	serum	NOUN
ajlsi-1012	335	23	or	or	CCONJ
ajlsi-1012	335	24	plasma	plasma	NOUN
ajlsi-1012	335	25	have	have	AUX
ajlsi-1012	335	26	been	be	AUX
ajlsi-1012	335	27	demonstrated	demonstrate	VERB
ajlsi-1012	335	28	.	.	PUNCT
ajlsi-1012	336	1	samples	sample	NOUN
ajlsi-1012	336	2	react	react	VERB
ajlsi-1012	336	3	with	with	ADP
ajlsi-1012	336	4	paramagnetic	paramagnetic	ADJ
ajlsi-1012	336	5	microparticles	microparticle	NOUN
ajlsi-1012	336	6	coated	coat	VERB
ajlsi-1012	336	7	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	336	8	pa	pa	PROPN
ajlsi-1012	336	9	ge	ge	PROPN
ajlsi-1012	336	10	37	37	NUM
ajlsi-1012	336	11	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	336	12	am	am	NOUN
ajlsi-1012	336	13	.	.	PUNCT
ajlsi-1012	337	1	j.	j.	PROPN
ajlsi-1012	337	2	life	life	PROPN
ajlsi-1012	337	3	sci	sci	PROPN
ajlsi-1012	337	4	.	.	PUNCT
ajlsi-1012	337	5	innov	innov	PROPN
ajlsi-1012	337	6	.	.	PUNCT
ajlsi-1012	338	1	1(2	1(2	NUM
ajlsi-1012	338	2	)	)	PUNCT
ajlsi-1012	338	3	29	29	NUM
ajlsi-1012	338	4	-	-	SYM
ajlsi-1012	338	5	42	42	NUM
ajlsi-1012	338	6	,	,	PUNCT
ajlsi-1012	338	7	2022	2022	NUM
ajlsi-1012	338	8	with	with	ADP
ajlsi-1012	338	9	sars	sar	NOUN
ajlsi-1012	338	10	-	-	PUNCT
ajlsi-1012	338	11	cov-2	cov-2	NOUN
ajlsi-1012	338	12	-	-	PUNCT
ajlsi-1012	338	13	specific	specific	ADJ
ajlsi-1012	338	14	antigens	antigen	NOUN
ajlsi-1012	338	15	(	(	PUNCT
ajlsi-1012	338	16	recombinant	recombinant	ADJ
ajlsi-1012	338	17	n	n	CCONJ
ajlsi-1012	338	18	and	and	CCONJ
ajlsi-1012	338	19	s	s	NOUN
ajlsi-1012	338	20	-	-	PUNCT
ajlsi-1012	338	21	proteins	protein	NOUN
ajlsi-1012	338	22	)	)	PUNCT
ajlsi-1012	338	23	,	,	PUNCT
ajlsi-1012	338	24	and	and	CCONJ
ajlsi-1012	338	25	alkaline	alkaline	ADJ
ajlsi-1012	338	26	phosphate	phosphate	NOUN
ajlsi-1012	338	27	-	-	PUNCT
ajlsi-1012	338	28	labeled	label	VERB
ajlsi-1012	338	29	antihuman	antihuman	NOUN
ajlsi-1012	338	30	igg	igg	PROPN
ajlsi-1012	338	31	or	or	CCONJ
ajlsi-1012	338	32	igm	igm	PROPN
ajlsi-1012	338	33	monoclonal	monoclonal	NOUN
ajlsi-1012	338	34	antibodies	antibody	NOUN
ajlsi-1012	338	35	are	be	AUX
ajlsi-1012	338	36	added	add	VERB
ajlsi-1012	338	37	to	to	ADP
ajlsi-1012	338	38	the	the	DET
ajlsi-1012	338	39	reaction	reaction	NOUN
ajlsi-1012	338	40	mixture	mixture	NOUN
ajlsi-1012	338	41	,	,	PUNCT
ajlsi-1012	338	42	resulting	result	VERB
ajlsi-1012	338	43	in	in	ADP
ajlsi-1012	338	44	a	a	DET
ajlsi-1012	338	45	chemiluminescent	chemiluminescent	NOUN
ajlsi-1012	338	46	emission	emission	NOUN
ajlsi-1012	338	47	,	,	PUNCT
ajlsi-1012	338	48	measured	measure	VERB
ajlsi-1012	338	49	as	as	ADP
ajlsi-1012	338	50	relative	relative	ADJ
ajlsi-1012	338	51	light	light	ADJ
ajlsi-1012	338	52	units	unit	NOUN
ajlsi-1012	338	53	(	(	PUNCT
ajlsi-1012	338	54	rlu	rlu	NOUN
ajlsi-1012	338	55	)	)	PUNCT
ajlsi-1012	338	56	by	by	ADP
ajlsi-1012	338	57	a	a	DET
ajlsi-1012	338	58	photomultiplier	photomultiplier	NOUN
ajlsi-1012	338	59	built	build	VERB
ajlsi-1012	338	60	into	into	ADP
ajlsi-1012	338	61	the	the	DET
ajlsi-1012	338	62	system	system	NOUN
ajlsi-1012	338	63	.	.	PUNCT
ajlsi-1012	339	1	after	after	ADP
ajlsi-1012	339	2	25	25	NUM
ajlsi-1012	339	3	minutes	minute	NOUN
ajlsi-1012	339	4	,	,	PUNCT
ajlsi-1012	339	5	the	the	DET
ajlsi-1012	339	6	first	first	ADJ
ajlsi-1012	339	7	results	result	NOUN
ajlsi-1012	339	8	were	be	AUX
ajlsi-1012	339	9	generated	generate	VERB
ajlsi-1012	339	10	(	(	PUNCT
ajlsi-1012	339	11	nuccetelli	nuccetelli	PROPN
ajlsi-1012	339	12	et	et	PROPN
ajlsi-1012	339	13	al	al	PROPN
ajlsi-1012	339	14	.	.	PROPN
ajlsi-1012	339	15	,	,	PUNCT
ajlsi-1012	339	16	2020	2020	NUM
ajlsi-1012	339	17	)	)	PUNCT
ajlsi-1012	339	18	antigen	antigen	ADJ
ajlsi-1012	339	19	detection	detection	NOUN
ajlsi-1012	339	20	assays	assay	VERB
ajlsi-1012	339	21	antigen	antigen	ADJ
ajlsi-1012	339	22	detection	detection	NOUN
ajlsi-1012	339	23	with	with	ADP
ajlsi-1012	339	24	monoclonal	monoclonal	NOUN
ajlsi-1012	339	25	antibodies	antibody	NOUN
ajlsi-1012	339	26	or	or	CCONJ
ajlsi-1012	339	27	monospecific	monospecific	ADJ
ajlsi-1012	339	28	polyclonal	polyclonal	ADJ
ajlsi-1012	339	29	antibodies	antibody	NOUN
ajlsi-1012	339	30	against	against	ADP
ajlsi-1012	339	31	the	the	DET
ajlsi-1012	339	32	protein	protein	NOUN
ajlsi-1012	339	33	was	be	AUX
ajlsi-1012	339	34	found	find	VERB
ajlsi-1012	339	35	to	to	PART
ajlsi-1012	339	36	be	be	AUX
ajlsi-1012	339	37	a	a	DET
ajlsi-1012	339	38	sensitive	sensitive	ADJ
ajlsi-1012	339	39	and	and	CCONJ
ajlsi-1012	339	40	specific	specific	ADJ
ajlsi-1012	339	41	test	test	NOUN
ajlsi-1012	339	42	for	for	ADP
ajlsi-1012	339	43	the	the	DET
ajlsi-1012	339	44	diagnosis	diagnosis	NOUN
ajlsi-1012	339	45	of	of	ADP
ajlsi-1012	339	46	sars	sar	NOUN
ajlsi-1012	339	47	(	(	PUNCT
ajlsi-1012	339	48	kumar	kumar	PROPN
ajlsi-1012	339	49	et	et	PROPN
ajlsi-1012	339	50	al	al	PROPN
ajlsi-1012	339	51	.	.	PROPN
ajlsi-1012	339	52	,	,	PUNCT
ajlsi-1012	339	53	2020	2020	NUM
ajlsi-1012	339	54	)	)	PUNCT
ajlsi-1012	339	55	.	.	PUNCT
ajlsi-1012	340	1	in	in	ADP
ajlsi-1012	340	2	a	a	DET
ajlsi-1012	340	3	large	large	ADJ
ajlsi-1012	340	4	study	study	NOUN
ajlsi-1012	340	5	with	with	ADP
ajlsi-1012	340	6	sera	sera	NOUN
ajlsi-1012	340	7	collected	collect	VERB
ajlsi-1012	340	8	from	from	ADP
ajlsi-1012	340	9	317	317	NUM
ajlsi-1012	340	10	sars	sar	NOUN
ajlsi-1012	340	11	patients	patient	NOUN
ajlsi-1012	340	12	at	at	ADP
ajlsi-1012	340	13	different	different	ADJ
ajlsi-1012	340	14	time	time	NOUN
ajlsi-1012	340	15	points	point	NOUN
ajlsi-1012	340	16	of	of	ADP
ajlsi-1012	340	17	illness	illness	NOUN
ajlsi-1012	340	18	,	,	PUNCT
ajlsi-1012	340	19	the	the	DET
ajlsi-1012	340	20	detection	detection	NOUN
ajlsi-1012	340	21	of	of	ADP
ajlsi-1012	340	22	sars	sar	NOUN
ajlsi-1012	340	23	-	-	PUNCT
ajlsi-1012	340	24	n	n	CCONJ
ajlsi-1012	340	25	antigen	antigen	NOUN
ajlsi-1012	340	26	was	be	AUX
ajlsi-1012	340	27	performed	perform	VERB
ajlsi-1012	340	28	using	use	VERB
ajlsi-1012	340	29	a	a	DET
ajlsi-1012	340	30	panel	panel	NOUN
ajlsi-1012	340	31	of	of	ADP
ajlsi-1012	340	32	three	three	NUM
ajlsi-1012	340	33	monoclonal	monoclonal	NOUN
ajlsi-1012	340	34	antibodies	antibodie	VERB
ajlsi-1012	340	35	.	.	PUNCT
ajlsi-1012	341	1	over	over	ADP
ajlsi-1012	341	2	80	80	NUM
ajlsi-1012	341	3	%	%	NOUN
ajlsi-1012	341	4	of	of	ADP
ajlsi-1012	341	5	sars	sar	NOUN
ajlsi-1012	341	6	cases	case	NOUN
ajlsi-1012	341	7	were	be	AUX
ajlsi-1012	341	8	discovered	discover	VERB
ajlsi-1012	341	9	within	within	ADP
ajlsi-1012	341	10	the	the	DET
ajlsi-1012	341	11	first	first	ADJ
ajlsi-1012	341	12	7	7	NUM
ajlsi-1012	341	13	days	day	NOUN
ajlsi-1012	341	14	of	of	ADP
ajlsi-1012	341	15	illness	illness	NOUN
ajlsi-1012	341	16	.	.	PUNCT
ajlsi-1012	342	1	as	as	SCONJ
ajlsi-1012	342	2	serum	serum	NOUN
ajlsi-1012	342	3	antibody	antibody	NOUN
ajlsi-1012	342	4	levels	level	NOUN
ajlsi-1012	342	5	started	start	VERB
ajlsi-1012	342	6	to	to	PART
ajlsi-1012	342	7	rise	rise	VERB
ajlsi-1012	342	8	at	at	ADP
ajlsi-1012	342	9	day	day	NOUN
ajlsi-1012	342	10	7	7	NUM
ajlsi-1012	342	11	,	,	PUNCT
ajlsi-1012	342	12	the	the	DET
ajlsi-1012	342	13	sensitivity	sensitivity	NOUN
ajlsi-1012	342	14	of	of	ADP
ajlsi-1012	342	15	the	the	DET
ajlsi-1012	342	16	serum	serum	NOUN
ajlsi-1012	342	17	antigen	antigen	NOUN
ajlsi-1012	342	18	assay	assay	VERB
ajlsi-1012	342	19	progressively	progressively	ADV
ajlsi-1012	342	20	decreased	decrease	VERB
ajlsi-1012	342	21	to	to	ADP
ajlsi-1012	342	22	0	0	NUM
ajlsi-1012	342	23	%	%	NOUN
ajlsi-1012	342	24	at	at	ADP
ajlsi-1012	342	25	day	day	NOUN
ajlsi-1012	342	26	21	21	NUM
ajlsi-1012	342	27	(	(	PUNCT
ajlsi-1012	342	28	chan	chan	PROPN
ajlsi-1012	342	29	et	et	PROPN
ajlsi-1012	342	30	al	al	PROPN
ajlsi-1012	342	31	.	.	PROPN
ajlsi-1012	342	32	,	,	PUNCT
ajlsi-1012	342	33	2004	2004	NUM
ajlsi-1012	342	34	,	,	PUNCT
ajlsi-1012	342	35	hsueh	hsueh	PROPN
ajlsi-1012	342	36	et	et	PROPN
ajlsi-1012	342	37	al	al	PROPN
ajlsi-1012	342	38	.	.	PROPN
ajlsi-1012	342	39	,	,	PUNCT
ajlsi-1012	342	40	2003	2003	NUM
ajlsi-1012	342	41	)	)	PUNCT
ajlsi-1012	342	42	.	.	PUNCT
ajlsi-1012	343	1	rapid	rapid	ADJ
ajlsi-1012	343	2	assay	assay	NOUN
ajlsi-1012	343	3	methods	method	NOUN
ajlsi-1012	343	4	rapid	rapid	ADJ
ajlsi-1012	343	5	tests	test	NOUN
ajlsi-1012	343	6	are	be	AUX
ajlsi-1012	343	7	non	non	ADJ
ajlsi-1012	343	8	-	-	ADJ
ajlsi-1012	343	9	automated	automated	ADJ
ajlsi-1012	343	10	,	,	PUNCT
ajlsi-1012	343	11	primarily	primarily	ADV
ajlsi-1012	343	12	qualitative	qualitative	ADJ
ajlsi-1012	343	13	(	(	PUNCT
ajlsi-1012	343	14	but	but	CCONJ
ajlsi-1012	343	15	also	also	ADV
ajlsi-1012	343	16	quantitative	quantitative	ADJ
ajlsi-1012	343	17	in	in	ADP
ajlsi-1012	343	18	some	some	DET
ajlsi-1012	343	19	cases	case	NOUN
ajlsi-1012	343	20	)	)	PUNCT
ajlsi-1012	343	21	,	,	PUNCT
ajlsi-1012	343	22	and	and	CCONJ
ajlsi-1012	343	23	used	use	VERB
ajlsi-1012	343	24	for	for	ADP
ajlsi-1012	343	25	in	in	ADP
ajlsi-1012	343	26	vitro	vitro	X
ajlsi-1012	343	27	diagnostics	diagnostic	NOUN
ajlsi-1012	343	28	.	.	PUNCT
ajlsi-1012	344	1	these	these	DET
ajlsi-1012	344	2	tests	test	NOUN
ajlsi-1012	344	3	can	can	AUX
ajlsi-1012	344	4	provide	provide	VERB
ajlsi-1012	344	5	results	result	NOUN
ajlsi-1012	344	6	within	within	ADP
ajlsi-1012	344	7	10–30	10–30	NUM
ajlsi-1012	344	8	min	min	NOUN
ajlsi-1012	344	9	,	,	PUNCT
ajlsi-1012	344	10	so	so	SCONJ
ajlsi-1012	344	11	their	their	PRON
ajlsi-1012	344	12	results	result	NOUN
ajlsi-1012	344	13	are	be	AUX
ajlsi-1012	344	14	considered	consider	VERB
ajlsi-1012	344	15	instant	instant	ADJ
ajlsi-1012	344	16	as	as	SCONJ
ajlsi-1012	344	17	compared	compare	VERB
ajlsi-1012	344	18	to	to	ADP
ajlsi-1012	344	19	the	the	DET
ajlsi-1012	344	20	molecular	molecular	ADJ
ajlsi-1012	344	21	tests	test	NOUN
ajlsi-1012	344	22	,	,	PUNCT
ajlsi-1012	344	23	which	which	PRON
ajlsi-1012	344	24	generally	generally	ADV
ajlsi-1012	344	25	take	take	VERB
ajlsi-1012	344	26	4–6	4–6	PROPN
ajlsi-1012	344	27	h.	h.	PROPN
ajlsi-1012	344	28	moreover	moreover	ADV
ajlsi-1012	344	29	,	,	PUNCT
ajlsi-1012	344	30	these	these	DET
ajlsi-1012	344	31	tests	test	NOUN
ajlsi-1012	344	32	are	be	AUX
ajlsi-1012	344	33	user	user	NOUN
ajlsi-1012	344	34	-	-	PUNCT
ajlsi-1012	344	35	friendly	friendly	ADJ
ajlsi-1012	344	36	,	,	PUNCT
ajlsi-1012	344	37	so	so	SCONJ
ajlsi-1012	344	38	they	they	PRON
ajlsi-1012	344	39	wo	will	AUX
ajlsi-1012	344	40	n’t	not	PART
ajlsi-1012	344	41	require	require	VERB
ajlsi-1012	344	42	any	any	DET
ajlsi-1012	344	43	extensive	extensive	ADJ
ajlsi-1012	344	44	training	training	NOUN
ajlsi-1012	344	45	or	or	CCONJ
ajlsi-1012	344	46	expertise	expertise	NOUN
ajlsi-1012	344	47	to	to	PART
ajlsi-1012	344	48	operate	operate	VERB
ajlsi-1012	344	49	and	and	CCONJ
ajlsi-1012	344	50	can	can	AUX
ajlsi-1012	344	51	be	be	AUX
ajlsi-1012	344	52	used	use	VERB
ajlsi-1012	344	53	either	either	CCONJ
ajlsi-1012	344	54	in	in	ADP
ajlsi-1012	344	55	a	a	DET
ajlsi-1012	344	56	hospital	hospital	NOUN
ajlsi-1012	344	57	environment	environment	NOUN
ajlsi-1012	344	58	or	or	CCONJ
ajlsi-1012	344	59	in	in	ADP
ajlsi-1012	344	60	the	the	DET
ajlsi-1012	344	61	field	field	NOUN
ajlsi-1012	344	62	without	without	ADP
ajlsi-1012	344	63	any	any	DET
ajlsi-1012	344	64	difficulty	difficulty	NOUN
ajlsi-1012	344	65	.	.	PUNCT
ajlsi-1012	345	1	the	the	DET
ajlsi-1012	345	2	manifestation	manifestation	NOUN
ajlsi-1012	345	3	of	of	ADP
ajlsi-1012	345	4	the	the	DET
ajlsi-1012	345	5	covid-19	covid-19	PROPN
ajlsi-1012	345	6	infection	infection	NOUN
ajlsi-1012	345	7	is	be	AUX
ajlsi-1012	345	8	highly	highly	ADV
ajlsi-1012	345	9	nonspecific	nonspecific	ADJ
ajlsi-1012	345	10	,	,	PUNCT
ajlsi-1012	345	11	including	include	VERB
ajlsi-1012	345	12	respiratory	respiratory	ADJ
ajlsi-1012	345	13	symptoms	symptom	NOUN
ajlsi-1012	345	14	such	such	ADJ
ajlsi-1012	345	15	as	as	ADP
ajlsi-1012	345	16	fever	fever	NOUN
ajlsi-1012	345	17	,	,	PUNCT
ajlsi-1012	345	18	cough	cough	NOUN
ajlsi-1012	345	19	,	,	PUNCT
ajlsi-1012	345	20	dyspnea	dyspnea	NOUN
ajlsi-1012	345	21	,	,	PUNCT
ajlsi-1012	345	22	and	and	CCONJ
ajlsi-1012	345	23	viral	viral	ADJ
ajlsi-1012	345	24	pneumonia	pneumonia	NOUN
ajlsi-1012	345	25	(	(	PUNCT
ajlsi-1012	345	26	huang	huang	PROPN
ajlsi-1012	345	27	et	et	PROPN
ajlsi-1012	345	28	al	al	PROPN
ajlsi-1012	345	29	.	.	PROPN
ajlsi-1012	345	30	,	,	PUNCT
ajlsi-1012	345	31	2020	2020	NUM
ajlsi-1012	345	32	)	)	PUNCT
ajlsi-1012	345	33	.	.	PUNCT
ajlsi-1012	346	1	thus	thus	ADV
ajlsi-1012	346	2	,	,	PUNCT
ajlsi-1012	346	3	extensive	extensive	ADJ
ajlsi-1012	346	4	diagnostic	diagnostic	ADJ
ajlsi-1012	346	5	tests	test	NOUN
ajlsi-1012	346	6	specific	specific	ADJ
ajlsi-1012	346	7	to	to	ADP
ajlsi-1012	346	8	this	this	DET
ajlsi-1012	346	9	infection	infection	NOUN
ajlsi-1012	346	10	are	be	AUX
ajlsi-1012	346	11	urgently	urgently	ADV
ajlsi-1012	346	12	required	require	VERB
ajlsi-1012	346	13	to	to	PART
ajlsi-1012	346	14	confirm	confirm	VERB
ajlsi-1012	346	15	suspected	suspected	ADJ
ajlsi-1012	346	16	cases	case	NOUN
ajlsi-1012	346	17	,	,	PUNCT
ajlsi-1012	346	18	screen	screen	NOUN
ajlsi-1012	346	19	patients	patient	NOUN
ajlsi-1012	346	20	,	,	PUNCT
ajlsi-1012	346	21	and	and	CCONJ
ajlsi-1012	346	22	conduct	conduct	VERB
ajlsi-1012	346	23	virus	virus	NOUN
ajlsi-1012	346	24	surveillance	surveillance	NOUN
ajlsi-1012	346	25	.	.	PUNCT
ajlsi-1012	347	1	rapid	rapid	ADJ
ajlsi-1012	347	2	tests	test	NOUN
ajlsi-1012	347	3	are	be	AUX
ajlsi-1012	347	4	used	use	VERB
ajlsi-1012	347	5	to	to	PART
ajlsi-1012	347	6	diagnose	diagnose	VERB
ajlsi-1012	347	7	patients	patient	NOUN
ajlsi-1012	347	8	without	without	ADP
ajlsi-1012	347	9	sending	send	VERB
ajlsi-1012	347	10	samples	sample	NOUN
ajlsi-1012	347	11	to	to	ADP
ajlsi-1012	347	12	centralized	centralized	ADJ
ajlsi-1012	347	13	facilities	facility	NOUN
ajlsi-1012	347	14	,	,	PUNCT
ajlsi-1012	347	15	thereby	thereby	ADV
ajlsi-1012	347	16	enabling	enable	VERB
ajlsi-1012	347	17	communities	community	NOUN
ajlsi-1012	347	18	without	without	ADP
ajlsi-1012	347	19	laboratory	laboratory	NOUN
ajlsi-1012	347	20	infrastructure	infrastructure	NOUN
ajlsi-1012	347	21	to	to	PART
ajlsi-1012	347	22	detect	detect	VERB
ajlsi-1012	347	23	infected	infected	ADJ
ajlsi-1012	347	24	patients	patient	NOUN
ajlsi-1012	347	25	.	.	PUNCT
ajlsi-1012	348	1	in	in	ADP
ajlsi-1012	348	2	this	this	PRON
ajlsi-1012	348	3	,	,	PUNCT
ajlsi-1012	348	4	a	a	DET
ajlsi-1012	348	5	point	point	NOUN
ajlsi-1012	348	6	-	-	PUNCT
ajlsi-1012	348	7	of	of	ADP
ajlsi-1012	348	8	-	-	PUNCT
ajlsi-1012	348	9	care	care	NOUN
ajlsi-1012	348	10	(	(	PUNCT
ajlsi-1012	348	11	poc	poc	NOUN
ajlsi-1012	348	12	)	)	PUNCT
ajlsi-1012	348	13	device	device	NOUN
ajlsi-1012	348	14	,	,	PUNCT
ajlsi-1012	348	15	i.e.	i.e.	X
ajlsi-1012	348	16	,	,	PUNCT
ajlsi-1012	348	17	a	a	DET
ajlsi-1012	348	18	rapid	rapid	ADJ
ajlsi-1012	348	19	,	,	PUNCT
ajlsi-1012	348	20	robust	robust	ADJ
ajlsi-1012	348	21	,	,	PUNCT
ajlsi-1012	348	22	and	and	CCONJ
ajlsi-1012	348	23	cost	cost	NOUN
ajlsi-1012	348	24	-	-	PUNCT
ajlsi-1012	348	25	efficient	efficient	ADJ
ajlsi-1012	348	26	device	device	NOUN
ajlsi-1012	348	27	that	that	PRON
ajlsi-1012	348	28	can	can	AUX
ajlsi-1012	348	29	be	be	AUX
ajlsi-1012	348	30	used	use	VERB
ajlsi-1012	348	31	onsite	onsite	ADJ
ajlsi-1012	348	32	and	and	CCONJ
ajlsi-1012	348	33	,	,	PUNCT
ajlsi-1012	348	34	in	in	ADP
ajlsi-1012	348	35	the	the	DET
ajlsi-1012	348	36	field	field	NOUN
ajlsi-1012	348	37	,	,	PUNCT
ajlsi-1012	348	38	and	and	CCONJ
ajlsi-1012	348	39	which	which	PRON
ajlsi-1012	348	40	does	do	AUX
ajlsi-1012	348	41	not	not	PART
ajlsi-1012	348	42	necessarily	necessarily	ADV
ajlsi-1012	348	43	require	require	VERB
ajlsi-1012	348	44	a	a	DET
ajlsi-1012	348	45	trained	train	VERB
ajlsi-1012	348	46	technician	technician	NOUN
ajlsi-1012	348	47	to	to	PART
ajlsi-1012	348	48	operate	operate	VERB
ajlsi-1012	348	49	(	(	PUNCT
ajlsi-1012	348	50	nguyen	nguyen	NOUN
ajlsi-1012	348	51	et	et	PROPN
ajlsi-1012	348	52	al	al	PROPN
ajlsi-1012	348	53	.	.	PROPN
ajlsi-1012	348	54	,	,	PUNCT
ajlsi-1012	348	55	2018	2018	NUM
ajlsi-1012	348	56	)	)	PUNCT
ajlsi-1012	348	57	,	,	PUNCT
ajlsi-1012	348	58	lamp	lamp	ADJ
ajlsi-1012	348	59	assays	assay	NOUN
ajlsi-1012	348	60	(	(	PUNCT
ajlsi-1012	348	61	explained	explain	VERB
ajlsi-1012	348	62	in	in	ADP
ajlsi-1012	348	63	2.3.2	2.3.2	NUM
ajlsi-1012	348	64	)	)	PUNCT
ajlsi-1012	348	65	in	in	ADP
ajlsi-1012	348	66	poc	poc	PROPN
ajlsi-1012	348	67	devices	device	NOUN
ajlsi-1012	348	68	have	have	VERB
ajlsi-1012	348	69	high	high	ADJ
ajlsi-1012	348	70	specificity	specificity	NOUN
ajlsi-1012	348	71	and	and	CCONJ
ajlsi-1012	348	72	sensitivity	sensitivity	NOUN
ajlsi-1012	348	73	and	and	CCONJ
ajlsi-1012	348	74	are	be	AUX
ajlsi-1012	348	75	simple	simple	ADJ
ajlsi-1012	348	76	to	to	PART
ajlsi-1012	348	77	perform	perform	VERB
ajlsi-1012	348	78	;	;	PUNCT
ajlsi-1012	348	79	hence	hence	ADV
ajlsi-1012	348	80	,	,	PUNCT
ajlsi-1012	348	81	soon	soon	ADV
ajlsi-1012	348	82	after	after	ADP
ajlsi-1012	348	83	their	their	PRON
ajlsi-1012	348	84	initial	initial	ADJ
ajlsi-1012	348	85	development	development	NOUN
ajlsi-1012	348	86	,	,	PUNCT
ajlsi-1012	348	87	they	they	PRON
ajlsi-1012	348	88	became	become	VERB
ajlsi-1012	348	89	an	an	DET
ajlsi-1012	348	90	enormously	enormously	ADV
ajlsi-1012	348	91	popular	popular	ADJ
ajlsi-1012	348	92	isothermal	isothermal	ADJ
ajlsi-1012	348	93	amplification	amplification	NOUN
ajlsi-1012	348	94	method	method	NOUN
ajlsi-1012	348	95	in	in	ADP
ajlsi-1012	348	96	molecular	molecular	ADJ
ajlsi-1012	348	97	biology	biology	NOUN
ajlsi-1012	348	98	,	,	PUNCT
ajlsi-1012	348	99	with	with	ADP
ajlsi-1012	348	100	applications	application	NOUN
ajlsi-1012	348	101	in	in	ADP
ajlsi-1012	348	102	pathogen	pathogen	NOUN
ajlsi-1012	348	103	detection	detection	NOUN
ajlsi-1012	348	104	.	.	PUNCT
ajlsi-1012	349	1	lamp	lamp	PROPN
ajlsi-1012	349	2	uses	use	VERB
ajlsi-1012	349	3	strand	strand	NOUN
ajlsi-1012	349	4	-	-	PUNCT
ajlsi-1012	349	5	displacement	displacement	NOUN
ajlsi-1012	349	6	polymerases	polymerase	NOUN
ajlsi-1012	349	7	instead	instead	ADV
ajlsi-1012	349	8	of	of	ADP
ajlsi-1012	349	9	heat	heat	NOUN
ajlsi-1012	349	10	denaturation	denaturation	NOUN
ajlsi-1012	349	11	to	to	PART
ajlsi-1012	349	12	generate	generate	VERB
ajlsi-1012	349	13	a	a	DET
ajlsi-1012	349	14	single	single	ADJ
ajlsi-1012	349	15	-	-	PUNCT
ajlsi-1012	349	16	stranded	strand	VERB
ajlsi-1012	349	17	template	template	NOUN
ajlsi-1012	349	18	;	;	PUNCT
ajlsi-1012	349	19	hence	hence	ADV
ajlsi-1012	349	20	,	,	PUNCT
ajlsi-1012	349	21	it	it	PRON
ajlsi-1012	349	22	has	have	VERB
ajlsi-1012	349	23	the	the	DET
ajlsi-1012	349	24	advantage	advantage	NOUN
ajlsi-1012	349	25	.	.	PUNCT
ajlsi-1012	350	1	lamp	lamp	NOUN
ajlsi-1012	350	2	technology	technology	NOUN
ajlsi-1012	350	3	is	be	AUX
ajlsi-1012	350	4	proven	prove	VERB
ajlsi-1012	350	5	to	to	PART
ajlsi-1012	350	6	be	be	AUX
ajlsi-1012	350	7	more	more	ADV
ajlsi-1012	350	8	stable	stable	ADJ
ajlsi-1012	350	9	and	and	CCONJ
ajlsi-1012	350	10	more	more	ADV
ajlsi-1012	350	11	sensitive	sensitive	ADJ
ajlsi-1012	350	12	in	in	ADP
ajlsi-1012	350	13	detection	detection	NOUN
ajlsi-1012	350	14	compared	compare	VERB
ajlsi-1012	350	15	to	to	ADP
ajlsi-1012	350	16	pcr	pcr	PROPN
ajlsi-1012	350	17	(	(	PUNCT
ajlsi-1012	350	18	francois	francois	PROPN
ajlsi-1012	350	19	et	et	PROPN
ajlsi-1012	350	20	al	al	PROPN
ajlsi-1012	350	21	.	.	PROPN
ajlsi-1012	350	22	,	,	PUNCT
ajlsi-1012	350	23	2011	2011	NUM
ajlsi-1012	350	24	)	)	PUNCT
ajlsi-1012	350	25	.	.	PUNCT
ajlsi-1012	351	1	lateral	lateral	ADJ
ajlsi-1012	351	2	flow	flow	NOUN
ajlsi-1012	351	3	antigen	antigen	ADJ
ajlsi-1012	351	4	detection	detection	NOUN
ajlsi-1012	351	5	(	(	PUNCT
ajlsi-1012	351	6	explained	explain	VERB
ajlsi-1012	351	7	in	in	ADP
ajlsi-1012	351	8	2.4.1	2.4.1	NUM
ajlsi-1012	351	9	)	)	PUNCT
ajlsi-1012	351	10	for	for	ADP
ajlsi-1012	351	11	sars	sar	NOUN
ajlsi-1012	351	12	-	-	PUNCT
ajlsi-1012	351	13	cov-2	cov-2	NUM
ajlsi-1012	351	14	is	be	AUX
ajlsi-1012	351	15	another	another	DET
ajlsi-1012	351	16	point	point	NOUN
ajlsi-1012	351	17	-	-	PUNCT
ajlsi-1012	351	18	of	of	ADP
ajlsi-1012	351	19	-	-	PUNCT
ajlsi-1012	351	20	care	care	NOUN
ajlsi-1012	351	21	approach	approach	NOUN
ajlsi-1012	351	22	under	under	ADP
ajlsi-1012	351	23	development	development	NOUN
ajlsi-1012	351	24	for	for	ADP
ajlsi-1012	351	25	diagnosing	diagnose	VERB
ajlsi-1012	351	26	covid-19	covid-19	PROPN
ajlsi-1012	351	27	.	.	PUNCT
ajlsi-1012	352	1	in	in	ADP
ajlsi-1012	352	2	commercial	commercial	ADJ
ajlsi-1012	352	3	lateral	lateral	ADJ
ajlsi-1012	352	4	flow	flow	NOUN
ajlsi-1012	352	5	assays	assay	NOUN
ajlsi-1012	352	6	,	,	PUNCT
ajlsi-1012	352	7	a	a	DET
ajlsi-1012	352	8	paper	paper	NOUN
ajlsi-1012	352	9	-	-	PUNCT
ajlsi-1012	352	10	like	like	ADJ
ajlsi-1012	352	11	membrane	membrane	NOUN
ajlsi-1012	352	12	strip	strip	NOUN
ajlsi-1012	352	13	is	be	AUX
ajlsi-1012	352	14	coated	coat	VERB
ajlsi-1012	352	15	with	with	ADP
ajlsi-1012	352	16	gold	gold	ADJ
ajlsi-1012	352	17	nanoparticle	nanoparticle	NOUN
ajlsi-1012	352	18	-	-	PUNCT
ajlsi-1012	352	19	antibody	antibody	NOUN
ajlsi-1012	352	20	conjugate	conjugate	NOUN
ajlsi-1012	352	21	,	,	PUNCT
ajlsi-1012	352	22	and	and	CCONJ
ajlsi-1012	352	23	capture	capture	VERB
ajlsi-1012	352	24	antibodies	antibody	NOUN
ajlsi-1012	352	25	are	be	AUX
ajlsi-1012	352	26	used	use	VERB
ajlsi-1012	352	27	.	.	PUNCT
ajlsi-1012	353	1	these	these	DET
ajlsi-1012	353	2	assays	assay	NOUN
ajlsi-1012	353	3	have	have	AUX
ajlsi-1012	353	4	previously	previously	ADV
ajlsi-1012	353	5	demonstrated	demonstrate	VERB
ajlsi-1012	353	6	reliable	reliable	ADJ
ajlsi-1012	353	7	clinical	clinical	ADJ
ajlsi-1012	353	8	sensitivity	sensitivity	NOUN
ajlsi-1012	353	9	(	(	PUNCT
ajlsi-1012	353	10	57	57	NUM
ajlsi-1012	353	11	%	%	NOUN
ajlsi-1012	353	12	)	)	PUNCT
ajlsi-1012	353	13	,	,	PUNCT
ajlsi-1012	353	14	specificity	specificity	NOUN
ajlsi-1012	353	15	(	(	PUNCT
ajlsi-1012	353	16	100	100	NUM
ajlsi-1012	353	17	%	%	NOUN
ajlsi-1012	353	18	)	)	PUNCT
ajlsi-1012	353	19	,	,	PUNCT
ajlsi-1012	353	20	and	and	CCONJ
ajlsi-1012	353	21	accuracy	accuracy	NOUN
ajlsi-1012	353	22	(	(	PUNCT
ajlsi-1012	353	23	69	69	NUM
ajlsi-1012	353	24	)	)	PUNCT
ajlsi-1012	353	25	for	for	ADP
ajlsi-1012	353	26	igm	igm	PROPN
ajlsi-1012	353	27	and	and	CCONJ
ajlsi-1012	353	28	81	81	NUM
ajlsi-1012	353	29	%	%	NOUN
ajlsi-1012	353	30	,	,	PUNCT
ajlsi-1012	353	31	100	100	NUM
ajlsi-1012	353	32	%	%	NOUN
ajlsi-1012	353	33	,	,	PUNCT
ajlsi-1012	353	34	and	and	CCONJ
ajlsi-1012	353	35	86	86	NUM
ajlsi-1012	353	36	%	%	NOUN
ajlsi-1012	353	37	for	for	ADP
ajlsi-1012	353	38	igg	igg	PROPN
ajlsi-1012	353	39	,	,	PUNCT
ajlsi-1012	353	40	respectively	respectively	ADV
ajlsi-1012	353	41	.	.	PUNCT
ajlsi-1012	354	1	a	a	DET
ajlsi-1012	354	2	test	test	NOUN
ajlsi-1012	354	3	that	that	PRON
ajlsi-1012	354	4	detected	detect	VERB
ajlsi-1012	354	5	both	both	DET
ajlsi-1012	354	6	igm	igm	PROPN
ajlsi-1012	354	7	and	and	CCONJ
ajlsi-1012	354	8	igg	igg	PROPN
ajlsi-1012	354	9	yielded	yield	VERB
ajlsi-1012	354	10	a	a	DET
ajlsi-1012	354	11	clinical	clinical	ADJ
ajlsi-1012	354	12	sensitivity	sensitivity	NOUN
ajlsi-1012	354	13	of	of	ADP
ajlsi-1012	354	14	82	82	NUM
ajlsi-1012	354	15	%	%	NOUN
ajlsi-1012	354	16	(	(	PUNCT
ajlsi-1012	354	17	xiang	xiang	PROPN
ajlsi-1012	354	18	et	et	PROPN
ajlsi-1012	354	19	al	al	PROPN
ajlsi-1012	354	20	.	.	PROPN
ajlsi-1012	354	21	,	,	PUNCT
ajlsi-1012	354	22	2020	2020	NUM
ajlsi-1012	354	23	)	)	PUNCT
ajlsi-1012	354	24	.	.	PUNCT
ajlsi-1012	355	1	however	however	ADV
ajlsi-1012	355	2	,	,	PUNCT
ajlsi-1012	355	3	lateral	lateral	ADJ
ajlsi-1012	355	4	flow	flow	NOUN
ajlsi-1012	355	5	assays	assay	NOUN
ajlsi-1012	355	6	do	do	AUX
ajlsi-1012	355	7	not	not	PART
ajlsi-1012	355	8	directly	directly	ADV
ajlsi-1012	355	9	confirm	confirm	VERB
ajlsi-1012	355	10	virus	virus	NOUN
ajlsi-1012	355	11	presence	presence	NOUN
ajlsi-1012	355	12	;	;	PUNCT
ajlsi-1012	355	13	instead	instead	ADV
ajlsi-1012	355	14	,	,	PUNCT
ajlsi-1012	355	15	they	they	PRON
ajlsi-1012	355	16	provide	provide	VERB
ajlsi-1012	355	17	serological	serological	ADJ
ajlsi-1012	355	18	evidence	evidence	NOUN
ajlsi-1012	355	19	of	of	ADP
ajlsi-1012	355	20	recent	recent	ADJ
ajlsi-1012	355	21	infections	infection	NOUN
ajlsi-1012	355	22	(	(	PUNCT
ajlsi-1012	355	23	li	li	PROPN
ajlsi-1012	355	24	et	et	PROPN
ajlsi-1012	355	25	al	al	PROPN
ajlsi-1012	355	26	.	.	PROPN
ajlsi-1012	355	27	,	,	PUNCT
ajlsi-1012	355	28	2020	2020	NUM
ajlsi-1012	355	29	)	)	PUNCT
ajlsi-1012	355	30	.	.	PUNCT
ajlsi-1012	356	1	microarray	microarray	NOUN
ajlsi-1012	356	2	assays	assay	NOUN
ajlsi-1012	356	3	have	have	AUX
ajlsi-1012	356	4	been	be	AUX
ajlsi-1012	356	5	used	use	VERB
ajlsi-1012	356	6	for	for	ADP
ajlsi-1012	356	7	rapid	rapid	ADJ
ajlsi-1012	356	8	,	,	PUNCT
ajlsi-1012	356	9	high	high	ADJ
ajlsi-1012	356	10	-	-	PUNCT
ajlsi-1012	356	11	throughput	throughput	NOUN
ajlsi-1012	356	12	detection	detection	NOUN
ajlsi-1012	356	13	of	of	ADP
ajlsi-1012	356	14	sars	sar	NOUN
ajlsi-1012	356	15	-	-	PUNCT
ajlsi-1012	356	16	cov-2	cov-2	PART
ajlsi-1012	356	17	nucleic	nucleic	ADJ
ajlsi-1012	356	18	acids	acid	NOUN
ajlsi-1012	356	19	.	.	PUNCT
ajlsi-1012	357	1	they	they	PRON
ajlsi-1012	357	2	rely	rely	VERB
ajlsi-1012	357	3	on	on	ADP
ajlsi-1012	357	4	the	the	DET
ajlsi-1012	357	5	generation	generation	NOUN
ajlsi-1012	357	6	of	of	ADP
ajlsi-1012	357	7	cdna	cdna	PROPN
ajlsi-1012	357	8	from	from	ADP
ajlsi-1012	357	9	viral	viral	ADJ
ajlsi-1012	357	10	rna	rna	NOUN
ajlsi-1012	357	11	using	use	VERB
ajlsi-1012	357	12	reverse	reverse	ADJ
ajlsi-1012	357	13	transcription	transcription	NOUN
ajlsi-1012	357	14	and	and	CCONJ
ajlsi-1012	357	15	the	the	DET
ajlsi-1012	357	16	subsequent	subsequent	ADJ
ajlsi-1012	357	17	labelling	labelling	NOUN
ajlsi-1012	357	18	of	of	ADP
ajlsi-1012	357	19	cdna	cdna	PROPN
ajlsi-1012	357	20	with	with	ADP
ajlsi-1012	357	21	specific	specific	ADJ
ajlsi-1012	357	22	probes	probe	NOUN
ajlsi-1012	357	23	loaded	load	VERB
ajlsi-1012	357	24	into	into	ADP
ajlsi-1012	357	25	the	the	DET
ajlsi-1012	357	26	wells	well	NOUN
ajlsi-1012	357	27	of	of	ADP
ajlsi-1012	357	28	microarray	microarray	PROPN
ajlsi-1012	357	29	trays	tray	NOUN
ajlsi-1012	357	30	.	.	PUNCT
ajlsi-1012	358	1	the	the	DET
ajlsi-1012	358	2	microarray	microarray	NOUN
ajlsi-1012	358	3	assay	assay	NOUN
ajlsi-1012	358	4	has	have	AUX
ajlsi-1012	358	5	proven	prove	VERB
ajlsi-1012	358	6	useful	useful	ADJ
ajlsi-1012	358	7	in	in	ADP
ajlsi-1012	358	8	identifying	identify	VERB
ajlsi-1012	358	9	mutations	mutation	NOUN
ajlsi-1012	358	10	associated	associate	VERB
ajlsi-1012	358	11	with	with	ADP
ajlsi-1012	358	12	sars	sar	NOUN
ajlsi-1012	358	13	-	-	PUNCT
ajlsi-1012	358	14	cov-2	cov-2	PUNCT
ajlsi-1012	358	15	and	and	CCONJ
ajlsi-1012	358	16	has	have	AUX
ajlsi-1012	358	17	been	be	AUX
ajlsi-1012	358	18	used	use	VERB
ajlsi-1012	358	19	to	to	PART
ajlsi-1012	358	20	detect	detect	VERB
ajlsi-1012	358	21	up	up	ADP
ajlsi-1012	358	22	to	to	PART
ajlsi-1012	358	23	24	24	NUM
ajlsi-1012	358	24	single	single	ADJ
ajlsi-1012	358	25	nucleotide	nucleotide	NOUN
ajlsi-1012	358	26	polymorphisms	polymorphism	NOUN
ajlsi-1012	358	27	(	(	PUNCT
ajlsi-1012	358	28	snp	snp	PROPN
ajlsi-1012	358	29	)	)	PUNCT
ajlsi-1012	358	30	associated	associate	VERB
ajlsi-1012	358	31	with	with	ADP
ajlsi-1012	358	32	mutations	mutation	NOUN
ajlsi-1012	358	33	in	in	ADP
ajlsi-1012	358	34	the	the	DET
ajlsi-1012	358	35	spike	spike	ADJ
ajlsi-1012	358	36	(	(	PUNCT
ajlsi-1012	358	37	s	s	NOUN
ajlsi-1012	358	38	)	)	PUNCT
ajlsi-1012	358	39	gene	gene	NOUN
ajlsi-1012	358	40	of	of	ADP
ajlsi-1012	358	41	sars	sar	NOUN
ajlsi-1012	358	42	-	-	PUNCT
ajlsi-1012	358	43	cov-2	cov-2	NOUN
ajlsi-1012	358	44	with	with	ADP
ajlsi-1012	358	45	100	100	NUM
ajlsi-1012	358	46	%	%	NOUN
ajlsi-1012	358	47	accuracy	accuracy	NOUN
ajlsi-1012	358	48	.	.	PUNCT
ajlsi-1012	359	1	the	the	DET
ajlsi-1012	359	2	ability	ability	NOUN
ajlsi-1012	359	3	to	to	PART
ajlsi-1012	359	4	detect	detect	VERB
ajlsi-1012	359	5	different	different	ADJ
ajlsi-1012	359	6	emergent	emergent	ADJ
ajlsi-1012	359	7	strains	strain	NOUN
ajlsi-1012	359	8	of	of	ADP
ajlsi-1012	359	9	sars	sar	NOUN
ajlsi-1012	359	10	-	-	PUNCT
ajlsi-1012	359	11	cov-2	cov-2	NUM
ajlsi-1012	359	12	may	may	AUX
ajlsi-1012	359	13	become	become	VERB
ajlsi-1012	359	14	necessary	necessary	ADJ
ajlsi-1012	359	15	as	as	SCONJ
ajlsi-1012	359	16	the	the	DET
ajlsi-1012	359	17	covid-19	covid-19	PROPN
ajlsi-1012	359	18	pandemic	pandemic	ADJ
ajlsi-1012	359	19	evolves	evolve	NOUN
ajlsi-1012	359	20	,	,	PUNCT
ajlsi-1012	359	21	and	and	CCONJ
ajlsi-1012	359	22	microarray	microarray	VERB
ajlsi-1012	359	23	assays	assay	NOUN
ajlsi-1012	359	24	provide	provide	VERB
ajlsi-1012	359	25	a	a	DET
ajlsi-1012	359	26	platform	platform	NOUN
ajlsi-1012	359	27	for	for	ADP
ajlsi-1012	359	28	rapid	rapid	ADJ
ajlsi-1012	359	29	detection	detection	NOUN
ajlsi-1012	359	30	of	of	ADP
ajlsi-1012	359	31	those	those	DET
ajlsi-1012	359	32	strains	strain	NOUN
ajlsi-1012	359	33	as	as	ADP
ajlsi-1012	359	34	a	a	DET
ajlsi-1012	359	35	result	result	NOUN
ajlsi-1012	359	36	of	of	ADP
ajlsi-1012	359	37	mutational	mutational	ADJ
ajlsi-1012	359	38	variations	variation	NOUN
ajlsi-1012	359	39	.	.	PUNCT
ajlsi-1012	360	1	a	a	DET
ajlsi-1012	360	2	next	next	ADJ
ajlsi-1012	360	3	-	-	PUNCT
ajlsi-1012	360	4	generation	generation	NOUN
ajlsi-1012	360	5	shotgun	shotgun	NOUN
ajlsi-1012	360	6	metagenomics	metagenomic	NOUN
ajlsi-1012	360	7	sequencing	sequence	VERB
ajlsi-1012	360	8	platform	platform	NOUN
ajlsi-1012	360	9	has	have	AUX
ajlsi-1012	360	10	been	be	AUX
ajlsi-1012	360	11	developed	develop	VERB
ajlsi-1012	360	12	by	by	ADP
ajlsi-1012	360	13	illumina	illumina	NOUN
ajlsi-1012	360	14	with	with	ADP
ajlsi-1012	360	15	the	the	DET
ajlsi-1012	360	16	ability	ability	NOUN
ajlsi-1012	360	17	not	not	PART
ajlsi-1012	360	18	only	only	ADV
ajlsi-1012	360	19	to	to	PART
ajlsi-1012	360	20	detect	detect	VERB
ajlsi-1012	360	21	the	the	DET
ajlsi-1012	360	22	presence	presence	NOUN
ajlsi-1012	360	23	of	of	ADP
ajlsi-1012	360	24	multiple	multiple	ADJ
ajlsi-1012	360	25	strains	strain	NOUN
ajlsi-1012	360	26	of	of	ADP
ajlsi-1012	360	27	coronaviruses	coronaviruse	NOUN
ajlsi-1012	360	28	but	but	CCONJ
ajlsi-1012	360	29	also	also	ADV
ajlsi-1012	360	30	to	to	PART
ajlsi-1012	360	31	comprehensively	comprehensively	ADV
ajlsi-1012	360	32	examine	examine	VERB
ajlsi-1012	360	33	multiple	multiple	ADJ
ajlsi-1012	360	34	pathogenic	pathogenic	ADJ
ajlsi-1012	360	35	organisms	organism	NOUN
ajlsi-1012	360	36	present	present	ADJ
ajlsi-1012	360	37	in	in	ADP
ajlsi-1012	360	38	a	a	DET
ajlsi-1012	360	39	complex	complex	ADJ
ajlsi-1012	360	40	sample	sample	NOUN
ajlsi-1012	360	41	.	.	PUNCT
ajlsi-1012	361	1	chest	chest	NOUN
ajlsi-1012	361	2	ct	ct	NUM
ajlsi-1012	361	3	images	image	NOUN
ajlsi-1012	361	4	from	from	ADP
ajlsi-1012	361	5	patients	patient	NOUN
ajlsi-1012	361	6	with	with	ADP
ajlsi-1012	361	7	covid-19	covid-19	PROPN
ajlsi-1012	361	8	typically	typically	ADV
ajlsi-1012	361	9	demonstrate	demonstrate	VERB
ajlsi-1012	361	10	bilateral	bilateral	ADJ
ajlsi-1012	361	11	,	,	PUNCT
ajlsi-1012	361	12	peripheral	peripheral	ADJ
ajlsi-1012	361	13	ground	ground	NOUN
ajlsi-1012	361	14	glass	glass	NOUN
ajlsi-1012	361	15	opacities	opacity	NOUN
ajlsi-1012	361	16	.	.	PUNCT
ajlsi-1012	362	1	because	because	SCONJ
ajlsi-1012	362	2	this	this	DET
ajlsi-1012	362	3	chest	chest	NOUN
ajlsi-1012	362	4	ct	ct	PROPN
ajlsi-1012	362	5	imaging	imaging	NOUN
ajlsi-1012	362	6	pattern	pattern	NOUN
ajlsi-1012	362	7	is	be	AUX
ajlsi-1012	362	8	nonspecific	nonspecific	ADJ
ajlsi-1012	362	9	and	and	CCONJ
ajlsi-1012	362	10	overlaps	overlap	NOUN
ajlsi-1012	362	11	with	with	ADP
ajlsi-1012	362	12	other	other	ADJ
ajlsi-1012	362	13	infections	infection	NOUN
ajlsi-1012	362	14	,	,	PUNCT
ajlsi-1012	362	15	the	the	DET
ajlsi-1012	362	16	diagnostic	diagnostic	ADJ
ajlsi-1012	362	17	value	value	NOUN
ajlsi-1012	362	18	of	of	ADP
ajlsi-1012	362	19	chest	chest	NOUN
ajlsi-1012	362	20	ct	ct	NUM
ajlsi-1012	362	21	imaging	imaging	NOUN
ajlsi-1012	362	22	for	for	ADP
ajlsi-1012	362	23	covid-19	covid-19	PROPN
ajlsi-1012	362	24	may	may	AUX
ajlsi-1012	362	25	be	be	AUX
ajlsi-1012	362	26	low	low	ADJ
ajlsi-1012	362	27	and	and	CCONJ
ajlsi-1012	362	28	dependent	dependent	ADJ
ajlsi-1012	362	29	upon	upon	SCONJ
ajlsi-1012	362	30	other	other	ADJ
ajlsi-1012	362	31	interpretations	interpretation	NOUN
ajlsi-1012	362	32	.	.	PUNCT
ajlsi-1012	363	1	given	give	VERB
ajlsi-1012	363	2	the	the	DET
ajlsi-1012	363	3	variability	variability	NOUN
ajlsi-1012	363	4	in	in	ADP
ajlsi-1012	363	5	chest	chest	NOUN
ajlsi-1012	363	6	imaging	imaging	NOUN
ajlsi-1012	363	7	findings	finding	NOUN
ajlsi-1012	363	8	,	,	PUNCT
ajlsi-1012	363	9	a	a	DET
ajlsi-1012	363	10	chest	chest	NOUN
ajlsi-1012	363	11	radiograph	radiograph	NOUN
ajlsi-1012	363	12	or	or	CCONJ
ajlsi-1012	363	13	ct	ct	PRON
ajlsi-1012	363	14	alone	alone	ADV
ajlsi-1012	363	15	is	be	AUX
ajlsi-1012	363	16	not	not	PART
ajlsi-1012	363	17	recommended	recommend	VERB
ajlsi-1012	363	18	for	for	ADP
ajlsi-1012	363	19	the	the	DET
ajlsi-1012	363	20	diagnosis	diagnosis	NOUN
ajlsi-1012	363	21	of	of	ADP
ajlsi-1012	363	22	covid-19	covid-19	PROPN
ajlsi-1012	363	23	.	.	PUNCT
ajlsi-1012	364	1	the	the	DET
ajlsi-1012	364	2	american	american	PROPN
ajlsi-1012	364	3	college	college	PROPN
ajlsi-1012	364	4	of	of	ADP
ajlsi-1012	364	5	radiology	radiology	NOUN
ajlsi-1012	364	6	also	also	ADV
ajlsi-1012	364	7	does	do	AUX
ajlsi-1012	364	8	not	not	PART
ajlsi-1012	364	9	recommend	recommend	VERB
ajlsi-1012	364	10	ct	ct	PRON
ajlsi-1012	364	11	for	for	ADP
ajlsi-1012	364	12	screening	screening	NOUN
ajlsi-1012	364	13	or	or	CCONJ
ajlsi-1012	364	14	as	as	ADP
ajlsi-1012	364	15	a	a	DET
ajlsi-1012	364	16	first	first	ADJ
ajlsi-1012	364	17	-	-	PUNCT
ajlsi-1012	364	18	line	line	NOUN
ajlsi-1012	364	19	test	test	NOUN
ajlsi-1012	364	20	for	for	ADP
ajlsi-1012	364	21	the	the	DET
ajlsi-1012	364	22	diagnosis	diagnosis	NOUN
ajlsi-1012	364	23	of	of	ADP
ajlsi-1012	364	24	covid-19	covid-19	PROPN
ajlsi-1012	364	25	.	.	PUNCT
ajlsi-1012	364	26	lymphopenia	lymphopenia	PROPN
ajlsi-1012	364	27	is	be	AUX
ajlsi-1012	364	28	the	the	DET
ajlsi-1012	364	29	most	most	ADV
ajlsi-1012	364	30	common	common	ADJ
ajlsi-1012	364	31	laboratory	laboratory	NOUN
ajlsi-1012	364	32	finding	finding	NOUN
ajlsi-1012	364	33	in	in	ADP
ajlsi-1012	364	34	covid-19	covid-19	PROPN
ajlsi-1012	364	35	and	and	CCONJ
ajlsi-1012	364	36	is	be	AUX
ajlsi-1012	364	37	found	find	VERB
ajlsi-1012	364	38	in	in	ADP
ajlsi-1012	364	39	as	as	ADV
ajlsi-1012	364	40	many	many	ADJ
ajlsi-1012	364	41	as	as	ADP
ajlsi-1012	364	42	83	83	NUM
ajlsi-1012	364	43	%	%	NOUN
ajlsi-1012	364	44	of	of	ADP
ajlsi-1012	364	45	hospitalized	hospitalize	VERB
ajlsi-1012	364	46	patients	patient	NOUN
ajlsi-1012	364	47	.	.	PUNCT
ajlsi-1012	365	1	(	(	PUNCT
ajlsi-1012	365	2	huang	huang	PROPN
ajlsi-1012	365	3	et	et	PROPN
ajlsi-1012	365	4	al	al	PROPN
ajlsi-1012	365	5	.	.	PROPN
ajlsi-1012	365	6	,	,	PUNCT
ajlsi-1012	365	7	2020	2020	NUM
ajlsi-1012	365	8	)	)	PUNCT
ajlsi-1012	365	9	lymphopenia	lymphopenia	NOUN
ajlsi-1012	365	10	,	,	PUNCT
ajlsi-1012	365	11	neutrophilia	neutrophilia	PROPN
ajlsi-1012	365	12	,	,	PUNCT
ajlsi-1012	365	13	elevated	elevate	VERB
ajlsi-1012	365	14	serum	serum	NOUN
ajlsi-1012	365	15	alanine	alanine	NOUN
ajlsi-1012	365	16	aminotransferase	aminotransferase	PROPN
ajlsi-1012	365	17	and	and	CCONJ
ajlsi-1012	365	18	aspartate	aspartate	NOUN
ajlsi-1012	365	19	aminotransferase	aminotransferase	PROPN
ajlsi-1012	365	20	levels	level	NOUN
ajlsi-1012	365	21	,	,	PUNCT
ajlsi-1012	365	22	elevated	elevated	ADJ
ajlsi-1012	365	23	lactate	lactate	NOUN
ajlsi-1012	365	24	dehydrogenase	dehydrogenase	NOUN
ajlsi-1012	365	25	,	,	PUNCT
ajlsi-1012	365	26	high	high	ADJ
ajlsi-1012	365	27	crp	crp	NOUN
ajlsi-1012	365	28	,	,	PUNCT
ajlsi-1012	365	29	and	and	CCONJ
ajlsi-1012	365	30	high	high	ADJ
ajlsi-1012	365	31	ferritin	ferritin	ADJ
ajlsi-1012	365	32	levels	level	NOUN
ajlsi-1012	365	33	may	may	AUX
ajlsi-1012	365	34	be	be	AUX
ajlsi-1012	365	35	associated	associate	VERB
ajlsi-1012	365	36	with	with	ADP
ajlsi-1012	365	37	greater	great	ADJ
ajlsi-1012	365	38	illness	illness	NOUN
ajlsi-1012	365	39	severity	severity	NOUN
ajlsi-1012	365	40	(	(	PUNCT
ajlsi-1012	365	41	chen	chen	PROPN
ajlsi-1012	365	42	et	et	PROPN
ajlsi-1012	365	43	al	al	PROPN
ajlsi-1012	365	44	.	.	PROPN
ajlsi-1012	365	45	,	,	PUNCT
ajlsi-1012	365	46	2020	2020	NUM
ajlsi-1012	365	47	)	)	PUNCT
ajlsi-1012	365	48	.	.	PUNCT
ajlsi-1012	366	1	patients	patient	NOUN
ajlsi-1012	366	2	with	with	ADP
ajlsi-1012	366	3	critical	critical	ADJ
ajlsi-1012	366	4	illness	illness	NOUN
ajlsi-1012	366	5	had	have	VERB
ajlsi-1012	366	6	high	high	ADJ
ajlsi-1012	366	7	plasma	plasma	NOUN
ajlsi-1012	366	8	levels	level	NOUN
ajlsi-1012	366	9	of	of	ADP
ajlsi-1012	366	10	inflammatory	inflammatory	ADJ
ajlsi-1012	366	11	markers	marker	NOUN
ajlsi-1012	366	12	,	,	PUNCT
ajlsi-1012	366	13	suggesting	suggest	VERB
ajlsi-1012	366	14	potential	potential	ADJ
ajlsi-1012	366	15	immune	immune	ADJ
ajlsi-1012	366	16	dysregulation	dysregulation	NOUN
ajlsi-1012	366	17	(	(	PUNCT
ajlsi-1012	366	18	wang	wang	PROPN
ajlsi-1012	366	19	et	et	PROPN
ajlsi-1012	366	20	al	al	PROPN
ajlsi-1012	366	21	.	.	PROPN
ajlsi-1012	366	22	,	,	PUNCT
ajlsi-1012	366	23	2020	2020	NUM
ajlsi-1012	366	24	)	)	PUNCT
ajlsi-1012	366	25	.	.	PUNCT
ajlsi-1012	367	1	this	this	DET
ajlsi-1012	367	2	review	review	NOUN
ajlsi-1012	367	3	summarizes	summarize	VERB
ajlsi-1012	367	4	various	various	ADJ
ajlsi-1012	367	5	diagnostic	diagnostic	ADJ
ajlsi-1012	367	6	methods	method	NOUN
ajlsi-1012	367	7	used	use	VERB
ajlsi-1012	367	8	for	for	ADP
ajlsi-1012	367	9	the	the	DET
ajlsi-1012	367	10	identification	identification	NOUN
ajlsi-1012	367	11	of	of	ADP
ajlsi-1012	367	12	covid-19	covid-19	PROPN
ajlsi-1012	367	13	infections	infection	NOUN
ajlsi-1012	367	14	.	.	PUNCT
ajlsi-1012	368	1	while	while	SCONJ
ajlsi-1012	368	2	rt	rt	PROPN
ajlsi-1012	368	3	-	-	PUNCT
ajlsi-1012	368	4	pcr	pcr	PROPN
ajlsi-1012	368	5	has	have	AUX
ajlsi-1012	368	6	been	be	AUX
ajlsi-1012	368	7	the	the	DET
ajlsi-1012	368	8	dominant	dominant	ADJ
ajlsi-1012	368	9	technique	technique	NOUN
ajlsi-1012	368	10	for	for	ADP
ajlsi-1012	368	11	detection	detection	NOUN
ajlsi-1012	368	12	of	of	ADP
ajlsi-1012	368	13	viral	viral	ADJ
ajlsi-1012	368	14	rna	rna	NOUN
ajlsi-1012	368	15	,	,	PUNCT
ajlsi-1012	368	16	other	other	ADJ
ajlsi-1012	368	17	nucleic	nucleic	ADJ
ajlsi-1012	368	18	acid	acid	NOUN
ajlsi-1012	368	19	assays	assay	NOUN
ajlsi-1012	368	20	,	,	PUNCT
ajlsi-1012	368	21	including	include	VERB
ajlsi-1012	368	22	isothermal	isothermal	ADJ
ajlsi-1012	368	23	amplification	amplification	NOUN
ajlsi-1012	368	24	assays	assay	NOUN
ajlsi-1012	368	25	,	,	PUNCT
ajlsi-1012	368	26	hybridization	hybridization	NOUN
ajlsi-1012	368	27	microarray	microarray	NOUN
ajlsi-1012	368	28	assays	assay	NOUN
ajlsi-1012	368	29	,	,	PUNCT
ajlsi-1012	368	30	amplicon	amplicon	NOUN
ajlsi-1012	368	31	-	-	PUNCT
ajlsi-1012	368	32	based	base	VERB
ajlsi-1012	368	33	metagenomics	metagenomic	NOUN
ajlsi-1012	368	34	sequencing	sequencing	NOUN
ajlsi-1012	368	35	,	,	PUNCT
ajlsi-1012	368	36	and	and	CCONJ
ajlsi-1012	368	37	the	the	DET
ajlsi-1012	368	38	cutting	cutting	NOUN
ajlsi-1012	368	39	-	-	PUNCT
ajlsi-1012	368	40	edge	edge	NOUN
ajlsi-1012	368	41	crispr	crispr	NOUN
ajlsi-1012	368	42	-	-	PUNCT
ajlsi-1012	368	43	related	relate	VERB
ajlsi-1012	368	44	technologies	technology	NOUN
ajlsi-1012	368	45	,	,	PUNCT
ajlsi-1012	368	46	are	be	AUX
ajlsi-1012	368	47	also	also	ADV
ajlsi-1012	368	48	under	under	ADP
ajlsi-1012	368	49	development	development	NOUN
ajlsi-1012	368	50	or	or	CCONJ
ajlsi-1012	368	51	have	have	AUX
ajlsi-1012	368	52	resulted	result	VERB
ajlsi-1012	368	53	in	in	ADP
ajlsi-1012	368	54	approved	approve	VERB
ajlsi-1012	368	55	tests	test	NOUN
ajlsi-1012	368	56	.	.	PUNCT
ajlsi-1012	369	1	a	a	DET
ajlsi-1012	369	2	comparative	comparative	ADJ
ajlsi-1012	369	3	account	account	NOUN
ajlsi-1012	369	4	of	of	ADP
ajlsi-1012	369	5	different	different	ADJ
ajlsi-1012	369	6	diagnostic	diagnostic	ADJ
ajlsi-1012	369	7	methods	method	NOUN
ajlsi-1012	369	8	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	369	9	pa	pa	PROPN
ajlsi-1012	369	10	ge	ge	PROPN
ajlsi-1012	369	11	38	38	NUM
ajlsi-1012	369	12	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	369	13	am	am	NOUN
ajlsi-1012	369	14	.	.	PUNCT
ajlsi-1012	370	1	j.	j.	PROPN
ajlsi-1012	370	2	life	life	PROPN
ajlsi-1012	370	3	sci	sci	PROPN
ajlsi-1012	370	4	.	.	PUNCT
ajlsi-1012	370	5	innov	innov	PROPN
ajlsi-1012	370	6	.	.	PUNCT
ajlsi-1012	371	1	1(2	1(2	NUM
ajlsi-1012	371	2	)	)	PUNCT
ajlsi-1012	371	3	29	29	NUM
ajlsi-1012	371	4	-	-	SYM
ajlsi-1012	371	5	42	42	NUM
ajlsi-1012	371	6	,	,	PUNCT
ajlsi-1012	371	7	2022	2022	NUM
ajlsi-1012	371	8	table	table	NOUN
ajlsi-1012	371	9	1	1	NUM
ajlsi-1012	371	10	:	:	PUNCT
ajlsi-1012	371	11	a	a	DET
ajlsi-1012	371	12	comparative	comparative	ADJ
ajlsi-1012	371	13	account	account	NOUN
ajlsi-1012	371	14	of	of	ADP
ajlsi-1012	371	15	different	different	ADJ
ajlsi-1012	371	16	diagnostic	diagnostic	ADJ
ajlsi-1012	371	17	methods	method	NOUN
ajlsi-1012	371	18	used	use	VERB
ajlsi-1012	371	19	for	for	ADP
ajlsi-1012	371	20	detection	detection	NOUN
ajlsi-1012	371	21	of	of	ADP
ajlsi-1012	371	22	covid-19	covid-19	PROPN
ajlsi-1012	371	23	method	method	NOUN
ajlsi-1012	371	24	working	work	VERB
ajlsi-1012	371	25	principle	principle	NOUN
ajlsi-1012	371	26	advantage	advantage	NOUN
ajlsi-1012	371	27	time	time	NOUN
ajlsi-1012	371	28	required	require	VERB
ajlsi-1012	371	29	disadvantage	disadvantage	NOUN
ajlsi-1012	371	30	next	next	ADJ
ajlsi-1012	371	31	generation	generation	NOUN
ajlsi-1012	371	32	sequencing	sequence	VERB
ajlsi-1012	371	33	(	(	PUNCT
ajlsi-1012	371	34	ngs	ng	NOUN
ajlsi-1012	371	35	)	)	PUNCT
ajlsi-1012	371	36	wholegenome	wholegenome	VERB
ajlsi-1012	371	37	sequencing	sequencing	NOUN
ajlsi-1012	371	38	,	,	PUNCT
ajlsi-1012	371	39	shotgun	shotgun	NOUN
ajlsi-1012	371	40	metagenomics	metagenomic	NOUN
ajlsi-1012	371	41	etc	etc	X
ajlsi-1012	371	42	.	.	X
ajlsi-1012	372	1	highly	highly	ADV
ajlsi-1012	372	2	sensitive	sensitive	ADJ
ajlsi-1012	372	3	and	and	CCONJ
ajlsi-1012	372	4	specific	specific	ADJ
ajlsi-1012	372	5	,	,	PUNCT
ajlsi-1012	372	6	could	could	AUX
ajlsi-1012	372	7	provide	provide	VERB
ajlsi-1012	372	8	all	all	DET
ajlsi-1012	372	9	related	relate	VERB
ajlsi-1012	372	10	information	information	NOUN
ajlsi-1012	372	11	;	;	PUNCT
ajlsi-1012	372	12	can	can	AUX
ajlsi-1012	372	13	identify	identify	VERB
ajlsi-1012	372	14	novel	novel	ADJ
ajlsi-1012	372	15	strain	strain	NOUN
ajlsi-1012	372	16	.	.	PUNCT
ajlsi-1012	373	1	helps	help	VERB
ajlsi-1012	373	2	to	to	PART
ajlsi-1012	373	3	examine	examine	VERB
ajlsi-1012	373	4	multiple	multiple	ADJ
ajlsi-1012	373	5	pathogenic	pathogenic	ADJ
ajlsi-1012	373	6	organisms	organism	NOUN
ajlsi-1012	373	7	present	present	ADJ
ajlsi-1012	373	8	in	in	ADP
ajlsi-1012	373	9	a	a	DET
ajlsi-1012	373	10	complex	complex	ADJ
ajlsi-1012	373	11	sample	sample	NOUN
ajlsi-1012	373	12	.	.	PUNCT
ajlsi-1012	374	1	1	1	NUM
ajlsi-1012	374	2	-	-	SYM
ajlsi-1012	374	3	2	2	NUM
ajlsi-1012	374	4	days	day	NOUN
ajlsi-1012	374	5	require	require	VERB
ajlsi-1012	374	6	high	high	ADJ
ajlsi-1012	374	7	expertise	expertise	NOUN
ajlsi-1012	374	8	&	&	CCONJ
ajlsi-1012	374	9	cost	cost	NOUN
ajlsi-1012	374	10	.	.	PUNCT
ajlsi-1012	375	1	highly	highly	ADV
ajlsi-1012	375	2	sophisticated	sophisticated	ADJ
ajlsi-1012	375	3	lab	lab	NOUN
ajlsi-1012	375	4	required	require	VERB
ajlsi-1012	375	5	.	.	PUNCT
ajlsi-1012	376	1	rt	rt	ADJ
ajlsi-1012	376	2	-	-	PUNCT
ajlsi-1012	376	3	pcr	pcr	ADJ
ajlsi-1012	376	4	specific	specific	ADJ
ajlsi-1012	376	5	primer	primer	NOUN
ajlsi-1012	376	6	-	-	PUNCT
ajlsi-1012	376	7	probe	probe	NOUN
ajlsi-1012	376	8	based	base	VERB
ajlsi-1012	376	9	detection	detection	NOUN
ajlsi-1012	376	10	fast	fast	ADJ
ajlsi-1012	376	11	results	result	NOUN
ajlsi-1012	376	12	,	,	PUNCT
ajlsi-1012	376	13	higher	high	ADJ
ajlsi-1012	376	14	sensitivity	sensitivity	NOUN
ajlsi-1012	376	15	,	,	PUNCT
ajlsi-1012	376	16	well	well	ADV
ajlsi-1012	376	17	established	establish	VERB
ajlsi-1012	376	18	methodology	methodology	NOUN
ajlsi-1012	376	19	in	in	ADP
ajlsi-1012	376	20	viral	viral	ADJ
ajlsi-1012	376	21	diagnostics	diagnostic	NOUN
ajlsi-1012	376	22	.	.	PUNCT
ajlsi-1012	377	1	3	3	NUM
ajlsi-1012	377	2	-	-	SYM
ajlsi-1012	377	3	4	4	NUM
ajlsi-1012	377	4	hrs	hrs	NOUN
ajlsi-1012	377	5	.	.	PUNCT
ajlsi-1012	378	1	high	high	ADJ
ajlsi-1012	378	2	cost	cost	NOUN
ajlsi-1012	378	3	due	due	ADP
ajlsi-1012	378	4	to	to	ADP
ajlsi-1012	378	5	expensive	expensive	ADJ
ajlsi-1012	378	6	consumables	consumable	NOUN
ajlsi-1012	378	7	.	.	PUNCT
ajlsi-1012	379	1	expensive	expensive	ADJ
ajlsi-1012	379	2	lab	lab	NOUN
ajlsi-1012	379	3	equipment	equipment	NOUN
ajlsi-1012	379	4	.	.	PUNCT
ajlsi-1012	380	1	rna	rna	NOUN
ajlsi-1012	380	2	extraction	extraction	NOUN
ajlsi-1012	380	3	is	be	AUX
ajlsi-1012	380	4	highly	highly	ADV
ajlsi-1012	380	5	tedious	tedious	ADJ
ajlsi-1012	380	6	and	and	CCONJ
ajlsi-1012	380	7	sensitive	sensitive	ADJ
ajlsi-1012	380	8	.	.	PUNCT
ajlsi-1012	381	1	isothermal	isothermal	ADJ
ajlsi-1012	381	2	nucleic	nucleic	ADJ
ajlsi-1012	381	3	acid	acid	NOUN
ajlsi-1012	381	4	amplification	amplification	NOUN
ajlsi-1012	381	5	synthesis	synthesis	NOUN
ajlsi-1012	381	6	of	of	ADP
ajlsi-1012	381	7	target	target	NOUN
ajlsi-1012	381	8	dna	dna	NOUN
ajlsi-1012	381	9	at	at	ADP
ajlsi-1012	381	10	constant	constant	ADJ
ajlsi-1012	381	11	temperature	temperature	NOUN
ajlsi-1012	381	12	of	of	ADP
ajlsi-1012	381	13	60	60	NUM
ajlsi-1012	381	14	-650c	-650c	VERB
ajlsi-1012	381	15	using	use	VERB
ajlsi-1012	381	16	specially	specially	ADV
ajlsi-1012	381	17	designed	design	VERB
ajlsi-1012	381	18	primer	primer	NOUN
ajlsi-1012	381	19	no	no	DET
ajlsi-1012	381	20	thermal	thermal	ADJ
ajlsi-1012	381	21	cycler	cycler	NOUN
ajlsi-1012	381	22	required	require	VERB
ajlsi-1012	381	23	.	.	PUNCT
ajlsi-1012	382	1	can	can	AUX
ajlsi-1012	382	2	be	be	AUX
ajlsi-1012	382	3	easily	easily	ADV
ajlsi-1012	382	4	detected	detect	VERB
ajlsi-1012	382	5	by	by	ADP
ajlsi-1012	382	6	color	color	NOUN
ajlsi-1012	382	7	change	change	NOUN
ajlsi-1012	382	8	or	or	CCONJ
ajlsi-1012	382	9	turbidity	turbidity	NOUN
ajlsi-1012	382	10	1	1	NUM
ajlsi-1012	382	11	-	-	SYM
ajlsi-1012	382	12	2	2	NUM
ajlsi-1012	382	13	hrs	hrs	NOUN
ajlsi-1012	382	14	.	.	PUNCT
ajlsi-1012	383	1	too	too	ADV
ajlsi-1012	383	2	sensitive	sensitive	ADJ
ajlsi-1012	383	3	,	,	PUNCT
ajlsi-1012	383	4	highly	highly	ADV
ajlsi-1012	383	5	prone	prone	ADJ
ajlsi-1012	383	6	to	to	ADP
ajlsi-1012	383	7	false	false	ADJ
ajlsi-1012	383	8	positive	positive	ADJ
ajlsi-1012	383	9	results	result	NOUN
ajlsi-1012	383	10	due	due	ADP
ajlsi-1012	383	11	to	to	PART
ajlsi-1012	383	12	carry	carry	VERB
ajlsi-1012	383	13	-	-	PUNCT
ajlsi-1012	383	14	over	over	ADP
ajlsi-1012	383	15	or	or	CCONJ
ajlsi-1012	383	16	cross	cross	VERB
ajlsi-1012	383	17	contamination	contamination	NOUN
ajlsi-1012	383	18	lamp	lamp	NOUN
ajlsi-1012	383	19	more	more	ADJ
ajlsi-1012	383	20	than	than	ADP
ajlsi-1012	383	21	two	two	NUM
ajlsi-1012	383	22	sets	set	NOUN
ajlsi-1012	383	23	of	of	ADP
ajlsi-1012	383	24	specific	specific	ADJ
ajlsi-1012	383	25	primers	primer	NOUN
ajlsi-1012	383	26	pairbased	pairbase	VERB
ajlsi-1012	383	27	detection	detection	NOUN
ajlsi-1012	383	28	.	.	PUNCT
ajlsi-1012	384	1	highly	highly	ADV
ajlsi-1012	384	2	repeatable	repeatable	ADJ
ajlsi-1012	384	3	and	and	CCONJ
ajlsi-1012	384	4	accurate	accurate	ADJ
ajlsi-1012	384	5	.	.	PUNCT
ajlsi-1012	385	1	no	no	DET
ajlsi-1012	385	2	thermal	thermal	ADJ
ajlsi-1012	385	3	cycler	cycler	NOUN
ajlsi-1012	385	4	required	require	VERB
ajlsi-1012	385	5	1	1	NUM
ajlsi-1012	385	6	hr	hr	NOUN
ajlsi-1012	385	7	.	.	PUNCT
ajlsi-1012	386	1	primer	primer	NOUN
ajlsi-1012	386	2	designing	designing	NOUN
ajlsi-1012	386	3	is	be	AUX
ajlsi-1012	386	4	complex	complex	ADJ
ajlsi-1012	386	5	cb	cb	PROPN
ajlsi-1012	386	6	naat/	naat/	PRON
ajlsi-1012	386	7	true	true	ADJ
ajlsi-1012	386	8	naat	naat	PROPN
ajlsi-1012	386	9	cartridge	cartridge	NOUN
ajlsi-1012	386	10	based	base	VERB
ajlsi-1012	386	11	nucleic	nucleic	ADJ
ajlsi-1012	386	12	acid	acid	NOUN
ajlsi-1012	386	13	amplification	amplification	NOUN
ajlsi-1012	386	14	and	and	CCONJ
ajlsi-1012	386	15	detection	detection	NOUN
ajlsi-1012	386	16	automated	automate	VERB
ajlsi-1012	386	17	sample	sample	NOUN
ajlsi-1012	386	18	preparation	preparation	NOUN
ajlsi-1012	386	19	,	,	PUNCT
ajlsi-1012	386	20	pre	pre	ADJ
ajlsi-1012	386	21	-	-	ADJ
ajlsi-1012	386	22	programmed	program	VERB
ajlsi-1012	386	23	reaction	reaction	NOUN
ajlsi-1012	386	24	.	.	PUNCT
ajlsi-1012	387	1	can	can	AUX
ajlsi-1012	387	2	be	be	AUX
ajlsi-1012	387	3	used	use	VERB
ajlsi-1012	387	4	in	in	ADP
ajlsi-1012	387	5	a	a	DET
ajlsi-1012	387	6	poc	poc	PROPN
ajlsi-1012	387	7	devices	device	NOUN
ajlsi-1012	387	8	15–30	15–30	PROPN
ajlsi-1012	387	9	min	min	PROPN
ajlsi-1012	387	10	crispr	crispr	PROPN
ajlsi-1012	387	11	based	base	VERB
ajlsi-1012	387	12	methods	method	NOUN
ajlsi-1012	387	13	enzymes	enzyme	NOUN
ajlsi-1012	387	14	programmed	program	VERB
ajlsi-1012	387	15	to	to	PART
ajlsi-1012	387	16	target	target	VERB
ajlsi-1012	387	17	and	and	CCONJ
ajlsi-1012	387	18	cut	cut	VERB
ajlsi-1012	387	19	viral	viral	ADJ
ajlsi-1012	387	20	rna	rna	NOUN
ajlsi-1012	387	21	sequences	sequence	NOUN
ajlsi-1012	387	22	low	low	ADJ
ajlsi-1012	387	23	-	-	PUNCT
ajlsi-1012	387	24	cost	cost	NOUN
ajlsi-1012	387	25	,	,	PUNCT
ajlsi-1012	387	26	do	do	AUX
ajlsi-1012	387	27	not	not	PART
ajlsi-1012	387	28	require	require	VERB
ajlsi-1012	387	29	complex	complex	ADJ
ajlsi-1012	387	30	instrumentation	instrumentation	NOUN
ajlsi-1012	387	31	,	,	PUNCT
ajlsi-1012	387	32	can	can	AUX
ajlsi-1012	387	33	be	be	AUX
ajlsi-1012	387	34	read	read	VERB
ajlsi-1012	387	35	using	use	VERB
ajlsi-1012	387	36	paper	paper	NOUN
ajlsi-1012	387	37	strips	strip	NOUN
ajlsi-1012	387	38	.	.	PUNCT
ajlsi-1012	388	1	15–30	15–30	NUM
ajlsi-1012	388	2	min	min	NOUN
ajlsi-1012	388	3	not	not	PART
ajlsi-1012	388	4	properly	properly	ADV
ajlsi-1012	388	5	standardized	standardize	VERB
ajlsi-1012	388	6	for	for	ADP
ajlsi-1012	388	7	sars	sars	PROPN
ajlsi-1012	388	8	cov2	cov2	PROPN
ajlsi-1012	388	9	detection	detection	PROPN
ajlsi-1012	388	10	serological	serological	ADJ
ajlsi-1012	388	11	(	(	PUNCT
ajlsi-1012	388	12	traditional	traditional	ADJ
ajlsi-1012	388	13	)	)	PUNCT
ajlsi-1012	388	14	antigen	antigen	PROPN
ajlsi-1012	388	15	/	/	SYM
ajlsi-1012	388	16	antibodies	antibodie	VERB
ajlsi-1012	388	17	igg/	igg/	PROPN
ajlsi-1012	388	18	igm	igm	PROPN
ajlsi-1012	388	19	/	/	SYM
ajlsi-1012	388	20	elisa	elisa	PROPN
ajlsi-1012	388	21	etc	etc	X
ajlsi-1012	388	22	.	.	X
ajlsi-1012	388	23	sensitive	sensitive	ADJ
ajlsi-1012	388	24	and	and	CCONJ
ajlsi-1012	388	25	specific	specific	ADJ
ajlsi-1012	388	26	.	.	PUNCT
ajlsi-1012	388	27	useful	useful	ADJ
ajlsi-1012	388	28	for	for	ADP
ajlsi-1012	388	29	choosing	choose	VERB
ajlsi-1012	388	30	the	the	DET
ajlsi-1012	388	31	convalescent	convalescent	NOUN
ajlsi-1012	388	32	plasma	plasma	NOUN
ajlsi-1012	388	33	therapy	therapy	NOUN
ajlsi-1012	388	34	.	.	PUNCT
ajlsi-1012	389	1	4	4	NUM
ajlsi-1012	389	2	-	-	SYM
ajlsi-1012	389	3	6	6	NUM
ajlsi-1012	389	4	hrs	hrs	NOUN
ajlsi-1012	389	5	samples	sample	NOUN
ajlsi-1012	389	6	taken	take	VERB
ajlsi-1012	389	7	after	after	ADP
ajlsi-1012	389	8	3	3	NUM
ajlsi-1012	389	9	-	-	SYM
ajlsi-1012	389	10	4	4	NUM
ajlsi-1012	389	11	days	day	NOUN
ajlsi-1012	389	12	of	of	ADP
ajlsi-1012	389	13	infection	infection	NOUN
ajlsi-1012	389	14	.	.	PUNCT
ajlsi-1012	390	1	rapid	rapid	ADJ
ajlsi-1012	390	2	serological	serological	ADJ
ajlsi-1012	390	3	(	(	PUNCT
ajlsi-1012	390	4	traditional	traditional	ADJ
ajlsi-1012	390	5	)	)	PUNCT
ajlsi-1012	390	6	antigen	antigen	PROPN
ajlsi-1012	390	7	/	/	SYM
ajlsi-1012	390	8	antibodies	antibodie	VERB
ajlsi-1012	390	9	igg	igg	PROPN
ajlsi-1012	390	10	/	/	SYM
ajlsi-1012	390	11	igm	igm	PROPN
ajlsi-1012	390	12	convenient	convenient	ADJ
ajlsi-1012	390	13	,	,	PUNCT
ajlsi-1012	390	14	can	can	AUX
ajlsi-1012	390	15	be	be	AUX
ajlsi-1012	390	16	used	use	VERB
ajlsi-1012	390	17	in	in	ADP
ajlsi-1012	390	18	a	a	DET
ajlsi-1012	390	19	poc	poc	NOUN
ajlsi-1012	390	20	devices	device	NOUN
ajlsi-1012	390	21	15	15	NUM
ajlsi-1012	390	22	-	-	SYM
ajlsi-1012	390	23	30	30	NUM
ajlsi-1012	390	24	min	min	NOUN
ajlsi-1012	390	25	samples	sample	NOUN
ajlsi-1012	390	26	taken	take	VERB
ajlsi-1012	390	27	after	after	ADP
ajlsi-1012	390	28	3	3	NUM
ajlsi-1012	390	29	-	-	SYM
ajlsi-1012	390	30	4	4	NUM
ajlsi-1012	390	31	days	day	NOUN
ajlsi-1012	390	32	of	of	ADP
ajlsi-1012	390	33	infection	infection	NOUN
ajlsi-1012	390	34	.	.	PUNCT
ajlsi-1012	391	1	lateral	lateral	ADJ
ajlsi-1012	391	2	flow	flow	NOUN
ajlsi-1012	391	3	assay	assay	VERB
ajlsi-1012	391	4	colorimetric	colorimetric	ADJ
ajlsi-1012	391	5	,	,	PUNCT
ajlsi-1012	391	6	qualitative	qualitative	ADJ
ajlsi-1012	391	7	detection	detection	NOUN
ajlsi-1012	391	8	of	of	ADP
ajlsi-1012	391	9	the	the	DET
ajlsi-1012	391	10	presence	presence	NOUN
ajlsi-1012	391	11	of	of	ADP
ajlsi-1012	391	12	antibodies	antibody	NOUN
ajlsi-1012	391	13	inexpensive	inexpensive	ADJ
ajlsi-1012	391	14	and	and	CCONJ
ajlsi-1012	391	15	convenient	convenient	ADJ
ajlsi-1012	391	16	,	,	PUNCT
ajlsi-1012	391	17	can	can	AUX
ajlsi-1012	391	18	be	be	AUX
ajlsi-1012	391	19	used	use	VERB
ajlsi-1012	391	20	in	in	ADP
ajlsi-1012	391	21	a	a	DET
ajlsi-1012	391	22	poc	poc	NOUN
ajlsi-1012	391	23	devices	device	NOUN
ajlsi-1012	391	24	10	10	NUM
ajlsi-1012	391	25	-	-	SYM
ajlsi-1012	391	26	15	15	NUM
ajlsi-1012	391	27	min	min	NOUN
ajlsi-1012	391	28	nature	nature	NOUN
ajlsi-1012	391	29	of	of	ADP
ajlsi-1012	391	30	the	the	DET
ajlsi-1012	391	31	sample	sample	NOUN
ajlsi-1012	391	32	affects	affect	VERB
ajlsi-1012	391	33	capillary	capillary	ADJ
ajlsi-1012	391	34	action	action	NOUN
ajlsi-1012	391	35	,	,	PUNCT
ajlsi-1012	391	36	(	(	PUNCT
ajlsi-1012	391	37	e.g.	e.g.	ADV
ajlsi-1012	391	38	blood	blood	NOUN
ajlsi-1012	391	39	clotting	clotting	NOUN
ajlsi-1012	391	40	)	)	PUNCT
ajlsi-1012	391	41	pretreat	pretreat	NOUN
ajlsi-1012	391	42	meant	mean	VERB
ajlsi-1012	391	43	is	be	AUX
ajlsi-1012	391	44	required	require	VERB
ajlsi-1012	391	45	.	.	PUNCT
ajlsi-1012	392	1	luminescent	luminescent	PROPN
ajlsi-1012	392	2	immune	immune	ADJ
ajlsi-1012	392	3	assay	assay	NOUN
ajlsi-1012	392	4	chemiluminescence	chemiluminescence	NOUN
ajlsi-1012	392	5	or	or	CCONJ
ajlsi-1012	392	6	fluorescencelabelled	fluorescencelabelle	VERB
ajlsi-1012	392	7	antibody	antibody	NOUN
ajlsi-1012	392	8	or	or	CCONJ
ajlsi-1012	392	9	antigen	antigen	ADV
ajlsi-1012	392	10	highly	highly	ADV
ajlsi-1012	392	11	sensitive	sensitive	ADJ
ajlsi-1012	392	12	,	,	PUNCT
ajlsi-1012	392	13	quantitative	quantitative	ADJ
ajlsi-1012	392	14	1	1	NUM
ajlsi-1012	392	15	-	-	SYM
ajlsi-1012	392	16	2	2	NUM
ajlsi-1012	392	17	hrs	hrs	NOUN
ajlsi-1012	392	18	.	.	PUNCT
ajlsi-1012	393	1	closed	close	VERB
ajlsi-1012	393	2	analytical	analytical	ADJ
ajlsi-1012	393	3	systems	system	NOUN
ajlsi-1012	393	4	required	require	VERB
ajlsi-1012	393	5	for	for	ADP
ajlsi-1012	393	6	detection	detection	NOUN
ajlsi-1012	393	7	microarray	microarray	NOUN
ajlsi-1012	393	8	rapid	rapid	ADJ
ajlsi-1012	393	9	high	high	ADJ
ajlsi-1012	393	10	-	-	PUNCT
ajlsi-1012	393	11	throughput	throughput	NOUN
ajlsi-1012	393	12	detection	detection	NOUN
ajlsi-1012	393	13	of	of	ADP
ajlsi-1012	393	14	viral	viral	ADJ
ajlsi-1012	393	15	rna	rna	NOUN
ajlsi-1012	393	16	using	use	VERB
ajlsi-1012	393	17	cdna	cdna	PROPN
ajlsi-1012	393	18	highly	highly	ADV
ajlsi-1012	393	19	sensitive	sensitive	ADJ
ajlsi-1012	393	20	,	,	PUNCT
ajlsi-1012	393	21	longer	long	ADJ
ajlsi-1012	393	22	target	target	VERB
ajlsi-1012	393	23	sequences	sequence	NOUN
ajlsi-1012	393	24	can	can	AUX
ajlsi-1012	393	25	be	be	AUX
ajlsi-1012	393	26	detected	detect	VERB
ajlsi-1012	393	27	1	1	NUM
ajlsi-1012	393	28	hr	hr	NOUN
ajlsi-1012	393	29	.	.	PUNCT
ajlsi-1012	394	1	fabrication	fabrication	NOUN
ajlsi-1012	394	2	of	of	ADP
ajlsi-1012	394	3	cdna	cdna	PROPN
ajlsi-1012	394	4	micro	micro	PROPN
ajlsi-1012	394	5	array	array	PROPN
ajlsi-1012	394	6	is	be	AUX
ajlsi-1012	394	7	labor	labor	NOUN
ajlsi-1012	394	8	intensive	intensive	ADJ
ajlsi-1012	394	9	.	.	PUNCT
ajlsi-1012	395	1	ct	ct	PROPN
ajlsi-1012	395	2	scan	scan	PROPN
ajlsi-1012	395	3	computerized	computerize	VERB
ajlsi-1012	395	4	tomography	tomography	NOUN
ajlsi-1012	395	5	of	of	ADP
ajlsi-1012	395	6	chest	chest	NOUN
ajlsi-1012	395	7	images	image	NOUN
ajlsi-1012	395	8	enhance	enhance	VERB
ajlsi-1012	395	9	sensitivity	sensitivity	NOUN
ajlsi-1012	395	10	of	of	ADP
ajlsi-1012	395	11	detection	detection	NOUN
ajlsi-1012	395	12	if	if	SCONJ
ajlsi-1012	395	13	findings	finding	NOUN
ajlsi-1012	395	14	combined	combine	VERB
ajlsi-1012	395	15	with	with	ADP
ajlsi-1012	395	16	rt	rt	PROPN
ajlsi-1012	395	17	-	-	PUNCT
ajlsi-1012	395	18	pcr	pcr	ADJ
ajlsi-1012	395	19	results	result	NOUN
ajlsi-1012	395	20	1	1	NUM
ajlsi-1012	395	21	hr	hr	NOUN
ajlsi-1012	395	22	.	.	NOUN
ajlsi-1012	395	23	indistinguishability	indistinguishability	NOUN
ajlsi-1012	395	24	from	from	ADP
ajlsi-1012	395	25	other	other	ADJ
ajlsi-1012	395	26	viral	viral	ADJ
ajlsi-1012	395	27	pneumonia	pneumonia	NOUN
ajlsi-1012	395	28	other	other	ADJ
ajlsi-1012	395	29	chest	chest	NOUN
ajlsi-1012	395	30	complications	complication	NOUN
ajlsi-1012	395	31	biochemical	biochemical	ADJ
ajlsi-1012	395	32	tests	test	NOUN
ajlsi-1012	395	33	blood	blood	NOUN
ajlsi-1012	395	34	counts	count	NOUN
ajlsi-1012	395	35	,	,	PUNCT
ajlsi-1012	395	36	lymphopenia	lymphopenia	NOUN
ajlsi-1012	395	37	,	,	PUNCT
ajlsi-1012	395	38	elevated	elevated	ADJ
ajlsi-1012	395	39	serum	serum	NOUN
ajlsi-1012	395	40	enzyme	enzyme	NOUN
ajlsi-1012	395	41	levels	level	NOUN
ajlsi-1012	395	42	,	,	PUNCT
ajlsi-1012	395	43	high	high	ADV
ajlsi-1012	395	44	could	could	AUX
ajlsi-1012	395	45	support	support	VERB
ajlsi-1012	395	46	routine	routine	ADJ
ajlsi-1012	395	47	symptomatic	symptomatic	ADJ
ajlsi-1012	395	48	treatment	treatment	NOUN
ajlsi-1012	395	49	regimens	regimen	NOUN
ajlsi-1012	395	50	of	of	ADP
ajlsi-1012	395	51	covid	covid	PROPN
ajlsi-1012	395	52	19	19	NUM
ajlsi-1012	395	53	1	1	NUM
ajlsi-1012	395	54	-	-	SYM
ajlsi-1012	395	55	24	24	NUM
ajlsi-1012	395	56	hrs	hrs	NOUN
ajlsi-1012	395	57	not	not	PART
ajlsi-1012	395	58	conclusive	conclusive	ADJ
ajlsi-1012	395	59	evidence	evidence	NOUN
ajlsi-1012	395	60	for	for	ADP
ajlsi-1012	395	61	covid	covid	PROPN
ajlsi-1012	395	62	19	19	NUM
ajlsi-1012	395	63	infections	infection	NOUN
ajlsi-1012	395	64	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	395	65	pa	pa	PROPN
ajlsi-1012	395	66	ge	ge	PROPN
ajlsi-1012	395	67	39	39	NUM
ajlsi-1012	395	68	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	395	69	am	am	NOUN
ajlsi-1012	395	70	.	.	PUNCT
ajlsi-1012	396	1	j.	j.	PROPN
ajlsi-1012	396	2	life	life	PROPN
ajlsi-1012	396	3	sci	sci	PROPN
ajlsi-1012	396	4	.	.	PUNCT
ajlsi-1012	396	5	innov	innov	PROPN
ajlsi-1012	396	6	.	.	PUNCT
ajlsi-1012	397	1	1(2	1(2	NUM
ajlsi-1012	397	2	)	)	PUNCT
ajlsi-1012	397	3	29	29	NUM
ajlsi-1012	397	4	-	-	SYM
ajlsi-1012	397	5	42	42	NUM
ajlsi-1012	397	6	,	,	PUNCT
ajlsi-1012	397	7	2022	2022	NUM
ajlsi-1012	397	8	available	available	ADJ
ajlsi-1012	397	9	for	for	ADP
ajlsi-1012	397	10	covid-19	covid-19	PROPN
ajlsi-1012	397	11	is	be	AUX
ajlsi-1012	397	12	given	give	VERB
ajlsi-1012	397	13	in	in	ADP
ajlsi-1012	397	14	table	table	NOUN
ajlsi-1012	397	15	1	1	NUM
ajlsi-1012	397	16	.	.	PUNCT
ajlsi-1012	398	1	the	the	DET
ajlsi-1012	398	2	urgent	urgent	ADJ
ajlsi-1012	398	3	need	need	NOUN
ajlsi-1012	398	4	for	for	ADP
ajlsi-1012	398	5	accurate	accurate	ADJ
ajlsi-1012	398	6	and	and	CCONJ
ajlsi-1012	398	7	rapid	rapid	ADJ
ajlsi-1012	398	8	diagnosis	diagnosis	NOUN
ajlsi-1012	398	9	of	of	ADP
ajlsi-1012	398	10	sars	sar	NOUN
ajlsi-1012	398	11	-	-	PUNCT
ajlsi-1012	398	12	cov-2	cov-2	PART
ajlsi-1012	398	13	infection	infection	NOUN
ajlsi-1012	398	14	remains	remain	VERB
ajlsi-1012	398	15	critical	critical	ADJ
ajlsi-1012	398	16	as	as	SCONJ
ajlsi-1012	398	17	global	global	ADJ
ajlsi-1012	398	18	healthcare	healthcare	PROPN
ajlsi-1012	398	19	systems	system	NOUN
ajlsi-1012	398	20	continue	continue	VERB
ajlsi-1012	398	21	to	to	PART
ajlsi-1012	398	22	operate	operate	VERB
ajlsi-1012	398	23	during	during	ADP
ajlsi-1012	398	24	the	the	DET
ajlsi-1012	398	25	course	course	NOUN
ajlsi-1012	398	26	of	of	ADP
ajlsi-1012	398	27	the	the	DET
ajlsi-1012	398	28	covid-19	covid-19	PROPN
ajlsi-1012	398	29	pandemic	pandemic	NOUN
ajlsi-1012	398	30	.	.	PUNCT
ajlsi-1012	399	1	in	in	ADP
ajlsi-1012	399	2	particular	particular	ADJ
ajlsi-1012	399	3	,	,	PUNCT
ajlsi-1012	399	4	serological	serological	ADJ
ajlsi-1012	399	5	and	and	CCONJ
ajlsi-1012	399	6	immunological	immunological	ADJ
ajlsi-1012	399	7	testing	testing	NOUN
ajlsi-1012	399	8	of	of	ADP
ajlsi-1012	399	9	infected	infected	ADJ
ajlsi-1012	399	10	asymptomatic	asymptomatic	ADJ
ajlsi-1012	399	11	and	and	CCONJ
ajlsi-1012	399	12	symptomatic	symptomatic	ADJ
ajlsi-1012	399	13	individuals	individual	NOUN
ajlsi-1012	399	14	,	,	PUNCT
ajlsi-1012	399	15	and	and	CCONJ
ajlsi-1012	399	16	their	their	PRON
ajlsi-1012	399	17	close	close	ADJ
ajlsi-1012	399	18	contacts	contact	NOUN
ajlsi-1012	399	19	,	,	PUNCT
ajlsi-1012	399	20	is	be	AUX
ajlsi-1012	399	21	expected	expect	VERB
ajlsi-1012	399	22	to	to	PART
ajlsi-1012	399	23	be	be	AUX
ajlsi-1012	399	24	in	in	ADP
ajlsi-1012	399	25	high	high	ADJ
ajlsi-1012	399	26	demand	demand	NOUN
ajlsi-1012	399	27	.	.	PUNCT
ajlsi-1012	400	1	conclusion	conclusion	NOUN
ajlsi-1012	400	2	the	the	DET
ajlsi-1012	400	3	covid-19	covid-19	PROPN
ajlsi-1012	400	4	pandemic	pandemic	NOUN
ajlsi-1012	400	5	,	,	PUNCT
ajlsi-1012	400	6	caused	cause	VERB
ajlsi-1012	400	7	by	by	ADP
ajlsi-1012	400	8	the	the	DET
ajlsi-1012	400	9	sars	sar	NOUN
ajlsi-1012	400	10	-	-	PUNCT
ajlsi-1012	400	11	cov-2	cov-2	NOUN
ajlsi-1012	400	12	,	,	PUNCT
ajlsi-1012	400	13	has	have	AUX
ajlsi-1012	400	14	resulted	result	VERB
ajlsi-1012	400	15	in	in	ADP
ajlsi-1012	400	16	over	over	ADP
ajlsi-1012	400	17	17	17	NUM
ajlsi-1012	400	18	million	million	NUM
ajlsi-1012	400	19	confirmed	confirm	VERB
ajlsi-1012	400	20	cases	case	NOUN
ajlsi-1012	400	21	and	and	CCONJ
ajlsi-1012	400	22	over	over	ADP
ajlsi-1012	400	23	7	7	NUM
ajlsi-1012	400	24	lakh	lakh	NOUN
ajlsi-1012	400	25	deaths	death	NOUN
ajlsi-1012	400	26	worldwide	worldwide	ADV
ajlsi-1012	400	27	in	in	ADP
ajlsi-1012	400	28	less	less	ADJ
ajlsi-1012	400	29	than	than	ADP
ajlsi-1012	400	30	six	six	NUM
ajlsi-1012	400	31	months	month	NOUN
ajlsi-1012	400	32	.	.	PUNCT
ajlsi-1012	401	1	the	the	DET
ajlsi-1012	401	2	living	live	VERB
ajlsi-1012	401	3	and	and	CCONJ
ajlsi-1012	401	4	working	working	NOUN
ajlsi-1012	401	5	conditions	condition	NOUN
ajlsi-1012	401	6	of	of	ADP
ajlsi-1012	401	7	billions	billion	NOUN
ajlsi-1012	401	8	of	of	ADP
ajlsi-1012	401	9	people	people	NOUN
ajlsi-1012	401	10	worldwide	worldwide	ADV
ajlsi-1012	401	11	have	have	AUX
ajlsi-1012	401	12	been	be	AUX
ajlsi-1012	401	13	significantly	significantly	ADV
ajlsi-1012	401	14	disrupted	disrupt	VERB
ajlsi-1012	401	15	due	due	ADP
ajlsi-1012	401	16	to	to	ADP
ajlsi-1012	401	17	different	different	ADJ
ajlsi-1012	401	18	forms	form	NOUN
ajlsi-1012	401	19	of	of	ADP
ajlsi-1012	401	20	social	social	ADJ
ajlsi-1012	401	21	distancing	distancing	NOUN
ajlsi-1012	401	22	and	and	CCONJ
ajlsi-1012	401	23	lockdowns	lockdown	NOUN
ajlsi-1012	401	24	in	in	ADP
ajlsi-1012	401	25	many	many	ADJ
ajlsi-1012	401	26	cities	city	NOUN
ajlsi-1012	401	27	.	.	PUNCT
ajlsi-1012	402	1	the	the	DET
ajlsi-1012	402	2	widespread	widespread	ADJ
ajlsi-1012	402	3	availability	availability	NOUN
ajlsi-1012	402	4	of	of	ADP
ajlsi-1012	402	5	accurate	accurate	ADJ
ajlsi-1012	402	6	and	and	CCONJ
ajlsi-1012	402	7	rapid	rapid	ADJ
ajlsi-1012	402	8	testing	testing	NOUN
ajlsi-1012	402	9	procedures	procedure	NOUN
ajlsi-1012	402	10	is	be	AUX
ajlsi-1012	402	11	extremely	extremely	ADV
ajlsi-1012	402	12	valuable	valuable	ADJ
ajlsi-1012	402	13	in	in	ADP
ajlsi-1012	402	14	unravelling	unravel	VERB
ajlsi-1012	402	15	the	the	DET
ajlsi-1012	402	16	complex	complex	ADJ
ajlsi-1012	402	17	dynamics	dynamic	NOUN
ajlsi-1012	402	18	involved	involve	VERB
ajlsi-1012	402	19	in	in	ADP
ajlsi-1012	402	20	sars	sar	NOUN
ajlsi-1012	402	21	-	-	PUNCT
ajlsi-1012	402	22	cov-2	cov-2	PART
ajlsi-1012	402	23	infection	infection	NOUN
ajlsi-1012	402	24	and	and	CCONJ
ajlsi-1012	402	25	immunity	immunity	NOUN
ajlsi-1012	402	26	.	.	PUNCT
ajlsi-1012	403	1	one	one	NUM
ajlsi-1012	403	2	of	of	ADP
ajlsi-1012	403	3	the	the	DET
ajlsi-1012	403	4	many	many	ADJ
ajlsi-1012	403	5	challenges	challenge	NOUN
ajlsi-1012	403	6	in	in	ADP
ajlsi-1012	403	7	containing	contain	VERB
ajlsi-1012	403	8	the	the	DET
ajlsi-1012	403	9	spread	spread	NOUN
ajlsi-1012	403	10	of	of	ADP
ajlsi-1012	403	11	covid-19	covid-19	PROPN
ajlsi-1012	403	12	is	be	AUX
ajlsi-1012	403	13	the	the	DET
ajlsi-1012	403	14	inability	inability	NOUN
ajlsi-1012	403	15	to	to	PART
ajlsi-1012	403	16	identify	identify	VERB
ajlsi-1012	403	17	asymptomatic	asymptomatic	ADJ
ajlsi-1012	403	18	cases	case	NOUN
ajlsi-1012	403	19	that	that	PRON
ajlsi-1012	403	20	result	result	VERB
ajlsi-1012	403	21	in	in	ADP
ajlsi-1012	403	22	the	the	DET
ajlsi-1012	403	23	virus	virus	NOUN
ajlsi-1012	403	24	spreading	spread	VERB
ajlsi-1012	403	25	to	to	ADP
ajlsi-1012	403	26	close	close	ADJ
ajlsi-1012	403	27	contacts	contact	NOUN
ajlsi-1012	403	28	.	.	PUNCT
ajlsi-1012	404	1	thus	thus	ADV
ajlsi-1012	404	2	,	,	PUNCT
ajlsi-1012	404	3	the	the	DET
ajlsi-1012	404	4	global	global	ADJ
ajlsi-1012	404	5	outbreak	outbreak	NOUN
ajlsi-1012	404	6	of	of	ADP
ajlsi-1012	404	7	covid-19	covid-19	PROPN
ajlsi-1012	404	8	has	have	AUX
ajlsi-1012	404	9	emphasized	emphasize	VERB
ajlsi-1012	404	10	the	the	DET
ajlsi-1012	404	11	importance	importance	NOUN
ajlsi-1012	404	12	of	of	ADP
ajlsi-1012	404	13	the	the	DET
ajlsi-1012	404	14	laboratory	laboratory	NOUN
ajlsi-1012	404	15	diagnosis	diagnosis	NOUN
ajlsi-1012	404	16	of	of	ADP
ajlsi-1012	404	17	human	human	ADJ
ajlsi-1012	404	18	coronavirus	coronavirus	NOUN
ajlsi-1012	404	19	infections	infection	NOUN
ajlsi-1012	404	20	in	in	ADP
ajlsi-1012	404	21	order	order	NOUN
ajlsi-1012	404	22	to	to	PART
ajlsi-1012	404	23	limit	limit	VERB
ajlsi-1012	404	24	the	the	DET
ajlsi-1012	404	25	spread	spread	NOUN
ajlsi-1012	404	26	as	as	ADV
ajlsi-1012	404	27	well	well	ADV
ajlsi-1012	404	28	as	as	ADP
ajlsi-1012	404	29	appropriately	appropriately	ADV
ajlsi-1012	404	30	treat	treat	VERB
ajlsi-1012	404	31	those	those	DET
ajlsi-1012	404	32	patients	patient	NOUN
ajlsi-1012	404	33	who	who	PRON
ajlsi-1012	404	34	have	have	VERB
ajlsi-1012	404	35	serious	serious	ADJ
ajlsi-1012	404	36	complications	complication	NOUN
ajlsi-1012	404	37	.	.	PUNCT
ajlsi-1012	405	1	who	who	PRON
ajlsi-1012	405	2	has	have	AUX
ajlsi-1012	405	3	published	publish	VERB
ajlsi-1012	405	4	a	a	DET
ajlsi-1012	405	5	uniform	uniform	ADJ
ajlsi-1012	405	6	case	case	NOUN
ajlsi-1012	405	7	definition	definition	NOUN
ajlsi-1012	405	8	for	for	ADP
ajlsi-1012	405	9	surveillance	surveillance	NOUN
ajlsi-1012	405	10	and	and	CCONJ
ajlsi-1012	405	11	testing	testing	NOUN
ajlsi-1012	405	12	for	for	ADP
ajlsi-1012	405	13	covid-19	covid-19	PROPN
ajlsi-1012	405	14	infections	infection	NOUN
ajlsi-1012	405	15	.	.	PUNCT
ajlsi-1012	406	1	however	however	ADV
ajlsi-1012	406	2	,	,	PUNCT
ajlsi-1012	406	3	the	the	DET
ajlsi-1012	406	4	focus	focus	NOUN
ajlsi-1012	406	5	on	on	ADP
ajlsi-1012	406	6	implementing	implement	VERB
ajlsi-1012	406	7	the	the	DET
ajlsi-1012	406	8	most	most	ADV
ajlsi-1012	406	9	reliable	reliable	ADJ
ajlsi-1012	406	10	diagnostic	diagnostic	ADJ
ajlsi-1012	406	11	tools	tool	NOUN
ajlsi-1012	406	12	varies	vary	VERB
ajlsi-1012	406	13	in	in	ADP
ajlsi-1012	406	14	different	different	ADJ
ajlsi-1012	406	15	places	place	NOUN
ajlsi-1012	406	16	.	.	PUNCT
ajlsi-1012	407	1	since	since	SCONJ
ajlsi-1012	407	2	covid-19	covid-19	PROPN
ajlsi-1012	407	3	is	be	AUX
ajlsi-1012	407	4	a	a	DET
ajlsi-1012	407	5	new	new	ADJ
ajlsi-1012	407	6	nosological	nosological	ADJ
ajlsi-1012	407	7	entity	entity	NOUN
ajlsi-1012	407	8	,	,	PUNCT
ajlsi-1012	407	9	there	there	PRON
ajlsi-1012	407	10	are	be	VERB
ajlsi-1012	407	11	no	no	DET
ajlsi-1012	407	12	data	datum	NOUN
ajlsi-1012	407	13	as	as	ADP
ajlsi-1012	407	14	of	of	ADP
ajlsi-1012	407	15	yet	yet	ADV
ajlsi-1012	407	16	that	that	PRON
ajlsi-1012	407	17	would	would	AUX
ajlsi-1012	407	18	enable	enable	VERB
ajlsi-1012	407	19	the	the	DET
ajlsi-1012	407	20	determination	determination	NOUN
ajlsi-1012	407	21	of	of	ADP
ajlsi-1012	407	22	standards	standard	NOUN
ajlsi-1012	407	23	for	for	ADP
ajlsi-1012	407	24	the	the	DET
ajlsi-1012	407	25	interpretation	interpretation	NOUN
ajlsi-1012	407	26	of	of	ADP
ajlsi-1012	407	27	specific	specific	ADJ
ajlsi-1012	407	28	diagnostic	diagnostic	ADJ
ajlsi-1012	407	29	tests	test	NOUN
ajlsi-1012	407	30	.	.	PUNCT
ajlsi-1012	408	1	as	as	ADP
ajlsi-1012	408	2	with	with	ADP
ajlsi-1012	408	3	any	any	DET
ajlsi-1012	408	4	other	other	ADJ
ajlsi-1012	408	5	infectious	infectious	ADJ
ajlsi-1012	408	6	disease	disease	NOUN
ajlsi-1012	408	7	,	,	PUNCT
ajlsi-1012	408	8	the	the	DET
ajlsi-1012	408	9	accuracy	accuracy	NOUN
ajlsi-1012	408	10	of	of	ADP
ajlsi-1012	408	11	each	each	DET
ajlsi-1012	408	12	method	method	NOUN
ajlsi-1012	408	13	depends	depend	VERB
ajlsi-1012	408	14	on	on	ADP
ajlsi-1012	408	15	the	the	DET
ajlsi-1012	408	16	method	method	NOUN
ajlsi-1012	408	17	of	of	ADP
ajlsi-1012	408	18	collecting	collect	VERB
ajlsi-1012	408	19	the	the	DET
ajlsi-1012	408	20	material	material	NOUN
ajlsi-1012	408	21	,	,	PUNCT
ajlsi-1012	408	22	the	the	DET
ajlsi-1012	408	23	quality	quality	NOUN
ajlsi-1012	408	24	of	of	ADP
ajlsi-1012	408	25	the	the	DET
ajlsi-1012	408	26	sample	sample	NOUN
ajlsi-1012	408	27	,	,	PUNCT
ajlsi-1012	408	28	and	and	CCONJ
ajlsi-1012	408	29	the	the	DET
ajlsi-1012	408	30	equipment	equipment	NOUN
ajlsi-1012	408	31	applied	apply	VERB
ajlsi-1012	408	32	.	.	PUNCT
ajlsi-1012	409	1	although	although	SCONJ
ajlsi-1012	409	2	rt	rt	PROPN
ajlsi-1012	409	3	-	-	PUNCT
ajlsi-1012	409	4	pcr	pcr	NOUN
ajlsi-1012	409	5	testing	testing	NOUN
ajlsi-1012	409	6	plays	play	VERB
ajlsi-1012	409	7	a	a	DET
ajlsi-1012	409	8	crucial	crucial	ADJ
ajlsi-1012	409	9	role	role	NOUN
ajlsi-1012	409	10	in	in	ADP
ajlsi-1012	409	11	accurately	accurately	ADV
ajlsi-1012	409	12	detecting	detect	VERB
ajlsi-1012	409	13	sarscov-2	sarscov-2	NUM
ajlsi-1012	409	14	on	on	ADP
ajlsi-1012	409	15	a	a	DET
ajlsi-1012	409	16	case	case	NOUN
ajlsi-1012	409	17	-	-	PUNCT
ajlsi-1012	409	18	by	by	ADP
ajlsi-1012	409	19	-	-	PUNCT
ajlsi-1012	409	20	case	case	NOUN
ajlsi-1012	409	21	basis	basis	NOUN
ajlsi-1012	409	22	,	,	PUNCT
ajlsi-1012	409	23	it	it	PRON
ajlsi-1012	409	24	also	also	ADV
ajlsi-1012	409	25	has	have	VERB
ajlsi-1012	409	26	inherent	inherent	ADJ
ajlsi-1012	409	27	problems	problem	NOUN
ajlsi-1012	409	28	that	that	PRON
ajlsi-1012	409	29	limit	limit	VERB
ajlsi-1012	409	30	its	its	PRON
ajlsi-1012	409	31	utility	utility	NOUN
ajlsi-1012	409	32	.	.	PUNCT
ajlsi-1012	410	1	current	current	ADJ
ajlsi-1012	410	2	obstacles	obstacle	NOUN
ajlsi-1012	410	3	to	to	ADP
ajlsi-1012	410	4	the	the	DET
ajlsi-1012	410	5	widespread	widespread	ADJ
ajlsi-1012	410	6	use	use	NOUN
ajlsi-1012	410	7	of	of	ADP
ajlsi-1012	410	8	rt	rt	ADJ
ajlsi-1012	410	9	-	-	PUNCT
ajlsi-1012	410	10	pcr	pcr	ADJ
ajlsi-1012	410	11	testing	testing	NOUN
ajlsi-1012	410	12	include	include	VERB
ajlsi-1012	410	13	a	a	DET
ajlsi-1012	410	14	shortage	shortage	NOUN
ajlsi-1012	410	15	of	of	ADP
ajlsi-1012	410	16	testing	testing	NOUN
ajlsi-1012	410	17	kits	kit	NOUN
ajlsi-1012	410	18	and	and	CCONJ
ajlsi-1012	410	19	an	an	DET
ajlsi-1012	410	20	extended	extended	ADJ
ajlsi-1012	410	21	processing	processing	NOUN
ajlsi-1012	410	22	period	period	NOUN
ajlsi-1012	410	23	of	of	ADP
ajlsi-1012	410	24	several	several	ADJ
ajlsi-1012	410	25	hours	hour	NOUN
ajlsi-1012	410	26	before	before	SCONJ
ajlsi-1012	410	27	results	result	NOUN
ajlsi-1012	410	28	are	be	AUX
ajlsi-1012	410	29	obtained	obtain	VERB
ajlsi-1012	410	30	.	.	PUNCT
ajlsi-1012	411	1	moreover	moreover	ADV
ajlsi-1012	411	2	,	,	PUNCT
ajlsi-1012	411	3	the	the	DET
ajlsi-1012	411	4	results	result	NOUN
ajlsi-1012	411	5	of	of	ADP
ajlsi-1012	411	6	real	real	ADJ
ajlsi-1012	411	7	-	-	PUNCT
ajlsi-1012	411	8	time	time	NOUN
ajlsi-1012	411	9	rt	rt	ADJ
ajlsi-1012	411	10	-	-	PUNCT
ajlsi-1012	411	11	pcr	pcr	ADJ
ajlsi-1012	411	12	tests	test	NOUN
ajlsi-1012	411	13	must	must	AUX
ajlsi-1012	411	14	be	be	AUX
ajlsi-1012	411	15	cautiously	cautiously	ADV
ajlsi-1012	411	16	interpreted	interpret	VERB
ajlsi-1012	411	17	.	.	PUNCT
ajlsi-1012	412	1	a	a	DET
ajlsi-1012	412	2	combination	combination	NOUN
ajlsi-1012	412	3	of	of	ADP
ajlsi-1012	412	4	real	real	ADJ
ajlsi-1012	412	5	-	-	PUNCT
ajlsi-1012	412	6	time	time	NOUN
ajlsi-1012	412	7	rt	rt	NOUN
ajlsi-1012	412	8	-	-	PUNCT
ajlsi-1012	412	9	pcr	pcr	ADJ
ajlsi-1012	412	10	and	and	CCONJ
ajlsi-1012	412	11	clinical	clinical	ADJ
ajlsi-1012	412	12	features	feature	NOUN
ajlsi-1012	412	13	,	,	PUNCT
ajlsi-1012	412	14	especially	especially	ADV
ajlsi-1012	412	15	ct	ct	NUM
ajlsi-1012	412	16	images	image	NOUN
ajlsi-1012	412	17	,	,	PUNCT
ajlsi-1012	412	18	could	could	AUX
ajlsi-1012	412	19	facilitate	facilitate	VERB
ajlsi-1012	412	20	better	well	ADJ
ajlsi-1012	412	21	disease	disease	NOUN
ajlsi-1012	412	22	management	management	NOUN
ajlsi-1012	412	23	.	.	PUNCT
ajlsi-1012	413	1	proper	proper	ADJ
ajlsi-1012	413	2	sampling	sampling	NOUN
ajlsi-1012	413	3	procedures	procedure	NOUN
ajlsi-1012	413	4	,	,	PUNCT
ajlsi-1012	413	5	good	good	ADJ
ajlsi-1012	413	6	laboratory	laboratory	NOUN
ajlsi-1012	413	7	practice	practice	NOUN
ajlsi-1012	413	8	standards	standard	NOUN
ajlsi-1012	413	9	,	,	PUNCT
ajlsi-1012	413	10	and	and	CCONJ
ajlsi-1012	413	11	using	use	VERB
ajlsi-1012	413	12	highquality	highquality	NOUN
ajlsi-1012	413	13	extraction	extraction	NOUN
ajlsi-1012	413	14	and	and	CCONJ
ajlsi-1012	413	15	a	a	DET
ajlsi-1012	413	16	real	real	ADJ
ajlsi-1012	413	17	-	-	PUNCT
ajlsi-1012	413	18	time	time	NOUN
ajlsi-1012	413	19	rt	rt	ADJ
ajlsi-1012	413	20	-	-	PUNCT
ajlsi-1012	413	21	pcr	pcr	ADJ
ajlsi-1012	413	22	kit	kit	NOUN
ajlsi-1012	413	23	could	could	AUX
ajlsi-1012	413	24	improve	improve	VERB
ajlsi-1012	413	25	the	the	DET
ajlsi-1012	413	26	approach	approach	NOUN
ajlsi-1012	413	27	and	and	CCONJ
ajlsi-1012	413	28	reduce	reduce	VERB
ajlsi-1012	413	29	inaccurate	inaccurate	ADJ
ajlsi-1012	413	30	results	result	NOUN
ajlsi-1012	413	31	.	.	PUNCT
ajlsi-1012	414	1	loop	loop	NOUN
ajlsi-1012	414	2	-	-	PUNCT
ajlsi-1012	414	3	mediated	mediate	VERB
ajlsi-1012	414	4	isothermal	isothermal	ADJ
ajlsi-1012	414	5	amplification	amplification	NOUN
ajlsi-1012	414	6	(	(	PUNCT
ajlsi-1012	414	7	lamp	lamp	NOUN
ajlsi-1012	414	8	)	)	PUNCT
ajlsi-1012	414	9	is	be	AUX
ajlsi-1012	414	10	a	a	DET
ajlsi-1012	414	11	relatively	relatively	ADV
ajlsi-1012	414	12	new	new	ADJ
ajlsi-1012	414	13	,	,	PUNCT
ajlsi-1012	414	14	convenient	convenient	ADJ
ajlsi-1012	414	15	molecular	molecular	ADJ
ajlsi-1012	414	16	amplification	amplification	NOUN
ajlsi-1012	414	17	pointof	pointof	NOUN
ajlsi-1012	414	18	-	-	PUNCT
ajlsi-1012	414	19	care	care	NOUN
ajlsi-1012	414	20	technique	technique	NOUN
ajlsi-1012	414	21	that	that	PRON
ajlsi-1012	414	22	is	be	AUX
ajlsi-1012	414	23	widely	widely	ADV
ajlsi-1012	414	24	used	use	VERB
ajlsi-1012	414	25	for	for	ADP
ajlsi-1012	414	26	covid-19	covid-19	PROPN
ajlsi-1012	414	27	diagnosis	diagnosis	NOUN
ajlsi-1012	414	28	.	.	PUNCT
ajlsi-1012	415	1	the	the	DET
ajlsi-1012	415	2	technique	technique	NOUN
ajlsi-1012	415	3	does	do	AUX
ajlsi-1012	415	4	require	require	VERB
ajlsi-1012	415	5	sophisticated	sophisticated	ADJ
ajlsi-1012	415	6	laboratory	laboratory	NOUN
ajlsi-1012	415	7	equipment	equipment	NOUN
ajlsi-1012	415	8	to	to	PART
ajlsi-1012	415	9	provide	provide	VERB
ajlsi-1012	415	10	similar	similar	ADJ
ajlsi-1012	415	11	analytical	analytical	ADJ
ajlsi-1012	415	12	sensitivity	sensitivity	NOUN
ajlsi-1012	415	13	to	to	ADP
ajlsi-1012	415	14	rt	rt	NOUN
ajlsi-1012	415	15	-	-	PUNCT
ajlsi-1012	415	16	pcr	pcr	NOUN
ajlsi-1012	415	17	.	.	PUNCT
ajlsi-1012	416	1	serological	serological	ADJ
ajlsi-1012	416	2	testing	testing	NOUN
ajlsi-1012	416	3	for	for	ADP
ajlsi-1012	416	4	covid-19	covid-19	PROPN
ajlsi-1012	416	5	is	be	AUX
ajlsi-1012	416	6	particularly	particularly	ADV
ajlsi-1012	416	7	attractive	attractive	ADJ
ajlsi-1012	416	8	because	because	SCONJ
ajlsi-1012	416	9	of	of	ADP
ajlsi-1012	416	10	the	the	DET
ajlsi-1012	416	11	relatively	relatively	ADV
ajlsi-1012	416	12	short	short	ADJ
ajlsi-1012	416	13	time	time	NOUN
ajlsi-1012	416	14	to	to	ADP
ajlsi-1012	416	15	diagnosis	diagnosis	VERB
ajlsi-1012	416	16	and	and	CCONJ
ajlsi-1012	416	17	the	the	DET
ajlsi-1012	416	18	ability	ability	NOUN
ajlsi-1012	416	19	to	to	PART
ajlsi-1012	416	20	test	test	VERB
ajlsi-1012	416	21	for	for	ADP
ajlsi-1012	416	22	an	an	DET
ajlsi-1012	416	23	active	active	ADJ
ajlsi-1012	416	24	immune	immune	ADJ
ajlsi-1012	416	25	response	response	NOUN
ajlsi-1012	416	26	against	against	ADP
ajlsi-1012	416	27	the	the	DET
ajlsi-1012	416	28	virus	virus	NOUN
ajlsi-1012	416	29	.	.	PUNCT
ajlsi-1012	417	1	a	a	DET
ajlsi-1012	417	2	lot	lot	NOUN
ajlsi-1012	417	3	remains	remain	VERB
ajlsi-1012	417	4	to	to	PART
ajlsi-1012	417	5	be	be	AUX
ajlsi-1012	417	6	understood	understand	VERB
ajlsi-1012	417	7	regarding	regard	VERB
ajlsi-1012	417	8	the	the	DET
ajlsi-1012	417	9	value	value	NOUN
ajlsi-1012	417	10	of	of	ADP
ajlsi-1012	417	11	serological	serological	ADJ
ajlsi-1012	417	12	testing	testing	NOUN
ajlsi-1012	417	13	in	in	ADP
ajlsi-1012	417	14	covid-19	covid-19	PROPN
ajlsi-1012	417	15	diagnosis	diagnosis	NOUN
ajlsi-1012	417	16	and	and	CCONJ
ajlsi-1012	417	17	monitoring	monitoring	NOUN
ajlsi-1012	417	18	.	.	PUNCT
ajlsi-1012	418	1	the	the	DET
ajlsi-1012	418	2	results	result	NOUN
ajlsi-1012	418	3	of	of	ADP
ajlsi-1012	418	4	serological	serological	ADJ
ajlsi-1012	418	5	tests	test	NOUN
ajlsi-1012	418	6	can	can	AUX
ajlsi-1012	418	7	then	then	ADV
ajlsi-1012	418	8	be	be	AUX
ajlsi-1012	418	9	used	use	VERB
ajlsi-1012	418	10	to	to	PART
ajlsi-1012	418	11	estimate	estimate	VERB
ajlsi-1012	418	12	the	the	DET
ajlsi-1012	418	13	true	true	ADJ
ajlsi-1012	418	14	spread	spread	NOUN
ajlsi-1012	418	15	of	of	ADP
ajlsi-1012	418	16	the	the	DET
ajlsi-1012	418	17	virus	virus	NOUN
ajlsi-1012	418	18	through	through	ADP
ajlsi-1012	418	19	a	a	DET
ajlsi-1012	418	20	population	population	NOUN
ajlsi-1012	418	21	,	,	PUNCT
ajlsi-1012	418	22	even	even	ADV
ajlsi-1012	418	23	if	if	SCONJ
ajlsi-1012	418	24	individuals	individual	NOUN
ajlsi-1012	418	25	were	be	AUX
ajlsi-1012	418	26	asymptomatic	asymptomatic	ADJ
ajlsi-1012	418	27	or	or	CCONJ
ajlsi-1012	418	28	were	be	AUX
ajlsi-1012	418	29	never	never	ADV
ajlsi-1012	418	30	diagnosed	diagnose	VERB
ajlsi-1012	418	31	.	.	PUNCT
ajlsi-1012	419	1	more	more	ADJ
ajlsi-1012	419	2	comprehensive	comprehensive	ADJ
ajlsi-1012	419	3	evaluations	evaluation	NOUN
ajlsi-1012	419	4	of	of	ADP
ajlsi-1012	419	5	the	the	DET
ajlsi-1012	419	6	performance	performance	NOUN
ajlsi-1012	419	7	of	of	ADP
ajlsi-1012	419	8	serology	serology	NOUN
ajlsi-1012	419	9	tests	test	NOUN
ajlsi-1012	419	10	are	be	AUX
ajlsi-1012	419	11	rapidly	rapidly	ADV
ajlsi-1012	419	12	under	under	ADP
ajlsi-1012	419	13	way	way	NOUN
ajlsi-1012	419	14	.	.	PUNCT
ajlsi-1012	420	1	considerations	consideration	NOUN
ajlsi-1012	420	2	for	for	ADP
ajlsi-1012	420	3	the	the	DET
ajlsi-1012	420	4	use	use	NOUN
ajlsi-1012	420	5	of	of	ADP
ajlsi-1012	420	6	serology	serology	NOUN
ajlsi-1012	420	7	methods	method	NOUN
ajlsi-1012	420	8	for	for	ADP
ajlsi-1012	420	9	covid-19	covid-19	PROPN
ajlsi-1012	420	10	require	require	VERB
ajlsi-1012	420	11	the	the	DET
ajlsi-1012	420	12	correct	correct	ADJ
ajlsi-1012	420	13	and	and	CCONJ
ajlsi-1012	420	14	appropriate	appropriate	ADJ
ajlsi-1012	420	15	interpretation	interpretation	NOUN
ajlsi-1012	420	16	of	of	ADP
ajlsi-1012	420	17	the	the	DET
ajlsi-1012	420	18	results	result	NOUN
ajlsi-1012	420	19	and	and	CCONJ
ajlsi-1012	420	20	understanding	understand	VERB
ajlsi-1012	420	21	the	the	DET
ajlsi-1012	420	22	strengths	strength	NOUN
ajlsi-1012	420	23	and	and	CCONJ
ajlsi-1012	420	24	limitations	limitation	NOUN
ajlsi-1012	420	25	of	of	ADP
ajlsi-1012	420	26	such	such	ADJ
ajlsi-1012	420	27	tests	test	NOUN
ajlsi-1012	420	28	.	.	PUNCT
ajlsi-1012	421	1	reference	reference	NOUN
ajlsi-1012	421	2	abdalhamid	abdalhamid	PROPN
ajlsi-1012	421	3	,	,	PUNCT
ajlsi-1012	421	4	b.	b.	PROPN
ajlsi-1012	421	5	,	,	PUNCT
ajlsi-1012	421	6	bilder	bilder	NOUN
ajlsi-1012	421	7	,	,	PUNCT
ajlsi-1012	421	8	c.	c.	PROPN
ajlsi-1012	421	9	r.	r.	PROPN
ajlsi-1012	421	10	,	,	PUNCT
ajlsi-1012	421	11	mccutchen	mccutchen	PROPN
ajlsi-1012	421	12	,	,	PUNCT
ajlsi-1012	421	13	et	et	PROPN
ajlsi-1012	421	14	al	al	PROPN
ajlsi-1012	421	15	.	.	PROPN
ajlsi-1012	421	16	,	,	PUNCT
ajlsi-1012	421	17	(	(	PUNCT
ajlsi-1012	421	18	2020	2020	NUM
ajlsi-1012	421	19	)	)	PUNCT
ajlsi-1012	421	20	.	.	PUNCT
ajlsi-1012	422	1	assessment	assessment	NOUN
ajlsi-1012	422	2	of	of	ADP
ajlsi-1012	422	3	specimen	speciman	NOUN
ajlsi-1012	422	4	pooling	pool	VERB
ajlsi-1012	422	5	to	to	PART
ajlsi-1012	422	6	conserve	conserve	VERB
ajlsi-1012	422	7	sarscov-2	sarscov-2	NUM
ajlsi-1012	422	8	testing	testing	NOUN
ajlsi-1012	422	9	resources	resource	NOUN
ajlsi-1012	422	10	.	.	PUNCT
ajlsi-1012	423	1	american	american	ADJ
ajlsi-1012	423	2	journal	journal	PROPN
ajlsi-1012	423	3	of	of	ADP
ajlsi-1012	423	4	clinical	clinical	ADJ
ajlsi-1012	423	5	pathology	pathology	NOUN
ajlsi-1012	423	6	,	,	PUNCT
ajlsi-1012	423	7	153(6),715–718	153(6),715–718	NUM
ajlsi-1012	423	8	.	.	PUNCT
ajlsi-1012	424	1	https://doi.org/10.1093/	https://doi.org/10.1093/	PROPN
ajlsi-1012	424	2	ajcp	ajcp	PROPN
ajlsi-1012	424	3	/	/	SYM
ajlsi-1012	424	4	aqaa064	aqaa064	PROPN
ajlsi-1012	424	5	broughton	broughton	PROPN
ajlsi-1012	424	6	,	,	PUNCT
ajlsi-1012	424	7	j.	j.	PROPN
ajlsi-1012	424	8	p.	p.	PROPN
ajlsi-1012	424	9	,	,	PUNCT
ajlsi-1012	424	10	deng	deng	PROPN
ajlsi-1012	424	11	,	,	PUNCT
ajlsi-1012	424	12	x.	x.	PROPN
ajlsi-1012	424	13	,	,	PUNCT
ajlsi-1012	424	14	yu	yu	PROPN
ajlsi-1012	424	15	,	,	PUNCT
ajlsi-1012	424	16	g.	g.	PROPN
ajlsi-1012	424	17	,	,	PUNCT
ajlsi-1012	424	18	et	et	PROPN
ajlsi-1012	424	19	al	al	PROPN
ajlsi-1012	424	20	.	.	PROPN
ajlsi-1012	424	21	,	,	PUNCT
ajlsi-1012	424	22	(	(	PUNCT
ajlsi-1012	424	23	2020	2020	NUM
ajlsi-1012	424	24	)	)	PUNCT
ajlsi-1012	424	25	.	.	PUNCT
ajlsi-1012	425	1	crispr	crispr	ADJ
ajlsi-1012	425	2	–	–	PUNCT
ajlsi-1012	425	3	cas12	cas12	NOUN
ajlsi-1012	425	4	-	-	PUNCT
ajlsi-1012	425	5	based	base	VERB
ajlsi-1012	425	6	detection	detection	NOUN
ajlsi-1012	425	7	of	of	ADP
ajlsi-1012	425	8	sars	sar	NOUN
ajlsi-1012	425	9	-	-	PUNCT
ajlsi-1012	425	10	cov-2	cov-2	NOUN
ajlsi-1012	425	11	.	.	PUNCT
ajlsi-1012	425	12	nature	nature	NOUN
ajlsi-1012	425	13	biotechnology	biotechnology	NOUN
ajlsi-1012	425	14	,	,	PUNCT
ajlsi-1012	425	15	38(7	38(7	NUM
ajlsi-1012	425	16	)	)	PUNCT
ajlsi-1012	425	17	,	,	PUNCT
ajlsi-1012	425	18	870–874	870–874	NUM
ajlsi-1012	425	19	.	.	PUNCT
ajlsi-1012	426	1	https://doi	https://doi	X
ajlsi-1012	426	2	.	.	PUNCT
ajlsi-1012	427	1	org/10.1038	org/10.1038	PROPN
ajlsi-1012	427	2	/	/	SYM
ajlsi-1012	427	3	s41587	s41587	PROPN
ajlsi-1012	427	4	-	-	PUNCT
ajlsi-1012	427	5	020	020	NUM
ajlsi-1012	427	6	-	-	PUNCT
ajlsi-1012	427	7	0513	0513	NUM
ajlsi-1012	427	8	-	-	PUNCT
ajlsi-1012	427	9	4	4	NUM
ajlsi-1012	427	10	carter	carter	NOUN
ajlsi-1012	427	11	,	,	PUNCT
ajlsi-1012	427	12	l.	l.	PROPN
ajlsi-1012	427	13	j.	j.	PROPN
ajlsi-1012	427	14	,	,	PUNCT
ajlsi-1012	427	15	garner	garner	PROPN
ajlsi-1012	427	16	,	,	PUNCT
ajlsi-1012	427	17	l.	l.	PROPN
ajlsi-1012	427	18	v.	v.	PROPN
ajlsi-1012	427	19	,	,	PUNCT
ajlsi-1012	427	20	smoot	smoot	PROPN
ajlsi-1012	427	21	,	,	PUNCT
ajlsi-1012	427	22	j.	j.	PROPN
ajlsi-1012	427	23	w.	w.	PROPN
ajlsi-1012	427	24	,	,	PUNCT
ajlsi-1012	427	25	li	li	PROPN
ajlsi-1012	427	26	,	,	PUNCT
ajlsi-1012	427	27	y.	y.	PROPN
ajlsi-1012	427	28	,	,	PUNCT
ajlsi-1012	427	29	et	et	PROPN
ajlsi-1012	427	30	al	al	PROPN
ajlsi-1012	427	31	.	.	PROPN
ajlsi-1012	427	32	,	,	PUNCT
ajlsi-1012	427	33	(	(	PUNCT
ajlsi-1012	427	34	2020	2020	NUM
ajlsi-1012	427	35	)	)	PUNCT
ajlsi-1012	427	36	assay	assay	VERB
ajlsi-1012	427	37	techniques	technique	NOUN
ajlsi-1012	427	38	and	and	CCONJ
ajlsi-1012	427	39	test	test	NOUN
ajlsi-1012	427	40	development	development	NOUN
ajlsi-1012	427	41	for	for	ADP
ajlsi-1012	427	42	covid-19	covid-19	PROPN
ajlsi-1012	427	43	diagnosis	diagnosis	NOUN
ajlsi-1012	427	44	.	.	PUNCT
ajlsi-1012	428	1	acs	acs	PROPN
ajlsi-1012	428	2	central	central	ADJ
ajlsi-1012	428	3	science	science	NOUN
ajlsi-1012	428	4	,	,	PUNCT
ajlsi-1012	428	5	6(5),591	6(5),591	NUM
ajlsi-1012	428	6	–	–	PUNCT
ajlsi-1012	428	7	605	605	NUM
ajlsi-1012	428	8	.	.	PUNCT
ajlsi-1012	429	1	https://doi.org/10.1021/acscentsci.0c00501	https://doi.org/10.1021/acscentsci.0c00501	PROPN
ajlsi-1012	429	2	cdc	cdc	PROPN
ajlsi-1012	429	3	centre	centre	NOUN
ajlsi-1012	429	4	of	of	ADP
ajlsi-1012	429	5	disease	disease	NOUN
ajlsi-1012	429	6	control	control	NOUN
ajlsi-1012	429	7	and	and	CCONJ
ajlsi-1012	429	8	prevention	prevention	NOUN
ajlsi-1012	429	9	(	(	PUNCT
ajlsi-1012	429	10	2020	2020	NUM
ajlsi-1012	429	11	):	):	PUNCT
ajlsi-1012	429	12	coronavirus	coronavirus	NOUN
ajlsi-1012	429	13	disease	disease	NOUN
ajlsi-1012	429	14	2019	2019	NUM
ajlsi-1012	429	15	(	(	PUNCT
ajlsi-1012	429	16	covid-19	covid-19	PROPN
ajlsi-1012	429	17	)	)	PUNCT
ajlsi-1012	429	18	.	.	PUNCT
ajlsi-1012	430	1	testing	test	VERB
ajlsi-1012	430	2	for	for	ADP
ajlsi-1012	430	3	covid	covid	PROPN
ajlsi-1012	430	4	-19	-19	PROPN
ajlsi-1012	430	5	centre	centre	NOUN
ajlsi-1012	430	6	of	of	ADP
ajlsi-1012	430	7	disease	disease	NOUN
ajlsi-1012	430	8	control	control	NOUN
ajlsi-1012	430	9	and	and	CCONJ
ajlsi-1012	430	10	prevention,(2020	prevention,(2020	NOUN
ajlsi-1012	430	11	)	)	PUNCT
ajlsi-1012	430	12	.	.	PUNCT
ajlsi-1012	431	1	coronavirus	coronavirus	NOUN
ajlsi-1012	431	2	disease	disease	NOUN
ajlsi-1012	431	3	(	(	PUNCT
ajlsi-1012	431	4	covid-19	covid-19	PROPN
ajlsi-1012	431	5	)	)	PUNCT
ajlsi-1012	431	6	guidelines	guideline	NOUN
ajlsi-1012	431	7	for	for	ADP
ajlsi-1012	431	8	clinical	clinical	ADJ
ajlsi-1012	431	9	specimen	speciman	NOUN
ajlsi-1012	431	10	.	.	PUNCT
ajlsi-1012	431	11	,	,	PUNCT
ajlsi-1012	431	12	.	.	PUNCT
ajlsi-1012	432	1	chan	chan	PROPN
ajlsi-1012	432	2	,	,	PUNCT
ajlsi-1012	432	3	c.	c.	PROPN
ajlsi-1012	432	4	m.	m.	PROPN
ajlsi-1012	432	5	,	,	PUNCT
ajlsi-1012	432	6	tse	tse	PROPN
ajlsi-1012	432	7	,	,	PUNCT
ajlsi-1012	432	8	h.	h.	PROPN
ajlsi-1012	432	9	,	,	PUNCT
ajlsi-1012	432	10	wong	wong	PROPN
ajlsi-1012	432	11	,	,	PUNCT
ajlsi-1012	432	12	s.	s.	PROPN
ajlsi-1012	432	13	s.	s.	PROPN
ajlsi-1012	432	14	y.	y.	PROPN
ajlsi-1012	432	15	,	,	PUNCT
ajlsi-1012	432	16	et	et	PROPN
ajlsi-1012	432	17	al	al	PROPN
ajlsi-1012	432	18	.	.	PROPN
ajlsi-1012	432	19	,	,	PUNCT
ajlsi-1012	432	20	(	(	PUNCT
ajlsi-1012	432	21	2009	2009	NUM
ajlsi-1012	432	22	)	)	PUNCT
ajlsi-1012	432	23	.	.	PUNCT
ajlsi-1012	433	1	examination	examination	NOUN
ajlsi-1012	433	2	of	of	ADP
ajlsi-1012	433	3	seroprevalence	seroprevalence	NOUN
ajlsi-1012	433	4	of	of	ADP
ajlsi-1012	433	5	coronavirus	coronavirus	NOUN
ajlsi-1012	433	6	hku1	hku1	NOUN
ajlsi-1012	433	7	infection	infection	NOUN
ajlsi-1012	433	8	with	with	ADP
ajlsi-1012	433	9	s	s	VERB
ajlsi-1012	433	10	protein	protein	NOUN
ajlsi-1012	433	11	-	-	PUNCT
ajlsi-1012	433	12	based	base	VERB
ajlsi-1012	433	13	elisa	elisa	NOUN
ajlsi-1012	433	14	and	and	CCONJ
ajlsi-1012	433	15	neutralization	neutralization	NOUN
ajlsi-1012	433	16	assay	assay	VERB
ajlsi-1012	433	17	against	against	ADP
ajlsi-1012	433	18	viral	viral	ADJ
ajlsi-1012	433	19	spike	spike	ADJ
ajlsi-1012	433	20	pseudo	pseudo	NOUN
ajlsi-1012	433	21	typed	type	VERB
ajlsi-1012	433	22	virus	virus	NOUN
ajlsi-1012	433	23	.	.	PUNCT
ajlsi-1012	434	1	journal	journal	PROPN
ajlsi-1012	434	2	of	of	ADP
ajlsi-1012	434	3	clinical	clinical	ADJ
ajlsi-1012	434	4	virology	virology	NOUN
ajlsi-1012	434	5	,	,	PUNCT
ajlsi-1012	434	6	45(1	45(1	NOUN
ajlsi-1012	434	7	)	)	PUNCT
ajlsi-1012	434	8	,	,	PUNCT
ajlsi-1012	434	9	54	54	NUM
ajlsi-1012	434	10	-	-	SYM
ajlsi-1012	434	11	60	60	NUM
ajlsi-1012	434	12	.	.	PUNCT
ajlsi-1012	435	1	chan	chan	PROPN
ajlsi-1012	435	2	,	,	PUNCT
ajlsi-1012	435	3	k.	k.	PROPN
ajlsi-1012	435	4	h.	h.	PROPN
ajlsi-1012	435	5	,	,	PUNCT
ajlsi-1012	435	6	poon	poon	NOUN
ajlsi-1012	435	7	,	,	PUNCT
ajlsi-1012	435	8	l.	l.	PROPN
ajlsi-1012	435	9	l.	l.	PROPN
ajlsi-1012	435	10	,	,	PUNCT
ajlsi-1012	435	11	cheng	cheng	PROPN
ajlsi-1012	435	12	,	,	PUNCT
ajlsi-1012	435	13	v.	v.	PROPN
ajlsi-1012	435	14	c.	c.	PROPN
ajlsi-1012	435	15	c.	c.	PROPN
ajlsi-1012	435	16	,	,	PUNCT
ajlsi-1012	435	17	et	et	PROPN
ajlsi-1012	435	18	al	al	PROPN
ajlsi-1012	435	19	.	.	PROPN
ajlsi-1012	435	20	,	,	PUNCT
ajlsi-1012	435	21	(	(	PUNCT
ajlsi-1012	435	22	2004	2004	NUM
ajlsi-1012	435	23	)	)	PUNCT
ajlsi-1012	435	24	.	.	PUNCT
ajlsi-1012	436	1	detection	detection	NOUN
ajlsi-1012	436	2	of	of	ADP
ajlsi-1012	436	3	sars	sars	PROPN
ajlsi-1012	436	4	coronavirus	coronavirus	PROPN
ajlsi-1012	436	5	in	in	ADP
ajlsi-1012	436	6	patients	patient	NOUN
ajlsi-1012	436	7	with	with	ADP
ajlsi-1012	436	8	suspected	suspect	VERB
ajlsi-1012	436	9	sars	sar	NOUN
ajlsi-1012	436	10	.	.	PUNCT
ajlsi-1012	437	1	emerging	emerge	VERB
ajlsi-1012	437	2	infectious	infectious	ADJ
ajlsi-1012	437	3	diseases	disease	NOUN
ajlsi-1012	437	4	,	,	PUNCT
ajlsi-1012	437	5	10(2	10(2	NUM
ajlsi-1012	437	6	)	)	PUNCT
ajlsi-1012	437	7	,	,	PUNCT
ajlsi-1012	437	8	294	294	NUM
ajlsi-1012	437	9	.	.	PUNCT
ajlsi-1012	437	10	chan	chan	PROPN
ajlsi-1012	437	11	,	,	PUNCT
ajlsi-1012	437	12	m.	m.	NOUN
ajlsi-1012	437	13	s.	s.	PROPN
ajlsi-1012	437	14	,	,	PUNCT
ajlsi-1012	437	15	chan	chan	PROPN
ajlsi-1012	437	16	,	,	PUNCT
ajlsi-1012	437	17	i.	i.	PROPN
ajlsi-1012	437	18	y.	y.	PROPN
ajlsi-1012	437	19	,	,	PUNCT
ajlsi-1012	437	20	fung	fung	PROPN
ajlsi-1012	437	21	,	,	PUNCT
ajlsi-1012	437	22	k.	k.	PROPN
ajlsi-1012	437	23	h.	h.	PROPN
ajlsi-1012	437	24	,	,	PUNCT
ajlsi-1012	437	25	poon	poon	NOUN
ajlsi-1012	437	26	,	,	PUNCT
ajlsi-1012	437	27	e.	e.	PROPN
ajlsi-1012	437	28	,	,	PUNCT
ajlsi-1012	437	29	et	et	PROPN
ajlsi-1012	437	30	al	al	PROPN
ajlsi-1012	437	31	.	.	PROPN
ajlsi-1012	437	32	,	,	PUNCT
ajlsi-1012	437	33	(	(	PUNCT
ajlsi-1012	437	34	2004	2004	NUM
ajlsi-1012	437	35	)	)	PUNCT
ajlsi-1012	437	36	.	.	PUNCT
ajlsi-1012	438	1	high	high	ADJ
ajlsi-1012	438	2	-	-	PUNCT
ajlsi-1012	438	3	resolution	resolution	NOUN
ajlsi-1012	438	4	ct	ct	PROPN
ajlsi-1012	438	5	findings	finding	NOUN
ajlsi-1012	438	6	in	in	ADP
ajlsi-1012	438	7	patients	patient	NOUN
ajlsi-1012	438	8	with	with	ADP
ajlsi-1012	438	9	severe	severe	ADJ
ajlsi-1012	438	10	acute	acute	ADJ
ajlsi-1012	438	11	respiratory	respiratory	ADJ
ajlsi-1012	438	12	syndrome	syndrome	NOUN
ajlsi-1012	438	13	:	:	PUNCT
ajlsi-1012	438	14	a	a	DET
ajlsi-1012	438	15	pattern	pattern	NOUN
ajlsi-1012	438	16	-	-	PUNCT
ajlsi-1012	438	17	based	base	VERB
ajlsi-1012	438	18	approach	approach	NOUN
ajlsi-1012	438	19	.	.	PUNCT
ajlsi-1012	439	1	american	american	PROPN
ajlsi-1012	439	2	journal	journal	PROPN
ajlsi-1012	439	3	of	of	ADP
ajlsi-1012	439	4	roentgenology	roentgenology	NOUN
ajlsi-1012	439	5	,	,	PUNCT
ajlsi-1012	439	6	182(1	182(1	NUM
ajlsi-1012	439	7	)	)	PUNCT
ajlsi-1012	439	8	,	,	PUNCT
ajlsi-1012	439	9	49	49	NUM
ajlsi-1012	439	10	-	-	SYM
ajlsi-1012	439	11	56	56	NUM
ajlsi-1012	439	12	.	.	PUNCT
ajlsi-1012	439	13	chapin	chapin	PROPN
ajlsi-1012	439	14	,	,	PUNCT
ajlsi-1012	439	15	s.	s.	PROPN
ajlsi-1012	439	16	c.	c.	PROPN
ajlsi-1012	439	17	,	,	PUNCT
ajlsi-1012	439	18	&	&	CCONJ
ajlsi-1012	439	19	doyle	doyle	PROPN
ajlsi-1012	439	20	,	,	PUNCT
ajlsi-1012	439	21	p.	p.	PROPN
ajlsi-1012	439	22	s.	s.	PROPN
ajlsi-1012	439	23	(	(	PUNCT
ajlsi-1012	439	24	2011	2011	NUM
ajlsi-1012	439	25	)	)	PUNCT
ajlsi-1012	439	26	.	.	PUNCT
ajlsi-1012	440	1	ultrasensitive	ultrasensitive	ADJ
ajlsi-1012	440	2	multiplexed	multiplexed	PROPN
ajlsi-1012	440	3	microrna	microrna	PROPN
ajlsi-1012	440	4	quantification	quantification	NOUN
ajlsi-1012	440	5	on	on	ADP
ajlsi-1012	440	6	encoded	encode	VERB
ajlsi-1012	440	7	gel	gel	NOUN
ajlsi-1012	440	8	microparticles	microparticle	NOUN
ajlsi-1012	440	9	using	use	VERB
ajlsi-1012	440	10	rolling	roll	VERB
ajlsi-1012	440	11	circle	circle	NOUN
ajlsi-1012	440	12	amplification	amplification	NOUN
ajlsi-1012	440	13	.	.	PUNCT
ajlsi-1012	441	1	analytical	analytical	ADJ
ajlsi-1012	441	2	chemistry	chemistry	NOUN
ajlsi-1012	441	3	,	,	PUNCT
ajlsi-1012	441	4	83(18	83(18	NUM
ajlsi-1012	441	5	)	)	PUNCT
ajlsi-1012	441	6	,	,	PUNCT
ajlsi-1012	441	7	7179	7179	NUM
ajlsi-1012	441	8	-	-	SYM
ajlsi-1012	441	9	7185	7185	NUM
ajlsi-1012	441	10	.	.	PUNCT
ajlsi-1012	442	1	chen	chen	PROPN
ajlsi-1012	442	2	,	,	PUNCT
ajlsi-1012	442	3	n.	n.	PROPN
ajlsi-1012	442	4	,	,	PUNCT
ajlsi-1012	442	5	zhou	zhou	PROPN
ajlsi-1012	442	6	,	,	PUNCT
ajlsi-1012	442	7	m.	m.	NOUN
ajlsi-1012	442	8	,	,	PUNCT
ajlsi-1012	442	9	dong	dong	PROPN
ajlsi-1012	442	10	,	,	PUNCT
ajlsi-1012	442	11	x.	x.	PROPN
ajlsi-1012	442	12	,	,	PUNCT
ajlsi-1012	442	13	qu	qu	PROPN
ajlsi-1012	442	14	,	,	PUNCT
ajlsi-1012	442	15	j.	j.	PROPN
ajlsi-1012	442	16	,	,	PUNCT
ajlsi-1012	442	17	et	et	PROPN
ajlsi-1012	442	18	al	al	PROPN
ajlsi-1012	442	19	.	.	PROPN
ajlsi-1012	442	20	,	,	PUNCT
ajlsi-1012	442	21	(	(	PUNCT
ajlsi-1012	442	22	2020	2020	NUM
ajlsi-1012	442	23	)	)	PUNCT
ajlsi-1012	442	24	.	.	PUNCT
ajlsi-1012	443	1	epidemiological	epidemiological	ADJ
ajlsi-1012	443	2	and	and	CCONJ
ajlsi-1012	443	3	clinical	clinical	ADJ
ajlsi-1012	443	4	characteristics	characteristic	NOUN
ajlsi-1012	443	5	of	of	ADP
ajlsi-1012	443	6	99	99	NUM
ajlsi-1012	443	7	cases	case	NOUN
ajlsi-1012	443	8	of	of	ADP
ajlsi-1012	443	9	2019	2019	NUM
ajlsi-1012	443	10	novel	novel	ADJ
ajlsi-1012	443	11	coronavirus	coronavirus	NOUN
ajlsi-1012	443	12	pneumonia	pneumonia	NOUN
ajlsi-1012	443	13	in	in	ADP
ajlsi-1012	443	14	wuhan	wuhan	PROPN
ajlsi-1012	443	15	,	,	PUNCT
ajlsi-1012	443	16	china	china	PROPN
ajlsi-1012	443	17	:	:	PUNCT
ajlsi-1012	443	18	a	a	DET
ajlsi-1012	443	19	descriptive	descriptive	ADJ
ajlsi-1012	443	20	study	study	NOUN
ajlsi-1012	443	21	.	.	PUNCT
ajlsi-1012	444	1	the	the	DET
ajlsi-1012	444	2	lancet	lancet	NOUN
ajlsi-1012	444	3	,	,	PUNCT
ajlsi-1012	444	4	395(10223	395(10223	NUM
ajlsi-1012	444	5	)	)	PUNCT
ajlsi-1012	444	6	,	,	PUNCT
ajlsi-1012	444	7	507	507	NUM
ajlsi-1012	444	8	-	-	SYM
ajlsi-1012	444	9	513	513	NUM
ajlsi-1012	444	10	.	.	PUNCT
ajlsi-1012	445	1	cheng	cheng	PROPN
ajlsi-1012	445	2	,	,	PUNCT
ajlsi-1012	445	3	p.	p.	PROPN
ajlsi-1012	445	4	k.	k.	PROPN
ajlsi-1012	445	5	,	,	PUNCT
ajlsi-1012	445	6	wong	wong	PROPN
ajlsi-1012	445	7	,	,	PUNCT
ajlsi-1012	445	8	d.	d.	PROPN
ajlsi-1012	445	9	a.	a.	PROPN
ajlsi-1012	445	10	,	,	PUNCT
ajlsi-1012	445	11	tong	tong	PROPN
ajlsi-1012	445	12	,	,	PUNCT
ajlsi-1012	445	13	l.	l.	PROPN
ajlsi-1012	445	14	k.	k.	PROPN
ajlsi-1012	445	15	,	,	PUNCT
ajlsi-1012	445	16	et	et	PROPN
ajlsi-1012	445	17	al	al	PROPN
ajlsi-1012	445	18	.	.	PROPN
ajlsi-1012	445	19	,	,	PUNCT
ajlsi-1012	445	20	(	(	PUNCT
ajlsi-1012	445	21	2004	2004	NUM
ajlsi-1012	445	22	)	)	PUNCT
ajlsi-1012	445	23	.	.	PUNCT
ajlsi-1012	446	1	viral	viral	ADJ
ajlsi-1012	446	2	shedding	shedding	ADJ
ajlsi-1012	446	3	patterns	pattern	NOUN
ajlsi-1012	446	4	of	of	ADP
ajlsi-1012	446	5	coronavirus	coronavirus	NOUN
ajlsi-1012	446	6	in	in	ADP
ajlsi-1012	446	7	patients	patient	NOUN
ajlsi-1012	446	8	with	with	ADP
ajlsi-1012	446	9	probable	probable	ADJ
ajlsi-1012	446	10	severe	severe	ADJ
ajlsi-1012	446	11	acute	acute	ADJ
ajlsi-1012	446	12	respiratory	respiratory	ADJ
ajlsi-1012	446	13	syndrome	syndrome	NOUN
ajlsi-1012	446	14	.	.	PUNCT
ajlsi-1012	447	1	the	the	DET
ajlsi-1012	447	2	lancet	lancet	NOUN
ajlsi-1012	447	3	,	,	PUNCT
ajlsi-1012	447	4	363(9422	363(9422	NUM
ajlsi-1012	447	5	)	)	PUNCT
ajlsi-1012	447	6	,	,	PUNCT
ajlsi-1012	447	7	1699	1699	NUM
ajlsi-1012	447	8	-	-	SYM
ajlsi-1012	447	9	1700	1700	NUM
ajlsi-1012	447	10	.	.	PUNCT
ajlsi-1012	448	1	cho	cho	PROPN
ajlsi-1012	448	2	,	,	PUNCT
ajlsi-1012	448	3	c.	c.	PROPN
ajlsi-1012	448	4	h.	h.	PROPN
ajlsi-1012	448	5	,	,	PUNCT
ajlsi-1012	448	6	lee	lee	PROPN
ajlsi-1012	448	7	,	,	PUNCT
ajlsi-1012	448	8	c.	c.	PROPN
ajlsi-1012	448	9	k.	k.	PROPN
ajlsi-1012	448	10	,	,	PUNCT
ajlsi-1012	448	11	nam	nam	PROPN
ajlsi-1012	448	12	,	,	PUNCT
ajlsi-1012	448	13	m.	m.	PROPN
ajlsi-1012	448	14	h.	h.	PROPN
ajlsi-1012	448	15	,	,	PUNCT
ajlsi-1012	448	16	yoon	yoon	PROPN
ajlsi-1012	448	17	,	,	PUNCT
ajlsi-1012	448	18	s.	s.	PROPN
ajlsi-1012	448	19	y.	y.	PROPN
ajlsi-1012	448	20	,	,	PUNCT
ajlsi-1012	448	21	et	et	PROPN
ajlsi-1012	448	22	al	al	PROPN
ajlsi-1012	448	23	.	.	PROPN
ajlsi-1012	448	24	,	,	PUNCT
ajlsi-1012	449	1	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	449	2	pa	pa	PROPN
ajlsi-1012	449	3	ge	ge	PROPN
ajlsi-1012	449	4	40	40	NUM
ajlsi-1012	449	5	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	449	6	am	am	NOUN
ajlsi-1012	449	7	.	.	PUNCT
ajlsi-1012	450	1	j.	j.	PROPN
ajlsi-1012	450	2	life	life	PROPN
ajlsi-1012	450	3	sci	sci	PROPN
ajlsi-1012	450	4	.	.	PUNCT
ajlsi-1012	450	5	innov	innov	PROPN
ajlsi-1012	450	6	.	.	PUNCT
ajlsi-1012	451	1	1(2	1(2	NUM
ajlsi-1012	451	2	)	)	PUNCT
ajlsi-1012	451	3	29	29	NUM
ajlsi-1012	451	4	-	-	SYM
ajlsi-1012	451	5	42	42	NUM
ajlsi-1012	451	6	,	,	PUNCT
ajlsi-1012	451	7	2022	2022	NUM
ajlsi-1012	451	8	(	(	PUNCT
ajlsi-1012	451	9	2014	2014	NUM
ajlsi-1012	451	10	)	)	PUNCT
ajlsi-1012	451	11	.	.	PUNCT
ajlsi-1012	452	1	evaluation	evaluation	NOUN
ajlsi-1012	452	2	of	of	ADP
ajlsi-1012	452	3	the	the	DET
ajlsi-1012	452	4	advansure	advansure	NOUN
ajlsi-1012	452	5	™	™	VERB
ajlsi-1012	452	6	real	real	ADJ
ajlsi-1012	452	7	-	-	PUNCT
ajlsi-1012	452	8	time	time	NOUN
ajlsi-1012	452	9	rt	rt	NOUN
ajlsi-1012	452	10	-	-	PUNCT
ajlsi-1012	452	11	pcr	pcr	NOUN
ajlsi-1012	452	12	compared	compare	VERB
ajlsi-1012	452	13	with	with	ADP
ajlsi-1012	452	14	culture	culture	NOUN
ajlsi-1012	452	15	and	and	CCONJ
ajlsi-1012	452	16	seeplex	seeplex	NOUN
ajlsi-1012	452	17	rv15	rv15	PROPN
ajlsi-1012	452	18	for	for	ADP
ajlsi-1012	452	19	simultaneous	simultaneous	ADJ
ajlsi-1012	452	20	detection	detection	NOUN
ajlsi-1012	452	21	of	of	ADP
ajlsi-1012	452	22	respiratory	respiratory	ADJ
ajlsi-1012	452	23	viruses	virus	NOUN
ajlsi-1012	452	24	.	.	PUNCT
ajlsi-1012	453	1	diagnostic	diagnostic	ADJ
ajlsi-1012	453	2	microbiology	microbiology	NOUN
ajlsi-1012	453	3	and	and	CCONJ
ajlsi-1012	453	4	infectious	infectious	ADJ
ajlsi-1012	453	5	disease	disease	NOUN
ajlsi-1012	453	6	,	,	PUNCT
ajlsi-1012	453	7	79(1	79(1	NOUN
ajlsi-1012	453	8	)	)	PUNCT
ajlsi-1012	453	9	,	,	PUNCT
ajlsi-1012	453	10	14	14	NUM
ajlsi-1012	453	11	-	-	SYM
ajlsi-1012	453	12	18	18	NUM
ajlsi-1012	453	13	.	.	PUNCT
ajlsi-1012	454	1	chu	chu	PROPN
ajlsi-1012	454	2	,	,	PUNCT
ajlsi-1012	454	3	d.	d.	PROPN
ajlsi-1012	454	4	k.	k.	PROPN
ajlsi-1012	454	5	,	,	PUNCT
ajlsi-1012	454	6	pan	pan	PROPN
ajlsi-1012	454	7	,	,	PUNCT
ajlsi-1012	454	8	y.	y.	PROPN
ajlsi-1012	454	9	,	,	PUNCT
ajlsi-1012	454	10	cheng	cheng	PROPN
ajlsi-1012	454	11	,	,	PUNCT
ajlsi-1012	454	12	s.	s.	PROPN
ajlsi-1012	454	13	m.	m.	PROPN
ajlsi-1012	454	14	,	,	PUNCT
ajlsi-1012	454	15	hui	hui	PROPN
ajlsi-1012	454	16	,	,	PUNCT
ajlsi-1012	454	17	k.	k.	PROPN
ajlsi-1012	455	1	p.	p.	PROPN
ajlsi-1012	455	2	,	,	PUNCT
ajlsi-1012	455	3	et	et	PROPN
ajlsi-1012	455	4	al	al	PROPN
ajlsi-1012	455	5	.	.	PROPN
ajlsi-1012	455	6	,	,	PUNCT
ajlsi-1012	455	7	(	(	PUNCT
ajlsi-1012	455	8	2020	2020	NUM
ajlsi-1012	455	9	)	)	PUNCT
ajlsi-1012	455	10	.	.	PUNCT
ajlsi-1012	456	1	molecular	molecular	ADJ
ajlsi-1012	456	2	diagnosis	diagnosis	NOUN
ajlsi-1012	456	3	of	of	ADP
ajlsi-1012	456	4	a	a	DET
ajlsi-1012	456	5	novel	novel	ADJ
ajlsi-1012	456	6	coronavirus	coronavirus	NOUN
ajlsi-1012	456	7	(	(	PUNCT
ajlsi-1012	456	8	2019ncov	2019ncov	NUM
ajlsi-1012	456	9	)	)	PUNCT
ajlsi-1012	456	10	causing	cause	VERB
ajlsi-1012	456	11	an	an	DET
ajlsi-1012	456	12	outbreak	outbreak	NOUN
ajlsi-1012	456	13	of	of	ADP
ajlsi-1012	456	14	pneumonia	pneumonia	NOUN
ajlsi-1012	456	15	.	.	PUNCT
ajlsi-1012	457	1	clinical	clinical	ADJ
ajlsi-1012	457	2	chemistry	chemistry	NOUN
ajlsi-1012	457	3	,	,	PUNCT
ajlsi-1012	457	4	66(4	66(4	NUM
ajlsi-1012	457	5	)	)	PUNCT
ajlsi-1012	457	6	,	,	PUNCT
ajlsi-1012	457	7	549	549	NUM
ajlsi-1012	457	8	-	-	SYM
ajlsi-1012	457	9	555	555	NUM
ajlsi-1012	457	10	.	.	PUNCT
ajlsi-1012	458	1	corman	corman	NOUN
ajlsi-1012	458	2	,	,	PUNCT
ajlsi-1012	458	3	v.	v.	ADP
ajlsi-1012	458	4	m.	m.	NOUN
ajlsi-1012	458	5	,	,	PUNCT
ajlsi-1012	458	6	landt	landt	PROPN
ajlsi-1012	458	7	,	,	PUNCT
ajlsi-1012	458	8	o.	o.	PROPN
ajlsi-1012	458	9	,	,	PUNCT
ajlsi-1012	458	10	kaiser	kaiser	PROPN
ajlsi-1012	458	11	,	,	PUNCT
ajlsi-1012	458	12	m.	m.	NOUN
ajlsi-1012	458	13	,	,	PUNCT
ajlsi-1012	458	14	et	et	PROPN
ajlsi-1012	458	15	al	al	PROPN
ajlsi-1012	458	16	.	.	PROPN
ajlsi-1012	458	17	,	,	PUNCT
ajlsi-1012	458	18	(	(	PUNCT
ajlsi-1012	458	19	2020	2020	NUM
ajlsi-1012	458	20	)	)	PUNCT
ajlsi-1012	458	21	.	.	PUNCT
ajlsi-1012	459	1	detection	detection	NOUN
ajlsi-1012	459	2	of	of	ADP
ajlsi-1012	459	3	2019	2019	NUM
ajlsi-1012	459	4	novel	novel	ADJ
ajlsi-1012	459	5	coronavirus	coronavirus	NOUN
ajlsi-1012	459	6	(	(	PUNCT
ajlsi-1012	459	7	2019	2019	NUM
ajlsi-1012	459	8	-	-	PUNCT
ajlsi-1012	459	9	ncov	ncov	NOUN
ajlsi-1012	459	10	)	)	PUNCT
ajlsi-1012	459	11	by	by	ADP
ajlsi-1012	459	12	real	real	ADJ
ajlsi-1012	459	13	-	-	PUNCT
ajlsi-1012	459	14	time	time	NOUN
ajlsi-1012	459	15	rt	rt	NOUN
ajlsi-1012	459	16	-	-	PUNCT
ajlsi-1012	459	17	pcr	pcr	NOUN
ajlsi-1012	459	18	.	.	PUNCT
ajlsi-1012	460	1	euro	euro	NOUN
ajlsi-1012	460	2	surveillance	surveillance	NOUN
ajlsi-1012	460	3	,	,	PUNCT
ajlsi-1012	460	4	25(3	25(3	NUM
ajlsi-1012	460	5	)	)	PUNCT
ajlsi-1012	460	6	,	,	PUNCT
ajlsi-1012	460	7	2000045	2000045	NUM
ajlsi-1012	460	8	.	.	PUNCT
ajlsi-1012	461	1	cui	cui	PROPN
ajlsi-1012	461	2	,	,	PUNCT
ajlsi-1012	461	3	j.	j.	PROPN
ajlsi-1012	461	4	,	,	PUNCT
ajlsi-1012	461	5	li	li	PROPN
ajlsi-1012	461	6	,	,	PUNCT
ajlsi-1012	461	7	f.	f.	PROPN
ajlsi-1012	461	8	,	,	PUNCT
ajlsi-1012	461	9	&	&	CCONJ
ajlsi-1012	461	10	shi	shi	PROPN
ajlsi-1012	461	11	,	,	PUNCT
ajlsi-1012	461	12	z.	z.	PROPN
ajlsi-1012	461	13	l.	l.	PROPN
ajlsi-1012	461	14	(	(	PUNCT
ajlsi-1012	461	15	2019	2019	NUM
ajlsi-1012	461	16	)	)	PUNCT
ajlsi-1012	461	17	.	.	PUNCT
ajlsi-1012	462	1	origin	origin	NOUN
ajlsi-1012	462	2	and	and	CCONJ
ajlsi-1012	462	3	evolution	evolution	NOUN
ajlsi-1012	462	4	of	of	ADP
ajlsi-1012	462	5	pathogenic	pathogenic	ADJ
ajlsi-1012	462	6	coronaviruses	coronaviruse	NOUN
ajlsi-1012	462	7	.	.	PUNCT
ajlsi-1012	463	1	nature	nature	NOUN
ajlsi-1012	463	2	reviews	review	VERB
ajlsi-1012	463	3	microbiology	microbiology	NOUN
ajlsi-1012	463	4	,	,	PUNCT
ajlsi-1012	463	5	17(3	17(3	NUM
ajlsi-1012	463	6	)	)	PUNCT
ajlsi-1012	463	7	,	,	PUNCT
ajlsi-1012	463	8	181	181	NUM
ajlsi-1012	463	9	-	-	SYM
ajlsi-1012	463	10	192	192	NUM
ajlsi-1012	463	11	.	.	PUNCT
ajlsi-1012	464	1	ding	ding	NOUN
ajlsi-1012	464	2	,	,	PUNCT
ajlsi-1012	464	3	y.	y.	PROPN
ajlsi-1012	464	4	,	,	PUNCT
ajlsi-1012	464	5	he	he	PRON
ajlsi-1012	464	6	,	,	PUNCT
ajlsi-1012	464	7	l.	l.	PROPN
ajlsi-1012	464	8	i.	i.	PROPN
ajlsi-1012	464	9	,	,	PUNCT
ajlsi-1012	464	10	zhang	zhang	PROPN
ajlsi-1012	464	11	,	,	PUNCT
ajlsi-1012	464	12	q.	q.	PROPN
ajlsi-1012	464	13	,	,	PUNCT
ajlsi-1012	464	14	huang	huang	PROPN
ajlsi-1012	464	15	,	,	PUNCT
ajlsi-1012	464	16	z.	z.	PROPN
ajlsi-1012	464	17	,	,	PUNCT
ajlsi-1012	464	18	che	che	PROPN
ajlsi-1012	464	19	,	,	PUNCT
ajlsi-1012	464	20	x.	x.	NOUN
ajlsi-1012	464	21	,	,	PUNCT
ajlsi-1012	464	22	hou	hou	PROPN
ajlsi-1012	464	23	,	,	PUNCT
ajlsi-1012	464	24	j.	j.	PROPN
ajlsi-1012	464	25	,	,	PUNCT
ajlsi-1012	464	26	et	et	PROPN
ajlsi-1012	464	27	al	al	PROPN
ajlsi-1012	464	28	.	.	PROPN
ajlsi-1012	464	29	,	,	PUNCT
ajlsi-1012	464	30	(	(	PUNCT
ajlsi-1012	464	31	2004	2004	NUM
ajlsi-1012	464	32	)	)	PUNCT
ajlsi-1012	464	33	.	.	PUNCT
ajlsi-1012	465	1	organ	organ	NOUN
ajlsi-1012	465	2	distribution	distribution	NOUN
ajlsi-1012	465	3	of	of	ADP
ajlsi-1012	465	4	severe	severe	ADJ
ajlsi-1012	465	5	acute	acute	ADJ
ajlsi-1012	465	6	respiratory	respiratory	ADJ
ajlsi-1012	465	7	syndrome	syndrome	NOUN
ajlsi-1012	465	8	(	(	PUNCT
ajlsi-1012	465	9	sars	sars	PROPN
ajlsi-1012	465	10	)	)	PUNCT
ajlsi-1012	465	11	associated	associate	VERB
ajlsi-1012	465	12	coronavirus	coronavirus	NOUN
ajlsi-1012	465	13	(	(	PUNCT
ajlsi-1012	465	14	sars‐cov-2	sars‐cov-2	NOUN
ajlsi-1012	465	15	)	)	PUNCT
ajlsi-1012	465	16	in	in	ADP
ajlsi-1012	465	17	sars	sars	PROPN
ajlsi-1012	465	18	patients	patient	NOUN
ajlsi-1012	465	19	:	:	PUNCT
ajlsi-1012	465	20	implications	implication	NOUN
ajlsi-1012	465	21	for	for	ADP
ajlsi-1012	465	22	pathogenesis	pathogenesis	NOUN
ajlsi-1012	465	23	and	and	CCONJ
ajlsi-1012	465	24	virus	virus	NOUN
ajlsi-1012	465	25	transmission	transmission	NOUN
ajlsi-1012	465	26	pathways	pathway	NOUN
ajlsi-1012	465	27	.	.	PUNCT
ajlsi-1012	466	1	the	the	DET
ajlsi-1012	466	2	journal	journal	PROPN
ajlsi-1012	466	3	of	of	ADP
ajlsi-1012	466	4	pathology	pathology	PROPN
ajlsi-1012	466	5	:	:	PUNCT
ajlsi-1012	466	6	a	a	DET
ajlsi-1012	466	7	journal	journal	NOUN
ajlsi-1012	466	8	of	of	ADP
ajlsi-1012	466	9	the	the	DET
ajlsi-1012	466	10	pathological	pathological	ADJ
ajlsi-1012	466	11	society	society	NOUN
ajlsi-1012	466	12	of	of	ADP
ajlsi-1012	466	13	great	great	ADJ
ajlsi-1012	466	14	britain	britain	PROPN
ajlsi-1012	466	15	and	and	CCONJ
ajlsi-1012	466	16	ireland	ireland	PROPN
ajlsi-1012	466	17	,	,	PUNCT
ajlsi-1012	466	18	203(2	203(2	NUM
ajlsi-1012	466	19	)	)	PUNCT
ajlsi-1012	466	20	,	,	PUNCT
ajlsi-1012	466	21	622	622	NUM
ajlsi-1012	466	22	-	-	SYM
ajlsi-1012	466	23	630	630	NUM
ajlsi-1012	466	24	.	.	PUNCT
ajlsi-1012	467	1	dorfman	dorfman	PROPN
ajlsi-1012	467	2	,	,	PUNCT
ajlsi-1012	467	3	r.	r.	PROPN
ajlsi-1012	467	4	(	(	PUNCT
ajlsi-1012	467	5	1943	1943	NUM
ajlsi-1012	467	6	)	)	PUNCT
ajlsi-1012	467	7	.	.	PUNCT
ajlsi-1012	468	1	the	the	DET
ajlsi-1012	468	2	detection	detection	NOUN
ajlsi-1012	468	3	of	of	ADP
ajlsi-1012	468	4	defective	defective	ADJ
ajlsi-1012	468	5	members	member	NOUN
ajlsi-1012	468	6	of	of	ADP
ajlsi-1012	468	7	large	large	ADJ
ajlsi-1012	468	8	populations	population	NOUN
ajlsi-1012	468	9	.	.	PUNCT
ajlsi-1012	469	1	the	the	DET
ajlsi-1012	469	2	annals	annal	NOUN
ajlsi-1012	469	3	of	of	ADP
ajlsi-1012	469	4	mathematical	mathematical	ADJ
ajlsi-1012	469	5	statistics	statistic	NOUN
ajlsi-1012	469	6	,	,	PUNCT
ajlsi-1012	469	7	14(4	14(4	NUM
ajlsi-1012	469	8	)	)	PUNCT
ajlsi-1012	469	9	,	,	PUNCT
ajlsi-1012	469	10	436	436	NUM
ajlsi-1012	469	11	-	-	SYM
ajlsi-1012	469	12	440	440	NUM
ajlsi-1012	469	13	.	.	PUNCT
ajlsi-1012	470	1	drosten	drosten	PROPN
ajlsi-1012	470	2	,	,	PUNCT
ajlsi-1012	470	3	c.	c.	NOUN
ajlsi-1012	470	4	,	,	PUNCT
ajlsi-1012	470	5	günther	günther	NOUN
ajlsi-1012	470	6	,	,	PUNCT
ajlsi-1012	470	7	s.	s.	PROPN
ajlsi-1012	470	8	,	,	PUNCT
ajlsi-1012	470	9	preiser	preiser	PROPN
ajlsi-1012	470	10	,	,	PUNCT
ajlsi-1012	470	11	w.	w.	PROPN
ajlsi-1012	470	12	,	,	PUNCT
ajlsi-1012	470	13	et	et	PROPN
ajlsi-1012	470	14	al	al	PROPN
ajlsi-1012	470	15	.	.	PROPN
ajlsi-1012	470	16	,	,	PUNCT
ajlsi-1012	470	17	(	(	PUNCT
ajlsi-1012	470	18	2003	2003	NUM
ajlsi-1012	470	19	)	)	PUNCT
ajlsi-1012	470	20	.	.	PUNCT
ajlsi-1012	471	1	identification	identification	NOUN
ajlsi-1012	471	2	of	of	ADP
ajlsi-1012	471	3	a	a	DET
ajlsi-1012	471	4	novel	novel	ADJ
ajlsi-1012	471	5	coronavirus	coronavirus	NOUN
ajlsi-1012	471	6	in	in	ADP
ajlsi-1012	471	7	patients	patient	NOUN
ajlsi-1012	471	8	with	with	ADP
ajlsi-1012	471	9	severe	severe	ADJ
ajlsi-1012	471	10	acute	acute	ADJ
ajlsi-1012	471	11	respiratory	respiratory	ADJ
ajlsi-1012	471	12	syndrome	syndrome	NOUN
ajlsi-1012	471	13	.	.	PUNCT
ajlsi-1012	472	1	new	new	PROPN
ajlsi-1012	472	2	england	england	PROPN
ajlsi-1012	472	3	journal	journal	PROPN
ajlsi-1012	472	4	of	of	ADP
ajlsi-1012	472	5	medicine	medicine	NOUN
ajlsi-1012	472	6	,	,	PUNCT
ajlsi-1012	472	7	348(20	348(20	NUM
ajlsi-1012	472	8	)	)	PUNCT
ajlsi-1012	472	9	,	,	PUNCT
ajlsi-1012	472	10	1967	1967	NUM
ajlsi-1012	472	11	-	-	SYM
ajlsi-1012	472	12	1976	1976	NUM
ajlsi-1012	472	13	.	.	PUNCT
ajlsi-1012	473	1	druce	druce	PROPN
ajlsi-1012	473	2	,	,	PUNCT
ajlsi-1012	473	3	j.	j.	PROPN
ajlsi-1012	473	4	,	,	PUNCT
ajlsi-1012	473	5	garcia	garcia	PROPN
ajlsi-1012	473	6	,	,	PUNCT
ajlsi-1012	473	7	k.	k.	PROPN
ajlsi-1012	473	8	,	,	PUNCT
ajlsi-1012	473	9	tran	tran	PROPN
ajlsi-1012	473	10	,	,	PUNCT
ajlsi-1012	473	11	t.	t.	PROPN
ajlsi-1012	473	12	,	,	PUNCT
ajlsi-1012	473	13	et	et	PROPN
ajlsi-1012	473	14	al	al	PROPN
ajlsi-1012	473	15	.	.	PROPN
ajlsi-1012	473	16	,	,	PUNCT
ajlsi-1012	473	17	2012	2012	NUM
ajlsi-1012	473	18	)	)	PUNCT
ajlsi-1012	473	19	.	.	PUNCT
ajlsi-1012	474	1	evaluation	evaluation	NOUN
ajlsi-1012	474	2	of	of	ADP
ajlsi-1012	474	3	swabs	swab	NOUN
ajlsi-1012	474	4	,	,	PUNCT
ajlsi-1012	474	5	transport	transport	NOUN
ajlsi-1012	474	6	media	medium	NOUN
ajlsi-1012	474	7	,	,	PUNCT
ajlsi-1012	474	8	and	and	CCONJ
ajlsi-1012	474	9	specimen	speciman	NOUN
ajlsi-1012	474	10	transport	transport	VERB
ajlsi-1012	474	11	conditions	condition	NOUN
ajlsi-1012	474	12	for	for	ADP
ajlsi-1012	474	13	optimal	optimal	ADJ
ajlsi-1012	474	14	detection	detection	NOUN
ajlsi-1012	474	15	of	of	ADP
ajlsi-1012	474	16	viruses	virus	NOUN
ajlsi-1012	474	17	by	by	ADP
ajlsi-1012	474	18	pcr	pcr	PROPN
ajlsi-1012	474	19	.	.	PUNCT
ajlsi-1012	475	1	journal	journal	PROPN
ajlsi-1012	475	2	of	of	ADP
ajlsi-1012	475	3	clinical	clinical	ADJ
ajlsi-1012	475	4	microbiology	microbiology	NOUN
ajlsi-1012	475	5	,	,	PUNCT
ajlsi-1012	475	6	50(3	50(3	NUM
ajlsi-1012	475	7	)	)	PUNCT
ajlsi-1012	475	8	,	,	PUNCT
ajlsi-1012	475	9	1064	1064	NUM
ajlsi-1012	475	10	-	-	SYM
ajlsi-1012	475	11	1065	1065	NUM
ajlsi-1012	475	12	.	.	PUNCT
ajlsi-1012	476	1	fouchier	fouchier	PROPN
ajlsi-1012	476	2	,	,	PUNCT
ajlsi-1012	476	3	r.	r.	PROPN
ajlsi-1012	476	4	a.	a.	PROPN
ajlsi-1012	476	5	m.	m.	PROPN
ajlsi-1012	476	6	,	,	PUNCT
ajlsi-1012	476	7	kuiken	kuiken	VERB
ajlsi-1012	476	8	,	,	PUNCT
ajlsi-1012	476	9	t.	t.	PROPN
ajlsi-1012	476	10	,	,	PUNCT
ajlsi-1012	476	11	schutten	schutten	NOUN
ajlsi-1012	476	12	,	,	PUNCT
ajlsi-1012	476	13	m.	m.	NOUN
ajlsi-1012	476	14	,	,	PUNCT
ajlsi-1012	476	15	et	et	PROPN
ajlsi-1012	476	16	al	al	PROPN
ajlsi-1012	476	17	.	.	PROPN
ajlsi-1012	476	18	,	,	PUNCT
ajlsi-1012	476	19	(	(	PUNCT
ajlsi-1012	476	20	2003	2003	NUM
ajlsi-1012	476	21	,	,	PUNCT
ajlsi-1012	476	22	may	may	AUX
ajlsi-1012	476	23	)	)	PUNCT
ajlsi-1012	476	24	.	.	PUNCT
ajlsi-1012	477	1	koch	koch	PROPN
ajlsi-1012	477	2	’s	’s	PART
ajlsi-1012	477	3	postulates	postulate	NOUN
ajlsi-1012	477	4	fulfilled	fulfil	VERB
ajlsi-1012	477	5	for	for	ADP
ajlsi-1012	477	6	sars	sars	PROPN
ajlsi-1012	477	7	virus	virus	PROPN
ajlsi-1012	477	8	.	.	PUNCT
ajlsi-1012	478	1	nature	nature	NOUN
ajlsi-1012	478	2	,	,	PUNCT
ajlsi-1012	478	3	423(6937	423(6937	X
ajlsi-1012	478	4	)	)	PUNCT
ajlsi-1012	478	5	,	,	PUNCT
ajlsi-1012	478	6	240–240	240–240	NUM
ajlsi-1012	478	7	.	.	PUNCT
ajlsi-1012	479	1	https://doi	https://doi	PROPN
ajlsi-1012	479	2	.	.	PUNCT
ajlsi-1012	480	1	org/10.1038/423240a	org/10.1038/423240a	PROPN
ajlsi-1012	480	2	francois	francois	PROPN
ajlsi-1012	480	3	,	,	PUNCT
ajlsi-1012	480	4	p.	p.	NOUN
ajlsi-1012	480	5	,	,	PUNCT
ajlsi-1012	480	6	tangomo	tangomo	PROPN
ajlsi-1012	480	7	,	,	PUNCT
ajlsi-1012	480	8	m.	m.	NOUN
ajlsi-1012	480	9	,	,	PUNCT
ajlsi-1012	480	10	hibbs	hibbs	PROPN
ajlsi-1012	480	11	,	,	PUNCT
ajlsi-1012	480	12	j.	j.	PROPN
ajlsi-1012	480	13	,	,	PUNCT
ajlsi-1012	480	14	bonetti	bonetti	PROPN
ajlsi-1012	480	15	,	,	PUNCT
ajlsi-1012	480	16	e.	e.	PROPN
ajlsi-1012	480	17	j.	j.	PROPN
ajlsi-1012	480	18	,	,	PUNCT
ajlsi-1012	480	19	et	et	PROPN
ajlsi-1012	480	20	al	al	PROPN
ajlsi-1012	480	21	.	.	PROPN
ajlsi-1012	480	22	,	,	PUNCT
ajlsi-1012	480	23	(	(	PUNCT
ajlsi-1012	480	24	2011	2011	NUM
ajlsi-1012	480	25	,	,	PUNCT
ajlsi-1012	480	26	june	june	PROPN
ajlsi-1012	480	27	)	)	PUNCT
ajlsi-1012	480	28	.	.	PUNCT
ajlsi-1012	481	1	robustness	robustness	NOUN
ajlsi-1012	481	2	of	of	ADP
ajlsi-1012	481	3	a	a	DET
ajlsi-1012	481	4	loop	loop	NOUN
ajlsi-1012	481	5	-	-	PUNCT
ajlsi-1012	481	6	mediated	mediate	VERB
ajlsi-1012	481	7	isothermal	isothermal	ADJ
ajlsi-1012	481	8	amplification	amplification	NOUN
ajlsi-1012	481	9	reaction	reaction	NOUN
ajlsi-1012	481	10	for	for	ADP
ajlsi-1012	481	11	diagnostic	diagnostic	ADJ
ajlsi-1012	481	12	applications	application	NOUN
ajlsi-1012	481	13	.	.	PUNCT
ajlsi-1012	482	1	fems	fems	PROPN
ajlsi-1012	482	2	immunology	immunology	PROPN
ajlsi-1012	482	3	&	&	CCONJ
ajlsi-1012	482	4	medical	medical	ADJ
ajlsi-1012	482	5	microbiology	microbiology	NOUN
ajlsi-1012	482	6	,	,	PUNCT
ajlsi-1012	482	7	62(1	62(1	NOUN
ajlsi-1012	482	8	)	)	PUNCT
ajlsi-1012	482	9	,	,	PUNCT
ajlsi-1012	482	10	41–48	41–48	NUM
ajlsi-1012	482	11	.	.	PUNCT
ajlsi-1012	483	1	https://doi.org/10.1111/j.1574-695x.2011.00785.x	https://doi.org/10.1111/j.1574-695x.2011.00785.x	PROPN
ajlsi-1012	483	2	gollier	gollier	PROPN
ajlsi-1012	483	3	,	,	PUNCT
ajlsi-1012	483	4	c.	c.	PROPN
ajlsi-1012	483	5	,	,	PUNCT
ajlsi-1012	483	6	&	&	CCONJ
ajlsi-1012	483	7	gossner	gossner	NOUN
ajlsi-1012	483	8	,	,	PUNCT
ajlsi-1012	483	9	o.	o.	PROPN
ajlsi-1012	483	10	(	(	PUNCT
ajlsi-1012	483	11	2020	2020	NUM
ajlsi-1012	483	12	)	)	PUNCT
ajlsi-1012	483	13	.	.	PUNCT
ajlsi-1012	484	1	group	group	NOUN
ajlsi-1012	484	2	testing	testing	NOUN
ajlsi-1012	484	3	against	against	ADP
ajlsi-1012	484	4	covid-19	covid-19	PROPN
ajlsi-1012	484	5	(	(	PUNCT
ajlsi-1012	484	6	no	no	NOUN
ajlsi-1012	484	7	.	.	NOUN
ajlsi-1012	484	8	24	24	NUM
ajlsi-1012	484	9	)	)	PUNCT
ajlsi-1012	484	10	.	.	PUNCT
ajlsi-1012	485	1	econpol	econpol	PROPN
ajlsi-1012	485	2	policy	policy	PROPN
ajlsi-1012	485	3	brief	brief	NOUN
ajlsi-1012	485	4	.	.	PUNCT
ajlsi-1012	486	1	holshue	holshue	NOUN
ajlsi-1012	486	2	,	,	PUNCT
ajlsi-1012	486	3	m.	m.	NOUN
ajlsi-1012	486	4	l.	l.	PROPN
ajlsi-1012	486	5	,	,	PUNCT
ajlsi-1012	486	6	debolt	debolt	NOUN
ajlsi-1012	486	7	,	,	PUNCT
ajlsi-1012	486	8	c.	c.	PROPN
ajlsi-1012	486	9	,	,	PUNCT
ajlsi-1012	486	10	et	et	PROPN
ajlsi-1012	486	11	al	al	PROPN
ajlsi-1012	486	12	.	.	PROPN
ajlsi-1012	486	13	,	,	PUNCT
ajlsi-1012	486	14	(	(	PUNCT
ajlsi-1012	486	15	2020	2020	NUM
ajlsi-1012	486	16	)	)	PUNCT
ajlsi-1012	486	17	.	.	PUNCT
ajlsi-1012	487	1	first	first	ADJ
ajlsi-1012	487	2	case	case	NOUN
ajlsi-1012	487	3	of	of	ADP
ajlsi-1012	487	4	2019	2019	NUM
ajlsi-1012	487	5	novel	novel	ADJ
ajlsi-1012	487	6	coronavirus	coronavirus	NOUN
ajlsi-1012	487	7	in	in	ADP
ajlsi-1012	487	8	the	the	DET
ajlsi-1012	487	9	united	united	PROPN
ajlsi-1012	487	10	states	states	PROPN
ajlsi-1012	487	11	.	.	PUNCT
ajlsi-1012	488	1	new	new	PROPN
ajlsi-1012	488	2	england	england	PROPN
ajlsi-1012	488	3	journal	journal	PROPN
ajlsi-1012	488	4	of	of	ADP
ajlsi-1012	488	5	medicine	medicine	NOUN
ajlsi-1012	488	6	,	,	PUNCT
ajlsi-1012	488	7	382	382	NUM
ajlsi-1012	488	8	,	,	PUNCT
ajlsi-1012	488	9	929–936	929–936	NUM
ajlsi-1012	488	10	.	.	PUNCT
ajlsi-1012	489	1	hong	hong	PROPN
ajlsi-1012	489	2	,	,	PUNCT
ajlsi-1012	489	3	k.	k.	PROPN
ajlsi-1012	489	4	h.	h.	PROPN
ajlsi-1012	489	5	,	,	PUNCT
ajlsi-1012	489	6	lee	lee	PROPN
ajlsi-1012	489	7	,	,	PUNCT
ajlsi-1012	489	8	s.	s.	PROPN
ajlsi-1012	489	9	w.	w.	PROPN
ajlsi-1012	489	10	,	,	PUNCT
ajlsi-1012	489	11	kim	kim	PROPN
ajlsi-1012	489	12	,	,	PUNCT
ajlsi-1012	489	13	t.	t.	PROPN
ajlsi-1012	489	14	s.	s.	PROPN
ajlsi-1012	489	15	,	,	PUNCT
ajlsi-1012	489	16	et	et	PROPN
ajlsi-1012	489	17	al	al	PROPN
ajlsi-1012	489	18	.	.	PROPN
ajlsi-1012	489	19	,	,	PUNCT
ajlsi-1012	489	20	(	(	PUNCT
ajlsi-1012	489	21	2020	2020	NUM
ajlsi-1012	489	22	)	)	PUNCT
ajlsi-1012	489	23	.	.	PUNCT
ajlsi-1012	490	1	guidelines	guideline	NOUN
ajlsi-1012	490	2	for	for	ADP
ajlsi-1012	490	3	laboratory	laboratory	NOUN
ajlsi-1012	490	4	diagnosis	diagnosis	NOUN
ajlsi-1012	490	5	of	of	ADP
ajlsi-1012	490	6	coronavirus	coronavirus	NOUN
ajlsi-1012	490	7	disease	disease	NOUN
ajlsi-1012	490	8	2019	2019	NUM
ajlsi-1012	490	9	(	(	PUNCT
ajlsi-1012	490	10	covid-19	covid-19	PROPN
ajlsi-1012	490	11	)	)	PUNCT
ajlsi-1012	490	12	in	in	ADP
ajlsi-1012	490	13	korea	korea	PROPN
ajlsi-1012	490	14	.	.	PUNCT
ajlsi-1012	491	1	annals	annal	NOUN
ajlsi-1012	491	2	of	of	ADP
ajlsi-1012	491	3	laboratory	laboratory	NOUN
ajlsi-1012	491	4	medicine	medicine	NOUN
ajlsi-1012	491	5	,	,	PUNCT
ajlsi-1012	491	6	40(5	40(5	NOUN
ajlsi-1012	491	7	)	)	PUNCT
ajlsi-1012	491	8	,	,	PUNCT
ajlsi-1012	491	9	351	351	NUM
ajlsi-1012	491	10	-	-	SYM
ajlsi-1012	491	11	360	360	NUM
ajlsi-1012	491	12	.	.	PUNCT
ajlsi-1012	492	1	hsueh	hsueh	PROPN
ajlsi-1012	492	2	,	,	PUNCT
ajlsi-1012	492	3	p.	p.	PROPN
ajlsi-1012	492	4	r.	r.	PROPN
ajlsi-1012	492	5	,	,	PUNCT
ajlsi-1012	492	6	hsiao	hsiao	PROPN
ajlsi-1012	492	7	,	,	PUNCT
ajlsi-1012	492	8	c.	c.	PROPN
ajlsi-1012	492	9	h.	h.	PROPN
ajlsi-1012	492	10	,	,	PUNCT
ajlsi-1012	492	11	yeh	yeh	PROPN
ajlsi-1012	492	12	,	,	PUNCT
ajlsi-1012	492	13	s.	s.	PROPN
ajlsi-1012	492	14	h.	h.	PROPN
ajlsi-1012	492	15	,	,	PUNCT
ajlsi-1012	492	16	et	et	PROPN
ajlsi-1012	492	17	al	al	PROPN
ajlsi-1012	492	18	.	.	PROPN
ajlsi-1012	492	19	,	,	PUNCT
ajlsi-1012	492	20	(	(	PUNCT
ajlsi-1012	492	21	2003	2003	NUM
ajlsi-1012	492	22	)	)	PUNCT
ajlsi-1012	492	23	.	.	PUNCT
ajlsi-1012	493	1	microbiologic	microbiologic	ADJ
ajlsi-1012	493	2	characteristics	characteristic	NOUN
ajlsi-1012	493	3	,	,	PUNCT
ajlsi-1012	493	4	serologic	serologic	ADJ
ajlsi-1012	493	5	responses	response	NOUN
ajlsi-1012	493	6	,	,	PUNCT
ajlsi-1012	493	7	and	and	CCONJ
ajlsi-1012	493	8	clinical	clinical	ADJ
ajlsi-1012	493	9	manifestations	manifestation	NOUN
ajlsi-1012	493	10	in	in	ADP
ajlsi-1012	493	11	severe	severe	ADJ
ajlsi-1012	493	12	acute	acute	ADJ
ajlsi-1012	493	13	respiratory	respiratory	ADJ
ajlsi-1012	493	14	syndrome	syndrome	NOUN
ajlsi-1012	493	15	,	,	PUNCT
ajlsi-1012	493	16	emerging	emerge	VERB
ajlsi-1012	493	17	infectious	infectious	ADJ
ajlsi-1012	493	18	diseases	disease	NOUN
ajlsi-1012	493	19	,	,	PUNCT
ajlsi-1012	493	20	9(9	9(9	NUM
ajlsi-1012	493	21	)	)	PUNCT
ajlsi-1012	493	22	,	,	PUNCT
ajlsi-1012	493	23	1163	1163	NUM
ajlsi-1012	493	24	.	.	PUNCT
ajlsi-1012	494	1	huang	huang	PROPN
ajlsi-1012	494	2	,	,	PUNCT
ajlsi-1012	494	3	c.	c.	PROPN
ajlsi-1012	494	4	,	,	PUNCT
ajlsi-1012	494	5	wang	wang	PROPN
ajlsi-1012	494	6	,	,	PUNCT
ajlsi-1012	494	7	y.	y.	PROPN
ajlsi-1012	494	8	,	,	PUNCT
ajlsi-1012	494	9	li	li	PROPN
ajlsi-1012	494	10	,	,	PUNCT
ajlsi-1012	494	11	x.	x.	PROPN
ajlsi-1012	494	12	,	,	PUNCT
ajlsi-1012	494	13	ren	ren	PROPN
ajlsi-1012	494	14	,	,	PUNCT
ajlsi-1012	494	15	l.	l.	PROPN
ajlsi-1012	494	16	,	,	PUNCT
ajlsi-1012	494	17	zhao	zhao	PROPN
ajlsi-1012	494	18	,	,	PUNCT
ajlsi-1012	494	19	j.	j.	PROPN
ajlsi-1012	494	20	,	,	PUNCT
ajlsi-1012	494	21	et	et	PROPN
ajlsi-1012	494	22	al	al	PROPN
ajlsi-1012	494	23	.	.	PROPN
ajlsi-1012	494	24	,	,	PUNCT
ajlsi-1012	494	25	(	(	PUNCT
ajlsi-1012	494	26	2020	2020	NUM
ajlsi-1012	494	27	)	)	PUNCT
ajlsi-1012	494	28	.	.	PUNCT
ajlsi-1012	495	1	clinical	clinical	ADJ
ajlsi-1012	495	2	features	feature	NOUN
ajlsi-1012	495	3	of	of	ADP
ajlsi-1012	495	4	patients	patient	NOUN
ajlsi-1012	495	5	infected	infect	VERB
ajlsi-1012	495	6	with	with	ADP
ajlsi-1012	495	7	2019	2019	NUM
ajlsi-1012	495	8	novel	novel	ADJ
ajlsi-1012	495	9	coronavirus	coronavirus	NOUN
ajlsi-1012	495	10	in	in	ADP
ajlsi-1012	495	11	wuhan	wuhan	PROPN
ajlsi-1012	495	12	,	,	PUNCT
ajlsi-1012	495	13	china	china	PROPN
ajlsi-1012	495	14	.	.	PUNCT
ajlsi-1012	496	1	the	the	DET
ajlsi-1012	496	2	lancet	lancet	PROPN
ajlsi-1012	496	3	,	,	PUNCT
ajlsi-1012	496	4	395(10223	395(10223	NUM
ajlsi-1012	496	5	)	)	PUNCT
ajlsi-1012	496	6	,	,	PUNCT
ajlsi-1012	496	7	497	497	NUM
ajlsi-1012	496	8	-	-	SYM
ajlsi-1012	496	9	506	506	NUM
ajlsi-1012	496	10	.	.	PUNCT
ajlsi-1012	496	11	kacian	kacian	PROPN
ajlsi-1012	496	12	,	,	PUNCT
ajlsi-1012	496	13	d.	d.	PROPN
ajlsi-1012	496	14	l.	l.	PROPN
ajlsi-1012	496	15	,	,	PUNCT
ajlsi-1012	496	16	&	&	CCONJ
ajlsi-1012	496	17	fultz	fultz	NOUN
ajlsi-1012	496	18	,	,	PUNCT
ajlsi-1012	496	19	t.	t.	PROPN
ajlsi-1012	496	20	j.	j.	PROPN
ajlsi-1012	496	21	(	(	PUNCT
ajlsi-1012	496	22	1999	1999	NUM
ajlsi-1012	496	23	)	)	PUNCT
ajlsi-1012	496	24	.	.	PUNCT
ajlsi-1012	497	1	u.s	u.s	PROPN
ajlsi-1012	497	2	.	.	PROPN
ajlsi-1012	497	3	patent	patent	NOUN
ajlsi-1012	497	4	no	no	PROPN
ajlsi-1012	497	5	.	.	PROPN
ajlsi-1012	498	1	5,888	5,888	NUM
ajlsi-1012	498	2	,	,	PUNCT
ajlsi-1012	498	3	779	779	NUM
ajlsi-1012	498	4	.	.	PUNCT
ajlsi-1012	499	1	washington	washington	PROPN
ajlsi-1012	499	2	,	,	PUNCT
ajlsi-1012	499	3	dc	dc	PROPN
ajlsi-1012	499	4	:	:	PUNCT
ajlsi-1012	499	5	u.s	u.s	PROPN
ajlsi-1012	499	6	.	.	PROPN
ajlsi-1012	499	7	patent	patent	NOUN
ajlsi-1012	499	8	and	and	CCONJ
ajlsi-1012	499	9	trademark	trademark	NOUN
ajlsi-1012	499	10	office	office	NOUN
ajlsi-1012	499	11	.	.	PUNCT
ajlsi-1012	500	1	kannan	kannan	PROPN
ajlsi-1012	500	2	,	,	PUNCT
ajlsi-1012	500	3	s.	s.	PROPN
ajlsi-1012	500	4	p.	p.	PROPN
ajlsi-1012	500	5	a.	a.	PROPN
ajlsi-1012	500	6	s.	s.	PROPN
ajlsi-1012	500	7	,	,	PUNCT
ajlsi-1012	500	8	ali	ali	PROPN
ajlsi-1012	500	9	,	,	PUNCT
ajlsi-1012	500	10	p.	p.	PROPN
ajlsi-1012	500	11	s.	s.	PROPN
ajlsi-1012	500	12	s.	s.	PROPN
ajlsi-1012	500	13	,	,	PUNCT
ajlsi-1012	500	14	sheeza	sheeza	PROPN
ajlsi-1012	500	15	,	,	PUNCT
ajlsi-1012	500	16	a.	a.	PROPN
ajlsi-1012	500	17	,	,	PUNCT
ajlsi-1012	500	18	et	et	PROPN
ajlsi-1012	500	19	al	al	PROPN
ajlsi-1012	500	20	.	.	PROPN
ajlsi-1012	500	21	,	,	PUNCT
ajlsi-1012	500	22	(	(	PUNCT
ajlsi-1012	500	23	2020	2020	NUM
ajlsi-1012	500	24	)	)	PUNCT
ajlsi-1012	500	25	.	.	PUNCT
ajlsi-1012	501	1	covid-19	covid-19	PROPN
ajlsi-1012	501	2	(	(	PUNCT
ajlsi-1012	501	3	novel	novel	ADJ
ajlsi-1012	501	4	coronavirus	coronavirus	NOUN
ajlsi-1012	501	5	2019)-recent	2019)-recent	NUM
ajlsi-1012	501	6	trends	trend	NOUN
ajlsi-1012	501	7	.	.	PUNCT
ajlsi-1012	502	1	eur	eur	PROPN
ajlsi-1012	502	2	rev	rev	PROPN
ajlsi-1012	502	3	med	med	PROPN
ajlsi-1012	502	4	pharmacol	pharmacol	PROPN
ajlsi-1012	502	5	sci	sci	PROPN
ajlsi-1012	502	6	,	,	PUNCT
ajlsi-1012	502	7	24(4	24(4	NUM
ajlsi-1012	502	8	)	)	PUNCT
ajlsi-1012	502	9	,	,	PUNCT
ajlsi-1012	502	10	2006	2006	NUM
ajlsi-1012	502	11	-	-	SYM
ajlsi-1012	502	12	2011	2011	NUM
ajlsi-1012	502	13	.	.	PUNCT
ajlsi-1012	503	1	kumar	kumar	PROPN
ajlsi-1012	503	2	,	,	PUNCT
ajlsi-1012	503	3	r.	r.	PROPN
ajlsi-1012	503	4	,	,	PUNCT
ajlsi-1012	503	5	nagpal	nagpal	NOUN
ajlsi-1012	503	6	,	,	PUNCT
ajlsi-1012	503	7	s.	s.	PROPN
ajlsi-1012	503	8	,	,	PUNCT
ajlsi-1012	503	9	kaushik	kaushik	PROPN
ajlsi-1012	503	10	,	,	PUNCT
ajlsi-1012	503	11	s.	s.	PROPN
ajlsi-1012	503	12	,	,	PUNCT
ajlsi-1012	503	13	et	et	PROPN
ajlsi-1012	503	14	al	al	PROPN
ajlsi-1012	503	15	.	.	PROPN
ajlsi-1012	503	16	,	,	PUNCT
ajlsi-1012	503	17	(	(	PUNCT
ajlsi-1012	503	18	2020	2020	NUM
ajlsi-1012	503	19	)	)	PUNCT
ajlsi-1012	503	20	.	.	PUNCT
ajlsi-1012	504	1	covid-19	covid-19	PROPN
ajlsi-1012	504	2	diagnostic	diagnostic	ADJ
ajlsi-1012	504	3	approaches	approach	NOUN
ajlsi-1012	504	4	:	:	PUNCT
ajlsi-1012	504	5	different	different	ADJ
ajlsi-1012	504	6	roads	road	NOUN
ajlsi-1012	504	7	to	to	ADP
ajlsi-1012	504	8	the	the	DET
ajlsi-1012	504	9	same	same	ADJ
ajlsi-1012	504	10	destination	destination	NOUN
ajlsi-1012	504	11	.	.	PUNCT
ajlsi-1012	505	1	virus	virus	NOUN
ajlsi-1012	505	2	disease	disease	NOUN
ajlsi-1012	505	3	,	,	PUNCT
ajlsi-1012	505	4	31(2	31(2	NUM
ajlsi-1012	505	5	)	)	PUNCT
ajlsi-1012	505	6	,	,	PUNCT
ajlsi-1012	505	7	97	97	NUM
ajlsi-1012	505	8	-	-	SYM
ajlsi-1012	505	9	105	105	NUM
ajlsi-1012	505	10	.	.	PUNCT
ajlsi-1012	506	1	kwon	kwon	PROPN
ajlsi-1012	506	2	,	,	PUNCT
ajlsi-1012	506	3	k.	k.	PROPN
ajlsi-1012	506	4	t.	t.	PROPN
ajlsi-1012	506	5	,	,	PUNCT
ajlsi-1012	506	6	ko	ko	PROPN
ajlsi-1012	506	7	,	,	PUNCT
ajlsi-1012	506	8	j.	j.	PROPN
ajlsi-1012	506	9	h.	h.	PROPN
ajlsi-1012	506	10	,	,	PUNCT
ajlsi-1012	506	11	shin	shin	PROPN
ajlsi-1012	506	12	,	,	PUNCT
ajlsi-1012	506	13	h.	h.	PROPN
ajlsi-1012	506	14	,	,	PUNCT
ajlsi-1012	506	15	et	et	PROPN
ajlsi-1012	506	16	al	al	PROPN
ajlsi-1012	506	17	.	.	PROPN
ajlsi-1012	506	18	,	,	PUNCT
ajlsi-1012	506	19	(	(	PUNCT
ajlsi-1012	506	20	2020	2020	NUM
ajlsi-1012	506	21	)	)	PUNCT
ajlsi-1012	506	22	.	.	PUNCT
ajlsi-1012	507	1	drivethrough	drivethrough	PROPN
ajlsi-1012	507	2	screening	screening	NOUN
ajlsi-1012	507	3	center	center	NOUN
ajlsi-1012	507	4	for	for	ADP
ajlsi-1012	507	5	covid-19	covid-19	PROPN
ajlsi-1012	507	6	:	:	PUNCT
ajlsi-1012	507	7	a	a	DET
ajlsi-1012	507	8	safe	safe	ADJ
ajlsi-1012	507	9	and	and	CCONJ
ajlsi-1012	507	10	efficient	efficient	ADJ
ajlsi-1012	507	11	screening	screening	NOUN
ajlsi-1012	507	12	system	system	NOUN
ajlsi-1012	507	13	against	against	ADP
ajlsi-1012	507	14	massive	massive	ADJ
ajlsi-1012	507	15	community	community	NOUN
ajlsi-1012	507	16	outbreak	outbreak	NOUN
ajlsi-1012	507	17	.	.	PUNCT
ajlsi-1012	508	1	journal	journal	PROPN
ajlsi-1012	508	2	of	of	ADP
ajlsi-1012	508	3	korean	korean	PROPN
ajlsi-1012	508	4	medical	medical	ADJ
ajlsi-1012	508	5	science	science	NOUN
ajlsi-1012	508	6	,	,	PUNCT
ajlsi-1012	508	7	35(11	35(11	NUM
ajlsi-1012	508	8	)	)	PUNCT
ajlsi-1012	508	9	.	.	PUNCT
ajlsi-1012	509	1	lamb	lamb	PROPN
ajlsi-1012	509	2	,	,	PUNCT
ajlsi-1012	509	3	l.	l.	PROPN
ajlsi-1012	509	4	e.	e.	PROPN
ajlsi-1012	509	5	,	,	PUNCT
ajlsi-1012	509	6	bartolone	bartolone	PROPN
ajlsi-1012	509	7	,	,	PUNCT
ajlsi-1012	509	8	s.	s.	PROPN
ajlsi-1012	509	9	n.	n.	PROPN
ajlsi-1012	509	10	,	,	PUNCT
ajlsi-1012	509	11	ward	ward	PROPN
ajlsi-1012	509	12	,	,	PUNCT
ajlsi-1012	509	13	e.	e.	PROPN
ajlsi-1012	509	14	,	,	PUNCT
ajlsi-1012	509	15	et	et	PROPN
ajlsi-1012	509	16	al	al	PROPN
ajlsi-1012	509	17	.	.	PROPN
ajlsi-1012	509	18	,	,	PUNCT
ajlsi-1012	509	19	(	(	PUNCT
ajlsi-1012	509	20	2020	2020	NUM
ajlsi-1012	509	21	)	)	PUNCT
ajlsi-1012	509	22	.	.	PUNCT
ajlsi-1012	510	1	rapid	rapid	ADJ
ajlsi-1012	510	2	detection	detection	NOUN
ajlsi-1012	510	3	of	of	ADP
ajlsi-1012	510	4	novel	novel	ADJ
ajlsi-1012	510	5	coronavirus	coronavirus	NOUN
ajlsi-1012	510	6	/	/	SYM
ajlsi-1012	510	7	severe	severe	ADJ
ajlsi-1012	510	8	acute	acute	ADJ
ajlsi-1012	510	9	respiratory	respiratory	ADJ
ajlsi-1012	510	10	syndrome	syndrome	NOUN
ajlsi-1012	510	11	coronavirus	coronavirus	NOUN
ajlsi-1012	510	12	2	2	NUM
ajlsi-1012	510	13	(	(	PUNCT
ajlsi-1012	510	14	sars	sar	NOUN
ajlsi-1012	510	15	-	-	PUNCT
ajlsi-1012	510	16	cov-2	cov-2	NOUN
ajlsi-1012	510	17	)	)	PUNCT
ajlsi-1012	510	18	by	by	ADP
ajlsi-1012	510	19	reverse	reverse	ADJ
ajlsi-1012	510	20	transcription	transcription	NOUN
ajlsi-1012	510	21	-	-	PUNCT
ajlsi-1012	510	22	loop	loop	NOUN
ajlsi-1012	510	23	-	-	PUNCT
ajlsi-1012	510	24	mediated	mediate	VERB
ajlsi-1012	510	25	isothermal	isothermal	ADJ
ajlsi-1012	510	26	amplification	amplification	NOUN
ajlsi-1012	510	27	.	.	PUNCT
ajlsi-1012	511	1	plos	plos	PROPN
ajlsi-1012	511	2	one	one	NUM
ajlsi-1012	511	3	,	,	PUNCT
ajlsi-1012	511	4	15(6	15(6	NUM
ajlsi-1012	511	5	)	)	PUNCT
ajlsi-1012	511	6	,	,	PUNCT
ajlsi-1012	511	7	e0234682.6	e0234682.6	PROPN
ajlsi-1012	511	8	.	.	PUNCT
ajlsi-1012	511	9	lan	lan	PROPN
ajlsi-1012	511	10	,	,	PUNCT
ajlsi-1012	511	11	l.	l.	PROPN
ajlsi-1012	511	12	,	,	PUNCT
ajlsi-1012	511	13	xu	xu	PROPN
ajlsi-1012	511	14	,	,	PUNCT
ajlsi-1012	511	15	d.	d.	PROPN
ajlsi-1012	511	16	,	,	PUNCT
ajlsi-1012	511	17	ye	ye	PROPN
ajlsi-1012	511	18	,	,	PUNCT
ajlsi-1012	511	19	g.	g.	PROPN
ajlsi-1012	511	20	,	,	PUNCT
ajlsi-1012	511	21	xia	xia	PROPN
ajlsi-1012	511	22	,	,	PUNCT
ajlsi-1012	511	23	c.	c.	PROPN
ajlsi-1012	511	24	,	,	PUNCT
ajlsi-1012	511	25	wang	wang	PROPN
ajlsi-1012	511	26	,	,	PUNCT
ajlsi-1012	511	27	s.	s.	PROPN
ajlsi-1012	511	28	,	,	PUNCT
ajlsi-1012	511	29	et	et	PROPN
ajlsi-1012	511	30	al	al	PROPN
ajlsi-1012	511	31	.	.	PROPN
ajlsi-1012	511	32	,	,	PUNCT
ajlsi-1012	511	33	(	(	PUNCT
ajlsi-1012	511	34	2020	2020	NUM
ajlsi-1012	511	35	)	)	PUNCT
ajlsi-1012	511	36	.	.	PUNCT
ajlsi-1012	512	1	positive	positive	ADJ
ajlsi-1012	512	2	rt	rt	ADJ
ajlsi-1012	512	3	-	-	PUNCT
ajlsi-1012	512	4	pcr	pcr	ADJ
ajlsi-1012	512	5	test	test	NOUN
ajlsi-1012	512	6	results	result	NOUN
ajlsi-1012	512	7	in	in	ADP
ajlsi-1012	512	8	patients	patient	NOUN
ajlsi-1012	512	9	recovered	recover	VERB
ajlsi-1012	512	10	from	from	ADP
ajlsi-1012	512	11	covid-19	covid-19	PROPN
ajlsi-1012	512	12	.	.	PROPN
ajlsi-1012	512	13	journal	journal	PROPN
ajlsi-1012	512	14	of	of	ADP
ajlsi-1012	512	15	american	american	PROPN
ajlsi-1012	512	16	medical	medical	PROPN
ajlsi-1012	512	17	association	association	PROPN
ajlsi-1012	512	18	,	,	PUNCT
ajlsi-1012	512	19	323(15	323(15	NUM
ajlsi-1012	512	20	)	)	PUNCT
ajlsi-1012	512	21	,	,	PUNCT
ajlsi-1012	512	22	1502	1502	NUM
ajlsi-1012	512	23	-	-	SYM
ajlsi-1012	512	24	1503	1503	NUM
ajlsi-1012	512	25	.	.	PUNCT
ajlsi-1012	513	1	landreneau	landreneau	PROPN
ajlsi-1012	513	2	,	,	PUNCT
ajlsi-1012	513	3	k.	k.	PROPN
ajlsi-1012	513	4	j.	j.	PROPN
ajlsi-1012	513	5	,	,	PUNCT
ajlsi-1012	513	6	&	&	CCONJ
ajlsi-1012	513	7	creek	creek	PROPN
ajlsi-1012	513	8	,	,	PUNCT
ajlsi-1012	513	9	w.	w.	PROPN
ajlsi-1012	513	10	(	(	PUNCT
ajlsi-1012	513	11	2009	2009	NUM
ajlsi-1012	513	12	)	)	PUNCT
ajlsi-1012	513	13	.	.	PUNCT
ajlsi-1012	514	1	sampling	sample	VERB
ajlsi-1012	514	2	strategies	strategy	NOUN
ajlsi-1012	514	3	.	.	PUNCT
ajlsi-1012	515	1	retrieved	retrieve	VERB
ajlsi-1012	515	2	on	on	ADP
ajlsi-1012	515	3	:	:	PUNCT
ajlsi-1012	515	4	http://www	http://www	PROPN
ajlsi-1012	515	5	.	.	PROPN
ajlsi-1012	515	6	natco1	natco1	PROPN
ajlsi-1012	515	7	.	.	PUNCT
ajlsi-1012	516	1	org	org	PROPN
ajlsi-1012	516	2	.	.	PUNCT
ajlsi-1012	517	1	lee	lee	PROPN
ajlsi-1012	517	2	,	,	PUNCT
ajlsi-1012	517	3	j.	j.	PROPN
ajlsi-1012	517	4	(	(	PUNCT
ajlsi-1012	517	5	2020	2020	NUM
ajlsi-1012	517	6	)	)	PUNCT
ajlsi-1012	517	7	.	.	PUNCT
ajlsi-1012	518	1	covid-19	covid-19	PROPN
ajlsi-1012	518	2	screening	screen	VERB
ajlsi-1012	518	3	center	center	NOUN
ajlsi-1012	518	4	:	:	PUNCT
ajlsi-1012	518	5	how	how	SCONJ
ajlsi-1012	518	6	to	to	PART
ajlsi-1012	518	7	balance	balance	VERB
ajlsi-1012	518	8	between	between	ADP
ajlsi-1012	518	9	the	the	DET
ajlsi-1012	518	10	speed	speed	NOUN
ajlsi-1012	518	11	and	and	CCONJ
ajlsi-1012	518	12	safety	safety	NOUN
ajlsi-1012	518	13	?	?	PUNCT
ajlsi-1012	519	1	journal	journal	NOUN
ajlsi-1012	519	2	of	of	ADP
ajlsi-1012	519	3	korean	korean	PROPN
ajlsi-1012	519	4	medical	medical	ADJ
ajlsi-1012	519	5	science	science	NOUN
ajlsi-1012	519	6	,	,	PUNCT
ajlsi-1012	519	7	35(15	35(15	NUM
ajlsi-1012	519	8	)	)	PUNCT
ajlsi-1012	519	9	.	.	PUNCT
ajlsi-1012	520	1	li	li	PROPN
ajlsi-1012	520	2	,	,	PUNCT
ajlsi-1012	520	3	q.	q.	PROPN
ajlsi-1012	520	4	,	,	PUNCT
ajlsi-1012	520	5	guan	guan	PROPN
ajlsi-1012	520	6	,	,	PUNCT
ajlsi-1012	520	7	x.	x.	PROPN
ajlsi-1012	520	8	,	,	PUNCT
ajlsi-1012	520	9	wu	wu	PROPN
ajlsi-1012	520	10	,	,	PUNCT
ajlsi-1012	520	11	p.	p.	PROPN
ajlsi-1012	520	12	,	,	PUNCT
ajlsi-1012	520	13	wang	wang	PROPN
ajlsi-1012	520	14	,	,	PUNCT
ajlsi-1012	520	15	x.	x.	PROPN
ajlsi-1012	520	16	,	,	PUNCT
ajlsi-1012	520	17	zhou	zhou	PROPN
ajlsi-1012	520	18	,	,	PUNCT
ajlsi-1012	520	19	l.	l.	PROPN
ajlsi-1012	520	20	,	,	PUNCT
ajlsi-1012	520	21	et	et	PROPN
ajlsi-1012	520	22	al	al	PROPN
ajlsi-1012	520	23	.	.	PROPN
ajlsi-1012	520	24	,	,	PUNCT
ajlsi-1012	520	25	(	(	PUNCT
ajlsi-1012	520	26	2020	2020	NUM
ajlsi-1012	520	27	)	)	PUNCT
ajlsi-1012	520	28	.	.	PUNCT
ajlsi-1012	521	1	early	early	ADJ
ajlsi-1012	521	2	transmission	transmission	NOUN
ajlsi-1012	521	3	dynamics	dynamic	NOUN
ajlsi-1012	521	4	in	in	ADP
ajlsi-1012	521	5	wuhan	wuhan	PROPN
ajlsi-1012	521	6	,	,	PUNCT
ajlsi-1012	521	7	china	china	PROPN
ajlsi-1012	521	8	,	,	PUNCT
ajlsi-1012	521	9	of	of	ADP
ajlsi-1012	521	10	novel	novel	ADJ
ajlsi-1012	521	11	coronavirus	coronavirus	NOUN
ajlsi-1012	521	12	–	–	PUNCT
ajlsi-1012	521	13	infected	infected	ADJ
ajlsi-1012	521	14	pneumonia	pneumonia	NOUN
ajlsi-1012	521	15	.	.	PUNCT
ajlsi-1012	522	1	new	new	PROPN
ajlsi-1012	522	2	england	england	PROPN
ajlsi-1012	522	3	journal	journal	PROPN
ajlsi-1012	522	4	of	of	ADP
ajlsi-1012	522	5	medicine	medicine	NOUN
ajlsi-1012	522	6	.	.	PUNCT
ajlsi-1012	523	1	li	li	PROPN
ajlsi-1012	523	2	,	,	PUNCT
ajlsi-1012	523	3	z.	z.	PROPN
ajlsi-1012	523	4	,	,	PUNCT
ajlsi-1012	523	5	yi	yi	PROPN
ajlsi-1012	523	6	,	,	PUNCT
ajlsi-1012	523	7	y.	y.	PROPN
ajlsi-1012	523	8	,	,	PUNCT
ajlsi-1012	523	9	luo	luo	PROPN
ajlsi-1012	523	10	,	,	PUNCT
ajlsi-1012	523	11	x.	x.	PROPN
ajlsi-1012	523	12	,	,	PUNCT
ajlsi-1012	523	13	xiong	xiong	PROPN
ajlsi-1012	523	14	,	,	PUNCT
ajlsi-1012	523	15	n.	n.	PROPN
ajlsi-1012	523	16	,	,	PUNCT
ajlsi-1012	523	17	et	et	PROPN
ajlsi-1012	523	18	al	al	PROPN
ajlsi-1012	523	19	.	.	PROPN
ajlsi-1012	523	20	,	,	PUNCT
ajlsi-1012	523	21	(	(	PUNCT
ajlsi-1012	523	22	2020	2020	NUM
ajlsi-1012	523	23	)	)	PUNCT
ajlsi-1012	523	24	.	.	PUNCT
ajlsi-1012	524	1	development	development	NOUN
ajlsi-1012	524	2	and	and	CCONJ
ajlsi-1012	524	3	clinical	clinical	ADJ
ajlsi-1012	524	4	application	application	NOUN
ajlsi-1012	524	5	of	of	ADP
ajlsi-1012	524	6	a	a	DET
ajlsi-1012	524	7	rapid	rapid	ADJ
ajlsi-1012	524	8	igm‐igg	igm‐igg	NOUN
ajlsi-1012	524	9	combined	combined	ADJ
ajlsi-1012	524	10	antibody	antibody	NOUN
ajlsi-1012	524	11	test	test	NOUN
ajlsi-1012	524	12	for	for	ADP
ajlsi-1012	524	13	sars‐cov‐2	sars‐cov‐2	PROPN
ajlsi-1012	524	14	infection	infection	NOUN
ajlsi-1012	524	15	diagnosis	diagnosis	NOUN
ajlsi-1012	524	16	.	.	PUNCT
ajlsi-1012	525	1	journal	journal	PROPN
ajlsi-1012	525	2	of	of	ADP
ajlsi-1012	525	3	medical	medical	ADJ
ajlsi-1012	525	4	virology	virology	NOUN
ajlsi-1012	525	5	,	,	PUNCT
ajlsi-1012	525	6	92(9	92(9	NUM
ajlsi-1012	525	7	)	)	PUNCT
ajlsi-1012	525	8	,	,	PUNCT
ajlsi-1012	525	9	1518	1518	NUM
ajlsi-1012	525	10	-	-	SYM
ajlsi-1012	525	11	1524	1524	NUM
ajlsi-1012	525	12	.	.	PUNCT
ajlsi-1012	526	1	liu	liu	PROPN
ajlsi-1012	526	2	,	,	PUNCT
ajlsi-1012	526	3	l.	l.	PROPN
ajlsi-1012	526	4	,	,	PUNCT
ajlsi-1012	526	5	liu	liu	PROPN
ajlsi-1012	526	6	,	,	PUNCT
ajlsi-1012	526	7	w.	w.	PROPN
ajlsi-1012	526	8	,	,	PUNCT
ajlsi-1012	526	9	zheng	zheng	PROPN
ajlsi-1012	526	10	,	,	PUNCT
ajlsi-1012	526	11	y.	y.	PROPN
ajlsi-1012	526	12	,	,	PUNCT
ajlsi-1012	526	13	jiang	jiang	PROPN
ajlsi-1012	526	14	,	,	PUNCT
ajlsi-1012	526	15	x.	x.	PROPN
ajlsi-1012	526	16	,	,	PUNCT
ajlsi-1012	526	17	kou	kou	PROPN
ajlsi-1012	526	18	,	,	PUNCT
ajlsi-1012	526	19	g.	g.	PROPN
ajlsi-1012	526	20	,	,	PUNCT
ajlsi-1012	526	21	et	et	PROPN
ajlsi-1012	526	22	al	al	PROPN
ajlsi-1012	526	23	.	.	PROPN
ajlsi-1012	526	24	,	,	PUNCT
ajlsi-1012	526	25	(	(	PUNCT
ajlsi-1012	526	26	2020	2020	NUM
ajlsi-1012	526	27	)	)	PUNCT
ajlsi-1012	526	28	.	.	PUNCT
ajlsi-1012	527	1	a	a	DET
ajlsi-1012	527	2	preliminary	preliminary	ADJ
ajlsi-1012	527	3	study	study	NOUN
ajlsi-1012	527	4	on	on	ADP
ajlsi-1012	527	5	serological	serological	ADJ
ajlsi-1012	527	6	assay	assay	NOUN
ajlsi-1012	527	7	for	for	ADP
ajlsi-1012	527	8	severe	severe	ADJ
ajlsi-1012	527	9	acute	acute	ADJ
ajlsi-1012	527	10	respiratory	respiratory	ADJ
ajlsi-1012	527	11	syndrome	syndrome	NOUN
ajlsi-1012	527	12	coronavirus	coronavirus	NOUN
ajlsi-1012	527	13	2	2	NUM
ajlsi-1012	527	14	(	(	PUNCT
ajlsi-1012	527	15	sarscov-2	sarscov-2	NUM
ajlsi-1012	527	16	)	)	PUNCT
ajlsi-1012	527	17	in	in	ADP
ajlsi-1012	527	18	238	238	NUM
ajlsi-1012	527	19	admitted	admit	VERB
ajlsi-1012	527	20	hospital	hospital	NOUN
ajlsi-1012	527	21	patients	patient	NOUN
ajlsi-1012	527	22	.	.	PUNCT
ajlsi-1012	528	1	microbes	microbe	NOUN
ajlsi-1012	528	2	and	and	CCONJ
ajlsi-1012	528	3	infection	infection	NOUN
ajlsi-1012	528	4	,	,	PUNCT
ajlsi-1012	528	5	22(4	22(4	NUM
ajlsi-1012	528	6	-	-	SYM
ajlsi-1012	528	7	5	5	NUM
ajlsi-1012	528	8	)	)	PUNCT
ajlsi-1012	528	9	,	,	PUNCT
ajlsi-1012	528	10	206	206	NUM
ajlsi-1012	528	11	-	-	SYM
ajlsi-1012	528	12	211	211	NUM
ajlsi-1012	528	13	.	.	PUNCT
ajlsi-1012	529	1	loeffelholz	loeffelholz	PROPN
ajlsi-1012	529	2	,	,	PUNCT
ajlsi-1012	529	3	m.	m.	NOUN
ajlsi-1012	529	4	j.	j.	PROPN
ajlsi-1012	529	5	,	,	PUNCT
ajlsi-1012	529	6	&	&	CCONJ
ajlsi-1012	529	7	tang	tang	PROPN
ajlsi-1012	529	8	,	,	PUNCT
ajlsi-1012	529	9	y.	y.	PROPN
ajlsi-1012	529	10	w.	w.	PROPN
ajlsi-1012	529	11	(	(	PUNCT
ajlsi-1012	529	12	2020	2020	NUM
ajlsi-1012	529	13	)	)	PUNCT
ajlsi-1012	529	14	.	.	PUNCT
ajlsi-1012	530	1	laboratory	laboratory	NOUN
ajlsi-1012	530	2	diagnosis	diagnosis	NOUN
ajlsi-1012	530	3	of	of	ADP
ajlsi-1012	530	4	emerging	emerge	VERB
ajlsi-1012	530	5	human	human	ADJ
ajlsi-1012	530	6	coronavirus	coronavirus	NOUN
ajlsi-1012	530	7	infections	infection	NOUN
ajlsi-1012	530	8	–	–	PUNCT
ajlsi-1012	530	9	the	the	DET
ajlsi-1012	530	10	state	state	NOUN
ajlsi-1012	530	11	of	of	ADP
ajlsi-1012	530	12	the	the	DET
ajlsi-1012	530	13	art	art	NOUN
ajlsi-1012	530	14	.	.	PUNCT
ajlsi-1012	531	1	emerging	emerge	VERB
ajlsi-1012	531	2	microbes	microbe	NOUN
ajlsi-1012	531	3	&	&	CCONJ
ajlsi-1012	531	4	infections	infection	NOUN
ajlsi-1012	531	5	,	,	PUNCT
ajlsi-1012	531	6	9(1	9(1	NUM
ajlsi-1012	531	7	)	)	PUNCT
ajlsi-1012	531	8	,	,	PUNCT
ajlsi-1012	531	9	747	747	NUM
ajlsi-1012	531	10	-	-	SYM
ajlsi-1012	531	11	756	756	NUM
ajlsi-1012	531	12	.	.	PUNCT
ajlsi-1012	532	1	long	long	ADV
ajlsi-1012	532	2	,	,	PUNCT
ajlsi-1012	532	3	c.	c.	PROPN
ajlsi-1012	532	4	,	,	PUNCT
ajlsi-1012	532	5	xu	xu	PROPN
ajlsi-1012	532	6	,	,	PUNCT
ajlsi-1012	532	7	h.	h.	PROPN
ajlsi-1012	532	8	,	,	PUNCT
ajlsi-1012	532	9	shen	shen	PROPN
ajlsi-1012	532	10	,	,	PUNCT
ajlsi-1012	532	11	q.	q.	PROPN
ajlsi-1012	532	12	,	,	PUNCT
ajlsi-1012	532	13	zhang	zhang	PROPN
ajlsi-1012	532	14	,	,	PUNCT
ajlsi-1012	532	15	x.	x.	PROPN
ajlsi-1012	532	16	,	,	PUNCT
ajlsi-1012	532	17	fan	fan	PROPN
ajlsi-1012	532	18	,	,	PUNCT
ajlsi-1012	532	19	b.	b.	PROPN
ajlsi-1012	532	20	,	,	PUNCT
ajlsi-1012	532	21	et	et	PROPN
ajlsi-1012	532	22	al	al	PROPN
ajlsi-1012	532	23	.	.	PROPN
ajlsi-1012	532	24	,	,	PUNCT
ajlsi-1012	532	25	(	(	PUNCT
ajlsi-1012	532	26	2020	2020	NUM
ajlsi-1012	532	27	)	)	PUNCT
ajlsi-1012	532	28	.	.	PUNCT
ajlsi-1012	533	1	diagnosis	diagnosis	NOUN
ajlsi-1012	533	2	of	of	ADP
ajlsi-1012	533	3	the	the	DET
ajlsi-1012	533	4	coronavirus	coronavirus	NOUN
ajlsi-1012	533	5	disease	disease	NOUN
ajlsi-1012	533	6	(	(	PUNCT
ajlsi-1012	533	7	covid-19	covid-19	PROPN
ajlsi-1012	533	8	):	):	PUNCT
ajlsi-1012	533	9	rrt	rrt	NOUN
ajlsi-1012	533	10	-	-	ADJ
ajlsi-1012	533	11	pcr	pcr	ADJ
ajlsi-1012	533	12	or	or	CCONJ
ajlsi-1012	533	13	ct	ct	PROPN
ajlsi-1012	533	14	?	?	PUNCT
ajlsi-1012	534	1	european	european	ADJ
ajlsi-1012	534	2	journal	journal	PROPN
ajlsi-1012	534	3	of	of	ADP
ajlsi-1012	534	4	radiology	radiology	NOUN
ajlsi-1012	534	5	,	,	PUNCT
ajlsi-1012	534	6	126	126	NUM
ajlsi-1012	534	7	,	,	PUNCT
ajlsi-1012	534	8	108961	108961	NUM
ajlsi-1012	534	9	.	.	PUNCT
ajlsi-1012	535	1	malik	malik	PROPN
ajlsi-1012	535	2	,	,	PUNCT
ajlsi-1012	535	3	y.	y.	PROPN
ajlsi-1012	535	4	s.	s.	PROPN
ajlsi-1012	535	5	,	,	PUNCT
ajlsi-1012	535	6	sircar	sircar	PROPN
ajlsi-1012	535	7	,	,	PUNCT
ajlsi-1012	535	8	s.	s.	PROPN
ajlsi-1012	535	9	,	,	PUNCT
ajlsi-1012	535	10	bhat	bhat	PROPN
ajlsi-1012	535	11	,	,	PUNCT
ajlsi-1012	535	12	s.	s.	PROPN
ajlsi-1012	535	13	,	,	PUNCT
ajlsi-1012	535	14	et	et	PROPN
ajlsi-1012	535	15	al	al	PROPN
ajlsi-1012	535	16	.	.	PROPN
ajlsi-1012	535	17	,	,	PUNCT
ajlsi-1012	535	18	(	(	PUNCT
ajlsi-1012	535	19	2020	2020	NUM
ajlsi-1012	535	20	)	)	PUNCT
ajlsi-1012	535	21	.	.	PUNCT
ajlsi-1012	536	1	emerging	emerge	VERB
ajlsi-1012	536	2	novel	novel	ADJ
ajlsi-1012	536	3	coronavirus	coronavirus	NOUN
ajlsi-1012	536	4	(	(	PUNCT
ajlsi-1012	536	5	2019	2019	NUM
ajlsi-1012	536	6	-	-	PUNCT
ajlsi-1012	536	7	ncov)—current	ncov)—current	NOUN
ajlsi-1012	536	8	scenario	scenario	NOUN
ajlsi-1012	536	9	,	,	PUNCT
ajlsi-1012	536	10	evolutionary	evolutionary	ADJ
ajlsi-1012	536	11	perspective	perspective	NOUN
ajlsi-1012	536	12	based	base	VERB
ajlsi-1012	536	13	on	on	ADP
ajlsi-1012	536	14	genome	genome	NOUN
ajlsi-1012	536	15	analysis	analysis	NOUN
ajlsi-1012	536	16	and	and	CCONJ
ajlsi-1012	536	17	recent	recent	ADJ
ajlsi-1012	536	18	developments	development	NOUN
ajlsi-1012	536	19	.	.	PUNCT
ajlsi-1012	537	1	veterinary	veterinary	ADJ
ajlsi-1012	537	2	quarterly	quarterly	ADV
ajlsi-1012	537	3	,	,	PUNCT
ajlsi-1012	537	4	40(1	40(1	PROPN
ajlsi-1012	537	5	)	)	PUNCT
ajlsi-1012	537	6	,	,	PUNCT
ajlsi-1012	537	7	68	68	NUM
ajlsi-1012	537	8	-	-	SYM
ajlsi-1012	537	9	76	76	NUM
ajlsi-1012	537	10	.	.	PUNCT
ajlsi-1012	538	1	mathuria	mathuria	PROPN
ajlsi-1012	538	2	,	,	PUNCT
ajlsi-1012	538	3	j	j	PROPN
ajlsi-1012	538	4	,	,	PUNCT
ajlsi-1012	538	5	p.	p.	PROPN
ajlsi-1012	538	6	,	,	PUNCT
ajlsi-1012	538	7	yadav	yadav	PROPN
ajlsi-1012	538	8	,	,	PUNCT
ajlsi-1012	538	9	r.	r.	PROPN
ajlsi-1012	538	10	,	,	PUNCT
ajlsi-1012	538	11	and	and	CCONJ
ajlsi-1012	538	12	rajakumar	rajakumar	ADJ
ajlsi-1012	538	13	.(2020	.(2020	NUM
ajlsi-1012	538	14	)	)	PUNCT
ajlsi-1012	538	15	.	.	PUNCT
ajlsi-1012	539	1	laboratory	laboratory	NOUN
ajlsi-1012	539	2	diagnosis	diagnosis	NOUN
ajlsi-1012	539	3	of	of	ADP
ajlsi-1012	539	4	sars	sar	NOUN
ajlsi-1012	539	5	-	-	PUNCT
ajlsi-1012	539	6	cov-2	cov-2	PART
ajlsi-1012	539	7	a	a	DET
ajlsi-1012	539	8	review	review	NOUN
ajlsi-1012	539	9	of	of	ADP
ajlsi-1012	539	10	current	current	ADJ
ajlsi-1012	539	11	methods	method	NOUN
ajlsi-1012	539	12	.	.	PUNCT
ajlsi-1012	540	1	journal	journal	NOUN
ajlsi-1012	540	2	of	of	ADP
ajlsi-1012	540	3	infection	infection	NOUN
ajlsi-1012	540	4	and	and	CCONJ
ajlsi-1012	540	5	public	public	ADJ
ajlsi-1012	540	6	health	health	NOUN
ajlsi-1012	540	7	,	,	PUNCT
ajlsi-1012	540	8	13(7	13(7	NUM
ajlsi-1012	540	9	)	)	PUNCT
ajlsi-1012	540	10	,	,	PUNCT
ajlsi-1012	540	11	901	901	NUM
ajlsi-1012	540	12	-	-	SYM
ajlsi-1012	540	13	905	905	NUM
ajlsi-1012	540	14	.	.	PUNCT
ajlsi-1012	541	1	miller	miller	PROPN
ajlsi-1012	541	2	,	,	PUNCT
ajlsi-1012	541	3	s	s	PROPN
ajlsi-1012	541	4	,	,	PUNCT
ajlsi-1012	541	5	e.	e.	PROPN
ajlsi-1012	541	6	,	,	PUNCT
ajlsi-1012	541	7	(	(	PUNCT
ajlsi-1012	541	8	2016	2016	NUM
ajlsi-1012	541	9	)	)	PUNCT
ajlsi-1012	541	10	.	.	PUNCT
ajlsi-1012	542	1	electron	electron	NOUN
ajlsi-1012	542	2	microscopy	microscopy	NOUN
ajlsi-1012	542	3	of	of	ADP
ajlsi-1012	542	4	viral	viral	ADJ
ajlsi-1012	542	5	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	542	6	pa	pa	PROPN
ajlsi-1012	542	7	ge	ge	PROPN
ajlsi-1012	542	8	41	41	NUM
ajlsi-1012	542	9	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	542	10	am	am	NOUN
ajlsi-1012	542	11	.	.	PUNCT
ajlsi-1012	543	1	j.	j.	PROPN
ajlsi-1012	543	2	life	life	PROPN
ajlsi-1012	543	3	sci	sci	PROPN
ajlsi-1012	543	4	.	.	PUNCT
ajlsi-1012	543	5	innov	innov	PROPN
ajlsi-1012	543	6	.	.	PUNCT
ajlsi-1012	544	1	1(2	1(2	NUM
ajlsi-1012	544	2	)	)	PUNCT
ajlsi-1012	544	3	29	29	NUM
ajlsi-1012	544	4	-	-	SYM
ajlsi-1012	544	5	42	42	NUM
ajlsi-1012	544	6	,	,	PUNCT
ajlsi-1012	544	7	2022	2022	NUM
ajlsi-1012	544	8	infections	infection	NOUN
ajlsi-1012	544	9	.	.	PUNCT
ajlsi-1012	545	1	lennette	lennette	PROPN
ajlsi-1012	545	2	’s	’s	PART
ajlsi-1012	545	3	laboratory	laboratory	NOUN
ajlsi-1012	545	4	diagnosis	diagnosis	NOUN
ajlsi-1012	545	5	of	of	ADP
ajlsi-1012	545	6	viral	viral	ADJ
ajlsi-1012	545	7	infections	infection	NOUN
ajlsi-1012	545	8	:	:	PUNCT
ajlsi-1012	545	9	keith	keith	PROPN
ajlsi-1012	545	10	r	r	PROPN
ajlsi-1012	545	11	jerome	jerome	PROPN
ajlsi-1012	545	12	(	(	PUNCT
ajlsi-1012	545	13	ed	ed	NOUN
ajlsi-1012	545	14	.	.	PUNCT
ajlsi-1012	545	15	)	)	PUNCT
ajlsi-1012	546	1	crc	crc	NOUN
ajlsi-1012	546	2	press	press	NOUN
ajlsi-1012	546	3	.	.	PUNCT
ajlsi-1012	547	1	mizumoto	mizumoto	PROPN
ajlsi-1012	547	2	,	,	PUNCT
ajlsi-1012	547	3	k.	k.	PROPN
ajlsi-1012	547	4	,	,	PUNCT
ajlsi-1012	547	5	kagaya	kagaya	PROPN
ajlsi-1012	547	6	,	,	PUNCT
ajlsi-1012	547	7	k.	k.	PROPN
ajlsi-1012	547	8	,	,	PUNCT
ajlsi-1012	547	9	zarebski	zarebski	PROPN
ajlsi-1012	547	10	,	,	PUNCT
ajlsi-1012	547	11	a.	a.	NOUN
ajlsi-1012	547	12	,	,	PUNCT
ajlsi-1012	547	13	et	et	PROPN
ajlsi-1012	547	14	al	al	PROPN
ajlsi-1012	547	15	.	.	PROPN
ajlsi-1012	547	16	,	,	PUNCT
ajlsi-1012	547	17	(	(	PUNCT
ajlsi-1012	547	18	2020	2020	NUM
ajlsi-1012	547	19	)	)	PUNCT
ajlsi-1012	547	20	.	.	PUNCT
ajlsi-1012	548	1	estimating	estimate	VERB
ajlsi-1012	548	2	the	the	DET
ajlsi-1012	548	3	asymptomatic	asymptomatic	ADJ
ajlsi-1012	548	4	proportion	proportion	NOUN
ajlsi-1012	548	5	of	of	ADP
ajlsi-1012	548	6	coronavirus	coronavirus	NOUN
ajlsi-1012	548	7	disease	disease	NOUN
ajlsi-1012	548	8	2019	2019	NUM
ajlsi-1012	548	9	(	(	PUNCT
ajlsi-1012	548	10	covid-19	covid-19	PROPN
ajlsi-1012	548	11	)	)	PUNCT
ajlsi-1012	548	12	cases	case	NOUN
ajlsi-1012	548	13	on	on	ADP
ajlsi-1012	548	14	board	board	NOUN
ajlsi-1012	548	15	the	the	DET
ajlsi-1012	548	16	diamond	diamond	PROPN
ajlsi-1012	548	17	princess	princess	PROPN
ajlsi-1012	548	18	cruise	cruise	NOUN
ajlsi-1012	548	19	ship	ship	NOUN
ajlsi-1012	548	20	,	,	PUNCT
ajlsi-1012	548	21	yokohama	yokohama	PROPN
ajlsi-1012	548	22	,	,	PUNCT
ajlsi-1012	548	23	japan	japan	PROPN
ajlsi-1012	548	24	,	,	PUNCT
ajlsi-1012	548	25	2020	2020	NUM
ajlsi-1012	548	26	.	.	PUNCT
ajlsi-1012	549	1	eurosurveillance	eurosurveillance	NOUN
ajlsi-1012	549	2	,	,	PUNCT
ajlsi-1012	549	3	25(10	25(10	NOUN
ajlsi-1012	549	4	)	)	PUNCT
ajlsi-1012	549	5	,	,	PUNCT
ajlsi-1012	549	6	2000180	2000180	NUM
ajlsi-1012	549	7	.	.	PUNCT
ajlsi-1012	550	1	monchatre	monchatre	NOUN
ajlsi-1012	550	2	-	-	PUNCT
ajlsi-1012	550	3	leroy	leroy	PROPN
ajlsi-1012	550	4	,	,	PUNCT
ajlsi-1012	550	5	e.	e.	PROPN
ajlsi-1012	550	6	,	,	PUNCT
ajlsi-1012	550	7	boué	boué	PROPN
ajlsi-1012	550	8	,	,	PUNCT
ajlsi-1012	550	9	f.	f.	PROPN
ajlsi-1012	550	10	,	,	PUNCT
ajlsi-1012	550	11	boucher	boucher	PROPN
ajlsi-1012	550	12	,	,	PUNCT
ajlsi-1012	550	13	j.	j.	PROPN
ajlsi-1012	550	14	m.	m.	PROPN
ajlsi-1012	550	15	,	,	PUNCT
ajlsi-1012	550	16	et	et	PROPN
ajlsi-1012	550	17	al	al	PROPN
ajlsi-1012	550	18	.	.	PROPN
ajlsi-1012	550	19	,	,	PUNCT
ajlsi-1012	550	20	(	(	PUNCT
ajlsi-1012	550	21	2017	2017	NUM
ajlsi-1012	550	22	)	)	PUNCT
ajlsi-1012	550	23	.	.	PUNCT
ajlsi-1012	551	1	identification	identification	NOUN
ajlsi-1012	551	2	of	of	ADP
ajlsi-1012	551	3	alpha	alpha	NOUN
ajlsi-1012	551	4	and	and	CCONJ
ajlsi-1012	551	5	beta	beta	ADJ
ajlsi-1012	551	6	coronavirus	coronavirus	NOUN
ajlsi-1012	551	7	in	in	ADP
ajlsi-1012	551	8	wildlife	wildlife	NOUN
ajlsi-1012	551	9	species	specie	NOUN
ajlsi-1012	551	10	in	in	ADP
ajlsi-1012	551	11	france	france	PROPN
ajlsi-1012	551	12	:	:	PUNCT
ajlsi-1012	551	13	bats	bat	NOUN
ajlsi-1012	551	14	,	,	PUNCT
ajlsi-1012	551	15	rodents	rodent	NOUN
ajlsi-1012	551	16	,	,	PUNCT
ajlsi-1012	551	17	rabbits	rabbit	NOUN
ajlsi-1012	551	18	,	,	PUNCT
ajlsi-1012	551	19	and	and	CCONJ
ajlsi-1012	551	20	hedgehogs	hedgehog	NOUN
ajlsi-1012	551	21	.	.	PUNCT
ajlsi-1012	552	1	viruses	virus	NOUN
ajlsi-1012	552	2	,	,	PUNCT
ajlsi-1012	552	3	9(12	9(12	NUM
ajlsi-1012	552	4	)	)	PUNCT
ajlsi-1012	552	5	,	,	PUNCT
ajlsi-1012	552	6	364	364	NUM
ajlsi-1012	552	7	.	.	PUNCT
ajlsi-1012	553	1	nguyen	nguyen	NOUN
ajlsi-1012	553	2	,	,	PUNCT
ajlsi-1012	553	3	t.	t.	PROPN
ajlsi-1012	553	4	,	,	PUNCT
ajlsi-1012	553	5	zoëga	zoëga	NOUN
ajlsi-1012	553	6	andreasen	andreasen	PROPN
ajlsi-1012	553	7	,	,	PUNCT
ajlsi-1012	553	8	s.	s.	PROPN
ajlsi-1012	553	9	,	,	PUNCT
ajlsi-1012	553	10	wolff	wolff	PROPN
ajlsi-1012	553	11	,	,	PUNCT
ajlsi-1012	553	12	a.	a.	NOUN
ajlsi-1012	553	13	,	,	PUNCT
ajlsi-1012	553	14	&	&	CCONJ
ajlsi-1012	553	15	duong	duong	PROPN
ajlsi-1012	553	16	bang	bang	PROPN
ajlsi-1012	553	17	,	,	PUNCT
ajlsi-1012	553	18	d.	d.	PROPN
ajlsi-1012	553	19	(	(	PUNCT
ajlsi-1012	553	20	2018	2018	NUM
ajlsi-1012	553	21	)	)	PUNCT
ajlsi-1012	553	22	.	.	PUNCT
ajlsi-1012	554	1	from	from	ADP
ajlsi-1012	554	2	lab	lab	NOUN
ajlsi-1012	554	3	on	on	ADP
ajlsi-1012	554	4	a	a	DET
ajlsi-1012	554	5	chip	chip	NOUN
ajlsi-1012	554	6	to	to	PART
ajlsi-1012	554	7	point	point	VERB
ajlsi-1012	554	8	of	of	ADP
ajlsi-1012	554	9	care	care	NOUN
ajlsi-1012	554	10	devices	device	NOUN
ajlsi-1012	554	11	:	:	PUNCT
ajlsi-1012	554	12	the	the	DET
ajlsi-1012	554	13	role	role	NOUN
ajlsi-1012	554	14	of	of	ADP
ajlsi-1012	554	15	open	open	ADJ
ajlsi-1012	554	16	-	-	PUNCT
ajlsi-1012	554	17	source	source	NOUN
ajlsi-1012	554	18	microcontrollers	microcontroller	NOUN
ajlsi-1012	554	19	.	.	PUNCT
ajlsi-1012	555	1	micromachines	micromachine	NOUN
ajlsi-1012	555	2	,	,	PUNCT
ajlsi-1012	555	3	9(8	9(8	NUM
ajlsi-1012	555	4	)	)	PUNCT
ajlsi-1012	555	5	,	,	PUNCT
ajlsi-1012	555	6	403	403	NUM
ajlsi-1012	555	7	.	.	PUNCT
ajlsi-1012	556	1	9(8):403	9(8):403	NUM
ajlsi-1012	556	2	.	.	PUNCT
ajlsi-1012	556	3	noh	noh	PROPN
ajlsi-1012	556	4	,	,	PUNCT
ajlsi-1012	556	5	j.	j.	PROPN
ajlsi-1012	556	6	y.	y.	PROPN
ajlsi-1012	556	7	,	,	PUNCT
ajlsi-1012	556	8	yoon	yoon	PROPN
ajlsi-1012	556	9	,	,	PUNCT
ajlsi-1012	556	10	s.	s.	PROPN
ajlsi-1012	556	11	w.	w.	PROPN
ajlsi-1012	556	12	,	,	PUNCT
ajlsi-1012	556	13	kim	kim	PROPN
ajlsi-1012	556	14	,	,	PUNCT
ajlsi-1012	556	15	d.	d.	PROPN
ajlsi-1012	556	16	j.	j.	PROPN
ajlsi-1012	556	17	,	,	PUNCT
ajlsi-1012	556	18	(	(	PUNCT
ajlsi-1012	556	19	2017	2017	NUM
ajlsi-1012	556	20	)	)	PUNCT
ajlsi-1012	556	21	.	.	PUNCT
ajlsi-1012	557	1	simultaneous	simultaneous	ADJ
ajlsi-1012	557	2	detection	detection	NOUN
ajlsi-1012	557	3	of	of	ADP
ajlsi-1012	557	4	severe	severe	ADJ
ajlsi-1012	557	5	acute	acute	ADJ
ajlsi-1012	557	6	respiratory	respiratory	ADJ
ajlsi-1012	557	7	syndrome	syndrome	NOUN
ajlsi-1012	557	8	,	,	PUNCT
ajlsi-1012	557	9	middle	middle	PROPN
ajlsi-1012	557	10	east	east	PROPN
ajlsi-1012	557	11	respiratory	respiratory	ADJ
ajlsi-1012	557	12	syndrome	syndrome	NOUN
ajlsi-1012	557	13	,	,	PUNCT
ajlsi-1012	557	14	and	and	CCONJ
ajlsi-1012	557	15	related	related	ADJ
ajlsi-1012	557	16	bat	bat	NOUN
ajlsi-1012	557	17	coronaviruses	coronaviruse	NOUN
ajlsi-1012	557	18	by	by	ADP
ajlsi-1012	557	19	real	real	ADJ
ajlsi-1012	557	20	-	-	PUNCT
ajlsi-1012	557	21	time	time	NOUN
ajlsi-1012	557	22	reverse	reverse	ADJ
ajlsi-1012	557	23	transcription	transcription	NOUN
ajlsi-1012	557	24	pcr	pcr	NOUN
ajlsi-1012	557	25	.	.	PUNCT
ajlsi-1012	558	1	archives	archive	NOUN
ajlsi-1012	558	2	of	of	ADP
ajlsi-1012	558	3	virology	virology	NOUN
ajlsi-1012	558	4	,	,	PUNCT
ajlsi-1012	558	5	162(6	162(6	NUM
ajlsi-1012	558	6	)	)	PUNCT
ajlsi-1012	558	7	,	,	PUNCT
ajlsi-1012	558	8	1617	1617	NUM
ajlsi-1012	558	9	-	-	SYM
ajlsi-1012	558	10	1623	1623	NUM
ajlsi-1012	558	11	.	.	PUNCT
ajlsi-1012	559	1	notomi	notomi	NOUN
ajlsi-1012	559	2	,	,	PUNCT
ajlsi-1012	559	3	t.	t.	PROPN
ajlsi-1012	559	4	,	,	PUNCT
ajlsi-1012	559	5	okayama	okayama	PROPN
ajlsi-1012	559	6	,	,	PUNCT
ajlsi-1012	559	7	h.	h.	PROPN
ajlsi-1012	559	8	,	,	PUNCT
ajlsi-1012	559	9	masubuchi	masubuchi	PROPN
ajlsi-1012	559	10	,	,	PUNCT
ajlsi-1012	559	11	h.	h.	PROPN
ajlsi-1012	559	12	,	,	PUNCT
ajlsi-1012	559	13	et	et	PROPN
ajlsi-1012	559	14	al	al	PROPN
ajlsi-1012	559	15	.	.	PROPN
ajlsi-1012	559	16	,	,	PUNCT
ajlsi-1012	559	17	(	(	PUNCT
ajlsi-1012	559	18	2000	2000	NUM
ajlsi-1012	559	19	)	)	PUNCT
ajlsi-1012	559	20	.	.	PUNCT
ajlsi-1012	560	1	loop	loop	NOUN
ajlsi-1012	560	2	-	-	PUNCT
ajlsi-1012	560	3	mediated	mediate	VERB
ajlsi-1012	560	4	isothermal	isothermal	ADJ
ajlsi-1012	560	5	amplification	amplification	NOUN
ajlsi-1012	560	6	of	of	ADP
ajlsi-1012	560	7	dna	dna	PROPN
ajlsi-1012	560	8	.	.	PUNCT
ajlsi-1012	561	1	nucleic	nucleic	ADJ
ajlsi-1012	561	2	acids	acid	NOUN
ajlsi-1012	561	3	research	research	NOUN
ajlsi-1012	561	4	,	,	PUNCT
ajlsi-1012	561	5	28(12	28(12	NUM
ajlsi-1012	561	6	)	)	PUNCT
ajlsi-1012	561	7	,	,	PUNCT
ajlsi-1012	561	8	e63	e63	NOUN
ajlsi-1012	561	9	-	-	PUNCT
ajlsi-1012	561	10	e63	e63	NOUN
ajlsi-1012	561	11	.	.	PUNCT
ajlsi-1012	562	1	nuccetelli	nuccetelli	PROPN
ajlsi-1012	562	2	,	,	PUNCT
ajlsi-1012	562	3	m.	m.	NOUN
ajlsi-1012	562	4	,	,	PUNCT
ajlsi-1012	562	5	pieri	pieri	PROPN
ajlsi-1012	562	6	,	,	PUNCT
ajlsi-1012	562	7	m.	m.	NOUN
ajlsi-1012	562	8	,	,	PUNCT
ajlsi-1012	562	9	grelli	grelli	PROPN
ajlsi-1012	562	10	,	,	PUNCT
ajlsi-1012	562	11	s.	s.	PROPN
ajlsi-1012	562	12	,	,	PUNCT
ajlsi-1012	562	13	et	et	PROPN
ajlsi-1012	562	14	al	al	PROPN
ajlsi-1012	562	15	.	.	PROPN
ajlsi-1012	562	16	,	,	PUNCT
ajlsi-1012	562	17	(	(	PUNCT
ajlsi-1012	562	18	2020	2020	NUM
ajlsi-1012	562	19	)	)	PUNCT
ajlsi-1012	562	20	.	.	PUNCT
ajlsi-1012	563	1	sarscov-2	sarscov-2	NUM
ajlsi-1012	563	2	infection	infection	NOUN
ajlsi-1012	563	3	serology	serology	NOUN
ajlsi-1012	563	4	:	:	PUNCT
ajlsi-1012	563	5	a	a	DET
ajlsi-1012	563	6	useful	useful	ADJ
ajlsi-1012	563	7	tool	tool	NOUN
ajlsi-1012	563	8	to	to	PART
ajlsi-1012	563	9	overcome	overcome	VERB
ajlsi-1012	563	10	lockdown	lockdown	NOUN
ajlsi-1012	563	11	?	?	PUNCT
ajlsi-1012	564	1	cell	cell	NOUN
ajlsi-1012	564	2	death	death	NOUN
ajlsi-1012	564	3	discovery	discovery	NOUN
ajlsi-1012	564	4	,	,	PUNCT
ajlsi-1012	564	5	6(1	6(1	NUM
ajlsi-1012	564	6	)	)	PUNCT
ajlsi-1012	564	7	,	,	PUNCT
ajlsi-1012	564	8	1	1	NUM
ajlsi-1012	564	9	-	-	SYM
ajlsi-1012	564	10	9	9	NUM
ajlsi-1012	564	11	.	.	PUNCT
ajlsi-1012	565	1	okba	okba	PROPN
ajlsi-1012	565	2	,	,	PUNCT
ajlsi-1012	565	3	n.	n.	PROPN
ajlsi-1012	565	4	m.	m.	NOUN
ajlsi-1012	565	5	,	,	PUNCT
ajlsi-1012	565	6	müller	müller	PROPN
ajlsi-1012	565	7	,	,	PUNCT
ajlsi-1012	565	8	m.	m.	NOUN
ajlsi-1012	565	9	a.	a.	PROPN
ajlsi-1012	565	10	,	,	PUNCT
ajlsi-1012	565	11	li	li	PROPN
ajlsi-1012	565	12	,	,	PUNCT
ajlsi-1012	565	13	w.	w.	PROPN
ajlsi-1012	565	14	,	,	PUNCT
ajlsi-1012	565	15	et	et	PROPN
ajlsi-1012	565	16	al	al	PROPN
ajlsi-1012	565	17	.	.	PROPN
ajlsi-1012	565	18	,	,	PUNCT
ajlsi-1012	565	19	(	(	PUNCT
ajlsi-1012	565	20	2020	2020	NUM
ajlsi-1012	565	21	)	)	PUNCT
ajlsi-1012	565	22	.	.	PUNCT
ajlsi-1012	566	1	severe	severe	ADJ
ajlsi-1012	566	2	acute	acute	ADJ
ajlsi-1012	566	3	respiratory	respiratory	ADJ
ajlsi-1012	566	4	syndrome	syndrome	NOUN
ajlsi-1012	566	5	coronavirus	coronavirus	NOUN
ajlsi-1012	566	6	2−	2−	NUM
ajlsi-1012	566	7	specific	specific	ADJ
ajlsi-1012	566	8	antibody	antibody	NOUN
ajlsi-1012	566	9	responses	response	NOUN
ajlsi-1012	566	10	in	in	ADP
ajlsi-1012	566	11	coronavirus	coronavirus	NOUN
ajlsi-1012	566	12	disease	disease	NOUN
ajlsi-1012	566	13	patients	patient	NOUN
ajlsi-1012	566	14	.	.	PUNCT
ajlsi-1012	567	1	emerging	emerge	VERB
ajlsi-1012	567	2	infectious	infectious	ADJ
ajlsi-1012	567	3	diseases	disease	NOUN
ajlsi-1012	567	4	,	,	PUNCT
ajlsi-1012	567	5	26(7	26(7	NOUN
ajlsi-1012	567	6	)	)	PUNCT
ajlsi-1012	567	7	,	,	PUNCT
ajlsi-1012	567	8	1478	1478	NUM
ajlsi-1012	567	9	-	-	SYM
ajlsi-1012	567	10	1488	1488	NUM
ajlsi-1012	567	11	.	.	PUNCT
ajlsi-1012	568	1	pan	pan	PROPN
ajlsi-1012	568	2	,	,	PUNCT
ajlsi-1012	568	3	y.	y.	PROPN
ajlsi-1012	568	4	,	,	PUNCT
ajlsi-1012	568	5	long	long	ADV
ajlsi-1012	568	6	,	,	PUNCT
ajlsi-1012	568	7	l.	l.	PROPN
ajlsi-1012	568	8	,	,	PUNCT
ajlsi-1012	568	9	zhang	zhang	PROPN
ajlsi-1012	568	10	,	,	PUNCT
ajlsi-1012	568	11	d.	d.	PROPN
ajlsi-1012	568	12	,	,	PUNCT
ajlsi-1012	568	13	yuan	yuan	PROPN
ajlsi-1012	568	14	,	,	PUNCT
ajlsi-1012	568	15	t.	t.	PROPN
ajlsi-1012	568	16	,	,	PUNCT
ajlsi-1012	568	17	et	et	PROPN
ajlsi-1012	568	18	al	al	PROPN
ajlsi-1012	568	19	.	.	PROPN
ajlsi-1012	568	20	,	,	PUNCT
ajlsi-1012	568	21	2020	2020	NUM
ajlsi-1012	568	22	)	)	PUNCT
ajlsi-1012	568	23	.	.	PUNCT
ajlsi-1012	569	1	potential	potential	ADJ
ajlsi-1012	569	2	false	false	ADJ
ajlsi-1012	569	3	-	-	PUNCT
ajlsi-1012	569	4	negative	negative	ADJ
ajlsi-1012	569	5	nucleic	nucleic	ADJ
ajlsi-1012	569	6	acid	acid	NOUN
ajlsi-1012	569	7	testing	testing	NOUN
ajlsi-1012	569	8	results	result	NOUN
ajlsi-1012	569	9	for	for	ADP
ajlsi-1012	569	10	severe	severe	ADJ
ajlsi-1012	569	11	acute	acute	ADJ
ajlsi-1012	569	12	respiratory	respiratory	ADJ
ajlsi-1012	569	13	syndrome	syndrome	NOUN
ajlsi-1012	569	14	coronavirus	coronavirus	NOUN
ajlsi-1012	569	15	2	2	NUM
ajlsi-1012	569	16	from	from	ADP
ajlsi-1012	569	17	thermal	thermal	ADJ
ajlsi-1012	569	18	inactivation	inactivation	NOUN
ajlsi-1012	569	19	of	of	ADP
ajlsi-1012	569	20	samples	sample	NOUN
ajlsi-1012	569	21	with	with	ADP
ajlsi-1012	569	22	low	low	ADJ
ajlsi-1012	569	23	viral	viral	ADJ
ajlsi-1012	569	24	loads	load	NOUN
ajlsi-1012	569	25	.	.	PUNCT
ajlsi-1012	570	1	clinical	clinical	ADJ
ajlsi-1012	570	2	chemistry	chemistry	NOUN
ajlsi-1012	570	3	,	,	PUNCT
ajlsi-1012	570	4	66(6	66(6	NUM
ajlsi-1012	570	5	)	)	PUNCT
ajlsi-1012	570	6	,	,	PUNCT
ajlsi-1012	570	7	794	794	NUM
ajlsi-1012	570	8	-	-	SYM
ajlsi-1012	570	9	801	801	NUM
ajlsi-1012	570	10	.	.	PUNCT
ajlsi-1012	570	11	peiris	peiris	PROPN
ajlsi-1012	570	12	,	,	PUNCT
ajlsi-1012	570	13	j.	j.	PROPN
ajlsi-1012	570	14	s.	s.	PROPN
ajlsi-1012	570	15	m.	m.	PROPN
ajlsi-1012	570	16	,	,	PUNCT
ajlsi-1012	570	17	lai	lai	PROPN
ajlsi-1012	570	18	,	,	PUNCT
ajlsi-1012	570	19	s.	s.	PROPN
ajlsi-1012	570	20	t.	t.	PROPN
ajlsi-1012	570	21	,	,	PUNCT
ajlsi-1012	570	22	poon	poon	NOUN
ajlsi-1012	570	23	,	,	PUNCT
ajlsi-1012	570	24	l.	l.	PROPN
ajlsi-1012	570	25	l.	l.	PROPN
ajlsi-1012	570	26	m.	m.	PROPN
ajlsi-1012	570	27	,	,	PUNCT
ajlsi-1012	570	28	et	et	PROPN
ajlsi-1012	570	29	al	al	PROPN
ajlsi-1012	570	30	.	.	PROPN
ajlsi-1012	570	31	,	,	PUNCT
ajlsi-1012	570	32	(	(	PUNCT
ajlsi-1012	570	33	2003	2003	NUM
ajlsi-1012	570	34	)	)	PUNCT
ajlsi-1012	570	35	.	.	PUNCT
ajlsi-1012	571	1	coronavirus	coronavirus	NOUN
ajlsi-1012	571	2	as	as	ADP
ajlsi-1012	571	3	a	a	DET
ajlsi-1012	571	4	possible	possible	ADJ
ajlsi-1012	571	5	cause	cause	NOUN
ajlsi-1012	571	6	of	of	ADP
ajlsi-1012	571	7	severe	severe	ADJ
ajlsi-1012	571	8	acute	acute	ADJ
ajlsi-1012	571	9	respiratory	respiratory	ADJ
ajlsi-1012	571	10	syndrome	syndrome	NOUN
ajlsi-1012	571	11	.	.	PUNCT
ajlsi-1012	572	1	the	the	DET
ajlsi-1012	572	2	lancet	lancet	PROPN
ajlsi-1012	572	3	,	,	PUNCT
ajlsi-1012	572	4	361(9366	361(9366	PROPN
ajlsi-1012	572	5	)	)	PUNCT
ajlsi-1012	572	6	,	,	PUNCT
ajlsi-1012	572	7	13191325	13191325	NUM
ajlsi-1012	572	8	.	.	PUNCT
ajlsi-1012	573	1	pung	pung	PROPN
ajlsi-1012	573	2	,	,	PUNCT
ajlsi-1012	573	3	r.	r.	PROPN
ajlsi-1012	573	4	,	,	PUNCT
ajlsi-1012	573	5	chiew	chiew	PROPN
ajlsi-1012	573	6	,	,	PUNCT
ajlsi-1012	573	7	c.	c.	PROPN
ajlsi-1012	573	8	j.	j.	PROPN
ajlsi-1012	573	9	,	,	PUNCT
ajlsi-1012	573	10	young	young	PROPN
ajlsi-1012	573	11	,	,	PUNCT
ajlsi-1012	573	12	b.	b.	PROPN
ajlsi-1012	573	13	e.	e.	PROPN
ajlsi-1012	573	14	,	,	PUNCT
ajlsi-1012	573	15	chin	chin	PROPN
ajlsi-1012	573	16	,	,	PUNCT
ajlsi-1012	573	17	s.	s.	PROPN
ajlsi-1012	573	18	,	,	PUNCT
ajlsi-1012	573	19	et	et	PROPN
ajlsi-1012	573	20	al	al	PROPN
ajlsi-1012	573	21	.	.	PROPN
ajlsi-1012	573	22	,	,	PUNCT
ajlsi-1012	573	23	(	(	PUNCT
ajlsi-1012	573	24	2020	2020	NUM
ajlsi-1012	573	25	)	)	PUNCT
ajlsi-1012	573	26	.	.	PUNCT
ajlsi-1012	574	1	investigation	investigation	NOUN
ajlsi-1012	574	2	of	of	ADP
ajlsi-1012	574	3	three	three	NUM
ajlsi-1012	574	4	clusters	cluster	NOUN
ajlsi-1012	574	5	of	of	ADP
ajlsi-1012	574	6	covid-19	covid-19	PROPN
ajlsi-1012	574	7	in	in	ADP
ajlsi-1012	574	8	singapore	singapore	PROPN
ajlsi-1012	574	9	:	:	PUNCT
ajlsi-1012	574	10	implications	implication	NOUN
ajlsi-1012	574	11	for	for	ADP
ajlsi-1012	574	12	surveillance	surveillance	NOUN
ajlsi-1012	574	13	and	and	CCONJ
ajlsi-1012	574	14	response	response	NOUN
ajlsi-1012	574	15	measures	measure	NOUN
ajlsi-1012	574	16	.	.	PUNCT
ajlsi-1012	575	1	the	the	DET
ajlsi-1012	575	2	lancet	lancet	PROPN
ajlsi-1012	575	3	,	,	PUNCT
ajlsi-1012	575	4	395(10229	395(10229	NUM
ajlsi-1012	575	5	)	)	PUNCT
ajlsi-1012	575	6	,	,	PUNCT
ajlsi-1012	575	7	1039	1039	NUM
ajlsi-1012	575	8	-	-	SYM
ajlsi-1012	575	9	1046	1046	NUM
ajlsi-1012	575	10	.	.	PUNCT
ajlsi-1012	576	1	sethuraman	sethuraman	NOUN
ajlsi-1012	576	2	,	,	PUNCT
ajlsi-1012	576	3	n.	n.	PROPN
ajlsi-1012	576	4	,	,	PUNCT
ajlsi-1012	576	5	jeremiah	jeremiah	PROPN
ajlsi-1012	576	6	,	,	PUNCT
ajlsi-1012	576	7	s.	s.	PROPN
ajlsi-1012	576	8	s.	s.	PROPN
ajlsi-1012	576	9	,	,	PUNCT
ajlsi-1012	576	10	et	et	PROPN
ajlsi-1012	576	11	al	al	PROPN
ajlsi-1012	576	12	.	.	PROPN
ajlsi-1012	576	13	,	,	PUNCT
ajlsi-1012	576	14	(	(	PUNCT
ajlsi-1012	576	15	2020	2020	NUM
ajlsi-1012	576	16	)	)	PUNCT
ajlsi-1012	576	17	.	.	PUNCT
ajlsi-1012	577	1	interpreting	interpret	VERB
ajlsi-1012	577	2	diagnostic	diagnostic	ADJ
ajlsi-1012	577	3	tests	test	NOUN
ajlsi-1012	577	4	for	for	ADP
ajlsi-1012	577	5	sars	sar	NOUN
ajlsi-1012	577	6	-	-	PUNCT
ajlsi-1012	577	7	cov-2	cov-2	NOUN
ajlsi-1012	577	8	.	.	NOUN
ajlsi-1012	577	9	journal	journal	PROPN
ajlsi-1012	577	10	of	of	ADP
ajlsi-1012	577	11	american	american	PROPN
ajlsi-1012	577	12	medical	medical	PROPN
ajlsi-1012	577	13	association	association	PROPN
ajlsi-1012	577	14	,	,	PUNCT
ajlsi-1012	577	15	323(22	323(22	NUM
ajlsi-1012	577	16	)	)	PUNCT
ajlsi-1012	577	17	,	,	PUNCT
ajlsi-1012	577	18	2249	2249	NUM
ajlsi-1012	577	19	-	-	SYM
ajlsi-1012	577	20	2251	2251	NUM
ajlsi-1012	577	21	.	.	PUNCT
ajlsi-1012	578	1	shani	shani	PROPN
ajlsi-1012	578	2	-	-	PUNCT
ajlsi-1012	578	3	narkiss	narkiss	PROPN
ajlsi-1012	578	4	,	,	PUNCT
ajlsi-1012	578	5	h.	h.	PROPN
ajlsi-1012	578	6	,	,	PUNCT
ajlsi-1012	578	7	gilday	gilday	PROPN
ajlsi-1012	578	8	,	,	PUNCT
ajlsi-1012	578	9	o.	o.	PROPN
ajlsi-1012	578	10	d.	d.	PROPN
ajlsi-1012	578	11	,	,	PUNCT
ajlsi-1012	578	12	et	et	PROPN
ajlsi-1012	578	13	al	al	PROPN
ajlsi-1012	578	14	.	.	PROPN
ajlsi-1012	578	15	,	,	PUNCT
ajlsi-1012	578	16	(	(	PUNCT
ajlsi-1012	578	17	2020	2020	NUM
ajlsi-1012	578	18	)	)	PUNCT
ajlsi-1012	578	19	.	.	PUNCT
ajlsi-1012	579	1	efficient	efficient	ADJ
ajlsi-1012	579	2	and	and	CCONJ
ajlsi-1012	579	3	practical	practical	ADJ
ajlsi-1012	579	4	sample	sample	NOUN
ajlsi-1012	579	5	pooling	pooling	NOUN
ajlsi-1012	579	6	for	for	ADP
ajlsi-1012	579	7	high	high	ADJ
ajlsi-1012	579	8	-	-	PUNCT
ajlsi-1012	579	9	throughput	throughput	NOUN
ajlsi-1012	579	10	pcr	pcr	ADJ
ajlsi-1012	579	11	diagnosis	diagnosis	NOUN
ajlsi-1012	579	12	of	of	ADP
ajlsi-1012	579	13	covid-19	covid-19	PROPN
ajlsi-1012	579	14	.	.	PUNCT
ajlsi-1012	580	1	medrxiv	medrxiv	PROPN
ajlsi-1012	580	2	.	.	PUNCT
ajlsi-1012	581	1	shen	shen	PROPN
ajlsi-1012	581	2	,	,	PUNCT
ajlsi-1012	581	3	m.	m.	NOUN
ajlsi-1012	581	4	,	,	PUNCT
ajlsi-1012	581	5	zhou	zhou	PROPN
ajlsi-1012	581	6	,	,	PUNCT
ajlsi-1012	581	7	y.	y.	PROPN
ajlsi-1012	581	8	,	,	PUNCT
ajlsi-1012	581	9	ye	ye	PROPN
ajlsi-1012	581	10	,	,	PUNCT
ajlsi-1012	581	11	j.	j.	PROPN
ajlsi-1012	581	12	,	,	PUNCT
ajlsi-1012	581	13	et	et	PROPN
ajlsi-1012	581	14	al	al	PROPN
ajlsi-1012	581	15	.	.	PROPN
ajlsi-1012	581	16	,	,	PUNCT
ajlsi-1012	581	17	(	(	PUNCT
ajlsi-1012	581	18	2020	2020	NUM
ajlsi-1012	581	19	)	)	PUNCT
ajlsi-1012	581	20	.	.	PUNCT
ajlsi-1012	582	1	recent	recent	ADJ
ajlsi-1012	582	2	advances	advance	NOUN
ajlsi-1012	582	3	and	and	CCONJ
ajlsi-1012	582	4	perspectives	perspective	NOUN
ajlsi-1012	582	5	of	of	ADP
ajlsi-1012	582	6	nucleic	nucleic	ADJ
ajlsi-1012	582	7	acid	acid	NOUN
ajlsi-1012	582	8	detection	detection	NOUN
ajlsi-1012	582	9	for	for	ADP
ajlsi-1012	582	10	coronavirus	coronavirus	NOUN
ajlsi-1012	582	11	.	.	PUNCT
ajlsi-1012	583	1	journal	journal	PROPN
ajlsi-1012	583	2	of	of	ADP
ajlsi-1012	583	3	pharmaceutical	pharmaceutical	ADJ
ajlsi-1012	583	4	analysis	analysis	NOUN
ajlsi-1012	583	5	,	,	PUNCT
ajlsi-1012	583	6	10(2	10(2	NUM
ajlsi-1012	583	7	)	)	PUNCT
ajlsi-1012	583	8	,	,	PUNCT
ajlsi-1012	583	9	97	97	NUM
ajlsi-1012	583	10	-	-	SYM
ajlsi-1012	583	11	101	101	NUM
ajlsi-1012	583	12	.	.	PUNCT
ajlsi-1012	584	1	shi	shi	PROPN
ajlsi-1012	584	2	,	,	PUNCT
ajlsi-1012	584	3	x.	x.	PROPN
ajlsi-1012	584	4	,	,	PUNCT
ajlsi-1012	584	5	gong	gong	PROPN
ajlsi-1012	584	6	,	,	PUNCT
ajlsi-1012	584	7	e.	e.	PROPN
ajlsi-1012	584	8	,	,	PUNCT
ajlsi-1012	584	9	gao	gao	PROPN
ajlsi-1012	584	10	,	,	PUNCT
ajlsi-1012	584	11	d.	d.	PROPN
ajlsi-1012	584	12	,	,	PUNCT
ajlsi-1012	584	13	et	et	PROPN
ajlsi-1012	584	14	al	al	PROPN
ajlsi-1012	584	15	.	.	PROPN
ajlsi-1012	584	16	,	,	PUNCT
ajlsi-1012	584	17	(	(	PUNCT
ajlsi-1012	584	18	2005	2005	NUM
ajlsi-1012	584	19	)	)	PUNCT
ajlsi-1012	584	20	.	.	PUNCT
ajlsi-1012	585	1	severe	severe	ADJ
ajlsi-1012	585	2	acute	acute	ADJ
ajlsi-1012	585	3	respiratory	respiratory	ADJ
ajlsi-1012	585	4	syndrome	syndrome	NOUN
ajlsi-1012	585	5	associated	associate	VERB
ajlsi-1012	585	6	coronavirus	coronavirus	NOUN
ajlsi-1012	585	7	is	be	AUX
ajlsi-1012	585	8	detected	detect	VERB
ajlsi-1012	585	9	in	in	ADP
ajlsi-1012	585	10	intestinal	intestinal	ADJ
ajlsi-1012	585	11	tissues	tissue	NOUN
ajlsi-1012	585	12	of	of	ADP
ajlsi-1012	585	13	fatal	fatal	ADJ
ajlsi-1012	585	14	cases	case	NOUN
ajlsi-1012	585	15	.	.	PUNCT
ajlsi-1012	586	1	official	official	ADJ
ajlsi-1012	586	2	journal	journal	NOUN
ajlsi-1012	586	3	of	of	ADP
ajlsi-1012	586	4	the	the	DET
ajlsi-1012	586	5	american	american	PROPN
ajlsi-1012	586	6	college	college	PROPN
ajlsi-1012	586	7	of	of	ADP
ajlsi-1012	586	8	gastroenterology|	gastroenterology|	PROPN
ajlsi-1012	586	9	.	.	PUNCT
ajlsi-1012	587	1	american	american	PROPN
ajlsi-1012	587	2	journal	journal	PROPN
ajlsi-1012	587	3	of	of	ADP
ajlsi-1012	587	4	gastroenterology	gastroenterology	NOUN
ajlsi-1012	587	5	.	.	PUNCT
ajlsi-1012	588	1	100(1	100(1	NUM
ajlsi-1012	588	2	)	)	PUNCT
ajlsi-1012	588	3	,	,	PUNCT
ajlsi-1012	588	4	169	169	NUM
ajlsi-1012	588	5	-	-	SYM
ajlsi-1012	588	6	176	176	NUM
ajlsi-1012	588	7	.	.	PUNCT
ajlsi-1012	589	1	smyrlaki	smyrlaki	PROPN
ajlsi-1012	589	2	,	,	PUNCT
ajlsi-1012	589	3	i.	i.	PROPN
ajlsi-1012	589	4	,	,	PUNCT
ajlsi-1012	589	5	ekman	ekman	PROPN
ajlsi-1012	589	6	,	,	PUNCT
ajlsi-1012	589	7	m.	m.	NOUN
ajlsi-1012	589	8	,	,	PUNCT
ajlsi-1012	589	9	lentini	lentini	NOUN
ajlsi-1012	589	10	,	,	PUNCT
ajlsi-1012	589	11	a.	a.	NOUN
ajlsi-1012	589	12	,	,	PUNCT
ajlsi-1012	589	13	et	et	PROPN
ajlsi-1012	589	14	al	al	PROPN
ajlsi-1012	589	15	.	.	PROPN
ajlsi-1012	589	16	,	,	PUNCT
ajlsi-1012	589	17	(	(	PUNCT
ajlsi-1012	589	18	2020	2020	NUM
ajlsi-1012	589	19	)	)	PUNCT
ajlsi-1012	589	20	.	.	PUNCT
ajlsi-1012	590	1	massive	massive	ADJ
ajlsi-1012	590	2	and	and	CCONJ
ajlsi-1012	590	3	rapid	rapid	ADJ
ajlsi-1012	590	4	covid-19	covid-19	PROPN
ajlsi-1012	590	5	testing	testing	NOUN
ajlsi-1012	590	6	is	be	AUX
ajlsi-1012	590	7	feasible	feasible	ADJ
ajlsi-1012	590	8	by	by	ADP
ajlsi-1012	590	9	extractionfree	extractionfree	PROPN
ajlsi-1012	590	10	sars	sar	NOUN
ajlsi-1012	590	11	-	-	PUNCT
ajlsi-1012	590	12	cov-2	cov-2	NOUN
ajlsi-1012	590	13	rt	rt	NOUN
ajlsi-1012	590	14	-	-	PUNCT
ajlsi-1012	590	15	pcr	pcr	NOUN
ajlsi-1012	590	16	.	.	PUNCT
ajlsi-1012	591	1	nature	nature	NOUN
ajlsi-1012	591	2	communications	communication	NOUN
ajlsi-1012	591	3	,	,	PUNCT
ajlsi-1012	591	4	11(1	11(1	NUM
ajlsi-1012	591	5	)	)	PUNCT
ajlsi-1012	591	6	,	,	PUNCT
ajlsi-1012	591	7	1	1	NUM
ajlsi-1012	591	8	-	-	SYM
ajlsi-1012	591	9	12	12	NUM
ajlsi-1012	591	10	.	.	PUNCT
ajlsi-1012	592	1	thai	thai	PROPN
ajlsi-1012	592	2	,	,	PUNCT
ajlsi-1012	592	3	h.	h.	PROPN
ajlsi-1012	592	4	t.	t.	PROPN
ajlsi-1012	592	5	c.	c.	PROPN
ajlsi-1012	592	6	,	,	PUNCT
ajlsi-1012	592	7	le	le	PROPN
ajlsi-1012	592	8	,	,	PUNCT
ajlsi-1012	592	9	m.	m.	NOUN
ajlsi-1012	592	10	q.	q.	PROPN
ajlsi-1012	592	11	,	,	PUNCT
ajlsi-1012	592	12	et	et	PROPN
ajlsi-1012	592	13	al	al	PROPN
ajlsi-1012	592	14	.	.	PROPN
ajlsi-1012	592	15	,	,	PUNCT
ajlsi-1012	592	16	(	(	PUNCT
ajlsi-1012	592	17	2004	2004	NUM
ajlsi-1012	592	18	)	)	PUNCT
ajlsi-1012	592	19	.	.	PUNCT
ajlsi-1012	593	1	development	development	NOUN
ajlsi-1012	593	2	and	and	CCONJ
ajlsi-1012	593	3	evaluation	evaluation	NOUN
ajlsi-1012	593	4	of	of	ADP
ajlsi-1012	593	5	a	a	DET
ajlsi-1012	593	6	novel	novel	ADJ
ajlsi-1012	593	7	loop	loop	NOUN
ajlsi-1012	593	8	-	-	PUNCT
ajlsi-1012	593	9	mediated	mediate	VERB
ajlsi-1012	593	10	isothermal	isothermal	ADJ
ajlsi-1012	593	11	amplification	amplification	NOUN
ajlsi-1012	593	12	method	method	NOUN
ajlsi-1012	593	13	for	for	ADP
ajlsi-1012	593	14	rapid	rapid	ADJ
ajlsi-1012	593	15	detection	detection	NOUN
ajlsi-1012	593	16	of	of	ADP
ajlsi-1012	593	17	severe	severe	ADJ
ajlsi-1012	593	18	acute	acute	ADJ
ajlsi-1012	593	19	respiratory	respiratory	ADJ
ajlsi-1012	593	20	syndrome	syndrome	NOUN
ajlsi-1012	593	21	coronavirus	coronavirus	NOUN
ajlsi-1012	593	22	.	.	PUNCT
ajlsi-1012	594	1	journal	journal	PROPN
ajlsi-1012	594	2	of	of	ADP
ajlsi-1012	594	3	clinical	clinical	ADJ
ajlsi-1012	594	4	microbiology	microbiology	NOUN
ajlsi-1012	594	5	,	,	PUNCT
ajlsi-1012	594	6	42(5	42(5	NUM
ajlsi-1012	594	7	)	)	PUNCT
ajlsi-1012	594	8	,	,	PUNCT
ajlsi-1012	594	9	1956	1956	NUM
ajlsi-1012	594	10	-	-	SYM
ajlsi-1012	594	11	1961	1961	NUM
ajlsi-1012	594	12	.	.	PUNCT
ajlsi-1012	595	1	to	to	ADP
ajlsi-1012	595	2	,	,	PUNCT
ajlsi-1012	595	3	k.	k.	PROPN
ajlsi-1012	595	4	k.	k.	PROPN
ajlsi-1012	596	1	w.	w.	PROPN
ajlsi-1012	596	2	,	,	PUNCT
ajlsi-1012	596	3	tsang	tsang	PROPN
ajlsi-1012	596	4	,	,	PUNCT
ajlsi-1012	596	5	o.	o.	PROPN
ajlsi-1012	596	6	t.	t.	PROPN
ajlsi-1012	596	7	y.	y.	PROPN
ajlsi-1012	596	8	,	,	PUNCT
ajlsi-1012	596	9	et	et	PROPN
ajlsi-1012	596	10	al	al	PROPN
ajlsi-1012	596	11	.	.	PROPN
ajlsi-1012	596	12	,	,	PUNCT
ajlsi-1012	596	13	(	(	PUNCT
ajlsi-1012	596	14	2020	2020	NUM
ajlsi-1012	596	15	)	)	PUNCT
ajlsi-1012	596	16	.	.	PUNCT
ajlsi-1012	597	1	temporal	temporal	ADJ
ajlsi-1012	597	2	profiles	profile	NOUN
ajlsi-1012	597	3	of	of	ADP
ajlsi-1012	597	4	viral	viral	ADJ
ajlsi-1012	597	5	load	load	NOUN
ajlsi-1012	597	6	in	in	ADP
ajlsi-1012	597	7	posterior	posterior	ADJ
ajlsi-1012	597	8	oropharyngeal	oropharyngeal	ADJ
ajlsi-1012	597	9	saliva	saliva	NOUN
ajlsi-1012	597	10	samples	sample	NOUN
ajlsi-1012	597	11	and	and	CCONJ
ajlsi-1012	597	12	serum	serum	NOUN
ajlsi-1012	597	13	antibody	antibody	NOUN
ajlsi-1012	597	14	responses	response	NOUN
ajlsi-1012	597	15	during	during	ADP
ajlsi-1012	597	16	infection	infection	NOUN
ajlsi-1012	597	17	by	by	ADP
ajlsi-1012	597	18	sars	sar	NOUN
ajlsi-1012	597	19	-	-	PUNCT
ajlsi-1012	597	20	cov-2	cov-2	NOUN
ajlsi-1012	597	21	:	:	PUNCT
ajlsi-1012	597	22	an	an	DET
ajlsi-1012	597	23	observational	observational	ADJ
ajlsi-1012	597	24	cohort	cohort	NOUN
ajlsi-1012	597	25	study	study	NOUN
ajlsi-1012	597	26	.	.	PUNCT
ajlsi-1012	598	1	the	the	DET
ajlsi-1012	598	2	lancet	lancet	ADJ
ajlsi-1012	598	3	infectious	infectious	ADJ
ajlsi-1012	598	4	diseases	disease	NOUN
ajlsi-1012	598	5	,	,	PUNCT
ajlsi-1012	598	6	20(5	20(5	NUM
ajlsi-1012	598	7	)	)	PUNCT
ajlsi-1012	598	8	,	,	PUNCT
ajlsi-1012	598	9	565	565	NUM
ajlsi-1012	598	10	-	-	SYM
ajlsi-1012	598	11	574	574	NUM
ajlsi-1012	598	12	.	.	PUNCT
ajlsi-1012	599	1	to	to	ADP
ajlsi-1012	599	2	,	,	PUNCT
ajlsi-1012	599	3	k.	k.	PROPN
ajlsi-1012	599	4	k.	k.	PROPN
ajlsi-1012	600	1	w.	w.	PROPN
ajlsi-1012	600	2	,	,	PUNCT
ajlsi-1012	600	3	yip	yip	PROPN
ajlsi-1012	600	4	,	,	PUNCT
ajlsi-1012	600	5	c.	c.	PROPN
ajlsi-1012	600	6	c.	c.	PROPN
ajlsi-1012	600	7	y.	y.	PROPN
ajlsi-1012	600	8	,	,	PUNCT
ajlsi-1012	600	9	et	et	PROPN
ajlsi-1012	600	10	al	al	PROPN
ajlsi-1012	600	11	.	.	PROPN
ajlsi-1012	600	12	,	,	PUNCT
ajlsi-1012	600	13	(	(	PUNCT
ajlsi-1012	600	14	2019	2019	NUM
ajlsi-1012	600	15	)	)	PUNCT
ajlsi-1012	600	16	.	.	PUNCT
ajlsi-1012	601	1	saliva	saliva	NOUN
ajlsi-1012	601	2	as	as	ADP
ajlsi-1012	601	3	a	a	DET
ajlsi-1012	601	4	diagnostic	diagnostic	ADJ
ajlsi-1012	601	5	specimen	speciman	NOUN
ajlsi-1012	601	6	for	for	ADP
ajlsi-1012	601	7	testing	test	VERB
ajlsi-1012	601	8	respiratory	respiratory	ADJ
ajlsi-1012	601	9	virus	virus	NOUN
ajlsi-1012	601	10	by	by	ADP
ajlsi-1012	601	11	a	a	DET
ajlsi-1012	601	12	point	point	NOUN
ajlsi-1012	601	13	-	-	PUNCT
ajlsi-1012	601	14	of	of	ADP
ajlsi-1012	601	15	-	-	PUNCT
ajlsi-1012	601	16	care	care	NOUN
ajlsi-1012	601	17	molecular	molecular	ADJ
ajlsi-1012	601	18	assay	assay	ADV
ajlsi-1012	601	19	:	:	PUNCT
ajlsi-1012	601	20	a	a	DET
ajlsi-1012	601	21	diagnostic	diagnostic	ADJ
ajlsi-1012	601	22	validity	validity	NOUN
ajlsi-1012	601	23	study	study	NOUN
ajlsi-1012	601	24	.	.	PUNCT
ajlsi-1012	602	1	clinical	clinical	ADJ
ajlsi-1012	602	2	microbiology	microbiology	NOUN
ajlsi-1012	602	3	and	and	CCONJ
ajlsi-1012	602	4	infection	infection	NOUN
ajlsi-1012	602	5	,	,	PUNCT
ajlsi-1012	602	6	25(3	25(3	NUM
ajlsi-1012	602	7	)	)	PUNCT
ajlsi-1012	602	8	,	,	PUNCT
ajlsi-1012	602	9	372	372	NUM
ajlsi-1012	602	10	-	-	SYM
ajlsi-1012	602	11	378	378	NUM
ajlsi-1012	602	12	.	.	PUNCT
ajlsi-1012	603	1	tsang	tsang	PROPN
ajlsi-1012	603	2	,	,	PUNCT
ajlsi-1012	603	3	j.	j.	PROPN
ajlsi-1012	603	4	,	,	PUNCT
ajlsi-1012	603	5	&	&	CCONJ
ajlsi-1012	603	6	bajpai	bajpai	PROPN
ajlsi-1012	603	7	,	,	PUNCT
ajlsi-1012	603	8	j.	j.	PROPN
ajlsi-1012	603	9	(	(	PUNCT
ajlsi-1012	603	10	2020	2020	NUM
ajlsi-1012	603	11	)	)	PUNCT
ajlsi-1012	603	12	.	.	PUNCT
ajlsi-1012	604	1	novel	novel	ADJ
ajlsi-1012	604	2	coronavirus	coronavirus	NOUN
ajlsi-1012	604	3	infection	infection	NOUN
ajlsi-1012	604	4	–	–	PUNCT
ajlsi-1012	604	5	knowns	known	NOUN
ajlsi-1012	604	6	and	and	CCONJ
ajlsi-1012	604	7	unknowns	unknown	NOUN
ajlsi-1012	604	8	with	with	ADP
ajlsi-1012	604	9	particular	particular	ADJ
ajlsi-1012	604	10	reference	reference	NOUN
ajlsi-1012	604	11	to	to	ADP
ajlsi-1012	604	12	oncology	oncology	NOUN
ajlsi-1012	604	13	–	–	PUNCT
ajlsi-1012	604	14	combating	combat	VERB
ajlsi-1012	604	15	against	against	ADP
ajlsi-1012	604	16	covid-19	covid-19	PROPN
ajlsi-1012	604	17	with	with	ADP
ajlsi-1012	604	18	“	"	PUNCT
ajlsi-1012	604	19	covid	covid	PROPN
ajlsi-1012	604	20	”	"	PUNCT
ajlsi-1012	604	21	.	.	PUNCT
ajlsi-1012	605	1	indian	indian	PROPN
ajlsi-1012	605	2	journal	journal	PROPN
ajlsi-1012	605	3	of	of	ADP
ajlsi-1012	605	4	medical	medical	ADJ
ajlsi-1012	605	5	and	and	CCONJ
ajlsi-1012	605	6	pediatric	pediatric	ADJ
ajlsi-1012	605	7	oncology	oncology	NOUN
ajlsi-1012	605	8	,	,	PUNCT
ajlsi-1012	605	9	41(02	41(02	NOUN
ajlsi-1012	605	10	)	)	PUNCT
ajlsi-1012	605	11	,	,	PUNCT
ajlsi-1012	605	12	116	116	NUM
ajlsi-1012	605	13	-	-	SYM
ajlsi-1012	605	14	120	120	NUM
ajlsi-1012	605	15	.	.	PUNCT
ajlsi-1012	606	1	vanguilder	vanguilder	NOUN
ajlsi-1012	606	2	,	,	PUNCT
ajlsi-1012	606	3	h.	h.	PROPN
ajlsi-1012	606	4	d.	d.	PROPN
ajlsi-1012	606	5	,	,	PUNCT
ajlsi-1012	606	6	vrana	vrana	PROPN
ajlsi-1012	606	7	,	,	PUNCT
ajlsi-1012	606	8	k.	k.	PROPN
ajlsi-1012	606	9	e.	e.	PROPN
ajlsi-1012	606	10	,	,	PUNCT
ajlsi-1012	606	11	et	et	PROPN
ajlsi-1012	606	12	al	al	PROPN
ajlsi-1012	606	13	.	.	PROPN
ajlsi-1012	606	14	,	,	PUNCT
ajlsi-1012	606	15	(	(	PUNCT
ajlsi-1012	606	16	2008	2008	NUM
ajlsi-1012	606	17	)	)	PUNCT
ajlsi-1012	606	18	.	.	PUNCT
ajlsi-1012	607	1	twentyfive	twentyfive	ADJ
ajlsi-1012	607	2	years	year	NOUN
ajlsi-1012	607	3	of	of	ADP
ajlsi-1012	607	4	quantitative	quantitative	ADJ
ajlsi-1012	607	5	pcr	pcr	NOUN
ajlsi-1012	607	6	for	for	ADP
ajlsi-1012	607	7	gene	gene	NOUN
ajlsi-1012	607	8	expression	expression	NOUN
ajlsi-1012	607	9	analysis	analysis	NOUN
ajlsi-1012	607	10	.	.	PUNCT
ajlsi-1012	608	1	biotechniques	biotechnique	NOUN
ajlsi-1012	608	2	,	,	PUNCT
ajlsi-1012	608	3	44(5	44(5	NOUN
ajlsi-1012	608	4	)	)	PUNCT
ajlsi-1012	608	5	,	,	PUNCT
ajlsi-1012	608	6	619	619	NUM
ajlsi-1012	608	7	-	-	SYM
ajlsi-1012	608	8	626	626	NUM
ajlsi-1012	608	9	.	.	PUNCT
ajlsi-1012	609	1	venter	venter	NOUN
ajlsi-1012	609	2	,	,	PUNCT
ajlsi-1012	609	3	m.	m.	NOUN
ajlsi-1012	609	4	,	,	PUNCT
ajlsi-1012	609	5	&	&	CCONJ
ajlsi-1012	609	6	richter	richter	PROPN
ajlsi-1012	609	7	,	,	PUNCT
ajlsi-1012	609	8	k.	k.	PROPN
ajlsi-1012	609	9	(	(	PUNCT
ajlsi-1012	609	10	2020	2020	NUM
ajlsi-1012	609	11	)	)	PUNCT
ajlsi-1012	609	12	.	.	PUNCT
ajlsi-1012	610	1	towards	towards	ADP
ajlsi-1012	610	2	effective	effective	ADJ
ajlsi-1012	610	3	diagnostic	diagnostic	ADJ
ajlsi-1012	610	4	assays	assay	NOUN
ajlsi-1012	610	5	for	for	ADP
ajlsi-1012	610	6	covid-19	covid-19	PROPN
ajlsi-1012	610	7	:	:	PUNCT
ajlsi-1012	610	8	a	a	DET
ajlsi-1012	610	9	review	review	NOUN
ajlsi-1012	610	10	.	.	PUNCT
ajlsi-1012	611	1	journal	journal	NOUN
ajlsi-1012	611	2	of	of	ADP
ajlsi-1012	611	3	clinical	clinical	ADJ
ajlsi-1012	611	4	pathology	pathology	NOUN
ajlsi-1012	611	5	,	,	PUNCT
ajlsi-1012	611	6	73(7	73(7	NOUN
ajlsi-1012	611	7	)	)	PUNCT
ajlsi-1012	611	8	,	,	PUNCT
ajlsi-1012	611	9	370	370	NUM
ajlsi-1012	611	10	-	-	SYM
ajlsi-1012	611	11	377	377	NUM
ajlsi-1012	611	12	.	.	PUNCT
ajlsi-1012	612	1	verdun	verdun	PROPN
ajlsi-1012	612	2	,	,	PUNCT
ajlsi-1012	612	3	c.	c.	PROPN
ajlsi-1012	612	4	m.	m.	NOUN
ajlsi-1012	612	5	,	,	PUNCT
ajlsi-1012	612	6	fuchs	fuch	NOUN
ajlsi-1012	612	7	,	,	PUNCT
ajlsi-1012	612	8	t.	t.	PROPN
ajlsi-1012	612	9	,	,	PUNCT
ajlsi-1012	612	10	harar	harar	PROPN
ajlsi-1012	612	11	,	,	PUNCT
ajlsi-1012	612	12	p.	p.	PROPN
ajlsi-1012	612	13	,	,	PUNCT
ajlsi-1012	612	14	et	et	PROPN
ajlsi-1012	612	15	al	al	PROPN
ajlsi-1012	612	16	.	.	PROPN
ajlsi-1012	612	17	,	,	PUNCT
ajlsi-1012	612	18	(	(	PUNCT
ajlsi-1012	612	19	2021	2021	NUM
ajlsi-1012	612	20	)	)	PUNCT
ajlsi-1012	612	21	.	.	PUNCT
ajlsi-1012	613	1	group	group	NOUN
ajlsi-1012	613	2	testing	testing	NOUN
ajlsi-1012	613	3	for	for	ADP
ajlsi-1012	613	4	sars	sar	NOUN
ajlsi-1012	613	5	-	-	PUNCT
ajlsi-1012	613	6	cov-2	cov-2	PART
ajlsi-1012	613	7	allows	allow	VERB
ajlsi-1012	613	8	for	for	ADP
ajlsi-1012	613	9	up	up	ADP
ajlsi-1012	613	10	to	to	PART
ajlsi-1012	613	11	10	10	NUM
ajlsi-1012	613	12	fold	fold	ADJ
ajlsi-1012	613	13	efficiency	efficiency	NOUN
ajlsi-1012	613	14	increase	increase	NOUN
ajlsi-1012	613	15	across	across	ADP
ajlsi-1012	613	16	realistic	realistic	ADJ
ajlsi-1012	613	17	scenarios	scenario	NOUN
ajlsi-1012	613	18	and	and	CCONJ
ajlsi-1012	613	19	testing	testing	NOUN
ajlsi-1012	613	20	strategies	strategy	NOUN
ajlsi-1012	613	21	.	.	PUNCT
ajlsi-1012	614	1	frontiers	frontier	NOUN
ajlsi-1012	614	2	in	in	ADP
ajlsi-1012	614	3	public	public	ADJ
ajlsi-1012	614	4	health	health	NOUN
ajlsi-1012	614	5	,	,	PUNCT
ajlsi-1012	614	6	1205	1205	NUM
ajlsi-1012	614	7	.	.	PUNCT
ajlsi-1012	615	1	wan	wan	PROPN
ajlsi-1012	615	2	,	,	PUNCT
ajlsi-1012	615	3	z.	z.	PROPN
ajlsi-1012	615	4	,	,	PUNCT
ajlsi-1012	615	5	zhang	zhang	PROPN
ajlsi-1012	615	6	,	,	PUNCT
ajlsi-1012	615	7	y.	y.	PROPN
ajlsi-1012	615	8	n.	n.	PROPN
ajlsi-1012	615	9	,	,	PUNCT
ajlsi-1012	615	10	he	he	PRON
ajlsi-1012	615	11	,	,	PUNCT
ajlsi-1012	615	12	z.	z.	PROPN
ajlsi-1012	615	13	,	,	PUNCT
ajlsi-1012	615	14	(	(	PUNCT
ajlsi-1012	615	15	2016	2016	NUM
ajlsi-1012	615	16	)	)	PUNCT
ajlsi-1012	615	17	.	.	PUNCT
ajlsi-1012	616	1	a	a	DET
ajlsi-1012	616	2	melting	melting	NOUN
ajlsi-1012	616	3	curvebased	curvebase	VERB
ajlsi-1012	616	4	multiplex	multiplex	PROPN
ajlsi-1012	616	5	rt	rt	PROPN
ajlsi-1012	616	6	-	-	PUNCT
ajlsi-1012	616	7	qpcr	qpcr	ADV
ajlsi-1012	616	8	assay	assay	VERB
ajlsi-1012	616	9	for	for	ADP
ajlsi-1012	616	10	simultaneous	simultaneous	ADJ
ajlsi-1012	616	11	detection	detection	NOUN
ajlsi-1012	616	12	of	of	ADP
ajlsi-1012	616	13	four	four	NUM
ajlsi-1012	616	14	human	human	PROPN
ajlsi-1012	616	15	et	et	PROPN
ajlsi-1012	616	16	al	al	PROPN
ajlsi-1012	616	17	.	.	PROPN
ajlsi-1012	616	18	,	,	PUNCT
ajlsi-1012	616	19	coronaviruses	coronaviruse	NOUN
ajlsi-1012	616	20	.	.	PUNCT
ajlsi-1012	617	1	international	international	ADJ
ajlsi-1012	617	2	journal	journal	NOUN
ajlsi-1012	617	3	of	of	ADP
ajlsi-1012	617	4	molecular	molecular	ADJ
ajlsi-1012	617	5	sciences	science	NOUN
ajlsi-1012	617	6	,	,	PUNCT
ajlsi-1012	617	7	17(11	17(11	NUM
ajlsi-1012	617	8	)	)	PUNCT
ajlsi-1012	617	9	,	,	PUNCT
ajlsi-1012	617	10	1880	1880	NUM
ajlsi-1012	617	11	.	.	PUNCT
ajlsi-1012	618	1	wang	wang	PROPN
ajlsi-1012	618	2	,	,	PUNCT
ajlsi-1012	618	3	d.	d.	PROPN
ajlsi-1012	618	4	,	,	PUNCT
ajlsi-1012	618	5	hu	hu	PROPN
ajlsi-1012	618	6	,	,	PUNCT
ajlsi-1012	618	7	b.	b.	PROPN
ajlsi-1012	618	8	,	,	PUNCT
ajlsi-1012	618	9	hu	hu	PROPN
ajlsi-1012	618	10	,	,	PUNCT
ajlsi-1012	618	11	c.	c.	PROPN
ajlsi-1012	618	12	,	,	PUNCT
ajlsi-1012	618	13	zhu	zhu	PROPN
ajlsi-1012	618	14	,	,	PUNCT
ajlsi-1012	618	15	f.	f.	PROPN
ajlsi-1012	618	16	,	,	PUNCT
ajlsi-1012	618	17	et	et	PROPN
ajlsi-1012	618	18	al	al	PROPN
ajlsi-1012	618	19	.	.	PROPN
ajlsi-1012	618	20	,	,	PUNCT
ajlsi-1012	618	21	(	(	PUNCT
ajlsi-1012	618	22	2020	2020	NUM
ajlsi-1012	618	23	)	)	PUNCT
ajlsi-1012	618	24	.	.	PUNCT
ajlsi-1012	619	1	clinical	clinical	ADJ
ajlsi-1012	619	2	characteristics	characteristic	NOUN
ajlsi-1012	619	3	of	of	ADP
ajlsi-1012	619	4	138	138	NUM
ajlsi-1012	619	5	hospitalized	hospitalize	VERB
ajlsi-1012	619	6	patients	patient	NOUN
ajlsi-1012	619	7	with	with	ADP
ajlsi-1012	619	8	2019	2019	NUM
ajlsi-1012	619	9	novel	novel	ADJ
ajlsi-1012	619	10	coronavirus	coronavirus	NOUN
ajlsi-1012	619	11	–	–	PUNCT
ajlsi-1012	619	12	infected	infected	ADJ
ajlsi-1012	619	13	pneumonia	pneumonia	NOUN
ajlsi-1012	619	14	in	in	ADP
ajlsi-1012	619	15	wuhan	wuhan	PROPN
ajlsi-1012	619	16	,	,	PUNCT
ajlsi-1012	619	17	china	china	PROPN
ajlsi-1012	619	18	:	:	PUNCT
ajlsi-1012	619	19	journal	journal	PROPN
ajlsi-1012	619	20	of	of	ADP
ajlsi-1012	619	21	american	american	PROPN
ajlsi-1012	619	22	medical	medical	PROPN
ajlsi-1012	619	23	association	association	PROPN
ajlsi-1012	619	24	,	,	PUNCT
ajlsi-1012	619	25	323(11	323(11	NUM
ajlsi-1012	619	26	)	)	PUNCT
ajlsi-1012	619	27	,	,	PUNCT
ajlsi-1012	619	28	1061	1061	NUM
ajlsi-1012	619	29	-	-	SYM
ajlsi-1012	619	30	1069	1069	NUM
ajlsi-1012	619	31	.	.	PUNCT
ajlsi-1012	620	1	wang	wang	PROPN
ajlsi-1012	620	2	,	,	PUNCT
ajlsi-1012	620	3	w.	w.	PROPN
ajlsi-1012	620	4	k.	k.	PROPN
ajlsi-1012	620	5	,	,	PUNCT
ajlsi-1012	620	6	fang	fang	PROPN
ajlsi-1012	620	7	,	,	PUNCT
ajlsi-1012	620	8	c.	c.	PROPN
ajlsi-1012	620	9	t.	t.	PROPN
ajlsi-1012	620	10	,	,	PUNCT
ajlsi-1012	620	11	chen	chen	PROPN
ajlsi-1012	620	12	,	,	PUNCT
ajlsi-1012	620	13	h.	h.	PROPN
ajlsi-1012	620	14	l.	l.	PROPN
ajlsi-1012	620	15	,	,	PUNCT
ajlsi-1012	620	16	et	et	PROPN
ajlsi-1012	620	17	al	al	PROPN
ajlsi-1012	620	18	.	.	PROPN
ajlsi-1012	620	19	,	,	PUNCT
ajlsi-1012	620	20	(	(	PUNCT
ajlsi-1012	620	21	2005	2005	NUM
ajlsi-1012	620	22	)	)	PUNCT
ajlsi-1012	620	23	.	.	PUNCT
ajlsi-1012	621	1	detection	detection	NOUN
ajlsi-1012	621	2	of	of	ADP
ajlsi-1012	621	3	severe	severe	ADJ
ajlsi-1012	621	4	acute	acute	ADJ
ajlsi-1012	621	5	respiratory	respiratory	ADJ
ajlsi-1012	621	6	syndrome	syndrome	NOUN
ajlsi-1012	621	7	coronavirus	coronavirus	NOUN
ajlsi-1012	621	8	rna	rna	NOUN
ajlsi-1012	621	9	in	in	ADP
ajlsi-1012	621	10	plasma	plasma	NOUN
ajlsi-1012	621	11	during	during	ADP
ajlsi-1012	621	12	the	the	DET
ajlsi-1012	621	13	course	course	NOUN
ajlsi-1012	621	14	of	of	ADP
ajlsi-1012	621	15	infection	infection	NOUN
ajlsi-1012	621	16	.	.	PUNCT
ajlsi-1012	621	17	:	:	PUNCT
ajlsi-1012	622	1	journal	journal	NOUN
ajlsi-1012	622	2	of	of	ADP
ajlsi-1012	622	3	clinical	clinical	ADJ
ajlsi-1012	622	4	microbiology	microbiology	NOUN
ajlsi-1012	622	5	,	,	PUNCT
ajlsi-1012	622	6	43(2	43(2	NUM
ajlsi-1012	622	7	)	)	PUNCT
ajlsi-1012	622	8	,	,	PUNCT
ajlsi-1012	622	9	962	962	NUM
ajlsi-1012	622	10	-	-	SYM
ajlsi-1012	622	11	965	965	NUM
ajlsi-1012	622	12	.	.	PUNCT
ajlsi-1012	623	1	wang	wang	PROPN
ajlsi-1012	623	2	,	,	PUNCT
ajlsi-1012	623	3	w.	w.	PROPN
ajlsi-1012	623	4	,	,	PUNCT
ajlsi-1012	623	5	xu	xu	PROPN
ajlsi-1012	623	6	,	,	PUNCT
ajlsi-1012	623	7	y.	y.	PROPN
ajlsi-1012	623	8	,	,	PUNCT
ajlsi-1012	623	9	gao	gao	PROPN
ajlsi-1012	623	10	,	,	PUNCT
ajlsi-1012	623	11	r.	r.	PROPN
ajlsi-1012	623	12	,	,	PUNCT
ajlsi-1012	623	13	et	et	PROPN
ajlsi-1012	623	14	al	al	PROPN
ajlsi-1012	623	15	.	.	PROPN
ajlsi-1012	623	16	,	,	PUNCT
ajlsi-1012	623	17	(	(	PUNCT
ajlsi-1012	623	18	2020	2020	NUM
ajlsi-1012	623	19	)	)	PUNCT
ajlsi-1012	623	20	.	.	PUNCT
ajlsi-1012	624	1	detection	detection	NOUN
ajlsi-1012	624	2	of	of	ADP
ajlsi-1012	624	3	sars	sar	NOUN
ajlsi-1012	624	4	-	-	PUNCT
ajlsi-1012	624	5	cov-2	cov-2	NOUN
ajlsi-1012	624	6	in	in	ADP
ajlsi-1012	624	7	different	different	ADJ
ajlsi-1012	624	8	types	type	NOUN
ajlsi-1012	624	9	of	of	ADP
ajlsi-1012	624	10	clinical	clinical	ADJ
ajlsi-1012	624	11	specimens	specimen	NOUN
ajlsi-1012	624	12	.	.	PROPN
ajlsi-1012	624	13	journal	journal	PROPN
ajlsi-1012	624	14	of	of	ADP
ajlsi-1012	624	15	american	american	PROPN
ajlsi-1012	624	16	medical	medical	PROPN
ajlsi-1012	624	17	association	association	PROPN
ajlsi-1012	624	18	,	,	PUNCT
ajlsi-1012	624	19	323(18),1843	323(18),1843	NUM
ajlsi-1012	624	20	-	-	SYM
ajlsi-1012	624	21	1844	1844	NUM
ajlsi-1012	624	22	.	.	PUNCT
ajlsi-1012	625	1	wong	wong	PROPN
ajlsi-1012	625	2	,	,	PUNCT
ajlsi-1012	625	3	m.	m.	PROPN
ajlsi-1012	625	4	l.	l.	PROPN
ajlsi-1012	625	5	,	,	PUNCT
ajlsi-1012	625	6	&	&	CCONJ
ajlsi-1012	625	7	medrano	medrano	PROPN
ajlsi-1012	625	8	,	,	PUNCT
ajlsi-1012	625	9	j.	j.	PROPN
ajlsi-1012	625	10	f.	f.	PROPN
ajlsi-1012	625	11	(	(	PUNCT
ajlsi-1012	625	12	2005	2005	NUM
ajlsi-1012	625	13	)	)	PUNCT
ajlsi-1012	625	14	.	.	PUNCT
ajlsi-1012	626	1	real	real	ADJ
ajlsi-1012	626	2	-	-	PUNCT
ajlsi-1012	626	3	time	time	NOUN
ajlsi-1012	626	4	pcr	pcr	NOUN
ajlsi-1012	626	5	for	for	ADP
ajlsi-1012	626	6	mrna	mrna	PROPN
ajlsi-1012	626	7	quantitation	quantitation	NOUN
ajlsi-1012	626	8	.	.	PUNCT
ajlsi-1012	627	1	biotechniques	biotechnique	NOUN
ajlsi-1012	627	2	,	,	PUNCT
ajlsi-1012	627	3	39(1	39(1	NUM
ajlsi-1012	627	4	)	)	PUNCT
ajlsi-1012	627	5	,	,	PUNCT
ajlsi-1012	627	6	75	75	NUM
ajlsi-1012	627	7	-	-	SYM
ajlsi-1012	627	8	85	85	NUM
ajlsi-1012	627	9	.	.	PUNCT
ajlsi-1012	628	1	world	world	PROPN
ajlsi-1012	628	2	health	health	PROPN
ajlsi-1012	628	3	organization	organization	PROPN
ajlsi-1012	628	4	.	.	PUNCT
ajlsi-1012	629	1	(	(	PUNCT
ajlsi-1012	629	2	2020	2020	NUM
ajlsi-1012	629	3	)	)	PUNCT
ajlsi-1012	629	4	.	.	PUNCT
ajlsi-1012	630	1	global	global	ADJ
ajlsi-1012	630	2	surveillance	surveillance	NOUN
ajlsi-1012	630	3	for	for	ADP
ajlsi-1012	630	4	covid-19	covid-19	PROPN
ajlsi-1012	630	5	caused	cause	VERB
ajlsi-1012	630	6	by	by	ADP
ajlsi-1012	630	7	human	human	ADJ
ajlsi-1012	630	8	infection	infection	NOUN
ajlsi-1012	630	9	with	with	ADP
ajlsi-1012	630	10	covid-19	covid-19	PROPN
ajlsi-1012	630	11	virus	virus	NOUN
ajlsi-1012	630	12	:	:	PUNCT
ajlsi-1012	630	13	interim	interim	ADJ
ajlsi-1012	630	14	guidance	guidance	NOUN
ajlsi-1012	630	15	,	,	PUNCT
ajlsi-1012	630	16	20	20	NUM
ajlsi-1012	630	17	march	march	NOUN
ajlsi-1012	630	18	2020	2020	NUM
ajlsi-1012	630	19	(	(	PUNCT
ajlsi-1012	630	20	no	no	INTJ
ajlsi-1012	630	21	.	.	PUNCT
ajlsi-1012	630	22	who/2019	who/2019	PROPN
ajlsi-1012	630	23	-	-	PUNCT
ajlsi-1012	630	24	ncov	ncov	NOUN
ajlsi-1012	630	25	/	/	SYM
ajlsi-1012	630	26	surveillance	surveillance	NOUN
ajlsi-1012	630	27	guidance/2020.6	guidance/2020.6	NOUN
ajlsi-1012	630	28	)	)	PUNCT
ajlsi-1012	630	29	.	.	PUNCT
ajlsi-1012	631	1	world	world	PROPN
ajlsi-1012	631	2	health	health	PROPN
ajlsi-1012	631	3	organization	organization	PROPN
ajlsi-1012	631	4	.	.	PUNCT
ajlsi-1012	632	1	world	world	PROPN
ajlsi-1012	632	2	health	health	PROPN
ajlsi-1012	632	3	organization	organization	PROPN
ajlsi-1012	632	4	.	.	PUNCT
ajlsi-1012	633	1	(	(	PUNCT
ajlsi-1012	633	2	2020	2020	NUM
ajlsi-1012	633	3	)	)	PUNCT
ajlsi-1012	633	4	.	.	PUNCT
ajlsi-1012	634	1	laboratory	laboratory	NOUN
ajlsi-1012	634	2	testing	test	VERB
ajlsi-1012	634	3	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	634	4	pa	pa	PROPN
ajlsi-1012	634	5	ge	ge	PROPN
ajlsi-1012	634	6	42	42	NUM
ajlsi-1012	634	7	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-1012	634	8	am	am	NOUN
ajlsi-1012	634	9	.	.	PUNCT
ajlsi-1012	635	1	j.	j.	PROPN
ajlsi-1012	635	2	life	life	PROPN
ajlsi-1012	635	3	sci	sci	PROPN
ajlsi-1012	635	4	.	.	PUNCT
ajlsi-1012	635	5	innov	innov	PROPN
ajlsi-1012	635	6	.	.	PUNCT
ajlsi-1012	636	1	1(2	1(2	NUM
ajlsi-1012	636	2	)	)	PUNCT
ajlsi-1012	636	3	29	29	NUM
ajlsi-1012	636	4	-	-	SYM
ajlsi-1012	636	5	42	42	NUM
ajlsi-1012	636	6	,	,	PUNCT
ajlsi-1012	636	7	2022	2022	NUM
ajlsi-1012	636	8	for	for	ADP
ajlsi-1012	636	9	coronavirus	coronavirus	NOUN
ajlsi-1012	636	10	disease	disease	NOUN
ajlsi-1012	636	11	2019	2019	NUM
ajlsi-1012	636	12	(	(	PUNCT
ajlsi-1012	636	13	covid-19	covid-19	PROPN
ajlsi-1012	636	14	)	)	PUNCT
ajlsi-1012	636	15	in	in	ADP
ajlsi-1012	636	16	suspected	suspect	VERB
ajlsi-1012	636	17	human	human	ADJ
ajlsi-1012	636	18	cases	case	NOUN
ajlsi-1012	636	19	:	:	PUNCT
ajlsi-1012	636	20	interim	interim	ADJ
ajlsi-1012	636	21	guidance	guidance	NOUN
ajlsi-1012	636	22	,	,	PUNCT
ajlsi-1012	636	23	2	2	NUM
ajlsi-1012	636	24	march	march	NOUN
ajlsi-1012	636	25	2020	2020	NUM
ajlsi-1012	636	26	(	(	PUNCT
ajlsi-1012	636	27	no	no	INTJ
ajlsi-1012	636	28	.	.	PUNCT
ajlsi-1012	637	1	who	who	PRON
ajlsi-1012	637	2	/	/	SYM
ajlsi-1012	637	3	covid-19	covid-19	PROPN
ajlsi-1012	637	4	/	/	SYM
ajlsi-1012	637	5	laboratory/2020.4	laboratory/2020.4	PROPN
ajlsi-1012	637	6	)	)	PUNCT
ajlsi-1012	637	7	.	.	PUNCT
ajlsi-1012	638	1	world	world	PROPN
ajlsi-1012	638	2	health	health	PROPN
ajlsi-1012	638	3	organization	organization	PROPN
ajlsi-1012	638	4	.	.	PUNCT
ajlsi-1012	639	1	world	world	PROPN
ajlsi-1012	639	2	health	health	PROPN
ajlsi-1012	639	3	organization	organization	PROPN
ajlsi-1012	639	4	.	.	PUNCT
ajlsi-1012	640	1	(	(	PUNCT
ajlsi-1012	640	2	2020	2020	NUM
ajlsi-1012	640	3	)	)	PUNCT
ajlsi-1012	640	4	.	.	PUNCT
ajlsi-1012	641	1	operational	operational	ADJ
ajlsi-1012	641	2	considerations	consideration	NOUN
ajlsi-1012	641	3	for	for	ADP
ajlsi-1012	641	4	covid-19	covid-19	PROPN
ajlsi-1012	641	5	surveillance	surveillance	NOUN
ajlsi-1012	641	6	using	use	VERB
ajlsi-1012	641	7	gisrs	gisrs	NOUN
ajlsi-1012	641	8	:	:	PUNCT
ajlsi-1012	641	9	interim	interim	ADJ
ajlsi-1012	641	10	guidance	guidance	NOUN
ajlsi-1012	641	11	,	,	PUNCT
ajlsi-1012	641	12	26	26	NUM
ajlsi-1012	641	13	march	march	NOUN
ajlsi-1012	641	14	2020	2020	NUM
ajlsi-1012	641	15	(	(	PUNCT
ajlsi-1012	641	16	no	no	INTJ
ajlsi-1012	641	17	.	.	PUNCT
ajlsi-1012	641	18	who/2019ncov	who/2019ncov	NOUN
ajlsi-1012	641	19	/	/	SYM
ajlsi-1012	641	20	leveraging	leverage	VERB
ajlsi-1012	641	21	gisrs/2020.1	gisrs/2020.1	NOUN
ajlsi-1012	641	22	)	)	PUNCT
ajlsi-1012	641	23	.	.	PUNCT
ajlsi-1012	642	1	world	world	PROPN
ajlsi-1012	642	2	health	health	PROPN
ajlsi-1012	642	3	organization.2020	organization.2020	PROPN
ajlsi-1012	642	4	.	.	PROPN
ajlsi-1012	642	5	wu	wu	PROPN
ajlsi-1012	642	6	,	,	PUNCT
ajlsi-1012	642	7	f.	f.	PROPN
ajlsi-1012	642	8	,	,	PUNCT
ajlsi-1012	642	9	zhao	zhao	PROPN
ajlsi-1012	642	10	,	,	PUNCT
ajlsi-1012	642	11	s.	s.	PROPN
ajlsi-1012	642	12	,	,	PUNCT
ajlsi-1012	642	13	yu	yu	PROPN
ajlsi-1012	642	14	,	,	PUNCT
ajlsi-1012	642	15	b.	b.	PROPN
ajlsi-1012	642	16	,	,	PUNCT
ajlsi-1012	642	17	chen	chen	PROPN
ajlsi-1012	642	18	,	,	PUNCT
ajlsi-1012	642	19	y.	y.	PROPN
ajlsi-1012	642	20	m.	m.	PROPN
ajlsi-1012	642	21	,	,	PUNCT
ajlsi-1012	642	22	et	et	PROPN
ajlsi-1012	642	23	al	al	PROPN
ajlsi-1012	642	24	.	.	PROPN
ajlsi-1012	642	25	,	,	PUNCT
ajlsi-1012	642	26	(	(	PUNCT
ajlsi-1012	642	27	2020	2020	NUM
ajlsi-1012	642	28	)	)	PUNCT
ajlsi-1012	642	29	.	.	PUNCT
ajlsi-1012	643	1	a	a	DET
ajlsi-1012	643	2	new	new	ADJ
ajlsi-1012	643	3	coronavirus	coronavirus	NOUN
ajlsi-1012	643	4	associated	associate	VERB
ajlsi-1012	643	5	with	with	ADP
ajlsi-1012	643	6	human	human	ADJ
ajlsi-1012	643	7	respiratory	respiratory	ADJ
ajlsi-1012	643	8	disease	disease	NOUN
ajlsi-1012	643	9	in	in	ADP
ajlsi-1012	643	10	china	china	PROPN
ajlsi-1012	643	11	.	.	PUNCT
ajlsi-1012	644	1	nature	nature	PROPN
ajlsi-1012	644	2	,	,	PUNCT
ajlsi-1012	644	3	579(7798	579(7798	NUM
ajlsi-1012	644	4	)	)	PUNCT
ajlsi-1012	644	5	,	,	PUNCT
ajlsi-1012	644	6	265	265	NUM
ajlsi-1012	644	7	-	-	SYM
ajlsi-1012	644	8	269	269	NUM
ajlsi-1012	644	9	.	.	PUNCT
ajlsi-1012	645	1	xiang	xiang	PROPN
ajlsi-1012	645	2	,	,	PUNCT
ajlsi-1012	645	3	j.	j.	PROPN
ajlsi-1012	645	4	,	,	PUNCT
ajlsi-1012	645	5	yan	yan	PROPN
ajlsi-1012	645	6	,	,	PUNCT
ajlsi-1012	645	7	m.	m.	NOUN
ajlsi-1012	645	8	,	,	PUNCT
ajlsi-1012	645	9	li	li	PROPN
ajlsi-1012	645	10	,	,	PUNCT
ajlsi-1012	645	11	h.	h.	PROPN
ajlsi-1012	645	12	,	,	PUNCT
ajlsi-1012	645	13	liu	liu	PROPN
ajlsi-1012	645	14	,	,	PUNCT
ajlsi-1012	645	15	t.	t.	PROPN
ajlsi-1012	645	16	,	,	PUNCT
ajlsi-1012	645	17	et	et	PROPN
ajlsi-1012	645	18	al	al	PROPN
ajlsi-1012	645	19	.	.	PROPN
ajlsi-1012	645	20	,	,	PUNCT
ajlsi-1012	645	21	(	(	PUNCT
ajlsi-1012	645	22	2020	2020	NUM
ajlsi-1012	645	23	)	)	PUNCT
ajlsi-1012	645	24	.	.	PUNCT
ajlsi-1012	646	1	evaluation	evaluation	NOUN
ajlsi-1012	646	2	of	of	ADP
ajlsi-1012	646	3	enzyme	enzyme	NOUN
ajlsi-1012	646	4	-	-	PUNCT
ajlsi-1012	646	5	linked	link	VERB
ajlsi-1012	646	6	immunoassay	immunoassay	NOUN
ajlsi-1012	646	7	and	and	CCONJ
ajlsi-1012	646	8	colloidal	colloidal	NOUN
ajlsi-1012	646	9	goldimmunochromatographic	goldimmunochromatographic	ADJ
ajlsi-1012	646	10	assay	assay	NOUN
ajlsi-1012	646	11	kit	kit	NOUN
ajlsi-1012	646	12	for	for	ADP
ajlsi-1012	646	13	detection	detection	NOUN
ajlsi-1012	646	14	of	of	ADP
ajlsi-1012	646	15	novel	novel	ADJ
ajlsi-1012	646	16	coronavirus	coronavirus	NOUN
ajlsi-1012	646	17	(	(	PUNCT
ajlsi-1012	646	18	sars	sar	NOUN
ajlsi-1012	646	19	-	-	PUNCT
ajlsi-1012	646	20	cov-2	cov-2	NOUN
ajlsi-1012	646	21	)	)	PUNCT
ajlsi-1012	646	22	causing	cause	VERB
ajlsi-1012	646	23	an	an	DET
ajlsi-1012	646	24	outbreak	outbreak	NOUN
ajlsi-1012	646	25	of	of	ADP
ajlsi-1012	646	26	pneumonia	pneumonia	NOUN
ajlsi-1012	646	27	(	(	PUNCT
ajlsi-1012	646	28	covid-19	covid-19	PROPN
ajlsi-1012	646	29	)	)	PUNCT
ajlsi-1012	646	30	.	.	PUNCT
ajlsi-1012	647	1	medrxiv	medrxiv	X
ajlsi-1012	647	2	:	:	PUNCT
ajlsi-1012	647	3	https://doi.or	https://doi.or	PROPN
ajlsi-1012	647	4	g/10.1101/2020.02.27.20028787	g/10.1101/2020.02.27.20028787	PROPN
ajlsi-1012	647	5	xu	xu	PROPN
ajlsi-1012	648	1	k	k	PROPN
ajlsi-1012	648	2	,	,	PUNCT
ajlsi-1012	648	3	cai	cai	PROPN
ajlsi-1012	648	4	h	h	PROPN
ajlsi-1012	648	5	,	,	PUNCT
ajlsi-1012	648	6	shen	shen	PROPN
ajlsi-1012	648	7	y.	y.	PROPN
ajlsi-1012	648	8	,	,	PUNCT
ajlsi-1012	648	9	et	et	PROPN
ajlsi-1012	648	10	al	al	PROPN
ajlsi-1012	648	11	.	.	PROPN
ajlsi-1012	648	12	,	,	PUNCT
ajlsi-1012	648	13	(	(	PUNCT
ajlsi-1012	648	14	2020	2020	NUM
ajlsi-1012	648	15	)	)	PUNCT
ajlsi-1012	648	16	.	.	PUNCT
ajlsi-1012	649	1	management	management	NOUN
ajlsi-1012	649	2	of	of	ADP
ajlsi-1012	649	3	coronavirus	coronavirus	NOUN
ajlsi-1012	649	4	disease	disease	NOUN
ajlsi-1012	649	5	2019	2019	NUM
ajlsi-1012	649	6	(	(	PUNCT
ajlsi-1012	649	7	covid-19	covid-19	PROPN
ajlsi-1012	649	8	):	):	PUNCT
ajlsi-1012	649	9	infectious	infectious	ADJ
ajlsi-1012	649	10	microbes	microbe	NOUN
ajlsi-1012	649	11	&	&	CCONJ
ajlsi-1012	649	12	diseases	disease	NOUN
ajlsi-1012	649	13	.	.	PUNCT
ajlsi-1012	650	1	https://doi.org/10.1097/	https://doi.org/10.1097/	PROPN
ajlsi-1012	650	2	im9.0000000000000023	im9.0000000000000023	PROPN
ajlsi-1012	650	3	.	.	PUNCT
ajlsi-1012	651	1	xu	xu	PROPN
ajlsi-1012	651	2	,	,	PUNCT
ajlsi-1012	651	3	m.	m.	NOUN
ajlsi-1012	651	4	,	,	PUNCT
ajlsi-1012	651	5	ye	ye	PROPN
ajlsi-1012	651	6	,	,	PUNCT
ajlsi-1012	651	7	j.	j.	PROPN
ajlsi-1012	651	8	,	,	PUNCT
ajlsi-1012	651	9	yang	yang	PROPN
ajlsi-1012	651	10	,	,	PUNCT
ajlsi-1012	651	11	d.	d.	PROPN
ajlsi-1012	651	12	,	,	PUNCT
ajlsi-1012	651	13	et	et	PROPN
ajlsi-1012	651	14	al	al	PROPN
ajlsi-1012	651	15	.	.	PROPN
ajlsi-1012	651	16	,	,	PUNCT
ajlsi-1012	651	17	(	(	PUNCT
ajlsi-1012	651	18	2019	2019	NUM
ajlsi-1012	651	19	)	)	PUNCT
ajlsi-1012	651	20	.	.	PUNCT
ajlsi-1012	652	1	ultrasensitive	ultrasensitive	ADJ
ajlsi-1012	652	2	detection	detection	NOUN
ajlsi-1012	652	3	of	of	ADP
ajlsi-1012	652	4	mirna	mirna	PROPN
ajlsi-1012	652	5	via	via	ADP
ajlsi-1012	652	6	one	one	NUM
ajlsi-1012	652	7	-	-	PUNCT
ajlsi-1012	652	8	step	step	NOUN
ajlsi-1012	652	9	rolling	rolling	NOUN
ajlsi-1012	652	10	circlequantitative	circlequantitative	ADJ
ajlsi-1012	652	11	pcr	pcr	NOUN
ajlsi-1012	652	12	(	(	PUNCT
ajlsi-1012	652	13	rc	rc	NOUN
ajlsi-1012	652	14	-	-	ADJ
ajlsi-1012	652	15	qpcr	qpcr	ADJ
ajlsi-1012	652	16	)	)	PUNCT
ajlsi-1012	652	17	.	.	PUNCT
ajlsi-1012	653	1	analytica	analytica	PROPN
ajlsi-1012	653	2	chimica	chimica	PROPN
ajlsi-1012	653	3	acta	acta	PROPN
ajlsi-1012	653	4	,	,	PUNCT
ajlsi-1012	653	5	1077	1077	NUM
ajlsi-1012	653	6	,	,	PUNCT
ajlsi-1012	653	7	208	208	NUM
ajlsi-1012	653	8	-	-	SYM
ajlsi-1012	653	9	215	215	NUM
ajlsi-1012	653	10	.	.	PUNCT
ajlsi-1012	654	1	yu	yu	PROPN
ajlsi-1012	654	2	,	,	PUNCT
ajlsi-1012	654	3	f.	f.	PROPN
ajlsi-1012	654	4	,	,	PUNCT
ajlsi-1012	654	5	yan	yan	PROPN
ajlsi-1012	654	6	,	,	PUNCT
ajlsi-1012	654	7	l.	l.	PROPN
ajlsi-1012	654	8	,	,	PUNCT
ajlsi-1012	654	9	wang	wang	PROPN
ajlsi-1012	654	10	,	,	PUNCT
ajlsi-1012	654	11	n.	n.	PROPN
ajlsi-1012	654	12	,	,	PUNCT
ajlsi-1012	654	13	yang	yang	PROPN
ajlsi-1012	654	14	,	,	PUNCT
ajlsi-1012	654	15	s.	s.	PROPN
ajlsi-1012	654	16	,	,	PUNCT
ajlsi-1012	654	17	et	et	PROPN
ajlsi-1012	654	18	al	al	PROPN
ajlsi-1012	654	19	.	.	PROPN
ajlsi-1012	654	20	,	,	PUNCT
ajlsi-1012	654	21	(	(	PUNCT
ajlsi-1012	654	22	2020	2020	NUM
ajlsi-1012	654	23	)	)	PUNCT
ajlsi-1012	654	24	.	.	PUNCT
ajlsi-1012	655	1	quantitative	quantitative	ADJ
ajlsi-1012	655	2	detection	detection	NOUN
ajlsi-1012	655	3	and	and	CCONJ
ajlsi-1012	655	4	viral	viral	ADJ
ajlsi-1012	655	5	load	load	NOUN
ajlsi-1012	655	6	analysis	analysis	NOUN
ajlsi-1012	655	7	of	of	ADP
ajlsi-1012	655	8	sars	sar	NOUN
ajlsi-1012	655	9	-	-	PUNCT
ajlsi-1012	655	10	cov-2	cov-2	NOUN
ajlsi-1012	655	11	in	in	ADP
ajlsi-1012	655	12	infected	infected	ADJ
ajlsi-1012	655	13	patients	patient	NOUN
ajlsi-1012	655	14	.	.	PUNCT
ajlsi-1012	656	1	clinical	clinical	ADJ
ajlsi-1012	656	2	infectious	infectious	ADJ
ajlsi-1012	656	3	diseases	disease	NOUN
ajlsi-1012	656	4	,	,	PUNCT
ajlsi-1012	656	5	71(15	71(15	PROPN
ajlsi-1012	656	6	)	)	PUNCT
ajlsi-1012	656	7	,	,	PUNCT
ajlsi-1012	656	8	793	793	NUM
ajlsi-1012	656	9	-	-	SYM
ajlsi-1012	656	10	798	798	NUM
ajlsi-1012	656	11	yu	yu	PROPN
ajlsi-1012	656	12	,	,	PUNCT
ajlsi-1012	656	13	h.	h.	PROPN
ajlsi-1012	656	14	,	,	PUNCT
ajlsi-1012	656	15	sun	sun	PROPN
ajlsi-1012	656	16	,	,	PUNCT
ajlsi-1012	656	17	b.	b.	PROPN
ajlsi-1012	656	18	,	,	PUNCT
ajlsi-1012	656	19	fang	fang	PROPN
ajlsi-1012	656	20	,	,	PUNCT
ajlsi-1012	656	21	z.	z.	PROPN
ajlsi-1012	656	22	,	,	PUNCT
ajlsi-1012	656	23	et	et	PROPN
ajlsi-1012	656	24	al	al	PROPN
ajlsi-1012	656	25	.	.	PROPN
ajlsi-1012	656	26	,	,	PUNCT
ajlsi-1012	656	27	(	(	PUNCT
ajlsi-1012	656	28	2020	2020	NUM
ajlsi-1012	656	29	)	)	PUNCT
ajlsi-1012	656	30	.	.	PUNCT
ajlsi-1012	657	1	distinct	distinct	ADJ
ajlsi-1012	657	2	features	feature	NOUN
ajlsi-1012	657	3	of	of	ADP
ajlsi-1012	657	4	sars	sar	NOUN
ajlsi-1012	657	5	-	-	PUNCT
ajlsi-1012	657	6	cov-2specific	cov-2specific	ADJ
ajlsi-1012	657	7	iga	iga	PROPN
ajlsi-1012	657	8	response	response	NOUN
ajlsi-1012	657	9	in	in	ADP
ajlsi-1012	657	10	covid19	covid19	NOUN
ajlsi-1012	657	11	patients	patient	NOUN
ajlsi-1012	657	12	.	.	PUNCT
ajlsi-1012	658	1	european	european	ADJ
ajlsi-1012	658	2	respiratory	respiratory	ADJ
ajlsi-1012	658	3	journal	journal	PROPN
ajlsi-1012	658	4	.	.	PUNCT
ajlsi-1012	659	1	https://doi.org/	https://doi.org/	VERB
ajlsi-1012	659	2	10.1183/13993003.01526	10.1183/13993003.01526	NUM
ajlsi-1012	659	3	-	-	SYM
ajlsi-1012	659	4	2020	2020	NUM
ajlsi-1012	659	5	zhang	zhang	PROPN
ajlsi-1012	659	6	,	,	PUNCT
ajlsi-1012	659	7	f.	f.	PROPN
ajlsi-1012	659	8	,	,	PUNCT
ajlsi-1012	659	9	abudayyeh	abudayyeh	PROPN
ajlsi-1012	659	10	,	,	PUNCT
ajlsi-1012	659	11	o.	o.	PROPN
ajlsi-1012	659	12	o.	o.	PROPN
ajlsi-1012	659	13	,	,	PUNCT
ajlsi-1012	659	14	&	&	CCONJ
ajlsi-1012	659	15	gootenberg	gootenberg	PROPN
ajlsi-1012	659	16	,	,	PUNCT
ajlsi-1012	659	17	j.	j.	PROPN
ajlsi-1012	659	18	s.	s.	PROPN
ajlsi-1012	659	19	(	(	PUNCT
ajlsi-1012	659	20	2020	2020	NUM
ajlsi-1012	659	21	)	)	PUNCT
ajlsi-1012	659	22	.	.	PUNCT
ajlsi-1012	660	1	a	a	DET
ajlsi-1012	660	2	protocol	protocol	NOUN
ajlsi-1012	660	3	for	for	ADP
ajlsi-1012	660	4	detection	detection	NOUN
ajlsi-1012	660	5	of	of	ADP
ajlsi-1012	660	6	covid-19	covid-19	PROPN
ajlsi-1012	660	7	using	use	VERB
ajlsi-1012	660	8	crispr	crispr	ADJ
ajlsi-1012	660	9	diagnostics	diagnostic	NOUN
ajlsi-1012	660	10	.	.	PUNCT
ajlsi-1012	661	1	a	a	DET
ajlsi-1012	661	2	protocol	protocol	NOUN
ajlsi-1012	661	3	for	for	ADP
ajlsi-1012	661	4	detection	detection	NOUN
ajlsi-1012	661	5	of	of	ADP
ajlsi-1012	661	6	covid-19	covid-19	PROPN
ajlsi-1012	661	7	using	use	VERB
ajlsi-1012	661	8	crispr	crispr	ADJ
ajlsi-1012	661	9	diagnostics	diagnostic	NOUN
ajlsi-1012	661	10	,	,	PUNCT
ajlsi-1012	661	11	8	8	NUM
ajlsi-1012	661	12	.	.	X
ajlsi-1012	662	1	zhang	zhang	PROPN
ajlsi-1012	662	2	,	,	PUNCT
ajlsi-1012	662	3	y.	y.	PROPN
ajlsi-1012	662	4	,	,	PUNCT
ajlsi-1012	662	5	chen	chen	PROPN
ajlsi-1012	662	6	,	,	PUNCT
ajlsi-1012	662	7	c.	c.	PROPN
ajlsi-1012	662	8	,	,	PUNCT
ajlsi-1012	662	9	zhu	zhu	PROPN
ajlsi-1012	662	10	,	,	PUNCT
ajlsi-1012	662	11	s.	s.	PROPN
ajlsi-1012	662	12	,	,	PUNCT
ajlsi-1012	662	13	et	et	PROPN
ajlsi-1012	662	14	al	al	PROPN
ajlsi-1012	662	15	.	.	PROPN
ajlsi-1012	662	16	,	,	PUNCT
ajlsi-1012	662	17	(	(	PUNCT
ajlsi-1012	662	18	2020	2020	NUM
ajlsi-1012	662	19	)	)	PUNCT
ajlsi-1012	662	20	.	.	PUNCT
ajlsi-1012	663	1	isolation	isolation	NOUN
ajlsi-1012	663	2	of	of	ADP
ajlsi-1012	663	3	2019	2019	NUM
ajlsi-1012	663	4	-	-	PUNCT
ajlsi-1012	663	5	ncov	ncov	ADV
ajlsi-1012	663	6	from	from	ADP
ajlsi-1012	663	7	a	a	DET
ajlsi-1012	663	8	stool	stool	NOUN
ajlsi-1012	663	9	specimen	speciman	NOUN
ajlsi-1012	663	10	of	of	ADP
ajlsi-1012	663	11	a	a	DET
ajlsi-1012	663	12	laboratoryconfirmed	laboratoryconfirmed	ADJ
ajlsi-1012	663	13	case	case	NOUN
ajlsi-1012	663	14	of	of	ADP
ajlsi-1012	663	15	the	the	DET
ajlsi-1012	663	16	coronavirus	coronavirus	NOUN
ajlsi-1012	663	17	disease	disease	NOUN
ajlsi-1012	663	18	2019	2019	NUM
ajlsi-1012	663	19	(	(	PUNCT
ajlsi-1012	663	20	covid-19	covid-19	PROPN
ajlsi-1012	663	21	)	)	PUNCT
ajlsi-1012	663	22	.	.	PUNCT
ajlsi-1012	664	1	china	china	PROPN
ajlsi-1012	664	2	cdc	cdc	PROPN
ajlsi-1012	664	3	weekly	weekly	PROPN
ajlsi-1012	664	4	,	,	PUNCT
ajlsi-1012	664	5	2(8	2(8	NUM
ajlsi-1012	664	6	)	)	PUNCT
ajlsi-1012	664	7	,	,	PUNCT
ajlsi-1012	664	8	123–124	123–124	NUM
ajlsi-1012	664	9	.	.	PUNCT
ajlsi-1012	665	1	https://doi.org/10.46234/ccdcw2020.033	https://doi.org/10.46234/ccdcw2020.033	PROPN
ajlsi-1012	665	2	zhong	zhong	PROPN
ajlsi-1012	665	3	,	,	PUNCT
ajlsi-1012	665	4	n	n	CCONJ
ajlsi-1012	665	5	,	,	PUNCT
ajlsi-1012	665	6	s.	s.	PROPN
ajlsi-1012	665	7	,	,	PUNCT
ajlsi-1012	665	8	zheng	zheng	PROPN
ajlsi-1012	665	9	,	,	PUNCT
ajlsi-1012	665	10	b.	b.	PROPN
ajlsi-1012	665	11	j.	j.	PROPN
ajlsi-1012	665	12	,	,	PUNCT
ajlsi-1012	665	13	et	et	PROPN
ajlsi-1012	665	14	al	al	PROPN
ajlsi-1012	665	15	.	.	PROPN
ajlsi-1012	665	16	,	,	PUNCT
ajlsi-1012	665	17	(	(	PUNCT
ajlsi-1012	665	18	2003	2003	NUM
ajlsi-1012	665	19	)	)	PUNCT
ajlsi-1012	665	20	.	.	PUNCT
ajlsi-1012	666	1	epidemiology	epidemiology	NOUN
ajlsi-1012	666	2	and	and	CCONJ
ajlsi-1012	666	3	cause	cause	NOUN
ajlsi-1012	666	4	of	of	ADP
ajlsi-1012	666	5	severe	severe	ADJ
ajlsi-1012	666	6	acute	acute	ADJ
ajlsi-1012	666	7	respiratory	respiratory	ADJ
ajlsi-1012	666	8	syndrome	syndrome	NOUN
ajlsi-1012	666	9	(	(	PUNCT
ajlsi-1012	666	10	sars	sars	PROPN
ajlsi-1012	666	11	)	)	PUNCT
ajlsi-1012	666	12	in	in	ADP
ajlsi-1012	666	13	guangdong	guangdong	PROPN
ajlsi-1012	666	14	,	,	PUNCT
ajlsi-1012	666	15	people	people	NOUN
ajlsi-1012	666	16	’s	’s	PART
ajlsi-1012	666	17	republic	republic	PROPN
ajlsi-1012	666	18	of	of	ADP
ajlsi-1012	666	19	china	china	PROPN
ajlsi-1012	666	20	,	,	PUNCT
ajlsi-1012	666	21	the	the	DET
ajlsi-1012	666	22	lancet	lancet	NOUN
ajlsi-1012	666	23	,	,	PUNCT
ajlsi-1012	666	24	362(9393	362(9393	PROPN
ajlsi-1012	666	25	)	)	PUNCT
ajlsi-1012	666	26	,	,	PUNCT
ajlsi-1012	666	27	1353	1353	NUM
ajlsi-1012	666	28	-	-	SYM
ajlsi-1012	666	29	1358	1358	NUM
ajlsi-1012	666	30	.	.	PUNCT
ajlsi-1012	667	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
ajlsi-1012	667	2	s0140	s0140	PROPN
ajlsi-1012	667	3	-	-	PUNCT
ajlsi-1012	667	4	6736(03)14630	6736(03)14630	NUM
ajlsi-1012	667	5	-	-	PUNCT
ajlsi-1012	667	6	2	2	NUM
ajlsi-1012	667	7	zhou	zhou	NOUN
ajlsi-1012	667	8	,	,	PUNCT
ajlsi-1012	667	9	p.	p.	PROPN
ajlsi-1012	667	10	,	,	PUNCT
ajlsi-1012	667	11	yang	yang	PROPN
ajlsi-1012	667	12	,	,	PUNCT
ajlsi-1012	667	13	x.	x.	PROPN
ajlsi-1012	667	14	l.	l.	PROPN
ajlsi-1012	667	15	,	,	PUNCT
ajlsi-1012	667	16	shi	shi	PROPN
ajlsi-1012	667	17	,	,	PUNCT
ajlsi-1012	667	18	z.	z.	PROPN
ajlsi-1012	667	19	l.	l.	PROPN
ajlsi-1012	667	20	,	,	PUNCT
ajlsi-1012	667	21	et	et	PROPN
ajlsi-1012	667	22	al	al	PROPN
ajlsi-1012	667	23	.	.	PROPN
ajlsi-1012	667	24	,	,	PUNCT
ajlsi-1012	667	25	(	(	PUNCT
ajlsi-1012	667	26	2020	2020	NUM
ajlsi-1012	667	27	)	)	PUNCT
ajlsi-1012	667	28	.	.	PUNCT
ajlsi-1012	668	1	a	a	DET
ajlsi-1012	668	2	pneumonia	pneumonia	NOUN
ajlsi-1012	668	3	outbreak	outbreak	NOUN
ajlsi-1012	668	4	associated	associate	VERB
ajlsi-1012	668	5	with	with	ADP
ajlsi-1012	668	6	a	a	DET
ajlsi-1012	668	7	new	new	ADJ
ajlsi-1012	668	8	coronavirus	coronavirus	NOUN
ajlsi-1012	668	9	of	of	ADP
ajlsi-1012	668	10	probable	probable	ADJ
ajlsi-1012	668	11	bat	bat	NOUN
ajlsi-1012	668	12	origin	origin	NOUN
ajlsi-1012	668	13	.	.	PUNCT
ajlsi-1012	669	1	nature	nature	NOUN
ajlsi-1012	669	2	,	,	PUNCT
ajlsi-1012	669	3	579	579	NUM
ajlsi-1012	669	4	,	,	PUNCT
ajlsi-1012	669	5	270–273	270–273	NUM
ajlsi-1012	669	6	.	.	PUNCT
ajlsi-1012	670	1	https://	https://	PROPN
ajlsi-1012	670	2	doi.org/10.1038/s41586-020-2012-7	doi.org/10.1038/s41586-020-2012-7	PROPN
ajlsi-1012	670	3	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN